Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
Neoplasm Metastasis,135/3920,2.8937325187063956E-50,1.5420700592186382E-46,0,0,9.067937346669183,1034.3497565148525,MAML2;PROS1;CIB1;IRS2;ANTXR2;NR3C1;ETS2;AQP1;MYLK;CDH5;RPS6KA3;ZFP36;CCND2;EFEMP1;CCND1;PLAU;KDR;LEPR;SIRPA;SVEP1;TNS1;HGF;LMO2;KRT8;TAP1;LIFR;KRT5;SOX10;RUNX2;CDC25B;MAP1B;ADAM12;TXNIP;S100A4;EZR;FKBP4;UTRN;S100A8;SKAP2;CFH;EPAS1;MAGED1;LPL;PIK3R1;FBLN2;FOXO1;SOCS3;GRK3;PPP4C;MAP3K20;FADD;A2M;ABCA1;STAT5A;STAT5B;EGR1;JUN;CAV2;CAV1;PLK1;ESR1;FLI1;EFNA1;CXCL10;RCAN1;NR4A1;TF;COL1A2;CXCL12;BCL6;BCL3;CALR;FGFR3;NRP1;ARF1;TINAGL1;FHL1;PKD2;SYNE1;AKAP12;GHR;MDK;TIMP1;CD36;TEAD1;CTSD;SREBF1;ANXA1;MME;VWF;DUSP1;BGN;FOS;DCN;TGFBR2;ACTA2;MMP14;ZEB2;VCAN;KIT;PECAM1;PPARG;CRYAB;TLR4;MET;YAP1;LRP1;LAMA4;LAMA3;NEDD9;CXCR4;EGFR;MUC1;RASD1;AGR2;S1PR1;SPP1;E2F2;SNCG;CCL2;DMD;CA12;TCF7L2;GSN;STAT1;GOLM1;KLF4;PER1;KRT19;KLF6;KRT18;FABP4;LEP;SAA1;VIM
Mammary Neoplasms,109/2387,4.6467801605231956E-49,1.2381345737714054E-45,0,0,9.421412435509168,1048.5136536934972,CIB1;IRS2;ANTXR2;NR3C1;ETS2;AQP1;MYLK;EPS8;CDH5;RPS6KA3;ZFP36;RGS2;CCND2;EFEMP1;CCND1;PPP2R1B;PLAU;KDR;LEPR;HGF;KRT8;LIFR;KRT5;RUNX2;CDC25B;ADAM12;MAPKAPK2;S100A4;EZR;UTRN;S100A8;EPAS1;LPL;PIK3R1;FOXO1;SOCS3;MAP3K20;FADD;ABCA1;STAT5A;STAT5B;EGR1;JUN;CAV2;CAV1;PLK1;ESR1;EFNA1;CXCL10;NR4A1;PTPRB;COL1A2;CXCL12;BCL3;FGFR3;NRP1;ARF1;THRB;SYNE1;AKAP12;GHR;MDK;TIMP1;CD36;CTSD;SREBF1;ANXA1;MME;VWF;DUSP1;FOS;DCN;TGFBR2;ACTA2;MMP14;ZEB2;F8;VCAN;KIT;PPARG;SGK1;CRYAB;TLR4;MET;YAP1;LRP1;LAMA3;NEDD9;CXCR4;EGFR;DEPP1;MUC1;AGR2;SPP1;E2F2;SNCG;CCL2;MEST;CA12;TCF7L2;GSN;STAT1;KLF4;PER1;KRT19;KLF6;KRT18;LEP;VIM
Breast Carcinoma,145/4963,8.76543927839853E-47,1.5570341971528588E-43,0,0,8.508501922820868,902.3324379780418,PROS1;UBE2L6;CIB1;IRS2;ANTXR2;NR3C1;ETS2;AQP1;MYLK;EPS8;RGS4;CDH5;RPS6KA3;ZFP36;RGS2;CCND2;EFEMP1;CCND1;PPP2R1B;PLAU;DPYSL2;KDR;LEPR;SIRPA;SVEP1;TNS1;HGF;LMO2;KRT8;LIFR;KRT5;SOX10;RUNX2;CDC25B;MAF;ADAM12;TXNIP;S100A4;PRTN3;EZR;FKBP4;UTRN;S100A8;EPAS1;PIK3R1;FBLN2;FOXO1;C3;SOCS3;GRK3;PPP4C;MAP3K20;FADD;A2M;ABCA1;STAT5A;STAT5B;EGR1;JUN;CAV2;CAV1;PLK1;ESR1;FLI1;EFNA1;CXCL10;NR4A1;TF;CXCL12;BCL6;BCL3;CALR;BMPR1B;FGFR3;NRP1;ARF1;TINAGL1;THRB;FHL1;PKD2;PRSS23;SYNE1;AKAP12;GHR;ALDH2;MDK;ELOB;TIMP1;CD36;TEAD1;CTSD;SREBF1;ANXA1;MME;DST;VWF;DUSP1;BGN;FOS;DCN;TGFBR2;ACTA2;MMP14;ZEB2;F8;VCAN;DNAJC1;KIT;PECAM1;PPARG;SGK1;CRYAB;TLR4;MET;RHOQ;YAP1;LRP1;NEDD9;CXCR4;EGFR;DEPP1;MUC1;RASD1;AGR2;S1PR1;SPP1;E2F2;SNCG;CCL2;MEST;CA12;TCF7L2;GSN;STAT1;SORBS1;KLF4;PER1;KRT19;KLF6;KRT18;FABP4;LEP;KRT15;TACC1;VIM
Glioblastoma,97/1937,6.465147030183754E-46,8.613192130962307E-43,0,0,9.375344382264313,975.5279137372901,ITSN1;CIB1;IRS2;ETS2;AQP1;EPS8;CDH5;ZFP36;CCND2;EFEMP1;CCND1;PLAU;KDR;LEPR;SIRPA;TNS2;TNS1;TPM3;HGF;LMO2;TAP1;LIFR;RUNX2;CDC25B;ADAM12;MAPKAPK2;S100A4;EZR;CFH;EPAS1;DTX1;PIK3R1;FOXO1;SOCS3;GRK3;MAP3K20;FADD;STAT5A;STAT5B;EGR1;JUN;CAV2;ZBTB16;CAV1;PLK1;ESR1;CXCL10;RCAN1;NR4A1;TF;CXCL12;BCL6;AMOTL2;CALR;BMPR1B;FGFR3;NRP1;FHL1;LAMC1;PKD2;MDK;TIMP1;CD36;TEAD1;CTSD;SREBF1;ANXA1;DUSP1;FOS;DCN;TGFBR2;MMP14;ZEB2;KIT;PECAM1;PPARG;SGK1;CRYAB;TLR4;MET;YAP1;LRP1;LAMA3;NEDD9;CXCR4;EGFR;DEPP1;RASD1;S1PR1;SPP1;CCL2;GSN;STAT1;KLF4;KLF6;LEP;VIM
Malignant neoplasm of breast,140/5054,2.620295112811645E-41,2.792710531234651E-38,0,0,7.313095588957658,683.3554108134821,PROS1;UBE2L6;CIB1;IRS2;ANTXR2;NR3C1;ETS2;AQP1;MYLK;EPS8;RGS4;CDH5;RPS6KA3;ZFP36;RGS2;CCND2;EFEMP1;CCND1;PPP2R1B;PLAU;KDR;LEPR;SIRPA;TNS1;HGF;LMO2;KRT8;RFX2;ANK2;LIFR;KRT5;SOX10;RUNX2;CDC25B;ADAM12;TXNIP;S100A4;PRTN3;EZR;FKBP4;UTRN;S100A8;EPAS1;LPL;PIK3R1;FBLN2;FOXO1;C3;SOCS3;GRK3;PPP4C;MAP3K20;FADD;A2M;ABCA1;STAT5A;STAT5B;EGR1;JUN;CAV2;CAV1;PLK1;ESR1;FLI1;EFNA1;CXCL10;NR4A1;TF;CXCL12;BCL6;BCL3;CALR;BMPR1B;FGFR3;NRP1;ARF1;TINAGL1;THRB;PRSS23;SYNE1;AKAP12;GHR;ALDH2;MDK;TIMP1;CD36;CTSD;SREBF1;ANXA1;MME;DST;VWF;DUSP1;BGN;FOS;DCN;TGFBR2;ACTA2;MMP14;ZEB2;F8;VCAN;KIT;PECAM1;PPARG;SGK1;CRYAB;TLR4;MET;RHOQ;YAP1;LRP1;LAMA3;NEDD9;CXCR4;EGFR;DEPP1;MUC1;RASD1;AGR2;S1PR1;SPP1;E2F2;SNCG;CCL2;DMD;CA12;TCF7L2;GSN;STAT1;SORBS1;KLF4;PER1;KRT19;KLF6;KRT18;FABP4;LEP;TACC1;VIM
Liver carcinoma,120/3593,5.961370165304927E-41,5.294690268484992E-38,0,0,7.233382799176061,669.9608947876283,CIB1;IRS2;NR3C1;ETS2;RPS6KA3;ZFP36;CCND2;EFEMP1;CCND1;PPP2R1B;PLAU;KDR;LEPR;TNS1;MEF2C;TPM3;HGF;KRT8;TAP1;LIFR;KRT5;SOX10;RUNX2;CDC25B;ADAM12;SERPING1;TXNIP;S100A4;EZR;FKBP4;S100A8;EPAS1;LPL;PIK3R1;FOXO1;C3;SOCS3;FADD;A2M;SPTBN1;ABCA1;STAT5A;STAT5B;EGR1;JUN;CAV1;PLK1;ESR1;EFNA1;CXCL10;NR4A1;TF;COL1A2;CXCL12;CALR;FGFR3;NRP1;SNAP25;TINAGL1;THRB;LAMC1;MEOX2;PKD2;SYNE1;AKAP12;GHR;ALDH2;MDK;ELOB;TIMP1;CD36;TEAD1;CTSD;CCT3;SREBF1;ANXA1;MME;DUSP1;BGN;FOS;DCN;TGFBR2;MMP14;ZEB2;VCAN;KIT;PECAM1;PPARG;SGK1;CRYAB;TLR4;MET;MATN2;YAP1;LRP1;LAMA4;NEDD9;CXCR4;EGFR;MUC1;AGR2;S1PR1;SPP1;E2F2;SNCG;CCL2;MEST;TCF7L2;GSN;STAT1;GOLM1;SORBS1;KLF4;PER1;KRT19;KLF6;KRT18;LEP;SAA1;VIM
Malignant neoplasm of prostate,114/3239,2.078560350678553E-40,1.582378301252287E-37,0,0,7.242582857142857,661.7673123234872,PROS1;ITSN1;F13A1;CIB1;IRS2;ANTXR2;NR3C1;ETS2;AQP1;MYLK;RPS6KA3;ZFP36;RGS2;CCND2;EFEMP1;CCND1;PLAU;KDR;LEPR;TNS1;HGF;LMO2;KRT8;TAP1;LIFR;RUNX2;CDC25B;MAPKAPK2;TXNIP;S100A4;EZR;FKBP4;S100A8;EPAS1;LPL;PIK3R1;FOXO1;SOCS3;GRK3;FADD;A2M;ABCA1;STAT5A;STAT5B;EGR1;JUN;FZD4;CAV2;ZBTB16;CAV1;PLK1;ESR1;FLI1;QKI;EFNA1;NR4A1;TF;CXCL12;BCL3;CALR;BMPR1B;FGFR3;NRP1;ARF1;LAMC1;AKAP12;GHR;MDK;TIMP1;TEAD1;CTSD;SREBF1;ANXA1;MME;DST;DUSP1;BGN;FOS;DCN;TGFBR2;MMP14;ZEB2;VCAN;KIT;PECAM1;PPARG;SGK1;CRYAB;TLR4;MET;YAP1;LRP1;LAMA3;NEDD9;CXCR4;EGFR;MUC1;RASD1;AGR2;SPP1;E2F2;CCL2;TCF7L2;GSN;STAT1;GOLM1;KLF4;PER1;KRT19;KLF6;KRT18;FABP4;LEP;VIM
Carcinogenesis,126/4065,2.575120862389043E-40,1.7153523844589013E-37,0,0,7.0475374460522975,642.4359458324366,MAML2;ITSN1;CIB1;IRS2;NR3C1;ETS2;AQP1;EPS8;RGS4;RPS6KA3;ZFP36;RGS2;CCND2;EFEMP1;CCND1;PPP2R1B;PLAU;DPYSL2;KDR;LEPR;TNS1;HGF;LMO2;KRT8;TAP1;LIFR;KRT5;SOX10;RUNX2;CDC25B;MAF;MAPKAPK2;TXNIP;S100A4;EZR;FKBP4;S100A8;COL17A1;CFH;EPAS1;MAGED1;PIK3R1;FOXO1;SOCS3;PRKAR2B;MAP3K20;FADD;SPTBN1;ABCA1;STAT5A;STAT5B;EGR1;JUN;FZD4;CAV2;ZBTB16;CAV1;PLK1;ESR1;FLI1;QKI;EFNA1;CXCL10;RCAN1;NR4A1;PTPRB;COL1A2;CXCL12;BCL6;BCL3;CALR;FGFR3;NRP1;THRB;FHL1;AKAP12;ALDH2;MDK;ELOB;TIMP1;CD36;TEAD1;CTSD;SREBF1;ANXA1;MME;DUSP1;BGN;FOS;DCN;TGFBR2;MMP14;ZEB2;VCAN;KIT;PECAM1;PPARG;SGK1;CRYAB;TLR4;MET;YAP1;PPP1R15A;LRP1;NEDD9;CXCR4;EGFR;MUC1;RASD1;AGR2;SPP1;E2F2;SNCG;CCL2;TCF7L2;GSN;STAT1;GOLM1;SORBS2;KLF4;PER1;KRT19;KLF6;FABP4;LEP;VIM
Glioma,95/2211,4.458524080380114E-39,2.639941647149514E-36,0,0,7.709040688604621,680.7545535172288,NRP1;MAML2;ITSN1;CIB1;NR3C1;PKD2;AQP1;MYLK;AKAP12;RGS4;CDH5;ZFP36;CCND2;EFEMP1;CCND1;PLAU;MDK;KDR;LEPR;TIMP1;TEAD1;CTSD;ANXA1;MME;DUSP1;TPM3;HGF;LMO2;TAP1;FOS;SOX10;RUNX2;DCN;CDC25B;TGFBR2;MMP14;ZEB2;VCAN;MAP1B;KIT;MAPKAPK2;PECAM1;SERPING1;PPARG;S100A4;EZR;SGK1;CRYAB;TLR4;MET;ARHGEF6;YAP1;PPP1R15A;LRP1;CFH;EPAS1;MAGED1;LAMA4;NEDD9;CXCR4;DTX1;PIK3R1;EGFR;FOXO1;SOCS3;PPP4C;SPP1;E2F2;CCL2;DMD;FADD;ABCA1;EGR1;TCF7L2;JUN;GSN;FZD4;STAT1;CAV2;ZBTB16;CAV1;PLK1;KLF4;ESR1;QKI;EFNA1;PER1;CXCL10;KLF6;CXCL12;BCL6;LEP;VIM;CALR;FGFR3
Prostatic Neoplasms,80/1554,1.888541254398011E-37,9.753625653660198E-35,0,0,8.429961134236368,712.836196184493,NRP1;PROS1;ITSN1;CIB1;LAMC1;ANTXR2;NR3C1;AKAP12;GHR;RPS6KA3;ZFP36;RGS2;CCND2;CCND1;PLAU;KDR;LEPR;TIMP1;TEAD1;CTSD;SREBF1;ANXA1;MME;TPM3;HGF;KRT8;TAP1;LIFR;FOS;RUNX2;DCN;CDC25B;TGFBR2;MMP14;VCAN;MAPKAPK2;PECAM1;TXNIP;PPARG;EZR;FKBP4;CRYAB;TLR4;MET;YAP1;EPAS1;CXCR4;LPL;PIK3R1;EGFR;FOXO1;SOCS3;MUC1;GRK3;RASD1;AGR2;SPP1;CCL2;A2M;STAT5A;STAT5B;EGR1;TCF7L2;JUN;STAT1;GOLM1;CAV2;ZBTB16;CAV1;PLK1;ESR1;CXCL10;NR4A1;KLF6;CXCL12;LEP;VIM;CALR;BMPR1B;FGFR3
Prostate carcinoma,109/3145,2.0133211144729253E-37,9.753625653660198E-35,0,0,6.763386182291898,571.4781508309779,PROS1;F13A1;CIB1;IRS2;ANTXR2;NR3C1;ETS2;AQP1;MYLK;RPS6KA3;ZFP36;RGS2;CCND2;EFEMP1;CCND1;PLAU;KDR;LEPR;TNS1;HGF;LMO2;KRT8;TAP1;RUNX2;CDC25B;MAPKAPK2;TXNIP;S100A4;EZR;FKBP4;S100A8;EPAS1;MAGED1;LPL;PIK3R1;FOXO1;SOCS3;GRK3;FADD;A2M;ABCA1;STAT5A;STAT5B;EGR1;JUN;FZD4;ZBTB16;CAV1;PLK1;ESR1;FLI1;QKI;EFNA1;NR4A1;TF;CXCL12;BCL3;CALR;FGFR3;NRP1;ARF1;FHL1;LAMC1;AKAP12;GHR;MDK;TIMP1;TEAD1;CTSD;SREBF1;ANXA1;MME;DST;DUSP1;BGN;FOS;DCN;TGFBR2;MMP14;ZEB2;VCAN;KIT;PECAM1;PPARG;SGK1;TLR4;MET;YAP1;LRP1;NEDD9;CXCR4;EGFR;MUC1;AGR2;SPP1;E2F2;CCL2;TCF7L2;GSN;STAT1;GOLM1;KLF4;PER1;KRT19;KLF6;KRT18;FABP4;LEP;VIM
Malignant neoplasm of pancreas,86/1846,2.3613257861787766E-37,1.048625426212225E-34,0,0,7.87140827922078,663.8464356038219,NRP1;CIB1;IRS2;PKD2;ETS2;EPS8;GHR;CDH5;ZFP36;CCND2;EFEMP1;CCND1;ALDH2;PLAU;MDK;KDR;TIMP1;TEAD1;CTSD;SREBF1;MME;DUSP1;HGF;LMO2;KRT8;BGN;FOS;RUNX2;DCN;CDC25B;TGFBR2;MMP14;ZEB2;MAPKAPK2;PECAM1;TXNIP;PPARG;S100A4;EZR;FKBP4;UTRN;TLR4;MET;S100A8;YAP1;LRP1;EPAS1;MAGED1;NEDD9;CXCR4;FBLN2;EGFR;FOXO1;C3;SOCS3;MUC1;MAP3K20;AGR2;SPP1;SNCG;CCL2;DMD;FADD;ABCA1;STAT5B;EGR1;TCF7L2;JUN;GSN;STAT1;CAV1;PLK1;SORBS2;KLF4;ESR1;PER1;CXCL10;NR4A1;TF;KRT19;KRT18;CXCL12;LEP;VIM;CALR;FGFR3
Pancreatic carcinoma,86/1869,6.104049119331383E-37,2.502190596685918E-34,0,0,7.759965147023475,647.0778554595548,NRP1;SNAP25;CIB1;IRS2;PKD2;ETS2;EPS8;GHR;CDH5;ZFP36;CCND2;EFEMP1;CCND1;ALDH2;PLAU;MDK;KDR;TIMP1;TEAD1;CTSD;SREBF1;MME;DUSP1;HGF;LMO2;KRT8;BGN;FOS;RUNX2;DCN;CDC25B;TGFBR2;MMP14;ZEB2;MAPKAPK2;PECAM1;TXNIP;PPARG;S100A4;EZR;FKBP4;UTRN;TLR4;MET;S100A8;YAP1;EPAS1;MAGED1;NEDD9;CXCR4;FBLN2;EGFR;FOXO1;C3;SOCS3;MUC1;MAP3K20;AGR2;SPP1;SNCG;CCL2;DMD;FADD;STAT5B;EGR1;TCF7L2;JUN;GSN;STAT1;CAV1;PLK1;SORBS2;KLF4;ESR1;PER1;CXCL10;NR4A1;TF;KRT19;KRT18;CXCL12;BCL6;LEP;VIM;CALR;FGFR3
Tumor Progression,89/2090,8.216235106106699E-36,3.1274512057459004E-33,0,0,7.263748859515196,586.8161250780101,NRP1;PROS1;CIB1;IRS2;LAMC1;PRSS23;ETS2;EPS8;AKAP12;RGS4;RPS6KA3;ZFP36;CCND2;EFEMP1;CCND1;PLAU;MDK;KDR;LEPR;TIMP1;CTSD;SREBF1;ANXA1;MME;VWF;DUSP1;TPM3;HGF;LMO2;KRT8;BGN;FOS;RUNX2;DCN;TGFBR2;MMP14;ZEB2;VCAN;ADAM12;KIT;PPARG;S100A4;PRTN3;EZR;SGK1;TLR4;MET;S100A8;YAP1;LRP1;EPAS1;LAMA4;NEDD9;CXCR4;EGFR;SOCS3;MUC1;PPP4C;AGR2;SPP1;SNCG;CCL2;DMD;STAT5A;CA12;STAT5B;EGR1;JUN;FZD4;STAT1;CAV2;CAV1;PLK1;KLF4;ESR1;FLI1;EFNA1;PER1;CXCL10;NR4A1;KRT19;KLF6;KRT18;CXCL12;LEP;SAA1;VIM;CALR;FGFR3
Colon Carcinoma,88/2091,6.154421348195643E-35,2.1864607576356387E-32,0,0,7.108936595107339,559.9944484958529,NRP1;PROS1;FHL1;CIB1;IRS2;NR3C1;PKD2;ETS2;AQP1;EPS8;GHR;RPS6KA3;ZFP36;CCND1;PPP2R1B;PLAU;MDK;DPYSL2;KDR;LEPR;TIMP1;CD36;CTSD;MME;VWF;TPM3;HGF;KRT8;BGN;TAP1;LIFR;FOS;RUNX2;DCN;TGFBR2;MMP14;ZEB2;KIT;PECAM1;PPARG;S100A4;EZR;SGK1;FKBP4;TLR4;MET;YAP1;LRP1;CFH;EPAS1;NEDD9;CXCR4;PIK3R1;EGFR;FOXO1;SOCS3;MUC1;MAP3K20;SPP1;CCL2;MEST;SPTBN1;ABCA1;STAT5A;EGR1;TCF7L2;JUN;GSN;STAT1;CAV1;PLK1;SORBS1;KLF4;ESR1;FLI1;EFNA1;PER1;CXCL10;NR4A1;KRT19;KRT18;CXCL12;LEP;SAA1;AMOTL2;VIM;CALR;FGFR3
Malignant neoplasm of lung,94/2449,1.5525911726137736E-34,5.171098974286749E-32,0,0,6.69613751429038,521.2806982823673,NRP1;F13A1;CIB1;IRS2;MEOX2;NR3C1;ETS2;AQP1;MYLK;RPS6KA3;ZFP36;CCND2;EFEMP1;CCND1;PPP2R1B;ALDH2;PLAU;MDK;DPYSL2;KDR;LEPR;TIMP1;TEAD1;CTSD;ANXA1;MME;DST;DUSP1;HGF;KRT8;TAP1;KRT5;FOS;CDC25B;TGFBR2;MMP14;ZEB2;MAP1B;KIT;MAPKAPK2;PECAM1;SERPING1;TXNIP;PPARG;S100A4;EZR;TLR4;MET;S100A8;SKAP2;YAP1;LRP1;CFH;EPAS1;MAGED1;NEDD9;CXCR4;PIK3R1;EGFR;FOXO1;SOCS3;MUC1;MAP3K20;AGR2;SPP1;E2F2;SNCG;CCL2;FADD;A2M;STAT5A;CA12;STAT5B;EGR1;TCF7L2;JUN;GSN;STAT1;ZBTB16;CAV1;PLK1;KLF4;ESR1;QKI;EFNA1;PER1;NR4A1;KRT19;KLF6;KRT18;CXCL12;LEP;VIM;FGFR3
Vascular Diseases,45/401,1.7557059135795153E-34,5.427403365610921E-32,0,0,16.065763384005287,1248.7118149715336,CFH;CXCR4;LPL;CIB1;PKD2;EGFR;MYLK;SOCS3;ALDH2;KDR;S1PR1;SPP1;CCL2;DMD;TIMP1;ABCA1;STAT5A;STAT5B;EGR1;JUN;VWF;STAT1;HGF;CAV1;KRT8;BGN;FOS;KLF4;ESR1;FLI1;TGFBR2;ACTA2;NR4A1;MMP14;VCAN;FABP4;CXCL12;LEP;PECAM1;TXNIP;PPARG;S100A4;SGK1;TLR4;S100A8
melanoma,94/2454,1.8332381418839669E-34,5.427403365610921E-32,0,0,6.680035853976532,518.9172712067561,NRP1;TINAGL1;MAML2;CIB1;PRSS23;AQP1;SYNE1;GHR;CDH5;ZFP36;CCND1;PLAU;KDR;LEPR;TIMP1;CD36;TEAD1;CTSD;TNS1;ANXA1;MME;DST;VWF;DUSP1;HGF;BGN;TAP1;LIFR;FOS;SOX10;RUNX2;DCN;TGFBR2;MMP14;ZEB2;VCAN;DNAJC1;KIT;PECAM1;TXNIP;PPARG;S100A4;PRTN3;FKBP4;UTRN;TLR4;MET;SKAP2;YAP1;PPP1R15A;LRP1;EPAS1;MAGED1;NEDD9;CXCR4;LPL;EGFR;FOXO1;SOCS3;MUC1;GNG2;RASD1;SPP1;CCL2;DMD;FADD;A2M;ABCA1;STAT5B;EGR1;TCF7L2;JUN;GSN;FZD4;STAT1;ZBTB16;CAV1;PLK1;KLF4;ESR1;FLI1;EFNA1;CXCL10;RCAN1;NR4A1;TF;KLF6;CXCL12;BCL6;LEP;BCL3;VIM;CALR;FGFR3
Ovarian Carcinoma,89/2203,4.974956621275361E-34,1.3953444123566524E-31,0,0,6.831833213265864,523.888721733582,NRP1;PROS1;CIB1;IRS2;NR3C1;ETS2;AQP1;SYNE1;EPS8;AKAP12;RPS6KA3;RGS2;CCND2;EFEMP1;CCND1;PPP2R1B;ALDH2;PLAU;MDK;KDR;LEPR;SIRPA;TIMP1;TEAD1;CTSD;DST;DUSP1;HGF;KRT8;LIFR;KRT5;FOS;RUNX2;DCN;TGFBR2;MMP14;ZEB2;VCAN;ADAM12;KIT;PECAM1;PPARG;S100A4;SGK1;CRYAB;TLR4;MET;YAP1;PPP1R15A;LRP1;EPAS1;LAMA3;NEDD9;CXCR4;PIK3R1;EGFR;FOXO1;C3;MUC1;AGR2;SPP1;E2F2;SNCG;CCL2;FADD;MEST;ABCA1;STAT5A;STAT5B;EGR1;TCF7L2;JUN;STAT1;ZBTB16;CAV1;PLK1;KLF4;ESR1;EFNA1;KLF6;KRT18;FABP4;CXCL12;BCL6;LEP;BCL3;VIM;CALR;BMPR1B
Colorectal Cancer,106/3298,4.17150048940503E-33,1.1114963054019701E-30,0,0,5.99549144600632,447.0060492031451,PROS1;CIB1;IRS2;ANTXR2;NR3C1;ETS2;EPS8;CDH5;RPS6KA3;CCND2;EFEMP1;CCND1;PPP2R1B;PLAU;DPYSL2;KDR;LEPR;TNS1;TPM3;HGF;KRT8;TAP1;ANK2;LIFR;RUNX2;MAF;MAP1B;S100A4;EZR;S100A8;EPAS1;FBLN2;SOCS3;FADD;SPTBN1;ABCA1;STAT5A;STAT5B;EGR1;JUN;FZD4;CAV2;ZBTB16;CAV1;PLK1;ESR1;QKI;EFNA1;CXCL10;RCAN1;NR4A1;CXCL12;CALR;FGFR3;NRP1;LAMC1;PKD2;SYNE1;AKAP12;GHR;ALDH2;MDK;TIMP1;CD36;CTSD;CCT3;ANXA1;MME;DUSP1;BGN;FOS;DCN;TGFBR2;MMP14;ZEB2;VCAN;KIT;PECAM1;PPARG;SGK1;CRYAB;TLR4;MET;RHOQ;YAP1;LRP1;NEDD9;CXCR4;EGFR;MUC1;AGR2;SPP1;E2F2;SNCG;CCL2;DMD;TCF7L2;GSN;STAT1;SORBS1;KLF4;PER1;KRT19;KLF6;LEP;VIM
Malignant neoplasm of urinary bladder,65/1144,3.2100998369723283E-32,8.14601049105978E-30,0,0,8.48038771627865,614.9673653450915,NRP1;SNAP25;CIB1;NR3C1;ETS2;MYLK;RGS4;RGS2;EFEMP1;CCND1;ALDH2;PLAU;MDK;KDR;TIMP1;TEAD1;CTSD;ANXA1;HGF;BGN;KRT5;FOS;SOX10;DCN;MMP14;ZEB2;VCAN;ADAM12;MAPKAPK2;TXNIP;PPARG;S100A4;PRTN3;TLR4;MET;S100A8;YAP1;EPAS1;CXCR4;PIK3R1;EGFR;FOXO1;MUC1;AGR2;CCL2;EGR1;JUN;GSN;FZD4;STAT1;CAV2;CAV1;PLK1;KLF4;ESR1;EFNA1;CXCL10;KRT19;COL1A2;FABP4;CXCL12;KRT15;VIM;CALR;FGFR3
Malignant tumor of colon,83/2001,3.740602271917418E-32,9.060758866839964E-30,0,0,6.729709389309516,486.98516618234436,NRP1;FHL1;CIB1;IRS2;NR3C1;PKD2;ETS2;AQP1;EPS8;GHR;RPS6KA3;ZFP36;CCND2;CCND1;PPP2R1B;PLAU;MDK;KDR;LEPR;TIMP1;CD36;MME;TPM3;HGF;KRT8;BGN;TAP1;LIFR;FOS;RUNX2;DCN;TGFBR2;ACTA2;MMP14;ZEB2;KIT;PPARG;S100A4;EZR;CRYAB;TLR4;MET;YAP1;CFH;EPAS1;NEDD9;CXCR4;LPL;PIK3R1;EGFR;FOXO1;C3;SOCS3;MUC1;MAP3K20;SPP1;CCL2;A2M;MEST;SPTBN1;STAT5A;EGR1;TCF7L2;JUN;GSN;STAT1;CAV1;PLK1;SORBS1;KLF4;ESR1;FLI1;PER1;CXCL10;NR4A1;KRT19;CXCL12;LEP;SAA1;AMOTL2;VIM;CALR;FGFR3
Adenocarcinoma,77/1712,7.716210420358321E-32,1.7878124056560648E-29,0,0,7.070836808451487,506.55050370118136,NRP1;SNAP25;THRB;MAML2;PROS1;CIB1;NR3C1;ETS2;AQP1;SYNE1;CCND2;EFEMP1;CCND1;ALDH2;PLAU;KDR;TIMP1;CTSD;ANXA1;MME;DST;DUSP1;TPM3;HGF;KRT8;KRT5;FOS;RUNX2;TGFBR2;ACTA2;MMP14;ADAM12;KIT;PECAM1;PPARG;S100A4;TLR4;MET;S100A8;SKAP2;YAP1;COL17A1;LRP1;CFH;EPAS1;LAMA3;CXCR4;LPL;FBLN2;EGFR;SOCS3;MUC1;AGR2;SPP1;CCL2;FADD;MEST;STAT5A;STAT5B;EGR1;TCF7L2;JUN;GSN;STAT1;CAV1;PLK1;ESR1;EFNA1;KRT19;KLF6;KRT18;FABP4;CXCL12;LEP;VIM;CALR;FGFR3
Brain Neoplasms,51/646,1.2132199395907655E-31,2.693853774199662E-29,0,0,11.199416909620991,797.2513230733855,NRP1;LAMC1;CCND2;EFEMP1;CCND1;PLAU;MDK;KDR;SIRPA;TIMP1;HGF;KRT5;SOX10;DCN;TGFBR2;MMP14;VCAN;KIT;PECAM1;TXNIP;PPARG;S100A4;CRYAB;MET;YAP1;EPAS1;MAGED1;LAMA4;CXCR4;PIK3R1;EGFR;FOXO1;SOCS3;SPP1;CCL2;DMD;FADD;STAT5A;STAT5B;EGR1;TCF7L2;STAT1;CAV1;ESR1;NR4A1;TF;KLF6;CXCL12;BCL6;LEP;VIM
leukemia,81/1941,1.9438871160902085E-31,4.1435897766578887E-29,0,0,6.678163771712159,472.249344578947,NRP1;SNAP25;THRB;PROS1;UBE2L6;CIB1;NR3C1;ETS2;SYNE1;RPS6KA3;ZFP36;CCND2;CCND1;KDR;LEPR;CD36;TEAD1;TNS1;MEF2C;ANXA1;MME;DUSP1;TPM3;HGF;LMO2;LIFR;FOS;SOX10;RUNX2;TGFBR2;ZEB2;KIT;PECAM1;TXNIP;PPARG;S100A4;PRTN3;EZR;TLR4;MET;S100A8;YAP1;COL17A1;LRP1;EPAS1;NEDD9;CXCR4;PIK3R1;EGFR;C3;SOCS3;MUC1;SPP1;CCL2;ABCA1;STAT5A;STAT5B;EGR1;TCF7L2;JUN;GSN;STAT1;ZBTB16;CAV1;PLK1;KLF4;ESR1;FLI1;PER1;CXCL10;RCAN1;NR4A1;TF;KRT19;CXCL12;BCL6;LEP;BCL3;VIM;CALR;FGFR3
Bladder Neoplasm,65/1217,1.2056825929061117E-30,2.4711855913833343E-28,0,0,7.91203268588137,545.0639424672677,NRP1;SNAP25;CIB1;NR3C1;ETS2;MYLK;RGS4;RGS2;CCND1;ALDH2;PLAU;MDK;KDR;LEPR;TIMP1;TEAD1;CTSD;ANXA1;MME;HGF;BGN;KRT5;FOS;SOX10;DCN;MMP14;ZEB2;VCAN;MAPKAPK2;TXNIP;PPARG;S100A4;PRTN3;TLR4;MET;S100A8;YAP1;EPAS1;CXCR4;PIK3R1;EGFR;FOXO1;MUC1;AGR2;SNCG;CCL2;EGR1;JUN;GSN;FZD4;STAT1;CAV2;CAV1;PLK1;KLF4;ESR1;EFNA1;CXCL10;KRT19;COL1A2;FABP4;CXCL12;VIM;CALR;FGFR3
Osteosarcoma,62/1103,2.3430270020020218E-30,4.6244410717291755E-28,0,0,8.21595468158445,560.5426205142538,CIB1;NR3C1;ETS2;AQP1;GHR;RPS6KA3;EFEMP1;CCND1;PLAU;MDK;KDR;TIMP1;CD36;TEAD1;CTSD;ANXA1;VWF;DUSP1;HGF;BGN;FOS;RUNX2;DCN;ACTA2;MMP14;ZEB2;VCAN;KIT;PPARG;S100A4;EZR;CRYAB;MET;S100A8;YAP1;LRP1;EPAS1;CXCR4;LPL;DTX1;EGFR;FOXO1;SOCS3;SPP1;E2F2;CCL2;FADD;EGR1;JUN;GSN;CAV2;CAV1;PLK1;KLF4;ESR1;EFNA1;KRT19;KLF6;COL1A2;CXCL12;BCL6;FGFR3
Carcinoma of lung,89/2476,3.7732735563824644E-30,7.181348136415055E-28,0,0,5.957095582724467,403.59090155556413,NRP1;F13A1;CIB1;IRS2;MEOX2;NR3C1;ETS2;AQP1;MYLK;RPS6KA3;ZFP36;CCND2;EFEMP1;CCND1;PPP2R1B;ALDH2;PLAU;MDK;DPYSL2;KDR;LEPR;TIMP1;TEAD1;CTSD;ANXA1;DST;VWF;DUSP1;HGF;KRT8;TAP1;KRT5;CDC25B;TGFBR2;MMP14;ZEB2;MAP1B;KIT;MAPKAPK2;PECAM1;TXNIP;PPARG;S100A4;EZR;TLR4;MET;S100A8;SKAP2;YAP1;LRP1;CFH;EPAS1;MAGED1;NEDD9;CXCR4;PIK3R1;EGFR;FOXO1;SOCS3;MUC1;MAP3K20;AGR2;SPP1;E2F2;SNCG;CCL2;ABCA1;STAT5B;EGR1;TCF7L2;JUN;GSN;STAT1;ZBTB16;CAV1;PLK1;KLF4;ESR1;QKI;EFNA1;PER1;NR4A1;KRT19;KLF6;KRT18;CXCL12;LEP;VIM;FGFR3
Carcinoma of bladder,63/1162,5.4012776173006764E-30,9.70355399613559E-28,0,0,7.941825902335457,535.2069323446354,NRP1;SNAP25;CIB1;NR3C1;ETS2;MYLK;RGS4;RGS2;CCND1;ALDH2;MDK;KDR;TIMP1;TEAD1;CTSD;ANXA1;HGF;KRT8;BGN;KRT5;FOS;SOX10;DCN;MMP14;ZEB2;VCAN;MAPKAPK2;TXNIP;PPARG;S100A4;PRTN3;TLR4;MET;S100A8;YAP1;EPAS1;CXCR4;PIK3R1;EGFR;FOXO1;MUC1;AGR2;CCL2;EGR1;JUN;GSN;FZD4;STAT1;CAV2;CAV1;PLK1;KLF4;ESR1;EFNA1;CXCL10;KRT19;COL1A2;KRT18;FABP4;CXCL12;VIM;CALR;FGFR3
Alzheimer's Disease,80/1982,5.462687556465898E-30,9.70355399613559E-28,0,0,6.380438075888003,429.9114412715594,SNAP25;ITSN1;F13A1;CIB1;IRS2;LAMC1;MEOX2;NR3C1;ETS2;AQP1;SYNE1;RGS4;RGS2;CCND1;ALDH2;PLAU;MDK;DPYSL2;TIMP1;CD36;CTSD;MEF2C;ANXA1;MME;DST;VWF;HGF;LIFR;FOS;DCN;CDC25B;TGFBR2;MMP14;VCAN;MAP1B;MAPKAPK2;PECAM1;SERPING1;PPARG;FKBP4;UTRN;CRYAB;TLR4;MET;S100A8;PPP1R15A;CCL11;LRP1;CFH;NEDD9;CXCR4;LPL;EGFR;FOXO1;C3;SOCS3;SNCG;CCL2;DMD;A2M;SPTBN1;ABCA1;EGR1;JUN;GSN;FZD4;STAT1;GOLM1;CAV1;PLK1;ESR1;PER1;RCAN1;TF;CXCL12;LEP;BCL3;VIM;CALR;FGFR3
Primary malignant neoplasm of lung,85/2268,7.71289732976687E-30,1.325871931300892E-27,0,0,6.071108606731825,406.9746945016901,NRP1;F13A1;CIB1;IRS2;MEOX2;NR3C1;ETS2;AQP1;MYLK;RPS6KA3;ZFP36;EFEMP1;CCND1;ALDH2;PLAU;MDK;DPYSL2;KDR;LEPR;TIMP1;TEAD1;CTSD;ANXA1;DST;DUSP1;HGF;KRT8;TAP1;KRT5;CDC25B;TGFBR2;MMP14;ZEB2;MAP1B;KIT;MAPKAPK2;PECAM1;TXNIP;PPARG;EZR;TLR4;MET;S100A8;SKAP2;YAP1;LRP1;CFH;EPAS1;MAGED1;NEDD9;CXCR4;PIK3R1;EGFR;FOXO1;SOCS3;MUC1;MAP3K20;AGR2;SPP1;E2F2;SNCG;CCL2;ABCA1;STAT5B;EGR1;TCF7L2;JUN;GSN;STAT1;ZBTB16;CAV1;PLK1;KLF4;ESR1;QKI;EFNA1;PER1;NR4A1;KRT19;KLF6;KRT18;CXCL12;LEP;VIM;FGFR3
Colorectal Carcinoma,96/2931,8.424416818529217E-30,1.4029286633106936E-27,0,0,5.632783483763876,377.0946806285913,NRP1;CIB1;IRS2;ANTXR2;PKD2;ETS2;AQP1;SYNE1;EPS8;AKAP12;GHR;CDH5;RPS6KA3;ZFP36;CCND2;EFEMP1;CCND1;PPP2R1B;ALDH2;PLAU;MDK;KDR;LEPR;TIMP1;CTSD;TNS1;CCT3;ANXA1;MME;DUSP1;TPM3;HGF;BGN;TAP1;LIFR;FOS;RUNX2;DCN;TGFBR2;MMP14;ZEB2;VCAN;KIT;PECAM1;PPARG;S100A4;EZR;SGK1;CRYAB;TLR4;MET;RHOQ;S100A8;YAP1;LRP1;EPAS1;NEDD9;CXCR4;FBLN2;EGFR;SOCS3;MUC1;PPP4C;AGR2;SPP1;E2F2;SNCG;CCL2;FADD;SPTBN1;ABCA1;STAT5A;STAT5B;EGR1;TCF7L2;JUN;GSN;STAT1;ZBTB16;CAV1;PLK1;SORBS1;KLF4;ESR1;EFNA1;PER1;CXCL10;RCAN1;NR4A1;KRT19;KLF6;CXCL12;LEP;VIM;CALR;FGFR3
Myocardial Infarction,58/966,8.935704475459874E-30,1.4429808833250203E-27,0,0,8.620610446821901,576.6110622950308,NRP1;PROS1;F13A1;NR3C1;MYLK;CCND1;ALDH2;PLAU;MDK;SIRPA;SVEP1;TIMP1;CD36;TEAD1;CTSD;MEF2C;VWF;HGF;BGN;ANK2;LIFR;DCN;TGFBR2;ACTA2;MMP14;VCAN;KIT;PECAM1;PPARG;TLR4;MET;YAP1;CCL11;LRP1;CFH;EPAS1;LAMA3;CXCR4;LPL;FOXO1;C3;SOCS3;SPP1;CCL2;A2M;ABCA1;EGR1;GSN;CAV1;KLF4;ESR1;QKI;CXCL10;RCAN1;FABP4;CXCL12;CALR;FGFR3
Endometriosis,52/749,1.455261192790323E-29,2.280907910699892E-27,0,0,9.76258328256127,648.2334046317682,NRP1;CIB1;IRS2;NR3C1;SYNE1;RGS4;CCND1;PLAU;MDK;KDR;LEPR;TIMP1;CD36;ANXA1;MME;DUSP1;HGF;FOS;DCN;ACTA2;MMP14;VCAN;TXNIP;PPARG;S100A4;EZR;FKBP4;UTRN;TLR4;MET;YAP1;CCL11;CXCR4;EGFR;FOXO1;DEPP1;C3;MUC1;AGR2;S1PR1;SPP1;SNCG;CCL2;EGR1;JUN;PLK1;ESR1;CXCL10;NR4A1;CXCL12;LEP;BMPR1B
Non-Small Cell Lung Carcinoma,84/2243,2.1142553654642814E-29,3.219104812159759E-27,0,0,6.021354915774847,397.5675754447441,NRP1;TINAGL1;CIB1;MEOX2;NR3C1;ETS2;AQP1;MYLK;CCND2;EFEMP1;CCND1;PLAU;MDK;DPYSL2;KDR;LEPR;TIMP1;TEAD1;CTSD;TNS1;MME;DUSP1;HGF;KRT8;TAP1;KRT5;FOS;RUNX2;DCN;CDC25B;TGFBR2;MMP14;ZEB2;ADAM12;KIT;MAPKAPK2;PECAM1;PPARG;S100A4;EZR;SGK1;UTRN;TLR4;MET;YAP1;LRP1;CFH;EPAS1;MAGED1;NEDD9;CXCR4;LPL;PIK3R1;EGFR;FOXO1;SOCS3;MUC1;KLC2;AGR2;SPP1;CCL2;ABCA1;STAT5A;STAT5B;EGR1;JUN;GSN;STAT1;ZBTB16;CAV1;PLK1;KLF4;ESR1;EFNA1;PER1;CXCL10;KRT19;KLF6;KRT18;CXCL12;LEP;BCL3;VIM;FGFR3
Malignant neoplasm of ovary,80/2026,2.4664868717654724E-29,3.651085705455056E-27,0,0,6.220844147926211,409.7805211578388,NRP1;PROS1;CIB1;IRS2;NR3C1;ETS2;AQP1;SYNE1;EPS8;AKAP12;RPS6KA3;RGS2;CCND2;EFEMP1;CCND1;PPP2R1B;ALDH2;PLAU;MDK;KDR;LEPR;TIMP1;TEAD1;CTSD;DST;DUSP1;HGF;KRT5;FOS;RUNX2;DCN;TGFBR2;MMP14;ZEB2;VCAN;ADAM12;KIT;PECAM1;PPARG;SGK1;CRYAB;TLR4;MET;YAP1;PPP1R15A;LRP1;EPAS1;NEDD9;CXCR4;PIK3R1;EGFR;FOXO1;C3;MUC1;AGR2;SPP1;E2F2;SNCG;CCL2;MEST;ABCA1;STAT5B;EGR1;TCF7L2;JUN;STAT1;ZBTB16;CAV1;PLK1;KLF4;ESR1;KLF6;KRT18;FABP4;CXCL12;BCL6;LEP;BCL3;VIM;BMPR1B
Diabetic Nephropathy,46/561,3.5297334242239743E-29,5.08377011288907E-27,0,0,11.333699540112416,742.5131054984433,CXCR4;LPL;IRS2;PIK3R1;EGFR;FOXO1;NCALD;AQP1;GHR;MUC1;ZFP36;ALDH2;MDK;KDR;SPP1;CCL2;TIMP1;CD36;ABCA1;STAT5A;STAT5B;TCF7L2;JUN;VWF;STAT1;HGF;CAV1;BGN;SORBS1;ESR1;DCN;TGFBR2;CXCL10;ZEB2;VCAN;KLF6;COL1A2;FABP4;LEP;SAA1;TXNIP;PPARG;SGK1;UTRN;TLR4;S100A8
Lung Neoplasms,62/1177,8.684903416200379E-29,1.217943429077153E-26,0,0,7.6404246900553945,493.67367469371726,NRP1;THRB;NR3C1;GHR;CCND2;EFEMP1;CCND1;PPP2R1B;ALDH2;PLAU;ANXA1;VWF;DUSP1;HGF;LMO2;KRT8;FOS;RUNX2;TGFBR2;MMP14;MAP1B;ADAM12;KIT;SERPING1;PPARG;EZR;TLR4;MET;YAP1;LRP1;CFH;NEDD9;CXCR4;LPL;EGFR;SOCS3;MUC1;SPP1;SNCG;CCL2;FADD;A2M;STAT5A;CA12;STAT5B;EGR1;TCF7L2;JUN;GSN;CAV1;PLK1;KLF4;ESR1;RCAN1;NR4A1;TF;KRT19;KLF6;CXCL12;LEP;VIM;CALR
Squamous cell carcinoma,76/1876,2.2302088496463225E-28,3.047380246093654E-26,0,0,6.230200364298725,396.67864755634326,NRP1;MAML2;CIB1;IRS2;NR3C1;PKD2;ETS2;AQP1;EPS8;AKAP12;RPS6KA3;CCND2;CCND1;ALDH2;PLAU;MDK;KDR;LEPR;TIMP1;CD36;CTSD;ANXA1;DST;DUSP1;HGF;KRT8;KRT5;FOS;DCN;CDC25B;TGFBR2;MMP14;ZEB2;ADAM12;KIT;PPARG;S100A4;EZR;SGK1;CRYAB;TLR4;MET;S100A8;YAP1;COL17A1;EPAS1;NEDD9;CXCR4;EGFR;SOCS3;MUC1;SPP1;SNCG;CCL2;ABCA1;STAT5A;EGR1;JUN;GSN;FZD4;STAT1;CAV2;CAV1;PLK1;KLF4;ESR1;EFNA1;CXCL10;NR4A1;KRT19;KRT18;CXCL12;LEP;VIM;CALR;FGFR3
Obesity,77/1961,6.527244071308756E-28,8.69592091400109E-26,0,0,6.052209998069871,378.8465445524967,SNAP25;IRS2;NR3C1;GHR;RPS6KA3;ZFP36;RGS2;CCND2;CCND1;LEPR;TIMP1;CD36;CTSD;SREBF1;ANXA1;MME;VWF;DUSP1;HGF;BGN;FOS;DCN;MMP14;MAF;ADAM12;KIT;PECAM1;PPARG;SGK1;TLR4;S100A8;CCL11;LRP1;CFH;EPAS1;MAGED1;CXCR4;LPL;PIK3R1;EGFR;FOXO1;DEPP1;C3;SOCS3;PRKAR2B;SPP1;SNCG;CCL2;FADD;A2M;MEST;ABCA1;STAT5A;STAT5B;EGR1;TCF7L2;JUN;FZD4;STAT1;CAV2;ZBTB16;CAV1;PLK1;SORBS1;KLF4;ESR1;PER1;CXCL10;NR4A1;TF;KRT18;FABP4;LEP;SAA1;VIM;CALR;FGFR3
Liver neoplasms,64/1321,9.934903516284998E-28,1.2912951423971404E-25,0,0,7.046390956909961,438.1187184490607,NRP1;SNAP25;CIB1;IRS2;NR3C1;GHR;CCND1;ALDH2;PLAU;KDR;LEPR;TIMP1;CD36;TEAD1;CTSD;SREBF1;DUSP1;HGF;KRT8;BGN;LIFR;KRT5;FOS;MMP14;ZEB2;ADAM12;KIT;SERPING1;PPARG;SGK1;TLR4;MET;CXCR4;LPL;EGFR;FOXO1;C3;SOCS3;MUC1;SPP1;SNCG;CCL2;A2M;ABCA1;STAT5A;STAT5B;EGR1;TCF7L2;JUN;STAT1;GOLM1;CAV1;PLK1;SORBS1;ESR1;EFNA1;CXCL10;TF;KRT19;KLF6;KRT18;CXCL12;LEP;VIM
Epithelial ovarian cancer,64/1329,1.3949848021006365E-27,1.7699700024748314E-25,0,0,6.998808329892042,432.7847087292669,NRP1;CIB1;NR3C1;ETS2;AQP1;SYNE1;RGS4;CDH5;RGS2;CCND2;EFEMP1;CCND1;ALDH2;PLAU;KDR;SIRPA;DUSP1;HGF;KRT8;KRT5;FOS;RUNX2;TGFBR2;MMP14;ZEB2;ADAM12;KIT;PECAM1;PPARG;S100A4;EZR;FKBP4;TLR4;MET;YAP1;LAMA3;NEDD9;CXCR4;EGFR;FOXO1;MUC1;SPP1;SNCG;CCL2;DMD;FADD;ABCA1;STAT5A;STAT5B;EGR1;JUN;GSN;STAT1;CAV1;SORBS1;ESR1;EFNA1;KLF6;KRT18;CXCL12;BCL6;LEP;VIM;CALR
Malignant neoplasm of stomach,84/2398,2.393974666096882E-27,2.96685837107681E-25,0,0,5.568666696993131,341.3416853826666,NRP1;ARF1;THRB;FHL1;CIB1;IRS2;NR3C1;ETS2;AKAP12;GHR;RGS2;CCND2;CCND1;ALDH2;PLAU;MDK;KDR;LEPR;TIMP1;CTSD;TNS1;ANXA1;MME;VWF;TPM3;HGF;KRT8;BGN;LIFR;FOS;RUNX2;TGFBR2;MMP14;ZEB2;VCAN;ADAM12;KIT;TXNIP;PPARG;S100A4;EZR;TLR4;MET;S100A8;YAP1;EPAS1;LAMA3;NEDD9;CXCR4;EGFR;FOXO1;SOCS3;MUC1;MAP3K20;SPP1;SNCG;CCL2;SPTBN1;STAT5A;STAT5B;EGR1;TCF7L2;JUN;GSN;STAT1;CAV1;PLK1;SORBS2;KLF4;ESR1;FLI1;EFNA1;CXCL10;NR4A1;KRT19;KLF6;COL1A2;KRT18;CXCL12;BCL6;LEP;TACC1;VIM;CALR
Osteosarcoma of bone,57/1042,3.740982742584033E-27,4.530840235279617E-25,0,0,7.722713035965007,469.93055703815406,CIB1;NR3C1;AQP1;GHR;RPS6KA3;EFEMP1;CCND1;PLAU;MDK;KDR;TIMP1;TEAD1;ANXA1;VWF;DUSP1;HGF;BGN;FOS;RUNX2;DCN;MMP14;ZEB2;VCAN;PPARG;S100A4;EZR;CRYAB;MET;S100A8;YAP1;LRP1;EPAS1;CXCR4;LPL;DTX1;EGFR;FOXO1;SOCS3;SPP1;E2F2;CCL2;FADD;ABCA1;EGR1;GSN;CAV2;CAV1;PLK1;KLF4;ESR1;EFNA1;KRT19;KLF6;COL1A2;CXCL12;BCL6;FGFR3
Atherosclerosis,59/1134,5.09821389841564E-27,6.037418192145988E-25,0,0,7.394298142881044,447.65751803551655,NRP1;PROS1;F13A1;IRS2;NR3C1;AQP1;MYLK;ZFP36;RGS2;ALDH2;PLAU;KDR;LEPR;TIMP1;CD36;SREBF1;MEF2C;VWF;DUSP1;HGF;BGN;FOS;DCN;MMP14;VCAN;MAF;KIT;PECAM1;PPARG;TLR4;S100A8;CCL11;LRP1;CFH;CXCR4;LPL;EGFR;FOXO1;C3;SOCS3;S1PR1;SPP1;CCL2;DMD;ABCA1;EGR1;TCF7L2;STAT1;CAV1;KLF4;ESR1;RCAN1;NR4A1;FABP4;CXCL12;LEP;BCL3;SAA1;VIM
Secondary malignant neoplasm of lymph node,62/1271,5.89046598891557E-27,6.823976794550233E-25,0,0,7.010935143288084,423.4356807777245,NRP1;ARF1;PROS1;FHL1;F13A1;EPS8;AKAP12;GHR;EFEMP1;CCND1;PLAU;MDK;KDR;LEPR;TIMP1;CTSD;MME;BGN;KRT5;FOS;RUNX2;CDC25B;TGFBR2;MMP14;ZEB2;KIT;PECAM1;PPARG;S100A4;EZR;TLR4;MET;EPAS1;NEDD9;CXCR4;LPL;EGFR;SOCS3;MUC1;AGR2;SPP1;SNCG;CCL2;FADD;EGR1;JUN;GSN;CAV1;KLF4;ESR1;FLI1;EFNA1;PER1;NR4A1;KRT19;KLF6;KRT18;CXCL12;LEP;VIM;CALR;FGFR3
"Leukemia, Myelocytic, Acute",70/1703,3.026541123242741E-26,3.4315824778213976E-24,0,0,6.0846122933251685,357.530552719102,NRP1;MAML2;CIB1;NR3C1;ETS2;AKAP12;RGS2;CCND2;CCND1;PLAU;KDR;LEPR;SIRPA;TIMP1;CD36;MEF2C;MME;VWF;DUSP1;HGF;LMO2;LIFR;FOS;RUNX2;CDC25B;MMP14;ZEB2;KIT;TXNIP;PPARG;S100A4;PRTN3;SGK1;FKBP4;TLR4;MET;S100A8;LRP1;EPAS1;CXCR4;PIK3R1;EGFR;FOXO1;SOCS3;MUC1;MAP3K20;SPP1;CCL2;SPTBN1;ABCA1;STAT5A;STAT5B;EGR1;JUN;GSN;FZD4;STAT1;ZBTB16;CAV1;PLK1;KLF4;ESR1;FLI1;NR4A1;KLF6;FABP4;CXCL12;LEP;VIM;CALR
Arteriosclerosis,57/1087,3.2002727468307125E-26,3.552969472471014E-24,0,0,7.367651311712456,432.51042856622377,PROS1;F13A1;IRS2;NR3C1;AQP1;MYLK;ZFP36;RGS2;ALDH2;PLAU;KDR;LEPR;TIMP1;CD36;SREBF1;MEF2C;VWF;DUSP1;HGF;BGN;FOS;DCN;MMP14;VCAN;KIT;PECAM1;PPARG;TLR4;S100A8;CCL11;LRP1;CFH;CXCR4;LPL;EGFR;FOXO1;C3;SOCS3;S1PR1;SPP1;CCL2;DMD;ABCA1;EGR1;TCF7L2;STAT1;CAV1;KLF4;ESR1;RCAN1;NR4A1;FABP4;CXCL12;LEP;BCL3;SAA1;VIM
Myocardial Ischemia,39/448,1.1373604176682877E-25,1.236937482807001E-23,0,0,11.63025326382802,667.9942631306025,YAP1;PPP1R15A;LPL;MEOX2;FOXO1;GHR;SOCS3;ZFP36;CCND2;CCND1;ALDH2;KDR;SPP1;CCL2;DMD;CD36;ABCA1;STAT5A;EGR1;TCF7L2;VWF;DUSP1;HGF;TAP1;ANK2;KLF4;ESR1;DCN;CXCL10;RCAN1;NR4A1;MMP14;CXCL12;KIT;PECAM1;TXNIP;PPARG;CALR;TLR4
Renal Cell Carcinoma,62/1348,1.4212984502566845E-25,1.5148198882835745E-23,0,0,6.563855091025523,375.5382119801906,NRP1;THRB;CIB1;IRS2;NR3C1;AQP1;CCND1;PLAU;KDR;TIMP1;CD36;CTSD;ANXA1;MME;VWF;DUSP1;HGF;KRT8;TAP1;DCN;TGFBR2;ACTA2;MMP14;ZEB2;VCAN;KIT;PECAM1;TXNIP;PPARG;S100A4;EZR;CRYAB;MET;CCL11;EPAS1;MAGED1;NEDD9;CXCR4;PIK3R1;EGFR;FOXO1;C3;SOCS3;MUC1;CCL2;FADD;CA12;EGR1;TCF7L2;JUN;STAT1;CAV2;CAV1;PLK1;KLF4;ESR1;CXCL10;NR4A1;KRT19;CXCL12;VIM;FGFR3
Stomach Neoplasms,50/835,1.9061969789796192E-25,1.9917889609769392E-23,0,0,8.184283009123773,465.8454373288267,FHL1;IRS2;AKAP12;RGS2;CCND2;CCND1;ALDH2;PLAU;MDK;KDR;LEPR;TIMP1;ANXA1;DUSP1;TPM3;HGF;KRT8;FOS;TGFBR2;MMP14;KIT;TXNIP;PPARG;S100A4;MET;S100A8;CXCR4;EGFR;SOCS3;MUC1;SPP1;CCL2;FADD;TCF7L2;JUN;CAV1;PLK1;KLF4;ESR1;EFNA1;NR4A1;KRT19;KLF6;KRT18;CXCL12;LEP;TACC1;VIM;CALR;FGFR3
Stomach Carcinoma,81/2378,2.1894510372318394E-25,2.2437662648862446E-23,0,0,5.275945212819397,299.57332104084975,NRP1;THRB;FHL1;CIB1;ANTXR2;NR3C1;ETS2;AKAP12;GHR;CCND2;CCND1;ALDH2;PLAU;MDK;KDR;LEPR;TIMP1;CTSD;TNS1;ANXA1;MME;VWF;HGF;KRT8;BGN;TAP1;LIFR;FOS;TGFBR2;MMP14;ZEB2;VCAN;ADAM12;KIT;TXNIP;PPARG;S100A4;EZR;TLR4;MET;S100A8;YAP1;EPAS1;LAMA3;NEDD9;CXCR4;EGFR;FOXO1;SOCS3;MUC1;MAP3K20;SPP1;SNCG;CCL2;SPTBN1;ABCA1;STAT5A;STAT5B;EGR1;JUN;GSN;STAT1;CAV1;PLK1;SORBS2;KLF4;ESR1;FLI1;EFNA1;CXCL10;NR4A1;KRT19;KLF6;COL1A2;KRT18;CXCL12;BCL6;LEP;TACC1;VIM;CALR
Rheumatoid Arthritis,71/1833,4.127744685537126E-25,4.150330458344782E-23,0,0,5.723810630368139,321.3742010342041,NRP1;TINAGL1;FHL1;F13A1;CIB1;NR3C1;ETS2;RPS6KA3;ZFP36;CCND1;PLAU;MDK;KDR;TIMP1;CTSD;CCT3;ANXA1;VWF;DUSP1;HGF;BGN;TAP1;FOS;RUNX2;MMP14;PECAM1;TXNIP;PPARG;S100A4;PRTN3;TLR4;MET;S100A8;PPP1R15A;LRP1;CFH;EPAS1;NEDD9;CXCR4;EGFR;FOXO1;C3;SOCS3;MUC1;S1PR1;SPP1;E2F2;CCL2;FADD;A2M;ABCA1;STAT5A;STAT5B;EGR1;JUN;GSN;STAT1;CAV2;ZBTB16;ESR1;CXCL10;RCAN1;NR4A1;TF;CXCL12;BCL6;LEP;BCL3;SAA1;VIM;CALR
Pancreatic Ductal Adenocarcinoma,46/701,5.007070351932374E-25,4.941236649156967E-23,0,0,8.846544797107272,494.9975889669741,YAP1;NRP1;EPAS1;NEDD9;CXCR4;PIK3R1;EGFR;FOXO1;AKAP12;GHR;SOCS3;MUC1;PPP4C;CCND1;PLAU;MDK;MAP3K20;AGR2;SPP1;CCL2;TEAD1;SREBF1;MME;DUSP1;HGF;CAV1;BGN;TAP1;KLF4;RUNX2;CDC25B;TGFBR2;CXCL10;MMP14;KRT19;VCAN;KLF6;CXCL12;MAPKAPK2;PECAM1;PPARG;S100A4;VIM;TLR4;FGFR3;SKAP2
Degenerative polyarthritis,53/976,5.221075625665767E-25,5.0587476380314316E-23,0,0,7.476273022751896,418.0128081962711,NR3C1;GHR;ZFP36;PLAU;DPYSL2;KDR;LEPR;TIMP1;CD36;CTSD;DUSP1;HGF;KRT5;FOS;RUNX2;TGFBR2;MMP14;F8;ADAM12;PECAM1;PPARG;S100A4;EZR;CRYAB;TLR4;MET;S100A8;CCL11;LRP1;EPAS1;CXCR4;PIK3R1;C3;SOCS3;PRKAR2B;SPP1;CCL2;A2M;ABCA1;EGR1;JUN;FZD4;CAV1;SORBS2;ESR1;CXCL10;COL1A2;CXCL12;LEP;SAA1;VIM;CALR;FGFR3
Colorectal Neoplasms,55/1073,8.968629807061614E-25,8.534612186041312E-23,0,0,7.096871694121203,392.9601332398111,FHL1;SYNE1;GHR;CDH5;CCND2;EFEMP1;CCND1;PPP2R1B;ALDH2;PLAU;DPYSL2;KDR;LEPR;TIMP1;MME;HGF;BGN;TAP1;FOS;TGFBR2;MMP14;MAF;PPARG;S100A4;EZR;TLR4;MET;S100A8;LRP1;NEDD9;CXCR4;PIK3R1;FBLN2;EGFR;MUC1;SNCG;ABCA1;CA12;TCF7L2;GSN;CAV1;PLK1;KLF4;ESR1;PER1;CXCL10;KRT19;KLF6;COL1A2;KRT18;CXCL12;LEP;VIM;CALR;FGFR3
Tumor Angiogenesis,40/511,1.400180203730151E-24,1.3090456676628025E-22,0,0,10.390496922787497,570.7026286708415,NRP1;EPAS1;LAMA4;CXCR4;PKD2;EGFR;ETS2;AQP1;EFEMP1;PLAU;MDK;KDR;SPP1;CCL2;TEAD1;JUN;VWF;FZD4;HGF;CAV1;BGN;FOS;RUNX2;DCN;TGFBR2;EFNA1;CXCL10;RCAN1;MMP14;CXCL12;ADAM12;PECAM1;TXNIP;PPARG;S100A4;EZR;CRYAB;TLR4;FGFR3;MET
Adenoma,53/1000,1.6375258431831245E-24,1.5045474514349777E-22,0,0,7.277537049848887,398.58237698111105,NRP1;SNAP25;FHL1;CIB1;NR3C1;SYNE1;EPS8;GHR;ZFP36;EFEMP1;CCND1;ALDH2;PLAU;MDK;LEPR;TIMP1;MME;HGF;FOS;TGFBR2;KIT;PPARG;S100A4;SGK1;TLR4;MET;S100A8;YAP1;LAMA3;NEDD9;CXCR4;EGFR;C3;MUC1;PRKAR2B;AGR2;SPP1;CCL2;TCF7L2;GSN;CAV2;CAV1;PLK1;KLF4;ESR1;EFNA1;TF;KRT19;COL1A2;CXCL12;LEP;VIM;CALR
Squamous cell carcinoma of the head and neck,51/934,3.8680310995625274E-24,3.493684360943849E-22,0,0,7.433448124436637,400.7319598056354,RPS6KA3;ZFP36;CCND1;ALDH2;KDR;ANXA1;MME;DST;DUSP1;HGF;TAP1;KRT5;FOS;TGFBR2;MMP14;ZEB2;ADAM12;TXNIP;S100A4;FKBP4;CRYAB;TLR4;MET;S100A8;YAP1;LAMA3;NEDD9;CXCR4;DTX1;EGFR;SOCS3;MUC1;AGR2;SPP1;E2F2;CCL2;FADD;STAT5A;STAT5B;EGR1;JUN;STAT1;CAV1;KLF4;ESR1;PER1;KRT19;KLF6;CXCL12;VIM;FGFR3
Colonic Neoplasms,47/778,4.804537739627382E-24,4.2672302690790525E-22,0,0,8.120392096465878,436.0040015847278,CFH;EPAS1;LPL;IRS2;EGFR;EPS8;MUC1;CCND2;CCND1;PLAU;MDK;KDR;SPP1;CCL2;TIMP1;A2M;EGR1;TCF7L2;JUN;STAT1;TPM3;CAV2;HGF;CAV1;PLK1;BGN;TAP1;KLF4;ESR1;RUNX2;DCN;TGFBR2;ACTA2;CXCL10;NR4A1;MMP14;CXCL12;LEP;KIT;SAA1;PPARG;S100A4;CALR;EZR;CRYAB;MET;S100A8
Neuroblastoma,67/1698,5.333789242340688E-24,4.659633257775987E-22,0,0,5.698077796134999,305.34848079541325,NRP1;SNAP25;ITSN1;CIB1;NR3C1;RGS4;CDH5;RPS6KA3;CCND2;CCND1;MDK;DPYSL2;KDR;LEPR;CTSD;MME;TPM3;HGF;ANK2;LIFR;FOS;RUNX2;MMP14;MAP1B;KIT;PECAM1;SERPING1;PPARG;SGK1;FKBP4;UTRN;MET;YAP1;LRP1;EPAS1;NEDD9;CXCR4;PIK3R1;EGFR;FOXO1;DEPP1;SOCS3;MUC1;SPP1;E2F2;CCL2;SPTBN1;ABCA1;STAT5A;STAT5B;EGR1;JUN;STAT1;CAV2;CAV1;PLK1;KLF4;ESR1;FLI1;RCAN1;KRT19;KLF6;CXCL12;LEP;SAA1;VIM;CALR
Hypertensive disease,59/1310,8.693477682322081E-24,7.472184285337802E-22,0,0,6.294296936551478,334.2238261861601,FHL1;IRS2;NR3C1;PKD2;AQP1;MYLK;GHR;RGS2;CCND1;ALDH2;KDR;LEPR;TIMP1;CD36;SREBF1;ANXA1;MME;VWF;DUSP1;HGF;BGN;TAP1;FOS;DCN;TGFBR2;ACTA2;TXNIP;PPARG;S100A4;SGK1;TLR4;YAP1;LRP1;CFH;EPAS1;CXCR4;LPL;PIK3R1;FBLN2;EGFR;FOXO1;C3;MUC1;SPP1;CCL2;DMD;FADD;ABCA1;STAT5A;EGR1;TCF7L2;JUN;CAV1;SORBS1;KLF4;ESR1;KLF6;LEP;CALR
Asthma,59/1313,9.763864595701373E-24,8.258989592141685E-22,0,0,6.27822335433089,332.6413301416532,F13A1;CIB1;NR3C1;ETS2;MYLK;ZFP36;RGS2;ALDH2;PLAU;KDR;LEPR;TIMP1;CTSD;TNS1;ANXA1;DUSP1;LIFR;FOS;DCN;TGFBR2;VCAN;ADAM12;KIT;PECAM1;SERPING1;TXNIP;PPARG;FKBP4;TLR4;MET;S100A8;CCL11;EGFR;C3;SOCS3;MUC1;AGR2;S1PR1;SPP1;CCL2;A2M;ABCA1;STAT5A;STAT5B;EGR1;JUN;GSN;STAT1;ZBTB16;CAV1;SORBS1;ESR1;EFNA1;CXCL10;KRT19;FABP4;CXCL12;LEP;BMPR1B
Invasive carcinoma of breast,35/385,1.0855561740102605E-23,9.03895133015731E-22,0,0,11.933742331288343,631.0248452538439,ARF1;NEDD9;CXCR4;CIB1;EGFR;EPS8;CDH5;MUC1;ZFP36;CCND1;PLAU;KDR;SNCG;CCL2;MEST;CTSD;JUN;GSN;HGF;PLK1;SORBS1;ESR1;RUNX2;TGFBR2;MMP14;KRT19;KLF6;CXCL12;BCL6;MAPKAPK2;S100A4;VIM;EZR;TLR4;MET
Secondary malignant neoplasm of lung,44/683,1.3310715385641027E-23,1.0912738813858621E-21,0,0,8.568298680974737,451.32204796796793,YAP1;LRP1;NEDD9;CXCR4;EGFR;FOXO1;ETS2;AKAP12;MUC1;PPP4C;PLAU;MDK;KDR;SPP1;E2F2;CCL2;TIMP1;CTSD;ANXA1;VWF;HGF;CAV1;ESR1;DCN;TGFBR2;EFNA1;RCAN1;MMP14;ZEB2;KRT19;VCAN;CXCL12;ADAM12;PECAM1;S100A4;PRTN3;VIM;CALR;EZR;CRYAB;TLR4;MET;S100A8;SKAP2
Autoimmune Diseases,53/1060,2.4836845648797706E-23,2.005387128218833E-21,0,0,6.822141560798548,355.09051689981254,NRP1;FHL1;NR3C1;ZFP36;KDR;SIRPA;TIMP1;CD36;ANXA1;DST;DUSP1;TPM3;HGF;F8;PECAM1;SERPING1;PPARG;PRTN3;SGK1;TLR4;S100A8;COL17A1;LRP1;CFH;CXCR4;LPL;PIK3R1;EGFR;FOXO1;C3;MUC1;S1PR1;SPP1;E2F2;CCL2;STAT5A;STAT5B;EGR1;GSN;STAT1;ZBTB16;CAV1;ESR1;FLI1;CXCL10;KRT19;CXCL12;BCL6;LEP;SAA1;VIM;CALR;FGFR3
Malignant Neoplasms,61/1438,2.7262897797992126E-23,2.168417647246269E-21,0,0,5.957757528531824,309.5443214302495,NRP1;LAMC1;NR3C1;ETS2;AQP1;GHR;RPS6KA3;ZFP36;CCND2;CCND1;ALDH2;KDR;CTSD;TNS1;ANXA1;TPM3;HGF;KRT5;FOS;SOX10;RUNX2;ZEB2;F8;VCAN;ADAM12;KIT;TXNIP;PPARG;SGK1;UTRN;CRYAB;TLR4;MET;S100A8;YAP1;EPAS1;MAGED1;NEDD9;CXCR4;PIK3R1;EGFR;SOCS3;MUC1;SPP1;STAT5A;CA12;STAT5B;TCF7L2;GSN;STAT1;CAV1;PLK1;ESR1;FLI1;TF;KRT19;CXCL12;BCL6;LEP;VIM;FGFR3
Pancreatic Neoplasm,43/665,3.996206695299548E-23,3.1317331587134256E-21,0,0,8.554506793901048,441.19108767694036,NRP1;MAGED1;CXCR4;CIB1;IRS2;EGFR;FOXO1;MUC1;EFEMP1;CCND1;ALDH2;PLAU;KDR;AGR2;SPP1;CCL2;TIMP1;CTSD;JUN;GSN;MME;DUSP1;HGF;CAV1;PLK1;KRT8;BGN;SORBS2;KLF4;DCN;CDC25B;TGFBR2;PER1;NR4A1;MMP14;CXCL12;KIT;TXNIP;PPARG;S100A4;EZR;MET;S100A8
Central neuroblastoma,65/1655,4.174805355763098E-23,3.22428083200892E-21,0,0,5.597862580980753,288.46003862253923,NRP1;SNAP25;ITSN1;CIB1;NR3C1;RGS4;CDH5;RPS6KA3;CCND2;CCND1;MDK;DPYSL2;KDR;LEPR;CTSD;MME;TPM3;HGF;ANK2;LIFR;FOS;RUNX2;MMP14;MAP1B;KIT;PECAM1;SERPING1;PPARG;SGK1;FKBP4;UTRN;LRP1;EPAS1;NEDD9;CXCR4;PIK3R1;EGFR;FOXO1;DEPP1;SOCS3;MUC1;SPP1;E2F2;CCL2;SPTBN1;ABCA1;STAT5A;STAT5B;EGR1;JUN;STAT1;CAV2;CAV1;PLK1;KLF4;ESR1;FLI1;RCAN1;KRT19;KLF6;CXCL12;LEP;SAA1;VIM;CALR
Astrocytoma,45/741,4.253137375917094E-23,3.2378527251803138E-21,0,0,8.073867478025694,415.8994485483245,YAP1;NRP1;EPAS1;CXCR4;CIB1;PIK3R1;EGFR;AQP1;C3;AKAP12;RGS4;MUC1;RGS2;CCND1;PLAU;MDK;KDR;SPP1;SIRPA;CCL2;TIMP1;A2M;CTSD;CA12;EGR1;TCF7L2;ANXA1;GSN;TPM3;HGF;CAV1;KLF4;SOX10;ESR1;FLI1;MMP14;VCAN;KLF6;CXCL12;PECAM1;S100A4;VIM;CALR;MET;MATN2
Kidney Diseases,42/639,7.407777936170829E-23,5.5600068481484994E-21,0,0,8.660932869475584,441.3345206749138,NRP1;CFH;LPL;IRS2;PKD2;EGFR;AQP1;GHR;SOCS3;MUC1;ZFP36;CCND1;KDR;SPP1;LEPR;CCL2;TIMP1;CD36;CTSD;ABCA1;EGR1;SREBF1;TCF7L2;ANXA1;DST;VWF;HGF;BGN;ESR1;FLI1;DCN;TGFBR2;ACTA2;NR4A1;MMP14;VCAN;LEP;SAA1;PPARG;EZR;SGK1;TLR4
Neoplasm Invasiveness,26/183,9.690183894009481E-23,7.172081940441183E-21,0,0,18.914605243667605,958.7500122109996,ARF1;CXCR4;EGFR;MYLK;EPS8;RPS6KA3;ZFP36;PLAU;CCL2;DMD;TIMP1;CTSD;ANXA1;HGF;ZBTB16;ESR1;TF;MMP14;ZEB2;KRT19;CXCL12;S100A4;CALR;VIM;MET;TLR4
Neoplasms,56/1236,1.238049710773288E-22,9.037762888645004E-21,0,0,6.223633325375984,313.9408189959993,RPS6KA3;ZFP36;PLAU;MDK;KDR;TIMP1;CTSD;TNS1;ANXA1;TPM3;HGF;SOX10;RUNX2;MMP14;ZEB2;F8;ADAM12;KIT;TXNIP;PPARG;EZR;CRYAB;TLR4;MET;YAP1;LRP1;EPAS1;CXCR4;DTX1;PIK3R1;EGFR;FOXO1;SOCS3;MUC1;AGR2;SPP1;SNCG;CCL2;STAT5A;CA12;STAT5B;GSN;FZD4;STAT1;CAV1;PLK1;KLF4;ESR1;FLI1;CXCL10;NR4A1;CXCL12;BCL6;LEP;VIM;FGFR3
Lymphoma,57/1307,2.985952397664963E-22,2.150289233399539E-20,0,0,5.999795744680851,297.36759623547414,NRP1;SNAP25;MAML2;CIB1;ANTXR2;NR3C1;ZFP36;CCND2;CCND1;PLAU;MDK;KDR;TIMP1;ANXA1;MME;DUSP1;TPM3;HGF;LMO2;FOS;RUNX2;CDC25B;TGFBR2;KIT;PPARG;S100A4;TLR4;MET;EPAS1;NEDD9;CXCR4;EGFR;FOXO1;MUC1;MAP3K20;SPP1;CCL2;STAT5A;CA12;STAT5B;EGR1;JUN;STAT1;PLK1;KLF4;ESR1;FLI1;CXCL10;RCAN1;NR4A1;KRT18;CXCL12;BCL6;LEP;BCL3;VIM;FGFR3
Solid Neoplasm,46/840,9.057882716779877E-22,6.435927599695995E-20,0,0,7.244862786689646,351.0370510918832,NRP1;EPAS1;CXCR4;LPL;CIB1;NR3C1;EGFR;FOXO1;SOCS3;MUC1;CCND1;PLAU;MDK;KDR;S1PR1;SPP1;SNCG;SIRPA;TEAD1;ABCA1;STAT5A;STAT5B;EGR1;MME;VWF;DUSP1;TPM3;HGF;PLK1;ESR1;RUNX2;FLI1;MMP14;KRT19;KLF6;CXCL12;KIT;BCL3;PECAM1;PPARG;S100A4;VIM;EZR;CRYAB;FGFR3;MET
"Liver Cirrhosis, Experimental",45/801,9.836129263626951E-22,6.896938532351055E-20,0,0,7.409741674447557,358.41520505150544,FHL1;LPL;MEOX2;PKD2;GHR;CDH5;RGS2;ALDH2;PLAU;EPB41L2;S1PR1;CCL2;TIMP1;CD36;A2M;SREBF1;ANXA1;GSN;MME;VWF;TPM3;HGF;CAV1;LMO2;KRT8;BGN;FOS;FLI1;TGFBR2;ACTA2;CXCL10;TF;ZEB2;KRT19;KLF6;COL1A2;KRT18;CXCL12;LEP;VIM;EZR;CRYAB;TLR4;RHOQ;SKAP2
ovarian neoplasm,48/938,1.731122390261041E-21,1.1980715867144269E-19,0,0,6.7998202247191015,325.06892117455305,YAP1;NRP1;THRB;PROS1;NEDD9;CIB1;PIK3R1;EGFR;FOXO1;ETS2;AQP1;MUC1;CCND2;EFEMP1;CCND1;PLAU;MDK;KDR;AGR2;SPP1;E2F2;SNCG;CCL2;TIMP1;CTSD;STAT5A;STAT5B;JUN;MME;DUSP1;HGF;CAV1;ESR1;QKI;DCN;TGFBR2;MMP14;VCAN;KLF6;CXCL12;KIT;PECAM1;PPARG;S100A4;SGK1;UTRN;TLR4;MET
Nasopharyngeal carcinoma,44/782,2.8458709625693997E-21,1.9443136358374783E-19,0,0,7.380565234223771,349.16286365772237,COL17A1;MAML2;NEDD9;CXCR4;UBE2L6;FBLN2;EGFR;FOXO1;SYNE1;EFEMP1;CCND1;SPP1;CCL2;CTSD;ABCA1;STAT5A;STAT5B;EGR1;JUN;ANXA1;DST;STAT1;HGF;CAV1;PLK1;KLF4;ESR1;TGFBR2;CXCL10;MMP14;KRT19;CXCL12;KIT;MAPKAPK2;BCL3;SAA1;S100A4;VIM;CALR;EZR;CRYAB;TLR4;FGFR3;MET
Hepatocarcinogenesis,37/527,4.011728060053395E-21,2.7061390926613343E-19,0,0,9.057472429965776,425.38478020181884,YAP1;LAMA4;CIB1;EGFR;ETS2;AKAP12;SOCS3;RPS6KA3;MUC1;CCND2;CCND1;ALDH2;PLAU;SPP1;E2F2;SNCG;EGR1;JUN;DUSP1;TPM3;HGF;CAV1;PLK1;FOS;ESR1;DCN;TGFBR2;NR4A1;ZEB2;KLF6;LEP;TXNIP;PPARG;TLR4;FGFR3;MET;S100A8
Ulcerative Colitis,47/915,4.238118953722024E-21,2.8231169880480833E-19,0,0,6.789590136417737,318.500810046891,CCL11;MAML2;NEDD9;CXCR4;LPL;ANTXR2;NR3C1;EGFR;SOCS3;CCND1;PLAU;KDR;SPP1;LEPR;CCL2;TIMP1;STAT5A;EGR1;TCF7L2;ANXA1;FZD4;DUSP1;STAT1;TPM3;HGF;KRT8;FOS;ESR1;TGFBR2;ACTA2;CXCL10;NR4A1;VCAN;CXCL12;MAF;LEP;BCL3;SAA1;PECAM1;TXNIP;PPARG;PRTN3;TLR4;MET;S100A8;SKAP2;ARHGEF6
Noninfiltrating Intraductal Carcinoma,29/287,5.2052968656890956E-21,3.424571234229283E-19,0,0,12.99885326361176,607.1063749543238,NRP1;CXCR4;IRS2;EGFR;MUC1;CCND2;CCND1;PLAU;LEPR;SNCG;STAT5A;STAT5B;SREBF1;GSN;MME;STAT1;HGF;CAV1;KRT5;ESR1;KRT19;CXCL12;BCL6;KRT15;KIT;PECAM1;VIM;MET;S100A8
"Aortic Aneurysm, Abdominal",29/288,5.740331187552745E-21,3.730515231520558E-19,0,0,12.948002101848255,603.4645565163294,LRP1;CXCR4;FBLN2;MYLK;C3;PLAU;SPP1;CCL2;TIMP1;ABCA1;STAT5A;STAT5B;EGR1;JUN;STAT1;BGN;FOS;KLF4;ESR1;DCN;TGFBR2;MMP14;VCAN;COL1A2;CXCL12;LEP;PECAM1;PPARG;TLR4
Endometrial Neoplasms,27/238,6.093084179080094E-21,3.91205368558046E-19,0,0,14.66026440508855,682.393270716279,CXCR4;PIK3R1;EGFR;FOXO1;SOCS3;CCND1;PLAU;MDK;SPP1;LEPR;CCL2;TCF7L2;JUN;MME;CAV1;FOS;ESR1;DCN;CDC25B;CXCL10;MMP14;VCAN;PPARG;S100A4;TLR4;MET;S100A8
Endometrial Carcinoma,45/840,6.541887711782594E-21,4.150204716201124E-19,0,0,7.03181650018498,326.8111339261536,LRP1;CXCR4;CIB1;PIK3R1;LAMC1;NR3C1;EGFR;FOXO1;AQP1;SOCS3;EFEMP1;CCND1;PLAU;KDR;AGR2;SPP1;LEPR;SNCG;CCL2;TIMP1;CTSD;EGR1;SREBF1;TCF7L2;HGF;CAV1;PLK1;BGN;FOS;ESR1;DCN;TGFBR2;PER1;MMP14;KRT19;VCAN;CXCL12;LEP;KIT;PPARG;S100A4;VIM;EZR;SGK1;MET
Cervix carcinoma,51/1105,6.958775124372238E-21,4.362742663268195E-19,0,0,6.171165240289664,286.43021287641415,CIB1;ANTXR2;ETS2;AQP1;ZFP36;EFEMP1;CCND1;PPP2R1B;PLAU;MDK;TIMP1;TEAD1;TPM3;HGF;TAP1;FOS;MMP14;ZEB2;VCAN;PPARG;EZR;SGK1;TLR4;MET;S100A8;NEDD9;CXCR4;EGFR;FOXO1;SOCS3;MUC1;SPP1;CCL2;STAT5A;CA12;STAT5B;EGR1;JUN;GSN;FZD4;STAT1;ZBTB16;CAV1;PLK1;KLF4;ESR1;KRT19;KLF6;VIM;CALR;FGFR3
Thyroid Neoplasm,35/476,1.192198690882809E-20,7.387473050830802E-19,0,0,9.426915960658292,432.4682786006085,YAP1;THRB;LRP1;CXCR4;EGFR;FOXO1;MUC1;CCND2;CCND1;PLAU;KDR;SPP1;CCL2;TIMP1;CA12;EGR1;JUN;ANXA1;TPM3;PLK1;FOS;ESR1;RUNX2;FLI1;DCN;TGFBR2;CXCL10;TF;MMP14;KRT19;KIT;TXNIP;PPARG;S100A4;MET
Glioblastoma Multiforme,45/854,1.2588153701288345E-20,7.710605870593747E-19,0,0,6.905038900603505,316.39945240788364,YAP1;NRP1;EPAS1;CXCR4;PIK3R1;EGFR;DEPP1;AQP1;SYNE1;EPS8;SOCS3;CDH5;RPS6KA3;GRK3;RASD1;EFEMP1;CCND1;PLAU;KDR;SPP1;CCL2;FADD;JUN;ANXA1;FZD4;STAT1;HGF;PLK1;TAP1;FOS;TGFBR2;ZEB2;KLF6;CXCL12;BCL6;LEP;PECAM1;PPARG;TACC1;S100A4;VIM;SGK1;FGFR3;MET;ARHGEF6
Chronic Obstructive Airway Disease,40/669,2.789766072068498E-20,1.6893935679605709E-18,0,0,7.716890382564247,347.45873171109014,NRP1;CCL11;CFH;EPAS1;NR3C1;EGFR;FOXO1;AKAP12;SOCS3;MUC1;CCND1;ALDH2;PLAU;MDK;KDR;SPP1;LEPR;CCL2;TIMP1;A2M;TNS1;ABCA1;EGR1;VWF;STAT1;HGF;CAV1;KRT5;SORBS1;CXCL10;MMP14;VCAN;LEP;MAP1B;PPARG;S100A4;PRTN3;VIM;TLR4;S100A8
"Myeloid Leukemia, Chronic",45/876,3.43141212097293E-20,2.054606201423005E-18,0,0,6.714447511856728,300.933010041429,YAP1;SNAP25;EPAS1;LAMA4;CXCR4;CIB1;PKD2;EGFR;FOXO1;ETS2;AKAP12;SOCS3;MUC1;CCND2;CCND1;KDR;SPP1;LEPR;FADD;TIMP1;STAT5A;STAT5B;EGR1;MME;STAT1;ZBTB16;HGF;CAV1;PLK1;FOS;KLF4;ESR1;TGFBR2;PER1;MMP14;CXCL12;BCL6;LEP;KIT;PECAM1;PPARG;PRTN3;VIM;FGFR3;MET
Malignant neoplasm of mouth,35/492,3.4754295597558444E-20,2.057840458215433E-18,0,0,9.089353076210548,407.2574064505333,NRP1;FHL1;CXCR4;CIB1;EGFR;FOXO1;CCND1;ALDH2;PLAU;AGR2;SPP1;LEPR;CCL2;CD36;JUN;ANXA1;STAT1;HGF;CAV1;PLK1;KRT5;FOS;KLF4;DCN;TGFBR2;MMP14;ZEB2;KLF6;CXCL12;LEP;BCL3;PPARG;S100A4;VIM;CRYAB
Liver Cirrhosis,40/683,5.85712094742295E-20,3.429955772397462E-18,0,0,7.543358859775184,334.05043326224694,CXCR4;EGFR;AQP1;GHR;SOCS3;ALDH2;PLAU;KDR;SPP1;SNCG;CCL2;TIMP1;CD36;A2M;TEAD1;EGR1;VWF;STAT1;GOLM1;HGF;CAV1;KRT8;ESR1;ACTA2;CXCL10;MMP14;KRT19;F8;KLF6;COL1A2;KRT18;LEP;ADAM12;PECAM1;SERPING1;PPARG;VIM;CALR;TLR4;MET
"Mammary Neoplasms, Human",34/476,1.1193468739881075E-19,6.4836950994376356E-18,0,0,9.080675422138837,396.2477252824106,YAP1;ARF1;CXCR4;EGFR;ETS2;DEPP1;SYNE1;AKAP12;CDH5;RGS2;EFEMP1;CCND1;KDR;AGR2;SPP1;LEPR;SNCG;STAT5A;JUN;MME;CAV1;KRT8;KRT5;FOS;ESR1;EFNA1;ACTA2;MMP14;ZEB2;KRT18;CXCL12;LEP;KIT;VIM
Cystic Fibrosis,37/594,2.273108217591862E-19,1.3025154507039821E-17,0,0,7.940330296508581,340.86224974634655,NRP1;NR3C1;EGFR;MUC1;ZFP36;PLAU;MDK;DMD;TIMP1;A2M;TCF7L2;JUN;ANXA1;FZD4;STAT1;CAV2;HGF;CAV1;KRT8;TAP1;FOS;ESR1;RCAN1;TF;KRT19;F8;COL1A2;KRT18;LEP;PECAM1;PPARG;PRTN3;EZR;SGK1;TLR4;MET;S100A8
Triple Negative Breast Neoplasms,38/632,2.3232539528105453E-19,1.3170872675029144E-17,0,0,7.67996632996633,329.51777197333666,ARF1;THRB;EPAS1;NEDD9;CXCR4;CIB1;NR3C1;EGFR;SOCS3;RPS6KA3;MUC1;GRK3;CCND1;KDR;LEPR;TEAD1;STAT1;HGF;CAV1;PLK1;KRT5;KLF4;ESR1;CDC25B;NR4A1;MMP14;ZEB2;FABP4;BCL6;LEP;ADAM12;KIT;TXNIP;PPARG;S100A4;VIM;CRYAB;MET
Diabetes Mellitus,57/1507,2.6659661431785277E-19,1.4954666923156183E-17,0,0,5.116478356566398,218.8243616686989,SNAP25;IRS2;NR3C1;AQP1;GHR;ZFP36;EFEMP1;ALDH2;KDR;LEPR;TIMP1;CD36;CTSD;SREBF1;VWF;HGF;FOS;DCN;MMP14;MAF;TXNIP;PPARG;EZR;SGK1;TLR4;S100A8;CCL11;CFH;CXCR4;LPL;PIK3R1;EGFR;FOXO1;C3;SOCS3;RASD1;SPP1;CCL2;DMD;FADD;A2M;MEST;ABCA1;STAT5A;STAT5B;EGR1;TCF7L2;STAT1;CAV1;SORBS1;ESR1;PER1;CXCL10;KLF6;FABP4;CXCL12;LEP
Esophageal Neoplasms,38/637,3.0382705297872756E-19,1.6865566305454574E-17,0,0,7.613877295492488,324.6391929597678,YAP1;THRB;MAGED1;CXCR4;UBE2L6;CIB1;NR3C1;EGFR;AKAP12;MUC1;CCND1;ALDH2;PLAU;MDK;KDR;SPP1;SNCG;TIMP1;EGR1;ANXA1;GSN;HGF;PLK1;KLF4;CDC25B;TGFBR2;CXCL10;MMP14;CXCL12;ADAM12;PECAM1;PPARG;S100A4;CALR;EZR;CRYAB;TLR4;MET
Thyroid carcinoma,40/721,4.0153114726311283E-19,2.205937612128998E-17,0,0,7.108310563393371,301.10094027141815,YAP1;NRP1;THRB;CXCR4;CIB1;EGFR;SOCS3;CDH5;MUC1;CCND2;CCND1;KDR;SPP1;CCL2;TIMP1;JUN;ANXA1;STAT1;TPM3;HGF;CAV1;PLK1;BGN;FOS;ESR1;RUNX2;CXCL10;RCAN1;NR4A1;MMP14;KRT19;FABP4;KIT;PECAM1;TXNIP;PPARG;S100A4;VIM;MET;S100A8
Coronary Artery Disease,46/981,4.569005253031348E-19,2.4845131625922504E-17,0,0,6.106684491978609,257.884194554464,CCL11;LRP1;CFH;NEDD9;F13A1;CXCR4;LPL;IRS2;NR3C1;MYLK;C3;CDH5;CCND1;ALDH2;KDR;SPP1;LEPR;CCL2;SVEP1;CD36;TNS1;ABCA1;EGR1;SREBF1;TCF7L2;ANXA1;VWF;STAT1;CAV1;FOS;ESR1;TGFBR2;ACTA2;ZEB2;F8;FABP4;CXCL12;MAF;LEP;BCL3;SAA1;PECAM1;PPARG;BMPR1B;TLR4;S100A8
Diabetes,52/1268,4.782727955064344E-19,2.574460330559383E-17,0,0,5.443808579668349,229.64219643336438,SNAP25;IRS2;NR3C1;GHR;ZFP36;EFEMP1;ALDH2;KDR;LEPR;TIMP1;CD36;SREBF1;VWF;HGF;DCN;MMP14;TXNIP;PPARG;EZR;SGK1;TLR4;S100A8;CCL11;CFH;CXCR4;LPL;PIK3R1;EGFR;FOXO1;C3;SOCS3;RASD1;SPP1;CCL2;DMD;FADD;A2M;ABCA1;STAT5A;STAT5B;EGR1;TCF7L2;STAT1;CAV1;SORBS1;ESR1;PER1;CXCL10;KLF6;FABP4;CXCL12;LEP
"Carcinoma, Spindle-Cell",23/188,1.0130442485056398E-18,5.3985128002865546E-17,0,0,15.641593073593073,648.0870691950099,STAT5A;ANXA1;TPM3;HGF;LPL;KRT5;PIK3R1;ESR1;EGFR;AQP1;TGFBR2;TF;ZEB2;EFEMP1;FABP4;CCND1;S1PR1;SNCG;VIM;EZR;SGK1;MET;TLR4
Precancerous Conditions,32/446,1.3066549767026795E-18,6.894222149355029E-17,0,0,9.0276468191607,371.75002135652625,CFH;FHL1;CIB1;EGFR;SYNE1;AKAP12;MUC1;CCND1;ALDH2;PLAU;AGR2;SPP1;SIRPA;STAT5A;STAT1;HGF;CAV1;LMO2;KRT8;KRT5;FOS;ESR1;DCN;CDC25B;VCAN;LEP;KIT;S100A4;VIM;TLR4;FGFR3;MET
"Diabetes Mellitus, Non-Insulin-Dependent",59/1672,1.4394059623142499E-18,7.520190561933957E-17,0,0,4.786429504877189,196.63753845593902,SNAP25;CIB1;IRS2;NR3C1;RPS6KA3;ZFP36;CCND2;ALDH2;KDR;LEPR;TIMP1;CD36;SREBF1;ANXA1;MME;DST;VWF;HGF;BGN;ANK2;RUNX2;DCN;TGFBR2;MMP14;SERPING1;TXNIP;PPARG;SGK1;TLR4;S100A8;LRP1;CFH;EPAS1;CXCR4;LPL;PIK3R1;EGFR;FOXO1;C3;SOCS3;RASD1;SPP1;CCL2;DMD;ABCA1;STAT5A;STAT5B;TCF7L2;CAV2;CAV1;SORBS1;ESR1;PER1;CXCL10;TF;FABP4;CXCL12;LEP;BCL3
Hodgkin Disease,36/592,1.6137783664792769E-18,8.3493445776389E-17,0,0,7.69224620303757,315.1355842402903,SNAP25;CCL11;NEDD9;LPL;CIB1;PIK3R1;FOXO1;MUC1;CCND2;CCND1;MDK;CCL2;TIMP1;STAT5A;STAT5B;EGR1;JUN;ANXA1;DUSP1;STAT1;HGF;PLK1;LMO2;TAP1;FOS;KLF4;CXCL10;KRT19;CXCL12;BCL6;KIT;BCL3;PECAM1;VIM;FKBP4;MET
Carcinoma,24/216,1.680728401631713E-18,8.569938270635659E-17,0,0,14.08764367816092,576.5692811236112,STAT5A;ANXA1;TPM3;LPL;KRT5;PIK3R1;ESR1;FLI1;EGFR;AQP1;TGFBR2;MUC1;TF;FABP4;EFEMP1;CCND1;MDK;S1PR1;SNCG;EZR;SGK1;TLR4;FGFR3;MET
Conventional (Clear Cell) Renal Cell Carcinoma,37/631,1.688578567117178E-18,8.569938270635659E-17,0,0,7.431415605328649,304.11317956850036,YAP1;THRB;EPAS1;CXCR4;CIB1;NR3C1;EGFR;FOXO1;SOCS3;MUC1;CCND1;KDR;SPP1;ELOB;CTSD;EGR1;TCF7L2;STAT1;HGF;CAV1;PLK1;KRT8;KLF4;EFNA1;MMP14;KRT19;VCAN;CXCL12;LEP;KIT;PECAM1;PPARG;VIM;SGK1;BMPR1B;CRYAB;MET
Multiple Myeloma,52/1312,2.0877019816892063E-18,1.0423421289767496E-16,0,0,5.241269841269841,213.37454680608346,CIB1;NR3C1;RPS6KA3;CCND2;CCND1;KDR;LEPR;TIMP1;TEAD1;MME;HGF;FOS;RUNX2;DCN;VCAN;MAF;KIT;MAPKAPK2;PECAM1;TXNIP;PPARG;SGK1;TLR4;MET;PPP1R15A;LRP1;EPAS1;CXCR4;PIK3R1;EGFR;SOCS3;MUC1;RASD1;S1PR1;SPP1;CCL2;STAT5A;STAT5B;EGR1;JUN;STAT1;CAV1;PLK1;KLF4;ESR1;CXCL10;KLF6;CXCL12;BCL6;LEP;BCL3;FGFR3
Congestive heart failure,43/884,2.0928993770034193E-18,1.0423421289767496E-16,0,0,6.254635418664416,254.61358170853453,SNAP25;CXCR4;NR3C1;PKD2;EGFR;MYLK;RGS4;GRK3;ALDH2;PRKAR2B;MAP3K20;S1PR1;SPP1;CCL2;DMD;TIMP1;CD36;SPTBN1;EGR1;MEF2C;GSN;MME;VWF;HGF;ANK2;LIFR;FOS;ESR1;DCN;NR4A1;TF;MMP14;COL1A2;FABP4;CXCL12;LEP;MAPKAPK2;PECAM1;PPARG;CALR;SGK1;UTRN;TLR4
Hyperglycemia,33/488,2.1476091985875807E-18,1.0596860573401127E-16,0,0,8.504175824175825,345.96838145065385,SNAP25;EPAS1;LPL;IRS2;PIK3R1;FOXO1;MYLK;SOCS3;CDH5;CCND1;ALDH2;KDR;SPP1;LEPR;CCL2;TIMP1;CD36;EGR1;TCF7L2;JUN;VWF;HGF;FOS;ESR1;RUNX2;CXCL10;CXCL12;LEP;TXNIP;PPARG;SGK1;UTRN;TLR4
Polycystic Ovary Syndrome,34/526,2.497216899672623E-18,1.2208870512252668E-16,0,0,8.136773745786238,329.79446363618973,YAP1;IRS2;PIK3R1;ANTXR2;NR3C1;EGFR;FOXO1;C3;SOCS3;MUC1;CCND2;PRKAR2B;SPP1;LEPR;CCL2;DMD;SVEP1;TIMP1;CD36;SREBF1;TCF7L2;CAV1;LIFR;FOS;SORBS1;ESR1;NR4A1;VCAN;FABP4;LEP;PPARG;VIM;FKBP4;TLR4
Chronic Lymphocytic Leukemia,48/1120,2.5778177361834106E-18,1.2488355196473995E-16,0,0,5.591044776119403,226.43501255896422,NRP1;MAML2;CFH;LAMA4;CXCR4;LPL;CIB1;PIK3R1;NR3C1;EGFR;ETS2;AQP1;ZFP36;CCND2;CCND1;PPP2R1B;KDR;MAP3K20;S1PR1;CCL2;DMD;FADD;ABCA1;STAT5A;STAT5B;JUN;MME;DUSP1;STAT1;HGF;CAV1;FOS;ESR1;ACTA2;CXCL10;NR4A1;TF;KLF6;CXCL12;BCL6;BCL3;PECAM1;VIM;CALR;TLR4;FGFR3;MET;S100A8
Secondary malignant neoplasm of bone,28/330,2.8120113701205257E-18,1.3500187920155207E-16,0,0,10.634982469809115,429.78762922598804,NRP1;F13A1;CXCR4;EGFR;FOXO1;MUC1;KDR;SPP1;CCL2;A2M;CTSD;HGF;KLF4;ESR1;RUNX2;DCN;EFNA1;MMP14;ZEB2;VCAN;FABP4;CXCL12;LEP;PECAM1;VIM;EZR;TLR4;MET
Prostatic Intraepithelial Neoplasias,22/174,2.8976111665452926E-18,1.3786937416535595E-16,0,0,16.15953947368421,652.5649461236932,ANXA1;MME;DUSP1;PROS1;CAV1;PLK1;KRT8;IRS2;ESR1;EGFR;AKAP12;MMP14;KRT19;CCND1;PLAU;SPP1;AGR2;TIMP1;VIM;EZR;SGK1;MET
Primary malignant neoplasm,46/1032,3.330117751711842E-18,1.5704599556524252E-16,0,0,5.775168143482438,232.4131178420084,YAP1;NRP1;EPAS1;MAGED1;NEDD9;CXCR4;PIK3R1;LAMC1;EGFR;GHR;SOCS3;RPS6KA3;MUC1;ZFP36;SPP1;CTSD;STAT5A;CA12;STAT5B;TCF7L2;ANXA1;DUSP1;HGF;CAV1;PLK1;KRT5;FOS;SOX10;ESR1;RUNX2;FLI1;TF;ZEB2;KRT19;F8;CXCL12;LEP;KIT;TXNIP;PPARG;VIM;SGK1;UTRN;CRYAB;FGFR3;MET
Heart failure,41/815,4.521034192001754E-18,2.1133851937874869E-16,0,0,6.420020079329811,256.4014195192811,CXCR4;NR3C1;PKD2;EGFR;MYLK;RGS4;GRK3;ALDH2;PRKAR2B;MAP3K20;S1PR1;SPP1;CCL2;DMD;TIMP1;CD36;SPTBN1;TCF7L2;MEF2C;GSN;MME;VWF;DUSP1;HGF;ANK2;LIFR;FOS;DCN;NR4A1;TF;MMP14;COL1A2;FABP4;CXCL12;LEP;MAPKAPK2;PPARG;CALR;SGK1;UTRN;TLR4
Adenocarcinoma of lung (disorder),49/1187,4.899100923847009E-18,2.2702007672331055E-16,0,0,5.393519774477772,214.97210638196378,CIB1;CCND1;MDK;KDR;TIMP1;CTSD;ANXA1;HGF;KRT8;FOS;RUNX2;TGFBR2;ACTA2;MMP14;ZEB2;KIT;PPARG;S100A4;PRTN3;EZR;TLR4;MET;YAP1;LRP1;CFH;EPAS1;FBLN2;EGFR;FOXO1;MUC1;SPP1;CCL2;MEST;STAT5A;STAT5B;EGR1;JUN;GSN;GOLM1;CAV1;PLK1;ESR1;EFNA1;TF;KRT19;KLF6;CXCL12;VIM;FGFR3
Malignant Glioma,33/504,5.661006806618737E-18,2.6006470062475217E-16,0,0,8.208492569002123,325.98329011263496,EPAS1;ITSN1;CXCR4;PIK3R1;EGFR;MYLK;ZFP36;CCND2;EFEMP1;CCND1;PLAU;MDK;KDR;SPP1;CCL2;FADD;TIMP1;TNS1;EGR1;STAT1;CAV2;HGF;CAV1;PLK1;FOS;QKI;DCN;CXCL10;NR4A1;MMP14;VIM;CALR;MET
Coronary heart disease,43/913,6.892490383965765E-18,3.139323184286629E-16,0,0,6.036900259547646,238.5547495477151,YAP1;CFH;PROS1;F13A1;CXCR4;LPL;IRS2;NR3C1;EGFR;FOXO1;ETS2;C3;ALDH2;PLAU;KDR;SPP1;LEPR;CCL2;SVEP1;TIMP1;CD36;ABCA1;EGR1;SREBF1;TCF7L2;MEF2C;ANXA1;VWF;CAV1;FOS;ESR1;QKI;TGFBR2;ACTA2;MMP14;F8;FABP4;CXCL12;MAF;LEP;PECAM1;PPARG;TLR4
"Fibrosis, Liver",34/545,7.426646959693322E-18,3.353949292220823E-16,0,0,7.82652379361367,308.689503238794,EGFR;SOCS3;ALDH2;PLAU;KDR;SPP1;LEPR;CCL2;FADD;TIMP1;A2M;TNS1;EGR1;SREBF1;ANXA1;STAT1;HGF;KRT8;DCN;TGFBR2;ACTA2;CXCL10;MMP14;ZEB2;KLF6;COL1A2;KRT18;LEP;SERPING1;PPARG;S100A4;VIM;TLR4;MET
Arthritis,36/630,1.1898767033586866E-17,5.328447858990287E-16,0,0,7.1859334081556305,280.0365211592331,NEDD9;CXCR4;PIK3R1;NR3C1;EGFR;FOXO1;C3;SOCS3;MUC1;ZFP36;GRK3;MDK;KDR;S1PR1;SPP1;CCL2;TIMP1;JUN;HGF;CAV1;LIFR;FOS;ESR1;RUNX2;CDC25B;CXCL10;MMP14;CXCL12;LEP;SAA1;PECAM1;PPARG;VIM;CALR;TLR4;S100A8
Small cell carcinoma of lung,37/673,1.396656665769311E-17,6.202319476570548E-16,0,0,6.925485370522286,268.7771543408118,YAP1;NRP1;SNAP25;THRB;LRP1;CFH;EPAS1;CXCR4;LPL;CIB1;NR3C1;EGFR;MUC1;CCND2;CCND1;PLAU;KDR;MAP3K20;SPP1;CCL2;ANXA1;TPM3;HGF;CAV1;PLK1;KRT8;TAP1;TGFBR2;RCAN1;MMP14;ZEB2;KRT19;KRT18;CXCL12;KIT;VIM;MET
Coronary Arteriosclerosis,39/760,1.7148823716288194E-17,7.55256872595866E-16,0,0,6.491324941773742,250.59501641799287,PPP1R15A;LRP1;CFH;F13A1;LPL;IRS2;NR3C1;C3;ALDH2;KDR;SPP1;LEPR;CCL2;SVEP1;CD36;ABCA1;EGR1;SREBF1;TCF7L2;ANXA1;VWF;HGF;CAV1;ANK2;FOS;ESR1;TGFBR2;ACTA2;RCAN1;MMP14;F8;FABP4;CXCL12;MAF;LEP;PECAM1;TXNIP;PPARG;TLR4
Malignant neoplasm of liver,40/805,1.892301983564359E-17,8.265637106897106E-16,0,0,6.299991726648465,242.58844225218945,YAP1;CFH;EPAS1;CXCR4;PIK3R1;EGFR;MUC1;ZFP36;CCND1;ALDH2;PLAU;KDR;SPP1;SNCG;TEAD1;TNS1;EGR1;TCF7L2;JUN;TPM3;GOLM1;HGF;CAV1;PLK1;KRT8;ESR1;RUNX2;DCN;TGFBR2;NR4A1;ZEB2;VCAN;KLF6;KRT18;LEP;ADAM12;MAPKAPK2;PPARG;TLR4;MET
Cerebrovascular accident,39/768,2.444552581149486E-17,1.0591073743858221E-15,0,0,6.417397831094546,245.46600910484625,CCL11;LRP1;CFH;F13A1;CXCR4;LPL;PIK3R1;C3;GHR;ALDH2;PLAU;KDR;SPP1;CCL2;TIMP1;CD36;A2M;TEAD1;ABCA1;EGR1;TCF7L2;ANXA1;VWF;STAT1;ZBTB16;CAV1;ANK2;SORBS1;ESR1;ACTA2;CXCL10;RCAN1;MMP14;PTPRB;F8;CXCL12;LEP;PPARG;TLR4
B-Cell Lymphomas,38/730,2.947112939738509E-17,1.2665455528924607E-15,0,0,6.558706647398844,249.644841799885,CXCR4;CIB1;IRS2;PIK3R1;NR3C1;FOXO1;SOCS3;MUC1;CCND2;CCND1;KDR;MAP3K20;TIMP1;STAT5A;STAT5B;EGR1;SREBF1;ANXA1;MME;TPM3;HGF;PLK1;LMO2;KLF4;ESR1;TGFBR2;NR4A1;KLF6;CXCL12;BCL6;LEP;KIT;BCL3;PPARG;PRTN3;VIM;TLR4;FGFR3
Malignant neoplasm of endometrium,34/577,4.2202421163896346E-17,1.793752741089197E-15,0,0,7.353074608094147,277.2407226848023,CXCR4;PIK3R1;NR3C1;EGFR;FOXO1;AQP1;CCND1;PLAU;KDR;AGR2;SPP1;LEPR;SNCG;CCL2;TIMP1;CTSD;EGR1;SREBF1;CAV1;FOS;ESR1;DCN;TGFBR2;PER1;KRT19;VCAN;CXCL12;LEP;KIT;S100A4;VIM;EZR;SGK1;MET
Pulmonary Fibrosis,30/432,4.241186815110506E-17,1.793752741089197E-15,0,0,8.617626154939588,324.8767798360881,CCL11;CXCR4;EGFR;ETS2;MUC1;PLAU;SPP1;CCL2;TIMP1;CD36;EGR1;ANXA1;VWF;STAT1;HGF;CAV1;KRT8;BGN;FOS;DCN;TGFBR2;COL1A2;CXCL12;MAPKAPK2;PPARG;S100A4;PRTN3;EZR;UTRN;CRYAB
Malignant mesothelioma,27/335,4.3568587325650715E-17,1.828165368963722E-15,0,0,9.993506493506494,376.4773279293357,YAP1;NRP1;CCL11;CXCR4;CIB1;EGFR;MUC1;CCND2;EFEMP1;CCND1;MDK;KDR;SPP1;TNS1;JUN;HGF;PLK1;ESR1;CXCL10;TF;MMP14;ZEB2;CXCL12;KIT;TXNIP;VIM;MET
Cirrhosis,30/433,4.5192312469748895E-17,1.8814830714944676E-15,0,0,8.595799361928394,323.50810669088804,CXCR4;EGFR;AQP1;GHR;SOCS3;CCND2;ALDH2;PLAU;LEPR;CCL2;TIMP1;TEAD1;VWF;STAT1;GOLM1;HGF;CAV1;KRT8;ESR1;DCN;CXCL10;MMP14;KRT19;KLF6;COL1A2;PECAM1;VIM;CALR;TLR4;MET
Uterine Corpus Cancer,34/579,4.686322053371919E-17,1.935923273055733E-15,0,0,7.325330051465652,275.42727133667324,CXCR4;PIK3R1;NR3C1;EGFR;FOXO1;AQP1;CCND1;PLAU;KDR;AGR2;SPP1;LEPR;SNCG;CCL2;TIMP1;CTSD;EGR1;SREBF1;CAV1;FOS;ESR1;DCN;TGFBR2;PER1;KRT19;VCAN;CXCL12;LEP;KIT;S100A4;VIM;EZR;SGK1;MET
Aneurysm,20/152,4.7761525988791435E-17,1.9578551691866887E-15,0,0,16.74327545114062,629.2175028674951,LRP1;STAT1;BGN;PKD2;KLF4;DCN;TGFBR2;ACTA2;CDH5;RCAN1;MMP14;COL1A2;PLAU;LEP;PECAM1;CCL2;FADD;TIMP1;VIM;TLR4
cervical cancer,43/965,5.218419633698483E-17,2.1228212387770394E-15,0,0,5.6807781120985235,212.98232401521335,CXCR4;CIB1;EGFR;FOXO1;AQP1;SOCS3;MUC1;ZFP36;EFEMP1;CCND1;PPP2R1B;PLAU;MDK;SPP1;CCL2;STAT5A;CA12;STAT5B;EGR1;JUN;GSN;FZD4;TPM3;HGF;CAV1;TAP1;KLF4;ESR1;CXCL10;MMP14;ZEB2;KRT19;VCAN;KLF6;PPARG;S100A4;VIM;CALR;EZR;TLR4;FGFR3;MET;S100A8
Cardiovascular Diseases,39/787,5.573804388075267E-17,2.2502123927312955E-15,0,0,6.248158611643628,233.84276410412886,CFH;PROS1;FHL1;LPL;NR3C1;FOXO1;RGS2;CCND1;ALDH2;PLAU;SPP1;LEPR;CCL2;CD36;ABCA1;TCF7L2;JUN;ANXA1;VWF;DUSP1;HGF;CAV1;BGN;ANK2;FOS;ESR1;FLI1;TGFBR2;F8;KLF6;FABP4;CXCL12;LEP;BCL3;SAA1;PECAM1;PPARG;TLR4;S100A8
Amyloidosis,40/833,6.137830438043325E-17,2.459285594310743E-15,0,0,6.068606637189331,226.53790126515736,SNAP25;LRP1;LPL;CIB1;MEOX2;EGFR;FOXO1;ETS2;C3;SOCS3;PLAU;SNCG;CCL2;DMD;TIMP1;CD36;A2M;CTSD;ABCA1;EGR1;GSN;MME;VWF;CAV1;BGN;LIFR;ESR1;DCN;RCAN1;MMP14;ZEB2;CXCL12;LEP;SAA1;PPARG;FKBP4;UTRN;CRYAB;TLR4;S100A8
Malignant tumor of cervix,41/884,7.909265242641698E-17,3.1454085431371348E-15,0,0,5.873163028613309,217.75287380811963,CXCR4;CIB1;EGFR;FOXO1;AQP1;SOCS3;MUC1;ZFP36;EFEMP1;CCND1;PPP2R1B;PLAU;MDK;SPP1;CCL2;STAT5A;CA12;STAT5B;EGR1;JUN;GSN;FZD4;TPM3;HGF;CAV1;TAP1;KLF4;ESR1;MMP14;ZEB2;KRT19;VCAN;KLF6;PPARG;VIM;CALR;EZR;TLR4;FGFR3;MET;S100A8
Anaplastic carcinoma,22/204,9.181701836999727E-17,3.624391784397893E-15,0,0,13.475274725274724,497.5978854670205,STAT5A;ANXA1;TPM3;LPL;KRT5;PIK3R1;ESR1;EGFR;AQP1;TGFBR2;TF;FABP4;EFEMP1;CCND1;S1PR1;SNCG;PPARG;S100A4;EZR;SGK1;TLR4;MET
Esophageal carcinoma,36/685,1.682329003363147E-16,6.5920082786192725E-15,0,0,6.558123608971067,238.19880342941414,YAP1;THRB;MAGED1;CXCR4;UBE2L6;CIB1;NR3C1;EGFR;AKAP12;MUC1;CCND1;ALDH2;KDR;SPP1;SNCG;TIMP1;EGR1;ANXA1;GSN;HGF;CAV1;PLK1;KLF4;ESR1;CDC25B;TGFBR2;CXCL10;MMP14;CXCL12;PECAM1;PPARG;S100A4;CALR;EZR;TLR4;MET
Undifferentiated carcinoma,23/237,1.857931470142263E-16,7.226946572546072E-15,0,0,12.030013351134846,435.74991331774925,STAT5A;EGR1;ANXA1;TPM3;LPL;KRT5;PIK3R1;ESR1;EGFR;AQP1;TGFBR2;MUC1;TF;FABP4;EFEMP1;CCND1;S1PR1;SNCG;PPARG;EZR;SGK1;TLR4;MET
Colitis,34/608,2.0421642688182404E-16,7.886009701835074E-15,0,0,6.944760771649529,250.8958122747318,PPP1R15A;NRP1;CCL11;PROS1;PIK3R1;EGFR;ETS2;SYNE1;SOCS3;MUC1;KDR;SPP1;CCL2;FADD;TIMP1;STAT5A;STAT5B;ANXA1;GSN;STAT1;HGF;KRT8;RUNX2;TGFBR2;CXCL10;NR4A1;LEP;BCL3;PPARG;PRTN3;VIM;EZR;SGK1;TLR4
"Diabetes Mellitus, Insulin-Dependent",42/956,2.1281688235251715E-16,8.159001194651539E-15,0,0,5.563709813162768,200.7725863809951,NRP1;CCL11;LPL;EGFR;C3;SOCS3;RGS2;ALDH2;PLAU;SPP1;CCL2;FADD;TIMP1;CD36;ABCA1;STAT5A;STAT5B;SREBF1;TCF7L2;ANXA1;GSN;MME;VWF;DUSP1;STAT1;HGF;TAP1;FOS;SORBS1;ESR1;DCN;CXCL10;MMP14;VCAN;COL1A2;CXCL12;LEP;TXNIP;PPARG;TLR4;S100A8;SKAP2
Inflammatory Bowel Diseases,41/911,2.25047033040618E-16,8.566254564810381E-15,0,0,5.682787905410352,204.7521112758571,CCL11;MAML2;CXCR4;LPL;NR3C1;EGFR;FOXO1;MYLK;C3;SOCS3;MUC1;CCND1;PLAU;AGR2;SPP1;CCL2;TIMP1;CD36;STAT5A;EGR1;TCF7L2;ANXA1;FZD4;HGF;KRT8;ESR1;CXCL10;NR4A1;MMP14;KLF6;KRT18;CXCL12;LEP;BCL3;SAA1;PPARG;EZR;TLR4;S100A8;SKAP2;ARHGEF6
Idiopathic pulmonary arterial hypertension,25/297,2.4806454967876963E-16,9.3754325194196E-15,0,0,10.375935056103366,372.8368420354196,CFH;ITSN1;FHL1;CXCR4;AQP1;CCL2;TIMP1;EGR1;CAV1;BGN;LIFR;KLF4;ESR1;TGFBR2;EFNA1;ACTA2;KLF6;COL1A2;CXCL12;LEP;PECAM1;PPARG;S100A4;UTRN;BMPR1B
Hepatitis C,38/783,2.9458399642752153E-16,1.1055198006776494E-14,0,0,6.075218120805369,217.2556777394891,ARF1;CXCR4;LPL;CIB1;EGFR;FOXO1;C3;SOCS3;PLAU;SPP1;LEPR;CCL2;ABCA1;STAT5A;STAT5B;SREBF1;DUSP1;STAT1;GOLM1;KRT8;TAP1;SORBS1;ESR1;CXCL10;MMP14;KLF6;KRT18;CXCL12;BCL6;LEP;KIT;SAA1;SERPING1;PPARG;VIM;FKBP4;TLR4;MET
Retinoblastoma,32/539,3.1798233487612E-16,1.1849845192691214E-14,0,0,7.336327558755733,261.7934437290463,NEDD9;CIB1;EGFR;FOXO1;AKAP12;GRK3;CCND1;PLAU;KDR;SNCG;CCL2;FADD;TPM3;CAV1;PLK1;LMO2;KRT8;BGN;FOS;ESR1;RUNX2;DCN;CDC25B;TGFBR2;KLF6;LEP;KIT;BCL3;PPARG;S100A4;CRYAB;FGFR3
Squamous cell carcinoma of esophagus,43/1023,4.274946981455542E-16,1.582027254456707E-14,0,0,5.328150098749177,188.5557181713504,YAP1;MAGED1;CXCR4;PIK3R1;EGFR;ETS2;AKAP12;GHR;MUC1;CCND1;ALDH2;PLAU;MDK;SPP1;FADD;EGR1;JUN;ANXA1;MME;STAT1;GOLM1;HGF;CAV1;PLK1;SORBS2;LIFR;KLF4;ESR1;CDC25B;TGFBR2;CXCL10;MMP14;ZEB2;KRT19;CXCL12;PECAM1;S100A4;VIM;CALR;EZR;TLR4;MET;S100A8
Lip and Oral Cavity Carcinoma,30/473,5.017672606242377E-16,1.844081194390733E-14,0,0,7.803531118993873,274.9058788862259,FHL1;CXCR4;CIB1;EGFR;FOXO1;CCND1;PLAU;AGR2;SPP1;LEPR;CCL2;CD36;STAT1;HGF;CAV1;PLK1;KRT5;KLF4;DCN;TGFBR2;MMP14;ZEB2;KLF6;CXCL12;LEP;BCL3;PPARG;S100A4;VIM;CRYAB
Metabolic Syndrome X,32/548,5.094222591257482E-16,1.859391245808981E-14,0,0,7.205006070794807,253.71171183647687,CCL11;LPL;IRS2;PIK3R1;NR3C1;FOXO1;C3;SOCS3;ZFP36;RGS2;CCND1;ALDH2;LEPR;CCL2;FADD;TIMP1;CD36;ABCA1;SREBF1;TCF7L2;MME;VWF;ZBTB16;HGF;CAV1;ANK2;ESR1;FABP4;LEP;PPARG;SGK1;TLR4
Medulloblastoma,33/590,5.926130446455258E-16,2.148323071371433E-14,0,0,6.910233393177738,242.28653431191148,SNAP25;CXCR4;CIB1;IRS2;EGFR;C3;AKAP12;CCND2;CCND1;PLAU;MDK;KDR;CCL2;GSN;TPM3;HGF;PLK1;LIFR;KLF4;ESR1;FLI1;NR4A1;TF;VCAN;COL1A2;FABP4;CXCL12;KIT;PPARG;S100A4;VIM;EZR;MET
Malignant neoplasm of esophagus,35/673,6.44321849727737E-16,2.3199940116210208E-14,0,0,6.449795180491182,225.60308557847407,YAP1;THRB;LRP1;MAGED1;CXCR4;UBE2L6;NR3C1;EGFR;AKAP12;MUC1;CCND1;ALDH2;KDR;SPP1;SNCG;TIMP1;EGR1;ANXA1;GSN;GOLM1;HGF;PLK1;KLF4;CDC25B;TGFBR2;CXCL10;MMP14;CXCL12;PECAM1;S100A4;CALR;EZR;CRYAB;TLR4;MET
Carcinomatosis,20/176,8.787280528518996E-16,3.142779727280385E-14,0,0,14.150100835494094,490.5564910925137,STAT5A;ANXA1;TPM3;LPL;KRT5;PIK3R1;ESR1;EGFR;AQP1;TGFBR2;TF;EFEMP1;FABP4;CCND1;S1PR1;SNCG;EZR;SGK1;MET;TLR4
Immunologic Deficiency Syndromes,34/641,9.869537058418088E-16,3.506317532287332E-14,0,0,6.555932816329811,226.51999106072694,NRP1;CFH;CXCR4;PIK3R1;ANTXR2;EGFR;FOXO1;C3;SOCS3;MUC1;ZFP36;CCND1;PLAU;KDR;SPP1;LEPR;CCL2;DMD;CD36;EGR1;STAT1;HGF;PLK1;LMO2;KRT5;TGFBR2;KRT19;F8;CXCL12;LEP;PPARG;CALR;TLR4;MET
Mesothelioma,27/383,1.2429593777978907E-15,4.38657650614898E-14,0,0,8.624778237729155,296.01343973405625,YAP1;EGFR;ETS2;AQP1;SOCS3;MUC1;PLAU;MDK;KDR;SPP1;CCL2;ABCA1;EGR1;GSN;STAT1;HGF;KRT5;ESR1;CXCL10;MMP14;ZEB2;F8;KIT;PPARG;S100A4;VIM;MET
Liver diseases,33/606,1.2871915372995613E-15,4.5127919093877384E-14,0,0,6.711692844677138,230.11920601344713,NRP1;CFH;CXCR4;EGFR;GHR;SOCS3;ALDH2;KDR;SPP1;LEPR;CCL2;TIMP1;CD36;TEAD1;ABCA1;TCF7L2;JUN;ANXA1;VWF;GOLM1;HGF;KRT8;TAP1;ESR1;ACTA2;CXCL10;TF;COL1A2;KRT18;CXCL12;LEP;PPARG;TLR4
Crohn Disease,40/912,1.3256720225752748E-15,4.6173243191527057E-14,0,0,5.495877366159563,188.27148434716563,NEDD9;F13A1;CXCR4;LPL;ANTXR2;NR3C1;C3;GHR;SOCS3;MUC1;PLAU;KDR;SPP1;CCL2;TIMP1;STAT5A;STAT5B;EGR1;TCF7L2;JUN;ANXA1;TPM3;HGF;KRT8;TAP1;FOS;TGFBR2;ACTA2;NR4A1;CXCL12;LEP;BCL3;SAA1;PPARG;S100A4;VIM;SGK1;TLR4;SKAP2;ARHGEF6
Liver and Intrahepatic Biliary Tract Carcinoma,33/607,1.3500198139527962E-15,4.671594538022371E-14,0,0,6.699651567944251,229.38707289560372,YAP1;CFH;EPAS1;CXCR4;EGFR;MUC1;ZFP36;CCND1;ALDH2;PLAU;SPP1;SNCG;TEAD1;TNS1;EGR1;TCF7L2;TPM3;GOLM1;HGF;CAV1;PLK1;ESR1;RUNX2;DCN;NR4A1;ZEB2;VCAN;KLF6;LEP;MAPKAPK2;PPARG;TLR4;MET
Benign Prostatic Hyperplasia,28/420,1.4692811004737728E-15,5.051483215757894E-14,0,0,8.155462184873949,278.5416812419224,THRB;PROS1;LPL;EGFR;AKAP12;KDR;SPP1;CCL2;A2M;ABCA1;EGR1;JUN;ANXA1;DUSP1;CAV1;PLK1;KLF4;ESR1;FLI1;VCAN;KLF6;KIT;TXNIP;PPARG;SGK1;FGFR3;MET;S100A8
Renal carcinoma,30/500,2.2319817157714146E-15,7.57594303397826E-14,0,0,7.344984802431611,247.78957394963206,THRB;EPAS1;CXCR4;CIB1;PIK3R1;NR3C1;EGFR;MYLK;C3;MUC1;CCND1;PLAU;KDR;LEPR;TNS1;EGR1;MME;HGF;CAV1;PLK1;KLF4;ZEB2;KRT19;CXCL12;LEP;PPARG;VIM;SGK1;MET;S100A8
Adult T-Cell Lymphoma/Leukemia,30/500,2.2319817157714146E-15,7.57594303397826E-14,0,0,7.344984802431611,247.78957394963206,NRP1;SNAP25;LRP1;CXCR4;CIB1;ANTXR2;ETS2;C3;MUC1;CCND1;PLAU;SPP1;CCL2;STAT5A;STAT5B;EGR1;JUN;GSN;STAT1;HGF;LMO2;FOS;KLF4;KIT;BCL3;TXNIP;S100A4;VIM;FKBP4;MET
Inflammation,28/429,2.516341431451313E-15,8.487078157091169E-14,0,0,7.9687252457092566,267.8764316763485,CCL11;NR3C1;C3;SOCS3;MUC1;ZFP36;PLAU;SPP1;CCL2;TIMP1;EGR1;ANXA1;MME;VWF;HGF;CXCL10;TF;CXCL12;LEP;SAA1;PECAM1;SERPING1;TXNIP;PPARG;PRTN3;FKBP4;CRYAB;TLR4
Malignant neoplasm of thyroid,30/505,2.911710220643882E-15,9.75880739988129E-14,0,0,7.265789473684211,243.18623366628765,YAP1;THRB;CXCR4;CIB1;EGFR;SOCS3;CDH5;MUC1;CCND2;CCND1;KDR;TIMP1;JUN;ANXA1;TPM3;HGF;CAV1;FOS;RUNX2;RCAN1;MMP14;KRT19;FABP4;KIT;PECAM1;TXNIP;PPARG;S100A4;VIM;MET
Hyperactive behavior,35/709,3.1139358490997987E-15,1.0371352587408017E-13,0,0,6.093826800895669,203.55141974335666,YAP1;SNAP25;CFH;LPL;NR3C1;EGFR;RPS6KA3;MUC1;KDR;SNCG;CCL2;DMD;CD36;STAT5B;MEF2C;VWF;DUSP1;STAT1;HGF;CAV1;FOS;ESR1;RUNX2;PER1;FABP4;CXCL12;BCL6;LEP;KIT;S100A4;VIM;EZR;CRYAB;FGFR3;MET
Aortic Valve Insufficiency,21/214,3.2455855514498348E-15,1.0742686586134266E-13,0,0,12.054360235356107,402.1513053029338,STAT5A;SREBF1;JUN;PROS1;CAV1;FOS;ESR1;FOXO1;MYLK;TGFBR2;ACTA2;MUC1;RGS2;COL1A2;CCND1;CCL2;TIMP1;SGK1;FKBP4;TEAD1;MET
Dyslipidemias,21/216,3.916819216982906E-15,1.288440099216167E-13,0,0,11.929508909169925,395.74352198220134,ABCA1;SREBF1;TCF7L2;LRP1;HGF;CAV1;LPL;NR3C1;ESR1;FOXO1;MYLK;C3;SOCS3;FABP4;CXCL12;LEP;LEPR;TXNIP;PPARG;CD36;TLR4
"Mammary Carcinoma, Animal",18/145,5.3160345609791386E-15,1.7273870838693797E-13,0,0,15.492125984251969,509.19595213441704,STAT5A;ANXA1;TPM3;LPL;KRT5;PIK3R1;ESR1;EGFR;AQP1;TF;EFEMP1;FABP4;CCND1;S1PR1;SNCG;EZR;SGK1;S100A8
Animal Mammary Neoplasms,18/145,5.3160345609791386E-15,1.7273870838693797E-13,0,0,15.492125984251969,509.19595213441704,STAT5A;ANXA1;TPM3;LPL;KRT5;PIK3R1;ESR1;EGFR;AQP1;TF;EFEMP1;FABP4;CCND1;S1PR1;SNCG;EZR;SGK1;S100A8
Fatty Liver,28/443,5.661861200790836E-15,1.8286095963039008E-13,0,0,7.694344436569809,252.41315177220255,EPAS1;CXCR4;LPL;EGFR;FOXO1;CCND1;ALDH2;PLAU;KDR;SPP1;LEPR;CCL2;CD36;ABCA1;EGR1;SREBF1;TCF7L2;HGF;CXCL10;TF;KLF6;KRT18;LEP;SAA1;TXNIP;PPARG;TLR4;MET
Fibrosis,19/169,5.804047773752165E-15,1.8632391919473065E-13,0,0,13.906443202979515,455.856279136075,EGR1;STAT1;HGF;CAV1;DCN;EGFR;TGFBR2;CCND2;COL1A2;CXCL12;CCND1;LEPR;SPP1;CCL2;TIMP1;VIM;SGK1;TLR4;MATN2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,27/408,5.891703803313522E-15,1.8800532675363928E-13,0,0,8.048487360132615,263.7105489120283,CXCR4;DTX1;NR3C1;RPS6KA3;ZFP36;CCND2;CCND1;MAP3K20;SPP1;STAT5A;CA12;STAT5B;MEF2C;MME;DUSP1;STAT1;ZBTB16;PLK1;LMO2;KLF4;RUNX2;TF;ZEB2;CXCL12;BCL6;KIT;S100A4
Acute lymphocytic leukemia,39/907,6.09178821170982E-15,1.9323297250120018E-13,0,0,5.350447787148943,175.1299726762017,NRP1;SNAP25;LRP1;CXCR4;CIB1;NR3C1;C3;SOCS3;CCND2;CCND1;MDK;KDR;MAP3K20;SPP1;CCL2;STAT5A;STAT5B;TCF7L2;JUN;MEF2C;MME;STAT1;ZBTB16;PLK1;LMO2;FOS;KLF4;ESR1;FLI1;CXCL10;ZEB2;CXCL12;BCL6;LEP;KIT;PECAM1;S100A4;FKBP4;TLR4
"Carcinoma, Papillary",20/196,7.176145816435296E-15,2.2628213642475557E-13,0,0,12.529366700715014,408.0565894978693,ANXA1;THRB;DUSP1;TPM3;HGF;PLK1;BGN;CIB1;ESR1;RUNX2;KRT19;MUC1;CCND1;MDK;KIT;KDR;PPARG;S100A4;FGFR3;MET
Gastrointestinal Carcinoid Tumor,21/225,8.910009328610024E-15,2.7858092603114227E-13,0,0,11.397972748421402,368.7426677790766,STAT5A;STAT1;KRT8;CXCR4;FOS;ESR1;RUNX2;FLI1;EGFR;FOXO1;TGFBR2;CXCL12;CCND2;KIT;KDR;SPP1;CCL2;PPARG;BMPR1B;TEAD1;FGFR3
Anaplasia,23/283,8.93926409294902E-15,2.7858092603114227E-13,0,0,9.878373626373627,319.5488220187546,NRP1;JUN;DUSP1;PROS1;HGF;CAV1;PLK1;KRT8;KLF4;ESR1;EGFR;FOXO1;DCN;SOCS3;MUC1;KRT18;CCND1;KIT;SPP1;CCL2;PPARG;VIM;CALR
Aplasia Cutis Congenita,20/199,9.626724772992279E-15,2.9826055997253404E-13,0,0,12.317494193710376,397.53768169303163,COL17A1;JUN;LAMA3;CXCR4;FOS;NR3C1;SOX10;ESR1;EGFR;AQP1;VCAN;CCND1;KRT15;KIT;SPP1;PPARG;VIM;TLR4;FGFR3;MET
Steatohepatitis,31/569,1.0199501980012472E-14,3.1418003497969054E-13,0,0,6.646751107450527,214.13464163988598,THRB;EPAS1;CXCR4;LPL;IRS2;EGFR;FOXO1;DEPP1;CCND1;ALDH2;SPP1;LEPR;CCL2;CD36;ABCA1;EGR1;SREBF1;TCF7L2;ANXA1;HGF;CAV1;DCN;CXCL10;TF;KLF6;KRT18;FABP4;LEP;TXNIP;PPARG;TLR4
Virus Diseases,38/875,1.0488444681625494E-14,3.212236879792084E-13,0,0,5.381347072879331,173.2175023648118,PPP1R15A;CFH;CXCR4;CIB1;NR3C1;EGFR;FOXO1;C3;SOCS3;RPS6KA3;ZFP36;SPP1;LEPR;SIRPA;CCL2;DMD;EGR1;JUN;MME;DUSP1;STAT1;ZBTB16;HGF;TAP1;FOS;ESR1;RUNX2;CXCL10;KLF6;LEP;SERPING1;PPARG;FKBP4;UTRN;TLR4;FGFR3;MET;S100A8
Papillary thyroid carcinoma,31/571,1.1217350802830214E-14,3.415219864108287E-13,0,0,6.6214459968950985,212.68955021502734,THRB;CXCR4;EGFR;MUC1;CCND1;PLAU;MDK;KDR;SPP1;LEPR;TIMP1;CA12;JUN;ANXA1;TPM3;HGF;FOS;ESR1;RUNX2;FLI1;CXCL10;ZEB2;KRT19;CXCL12;LEP;KIT;PPARG;S100A4;VIM;TLR4;MET
"Cardiomyopathy, Dilated",27/419,1.1279390055977828E-14,3.415219864108287E-13,0,0,7.818206229860365,251.08794156497396,YAP1;LAMA4;FHL1;LPL;PKD2;EGFR;SYNE1;GRK3;ALDH2;KDR;SPP1;CCL2;DMD;TIMP1;CD36;MME;TPM3;HGF;LIFR;ESR1;RCAN1;MMP14;PPARG;CALR;UTRN;CRYAB;TLR4
Anoxia,23/288,1.302873257005519E-14,3.9226054161482545E-13,0,0,9.689509433962264,309.7893066194957,STAT5B;EGR1;SREBF1;JUN;EPAS1;DUSP1;STAT1;HGF;CXCR4;FOS;ESR1;RUNX2;TGFBR2;MUC1;KLF6;CXCL12;CCND1;LEP;KDR;TXNIP;CCL2;SGK1;TLR4
Diffuse Large B-Cell Lymphoma,31/575,1.355156681548265E-14,4.054357410890773E-13,0,0,6.571393976752377,209.8395544873163,CXCR4;CIB1;FOXO1;MUC1;CCND2;CCND1;KDR;SPP1;LEPR;CCL2;FADD;CD36;STAT5A;STAT5B;MME;STAT1;HGF;PLK1;LMO2;FLI1;NR4A1;BCL6;LEP;BCL3;TXNIP;VIM;EZR;SGK1;FKBP4;TLR4;MET
Sarcoma,33/658,1.3618502093252926E-14,4.054357410890773E-13,0,0,6.13664,195.92663517707248,YAP1;EPAS1;CXCR4;CIB1;IRS2;EGFR;FOXO1;CCND1;PLAU;MDK;KDR;SPP1;CCL2;DMD;JUN;MME;STAT1;HGF;CAV1;PLK1;FOS;KLF4;ESR1;FLI1;LEP;KIT;PPARG;S100A4;VIM;EZR;BMPR1B;FGFR3;MET
Malignant Pleural Mesothelioma,22/260,1.5363140223698293E-14,4.5483430140049E-13,0,0,10.275210084033613,326.82160600910817,PPP1R15A;JUN;FZD4;STAT1;HGF;CXCR4;CIB1;EGFR;AQP1;EFNA1;SOCS3;CXCL10;MUC1;MMP14;KRT19;COL1A2;CXCL12;PLAU;KDR;SPP1;VIM;MET
Invasive Carcinoma,18/154,1.555354826126973E-14,4.579273960458916E-13,0,0,14.46029411764706,459.7576419914585,STAT5A;STAT5B;GSN;STAT1;HGF;LMO2;LPL;NEDD9;CXCR4;ESR1;EGFR;TGFBR2;MMP14;CCND2;CCND1;PLAU;VIM;MET
T-Cell Lymphoma,24/324,1.785236048019202E-14,5.227210384557323E-13,0,0,8.966436781609195,283.847267156927,CA12;STAT5B;EGR1;SNAP25;LRP1;MME;CAV1;CXCR4;EGFR;SOCS3;MUC1;TF;CXCL12;CCND2;MAF;BCL6;KIT;BCL3;KDR;MAP3K20;SAA1;PPARG;FKBP4;MET
Brain Ischemia,22/264,2.1073451304255768E-14,6.136635081987923E-13,0,0,10.103305785123966,318.160801718613,PPP1R15A;EGR1;JUN;ANXA1;CCL11;EPAS1;HGF;CAV1;NR3C1;C3;CXCL10;TF;MMP14;CXCL12;PLAU;MDK;DPYSL2;KDR;SPP1;CCL2;PRTN3;TLR4
Malignant Head and Neck Neoplasm,28/470,2.4903924636755718E-14,7.180357593827842E-13,0,0,7.214266702155975,225.97789373882094,YAP1;PROS1;CXCR4;CIB1;EGFR;SOCS3;ZFP36;CCND1;ALDH2;PLAU;KDR;FADD;TNS1;STAT5A;STAT5B;JUN;STAT1;FOS;MMP14;ZEB2;CXCL12;ADAM12;MAPKAPK2;PECAM1;S100A4;VIM;TLR4;MET
Rhabdomyosarcoma,26/397,2.492711868752394E-14,7.180357593827842E-13,0,0,7.917100231931298,247.98590612143096,YAP1;CFH;CXCR4;EGFR;FOXO1;CCND2;PLAU;SPP1;CCL2;DMD;FADD;EGR1;MEF2C;STAT1;HGF;CAV1;PLK1;LIFR;ESR1;MMP14;CXCL12;KIT;VIM;EZR;FGFR3;MET
"Mammary Neoplasms, Experimental",18/160,3.0599670173771946E-14,8.766970019141436E-13,0,0,13.845070422535212,430.82795468797707,STAT5A;ANXA1;TPM3;LPL;KRT5;PIK3R1;ESR1;EGFR;AQP1;TF;EFEMP1;FABP4;CCND1;S1PR1;SPP1;SNCG;EZR;SGK1
Hypercholesterolemia,21/240,3.234204709531541E-14,9.21661866154737E-13,0,0,10.609163377447565,329.54616395322205,ABCA1;SREBF1;VWF;CAV1;BGN;CXCR4;LPL;NR3C1;ESR1;MYLK;C3;NR4A1;CXCL12;LEP;KDR;LEPR;CCL2;CALR;CD36;TLR4;S100A8
Restenosis,20/215,4.252518220441446E-14,1.2054079572730033E-12,0,0,11.297608758282916,347.83846050758757,EGR1;JUN;ANXA1;FZD4;LPL;CIB1;FOS;ESR1;C3;NR4A1;VCAN;LEP;SPP1;PECAM1;SERPING1;CCL2;PPARG;TIMP1;TLR4;S100A8
Invasive Ductal Breast Carcinoma,20/218,5.5395164575556036E-14,1.561909164143588E-12,0,0,11.124730450573146,339.5744326645544,STAT5A;HGF;CAV1;LMO2;CXCR4;PKD2;ESR1;EGFR;MUC1;CXCL12;CCND2;CCND1;PLAU;ADAM12;KIT;SPP1;PECAM1;SNCG;CCL2;CTSD
Chronic Kidney Diseases,25/380,7.351665639490487E-14,2.061948746991832E-12,0,0,7.916225677766018,239.39667374564806,CFH;CXCR4;IRS2;PKD2;EGFR;C3;GHR;SOCS3;KDR;CCL2;TIMP1;CD36;EGR1;TCF7L2;VWF;HGF;ESR1;VCAN;CXCL12;LEP;SAA1;PECAM1;PPARG;S100A4;SGK1
Cholangiocarcinoma,27/455,8.265749582350923E-14,2.3061874096517316E-12,0,0,7.147319232661092,215.30635117515155,YAP1;CXCR4;CIB1;EGFR;FOXO1;AQP1;EPS8;SOCS3;MUC1;CCND1;KDR;SPP1;TIMP1;ANXA1;MME;STAT1;GOLM1;HGF;ESR1;TGFBR2;KRT19;KRT18;CXCL12;KIT;PECAM1;PPARG;MET
Encephalomyelitis,24/348,8.607422894527564E-14,2.3890081565071555E-12,0,0,8.292039165602384,249.45411036268175,EGR1;DUSP1;STAT1;BGN;CXCR4;ESR1;C3;CXCL10;NR4A1;CXCL12;LEP;DPYSL2;MAP1B;KIT;S1PR1;SPP1;PECAM1;SIRPA;CCL2;PPARG;FADD;TIMP1;CRYAB;TLR4
Malignant neoplasm of kidney,26/421,9.832075372231454E-14,2.714773557441524E-12,0,0,7.426876655872829,222.43897574190765,THRB;EPAS1;CXCR4;CIB1;PIK3R1;EGFR;MYLK;MUC1;CCND1;KDR;SPP1;LEPR;TNS1;EGR1;MME;HGF;CAV1;PLK1;KLF4;ZEB2;CXCL12;LEP;VIM;SGK1;MET;S100A8
Malignant neoplasm of salivary gland,13/69,1.403394774416328E-13,3.854995233435367E-12,0,0,24.77779922779923,733.2918338405556,STAT5A;STAT5B;MAML2;CXCR4;KRT5;EGFR;AQP1;VCAN;CXCL12;CCND1;KRT15;PPARG;MET
Carcinoma breast stage IV,25/392,1.4818125743931083E-13,4.0495277994568585E-12,0,0,7.652659432045486,226.06216273646575,YAP1;CXCR4;EGFR;RPS6KA3;MUC1;CCND1;PLAU;KDR;SPP1;CCL2;TIMP1;HGF;PLK1;ESR1;RUNX2;DCN;TGFBR2;KRT19;CXCL12;BCL6;LEP;TXNIP;VIM;TLR4;MET
Renal fibrosis,19/202,1.5473969495937322E-13,4.207182828767857E-12,0,0,11.37958298989529,335.66392447698655,EGR1;EPAS1;STAT1;HGF;PKD2;EGFR;DCN;SOCS3;NR4A1;RGS2;CXCL12;CCL2;S100A4;VIM;TIMP1;CD36;EZR;TLR4;MET
Anaplastic thyroid carcinoma,18/176,1.6280249252379847E-13,4.403931384057473E-12,0,0,12.432911392405064,366.102475740289,ANXA1;HGF;CAV1;PLK1;CXCR4;KLF4;EGFR;SOCS3;MUC1;CXCL12;CCND1;KIT;KDR;CCL2;S100A4;PPARG;MET;S100A8
Secondary malignant neoplasm of liver,28/508,1.6995508171274175E-13,4.574195103268691E-12,0,0,6.630098039215686,194.94637857610076,YAP1;NRP1;CFH;CXCR4;EGFR;MUC1;CCND1;PLAU;KDR;S1PR1;SPP1;SNCG;CCL2;TIMP1;GSN;HGF;ESR1;RUNX2;ZEB2;CXCL12;ADAM12;KIT;PECAM1;PPARG;S100A4;VIM;EZR;MET
"Carcinoma, Transitional Cell",25/399,2.2044728308213001E-13,5.903334530375231E-12,0,0,7.506723130660567,218.76931654587926,SNAP25;CIB1;PIK3R1;NR3C1;EGFR;MUC1;CCND2;CCND1;PLAU;KDR;ANXA1;GSN;DUSP1;CAV1;BGN;ESR1;DCN;EFNA1;MMP14;KRT19;FABP4;BCL6;S100A4;FGFR3;MET
"Kidney Failure, Chronic",26/437,2.33308968856414E-13,6.21651747517915E-12,0,0,7.131867820969841,207.4404512844476,CFH;CXCR4;LPL;NR3C1;PKD2;C3;MUC1;ZFP36;PLAU;KDR;SPP1;CCL2;TIMP1;ABCA1;SREBF1;VWF;HGF;CAV1;ESR1;LEP;PPARG;S100A4;PRTN3;SGK1;TLR4;MET
Meningioma,26/438,2.4594595708486946E-13,6.520626892066016E-12,0,0,7.114190562203658,206.55102246837217,YAP1;F13A1;CXCR4;NR3C1;EGFR;CCND1;PLAU;MDK;SPP1;LEPR;CCL2;TIMP1;HGF;CAV1;FOS;KLF4;ESR1;VCAN;CXCL12;BCL6;S100A4;EZR;SGK1;CRYAB;TLR4;FGFR3
Adenocarcinoma Of Esophagus,22/299,2.694618129806003E-13,7.1087227790773215E-12,0,0,8.81092057761733,255.00874462801542,GOLM1;HGF;PLK1;ESR1;EGFR;C3;AKAP12;MUC1;MMP14;CCND1;LEP;KDR;S1PR1;SPP1;PPARG;VIM;CALR;TIMP1;FKBP4;TLR4;CTSD;MET
Nonalcoholic Steatohepatitis,19/209,2.868912369116214E-13,7.531248283261233E-12,0,0,10.956424581005587,316.4179615200268,SREBF1;TCF7L2;ANXA1;CFH;IRS2;PIK3R1;FOXO1;DCN;CXCL10;MUC1;KRT18;LEP;KDR;SPP1;LEPR;CCL2;CD36;TLR4;S100A8
Non-alcoholic Fatty Liver Disease,23/334,3.022403648535525E-13,7.895288746591085E-12,0,0,8.236894809370694,237.44952813022817,ABCA1;YAP1;SREBF1;TCF7L2;JUN;CAV1;KRT8;LPL;IRS2;FOS;KLF6;FABP4;ALDH2;LEP;S1PR1;SPP1;LEPR;TXNIP;CCL2;PPARG;CD36;TLR4;S100A8
Intestinal Neoplasms,17/158,3.414713208753101E-13,8.876588628997695E-12,0,0,13.096547940911407,375.9431232347407,TCF7L2;ANXA1;CIB1;KLF4;DCN;EGFR;TGFBR2;EFNA1;MUC1;CCND1;LEP;KIT;KDR;SPP1;PPARG;SGK1;TLR4
Hepatitis B,35/839,4.4317013259299037E-13,1.1464338041689543E-11,0,0,5.073787504196807,144.32298573135589,DTX1;EGFR;ETS2;SOCS3;ZFP36;CCND2;ALDH2;PLAU;SPP1;LEPR;CCL2;CA12;SREBF1;JUN;ANXA1;STAT1;GOLM1;CAV1;PLK1;KRT8;TAP1;SORBS1;ESR1;CXCL10;NR4A1;MMP14;KRT19;BCL6;LEP;KIT;PPARG;S100A4;VIM;CALR;TLR4
Anemia,27/490,4.8204529616401E-13,1.2409755474676373E-11,0,0,6.595089234966466,187.04159992287074,COL17A1;CFH;EPAS1;LAMA3;CIB1;EGFR;AQP1;MUC1;CCND1;KDR;CCL2;CD36;ABCA1;EGR1;VWF;STAT1;CAV2;HGF;CAV1;CXCL10;TF;BCL6;LEP;KIT;CALR;TLR4;MET
Hyperinsulinism,24/377,4.8970806838469E-13,1.2546414886644293E-11,0,0,7.599492038683208,215.40735075047058,ABCA1;SREBF1;TCF7L2;STAT1;CAV1;LPL;IRS2;FOS;NR3C1;ESR1;FOXO1;MYLK;GHR;CXCL12;CCND1;ALDH2;LEP;LEPR;TXNIP;CCL2;PPARG;CD36;SGK1;TLR4
Infection,27/492,5.306910652872647E-13,1.353135256897528E-11,0,0,6.566044142614601,185.58658724773784,CFH;PROS1;CXCR4;LPL;EGFR;SOCS3;MUC1;PLAU;SPP1;CCL2;FADD;TIMP1;CD36;STAT1;CAV2;CAV1;TAP1;FOS;ESR1;CXCL10;CXCL12;LEP;SAA1;PPARG;VIM;EZR;TLR4
"Kidney Failure, Acute",22/310,5.590136310379984E-13,1.4185636380007114E-11,0,0,8.469618055555555,238.94996784471743,YAP1;ANXA1;CFH;EPAS1;HGF;BGN;CXCR4;PKD2;EGFR;C3;MUC1;TF;VCAN;CXCL12;CCND1;BCL3;SPP1;CCL2;PPARG;A2M;TLR4;MET
Classical Hodgkin's Lymphoma,17/166,7.716876677202453E-13,1.948968521934212E-11,0,0,12.38833475471838,345.5130906446318,STAT5A;STAT5B;SNAP25;JUN;ARF1;MAML2;DUSP1;STAT1;HGF;LPL;FOS;FOXO1;SOCS3;MUC1;BCL6;BCL3;MET
Cerebral Infarction,21/283,8.206708861606087E-13,2.0629033737499453E-11,0,0,8.848492689869323,246.2416435699832,ABCA1;NRP1;JUN;ANXA1;VWF;HGF;LPL;FOS;NR3C1;ESR1;TGFBR2;CXCL12;ALDH2;PLAU;MDK;KDR;CCL2;PPARG;VIM;SGK1;TLR4
Pulmonary Emphysema,19/225,1.0803128522821066E-12,2.7028108872353737E-11,0,0,10.09719585615881,278.2158166952131,EGR1;JUN;EPAS1;HGF;CAV1;KRT8;TAP1;FOS;C3;MMP14;VCAN;KDR;SERPING1;CCL2;PPARG;S100A4;PRTN3;A2M;TLR4
Lung diseases,24/393,1.1957092518395975E-12,2.9775395341370166E-11,0,0,7.2639940192505374,199.41320928760982,STAT5B;EGR1;JUN;ANXA1;GSN;HGF;CXCR4;FOS;NR3C1;EGFR;MYLK;CXCL10;VCAN;ALDH2;KIT;SPP1;CCL2;PPARG;PRTN3;VIM;EZR;A2M;TLR4;CTSD
Kaposi Sarcoma,22/323,1.274603726493934E-12,3.159238724877291E-11,0,0,8.0984219269103,221.80270401127234,YAP1;EGR1;LRP1;HGF;F13A1;CXCR4;CIB1;NR3C1;TGFBR2;CXCL10;RCAN1;RPS6KA3;MUC1;MMP14;CXCL12;CCND1;BCL6;KRT15;KIT;KDR;PECAM1;TLR4
Hematologic Neoplasms,28/557,1.587204861207773E-12,3.915840141377881E-11,0,0,6.000711664628044,163.0336148232069,YAP1;LRP1;CXCR4;CIB1;NR3C1;EGFR;MUC1;CCND2;CCND1;KDR;SPP1;LEPR;SIRPA;STAT5A;STAT5B;EGR1;PLK1;KLF4;CXCL10;NR4A1;KRT19;LEP;KIT;BCL3;PECAM1;S100A4;CALR;FGFR3
"Plaque, Amyloid",19/235,2.343789516349515E-12,5.7557854067403525E-11,0,0,9.624818953031243,257.745452630957,ABCA1;SNAP25;GSN;MME;VWF;BGN;SORBS1;DCN;TF;MMP14;SAA1;SERPING1;CCL2;PPARG;VIM;A2M;TLR4;CTSD;S100A8
Schizophrenia,53/1923,3.0968472863172785E-12,7.570228985681091E-11,0,0,3.5050562419325098,92.88622147187162,SNAP25;NR3C1;SYNE1;RGS4;GHR;RGS2;CCND2;CCND1;ALDH2;MDK;DPYSL2;KDR;LEPR;SIRPA;CCT3;SREBF1;ANXA1;TAP1;LIFR;SOX10;TGFBR2;ZEB2;ADAM12;KIT;TXNIP;PPARG;TLR4;MET;CCL11;LRP1;CXCR4;LPL;EGFR;C3;GRK3;CCL2;DMD;ABCA1;EGR1;TCF7L2;JUN;GSN;CAV1;SORBS1;ESR1;QKI;TF;KLF6;FABP4;CXCL12;LEP;VIM;CALR
Glomerulonephritis,18/210,3.3923938167929907E-12,8.254824954196277E-11,0,0,10.213541666666666,269.7343785383234,JUN;CFH;STAT1;HGF;FHL1;CXCR4;FOS;ESR1;FLI1;DCN;C3;CXCL10;KIT;SPP1;CCL2;PPARG;TIMP1;TLR4
"Lupus Erythematosus, Systemic",39/1113,3.900766159322175E-12,9.448719483194486E-11,0,0,4.277151189346825,112.36011217737598,CFH;CXCR4;LAMC1;NR3C1;EGFR;FOXO1;ETS2;C3;SOCS3;PRKAR2B;KDR;S1PR1;SPP1;LEPR;CCL2;TIMP1;CD36;TNS1;JUN;ANXA1;VWF;STAT1;HGF;BGN;TAP1;FOS;ESR1;FLI1;CXCL10;CXCL12;LEP;PECAM1;SERPING1;PPARG;PRTN3;CALR;SGK1;TLR4;S100A8
Idiopathic Pulmonary Fibrosis,23/379,4.141970732643924E-12,9.945563885244584E-11,0,0,7.179101123595506,188.1631594130416,EGR1;ANXA1;HGF;CAV1;KRT8;CXCR4;PKD2;EGFR;ETS2;DCN;TGFBR2;CXCL10;MUC1;CXCL12;CCND1;PLAU;SPP1;CCL2;S100A4;VIM;CD36;UTRN;CRYAB
Ulcer,17/184,4.143207323183144E-12,9.945563885244584E-11,0,0,11.042941740827736,289.43054377761,EGR1;MME;HGF;FLI1;TGFBR2;SOCS3;MMP14;MUC1;CXCL12;FABP4;CCND1;LEP;KIT;KDR;PECAM1;TLR4;S100A8
Luminal A Breast Carcinoma,14/110,4.3717245511653736E-12,1.0447049387067388E-10,0,0,15.618432971014492,408.5136016630268,KRT8;KRT5;SOX10;ESR1;EGFR;DEPP1;MUC1;FABP4;KRT18;CCND1;LEP;LEPR;CCL2;VIM
Rectal Carcinoma,20/276,4.578375534022343E-12,1.0892037152145119E-10,0,0,8.578827247191011,223.9904073272348,YAP1;NRP1;TCF7L2;ANXA1;HGF;PLK1;CXCR4;IRS2;KLF4;EGFR;CXCL12;CCND1;ALDH2;KIT;KDR;PPARG;VIM;BMPR1B;TLR4;MET
Fibroid Tumor,21/310,4.724373003322966E-12,1.1189414993203595E-10,0,0,8.01073250835728,208.90617551722417,PPP1R15A;EGR1;VWF;CAV1;FOS;NR3C1;ESR1;EGFR;FOXO1;GHR;VCAN;EFEMP1;CCND1;BCL6;ADAM12;KIT;PECAM1;CCL2;PPARG;S100A4;FGFR3
Myeloid Leukemia,26/501,5.235728461057667E-12,1.2345662375653233E-10,0,0,6.150575275397797,159.76436111951608,NRP1;EPAS1;NEDD9;PKD2;RPS6KA3;CCND1;PLAU;KDR;TIMP1;STAT5A;STAT5B;EGR1;JUN;MEF2C;DUSP1;STAT1;PLK1;LMO2;FOS;KLF4;ESR1;KIT;PRTN3;VIM;TLR4;MET
Psoriasis,33/818,5.5974772047150326E-12,1.314050926164159E-10,0,0,4.845095541401274,125.53015165482392,EPAS1;PROS1;F13A1;CXCR4;ANTXR2;EGFR;AQP1;C3;SOCS3;PLAU;KDR;SPP1;CCL2;TIMP1;EGR1;JUN;DUSP1;CAV1;TAP1;KRT5;FOS;ACTA2;CXCL10;CXCL12;LEP;MAPKAPK2;SAA1;PECAM1;PPARG;S100A4;TLR4;S100A8;SKAP2
Diabetic Retinopathy,19/247,5.653111246294109E-12,1.3212907820833907E-10,0,0,9.11266294227188,236.00717223934953,NRP1;TCF7L2;CFH;MME;VWF;HGF;SORBS1;CXCL10;ALDH2;KDR;PECAM1;SERPING1;TXNIP;CCL2;PPARG;TIMP1;CD36;TLR4;CTSD
"Cardiomyopathy, Familial Idiopathic",23/388,6.688265227590383E-12,1.5564089693375176E-10,0,0,6.998841487279844,180.0848567813442,HGF;CXCR4;ESR1;EGFR;FOXO1;ACTA2;CDH5;MUC1;MMP14;CXCL12;CCND1;KDR;SPP1;PECAM1;CCL2;DMD;S100A4;VIM;CALR;TIMP1;CD36;CRYAB;TLR4
Nasal Polyps,18/219,6.897268350221062E-12,1.5980670886229583E-10,0,0,9.751741293532339,250.6187338834559,JUN;ANXA1;CCL11;TAP1;FOS;NR3C1;EGFR;SOCS3;MUC1;LEP;SPP1;LEPR;CCL2;VIM;A2M;TLR4;MET;S100A8
androgen independent prostate cancer,16/163,7.179099479933592E-12,1.649026772783022E-10,0,0,11.754503999401958,301.6187760822056,EGR1;MEF2C;MME;PROS1;NR3C1;ESR1;RUNX2;EGFR;RGS2;MUC1;CCND1;LEP;KDR;PECAM1;PPARG;VIM
Metastatic malignant neoplasm to brain,16/163,7.179099479933592E-12,1.649026772783022E-10,0,0,11.754503999401958,301.6187760822056,ABCA1;ANXA1;CAV1;PLK1;CXCR4;KLF4;ESR1;EGFR;ACTA2;MMP14;ZEB2;CXCL12;KIT;KDR;CCL2;MET
"Carcinoma, Cribriform",14/115,8.112909271415549E-12,1.8475937396313443E-10,0,0,14.841476538958243,379.01516566064544,STAT5A;TCF7L2;TPM3;KRT8;ESR1;EGFR;MMP14;EFEMP1;CCND1;PLAU;KDR;SPP1;PPARG;MET
"Carcinoma, Granular Cell",14/115,8.112909271415549E-12,1.8475937396313443E-10,0,0,14.841476538958243,379.01516566064544,STAT5A;TCF7L2;TPM3;KRT8;ESR1;EGFR;MMP14;EFEMP1;CCND1;PLAU;KDR;SPP1;PPARG;MET
"Alzheimer Disease, Late Onset",19/253,8.618822926949812E-12,1.9544556330942788E-10,0,0,8.876283244998328,226.14171257975266,ABCA1;EGR1;LRP1;CFH;MME;NEDD9;PIK3R1;ESR1;TF;ALDH2;PLAU;LEP;DPYSL2;ADAM12;LEPR;PPARG;A2M;TLR4;CTSD
Anaplastic astrocytoma,16/166,9.500114058336928E-12,2.1451740600371817E-10,0,0,11.517655677655677,292.31484518725375,HGF;CAV1;ESR1;EGFR;KLF6;CCND2;CCND1;PLAU;KIT;SPP1;S100A4;TIMP1;VIM;CTSD;CRYAB;MET
"Adenocarcinoma, Basal Cell",14/117,1.0301139605027191E-11,2.3026087157423954E-10,0,0,14.551815111861545,368.1429739110422,STAT5A;TCF7L2;TPM3;KRT8;ESR1;EGFR;MMP14;EFEMP1;CCND1;PLAU;KDR;SPP1;PPARG;MET
Barrett Esophagus,21/323,1.0304845362800924E-11,2.3026087157423954E-10,0,0,7.660792457065888,193.80584481455625,ANXA1;GOLM1;HGF;CAV1;KRT5;KLF4;ESR1;EGFR;AKAP12;GHR;MUC1;CCND1;LEP;AGR2;S1PR1;LEPR;PPARG;S100A4;VIM;TIMP1;CTSD
"Lymphoma, Follicular",22/359,1.0326955959137409E-11,2.3026087157423954E-10,0,0,7.219955489614243,182.63789692701278,STAT5A;STAT5B;MME;STAT1;PLK1;LMO2;CXCR4;ESR1;FOXO1;SOCS3;NR4A1;CXCL12;CCND1;BCL6;LEP;KIT;BCL3;KDR;E2F2;CCL2;VIM;S100A8
Disseminated Malignant Neoplasm,17/195,1.05704255632478E-11,2.34707490943948E-10,0,0,10.354708548016637,261.69414587438615,ABCA1;HGF;CAV1;KRT8;ESR1;RUNX2;EGFR;FOXO1;CDC25B;CDH5;KLF6;CXCL12;PLAU;SPP1;S100A4;VIM;TNS1
Malnutrition,18/225,1.0866404998159653E-11,2.402783080298456E-10,0,0,9.466183574879228,238.9770720406765,ABCA1;STAT5A;STAT5B;CFH;VWF;STAT1;CXCR4;TAP1;NR3C1;GHR;ZFP36;RGS2;CXCL12;LEP;SAA1;LEPR;CD36;UTRN
Impaired glucose tolerance,21/326,1.2271960621419103E-11,2.702366865766215E-10,0,0,7.584273409280356,190.54504079751328,ABCA1;TCF7L2;CAV1;CXCR4;LPL;IRS2;PIK3R1;NR3C1;ESR1;FOXO1;MYLK;GHR;SOCS3;ALDH2;LEP;LEPR;TXNIP;PPARG;CD36;SGK1;TLR4
"Neoplasms, Intracranial",13/97,1.3291718075499661E-11,2.914879243799905E-10,0,0,16.495109395109395,413.10153987798486,YAP1;HGF;ESR1;EGFR;TGFBR2;EFEMP1;CCND1;MDK;LEP;KDR;LEPR;SPP1;CCL2
"Adenocarcinoma, Oxyphilic",14/122,1.8346770098113718E-11,4.006964666100328E-10,0,0,13.874597423510467,343.0017977586505,STAT5A;TCF7L2;TPM3;KRT8;ESR1;EGFR;MMP14;EFEMP1;CCND1;PLAU;KDR;SPP1;PPARG;MET
Fibrosarcoma,20/298,1.853597052619283E-11,4.017708590619857E-10,0,0,7.891035486217767,194.99780769877,ABCA1;EGR1;JUN;STAT1;HGF;CAV1;BGN;FOS;NR3C1;FLI1;EGFR;AKAP12;MMP14;CCND1;PLAU;MAP3K20;CCL2;FADD;CD36;MET
HIV Infections,32/806,1.8546750108697408E-11,4.017708590619857E-10,0,0,4.739080352417422,117.10611863266182,SNAP25;CCL11;F13A1;CXCR4;DTX1;PIK3R1;NR3C1;EGFR;GHR;SOCS3;MDK;SPP1;LEPR;CCL2;TIMP1;CD36;CTSD;ABCA1;CCT3;JUN;DUSP1;STAT1;FOS;SORBS1;CXCL10;CXCL12;BCL6;LEP;PECAM1;PPARG;FKBP4;TLR4
Choriocarcinoma,20/300,2.092145219283158E-11,4.513782135044514E-10,0,0,7.833868378812199,192.6367510574653,STAT1;CAV1;KRT8;CXCR4;ESR1;EGFR;ETS2;RPS6KA3;MUC1;KRT19;F8;KRT18;CCND2;LEP;KDR;CCL2;PPARG;TIMP1;EZR;TEAD1
Desmoplastic,12/80,2.1207870865554803E-11,4.5571267678444173E-10,0,0,18.722960151802656,460.14761494729515,GHR;MMP14;COL1A2;HGF;CAV1;ADAM12;PECAM1;PPARG;DMD;CD36;TIMP1;RUNX2
Adenocarcinoma of colon,19/267,2.20688354898199E-11,4.723085314267078E-10,0,0,8.369210668588934,205.35410580619165,NRP1;JUN;ANXA1;GSN;EPAS1;CAV1;PLK1;FOS;KLF4;ESR1;EGFR;FOXO1;ZFP36;CCND1;PPP2R1B;PLAU;SPP1;PPARG;S100A4
Senile Plaques,20/301,2.2219025631455677E-11,4.736207503601091E-10,0,0,7.8055899876044625,191.47168583189864,ABCA1;EGR1;LRP1;MME;VWF;BGN;LPL;DCN;RCAN1;TF;MMP14;CCND1;SERPING1;CCL2;PPARG;VIM;A2M;TLR4;CTSD;S100A8
Sarcoidosis,18/236,2.4132387224801576E-11,5.123565399241738E-10,0,0,8.98348623853211,219.6234771571638,CFH;STAT1;HGF;KRT8;CXCR4;TAP1;FOS;NR3C1;CXCL10;MUC1;MMP14;CXCL12;KDR;SPP1;CCL2;PPARG;TLR4;S100A8
Insulin Resistance,12/81,2.4682537491349914E-11,5.219573106801734E-10,0,0,18.45067788686302,450.6564255504462,C3;SREBF1;NR4A1;CAV1;LEP;LEPR;IRS2;PPARG;CD36;FOS;PIK3R1;EGFR
"Adenocarcinoma, Tubular",14/125,2.560984231307685E-11,5.394262833454012E-10,0,0,13.497551899725813,329.1788946570642,STAT5A;TCF7L2;TPM3;KRT8;ESR1;EGFR;MMP14;EFEMP1;CCND1;PLAU;KDR;SPP1;PPARG;MET
"Lymphoma, Non-Hodgkin",26/539,2.662224859251145E-11,5.585431604310768E-10,0,0,5.683779863094428,138.3959123127981,NEDD9;CXCR4;CIB1;FOXO1;MUC1;CCND2;CCND1;MDK;KDR;SPP1;LEPR;TIMP1;MME;ZBTB16;HGF;PLK1;LMO2;ESR1;TGFBR2;CXCL12;BCL6;LEP;ADAM12;KIT;BCL3;S100A4
Pneumonia,25/497,2.7147975117640336E-11,5.673394486349229E-10,0,0,5.918119917703537,143.98619255618465,NRP1;CCL11;CFH;CXCR4;NR3C1;ETS2;MYLK;C3;SOCS3;PLAU;S1PR1;SPP1;CCL2;TIMP1;JUN;DUSP1;HGF;CAV1;FOS;KLF4;CXCL10;CXCL12;PPARG;VIM;TLR4
Overweight,18/238,2.777034936020815E-11,5.780788739865204E-10,0,0,8.90090909090909,216.35486220458347,ABCA1;EGR1;TCF7L2;CXCR4;LPL;IRS2;NR3C1;ESR1;RPS6KA3;RGS2;LEP;SPP1;LEPR;CCL2;PPARG;CD36;A2M;TLR4
Metastatic melanoma,23/417,2.8730629694864975E-11,5.957413449180368E-10,0,0,6.474024655547498,157.14437159080722,STAT5A;JUN;STAT1;ZBTB16;HGF;CAV1;NEDD9;TAP1;FOS;EGFR;AKAP12;MUC1;KLF6;CCND1;PLAU;KIT;KDR;SPP1;CCL2;VIM;CALR;TIMP1;BMPR1B
Interstitial lung fibrosis,14/127,3.1826312943760836E-11,6.573737274314012E-10,0,0,13.257310504040015,320.4388424559199,YAP1;HGF;BGN;CXCR4;PKD2;DCN;VCAN;MUC1;ALDH2;SPP1;CCL2;PPARG;TIMP1;VIM
Chondrosarcoma,18/241,3.419327422252164E-11,7.008306089685299E-10,0,0,8.77982062780269,211.5848283997685,CCL11;EPAS1;HGF;CXCR4;RUNX2;EGFR;DCN;MMP14;VCAN;CXCL12;CCND1;PLAU;KIT;SPP1;PPARG;TIMP1;FGFR3;MET
Metastatic Prostate Carcinoma,18/241,3.419327422252164E-11,7.008306089685299E-10,0,0,8.77982062780269,211.5848283997685,PROS1;HGF;CAV1;CXCR4;CIB1;KLF4;RUNX2;EGFR;TGFBR2;MUC1;MMP14;KLF6;KDR;AGR2;S100A4;VIM;TIMP1;MET
Carotid Atherosclerosis,13/105,3.715889364275583E-11,7.586963380162674E-10,0,0,15.05464159811986,361.54953230271235,ABCA1;STAT1;HGF;ESR1;RGS2;CXCL12;FABP4;PLAU;LEP;CCL2;PPARG;CD36;TLR4
Neoplastic Cell Transformation,14/131,4.8591136693923936E-11,9.883288833661094E-10,0,0,12.801467855815682,304.00388169322315,JUN;EPAS1;CXCR4;KRT5;FOS;ESR1;MMP14;ZEB2;MUC1;KRT19;CCND2;CCND1;KRT15;VIM
Erythroblastosis,10/50,5.2417327698715786E-11,1.0620986285416595E-9,0,0,26.279255319148938,622.0768529150333,JUN;GSN;CCND1;PROS1;CAV1;KDR;BGN;FOS;ETS2;EGFR
Adenocarcinoma of prostate,17/216,5.391898382587978E-11,1.0883873666973992E-9,0,0,9.252089175157556,218.75212657627833,EGR1;ANXA1;GSN;PROS1;CXCR4;CIB1;ESR1;EGFR;VCAN;KLF6;CCND1;KDR;AGR2;CCL2;S100A4;TLR4;CTSD
Adenomatous Polyposis Coli,22/392,5.7031396521459467E-11,1.1468691021239907E-9,0,0,6.564864864864865,154.8482194510686,YAP1;TCF7L2;GSN;CAV1;PLK1;BGN;IRS2;FOS;KLF4;ESR1;EGFR;FOXO1;TGFBR2;GHR;MUC1;CCND1;LEP;KIT;PECAM1;PPARG;SGK1;MET
Neurodegenerative Disorders,30/745,6.066306478392566E-11,1.2153138053892475E-9,0,0,4.766983016983017,112.14654605855601,CFH;CXCR4;LPL;NR3C1;PKD2;EGFR;FOXO1;AQP1;SOCS3;DPYSL2;SNCG;CCL2;A2M;TEAD1;CTSD;ABCA1;JUN;ANXA1;GSN;CAV2;HGF;FOS;KLF4;MMP14;BCL6;TXNIP;PPARG;VIM;SGK1;CRYAB
Ischemic stroke,22/394,6.290073625699612E-11,1.255423309039447E-9,0,0,6.528897849462366,153.36030607896421,ABCA1;EGR1;CCL11;LRP1;CFH;VWF;F13A1;LPL;SORBS1;ESR1;ACTA2;F8;FABP4;PLAU;KDR;SAA1;SPP1;PECAM1;PPARG;A2M;SGK1;TLR4
"Muscular Dystrophy, Duchenne",16/190,7.38362348162787E-11,1.468183937820706E-9,0,0,9.916887709991158,231.35277431257975,FHL1;BGN;NR3C1;DCN;AQP1;SYNE1;TGFBR2;F8;PLAU;LEP;SPP1;CCL2;DMD;TIMP1;UTRN;TLR4
Inflammatory disorder,16/192,8.640895145863387E-11,1.7117966629110033E-9,0,0,9.803196803196803,227.1589885376612,HGF;BGN;CXCR4;NR3C1;ESR1;MYLK;CXCL10;MUC1;MAPKAPK2;BCL3;SPP1;SAA1;CCL2;PRTN3;SGK1;TLR4
Presenile dementia,21/362,8.694585301633228E-11,1.7160535212001287E-9,0,0,6.771062180028829,156.8566359916242,ABCA1;SREBF1;MEF2C;LRP1;MME;STAT1;CXCR4;NR3C1;ESR1;CXCL10;TF;CXCL12;ALDH2;PLAU;LEP;DPYSL2;SPP1;CCL2;PPARG;TIMP1;A2M
Osteoporosis,23/441,8.773845895691389E-11,1.7253071873852182E-9,0,0,6.0947641831852355,141.13438674904714,GSN;LRP1;STAT1;HGF;LIFR;IRS2;ANTXR2;ESR1;RUNX2;FOXO1;GHR;MMP14;COL1A2;CCND1;ALDH2;LEP;KIT;SPP1;LEPR;PPARG;DMD;BMPR1B;SPTBN1
Periodontal Diseases,14/137,8.923266363407763E-11,1.7482384724485284E-9,0,0,12.173294450335808,281.6872819187404,SNAP25;CFH;STAT1;HGF;CXCR4;CXCL10;CXCL12;ALDH2;PLAU;PECAM1;CCL2;PPARG;CTSD;TLR4
"Leukemia, T-Cell",21/364,9.62699924011635E-11,1.8792043571641038E-9,0,0,6.730888965755794,155.24031074140262,STAT5A;STAT5B;SNAP25;JUN;MEF2C;LRP1;STAT1;HGF;LMO2;CXCR4;CIB1;FOS;KLF4;RPS6KA3;CCND2;CCND1;BCL3;TXNIP;CCL2;TLR4;MET
Precursor Cell Lymphoblastic Leukemia Lymphoma,27/618,1.0033829225386143E-10,1.951469924893531E-9,0,0,5.132514026182207,118.1631692679225,NRP1;SNAP25;F13A1;CXCR4;CIB1;NR3C1;SOCS3;CCND1;MDK;SPP1;LEPR;CCL2;STAT5A;STAT5B;MEF2C;MME;ZBTB16;PLK1;LMO2;CXCL10;ZEB2;CXCL12;BCL6;LEP;KIT;S100A4;MET
Sepsis,25/529,1.0220472198609642E-10,1.9805416853233013E-9,0,0,5.533191118451234,127.28576772101712,NRP1;CFH;CXCR4;NR3C1;AQP1;MYLK;SOCS3;SPP1;CCL2;TIMP1;JUN;GSN;VWF;DUSP1;CAV1;FOS;RCAN1;F8;CXCL12;LEP;SAA1;SERPING1;PPARG;TLR4;S100A8
Mental Depression,26/575,1.0955057016869185E-10,2.115199233438257E-9,0,0,5.301160672681831,121.58018428399556,NRP1;SNAP25;CFH;MAGED1;NR3C1;EGFR;ETS2;SYNE1;MUC1;ALDH2;DPYSL2;SNCG;SIRPA;CD36;A2M;JUN;DST;DUSP1;ESR1;PER1;LEP;KIT;SERPING1;FKBP4;TLR4;MET
Pituitary Neoplasms,19/296,1.3026337631966194E-10,2.5060416332399943E-9,0,0,7.481899037976726,170.29896620201092,THRB;VWF;CXCR4;CIB1;NR3C1;ESR1;RUNX2;EGFR;EPS8;GHR;KLF6;CXCL12;CCND1;LEP;KDR;LEPR;PPARG;S100A4;TLR4
Insulin Sensitivity,10/55,1.429882254421186E-10,2.7409505517303956E-9,0,0,23.35342789598109,529.3815480817151,C3;SREBF1;NR4A1;LEP;LEPR;IRS2;PPARG;CD36;PIK3R1;EGFR
Vascular inflammations,14/142,1.447404129160638E-10,2.7547202158203713E-9,0,0,11.694802989130435,264.95838314404324,ABCA1;VWF;DUSP1;KLF4;NR4A1;ZFP36;MMP14;PECAM1;S1PR1;CCL2;PPARG;SGK1;TLR4;S100A8
Lymphatic Metastasis,14/142,1.447404129160638E-10,2.7547202158203713E-9,0,0,11.694802989130435,264.95838314404324,EGR1;ANXA1;HGF;CXCR4;ESR1;EGFR;MMP14;MUC1;CXCL12;PLAU;KDR;EZR;CRYAB;MET
Metastasis from malignant tumor of prostate,17/232,1.6567403199484187E-10,3.1419107348772683E-9,0,0,8.55657201593216,192.70254913627252,ABCA1;PROS1;HGF;CAV1;CXCR4;KLF4;RUNX2;EGFR;TGFBR2;MUC1;MMP14;KLF6;KDR;AGR2;S100A4;TIMP1;MET
Hamman-Rich syndrome,17/233,1.7717880631995395E-10,3.348176804535584E-9,0,0,8.516523429506854,191.22883914936406,ANXA1;CCL11;HGF;CAV1;KRT8;CXCR4;EGFR;ETS2;DCN;CXCL10;CCND1;SPP1;CCL2;S100A4;VIM;TIMP1;UTRN
Metastatic Neoplasm,25/544,1.8392572072198572E-10,3.460014675923359E-9,0,0,5.369095748827782,120.35627649986723,EPAS1;PROS1;CXCR4;PIK3R1;EGFR;FOXO1;RPS6KA3;MUC1;MDK;SPP1;MME;HGF;CAV1;KLF4;ESR1;ZEB2;KRT19;VCAN;CXCL12;KIT;S100A4;VIM;CALR;EZR;MET
Trichohepatoenteric Syndrome,18/267,1.8439560292029162E-10,3.460014675923359E-9,0,0,7.852610441767069,176.00792083484342,STAT5B;THRB;VWF;KRT8;CXCR4;LPL;NR3C1;SOX10;GHR;CXCL10;ZEB2;ZFP36;COL1A2;CXCL12;KIT;CCL2;PPARG;CALR
Pneumonitis,20/339,1.8609732524283092E-10,3.4796934955054247E-9,0,0,6.86238596738403,153.75005109589782,ABCA1;JUN;CCL11;CAV1;CXCR4;FOS;KLF4;NR3C1;ETS2;MYLK;SOCS3;CXCL10;ZFP36;CXCL12;S1PR1;SPP1;CCL2;PPARG;TIMP1;TLR4
Epstein-Barr Virus Infections,17/234,1.8941876273672107E-10,3.5294146385454076E-9,0,0,8.476843954477175,189.77162164526067,EGR1;MME;CXCR4;TAP1;PIK3R1;EGFR;FOXO1;DCN;CXCL10;MUC1;CXCL12;CCND1;BCL6;MAPKAPK2;CCL2;VIM;TIMP1
Thrombosis,12/98,2.4486047104217364E-10,4.538795510700748E-9,0,0,14.790697674418604,327.3230585299269,EGR1;F8;VWF;PLAU;PROS1;HGF;LEP;LEPR;PECAM1;F13A1;KLF4;DCN
Gastric Adenocarcinoma,21/383,2.4529425916341066E-10,4.538795510700748E-9,0,0,6.371383088304149,140.989549315936,YAP1;STAT1;PLK1;TAP1;KLF4;ESR1;EGFR;TGFBR2;RPS6KA3;MUC1;ZEB2;CCND1;MDK;LEP;KIT;KDR;PECAM1;PPARG;BMPR1B;MET;S100A8
Mammary Tumorigenesis,15/176,2.493760802840483E-10,4.598356857556033E-9,0,0,9.999490886875064,221.10933242382254,STAT5A;CAV1;IRS2;KLF4;ESR1;FOXO1;EGFR;MUC1;RASD1;CCND1;LEP;SNCG;S100A4;PPARG;MET
Hyperplasia,13/123,2.7984188851053297E-10,5.14233594438838E-9,0,0,12.579656019656019,276.7121316947175,TCF7L2;HGF;CAV1;CXCR4;IRS2;KRT5;FOXO1;EGFR;ZFP36;CCND1;PLAU;LEP;SAA1
"Meningioma, benign, no ICD-O subtype",17/241,2.9958287824694586E-10,5.486175801298881E-9,0,0,8.209007498026835,180.0122882115293,YAP1;CXCR4;FOS;NR3C1;ESR1;CXCL12;CCND1;BCL6;PLAU;MDK;SPP1;LEPR;CCL2;TIMP1;SGK1;TLR4;FGFR3
Major Depressive Disorder,24/513,3.056815305960639E-10,5.578687933378166E-9,0,0,5.447570693181017,119.34797890230739,EGR1;NRP1;SNAP25;JUN;LRP1;DST;DUSP1;ZBTB16;FOS;NR3C1;ESR1;EGFR;QKI;RGS4;PER1;CXCL10;MAF;CCND1;LEP;KDR;CCL2;SGK1;FKBP4;MET
Pre-Eclampsia,14/152,3.6006662108943095E-10,6.548788477083882E-9,0,0,10.841839949590423,235.75290455713005,VWF;TAP1;ESR1;C3;EFNA1;SOCS3;CXCL10;FABP4;LEP;ADAM12;LEPR;PPARG;CALR;TLR4
Systemic Scleroderma,25/562,3.6262004979917476E-10,6.5727967529925245E-9,0,0,5.184282192871982,112.69419229378745,CXCR4;EGFR;PLAU;KDR;SPP1;CCL2;TIMP1;EGR1;JUN;VWF;HGF;CAV1;TAP1;LIFR;FOS;FLI1;TGFBR2;ACTA2;CXCL10;MMP14;COL1A2;CXCL12;PPARG;TLR4;MET
Gastritis,15/181,3.6996863252921186E-10,6.68326387372261E-9,0,0,9.695832510369346,210.5702401562214,JUN;HGF;CAV1;FOS;EGFR;CXCL10;MUC1;LEP;SPP1;CCL2;PRTN3;PPARG;MET;TLR4;S100A8
Agenesis of corpus callosum,19/317,4.1616461063488945E-10,7.46714212145901E-9,0,0,6.947171084698737,150.05848023385383,JUN;CXCR4;FOS;NR3C1;SOX10;ESR1;EGFR;AQP1;ZEB2;VCAN;CCND1;KRT15;KIT;SPP1;PPARG;VIM;TLR4;FGFR3;MET
Hepatitis,19/317,4.1616461063488945E-10,7.46714212145901E-9,0,0,6.947171084698737,150.05848023385383,JUN;STAT1;HGF;NR3C1;ESR1;SOCS3;CXCL10;TF;VCAN;KRT18;CXCL12;LEP;SPP1;LEPR;PECAM1;TXNIP;PPARG;FADD;S100A8
Retinal Diseases,20/355,4.188089330964084E-10,7.489371827083089E-9,0,0,6.5292637933925874,140.99035182867064,TCF7L2;MEF2C;CFH;FZD4;PROS1;HGF;CAV1;PKD2;AQP1;CXCL12;EFEMP1;CCND1;ALDH2;KDR;TXNIP;CCL2;PPARG;VIM;CRYAB;MPDZ
Experimental Organism Basal Cell Carcinoma,18/282,4.474452172687458E-10,7.974700879013868E-9,0,0,7.400757575757575,159.31956452574354,COL17A1;JUN;DST;STAT1;HGF;BGN;CXCR4;KRT5;FOS;KLF4;EGFR;DCN;TGFBR2;CXCL10;COL1A2;CXCL12;CCL2;FGFR3
Ataxia Telangiectasia,21/396,4.505942453424519E-10,8.004055778099753E-9,0,0,6.146395480225989,132.27322033205613,STAT5B;SNAP25;HGF;CAV1;PLK1;CXCR4;IRS2;EGFR;CXCL10;RPS6KA3;MUC1;CXCL12;CCND1;PLAU;KIT;TXNIP;CCL2;PPARG;VIM;CRYAB;S100A8
Phyllodes Tumor,10/62,4.950202903257467E-10,8.763997100152505E-9,0,0,20.20253682487725,432.8680868268688,ZEB2;CXCL12;CCND1;KIT;CXCR4;S100A4;NR3C1;ESR1;DCN;EGFR
Adrenocortical carcinoma,15/185,5.027082008267841E-10,8.870635768893817E-9,0,0,9.465766634522662,202.67163572938836,STAT5A;STAT5B;LPL;LIFR;KRT5;ESR1;EGFR;TGFBR2;CXCL10;ZEB2;SPP1;PPARG;VIM;SGK1;MET
Severe Combined Immunodeficiency,16/217,5.325356756069377E-10,9.36594922544347E-9,0,0,8.572959378929529,183.06158410779074,STAT5A;THRB;MME;STAT1;HGF;CXCR4;PIK3R1;KLF4;GHR;MUC1;CCND2;CCND1;PLAU;PECAM1;PPARG;FADD
Impaired cognition,27/671,6.184115332146158E-10,1.0840510067436472E-8,0,0,4.697123242889833,99.59717637801701,SNAP25;LRP1;CFH;LPL;NR3C1;C3;RPS6KA3;ALDH2;KDR;S1PR1;SPP1;CCL2;DMD;CD36;SPTBN1;ABCA1;EGR1;SREBF1;MEF2C;MME;HGF;ESR1;LEP;PPARG;UTRN;TLR4;FGFR3
Heart Diseases,19/325,6.324436499897469E-10,1.1050138396050364E-8,0,0,6.762770657611275,143.2451532241141,ABCA1;VWF;HGF;LPL;ANK2;RUNX2;EGFR;MYLK;SYNE1;GHR;GRK3;ALDH2;LEP;SPP1;DMD;TIMP1;CD36;SGK1;MET
Juvenile arthritis,19/326,6.658298768620443E-10,1.1595449064698803E-8,0,0,6.7403963386894254,142.42448645975907,ABCA1;EGR1;TCF7L2;JUN;MAML2;DUSP1;STAT1;PROS1;CXCR4;TAP1;FOS;KLF4;ESR1;PER1;CXCL10;SPP1;VIM;TIMP1;TLR4
"Sleep Apnea, Obstructive",13/132,6.791782391606165E-10,1.1751106611970536E-8,0,0,11.622938905291846,245.36183868159182,GSN;LPL;NR3C1;MEOX2;PER1;FABP4;LEP;LEPR;CCL2;TIMP1;FGFR3;MET;S100A8
precancerous lesions,13/132,6.791782391606165E-10,1.1751106611970536E-8,0,0,11.622938905291846,245.36183868159182,EGR1;CIB1;ESR1;EGFR;MMP14;CXCL12;CCND1;MDK;PECAM1;TIMP1;VIM;TLR4;S100A8
Huntington Disease,26/627,7.020294160924594E-10,1.2107167502772543E-8,0,0,4.829412219943505,101.78974259278098,SNAP25;PROS1;F13A1;LPL;DTX1;CIB1;IRS2;FOXO1;C3;RGS2;DPYSL2;E2F2;CCL2;DMD;ABCA1;EGR1;VWF;DUSP1;CAV1;SORBS1;RCAN1;CXCL12;LEP;PPARG;SGK1;FGFR3
Hemangioblastoma,9/47,7.494813869080761E-10,1.2883826809139154E-8,0,0,24.76691729323308,520.393540978452,CXCL12;CCND1;MME;EPAS1;PLAU;CXCR4;ELOB;EGFR;AQP1
"Cicatrix, Hypertrophic",11/85,7.633689717675752E-10,1.3080364149676556E-8,0,0,15.682034976152623,329.21734528432955,COL1A2;CXCL12;CCND1;PLAU;TPM3;CXCR4;TIMP1;VIM;DCN;S100A8;TGFBR2
Urothelial Carcinoma,17/257,8.074686509266444E-10,1.3791668079449E-8,0,0,7.6554788213628,160.28365488560846,SNAP25;GSN;DUSP1;BGN;CIB1;PIK3R1;NR3C1;EGFR;DCN;EFNA1;MUC1;KRT19;CCND1;KDR;S100A4;FGFR3;MET
Leukemogenesis,28/730,8.463086895392791E-10,1.4408878615191112E-8,0,0,4.481313893078599,93.6152609048105,EPAS1;CXCR4;EGFR;FOXO1;ETS2;ZFP36;CCND1;KDR;SPP1;LEPR;TIMP1;STAT5A;STAT5B;EGR1;JUN;GSN;ZBTB16;PLK1;LMO2;FOS;KLF4;RUNX2;FLI1;NR4A1;CXCL12;BCL6;KIT;BCL3
Adenoma of large intestine,17/258,8.570024518391636E-10,1.454447791672262E-8,0,0,7.623323628527544,159.15655148480016,CXCR4;IRS2;KLF4;ESR1;EGFR;EPS8;VCAN;CXCL12;CCND1;ALDH2;PLAU;LEP;LEPR;PPARG;VIM;TIMP1;MET
Reperfusion Injury,12/110,9.56064741354362E-10,1.617418732278538E-8,0,0,12.971691902567478,269.3986331918847,EGR1;JUN;PLAU;HGF;CAV1;KDR;CCL2;PPARG;CD36;FOS;VIM;TLR4
Epithelioma,18/298,1.085061846161141E-9,1.8298400563901012E-8,0,0,6.972142857142857,143.91638514986545,EGR1;HGF;KRT8;ESR1;EGFR;MUC1;MMP14;KRT19;PLAU;MDK;LEP;KIT;KDR;SPP1;PPARG;VIM;SGK1;MET
Ki-1+ Anaplastic Large Cell Lymphoma,16/228,1.0986736367283774E-9,1.8469500978313954E-8,0,0,8.123574538668878,167.5825365540415,NRP1;JUN;CCL11;TPM3;CIB1;FOXO1;SOCS3;MUC1;CCND1;BCL6;MDK;KIT;BCL3;E2F2;TIMP1;FKBP4
Ductal Carcinoma,16/230,1.247787075240655E-9,2.09102431570989E-8,0,0,8.046831672999897,164.975291559533,STAT5A;CA12;CAV1;KRT8;KLF4;ESR1;EGFR;RPS6KA3;MUC1;KLF6;KRT18;CCND1;LEP;PECAM1;S100A4;S100A8
Venous Thrombosis,11/90,1.4259636172804064E-9,2.3821191587734437E-8,0,0,14.685778108711839,299.1260676009716,F8;VWF;PLAU;PROS1;LEP;KDR;SAA1;F13A1;CALR;TLR4;ESR1
Age related macular degeneration,20/382,1.4961033427221813E-9,2.4914795979270324E-8,0,0,6.033894096467813,122.6111529441212,ABCA1;NRP1;CFH;MME;FZD4;FHL1;LPL;ESR1;C3;TF;MMP14;EFEMP1;KDR;SERPING1;CCL2;TIMP1;CD36;EZR;CRYAB;TLR4
Pancreatic intraepithelial neoplasia,12/115,1.6054721112665963E-9,2.6614330114662058E-8,0,0,12.33886626996555,249.86016612963584,SOCS3;MUC1;CCND1;PLAU;EPAS1;LMO2;AGR2;CXCR4;S100A4;KLF4;RUNX2;EGFR
Prolactinoma,11/91,1.6081467999476793E-9,2.6614330114662058E-8,0,0,14.501470588235295,293.6284357046842,STAT5A;SNAP25;STAT5B;CCND1;CXCR4;CIB1;LIFR;PPARG;FOS;ESR1;EGFR
Septicemia,22/468,1.6203693004090477E-9,2.6733585145138745E-8,0,0,5.424887892376682,109.80304961940195,JUN;CFH;VWF;DUSP1;CAV1;CXCR4;FOS;NR3C1;AQP1;MYLK;SOCS3;RCAN1;F8;CXCL12;LEP;SAA1;SERPING1;CCL2;PPARG;TIMP1;TLR4;S100A8
Congenital Abnormality,25/607,1.76585981149747E-9,2.9044033751450675E-8,0,0,4.772262280754028,96.18317155900165,NRP1;THRB;FOXO1;RPS6KA3;ZFP36;ALDH2;TEAD1;MEF2C;VWF;STAT1;TPM3;LIFR;KLF4;ESR1;RUNX2;FLI1;RCAN1;MMP14;ZEB2;KLF6;KRT18;KIT;PECAM1;PPARG;FGFR3
"Hepatitis C, Chronic",20/386,1.7898680170991541E-9,2.934832819421967E-8,0,0,5.966721925462025,120.17648589546239,STAT1;KRT8;CXCR4;FOS;EGFR;FOXO1;C3;SOCS3;CXCL10;MUC1;KRT18;CXCL12;CCND1;BCL6;LEP;SPP1;CCL2;TIMP1;CD36;TLR4
IGA Glomerulonephritis,16/237,1.928537391877257E-9,3.1525079022435284E-8,0,0,7.789170105912187,156.30141269259633,CFH;VWF;STAT1;HGF;BGN;CIB1;DCN;C3;MMP14;PLAU;SPP1;CCL2;PPARG;TIMP1;EZR;TLR4
Chronic kidney disease stage 5,20/388,1.956054710996282E-9,3.187711178868253E-8,0,0,5.933683439179287,118.9842157897118,CFH;VWF;CAV1;CXCR4;LPL;NR3C1;PKD2;ESR1;C3;MUC1;ZFP36;PLAU;LEP;CCL2;PPARG;S100A4;PRTN3;TIMP1;SGK1;MET
Acute Promyelocytic Leukemia,22/475,2.1313928016258976E-9,3.462863487763539E-8,0,0,5.339128035320089,106.60364745198824,STAT5A;STAT5B;EGR1;ANXA1;STAT1;ZBTB16;HGF;F13A1;CXCR4;CIB1;RUNX2;EGFR;TF;ZFP36;BCL6;KIT;PECAM1;TXNIP;PPARG;VIM;TIMP1;S100A8
Cerebral Ischemia,17/275,2.2655486423747057E-9,3.669637907360123E-8,0,0,7.114822904621183,141.6237436262259,EGR1;NRP1;JUN;CCL11;VWF;FOS;TGFBR2;CXCL10;CXCL12;ALDH2;PLAU;KDR;CCL2;PPARG;PRTN3;SGK1;TLR4
Von Hippel-Lindau Syndrome,12/119,2.386677477373895E-9,3.8541225081592384E-8,0,0,11.875188423274043,235.76243376421033,MMP14;CXCL12;THRB;CCND1;PLAU;EPAS1;SPP1;CXCR4;ELOB;NR3C1;MET;EGFR
Copper-Overload Cirrhosis,6/14,2.452999660051242E-9,3.949255343931441E-8,0,0,77.3203125,1532.9489751476046,ACTA2;KRT19;KRT18;HGF;KRT8;MET
Marfan Syndrome,10/73,2.6032693219188114E-9,4.1785609085859474E-8,0,0,16.66582235731172,329.4249401329788,ACTA2;MMP14;COL1A2;LRP1;BGN;PPARG;LAMC1;DCN;MYLK;TGFBR2
Trisomy,15/209,2.727147501358588E-9,4.3642549653873616E-8,0,0,8.284603684299476,163.3724645619177,MME;LPL;EGFR;ETS2;RCAN1;VCAN;COL1A2;CXCL12;CCND2;CCND1;BCL6;KIT;BCL3;MET;S100A8
"Dermatitis, Atopic",22/484,3.009808247936201E-9,4.802176093788029E-8,0,0,5.232683982683983,102.67253037265812,ABCA1;STAT5A;STAT5B;NRP1;JUN;CCL11;DUSP1;CXCR4;TAP1;FOS;NR3C1;EGFR;C3;SOCS3;CXCL10;PLAU;BCL3;CCL2;PPARG;TIMP1;TLR4;S100A8
Pilocytic Astrocytoma,12/122,3.181635600830808E-9,5.061174960246978E-8,0,0,11.549560117302052,225.97719680747653,AKAP12;SOCS3;HGF;KIT;KDR;TIMP1;SOX10;ESR1;FGFR3;MET;EGFR;MATN2
Acute myocardial infarction,16/247,3.5011598544683853E-9,5.552881209661317E-8,0,0,7.448170876742306,145.01716460226834,VWF;HGF;CXCR4;LPL;KLF4;AKAP12;EFNA1;MMP14;CXCL12;CCND1;PLAU;CCL2;PPARG;DMD;PRTN3;TLR4
Lupus Vulgaris,17/284,3.6837417063144073E-9,5.8251215290651265E-8,0,0,6.871831481366524,133.44641019835782,VWF;STAT1;HGF;BGN;CXCR4;ESR1;FLI1;EGFR;FOXO1;C3;LEP;SPP1;CCL2;CALR;CD36;TLR4;TNS1
Peripheral Arterial Diseases,12/125,4.207666697000402E-9,6.633921842696789E-8,0,0,11.241221809877247,216.80222336735048,TCF7L2;F8;CXCL12;CCND1;HGF;PECAM1;LPL;CCL2;CD36;UTRN;TLR4;FOXO1
synovial sarcoma,15/217,4.558618804151542E-9,7.166041182101349E-8,0,0,7.953254341827625,152.75216060757646,EGR1;HGF;CAV1;CXCR4;CIB1;SOX10;EGFR;MUC1;CCND1;BCL6;KIT;S100A4;VIM;EZR;MET
Parkinson Disease,33/1064,4.9007434931563225E-9,7.681194727950013E-8,0,0,3.6413191076624636,69.67255887883924,LRP1;NEDD9;CXCR4;FOXO1;AQP1;SYNE1;RGS2;GRK3;ALDH2;SPP1;SNCG;CCL2;FADD;CTSD;ABCA1;EGR1;SREBF1;MEF2C;DST;HGF;LIFR;ESR1;PER1;TF;DNAJC1;CXCL12;LEP;PECAM1;PPARG;SGK1;FKBP4;UTRN;TLR4
Focal glomerulosclerosis,13/155,4.93295256725462E-9,7.70900417328442E-8,0,0,9.728968405024743,186.08917105063816,CFH;LPL;CXCR4;PKD2;TGFBR2;ACTA2;MMP14;KLF6;PLAU;SPP1;CCL2;PPARG;TIMP1
Renal glomerular disease,12/127,5.048109687412122E-9,7.865899568485145E-8,0,0,11.044600280504909,210.9988268109237,VCAN;MUC1;CFH;PLAU;EPAS1;BGN;PECAM1;SPP1;CCL2;CIB1;PRTN3;DCN
"Respiratory Distress Syndrome, Adult",14/186,5.087531539962501E-9,7.904214453778475E-8,0,0,8.683645096056622,165.82699487126226,STAT5A;STAT5B;EPAS1;PROS1;HGF;NR3C1;AQP1;MYLK;CXCL10;MUC1;CCL2;S100A4;TIMP1;TLR4
Osteopenia,18/329,5.1862557111110065E-9,8.03417345479958E-8,0,0,6.267202572347267,119.56101435867065,STAT1;KRT8;LIFR;IRS2;ANTXR2;NR3C1;ESR1;RUNX2;GHR;RPS6KA3;ZFP36;COL1A2;CCND1;LEP;SPP1;PPARG;DMD;S100A8
Depressive disorder,27/741,5.233035093994805E-9,8.083143193014005E-8,0,0,4.221141088014153,80.48987656126778,NRP1;SNAP25;CFH;MAGED1;NR3C1;EGFR;ETS2;SYNE1;MUC1;ALDH2;DPYSL2;KDR;SIRPA;CD36;A2M;ABCA1;DST;DUSP1;ESR1;TGFBR2;PER1;LEP;KIT;SERPING1;FKBP4;TLR4;MET
Acute Coronary Syndrome,16/255,5.52852421754426E-9,8.5148859986397E-8,0,0,7.19591705365764,136.8184529962266,STAT5A;STAT5B;GSN;VWF;HGF;EGFR;FABP4;CXCL12;ALDH2;LEP;SPP1;CCL2;PPARG;VIM;TIMP1;TLR4
Familial Alzheimer Disease (FAD),14/188,5.839976263731935E-9,8.952705493060511E-8,0,0,8.58295852073963,162.7203547481214,MME;FOS;ESR1;TF;CCND1;PLAU;DPYSL2;LEP;CCL2;SNCG;PPARG;VIM;A2M;CTSD
Skin Neoplasms,16/256,5.846390526524785E-9,8.952705493060511E-8,0,0,7.165567765567766,135.84083079952183,ANXA1;HGF;KRT8;KRT5;EGFR;MMP14;KRT19;VCAN;CCND1;KRT15;ADAM12;KIT;S100A4;TIMP1;FGFR3;S100A8
liposarcoma,12/129,6.036714656853452E-9,9.217665445951876E-8,0,0,10.854700854700855,205.42961964136572,SREBF1;JUN;KLF6;CCND1;CAV2;CAV1;LEP;PLK1;LEPR;PPARG;CALR;A2M
Neuroendocrine Tumors,16/257,6.180928905245113E-9,9.397161840483714E-8,0,0,7.135470338789841,134.87321375905705,YAP1;ARF1;GSN;FZD4;PKD2;ESR1;FLI1;EGFR;MUC1;KRT19;KLF6;CXCL12;CCND1;KIT;CALR;MET
Pituitary Adenoma,17/294,6.189536134377526E-9,9.397161840483714E-8,0,0,6.620360213016335,125.1274938463081,CXCR4;CIB1;NR3C1;ESR1;EGFR;GHR;CXCL12;EFEMP1;CCND1;MDK;LEP;KIT;LEPR;PPARG;S100A4;TIMP1;TLR4
Uveitis,12/130,6.593561659967787E-9,9.982127865331914E-8,0,0,10.762165117550573,202.72875724229323,CXCL10;CXCL12;ANXA1;CFH;CAV2;STAT1;CAV1;CXCR4;CCL2;NR3C1;TLR4;AQP1
Transient Ischemic Attack,14/191,7.15954847171807E-9,1.080828153138402E-7,0,0,8.436195038074183,158.2193103177059,PPP1R15A;VWF;DUSP1;CAV1;ANK2;ESR1;C3;CXCL12;PLAU;LEP;SPP1;CCL2;PPARG;SGK1
Kidney Failure,17/297,7.202388250260207E-9,1.0842239261479277E-7,0,0,6.548421468034728,122.77539256344349,GSN;CFH;MME;VWF;CAV1;PKD2;RUNX2;EGFR;C3;MUC1;PLAU;LEP;CCL2;PPARG;TIMP1;SGK1;TLR4
"Lymphoma, T-Cell, Cutaneous",16/260,7.292634037799678E-9,1.0947168109136474E-7,0,0,7.046658259773014,132.02901510556737,STAT5A;STAT5B;JUN;STAT1;PLK1;CXCR4;CIB1;FOS;SOCS3;CXCL10;NR4A1;MUC1;CCND2;CCND1;KIT;FGFR3
Hematopoietic Neoplasms,14/192,7.656261765041923E-9,1.1460735658963035E-7,0,0,8.388373229115778,156.7597546428793,STAT5A;STAT5B;PLK1;CIB1;ESR1;CCND2;CCND1;BCL6;LEP;KIT;LEPR;S100A4;PPARG;MET
Familial multiple trichoepitheliomata,13/161,7.827971841197482E-9,1.1681969443746935E-7,0,0,9.331701972242513,174.181465317471,ANXA1;GSN;ESR1;EGFR;GHR;AKAP12;CCND1;LEP;SPP1;PPARG;DMD;FKBP4;MET
Mouth Neoplasms,12/132,7.847898406570469E-9,1.1681969443746935E-7,0,0,10.581720430107527,197.48686065538664,CXCL12;ANXA1;CCND1;PLAU;CAV1;AGR2;CCL2;VIM;CRYAB;TLR4;DCN;EGFR
PACHYONYCHIA CONGENITA 3,12/133,8.55219995217591E-9,1.2694895137923517E-7,0,0,10.493735003998934,194.94292615395318,MDK;PROS1;HGF;PLK1;KDR;SPP1;CCL2;PPARG;VIM;ESR1;RUNX2;FOXO1
Malignant neoplasm of gastrointestinal tract,16/263,8.584852167191755E-9,1.270796588860135E-7,0,0,6.960003559193843,129.27000138183988,YAP1;FHL1;CXCR4;KLF4;PKD2;SOX10;EGFR;GHR;ZEB2;ALDH2;PLAU;LEP;AGR2;PPARG;TIMP1;SPTBN1
Endometrioma,15/229,9.461770175753417E-9,1.396725021235179E-7,0,0,7.502681170522445,138.6195849427095,NRP1;DUSP1;FOS;NR3C1;ESR1;EGFR;FOXO1;DEPP1;RGS4;ACTA2;NR4A1;VCAN;LEPR;TXNIP;TIMP1
Hemolytic-Uremic Syndrome,9/62,9.818622168150513E-9,1.4453988269081238E-7,0,0,17.743935309973047,327.18015761006825,C3;ZFP36;CXCL12;VWF;CFH;FHL1;SAA1;CXCR4;CCL2
Tumor Promotion,11/108,1.0128882218391909E-8,1.4869645548708122E-7,0,0,11.949666464523954,219.96796499887262,EPS8;STAT5A;STAT5B;ZFP36;JUN;CXCL12;STAT1;FOS;KLF4;ESR1;CTSD
Lupus Erythematosus,17/304,1.0185503977942743E-8,1.4911689752323318E-7,0,0,6.386413074864766,117.52469128260181,VWF;STAT1;HGF;BGN;CXCR4;ESR1;FLI1;EGFR;FOXO1;C3;LEP;SPP1;CCL2;CALR;CD36;TLR4;TNS1
Contracture,13/166,1.1330848418989071E-8,1.6537152969091812E-7,0,0,9.024447977389153,165.1089257012943,SNAP25;DST;TPM3;CAV1;FHL1;BGN;ANTXR2;DCN;KLC2;COL1A2;DMD;TIMP1;CRYAB
gliosarcoma,9/63,1.135784947773992E-8,1.6537152969091812E-7,0,0,17.414462081128747,318.5689674265419,PLAU;HGF;KIT;CCL2;PPARG;TACC1;ESR1;FGFR3;EGFR
Pancreatitis,16/269,1.181881206935155E-8,1.7161430386260057E-7,0,0,6.792859314598445,123.99395563139248,EGR1;DUSP1;HGF;CAV1;KRT8;LPL;TF;ALDH2;AGR2;LEPR;CCL2;PPARG;A2M;TLR4;MET;S100A8
Recurrent tumor,18/347,1.1876640280945491E-8,1.7198536972053946E-7,0,0,5.918844984802432,108.0111812994256,HGF;CAV1;CIB1;KRT5;ESR1;EGFR;ETS2;KRT19;KLF6;BCL6;LEP;KIT;KDR;SPP1;CCL2;S100A4;FGFR3;MET
Gallbladder Carcinoma,15/233,1.1949322658757998E-8,1.7256894430493596E-7,0,0,7.3635133102722214,134.32956342027853,YAP1;HGF;CXCR4;ESR1;EGFR;DEPP1;TGFBR2;MUC1;CXCL12;BCL6;VIM;FADD;TIMP1;TLR4;S100A8
Infection caused by Helicobacter pylori,17/308,1.2362792823016315E-8,1.7805762960501067E-7,0,0,6.297336295114959,114.6655167907624,JUN;HGF;CAV1;FHL1;FOS;EGFR;MUC1;ALDH2;LEP;SPP1;CCL2;PPARG;CALR;TIMP1;TLR4;TEAD1;S100A8
"Liposarcoma, Dedifferentiated",8/45,1.2612496465150497E-8,1.806774023193199E-7,0,0,22.49217638691323,409.1006985647065,JUN;CCND1;EPAS1;HGF;PLK1;CD36;CALR;MET
Enteritis,8/45,1.2612496465150497E-8,1.806774023193199E-7,0,0,22.49217638691323,409.1006985647065,STAT5A;STAT5B;JUN;CFH;DUSP1;TIMP1;FOS;TLR4
"Lupus Erythematosus, Discoid",17/309,1.297010103359064E-8,1.8494321529185495E-7,0,0,6.275448422008628,113.96602815285132,VWF;STAT1;HGF;BGN;CXCR4;ESR1;FLI1;EGFR;FOXO1;C3;LEP;SPP1;CCL2;CALR;CD36;TLR4;TNS1
Uterine Fibroids,18/349,1.2979688969629152E-8,1.8494321529185495E-7,0,0,5.882477341389728,106.82508314140131,PPP1R15A;EGR1;CAV1;FOS;NR3C1;ESR1;EGFR;FOXO1;GHR;VCAN;EFEMP1;CCND1;BCL6;LEP;ADAM12;KIT;CCL2;PPARG
Breast adenocarcinoma,13/168,1.3090057760576233E-8,1.8572492497763557E-7,0,0,8.907096774193548,161.67639079395988,EGR1;MME;CAV2;CAV1;KRT5;KLF4;ESR1;RUNX2;TGFBR2;MMP14;KRT19;KDR;CD36
Bronchiolitis Obliterans,9/64,1.3104254417637639E-8,1.8572492497763557E-7,0,0,17.096969696969698,310.3156231037244,CXCL10;VCAN;MUC1;CXCL12;HGF;CXCR4;CCL2;TIMP1;TLR4
Cardiomyopathies,21/480,1.36956051950497E-8,1.935911938578776E-7,0,0,4.999852294966951,90.52827984577561,MEF2C;GSN;LRP1;HGF;FHL1;LPL;EGFR;DCN;SYNE1;ACTA2;MMP14;RGS2;ALDH2;KDR;CCL2;PPARG;DMD;TIMP1;UTRN;CRYAB;CTSD
Uveal melanoma,15/236,1.4191439462400491E-8,2.0006926162733392E-7,0,0,7.262443438914027,131.2369058315294,YAP1;FZD4;HGF;CXCR4;CIB1;EGFR;VCAN;CXCL12;CCND2;CCND1;KIT;SPP1;CCL2;VIM;MET
Hemangiosarcoma,10/87,1.486812951490434E-8,2.0905610075178159E-7,0,0,13.626001657916552,245.59567895557066,CXCL10;JUN;PTPRB;CCND1;VWF;HGF;KIT;KDR;PECAM1;MET
Drusen,8/46,1.5139134900963165E-8,2.1230644707166502E-7,0,0,21.89916897506925,394.31605837810923,ABCA1;EFEMP1;CFH;MME;FHL1;CCL2;SERPING1;CRYAB
Keloid,13/171,1.619387602496851E-8,2.2650174629148866E-7,0,0,8.73664043790626,156.72338375432076,BGN;NR3C1;DCN;EGFR;VCAN;COL1A2;ADAM12;CCL2;S100A4;PPARG;TIMP1;VIM;S100A8
Giant Cell Tumor of Bone,9/66,1.7314303838239077E-8,2.415390710837069E-7,0,0,16.495405179615705,294.8014748799937,CXCL12;HGF;SPP1;CCL2;NR3C1;ESR1;RUNX2;DCN;EGFR
Squamous cell carcinoma of skin,14/205,1.767176144001159E-8,2.452417101922442E-7,0,0,7.812258137946733,139.45894705969374,YAP1;CFH;STAT1;PLK1;FHL1;KLF4;NR3C1;EGFR;CXCL12;CCND1;PPARG;S100A4;VIM;S100A8
Thymoma,14/205,1.767176144001159E-8,2.452417101922442E-7,0,0,7.812258137946733,139.45894705969374,STAT5A;STAT5B;STAT1;HGF;LMO2;CXCR4;IRS2;NR3C1;ESR1;EGFR;KRT19;CCND1;KIT;MET
Gingival Diseases,11/114,1.794272371742721E-8,2.477118515289368E-7,0,0,11.250142775556824,200.65845969783697,CXCL10;SNAP25;CXCL12;CFH;ALDH2;STAT1;CXCR4;CCL2;PPARG;CTSD;TLR4
leiomyosarcoma,11/114,1.794272371742721E-8,2.477118515289368E-7,0,0,11.250142775556824,200.65845969783697,SOCS3;VCAN;ZEB2;CCND1;BCL6;KIT;BGN;IRS2;DMD;VIM;ESR1
Essential Hypertension,16/278,1.8793905194355467E-8,2.5879256015689996E-7,0,0,6.556496938176328,116.63833133192192,HGF;BGN;LPL;NR3C1;MYLK;TGFBR2;SYNE1;RGS2;ALDH2;LEP;SPP1;LEPR;CCL2;PPARG;SGK1;TEAD1
Uremia,9/67,1.983130218372414E-8,2.7167354585363995E-7,0,0,16.210180623973727,287.50383210308775,STAT5A;STAT5B;PROS1;LEP;KDR;SPP1;SGK1;RUNX2;EGFR
Gestational Diabetes,9/67,1.983130218372414E-8,2.7167354585363995E-7,0,0,16.210180623973727,287.50383210308775,TCF7L2;LEP;KDR;LEPR;TXNIP;LPL;CCL2;PPARG;MET
Acute leukemia,21/492,2.0977119485675293E-8,2.8663351215170164E-7,0,0,4.869444744323293,86.09097251923313,STAT5A;STAT5B;NRP1;MME;STAT1;ZBTB16;LMO2;CXCR4;FLI1;ETS2;AKAP12;CDH5;NR4A1;TF;KLF6;BCL6;MDK;LEP;KIT;LEPR;TLR4
Addictive Behavior,14/208,2.124565635992504E-8,2.8882169066847073E-7,0,0,7.690273419991035,135.86493235006287,ABCA1;STAT5A;STAT5B;JUN;PLK1;FOS;NR3C1;ESR1;EGFR;BCL6;ALDH2;KIT;LEPR;MET
Colorectal cancer metastatic,14/208,2.124565635992504E-8,2.8882169066847073E-7,0,0,7.690273419991035,135.86493235006287,YAP1;PPP1R15A;EGR1;NRP1;DUSP1;HGF;IRS2;SORBS1;EGFR;KRT19;CCND1;KDR;TIMP1;MET
Multiple malignancy,13/176,2.286887978518278E-8,3.100973546443741E-7,0,0,8.466489802686121,148.95509362010915,YAP1;EGR1;CAV1;ZBTB16;NEDD9;CXCR4;SOX10;QKI;EGFR;MMP14;CCND2;ALDH2;MET
Lupus Nephritis,14/210,2.3979760540133343E-8,3.243353906557629E-7,0,0,7.611024844720497,133.5434656556721,CFH;DUSP1;STAT1;HGF;BGN;NR3C1;FLI1;CXCL10;SERPING1;CCL2;CALR;SGK1;TLR4;TNS1
Congenital chromosomal disease,21/497,2.4957927105195276E-8,3.3671086973059655E-7,0,0,4.817048853439681,84.32761535452877,SNAP25;MAML2;EPAS1;LMO2;KRT5;FOS;KLF4;RUNX2;EGFR;RPS6KA3;COL1A2;KRT18;CCND2;CCND1;BCL6;KIT;KDR;MAP3K20;S100A4;VIM;SPTBN1
Burkitt Lymphoma,19/407,2.5030308753590005E-8,3.3683463471687157E-7,0,0,5.311092553130219,92.96100043636736,EGR1;MME;PLK1;CXCR4;TAP1;CIB1;PIK3R1;KLF4;NR3C1;EGFR;TGFBR2;CXCL12;CCND2;CCND1;BCL6;KIT;VIM;TIMP1;MET
Cerebrovascular Disorders,13/178,2.6170775412563713E-8,3.5129486693589934E-7,0,0,8.363013923013924,146.0067029690163,ABCA1;NRP1;MEF2C;HGF;F13A1;LPL;PKD2;TGFBR2;ACTA2;CCND1;PLAU;PECAM1;SPP1
polyps,16/285,2.662819808358254E-8,3.565368532347019E-7,0,0,6.38359410106622,111.33814854285937,EGR1;JUN;NEDD9;CXCR4;DTX1;ESR1;EGFR;C3;MUC1;CCND1;ALDH2;KIT;SPP1;PPARG;VIM;CALR
Pterygium,9/71,3.33841242792596E-8,4.4587468241647715E-7,0,0,15.161290322580646,261.00442336593784,EFEMP1;CXCL12;LRP1;PLAU;KDR;PECAM1;CXCR4;S100A8;EGFR
Nephrotic Syndrome,13/182,3.4094495553080456E-8,4.542239170059144E-7,0,0,8.163409563409564,140.3627243492864,GSN;LPL;NR3C1;C3;TF;MAF;CCND1;LEP;KDR;LEPR;SAA1;CCL2;A2M
Pulmonary Hypertension,12/151,3.576109317446763E-8,4.7523906615146634E-7,0,0,9.126479461592016,156.48631596895007,EGR1;JUN;VWF;EPAS1;CAV1;PECAM1;CCL2;PPARG;BMPR1B;FOXO1;TGFBR2;ARHGEF6
Cholangitis,7/34,3.595040249153743E-8,4.765664051676691E-7,0,0,26.84215629241807,460.10477122819685,EGR1;KRT19;HGF;BCL3;PPARG;TIMP1;TGFBR2
"Hepatitis, Chronic",13/183,3.638644940841076E-8,4.811498483806971E-7,0,0,8.114976152623212,139.00198970260024,STAT1;HGF;PLK1;TAP1;ACTA2;SOCS3;CXCL10;TF;KRT19;KRT18;CCL2;CALR;MET
Idiopathic pulmonary hypertension,10/96,3.881047110150794E-8,5.119331695542966E-7,0,0,12.19445818901534,208.09325553295506,STAT5A;STAT5B;CFH;CAV1;FHL1;CCL2;PPARG;BMPR1B;DCN;TGFBR2
Idiopathic crescentic glomerulonephritis,8/52,4.150112619783731E-8,5.460728432303087E-7,0,0,18.90717703349282,321.37559760727345,JUN;BGN;SPP1;CCL2;PRTN3;FOS;DCN;EGFR
Bone neoplasms,9/73,4.2783407701466174E-8,5.615585705446138E-7,0,0,14.686011904761905,249.17925992946664,PLAU;CAV1;CXCR4;VIM;MET;RUNX2;EGFR;FLI1;TGFBR2
CNS disorder,11/124,4.327291447162657E-8,5.665881111039263E-7,0,0,10.24934929724102,173.7852908812498,SOCS3;ZFP36;MEF2C;CXCL12;DST;MME;SPP1;CCL2;PPARG;TIMP1;VIM
Acanthosis Nigricans,7/35,4.456344827738481E-8,5.820554310543717E-7,0,0,25.88219895287958,438.0912063683643,KRT18;CAV1;KDR;PPARG;FOS;ESR1;FGFR3
Status Epilepticus,14/221,4.558201482899406E-8,5.939035624051573E-7,0,0,7.202530980886368,121.74980186583947,JUN;MEF2C;FOS;NR3C1;AQP1;SOCS3;CXCL12;CCND1;PLAU;DPYSL2;CCL2;DMD;TLR4;CTSD
Biliary cirrhosis,12/155,4.7847949901295816E-8,6.203934915425923E-7,0,0,8.86938867584029,149.49565318089765,COL17A1;CDH5;CXCL10;CAV2;STAT1;HGF;CAV1;LEP;PPARG;ESR1;TLR4;TGFBR2
Other specified transient cerebral ischemias,12/155,4.7847949901295816E-8,6.203934915425923E-7,0,0,8.86938867584029,149.49565318089765,C3;PPP1R15A;CXCL12;VWF;PLAU;DUSP1;CAV1;CCL2;ANK2;PPARG;SGK1;ESR1
Nodular glomerulosclerosis,8/53,4.846748644642578E-8,6.269010564878713E-7,0,0,18.48608187134503,311.3494796482714,FABP4;MDK;KDR;TXNIP;CCL2;PPARG;CD36;TGFBR2
Malignant Peripheral Nerve Sheath Tumor,13/188,5.006684891387006E-8,6.460199463971272E-7,0,0,7.881111969111969,132.48075725713676,HGF;PLK1;CIB1;SOX10;ESR1;EGFR;CCND1;BCL6;MDK;KIT;KDR;SPP1;MET
Nodule,11/126,5.1101151759039393E-8,6.577730379804854E-7,0,0,10.07007672634271,169.0711383165663,VCAN;KRT19;MDK;KIT;SPP1;VIM;CTSD;TLR4;RUNX2;EGFR;AQP1
Somatotropin deficiency,7/36,5.485908928374864E-8,7.044435826339675E-7,0,0,24.98844556779202,417.76927605650224,STAT5B;LEP;LEPR;LPL;FOS;NR3C1;ESR1
Hypertriglyceridemia,12/157,5.516653672383306E-8,7.066886399069865E-7,0,0,8.746162402669633,146.1738188387101,C3;ABCA1;SOCS3;SREBF1;VWF;CAV1;LEP;TXNIP;LPL;PPARG;CD36;FOXO1
Polymyositis,10/100,5.755380273876087E-8,7.35501714136347E-7,0,0,11.650118203309693,194.21382706626895,CXCL10;CXCL12;HGF;CXCR4;CCL2;DMD;TIMP1;NR3C1;UTRN;TLR4
Varicosity,9/76,6.120007147537557E-8,7.802277054839149E-7,0,0,14.026297085998578,232.96441610414695,JUN;EPAS1;KDR;SPP1;CCL2;TIMP1;FOS;CALR;ESR1
tumor vasculature,11/129,6.520995050530931E-8,8.29364740436261E-7,0,0,9.812562313060818,162.3552585749389,EFNA1;RCAN1;CXCL10;ANXA1;PLAU;ADAM12;KDR;PECAM1;CXCR4;ANTXR2;MET
Refractory anemias,15/266,6.945457407112202E-8,8.812462505357364E-7,0,0,6.384625432695448,105.23518188075509,JUN;STAT1;ZBTB16;F13A1;CIB1;FOS;ESR1;EGFR;CCND1;KIT;CCL2;S100A4;PRTN3;VIM;FADD
Aortic Valve Stenosis,11/130,7.062833636456244E-8,8.940104619637844E-7,0,0,9.729609490855166,160.20613873127107,SREBF1;JUN;MMP14;MME;VWF;BGN;SPP1;PPARG;FOS;ESR1;RUNX2
"Ichthyosis, X-Linked",10/103,7.644812083226028E-8,9.653124092534635E-7,0,0,11.272592084191261,184.7200603639123,EPAS1;KIT;KDR;PECAM1;SPP1;CCL2;DMD;VIM;EZR;EGFR
"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse",17/349,7.662359713158473E-8,9.653124092534635E-7,0,0,5.508054316714372,90.24594896165472,MME;STAT1;PLK1;CXCR4;CIB1;FOXO1;SOCS3;KLF6;CXCL12;CCND2;CCND1;BCL6;PPP2R1B;KIT;PECAM1;FADD;TLR4
"Pleural Effusion, Malignant",9/78,7.701609301943811E-8,9.679687728787398E-7,0,0,13.618357487922705,223.05850144924975,MUC1;CCL11;CXCL12;MDK;PLAU;KDR;CCL2;ESR1;EGFR
MYELODYSPLASTIC SYNDROME,24/683,7.889579620698193E-8,9.892604658517806E-7,0,0,4.006697713358799,65.53009358764204,EGR1;MAML2;MME;CXCR4;CIB1;IRS2;FOS;RUNX2;FLI1;TGFBR2;AKAP12;MMP14;CXCL12;CCND1;KIT;SAA1;SPP1;CALR;FADD;TIMP1;CD36;TLR4;MET;S100A8
Hyperlipidemia,14/232,8.350545317372968E-8,1.0446022534338157E-6,0,0,6.8352612684483445,111.40350715044042,ABCA1;SREBF1;LRP1;LPL;MYLK;C3;MMP14;LEP;SAA1;LEPR;TXNIP;CCL2;PPARG;CD36
Ewings sarcoma,17/352,8.665483893488151E-8,1.081460507456636E-6,0,0,5.45788735878618,88.7525236962237,YAP1;LRP1;MME;STAT1;CAV1;PLK1;CXCR4;FLI1;FOXO1;TGFBR2;CXCL12;CCND2;CCND1;MDK;KIT;EZR;MET
Chronic myeloproliferative disorder,14/233,8.807986551577118E-8,1.0966766433026744E-6,0,0,6.803702600754417,110.5262975555864,ABCA1;STAT5A;STAT5B;EGR1;NRP1;CXCR4;IRS2;FLI1;SOCS3;CXCL10;RPS6KA3;CXCL12;KIT;CALR
Tumor Initiation,14/234,9.287949095496184E-8,1.1537408095547591E-6,0,0,6.772430830039526,109.65894928627799,STAT5A;HGF;CAV1;PLK1;IRS2;KLF4;EGFR;DCN;RPS6KA3;MUC1;VCAN;CCND1;KDR;MET
Childhood Acute Lymphoblastic Leukemia,19/443,9.512801664582581E-8,1.1789237225711763E-6,0,0,4.851138399915674,78.43341089581531,THRB;MME;PLK1;CIB1;KLF4;NR3C1;FBLN2;ESR1;TGFBR2;C3;MMP14;CCND2;CCND1;PLAU;LEP;BCL3;LEPR;S100A4;TIMP1
Bone Diseases,12/165,9.551277262339927E-8,1.1809456271695932E-6,0,0,8.285473329116593,133.926439392144,CXCL12;LRP1;HGF;SPP1;CXCR4;PPARG;DMD;ESR1;FGFR3;RUNX2;EGFR;TGFBR2
Thyroid Gland Follicular Adenoma,11/134,9.652166453013816E-8,1.1906572923173756E-6,0,0,9.411286465805835,152.0252004051996,NR4A1;CXCL10;CXCL12;CCND1;TPM3;PLK1;CXCR4;CCL2;PPARG;ESR1;DCN
Hormone refractory prostate cancer,11/135,1.0418520067194017E-7,1.2792694340570719E-6,0,0,9.334914611005692,150.07831598014096,MUC1;ANXA1;PROS1;PLK1;KDR;AGR2;NR3C1;FKBP4;ESR1;MET;EGFR
Neurilemmoma,11/135,1.0418520067194017E-7,1.2792694340570719E-6,0,0,9.334914611005692,150.07831598014096,STAT5A;STAT5B;VCAN;CCND1;KIT;SPP1;DMD;FOS;EZR;SOX10;EGFR
Primary chondrosarcoma of bone,5/13,1.0908748547037223E-7,1.3363843909692267E-6,0,0,64.09974093264249,1027.5903605165556,CXCL12;KIT;CXCR4;FGFR3;RUNX2
"Hepatitis B, Chronic",14/238,1.1453203427729598E-7,1.39986516207273E-6,0,0,6.650135869565218,106.28520652020505,GSN;STAT1;NR3C1;ESR1;SOCS3;CXCL10;KRT18;ALDH2;SPP1;LEPR;CCL2;PPARG;TIMP1;TLR4
"Fibromatosis, Aggressive",8/59,1.1526168614325415E-7,1.4055595548224287E-6,0,0,16.306295149638803,260.5103621138005,CCND1;BCL6;MDK;KIT;KDR;PECAM1;ESR1;FOXO1
Childhood Leukemia,12/168,1.1641204735947003E-7,1.4163465762068853E-6,0,0,8.124896608767576,129.7231539269052,STAT5A;STAT5B;ZEB2;MME;DUSP1;CAV1;SPP1;UBE2L6;CIB1;FOS;NR3C1;SPTBN1
"Hyperlipidemia, Familial Combined",9/82,1.196168097644492E-7,1.4487226800789766E-6,0,0,12.869536855838225,205.12719345942534,C3;EGR1;TCF7L2;LEP;LEPR;TXNIP;LPL;PPARG;CD36
Malignant neoplasm of tongue,9/82,1.196168097644492E-7,1.4487226800789766E-6,0,0,12.869536855838225,205.12719345942534,CCND1;PROS1;CAV1;FOS;SGK1;EZR;CRYAB;FGFR3;FOXO1
Osteogenesis Imperfecta,13/204,1.3047056579191078E-7,1.5765932995580332E-6,0,0,7.215027593038064,114.37347011367669,STAT5B;THRB;BGN;CXCR4;LIFR;ESR1;RUNX2;DCN;RPS6KA3;COL1A2;DMD;BMPR1B;FGFR3
Eczema,19/454,1.3920932438020098E-7,1.6783857231269028E-6,0,0,4.725781801836512,74.60727410495583,STAT5A;STAT5B;NRP1;JUN;CCL11;DUSP1;STAT1;CXCR4;TAP1;FOS;NR3C1;EGFR;SOCS3;CXCL10;BCL3;CCL2;PPARG;TLR4;S100A8
Weight Gain,10/110,1.4313477403642728E-7,1.7218176316932754E-6,0,0,10.479787234042552,165.15598867079603,GSN;CAV1;LEP;SORBS2;CD36;VIM;FBLN2;CTSD;MEST;SPTBN1
Multiple Sclerosis,31/1106,1.500689852971921E-7,1.8011658167764337E-6,0,0,3.2337390335607856,50.809059845224446,LRP1;CFH;CXCR4;NR3C1;EGFR;C3;SOCS3;CCND1;DPYSL2;S1PR1;SPP1;CCL2;TIMP1;A2M;ABCA1;ANXA1;DST;STAT1;CAV1;TAP1;ESR1;DCN;CXCL10;NR4A1;CXCL12;LEP;PECAM1;PPARG;CRYAB;TLR4;SKAP2
Polycythemia Vera,13/207,1.545985359648926E-7,1.8513608947346353E-6,0,0,7.102368347729173,111.38242406907025,STAT5A;STAT5B;DST;STAT1;HGF;KLF4;NR3C1;TGFBR2;SOCS3;KIT;CALR;CD36;MET
Prostatic Hyperplasia,9/85,1.638206641534491E-7,1.957399818999395E-6,0,0,12.359649122807017,193.1132576127208,AKAP12;EGR1;VCAN;LEPR;CCL2;A2M;ESR1;EGFR;FLI1
Kidney Neoplasm,14/246,1.7200914382204545E-7,2.050641448384072E-6,0,0,6.4181971514242875,99.96803018127908,EPAS1;CXCR4;EGFR;MUC1;KRT19;CXCL12;CCND1;KIT;KDR;PPARG;S100A4;VIM;MET;TNS1
Amyotrophic Lateral Sclerosis,23/660,1.742243268213786E-7,2.0724139232837646E-6,0,0,3.954204978694775,61.538984183228294,STAT5A;SNAP25;HGF;LAMA3;LAMC1;EGFR;ETS2;C3;CXCL10;MMP14;MAP1B;KDR;CCL2;PPARG;TIMP1;SGK1;CRYAB;TLR4;TEAD1;CTSD;MET;S100A8;TNS1
Lipodystrophy,10/113,1.8469528847696085E-7,2.1920739249303437E-6,0,0,10.173001445982235,157.72789562399188,SREBF1;FABP4;CAV1;LEP;LEPR;CCL2;PPARG;PIK3R1;NR3C1;ESR1
Non-small cell lung cancer metastatic,7/43,1.99723533459629E-7,2.365170466236362E-6,0,0,20.122454915648632,310.41566534243486,CCND2;CXCL12;SPP1;CXCR4;ESR1;MET;EGFR
Congenital contractural arachnodactyly,13/212,2.0382034649803133E-7,2.4083339833437006E-6,0,0,6.9221512970256684,106.64284898766671,ANXA1;MME;PLK1;CXCR4;EGFR;TGFBR2;COL1A2;CXCL12;PRKAR2B;SPP1;VIM;FKBP4;S100A8
Refractory cancer,12/177,2.057734663835856E-7,2.4260327485799282E-6,0,0,7.678201368523949,118.21735021219989,LEP;KIT;SPP1;CXCR4;PIK3R1;NR3C1;ESR1;FGFR3;CTSD;MET;TLR4;EGFR
"Thrombocythemia, Essential",11/145,2.1613684728844643E-7,2.54258997615923E-6,0,0,8.63388937664618,132.5073573303081,STAT5A;SOCS3;STAT5B;CXCL12;CCND1;STAT1;CXCR4;IRS2;CALR;NR3C1;FLI1
Malignant neoplasm of large intestine,20/516,2.2052428522368372E-7,2.588488801667424E-6,0,0,4.3734142805364264,67.03244906701556,YAP1;STAT1;CAV1;CXCR4;IRS2;KLF4;EGFR;TGFBR2;EFNA1;SOCS3;CXCL12;CCND1;SPP1;CCL2;S100A4;TIMP1;SGK1;CRYAB;MET;TNS1
"Brain Tumor, Primary",9/88,2.2159756566681783E-7,2.595370170194444E-6,0,0,11.888487040385774,182.1601879165556,YAP1;NRP1;CCND1;MDK;SPP1;TIMP1;SOX10;EGFR;TGFBR2
Unipolar Depression,20/517,2.27429378044007E-7,2.6578314815713012E-6,0,0,4.3643885786629895,66.75954724704874,SNAP25;LRP1;DST;DUSP1;ZBTB16;FOS;NR3C1;ESR1;EGFR;QKI;SYNE1;RGS4;PER1;CXCL10;CCND1;KDR;CCL2;SGK1;FKBP4;MET
"Alzheimer Disease, Early Onset",10/116,2.365043629439678E-7,2.745820806379966E-6,0,0,9.88358089120835,150.79675063894044,TF;MME;PLAU;DPYSL2;LEP;CIB1;PPARG;A2M;ESR1;AQP1
Respiratory Syncytial Virus Infections,10/116,2.365043629439678E-7,2.745820806379966E-6,0,0,9.88358089120835,150.79675063894044,CXCL10;MUC1;STAT1;SPP1;TAP1;CXCR4;CCL2;PPARG;NR3C1;TLR4
Ischemic cardiomyopathy,10/116,2.365043629439678E-7,2.745820806379966E-6,0,0,9.88358089120835,150.79675063894044,GRK3;MMP14;CXCL12;HGF;BCL3;SPP1;SVEP1;DMD;TIMP1;ESR1
Monosomy,11/147,2.4835144733932905E-7,2.8581325362522096E-6,0,0,8.5060553633218,129.36367073901695,STAT5A;EGR1;STAT5B;CCND1;BCL6;STAT1;KIT;VIM;ESR1;EGFR;AQP1
Hepatic methionine adenosyltransferase deficiency,8/65,2.493847292869955E-7,2.8581325362522096E-6,0,0,14.585410895660203,221.7605112491607,NRP1;HGF;CAV1;CXCR4;TIMP1;KLF4;MET;EGFR
Symmetric Diabetic Proximal Motor Neuropathy,5/15,2.504687360536277E-7,2.8581325362522096E-6,0,0,51.27461139896373,779.3705927661961,MME;HGF;LEPR;SGK1;TLR4
Asymmetric Diabetic Proximal Motor Neuropathy,5/15,2.504687360536277E-7,2.8581325362522096E-6,0,0,51.27461139896373,779.3705927661961,MME;HGF;LEPR;SGK1;TLR4
Diabetic Amyotrophy,5/15,2.504687360536277E-7,2.8581325362522096E-6,0,0,51.27461139896373,779.3705927661961,MME;HGF;LEPR;SGK1;TLR4
Diabetic Asymmetric Polyneuropathy,5/15,2.504687360536277E-7,2.8581325362522096E-6,0,0,51.27461139896373,779.3705927661961,MME;HGF;LEPR;SGK1;TLR4
Diabetic Autonomic Neuropathy,5/15,2.504687360536277E-7,2.8581325362522096E-6,0,0,51.27461139896373,779.3705927661961,MME;HGF;LEPR;SGK1;TLR4
Diabetic Mononeuropathy,5/15,2.504687360536277E-7,2.8581325362522096E-6,0,0,51.27461139896373,779.3705927661961,MME;HGF;LEPR;SGK1;TLR4
insulinoma,12/181,2.622016416451866E-7,2.9856251032632468E-6,0,0,7.494941782782974,113.57948704187976,STAT5A;EGR1;STAT5B;KRT19;CCND2;CXCL12;MDK;STAT1;LEP;LEPR;MET;S100A8
Endometrial Stromal Sarcoma,7/45,2.7659536482582286E-7,3.1361206365038514E-6,0,0,19.06144943510609,287.841423445167,PPP4C;CCND1;MME;CAV1;KIT;VIM;ESR1
Lipoatrophy,7/45,2.7659536482582286E-7,3.1361206365038514E-6,0,0,19.06144943510609,287.841423445167,SREBF1;CAV1;LEP;PPARG;PIK3R1;FOS;ESR1
Down Syndrome,19/475,2.7895023230754833E-7,3.156105706936147E-6,0,0,4.503258845437617,67.96422927724363,SNAP25;GSN;EPAS1;STAT1;ITSN1;KRT8;CIB1;ESR1;ETS2;GHR;RCAN1;CCND1;BCL6;LEP;DPYSL2;ADAM12;KIT;CCL2;A2M
Adenocarcinoma of large intestine,15/297,2.8976933124453104E-7,3.271569419919716E-6,0,0,5.673758865248227,85.41379086509782,STAT5A;STAT5B;TCF7L2;TINAGL1;PIK3R1;LAMC1;RUNX2;EGFR;CCND2;CCND1;KIT;S100A4;TIMP1;FGFR3;MET
Thrombocytopenia,16/341,3.110691304004178E-7,3.5046245156529103E-6,0,0,5.268503803888419,78.93931312434076,ABCA1;CFH;MME;VWF;STAT1;HGF;CXCR4;FLI1;SOCS3;CXCL10;F8;CXCL12;PLAU;PECAM1;CD36;TLR4
Thyroid associated opthalmopathies,9/92,3.2566676648169297E-7,3.661346410508316E-6,0,0,11.313253012048193,168.99048561307973,SOCS3;CXCL10;ZFP36;STAT1;LEP;CCL2;PPARG;FOS;NR3C1
Sjogren's Syndrome,14/260,3.3772346987045083E-7,3.7889018335571207E-6,0,0,6.048603746907034,90.13047677645349,NRP1;GSN;STAT1;CXCR4;ESR1;EGFR;C3;CXCL10;MUC1;CXCL12;BCL6;CALR;CTSD;SPTBN1
"Pancreatitis, Chronic",15/302,3.586554545900565E-7,4.015283440147922E-6,0,0,5.573484891757583,82.71555224999696,DUSP1;KRT8;LPL;EGFR;DCN;CXCL10;NR4A1;MUC1;KRT18;CCND1;ALDH2;LEP;SPP1;CCL2;S100A4
Endothelial dysfunction,14/262,3.70557016044693E-7,4.138105233042131E-6,0,0,5.999211079943899,88.83786855540599,ABCA1;VWF;STAT1;HGF;CAV1;FOXO1;CXCL10;CDH5;PECAM1;TXNIP;PPARG;VIM;UTRN;S100A8
Cachexia,11/153,3.719557903222332E-7,4.138105233042131E-6,0,0,8.144159072079535,120.57012832473272,STAT5A;SOCS3;EGR1;ZFP36;MDK;LEP;PECAM1;LPL;CCL2;TLR4;EGFR
Cervical Squamous Cell Carcinoma,11/153,3.719557903222332E-7,4.138105233042131E-6,0,0,8.144159072079535,120.57012832473272,KRT19;CCND1;TPM3;HGF;CIB1;KRT5;VIM;KLF4;CTSD;TLR4;EGFR
Craniofacial Abnormalities,12/187,3.72786917367629E-7,4.138711422191864E-6,0,0,7.235760368663595,107.10559793651677,RCAN1;THRB;ANXA1;FZD4;FADD;BMPR1B;PKD2;ETS2;RUNX2;FLI1;EGFR;TGFBR2
Acute Erythroblastic Leukemia,13/224,3.837599186107696E-7,4.251676936126385E-6,0,0,6.524478032534905,96.38773655906095,STAT5A;STAT5B;STAT1;HGF;CIB1;ESR1;FLI1;EGFR;ETS2;AQP1;TF;KIT;PPARG
Exanthema,13/225,4.037948914286578E-7,4.4643630216251395E-6,0,0,6.4933707292197855,95.59773358263828,MME;STAT1;KRT5;PIK3R1;SOX10;RUNX2;EGFR;KDR;SERPING1;DMD;PRTN3;VIM;FGFR3
Influenza,21/589,4.281841668354674E-7,4.7176678414789585E-6,0,0,4.017605633802817,58.91301370164964,ABCA1;JUN;CFH;STAT1;TAP1;UBE2L6;KRT5;FOS;EGFR;CDC25B;SOCS3;CXCL10;MUC1;KLF6;LEP;S1PR1;SERPING1;CCL2;PPARG;TLR4;S100A8
Gastric ulcer,9/95,4.2936177577731187E-7,4.7176678414789585E-6,0,0,10.916943521594684,160.05293750162048,ANXA1;PLAU;HGF;LEP;F13A1;CCL2;TIMP1;MET;S100A8
Membranous glomerulonephritis,9/95,4.2936177577731187E-7,4.7176678414789585E-6,0,0,10.916943521594684,160.05293750162048,C3;ABCA1;CXCL10;MME;CFH;PECAM1;CCL2;CIB1;A2M
Ovarian adenocarcinoma,8/70,4.47142428705261E-7,4.902925931214683E-6,0,0,13.405772495755517,195.9976041839983,ZEB2;CXCL12;CXCR4;CCL2;NR3C1;TEAD1;MET;ESR1
Steroid Sulfatase Deficiency Disease,9/96,4.697640698593023E-7,5.129862148115209E-6,0,0,10.790914066776136,157.2347892175666,EPAS1;KIT;KDR;PECAM1;SPP1;CCL2;VIM;EZR;EGFR
Aortic Aneurysm,9/96,4.697640698593023E-7,5.129862148115209E-6,0,0,10.790914066776136,157.2347892175666,ACTA2;CDH5;LEP;SPP1;CCL2;KLF4;TLR4;MYLK;TGFBR2
Arthropathy,10/125,4.7613390648565147E-7,5.188788522826252E-6,0,0,9.105920444033302,132.56004428473346,GHR;F8;MMP14;KDR;SPP1;CCL2;KRT5;CALR;TLR4;DCN
Adenocarcinoma of pancreas,16/354,5.126716597773638E-7,5.575565867252187E-6,0,0,5.062487808049938,73.32320148660351,NRP1;PLK1;CXCR4;IRS2;EGFR;TGFBR2;NR4A1;MUC1;CCND2;EFEMP1;CCND1;PLAU;KDR;SPP1;S100A4;TLR4
Sporadic Breast Carcinoma,11/159,5.470796969440773E-7,5.937653167036635E-6,0,0,7.8116057233704295,112.6329756167238,EFEMP1;CXCL12;CCND1;MME;CAV1;LEP;LEPR;CXCR4;NR3C1;ESR1;TGFBR2
Atypical Ductal Breast Hyperplasia,7/50,5.838844081252666E-7,6.324227664429971E-6,0,0,16.84074028978449,241.72462343214116,STAT5A;CXCL12;CCND1;KRT15;CXCR4;DMD;ESR1
Tuberculosis,21/602,6.102510991449541E-7,6.595243418086659E-6,0,0,3.9250561568307125,56.16518022694539,ANXA1;LRP1;STAT1;CXCR4;TAP1;CIB1;SORBS1;NR3C1;FOXO1;TGFBR2;C3;SOCS3;CXCL10;TF;MMP14;SPP1;CCL2;VIM;TIMP1;TLR4;FGFR3
"Aortic Aneurysm, Thoracic",9/99,6.113811687999267E-7,6.595243418086659E-6,0,0,10.42962962962963,149.22239763820542,ACTA2;VCAN;COL1A2;BGN;SPP1;PKD2;TLR4;MYLK;TGFBR2
Transitional Cell Neoplasm,4/8,6.323506344337567E-7,6.807669759388867E-6,0,0,102.05154639175258,1456.6655871332866,ANXA1;CCND2;CCND1;FGFR3
Tuberous Sclerosis,12/197,6.511436238262471E-7,6.995855587439659E-6,0,0,6.841150828247603,97.44901650941914,PPP1R15A;ANXA1;GSN;MME;CCND1;PLAU;HGF;KRT8;CCL2;VIM;FGFR3;EGFR
Nephritis,11/162,6.592827931730871E-7,7.069050311507809E-6,0,0,7.655239579275419,108.95023679968828,C3;CXCL10;CCND2;CFH;PLAU;CAV1;CCL2;ESR1;MET;FLI1;TGFBR2
Herpes Simplex Infections,19/503,6.639138756547433E-7,7.104411733662906E-6,0,0,4.236599104298444,60.26610269415957,PPP1R15A;EGR1;MME;VWF;STAT1;PROS1;CXCR4;TAP1;FOS;ANTXR2;ESR1;EGFR;CXCL10;KLF6;PLAU;MDK;CCL2;VIM;CALR
Bacterial Infections,14/276,6.930873885326869E-7,7.401728844670719E-6,0,0,5.674576833720544,80.47747140617565,STAT1;HGF;CXCR4;EGFR;TGFBR2;C3;MUC1;TF;SAA1;SPP1;FADD;TLR4;CTSD;S100A8
Diabetic Neuralgia,5/18,6.975633243986232E-7,7.405009871952716E-6,0,0,39.43603029095257,559.0322516703743,MME;HGF;LEPR;SGK1;TLR4
Malignant neoplasm of other specified sites of female breast,5/18,6.975633243986232E-7,7.405009871952716E-6,0,0,39.43603029095257,559.0322516703743,STAT1;CAV1;HGF;ESR1;MET
Nongerminomatous Germ Cell Tumor,5/18,6.975633243986232E-7,7.405009871952716E-6,0,0,39.43603029095257,559.0322516703743,CXCL12;KIT;ESR1;FGFR3;EGFR
Allergic rhinitis (disorder),11/163,7.009508056057857E-7,7.426176626388135E-6,0,0,7.604489164086687,107.76190895940341,ABCA1;EGR1;LEP;ADAM12;LAMA3;SPP1;CXCR4;VIM;NR3C1;TLR4;TGFBR2
Cognition Disorders,13/237,7.285915353016549E-7,7.68844414182677E-6,0,0,6.141747104247104,86.79610712478723,ABCA1;EGR1;SNAP25;MME;NR3C1;ETS2;LEP;SPP1;DMD;CD36;TLR4;MET;SPTBN1
Periodontitis,13/237,7.285915353016549E-7,7.68844414182677E-6,0,0,6.141747104247104,86.79610712478723,MME;CAV1;C3;ALDH2;LEP;LEPR;CCL2;PPARG;S100A4;PRTN3;TIMP1;TLR4;MET
Proliferative diabetic retinopathy,8/75,7.660555330898722E-7,8.067806197304208E-6,0,0,12.402199528672428,174.6479123241972,NRP1;TCF7L2;CXCL12;VWF;HGF;KDR;CCL2;PPARG
Carcinomatosis of peritoneal cavity,7/52,7.69087244863321E-7,8.083759226581139E-6,0,0,16.09063408958697,226.52493502437633,ZEB2;CXCL12;HGF;KDR;CXCR4;MET;EGFR
Medullary carcinoma of thyroid,13/239,8.010842465146038E-7,8.403499900937645E-6,0,0,6.08677349916288,85.44186392781076,YAP1;JUN;ANXA1;CXCR4;FOS;ESR1;EGFR;KRT19;CXCL12;KIT;KDR;SPP1;MET
invasive cancer,11/166,8.402248482755496E-7,8.779525914628243E-6,0,0,7.456166982922201,104.30876606934862,RPS6KA3;ZFP36;MMP14;EFEMP1;CCND1;CXCR4;VIM;ESR1;MET;S100A8;EGFR
Malignant neoplasm of brain,11/166,8.402248482755496E-7,8.779525914628243E-6,0,0,7.456166982922201,104.30876606934862,YAP1;MMP14;CCND1;PLAU;LEP;PLK1;SPP1;PPARG;FLI1;EGFR;TGFBR2
Stable angina,8/76,8.489805890601577E-7,8.853654714484502E-6,0,0,12.219195046439628,170.81493203288497,CXCL10;CXCL12;ALDH2;STAT1;CXCR4;CCL2;TIMP1;TLR4
Tumor-Associated Vasculature,7/53,8.787480134132299E-7,9.146187819295122E-6,0,0,15.740040974277258,219.49121425892528,ABCA1;CXCL12;KDR;PECAM1;EGFR;FLI1;AQP1
Melanocytic nevus,12/203,8.955280833291842E-7,9.302668920197314E-6,0,0,6.624218881945617,92.2478934576426,VCAN;CCND1;HGF;KIT;PPARG;FOS;SOX10;TLR4;CTSD;FGFR3;EGFR;TGFBR2
Nephroblastoma,16/370,9.194363445860207E-7,9.532444125095144E-6,0,0,4.829701372074253,67.13045848358495,ABCA1;EGR1;STAT1;HGF;ESR1;FLI1;EGFR;CCND2;CCND1;MDK;KIT;PECAM1;PRTN3;VIM;TIMP1;MET
Enterovirus Infections,9/104,9.29968924823941E-7,9.604272093772833E-6,0,0,9.878195488721804,137.18951163584197,EGR1;CXCL10;ARF1;CAV2;CAV1;SPP1;CCL2;DMD;VIM
Ischemia,9/104,9.29968924823941E-7,9.604272093772833E-6,0,0,9.878195488721804,137.18951163584197,ACTA2;EGR1;MMP14;CXCL12;ANXA1;PLAU;CCL2;S100A4;PPARG
High-Grade Prostatic Intraepithelial Neoplasia,8/77,9.394474262787079E-7,9.683395231410512E-6,0,0,12.041495041952707,167.11155485945326,ANXA1;DUSP1;CAV1;SPP1;AGR2;MET;DCN;EGFR
Papilloma,12/204,9.433445990998132E-7,9.704794147882055E-6,0,0,6.589381720430108,91.41998942060071,MUC1;CCND1;KRT15;CAV1;KIT;PPARG;KRT5;ESR1;FGFR3;S100A8;EGFR;DCN
Middle Cerebral Artery Occlusion,10/135,9.70519224542223E-7,9.965119359509645E-6,0,0,8.373191489361702,115.93047537382739,C3;EGR1;RCAN1;CFH;VWF;PLAU;HGF;KDR;CCL2;FOS
Embryonal Carcinoma,12/205,9.934115577892183E-7,1.0180558060497584E-5,0,0,6.554905565769681,90.60269656111006,KLF6;KRT18;CXCL12;CCND2;CCND1;MDK;KIT;SPP1;VIM;TLR4;EGFR;FOXO1
Biliary Atresia,9/105,1.0085389193046047E-6,1.0315746451006216E-5,0,0,9.774801587301587,134.960762629459,GHR;CXCL10;PLAU;EPAS1;STAT1;SPP1;CCL2;TIMP1;EGFR
Cerebral arterial aneurysm,8/78,1.038012034969666E-6,1.0596869989182662E-5,0,0,11.868872180451127,163.5317324067051,ACTA2;VCAN;COL1A2;STAT1;CCL2;PKD2;TLR4;TGFBR2
"Prostate Cancer, Hereditary, 7",6/35,1.1151830843808158E-6,1.134124171119345E-5,0,0,21.307112068965516,292.0457603768806,PROS1;CAV1;BGN;CCL2;ESR1;RUNX2
Abnormal pigmentation,6/35,1.1151830843808158E-6,1.134124171119345E-5,0,0,21.307112068965516,292.0457603768806,COL17A1;CAV1;LAMA3;PPARG;FOS;KRT5
Coinfection,11/171,1.126980837961136E-6,1.1439392162847416E-5,0,0,7.221323529411765,98.90301832879942,ABCA1;EGR1;CXCL10;SNAP25;F8;CFH;LPL;CXCR4;UTRN;TLR4;S100A8
Adenosquamous carcinoma,7/55,1.1376905667501758E-6,1.1526146445269366E-5,0,0,15.082678883071553,206.42923790807794,KRT18;MAML2;KIT;KDR;KRT5;EGFR;TGFBR2
"Dermatitis, Allergic Contact",9/107,1.1830344736577179E-6,1.1962790721294077E-5,0,0,9.574344023323615,130.66516910198436,SOCS3;CXCL10;SPP1;F13A1;CCL2;PPARG;CD36;ETS2;EGFR
"Adenocarcinoma of lung, stage I",5/20,1.2420941594936693E-6,1.251251375414322E-5,0,0,34.174438687392055,464.7283414244406,MUC1;MME;ADAM12;MET;EGFR
Overnutrition,5/20,1.2420941594936693E-6,1.251251375414322E-5,0,0,34.174438687392055,464.7283414244406,GHR;SREBF1;LPL;FOXO1;DEPP1
Luminal B Breast Carcinoma,8/80,1.2618161893531987E-6,1.2687204666156973E-5,0,0,11.538011695906432,156.72033351566384,MUC1;KRT18;CCND1;KRT8;CCL2;UTRN;ESR1;EGFR
Severe myopia,9/108,1.2796544405940404E-6,1.2829757798508921E-5,0,0,9.477152477152478,128.59472838449128,EGR1;JUN;ZEB2;HGF;TIMP1;FOS;ESR1;CRYAB;DCN
Neurofibromatosis 1,12/210,1.2808089977119058E-6,1.2829757798508921E-5,0,0,6.3877484522645815,86.6690901332195,CXCL12;CCND1;EPAS1;MDK;DPYSL2;HGF;KIT;SPP1;CIB1;ESR1;EGFR;MATN2
Hyperandrogenism,7/56,1.2894005327117585E-6,1.2891586189157526E-5,0,0,14.774121166791323,200.35677915495984,YAP1;FABP4;IRS2;PPARG;FOS;SORBS1;NR3C1
Triglycerides measurement,15/336,1.3735881116412588E-6,1.370758623021773E-5,0,0,4.974465042643379,67.14574790746877,ABCA1;TCF7L2;MEF2C;LRP1;VWF;LPL;ESR1;TGFBR2;C3;GRK3;COL1A2;BCL3;LEPR;CD36;MET
Vascular lesions,8/81,1.3883289636701325E-6,1.3828794481118011E-5,0,0,11.379379956741168,153.4783598183153,EGR1;ALDH2;VWF;BGN;CCL2;PPARG;PRTN3;NR3C1
Sentinel node (disorder),7/57,1.4576886945480626E-6,1.4492580323221316E-5,0,0,14.477905759162304,194.56363075072403,MUC1;KRT19;KRT18;KDR;CXCR4;KRT5;ESR1
Juvenile Pilocytic Astrocytoma,6/37,1.5711540434398533E-6,1.5591582676891952E-5,0,0,19.930443548387096,266.3444714194521,HGF;KIT;KDR;ESR1;MET;EGFR
Intrahepatic Cholangiocarcinoma,11/177,1.5821138908379511E-6,1.5671161569285206E-5,0,0,6.958185683912119,92.93873758468123,YAP1;MUC1;CXCL12;CCND1;HGF;KDR;BGN;SPP1;CXCR4;VIM;EGFR
Atrophic scar,5/21,1.6171785209237635E-6,1.598876500557094E-5,0,0,32.0369170984456,427.2067657317744,COL17A1;COL1A2;DST;LAMA3;KRT5
Myositis,10/143,1.6436596514341854E-6,1.6193603312098737E-5,0,0,7.866341385378339,104.76853879859081,ZFP36;GSN;FHL1;CXCR4;CCL2;S100A4;DMD;NR3C1;TLR4;S100A8
Congenital aneurysm of ascending aorta,7/58,1.6439743651426943E-6,1.6193603312098737E-5,0,0,14.193306642028539,189.03204795524408,ACTA2;COL1A2;BGN;PPARG;PKD2;MYLK;TGFBR2
Dementia,17/436,1.7215630771621875E-6,1.69265860483345E-5,0,0,4.344875327997468,57.666392854971086,ABCA1;SREBF1;MEF2C;LRP1;MME;STAT1;CXCR4;NR3C1;ESR1;CXCL10;CXCL12;ALDH2;LEP;SPP1;CCL2;PPARG;TIMP1
Scleroderma,11/179,1.7661671798680396E-6,1.7333158198005126E-5,0,0,6.874649859943977,91.06641601182137,EGR1;COL1A2;PLAU;HGF;CAV1;CCL2;TIMP1;TLR4;FLI1;EGFR;TGFBR2
Skin Ulcer,8/84,1.8346829141865008E-6,1.790663965146495E-5,0,0,10.92853185595568,144.35103088533978,COL17A1;CXCL12;HGF;CAV1;LAMA3;TAP1;ANTXR2;MET
Thrombophilia,8/84,1.8346829141865008E-6,1.790663965146495E-5,0,0,10.92853185595568,144.35103088533978,C3;F8;VWF;PROS1;F13A1;A2M;ESR1;EGFR
Venous Thromboembolism,8/84,1.8346829141865008E-6,1.790663965146495E-5,0,0,10.92853185595568,144.35103088533978,F8;EFEMP1;LRP1;PROS1;F13A1;LPL;CALR;ESR1
Squamous cell carcinoma of mouth,7/59,1.849764747938273E-6,1.8020834262820945E-5,0,0,13.919653644784535,183.7457210506653,CCND1;PLAU;CXCR4;CCL2;TIMP1;KLF4;EGFR
"COPPER TOXICOSIS, IDIOPATHIC",4/10,1.8677816826212199E-6,1.816315435527095E-5,0,0,68.02749140893471,897.3342511652409,KRT18;KRT8;TLR4;S100A8
"Obesity, Morbid",9/113,1.8718710891443216E-6,1.8169765089344426E-5,0,0,9.01923076923077,118.95077478972851,LEP;LEPR;SPP1;LPL;IRS2;PPARG;CD36;ESR1;MEST
"Neuroectodermal Tumor, Primitive",9/114,2.015113121702475E-6,1.9524614228277254E-5,0,0,8.932879818594104,117.15324689968217,COL1A2;CCND1;TPM3;MDK;KIT;KDR;SOX10;FLI1;EGFR
Basal-Like Breast Carcinoma,5/22,2.076043457936793E-6,1.9947857982734644E-5,0,0,30.150868637610486,394.525522944096,HGF;ESR1;SOX10;MET;EGFR
Diabetic Polyneuropathies,5/22,2.076043457936793E-6,1.9947857982734644E-5,0,0,30.150868637610486,394.525522944096,MME;HGF;LEPR;SGK1;TLR4
Fibromyxosarcoma,5/22,2.076043457936793E-6,1.9947857982734644E-5,0,0,30.150868637610486,394.525522944096,CCND1;CIB1;EZR;MET;DCN
Nephrosclerosis,5/22,2.076043457936793E-6,1.9947857982734644E-5,0,0,30.150868637610486,394.525522944096,MUC1;CXCL12;BGN;FGFR3;DCN
Primary Myelofibrosis,11/182,2.0775119497875264E-6,1.9947857982734644E-5,0,0,6.753009975920192,88.35867556505255,STAT5A;SOCS3;STAT5B;MMP14;CXCL12;KIT;CXCR4;CALR;NR3C1;FKBP4;TGFBR2
Ankylosing spondylitis,15/348,2.1195800201276376E-6,2.0315183322410398E-5,0,0,4.792251267661103,62.607372738073316,TAP1;ANTXR2;FOXO1;AQP1;ACTA2;PLAU;LEP;KDR;SAA1;SPP1;E2F2;CCL2;TIMP1;TLR4;SKAP2
Anxiety Disorders,16/396,2.225042180060909E-6,2.1287701575483992E-5,0,0,4.493233082706767,58.48272968325218,EGR1;CFH;MAGED1;PROS1;FOS;NR3C1;ESR1;QKI;RCAN1;F8;RGS2;CCND1;ALDH2;MDK;LEP;FKBP4
Actinic keratosis,8/87,2.3976821239777958E-6,2.2775843206199062E-5,0,0,10.511925383077948,136.0349112026531,GHR;COL17A1;CFH;FHL1;SPP1;VIM;FGFR3;EGFR
Chronic active hepatitis,8/87,2.3976821239777958E-6,2.2775843206199062E-5,0,0,10.511925383077948,136.0349112026531,ACTA2;KRT19;STAT1;HGF;LEP;NR3C1;MET;ESR1
Lipoma,8/87,2.3976821239777958E-6,2.2775843206199062E-5,0,0,10.511925383077948,136.0349112026531,STAT5A;STAT5B;CAV1;LEP;KIT;LEPR;PPARG;DCN
Nevus,8/87,2.3976821239777958E-6,2.2775843206199062E-5,0,0,10.511925383077948,136.0349112026531,CCND1;KIT;PPARG;FOS;SOX10;TLR4;FGFR3;EGFR
"Leukemia, B-Cell",9/117,2.5029533931231266E-6,2.3733520697425523E-5,0,0,8.68342151675485,111.99911081880968,NR4A1;CCND2;CCND1;BCL6;MME;LAMA4;BCL3;S100A8;AQP1
Pemphigus Vulgaris,7/62,2.600623278612832E-6,2.461584627305112E-5,0,0,13.158400761542122,169.21386813382733,COL17A1;C3;ZEB2;DST;PLAU;MAPKAPK2;EGFR
Hunger,5/23,2.6314618896770866E-6,2.486358228739219E-5,0,0,28.474381116868162,365.83802324861216,SNAP25;LEP;PPARG;CD36;NR3C1
Acute Kidney Insufficiency,8/89,2.8494533060214064E-6,2.6780840683929586E-5,0,0,10.251332033788174,130.89293781457457,C3;TF;VWF;SPP1;PPARG;A2M;TLR4;EGFR
Bronchioloalveolar Adenocarcinoma,8/89,2.8494533060214064E-6,2.6780840683929586E-5,0,0,10.251332033788174,130.89293781457457,MUC1;CCND1;PPP2R1B;HGF;CAV1;MET;EGFR;TGFBR2
Osteoarthrosis Deformans,8/89,2.8494533060214064E-6,2.6780840683929586E-5,0,0,10.251332033788174,130.89293781457457,COL1A2;DPYSL2;PPARG;S100A4;VIM;EZR;CTSD;RUNX2
Neutrophilia (disorder),7/63,2.901377094648817E-6,2.7220842495393565E-5,0,0,12.922774869109947,164.76958043227262,ABCA1;CXCL10;CXCL12;SPP1;CXCR4;PPARG;TLR4
Squamous cell carcinoma of tongue,10/153,3.030993335873452E-6,2.8386930556888618E-5,0,0,7.312527897634281,92.91751439401776,NRP1;MMP14;ZEB2;CCND1;EPAS1;CAV1;VIM;EZR;ESR1;EGFR
Cytomegalovirus Infections,13/270,3.1116723013658157E-6,2.9091406480663917E-5,0,0,5.344095067830477,67.76499727647158,SREBF1;JUN;LRP1;MME;STAT1;FOS;SORBS1;EGFR;CXCL10;CCL2;VIM;FKBP4;TLR4
Dermatitis,11/190,3.1548978277094154E-6,2.9435401628341955E-5,0,0,6.4485704896483735,81.68116921077014,ABCA1;STAT5A;STAT5B;ZFP36;CXCL12;CCL11;PLAU;LEP;CCL2;S100A8;EGFR
Seminoma,12/229,3.1595139297075618E-6,2.9435401628341955E-5,0,0,5.822803627174075,73.74634574342257,EGR1;KRT18;PLAU;KIT;LPL;FKBP4;KLF4;TEAD1;ESR1;FGFR3;EGFR;FOXO1
"Hypercholesterolemia, Familial",10/154,3.213901124724182E-6,2.9889841350183534E-5,0,0,7.26137706855792,91.8420790973127,ABCA1;CFH;F13A1;LPL;CD36;TIMP1;NR3C1;ESR1;TLR4;EGFR
Embryonal Rhabdomyosarcoma,8/91,3.371528651634268E-6,3.1301178021879814E-5,0,0,10.003297400126822,126.04299082366616,YAP1;HGF;CXCR4;DMD;TEAD1;ESR1;EGFR;FOXO1
"Mitral regurgitation, mild",6/42,3.4023824993837953E-6,3.147794503336153E-5,0,0,17.15798611111111,216.03679741980775,RPS6KA3;CCND2;COL1A2;FHL1;BGN;CRYAB
Clear Cell Sarcoma of Soft Tissue,6/42,3.4023824993837953E-6,3.147794503336153E-5,0,0,17.15798611111111,216.03679741980775,PLAU;KIT;PPARG;FOS;MET;EGFR
Paroxysmal nocturnal hemoglobinuria,7/65,3.5904109351406082E-6,3.3159965118482323E-5,0,0,12.475898176566167,156.41337825380995,C3;RPS6KA3;MME;CFH;CXCR4;PRTN3;CD36
Acute kidney injury,8/92,3.6616133473575204E-6,3.375906146724607E-5,0,0,9.883709273182957,123.72038544245109,C3;TF;CCND1;SPP1;PPARG;A2M;TLR4;EGFR
Promyelocytic leukemia,12/233,3.776987477418494E-6,3.476263604000545E-5,0,0,5.716245803532331,71.37638241710897,CXCL10;TF;ZFP36;ANXA1;CCND1;BCL6;ZBTB16;TXNIP;PPARG;VIM;S100A8;EGFR
Eclampsia,11/194,3.857492881296712E-6,3.538137618662681E-5,0,0,6.306332369013179,78.61154262044549,ABCA1;MMP14;CXCL12;LEP;ADAM12;KDR;LEPR;TAP1;LPL;CALR;TLR4
Mean Corpuscular Volume (result),11/194,3.857492881296712E-6,3.538137618662681E-5,0,0,6.306332369013179,78.61154262044549,MEF2C;TF;THRB;ALDH2;EPB41L2;ITSN1;LEPR;E2F2;PIK3R1;CD36;FOXO1
Dissection of aorta,6/43,3.921737906468241E-6,3.5847240657923254E-5,0,0,16.69341216216216,207.81588167112244,ACTA2;MMP14;STAT1;CCL2;MYLK;TGFBR2
intracranial glioma,6/43,3.921737906468241E-6,3.5847240657923254E-5,0,0,16.69341216216216,207.81588167112244,KLF6;MMP14;PLAU;HGF;CD36;EGFR
Childhood Medulloblastoma,8/93,3.972591110229302E-6,3.6249893880842383E-5,0,0,9.766934984520123,121.46250206029545,SNAP25;HGF;PLK1;CXCR4;IRS2;S100A4;EGFR;FLI1
"Encephalitis, St. Louis",9/124,4.051904900286431E-6,3.691042942500237E-5,0,0,8.151966873706003,101.2174573897456,C3;CXCL10;CFH;STAT1;CXCR4;CCL2;PPARG;CALR;CD36
Malignant lymphoma - lymphoplasmacytic,5/25,4.0886242539291036E-6,3.71813628825737E-5,0,0,25.624352331606218,317.9290782587518,CCND2;CCND1;BCL6;LPL;CXCR4
Dwarfism,13/277,4.116895142527439E-6,3.7373937841572654E-5,0,0,5.200532350532351,64.48874004697367,STAT5B;STAT1;BGN;PIK3R1;ANTXR2;GHR;MMP14;F8;COL1A2;CCND1;LEP;DMD;FGFR3
Hepatoblastoma,12/235,4.123827256679437E-6,3.7373937841572654E-5,0,0,5.664400405033994,70.23136488983522,ABCA1;YAP1;KRT19;CCND1;HGF;PLK1;PPARG;CIB1;TLR4;ESR1;MET;EGFR
airway disease,8/94,4.305671628171329E-6,3.8955728533998315E-5,0,0,9.652876376988985,119.26686141184173,C3;CCL11;AGR2;CXCR4;CCL2;EZR;TLR4;EGFR
Hemarthrosis,4/12,4.334720795152904E-6,3.9152079859948855E-5,0,0,51.01546391752577,629.9824828528621,F8;VWF;PLAU;F13A1
Gastrointestinal Stromal Tumors,14/323,4.38718570121535E-6,3.9558904571534007E-5,0,0,4.799880399606022,59.215273023742206,NEDD9;EGFR;TGFBR2;VCAN;CCND1;BCL6;KIT;MAPKAPK2;KDR;SPP1;DMD;EZR;FGFR3;MET
Arteriopathic disease,7/67,4.410731084935471E-6,3.963707580374558E-5,0,0,12.058813263525305,148.70289524102333,ACTA2;TCF7L2;VWF;CAV1;S100A4;TIMP1;ESR1
Idiopathic Inflammatory Myopathies,7/67,4.410731084935471E-6,3.963707580374558E-5,0,0,12.058813263525305,148.70289524102333,CXCL10;CXCL12;FHL1;CXCR4;CCL2;S100A4;NR3C1
Thyroiditis,6/44,4.503776430575278E-6,4.033718419921959E-5,0,0,16.25328947368421,200.0876528538804,CXCL10;THRB;STAT1;CCL2;CALR;CDC25B
Acute anterior uveitis,6/44,4.503776430575278E-6,4.033718419921959E-5,0,0,16.25328947368421,200.0876528538804,CFH;CCL2;SERPING1;ANTXR2;TLR4;FOXO1
Juvenile psoriatic arthritis,10/161,4.784797954236005E-6,4.2782195131079987E-5,0,0,6.922291108919262,84.79852820790728,EGR1;TCF7L2;PER1;JUN;MAML2;DUSP1;PROS1;CXCR4;FOS;KLF4
LATERAL MENINGOCELE SYNDROME,6/45,5.1541183941627675E-6,4.600719752511456E-5,0,0,15.835737179487179,192.81141439354064,VCAN;BCL6;KIT;DMD;ESR1;MYLK
Squamous cell carcinoma of lung,13/283,5.197227329616888E-6,4.6314422139679594E-5,0,0,5.083403403403404,61.85172774503082,YAP1;COL17A1;STAT1;PLK1;KRT8;EGFR;TGFBR2;CCND1;PLAU;SERPING1;VIM;FGFR3;MET
Ependymoma,9/128,5.2616593292368144E-6,4.681032147830214E-5,0,0,7.8763505402160865,95.73754584107218,YAP1;ANXA1;CAV1;KIT;SNCG;S100A4;SOX10;FGFR3;EGFR
Mucoepidermoid Carcinoma,7/69,5.3814519193431955E-6,4.779626213029981E-5,0,0,11.668637054551596,141.5703498791774,MUC1;CXCL12;MAML2;CCND1;KIT;CXCR4;EGFR
Sweating,8/97,5.45042186417152E-6,4.816799023908794E-5,0,0,9.32607924305145,113.03037884545965,KLC2;DST;CAV1;LIFR;PPARG;KRT5;FOS;FGFR3
Hyperhidrosis disorder,8/97,5.45042186417152E-6,4.816799023908794E-5,0,0,9.32607924305145,113.03037884545965,KLC2;DST;CAV1;LIFR;PPARG;KRT5;FOS;FGFR3
Increased sweating,8/97,5.45042186417152E-6,4.816799023908794E-5,0,0,9.32607924305145,113.03037884545965,KLC2;DST;CAV1;LIFR;PPARG;KRT5;FOS;FGFR3
"Cleft palate, isolated",9/129,5.608441961648829E-6,4.948242916163346E-5,0,0,7.81031746031746,94.43640416129985,FZD4;SPP1;F13A1;CXCR4;CIB1;ESR1;FGFR3;TNS1;TGFBR2
Stromal Neoplasm,7/70,5.929713466830019E-6,5.223048440452425E-5,0,0,11.48283885980221,138.20210515406464,VCAN;HGF;CAV1;KIT;LEPR;CCL2;TIMP1
Muscular Dystrophy,11/203,5.9577599733072565E-6,5.239092887418213E-5,0,0,6.00796568627451,72.2807296514422,STAT5A;F8;ANXA1;FHL1;BGN;DMD;TIMP1;UTRN;CRYAB;AQP1;SYNE1
Anterior uveitis,5/27,6.113463272458158E-6,5.35832989785025E-5,0,0,23.29251059821008,279.626988615597,C3;CFH;CCL2;SERPING1;TLR4
Benign neoplasm of breast,5/27,6.113463272458158E-6,5.35832989785025E-5,0,0,23.29251059821008,279.626988615597,DUSP1;SPP1;S100A4;TIMP1;ESR1
Pseudohyperkalemia Cardiff,9/131,6.361131787653784E-6,5.566251444401808E-5,0,0,7.681498829039812,91.91147052718189,SOCS3;CXCL10;MUC1;BCL6;STAT1;LEP;KDR;PECAM1;TLR4
Glaucoma,15/381,6.372204888602424E-6,5.566799975633167E-5,0,0,4.352772552181313,52.074677410092754,ABCA1;CA12;CAV2;CAV1;NEDD9;PIK3R1;NR3C1;MYLK;VCAN;CCND2;SAA1;SNCG;TXNIP;UTRN;TLR4
Rhabdoid Tumor,7/71,6.523628249812715E-6,5.6897569465224156E-5,0,0,11.302846858638743,134.95689410099627,SNAP25;CCND1;PLK1;KRT8;SPP1;VIM;EGFR
Follicular thyroid carcinoma,10/167,6.622966696425081E-6,5.763472865162164E-5,0,0,6.655712156118716,79.36914880125019,NR4A1;CCND2;THRB;CAV2;HGF;CAV1;KDR;PPARG;VIM;EGFR
Serum triglycerides raised,6/47,6.683854814543474E-6,5.763472865162164E-5,0,0,15.06173780487805,179.4728913348742,ABCA1;CAV1;LEP;LEPR;PPARG;FOS
Diabetic Foot,6/47,6.683854814543474E-6,5.763472865162164E-5,0,0,15.06173780487805,179.4728913348742,LEP;CCL2;TIMP1;TLR4;S100A8;TGFBR2
LIMB-MAMMARY SYNDROME,6/47,6.683854814543474E-6,5.763472865162164E-5,0,0,15.06173780487805,179.4728913348742,VCAN;BCL6;KIT;DMD;ESR1;MYLK
Mitral Valve Insufficiency,6/47,6.683854814543474E-6,5.763472865162164E-5,0,0,15.06173780487805,179.4728913348742,RPS6KA3;CCND2;COL1A2;FHL1;BGN;CRYAB
Muscular Atrophy,6/47,6.683854814543474E-6,5.763472865162164E-5,0,0,15.06173780487805,179.4728913348742,GHR;COL1A2;FHL1;DMD;NR3C1;FOXO1
Post MI,6/47,6.683854814543474E-6,5.763472865162164E-5,0,0,15.06173780487805,179.4728913348742,RCAN1;MMP14;CCL2;TIMP1;TLR4;DCN
Childhood Osteosarcoma,11/206,6.851249384549403E-6,5.898272693095923E-5,0,0,5.914630467571644,70.33134128291896,EPAS1;DUSP1;KIT;E2F2;CXCR4;FOS;KLF4;TEAD1;ESR1;RUNX2;FOXO1
Juvenile-Onset Still Disease,10/168,6.982264141888509E-6,6.0013686471167524E-5,0,0,6.613250740640991,78.51342091231096,EGR1;TCF7L2;PER1;JUN;MAML2;DUSP1;PROS1;CXCR4;FOS;KLF4
Benign melanocytic nevus,7/72,7.166149043109237E-6,6.149502133772806E-5,0,0,11.12839307289569,131.8285261385486,CCND1;KIT;PPARG;FOS;SOX10;TLR4;EGFR
Malignant Bone Neoplasm,5/28,7.3828823469136845E-6,6.32530225509695E-5,0,0,22.278666366298715,263.25243986475914,PLAU;SPP1;ESR1;RUNX2;TGFBR2
Adenoid Cystic Carcinoma,11/208,7.509906666700804E-6,6.423802989863336E-5,0,0,5.853986264556584,69.07286707442337,CDH5;VCAN;CCND1;KRT15;KIT;CXCR4;KRT5;SOX10;CTSD;EGFR;AQP1
Immune System Diseases,12/250,7.750023935611762E-6,6.618570120653057E-5,0,0,5.303334236920574,62.40865420053104,STAT5B;SOCS3;PER1;RCAN1;CFH;STAT1;LEP;CXCR4;KLF4;TLR4;ESR1;EGFR
Acoustic Neuroma,7/74,8.609496968116783E-6,7.312771026785025E-5,0,0,10.795108228491053,125.8995113931654,CCND1;HGF;CAV1;SPP1;MET;EGFR;AQP1
Hereditary gingival fibromatosis,7/74,8.609496968116783E-6,7.312771026785025E-5,0,0,10.795108228491053,125.8995113931654,HGF;CAV1;CIB1;ANTXR2;EZR;MET;EGFR
Junctional Epidermolysis Bullosa,4/14,8.63062059498524E-6,7.312771026785025E-5,0,0,40.80824742268041,475.8320876289387,COL17A1;DST;LAMA3;LAMC1
"Melanoma, B16",9/136,8.631512433566863E-6,7.312771026785025E-5,0,0,7.377202849643795,86.0188551890244,ZEB2;MUC1;HGF;KDR;CXCR4;PRTN3;CALR;NR3C1;ESR1
Follicular adenoma,9/136,8.631512433566863E-6,7.312771026785025E-5,0,0,7.377202849643795,86.0188551890244,NR4A1;MMP14;CCND2;CCND1;HGF;PLK1;S100A4;PPARG;RUNX2
Breast Fibrocystic Disease,7/75,9.416916903148092E-6,7.965515901091458E-5,0,0,10.635817677856483,123.08834793211975,KRT19;CCND1;HGF;CXCR4;TIMP1;ESR1;EGFR
Carcinosarcoma,6/50,9.650698447773819E-6,8.15032837213735E-5,0,0,14.032670454545455,162.05601784078792,CCND1;MME;KIT;VIM;MET;EGFR
"Hamartoma Syndrome, Multiple",9/138,9.716561419514127E-6,8.180024613679429E-5,0,0,7.262089331856774,83.81670223469493,STAT5A;STAT5B;VWF;CAV1;SIRPA;NR3C1;TLR4;EGFR;TNS1
Collecting Duct Carcinoma of the Kidney,9/138,9.716561419514127E-6,8.180024613679429E-5,0,0,7.262089331856774,83.81670223469493,MUC1;KRT19;MME;EPAS1;KRT8;VIM;CTSD;CRYAB;MET
Hereditary Diffuse Gastric Cancer,13/300,9.738446990963863E-6,8.185517983414263E-5,0,0,4.778133534231095,55.13693219074708,JUN;TPM3;CAV1;KRT8;IRS2;EGFR;MUC1;RGS2;KLF6;CCND1;PLAU;PPARG;MET
Blast Phase,11/214,9.828407016624687E-6,8.248122990802041E-5,0,0,5.679223413503332,65.48277313643463,AKAP12;SOCS3;CXCL12;CCND2;MME;CCND1;KIT;LEPR;CXCR4;CIB1;ETS2
Cutaneous Melanoma,13/301,1.009071637021761E-5,8.454941436617869E-5,0,0,4.761298798798799,54.7734801503132,YAP1;MAML2;HGF;CXCR4;PIK3R1;SYNE1;SOCS3;CCND1;KIT;S100A4;PRTN3;VIM;TEAD1
Lymphoproliferative Disorders,11/215,1.0269966538964811E-5,8.578218156678229E-5,0,0,5.651095732410611,64.91010627243679,ABCA1;MME;CCND1;BCL6;KIT;LMO2;BCL3;SPP1;PECAM1;CXCR4;LPL
Acromegaly,7/76,1.0286135113750025E-5,8.578218156678229E-5,0,0,10.481144244631611,120.3729406360067,GHR;CAV1;LPL;CCL2;CIB1;PPARG;FOS
Early-Stage Breast Carcinoma,7/76,1.0286135113750025E-5,8.578218156678229E-5,0,0,10.481144244631611,120.3729406360067,MUC1;KRT19;KRT18;CCND1;FKBP4;ESR1;EGFR
Mucosa-Associated Lymphoid Tissue Lymphoma,10/176,1.0516203317907009E-5,8.690124391327948E-5,0,0,6.291976416303512,72.12236682109109,CXCL12;CCND1;BCL6;MME;MAP3K20;CIB1;VIM;TLR4;S100A8;FOXO1
Stomach Diseases,5/30,1.05344724278436E-5,8.690124391327948E-5,0,0,20.494300518134715,234.8822596450573,ANXA1;HGF;SPP1;TLR4;S100A8
Hyperplasia of supraorbital margins,5/30,1.05344724278436E-5,8.690124391327948E-5,0,0,20.494300518134715,234.8822596450573,RPS6KA3;CAV1;FHL1;PPARG;FOS
Hyperplasia of supraorbital ridge,5/30,1.05344724278436E-5,8.690124391327948E-5,0,0,20.494300518134715,234.8822596450573,RPS6KA3;CAV1;FHL1;PPARG;FOS
Hypertrophy of supraorbital margins,5/30,1.05344724278436E-5,8.690124391327948E-5,0,0,20.494300518134715,234.8822596450573,RPS6KA3;CAV1;FHL1;PPARG;FOS
Hypertrophy of supraorbital ridge,5/30,1.05344724278436E-5,8.690124391327948E-5,0,0,20.494300518134715,234.8822596450573,RPS6KA3;CAV1;FHL1;PPARG;FOS
Prominent supraorbital ridges,5/30,1.05344724278436E-5,8.690124391327948E-5,0,0,20.494300518134715,234.8822596450573,RPS6KA3;CAV1;FHL1;PPARG;FOS
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site,11/216,1.0728688720646692E-5,8.836658762337902E-5,0,0,5.623242467718795,64.34445361796816,ABCA1;CXCL10;KLF6;STAT1;LEP;TAP1;CCL2;PPARG;NR3C1;TLR4;EGFR
Alcohol abuse,8/107,1.1299318443485971E-5,9.277976577093488E-5,0,0,8.37979797979798,95.45233592166761,TF;CCND1;ALDH2;LEP;NR3C1;MPDZ;TLR4;EGFR
Basal cell carcinoma,8/107,1.1299318443485971E-5,9.277976577093488E-5,0,0,8.37979797979798,95.45233592166761,STAT5B;MUC1;KRT19;CXCL12;KRT15;KRT5;EGFR;TGFBR2
Transient ischemia,4/15,1.167798240659697E-5,9.574148960731577E-5,0,0,37.09653233364573,421.33519283596934,PPP1R15A;RASD1;PIK3R1;TLR4
Hepatitis A,12/261,1.1956969237250462E-5,9.78781706072315E-5,0,0,5.0662002850110115,57.42130827116696,SOCS3;CXCL10;JUN;F8;VCAN;KRT18;LEP;HGF;SPP1;LEPR;ESR1;S100A8
Waldenstrom Macroglobulinemia,8/108,1.2100897747430471E-5,9.890442346021011E-5,0,0,8.295578947368421,93.92446040834561,STAT5A;STAT5B;CCND2;CXCL12;CCND1;BCL6;CXCR4;FGFR3
Endocrine System Diseases,6/52,1.2162633529714132E-5,9.925677500742206E-5,0,0,13.421195652173912,151.88957877310764,CDH5;TCF7L2;LEP;LEPR;DMD;CD36
"Multiple Sclerosis, Relapsing-Remitting",7/78,1.2224757824280334E-5,9.945913655815252E-5,0,0,10.184868372538899,115.21171310721827,LEP;LEPR;PECAM1;SPP1;CCL2;KLF4;CRYAB
Pulmonary Edema,7/78,1.2224757824280334E-5,9.945913655815252E-5,0,0,10.184868372538899,115.21171310721827,VWF;EPAS1;PECAM1;CCL2;SGK1;KLF4;AQP1
Malignant neoplasm of skin,13/307,1.2449995046157438E-5,1.0106293219766227E-4,0,0,4.662695348409634,52.65950365137195,JUN;LIFR;FOS;KLF4;EGFR;CXCL10;MMP14;KRT19;VCAN;CCND1;ADAM12;KIT;FGFR3
Large hand,5/31,1.2459813558615897E-5,1.0106293219766227E-4,0,0,19.705061777600637,222.52930222043187,RPS6KA3;CAV1;KIT;PPARG;FOS
"Neoplasm, Residual",11/220,1.2746608009300723E-5,1.0323202747957985E-4,0,0,5.514494793132564,62.14970935637307,NRP1;RPS6KA3;KRT19;MME;CCND1;MDK;KIT;SPP1;S100A4;CALR;ESR1
Myeloproliferative disease,12/264,1.340505901883704E-5,1.0839993856051985E-4,0,0,5.005120327700973,56.15684137177896,ABCA1;STAT5A;STAT5B;SOCS3;NR4A1;RPS6KA3;KIT;BCL3;IRS2;CALR;FGFR3;SPTBN1
"Turner Syndrome, Male",6/53,1.3603142032916122E-5,1.0966890150288959E-4,0,0,13.13497340425532,147.18013218767337,STAT5A;RPS6KA3;STAT5B;FHL1;SIRPA;DTX1
granulosa cell tumor,6/53,1.3603142032916122E-5,1.0966890150288959E-4,0,0,13.13497340425532,147.18013218767337,CCND2;KDR;LEPR;ESR1;EGFR;FOXO1
Encephalitis,9/144,1.3698249331896883E-5,1.1026883789981645E-4,0,0,6.937213403880071,77.68459810470756,EGR1;CXCL10;GSN;STAT1;SPP1;CXCR4;CCL2;PPARG;TIMP1
Deep Vein Thrombosis,8/110,1.3848389514992626E-5,1.1097453793292588E-4,0,0,8.132094943240453,90.9765241561115,F8;VWF;PLAU;PROS1;KDR;PECAM1;F13A1;A2M
Hyperplastic Polyp,8/110,1.3848389514992626E-5,1.1097453793292588E-4,0,0,8.132094943240453,90.9765241561115,SOCS3;MUC1;GSN;BGN;CALR;KLF4;S100A8;EGFR
Post-Traumatic Stress Disorder,8/110,1.3848389514992626E-5,1.1097453793292588E-4,0,0,8.132094943240453,90.9765241561115,EGR1;STAT5B;F8;KLF6;NR3C1;FKBP4;SGK1;ESR1
Paroxysmal kinesigenic choreoathetosis,7/80,1.4456481401863516E-5,1.1567355764343944E-4,0,0,9.90482679480743,110.38303184624559,EGR1;JUN;GSN;PPARG;PKD2;TEAD1;EGFR
Chronic Persistent Hepatitis,5/32,1.4649028692261044E-5,1.1703849160578576E-4,0,0,18.97428516599501,211.20535865776438,ACTA2;KRT19;TF;HGF;MET
Immune thrombocytopenic purpura,10/183,1.4780910302324026E-5,1.1791537575012685E-4,0,0,6.035235518386422,67.12493989356628,CXCL12;BCL6;VWF;STAT1;LEP;PECAM1;CXCR4;NR3C1;TLR4;S100A8
Cerebral Aneurysm,6/54,1.5178395208152775E-5,1.2090533342936643E-4,0,0,12.860677083333334,142.69741103823392,ACTA2;STAT1;KDR;CCL2;TLR4;ESR1
"Nuchal bleb, familial",4/16,1.545021824146898E-5,1.2270374516958003E-4,0,0,34.00343642611684,376.686240929682,C3;LEP;LEPR;LPL
Choroidal Neovascularization,4/16,1.545021824146898E-5,1.2270374516958003E-4,0,0,34.00343642611684,376.686240929682,CFH;EPAS1;KDR;CALR
Hypothyroidism,12/268,1.5573172674633806E-5,1.2349618628441006E-4,0,0,4.925907258064516,54.52960037157352,PER1;GRK3;COL1A2;ANXA1;GSN;THRB;LRP1;STAT1;LEP;DPYSL2;MAP1B;CAV1
Cholera,8/112,1.5803559338859583E-5,1.2476617439523366E-4,0,0,7.974898785425101,88.16470211030993,HGF;CAV1;LEP;KIT;ESR1;CTSD;S100A8;EGFR
Cleft Palate,8/112,1.5803559338859583E-5,1.2476617439523366E-4,0,0,7.974898785425101,88.16470211030993,FZD4;SPP1;F13A1;CIB1;FGFR3;RUNX2;TNS1;TGFBR2
Glomerulosclerosis (disorder),8/112,1.5803559338859583E-5,1.2476617439523366E-4,0,0,7.974898785425101,88.16470211030993,VCAN;MUC1;HGF;KDR;SPP1;CCL2;CIB1;PPARG
Graft-vs-Host Disease,11/226,1.6390276259893082E-5,1.2920677838605064E-4,0,0,5.358960328317374,59.04943162384051,STAT1;KRT15;CAV1;SPP1;PECAM1;CCL2;NR3C1;TLR4;SPTBN1;S100A8;EGFR
"Diabetes Mellitus, Experimental",8/113,1.68650291236379E-5,1.321672649998035E-4,0,0,7.898546365914787,86.80714423571305,SNAP25;SREBF1;CAV1;LEP;LEPR;IRS2;PPARG;TIMP1
Streptozotocin Diabetes,8/113,1.68650291236379E-5,1.321672649998035E-4,0,0,7.898546365914787,86.80714423571305,SNAP25;SREBF1;CAV1;LEP;LEPR;IRS2;PPARG;TIMP1
Alloxan Diabetes,8/113,1.68650291236379E-5,1.321672649998035E-4,0,0,7.898546365914787,86.80714423571305,SNAP25;SREBF1;CAV1;LEP;LEPR;IRS2;PPARG;TIMP1
Paresis,8/113,1.68650291236379E-5,1.321672649998035E-4,0,0,7.898546365914787,86.80714423571305,TPM3;HGF;FHL1;CCL2;DMD;UTRN;MET;SYNE1
Atherogenesis,6/55,1.6897679610254233E-5,1.3222868523207754E-4,0,0,12.597576530612244,138.42638161587269,ABCA1;SOCS3;CCL2;PPARG;TLR4;ESR1
Salivary Gland Neoplasms,7/82,1.701494816255533E-5,1.3295111254876444E-4,0,0,9.639720767888306,105.85780601450094,VCAN;CCND1;HGF;KRT15;PPARG;KRT5;AQP1
Primary Lesion,5/33,1.712680996111299E-5,1.3362923906701482E-4,0,0,18.295706883789784,200.79292206187816,COL1A2;KIT;CXCR4;VIM;EGFR
Psychotic Disorders,13/317,1.7470587168617456E-5,1.3611222079175792E-4,0,0,4.507005689900427,49.374210484812686,EGR1;SNAP25;NR3C1;ESR1;RGS4;GHR;RPS6KA3;ALDH2;LEP;DPYSL2;LEPR;CALR;FGFR3
Childhood Glioblastoma,10/187,1.7829932912518173E-5,1.3870906932964867E-4,0,0,5.897643947589854,64.48856557759989,ARF1;KLF6;STAT1;KIT;SPP1;CXCR4;S100A4;MET;TLR4;EGFR
"Carcinoma, Endometrioid",8/114,1.7985785681695693E-5,1.3947678156093704E-4,0,0,7.823634558093347,85.48047411065149,KIT;SPP1;S100A4;LAMC1;EZR;ESR1;EGFR;AQP1
Intracranial Aneurysm,8/114,1.7985785681695693E-5,1.3947678156093704E-4,0,0,7.823634558093347,85.48047411065149,ACTA2;VCAN;COL1A2;STAT1;CCL2;TIMP1;PKD2;TGFBR2
Chromophobe Renal Cell Carcinoma,9/149,1.8007135619051358E-5,1.3947678156093704E-4,0,0,6.687755102040816,73.06200209419822,CCND1;EPAS1;PROS1;KIT;KRT8;NR3C1;CTSD;CRYAB;MET
"Lymphoma, Large-Cell, Follicular",7/83,1.8427939393679145E-5,1.4232244786799444E-4,0,0,9.512400110223203,103.70078626712463,CXCL12;CCND1;BCL6;LEP;KIT;CXCR4;CIB1
bone destruction,7/83,1.8427939393679145E-5,1.4232244786799444E-4,0,0,9.512400110223203,103.70078626712463,SOCS3;CXCL10;MMP14;CXCL12;PECAM1;SPP1;TIMP1
Virchow's node (disorder),3/6,1.8698571000277073E-5,1.4399520933594873E-4,0,0,101.53333333333333,1105.399842708434,CCND1;AGR2;ESR1
Bile duct adenoma,3/6,1.8698571000277073E-5,1.4399520933594873E-4,0,0,101.53333333333333,1105.399842708434,KRT19;MME;PPARG
Adult Cholangiocarcinoma,6/56,1.8770688603223404E-5,1.441340051391607E-4,0,0,12.345,134.3532770974627,MUC1;HGF;SPP1;PPARG;MET;TGFBR2
Carotid Stenosis,6/56,1.8770688603223404E-5,1.441340051391607E-4,0,0,12.345,134.3532770974627,ANXA1;FABP4;SPP1;LPL;TIMP1;TLR4
Adult Glioblastoma,10/189,1.9547273330917874E-5,1.4988117925246238E-4,0,0,5.831154166171402,63.22530805737269,ARF1;KLF6;STAT1;KIT;SPP1;CXCR4;S100A4;MET;TLR4;EGFR
Rhabdoid Tumor of the Kidney,5/34,1.9919104580258435E-5,1.5242644041759619E-4,0,0,17.66392710380561,191.19136631828698,YAP1;KIT;CXCR4;CIB1;MET
Soft Tissue Neoplasms,7/84,1.9936428780458723E-5,1.5242644041759619E-4,0,0,9.38838648262732,101.61014927663982,HGF;KIT;SPP1;S100A4;MET;EGFR;FLI1
Familial partial lipodystrophy,4/17,2.004791091349473E-5,1.5284022497569872E-4,0,0,31.38620142743854,339.51664346912577,SREBF1;CAV1;LEP;PPARG
Hypopharyngeal Carcinoma,4/17,2.004791091349473E-5,1.5284022497569872E-4,0,0,31.38620142743854,339.51664346912577,CAV1;HGF;EGFR;ETS2
"Acute Myeloid Leukemia, M1",8/116,2.0415746188379973E-5,1.5542215919696697E-4,0,0,7.677972709551657,82.91599423319053,RGS2;CCND2;HGF;KIT;SGK1;MET;S100A8;FOXO1
Atrophic,6/57,2.0807528731810154E-5,1.5817877405394624E-4,0,0,12.102328431372548,130.46546865552463,MME;CFH;VIM;TEAD1;TLR4;FOXO1
Hypoglycemia,11/232,2.0905369052554498E-5,1.5869617048584463E-4,0,0,5.21187117380889,56.16054149276074,GHR;SOCS3;SREBF1;KIT;KDR;LPL;TXNIP;IRS2;CD36;NR3C1;DEPP1
"Alzheimer's Disease, Focal Onset",7/85,2.154537731094945E-5,1.6239790055169677E-4,0,0,9.267552691636462,99.58309059014856,TF;PLAU;DPYSL2;LEP;PPARG;A2M;ESR1
Acute Confusional Senile Dementia,7/85,2.154537731094945E-5,1.6239790055169677E-4,0,0,9.267552691636462,99.58309059014856,TF;PLAU;DPYSL2;LEP;PPARG;A2M;ESR1
Alcoholic Liver Diseases,7/85,2.154537731094945E-5,1.6239790055169677E-4,0,0,9.267552691636462,99.58309059014856,ALDH2;GOLM1;KRT8;SPP1;CCL2;PPARG;TLR4
Demyelinating Diseases,7/85,2.154537731094945E-5,1.6239790055169677E-4,0,0,9.267552691636462,99.58309059014856,CXCL12;SPP1;CXCR4;PPARG;CRYAB;EGFR;QKI
Hurthle Cell Tumor,7/85,2.154537731094945E-5,1.6239790055169677E-4,0,0,9.267552691636462,99.58309059014856,KRT19;CCND1;KIT;VIM;NR3C1;ESR1;EGFR
Abdominal Pain,9/153,2.2238513588114328E-5,1.6691413931135387E-4,0,0,6.500661375661376,69.6460377886883,ABCA1;SAA1;SERPING1;LPL;PRTN3;SOX10;MET;TLR4;TGFBR2
Familial lichen amyloidosis,9/153,2.2238513588114328E-5,1.6691413931135387E-4,0,0,6.500661375661376,69.6460377886883,GHR;KLF6;CCND1;PROS1;SPP1;CCL2;A2M;KLF4;EGFR
Primary Effusion Lymphoma,9/153,2.2238513588114328E-5,1.6691413931135387E-4,0,0,6.500661375661376,69.6460377886883,CXCL12;BCL6;HGF;CIB1;FADD;FKBP4;CTSD;MET;TGFBR2
Epidermolysis Bullosa,5/35,2.3053119015824147E-5,1.7278491031691543E-4,0,0,17.07426597582038,182.31405171598902,COL17A1;KRT18;DST;LAMA3;KRT5
Herpes NOS,7/86,2.325992265067654E-5,1.7409006714249337E-4,0,0,9.149777983961826,97.61695679717262,COL17A1;PPP1R15A;DST;STAT1;FKBP4;ESR1;MYLK
"Breast Cancer, Familial",9/154,2.3419359480163082E-5,1.750375409113451E-4,0,0,6.455500821018062,68.82821115903472,CXCL10;TCF7L2;PER1;ANXA1;CCND1;CAV1;SPP1;ESR1;EGFR
Adult type dermatomyositis,7/87,2.508538219075479E-5,1.8696503733501017E-4,0,0,9.034947643979057,95.70923564396898,STAT1;HGF;SPP1;CCL2;DMD;TIMP1;TLR4
DOSAGE-SENSITIVE SEX REVERSAL,7/87,2.508538219075479E-5,1.8696503733501017E-4,0,0,9.034947643979057,95.70923564396898,TCF7L2;NR4A1;CCL11;BCL3;CCL2;TLR4;TGFBR2
Acquired partial lipodystrophy,4/18,2.5576635816114396E-5,1.900946893501724E-4,0,0,29.142857142857142,308.15165463929964,SREBF1;LEP;PPARG;PIK3R1
Myoma,4/18,2.5576635816114396E-5,1.900946893501724E-4,0,0,29.142857142857142,308.15165463929964,CAV1;LEP;LEPR;ESR1
Diarrhea,13/329,2.5775193137135814E-5,1.9130362705821276E-4,0,0,4.3331850838179955,45.784858398956885,CFH;MME;STAT1;CAV2;CAV1;KRT8;PIK3R1;ANTXR2;EGFR;KIT;SAA1;LEPR;SERPING1
Mucocutaneous Lymph Node Syndrome,9/156,2.5941487907804095E-5,1.9227008214282062E-4,0,0,6.367022999676061,67.23364279245202,STAT1;HGF;KDR;PECAM1;CCL2;TIMP1;MET;S100A8;TGFBR2
Large cell neuroendocrine carcinoma,5/36,2.6557321499730707E-5,1.9656106426675686E-4,0,0,16.52264750125355,174.08600263012104,YAP1;KRT19;CCND1;KIT;EGFR
Spinal Muscular Atrophy,10/196,2.6725018845915767E-5,1.9752791321759377E-4,0,0,5.609700297414779,59.06964147948621,STAT5A;STAT5B;ZEB2;ANXA1;MAP1B;CCL2;DMD;CD36;VIM;FOXO1
Chordoma,7/88,2.7027255979773098E-5,1.9948510680915628E-4,0,0,8.9229526210329,93.85754693675439,BCL6;PLAU;KIT;MET;ESR1;ETS2;EGFR
Acute Myeloid Leukemia (AML-M2),8/121,2.7722483332849767E-5,2.043334905681278E-4,0,0,7.336376339077783,76.98255428093016,RGS2;CCND2;HGF;KIT;SGK1;MET;S100A8;FOXO1
Pain,16/485,2.79740095171938E-5,2.0590261977503557E-4,0,0,3.6238899693057474,37.993713002835,COL17A1;ANXA1;FZD4;HGF;BGN;NR3C1;ESR1;EGFR;AQP1;CXCL10;VCAN;CXCL12;LEP;SPP1;SERPING1;CCL2
Allergic disposition,11/240,2.8575496414199508E-5,2.1003975226381957E-4,0,0,5.027742101207295,52.605069402871464,CCL11;PLAU;KIT;SPP1;TAP1;CCL2;S100A4;SORBS1;TLR4;MET;TGFBR2
Gastrointestinal Neoplasms,8/122,2.9419332650510457E-5,2.1594438525422897E-4,0,0,7.271652816251154,75.87139673916803,CXCL12;FHL1;AGR2;CXCR4;FADD;CALR;SOX10;EGFR
Bipolar Disorder,22/837,3.0314725763395604E-5,2.2221069270032348E-4,0,0,2.912116564417178,30.297302443108297,ABCA1;EGR1;SNAP25;TCF7L2;FZD4;CAV2;CAV1;NR3C1;ESR1;EGFR;SYNE1;RGS4;GRK3;KLF6;ALDH2;LEP;DPYSL2;S1PR1;CCL2;CALR;CD36;TLR4
"Glomerulonephritis, Membranoproliferative",5/37,3.046144302868773E-5,2.2267356639214938E-4,0,0,16.00550518134715,166.4420300428516,C3;CFH;VWF;CCL2;TGFBR2
ACTH-Secreting Pituitary Adenoma,5/37,3.046144302868773E-5,2.2267356639214938E-4,0,0,16.00550518134715,166.4420300428516,CCND1;TXNIP;PPARG;NR3C1;EGFR
"MYELOPROLIFERATIVE SYNDROME, TRANSIENT",6/61,3.081012884424478E-5,2.246062607537352E-4,0,0,11.219886363636364,116.5484440353936,CCND1;KIT;CCL2;VIM;ESR1;EGFR
Noonan Syndrome,6/61,3.081012884424478E-5,2.246062607537352E-4,0,0,11.219886363636364,116.5484440353936,STAT5A;RPS6KA3;STAT5B;FHL1;SIRPA;DTX1
Peripheral T-Cell Lymphoma,8/123,3.120226313962882E-5,2.271541806981994E-4,0,0,7.2080549199084665,74.7837134451999,EGR1;CCND1;BCL6;MME;CAV1;BCL3;CXCR4;FGFR3
"Adenocarcinoma of lung, stage IV",4/19,3.2146707155873525E-5,2.3339210140824253E-4,0,0,27.198625429553264,281.375234312584,ACTA2;FBLN2;MET;EGFR
Milium Cyst,4/19,3.2146707155873525E-5,2.3339210140824253E-4,0,0,27.198625429553264,281.375234312584,COL17A1;LAMA3;KRT5;TGFBR2
Epidermolysis bullosa inversa dystrophica,3/7,3.248368268258101E-5,2.3487862281611156E-4,0,0,76.14615384615385,786.9531893913111,COL17A1;LAMA3;LAMC1
Fibrosis of bile duct,3/7,3.248368268258101E-5,2.3487862281611156E-4,0,0,76.14615384615385,786.9531893913111,HGF;TIMP1;EGFR
Non-small cell lung cancer stage III,3/7,3.248368268258101E-5,2.3487862281611156E-4,0,0,76.14615384615385,786.9531893913111,CCND2;CCND1;EGFR
Hyperthyroidism,8/124,3.3074714145166426E-5,2.3882811880703508E-4,0,0,7.145553539019963,73.71882866949639,KRT19;THRB;ANXA1;VWF;LEP;PPARG;VIM;AQP1
"Polycystic Kidney, Autosomal Dominant",9/161,3.3275398649003696E-5,2.3995209661778174E-4,0,0,6.156015037593985,63.47277631319491,STAT5A;STAT5B;JUN;PPARG;TIMP1;FOS;PKD2;ESR1;EGFR
Low grade glioma,6/62,3.383259880468656E-5,2.4364043112185766E-4,0,0,11.018973214285714,113.43025523949102,TCF7L2;BCL6;KDR;VIM;SOX10;EGFR
Septic Shock,5/38,3.4796476835281116E-5,2.5024348860352644E-4,0,0,15.519704820222955,159.3252030328449,VWF;SAA1;NR3C1;TLR4;AQP1
Familial M??ni??re disease,8/125,3.5040222984198777E-5,2.5165680361562706E-4,0,0,7.084120557804768,72.67609147165228,CXCL10;CCND1;CAV1;CCL2;FOS;ESR1;TLR4;AQP1
Leukopenia,11/246,3.5821504665968074E-5,2.5692166670921113E-4,0,0,4.897872340425532,50.139333793392545,STAT5B;SOCS3;GRK3;CXCL12;ALDH2;STAT1;CXCR4;TLR4;ESR1;MET;S100A8
Malignant neoplasm of gallbladder,10/203,3.605353283345724E-5,2.580484257051704E-4,0,0,5.404310439863301,55.28882876435041,YAP1;HGF;VIM;FADD;TIMP1;TLR4;ESR1;S100A8;EGFR;TGFBR2
Dejerine-Sottas Disease (disorder),7/92,3.6075450769441165E-5,2.580484257051704E-4,0,0,8.501324299353248,86.96768009059814,TCF7L2;NR4A1;CCL11;BCL3;CCL2;TLR4;TGFBR2
Laryngeal Squamous Cell Carcinoma,8/126,3.71024264191997E-5,2.650386466325941E-4,0,0,7.023728813559322,71.65487459752894,VCAN;ANXA1;CCND1;TIMP1;EZR;PKD2;CRYAB;EGFR
Intraepithelial Neoplasia,7/93,3.8688492328180576E-5,2.7562964654662337E-4,0,0,8.402045537562401,85.36451680418072,STAT5A;STAT5B;MUC1;CCND2;PLAU;S100A4;EGFR
Pregnancy Complications,7/93,3.8688492328180576E-5,2.7562964654662337E-4,0,0,8.402045537562401,85.36451680418072,ARF1;LEP;LEPR;PPARG;NR3C1;SGK1;EGFR
Stage IV Ovarian Carcinoma,5/39,3.959467643369315E-5,2.8170898626855915E-4,0,0,15.062480950929595,152.68559612922158,MMP14;CXCL12;PLAU;CXCR4;EGFR
Solitary fibrous tumor,4/20,3.987293076362928E-5,2.825569787757718E-4,0,0,25.49742268041237,258.2841209624788,EGR1;CCND1;BCL6;MET
Carcinoma of ampulla of Vater,4/20,3.987293076362928E-5,2.825569787757718E-4,0,0,25.49742268041237,258.2841209624788,PLAU;SPP1;AGR2;EGFR
Glycogen Storage Disease Type I,4/20,3.987293076362928E-5,2.825569787757718E-4,0,0,25.49742268041237,258.2841209624788,ABCA1;VWF;HGF;LPL
TARSAL-CARPAL COALITION SYNDROME,9/165,4.0342255395764095E-5,2.8550315936789756E-4,0,0,5.996947496947497,60.67778113896348,SNAP25;ANXA1;CCND1;PLAU;KRT8;PRTN3;ESR1;FGFR3;EGFR
Patent ductus arteriosus,11/251,4.301989472866238E-5,3.0404909682896794E-4,0,0,4.794607843137255,48.204257904719434,ACTA2;PER1;SREBF1;MUC1;ZEB2;HGF;SPP1;NEDD9;CCL2;KLF4;TGFBR2
"Hepatitis, Autoimmune",8/129,4.390709481251722E-5,3.0949855589405324E-4,0,0,6.848542844715094,68.7144069973048,CXCL10;CXCL12;KRT18;GOLM1;LEP;KRT8;CCL2;NR3C1
Endometrial adenocarcinoma,8/129,4.390709481251722E-5,3.0949855589405324E-4,0,0,6.848542844715094,68.7144069973048,RCAN1;CXCL12;CAV1;CXCR4;ESR1;CTSD;FOXO1;EGFR
Limb ischemia,7/95,4.4381667220914675E-5,3.124305212949198E-4,0,0,8.210257020466445,82.28881228430497,PLAU;HGF;KDR;BGN;SPP1;EZR;TLR4
Malignant neoplasm of stomach stage IV,5/40,4.488955227206061E-5,3.1558894994434167E-4,0,0,14.63138415988157,146.47925640679378,CXCL12;CXCR4;CALR;MET;EGFR
Kyphosis deformity of spine,9/168,4.644070805748099E-5,3.2606394366049564E-4,0,0,5.882899071578317,58.69564983454075,RPS6KA3;KLC2;COL1A2;FHL1;BGN;DMD;UTRN;FGFR3;RUNX2
Germ cell tumor,10/210,4.8037333214324454E-5,3.368301956567566E-4,0,0,5.2132978723404255,51.838594605289686,CCND2;CCND1;MDK;KIT;KDR;LPL;TEAD1;ESR1;FGFR3;EGFR
Skeletal dysplasia,6/66,4.839104306610398E-5,3.384197749334227E-4,0,0,10.282291666666667,102.16686349876662,COL1A2;STAT1;LIFR;FGFR3;RUNX2;EGFR
Diffuse Astrocytoma,6/66,4.839104306610398E-5,3.384197749334227E-4,0,0,10.282291666666667,102.16686349876662,BCL6;HGF;CAV1;MET;ESR1;EGFR
Cyst,9/169,4.863910660088551E-5,3.3970877991627634E-4,0,0,5.845833333333333,58.0554542139246,KRT19;EPAS1;HGF;CAV1;PLK1;PECAM1;SNCG;PKD2;ESR1
Helicobacter-associated gastritis,4/21,4.8874363449088317E-5,3.4090508222538174E-4,0,0,23.996361431170406,238.194064159909,CXCL10;MUC1;CAV1;TLR4
Juvenile rheumatoid arthritis,8/131,4.89982966211667E-5,3.413227747636567E-4,0,0,6.7364997860504925,66.85117149622522,C3;ABCA1;CXCL10;SPP1;CXCR4;CCL2;VIM;TLR4
Adult Hepatocellular Carcinoma,7/97,5.074437743203834E-5,3.530245265474312E-4,0,0,8.026992437463642,79.37659826470869,C3;ABCA1;PLAU;TXNIP;A2M;MET;TGFBR2
Respiratory function loss,9/170,5.092475024553498E-5,3.5335676309694776E-4,0,0,5.809228039041703,57.42515735754575,SNAP25;COL1A2;DST;TPM3;FHL1;LIFR;PRTN3;DMD;FGFR3
Complete atrioventricular block,9/170,5.092475024553498E-5,3.5335676309694776E-4,0,0,5.809228039041703,57.42515735754575,CXCL10;GSN;STAT1;SPP1;TAP1;PPARG;CALR;ESR1;TLR4
"Total Hypotrichosis, Mari type",3/8,5.1594689440181575E-5,3.5707545458016577E-4,0,0,60.91384615384615,601.3470816456503,CCL2;ESR1;TLR4
Mowat-Wilson syndrome,3/8,5.1594689440181575E-5,3.5707545458016577E-4,0,0,60.91384615384615,601.3470816456503,MEF2C;ZEB2;SOX10
Tongue Carcinoma,6/67,5.271700603321955E-5,3.6436955272506745E-4,0,0,10.113217213114755,99.62097895487518,CCND1;PROS1;CAV1;FADD;SGK1;FOXO1
Blood Coagulation Disorders,9/171,5.330040581051899E-5,3.6792469244074574E-4,0,0,5.773074661963551,56.80455269888055,ABCA1;F8;GSN;VWF;PLAU;F13A1;CD36;TLR4;FLI1
Lymphoid leukemia,10/213,5.412908896427568E-5,3.7313406853816484E-4,0,0,5.135467980295567,50.451550384202065,NRP1;CXCL12;CCND2;MME;BCL6;SPP1;CXCR4;PRTN3;NR3C1;TLR4
Myelofibrosis,7/98,5.4195115227723696E-5,3.7313406853816484E-4,0,0,7.938380990737012,77.97807964341652,STAT5A;STAT5B;CXCL12;KIT;CXCR4;CALR;NR3C1
Vascular Neoplasms,5/42,5.710962998375787E-5,3.926931847528331E-4,0,0,13.839098165523035,135.2154318039129,CDH5;CXCR4;PPARG;TIMP1;FOS
Alveolar rhabdomyosarcoma,6/68,5.734681101610696E-5,3.938159225577758E-4,0,0,9.949596774193548,97.17167548792366,CAV1;PLK1;MET;EGFR;FOXO1;FLI1
Skin Carcinogenesis,8/134,5.7551451664615815E-5,3.9471259449258393E-4,0,0,6.575104427736007,64.19163464186181,CCND1;STAT1;LEP;KIT;PPARG;KLF4;FGFR3;EGFR
Ischemia of kidney,7/99,5.7835626514213086E-5,3.9615173996689144E-4,0,0,7.851695879808787,76.61610716751564,EGR1;EPAS1;BGN;PECAM1;CCL2;SGK1;TLR4
Serum total cholesterol measurement,12/307,5.8733909033452714E-5,4.017881915780096E-4,0,0,4.266156369600875,41.56299998089209,ABCA1;TCF7L2;MMP14;LRP1;ADAM12;BCL3;KDR;LPL;PPARG;CD36;ESR1;MATN2
Shock,4/22,5.9274078696248217E-5,4.03927832956914E-4,0,0,22.66208476517755,220.57774143277368,KLF6;TAP1;CCL2;TLR4
Squamous cell carcinoma of tonsil,4/22,5.9274078696248217E-5,4.03927832956914E-4,0,0,22.66208476517755,220.57774143277368,CCND1;HGF;MET;EGFR
Familial generalized lipodystrophy,4/22,5.9274078696248217E-5,4.03927832956914E-4,0,0,22.66208476517755,220.57774143277368,CAV1;LEP;PPARG;FOS
Flexion contractures of joints,8/135,6.066469346486848E-5,4.1287631095055443E-4,0,0,6.523000414421881,63.33930389888997,SNAP25;KLC2;DST;TPM3;CAV1;FHL1;DMD;CRYAB
Increase in blood pressure,9/174,6.099607559488046E-5,4.1460215158816067E-4,0,0,5.667243867243867,54.998907397803436,ACTA2;MUC1;PPARG;CALR;NR3C1;PKD2;EGFR;MYLK;TGFBR2
"Histiocytosis, Langerhans-Cell",6/69,6.229592696368359E-5,4.2289808253435647E-4,0,0,9.791170634920634,94.81392205074602,GSN;MME;KIT;PECAM1;SPP1;FADD
Vasculitis,8/136,6.391678687115896E-5,4.324455789161034E-4,0,0,6.47171052631579,62.503317702455476,CXCL10;VWF;CAV1;SERPING1;CXCR4;PRTN3;TLR4;S100A8
Flexion contracture,8/136,6.391678687115896E-5,4.324455789161034E-4,0,0,6.47171052631579,62.503317702455476,SNAP25;KLC2;DST;TPM3;CAV1;FHL1;DMD;CRYAB
"Carcinoma of urinary bladder, superficial",5/43,6.410808919942235E-5,4.324455789161034E-4,0,0,13.4742296154895,130.09287855708635,CCL2;CIB1;S100A4;FGFR3;S100A8
Insulin resistance syndrome,5/43,6.410808919942235E-5,4.324455789161034E-4,0,0,13.4742296154895,130.09287855708635,VWF;LEP;LPL;PPARG;CD36
Primary Carcinoma,5/43,6.410808919942235E-5,4.324455789161034E-4,0,0,13.4742296154895,130.09287855708635,ALDH2;CCND1;KIT;S100A4;EGFR
Well Differentiated Oligodendroglioma,9/176,6.663021931774454E-5,4.483237862932584E-4,0,0,5.598802395209581,53.84005651335625,KLF6;ANXA1;CCND1;CAV1;DTX1;CIB1;SOX10;MET;EGFR
Liver Failure,9/176,6.663021931774454E-5,4.483237862932584E-4,0,0,5.598802395209581,53.84005651335625,PLAU;CAV1;KRT8;CXCR4;PPARG;FOS;NR3C1;MET;TLR4
Lymphopenia,8/137,6.731255756336369E-5,4.5234378216288157E-4,0,0,6.421215830273358,61.68325072609794,STAT5A;STAT5B;ALDH2;STAT1;CXCR4;CALR;CTSD;MYLK
"Angina, Unstable",6/70,6.758029543714595E-5,4.5300049608119593E-4,0,0,9.6376953125,92.54302111568866,PLAU;LEP;CXCR4;CCL2;TIMP1;TLR4
Pulmonary arterial hypertension,6/70,6.758029543714595E-5,4.5300049608119593E-4,0,0,9.6376953125,92.54302111568866,ACTA2;COL1A2;CAV1;LIFR;BMPR1B;AQP1
Abdominal discomfort,8/138,7.085694756138157E-5,4.736818270959957E-4,0,0,6.371497975708502,60.87869173694072,ABCA1;SAA1;SERPING1;PRTN3;SOX10;MET;TLR4;TGFBR2
Nonorganic psychosis,10/220,7.095281164672068E-5,4.736818270959957E-4,0,0,4.962512664640324,47.409342542227684,RGS4;GHR;RPS6KA3;LEP;DPYSL2;CALR;FOS;NR3C1;ESR1;FGFR3
Antibody Deficiency Syndrome,4/23,7.11989385445473E-5,4.736818270959957E-4,0,0,21.468258274552362,205.0225674120824,C3;CFH;LEPR;CD36
Cryptogenic Chronic Hepatitis,4/23,7.11989385445473E-5,4.736818270959957E-4,0,0,21.468258274552362,205.0225674120824,ACTA2;KRT19;HGF;MET
Granuloma,4/23,7.11989385445473E-5,4.736818270959957E-4,0,0,21.468258274552362,205.0225674120824,CXCL10;SPP1;PRTN3;S100A8
Hypofibrinogenemia,4/23,7.11989385445473E-5,4.736818270959957E-4,0,0,21.468258274552362,205.0225674120824,EGR1;CFH;VWF;PLAU
HELLP Syndrome,5/44,7.174972387703662E-5,4.7556502306060714E-4,0,0,13.128072273149993,125.27235262518337,CFH;PLAU;LEP;NR3C1;TLR4
Muscle damage,5/44,7.174972387703662E-5,4.7556502306060714E-4,0,0,13.128072273149993,125.27235262518337,FHL1;SPP1;CCL2;DMD;MYLK
Oral Submucous Fibrosis,5/44,7.174972387703662E-5,4.7556502306060714E-4,0,0,13.128072273149993,125.27235262518337,KRT19;COL1A2;S100A4;TIMP1;FGFR3
Duodenal Ulcer,6/71,7.321633333453424E-5,4.846830314779291E-4,0,0,9.488942307692307,90.35458191078816,EGR1;MUC1;ALDH2;TIMP1;TLR4;S100A8
WHIM syndrome,3/9,7.682757782274273E-5,5.067006958136089E-4,0,0,50.758974358974356,480.8878275740263,GRK3;CXCL12;CXCR4
Congenital kyphosis,3/9,7.682757782274273E-5,5.067006958136089E-4,0,0,50.758974358974356,480.8878275740263,FHL1;DMD;UTRN
Metaplastic breast carcinoma,3/9,7.682757782274273E-5,5.067006958136089E-4,0,0,50.758974358974356,480.8878275740263,NR3C1;MET;EGFR
Contracture of joint,8/140,7.841194325669263E-5,5.158731427344631E-4,0,0,6.274322169059011,59.31451986426703,SNAP25;KLC2;DST;TPM3;CAV1;FHL1;DMD;CRYAB
Gastrointestinal pain,8/140,7.841194325669263E-5,5.158731427344631E-4,0,0,6.274322169059011,59.31451986426703,ABCA1;SAA1;SERPING1;PRTN3;SOX10;MET;TLR4;TGFBR2
Rectal Neoplasms,6/72,7.922093534847752E-5,5.205528538496137E-4,0,0,9.344696969696969,88.24449616864777,TCF7L2;CXCL12;PPARG;CALR;EGFR;TGFBR2
"MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA",5/45,8.00742345869862E-5,5.235774185448459E-4,0,0,12.799222797927461,120.72939118916652,KIT;SPP1;CXCR4;CCL2;EGFR
Cerebral Amyloid Angiopathy,5/45,8.00742345869862E-5,5.235774185448459E-4,0,0,12.799222797927461,120.72939118916652,ABCA1;GSN;CCND1;MME;A2M
Chondrodysplasia,5/45,8.00742345869862E-5,5.235774185448459E-4,0,0,12.799222797927461,120.72939118916652,STAT5A;STAT5B;STAT1;BMPR1B;FGFR3
Mammary adenocarcinoma,5/45,8.00742345869862E-5,5.235774185448459E-4,0,0,12.799222797927461,120.72939118916652,MUC1;CXCL12;CCND1;S100A4;ESR1
Metabolic Diseases,14/421,8.229329243874483E-5,5.374276414290088E-4,0,0,3.6258145497275933,34.10158698187684,ABCA1;SREBF1;CFH;DUSP1;LPL;NR3C1;FOXO1;NR4A1;LEP;LEPR;CCL2;PPARG;CD36;TLR4
Pectus excavatum,8/141,8.243302655259198E-5,5.376812711123167E-4,0,0,6.226830233478433,58.55414999577935,RPS6KA3;ZEB2;COL1A2;TPM3;MAP3K20;DMD;SOX10;FGFR3
Ehlers-Danlos Syndrome,7/105,8.412198020674112E-5,5.473577930668173E-4,0,0,7.368735976065819,69.14263781355461,ACTA2;COL1A2;BGN;PKD2;DCN;MYLK;TGFBR2
Mixed Salivary Gland Tumor,7/105,8.412198020674112E-5,5.473577930668173E-4,0,0,7.368735976065819,69.14263781355461,MAML2;CCND1;MME;LEP;KDR;LIFR;EGFR
Dupuytren's Disease,4/24,8.477937165481335E-5,5.502914391577349E-4,0,0,20.39381443298969,191.20135686675377,YAP1;ACTA2;KLF6;MMP14
Healing ulcer,4/24,8.477937165481335E-5,5.502914391577349E-4,0,0,20.39381443298969,191.20135686675377,HGF;LEP;CXCR4;MET
"Hepatitis, Alcoholic",6/73,8.561147615331676E-5,5.550164919963808E-4,0,0,9.204757462686567,86.20891611913531,HGF;CAV1;SPP1;CXCR4;CCL2;TLR4
Respiratory Insufficiency,9/182,8.62302942584766E-5,5.583490134913995E-4,0,0,5.402972749793559,50.56366104906356,SNAP25;COL1A2;DST;TPM3;FHL1;LIFR;PRTN3;DMD;FGFR3
"Alcoholic Intoxication, Chronic",14/424,8.871240238715372E-5,5.737237770887648E-4,0,0,3.598727465535525,33.57652618837069,DST;VWF;PIK3R1;EGFR;RGS4;PER1;CDH5;TF;ALDH2;LEP;DPYSL2;PPARG;TLR4;MPDZ
Thrombus,5/46,8.912253281555649E-5,5.75677548332243E-4,0,0,12.486414760520661,116.44204039532522,VWF;PLAU;PROS1;HGF;KLF4
oligodendroglioma,9/183,8.992597201562094E-5,5.80164049480925E-4,0,0,5.371647509578544,50.04508164935717,KLF6;ANXA1;CCND1;CAV1;DTX1;CIB1;SOX10;MET;EGFR
Head and Neck Neoplasms,7/107,9.478636930406882E-5,6.100441570306555E-4,0,0,7.220628272251309,66.89106952852927,STAT5A;STAT5B;CCND1;EPAS1;KDR;VIM;EGFR
Pleural effusion disorder,7/107,9.478636930406882E-5,6.100441570306555E-4,0,0,7.220628272251309,66.89106952852927,MUC1;HGF;SPP1;CCL2;CALR;TIMP1;EGFR
"Carcinoma, Pancreatic Ductal",5/47,9.893672942738017E-5,6.35221483275312E-4,0,0,12.188502343942758,112.39054587621729,MUC1;DTX1;PPARG;KLF4;TEAD1
Carcinoma in situ of uterine cervix,5/47,9.893672942738017E-5,6.35221483275312E-4,0,0,12.188502343942758,112.39054587621729,CCND1;TAP1;VIM;KLF4;FGFR3
Malignant Fibrous Histiocytoma,6/75,9.962228404354033E-5,6.376282666048006E-4,0,0,8.937047101449275,82.34706629079254,EPAS1;STAT1;CCL2;EZR;FGFR3;EGFR
MYOTONIC DYSTROPHY 1,6/75,9.962228404354033E-5,6.376282666048006E-4,0,0,8.937047101449275,82.34706629079254,ALDH2;HGF;CXCR4;DMD;CTSD;ESR1
Cancer of Digestive System,4/25,1.0014915728058137E-4,6.376282666048006E-4,0,0,19.42169857633775,178.85150719569245,FHL1;CCL2;KLF4;TLR4
Diabetic foot ulcer,4/25,1.0014915728058137E-4,6.376282666048006E-4,0,0,19.42169857633775,178.85150719569245,LEP;CCL2;TIMP1;TLR4
Familial erythrocytosis,4/25,1.0014915728058137E-4,6.376282666048006E-4,0,0,19.42169857633775,178.85150719569245,STAT5A;STAT5B;EPAS1;PIK3R1
Insulin-resistant diabetes mellitus,4/25,1.0014915728058137E-4,6.376282666048006E-4,0,0,19.42169857633775,178.85150719569245,LEP;LEPR;PPARG;PIK3R1
Perianal Squamous Intraepithelial Neoplasia,4/25,1.0014915728058137E-4,6.376282666048006E-4,0,0,19.42169857633775,178.85150719569245,COL17A1;S100A4;FGFR3;TGFBR2
Drug-Induced Liver Disease,13/377,1.0329895866214255E-4,6.568975545472049E-4,0,0,3.7525096525096524,34.440095532530066,GSN;VWF;CDC25B;C3;CXCL10;TF;KRT18;SPP1;SERPING1;CCL2;PPARG;VIM;S100A8
Chest Pain,6/76,1.0727971646285191E-4,6.813988188683406E-4,0,0,8.808928571428572,80.51423224167704,ACTA2;PPARG;PRTN3;CALR;MYLK;TGFBR2
Retinal Drusen,3/10,1.0895350177156852E-4,6.830743658125749E-4,0,0,43.505494505494504,396.96977209243323,EFEMP1;CFH;CCL2
Sick Headaches,3/10,1.0895350177156852E-4,6.830743658125749E-4,0,0,43.505494505494504,396.96977209243323,LRP1;ESR1;TGFBR2
Status Migrainosus,3/10,1.0895350177156852E-4,6.830743658125749E-4,0,0,43.505494505494504,396.96977209243323,LRP1;ESR1;TGFBR2
Abdominal Migraine,3/10,1.0895350177156852E-4,6.830743658125749E-4,0,0,43.505494505494504,396.96977209243323,LRP1;ESR1;TGFBR2
Acute Confusional Migraine,3/10,1.0895350177156852E-4,6.830743658125749E-4,0,0,43.505494505494504,396.96977209243323,LRP1;ESR1;TGFBR2
Cervical Migraine Syndrome,3/10,1.0895350177156852E-4,6.830743658125749E-4,0,0,43.505494505494504,396.96977209243323,LRP1;ESR1;TGFBR2
Diarrhea-associated hemolytic uremic syndrome,3/10,1.0895350177156852E-4,6.830743658125749E-4,0,0,43.505494505494504,396.96977209243323,CXCL12;CFH;CXCR4
Hemicrania migraine,3/10,1.0895350177156852E-4,6.830743658125749E-4,0,0,43.505494505494504,396.96977209243323,LRP1;ESR1;TGFBR2
Laron Syndrome,3/10,1.0895350177156852E-4,6.830743658125749E-4,0,0,43.505494505494504,396.96977209243323,GHR;STAT5A;STAT5B
Melanosis,3/10,1.0895350177156852E-4,6.830743658125749E-4,0,0,43.505494505494504,396.96977209243323,ALDH2;HGF;MET
Melanosis coli,3/10,1.0895350177156852E-4,6.830743658125749E-4,0,0,43.505494505494504,396.96977209243323,ALDH2;HGF;MET
"Myasthenic Syndromes, Congenital",5/48,1.0956012215550163E-4,6.844617713560003E-4,0,0,11.904446318833594,108.55708761980242,SNAP25;TPM3;CAV1;UTRN;FGFR3
Barrett Epithelium,5/48,1.0956012215550163E-4,6.844617713560003E-4,0,0,11.904446318833594,108.55708761980242,HGF;LEPR;PPARG;KLF4;CTSD
Dupuytren Contracture,5/48,1.0956012215550163E-4,6.844617713560003E-4,0,0,11.904446318833594,108.55708761980242,YAP1;ACTA2;KLF6;MMP14;EGFR
Hypertrophic Cardiomyopathy,12/328,1.1004365906791788E-4,6.86071520133006E-4,0,0,3.9783585136790527,36.26127926779078,ACTA2;COL1A2;VWF;TPM3;CAV1;FHL1;PPARG;CD36;FOS;CRYAB;ESR1;MYLK
"Glaucoma, Primary Open Angle",8/147,1.1031901877531716E-4,6.86071520133006E-4,0,0,5.956228701249526,54.27395536406369,ABCA1;EGR1;EFEMP1;CAV2;CAV1;SPP1;TIMP1;TLR4
Hematological Disease,8/147,1.1031901877531716E-4,6.86071520133006E-4,0,0,5.956228701249526,54.27395536406369,EGR1;KRT19;CXCL12;VWF;KIT;CXCR4;FADD;EGFR
Acquired Immunodeficiency Syndrome,9/188,1.1046150577483941E-4,6.86071520133006E-4,0,0,5.220271348762969,47.56107508632265,CXCL10;CXCL12;BCL6;LRP1;CXCR4;CCL2;TIMP1;NR3C1;TLR4
Bronchopulmonary Dysplasia,9/188,1.1046150577483941E-4,6.86071520133006E-4,0,0,5.220271348762969,47.56107508632265,CXCL12;KDR;CXCR4;PRTN3;PPARG;TIMP1;NR3C1;TLR4;EGFR
Pheochromocytoma,11/280,1.1438570802983213E-4,7.096175065087024E-4,0,0,4.271375464684015,38.766723586283646,NRP1;CXCL10;CXCL12;CCND1;EPAS1;DUSP1;KIT;KDR;ELOB;NR3C1;PKD2
Superficial ulcer,6/77,1.1539742088493834E-4,7.150614603439959E-4,0,0,8.684419014084508,78.74274361308272,VCAN;MMP14;BGN;PRTN3;TIMP1;DCN
Fatigue,12/330,1.1650277497490805E-4,7.21072343601957E-4,0,0,3.9529316291336984,35.80405560032316,MEF2C;F8;CCND1;BCL6;KIT;DMD;PRTN3;PIK3R1;NR3C1;TLR4;MET;TGFBR2
Carotid Artery Plaque,4/26,1.1744521521464305E-4,7.243814257856862E-4,0,0,18.53795688847235,167.75995617900264,STAT1;LPL;CCL2;TLR4
Klatskin Tumor,4/26,1.1744521521464305E-4,7.243814257856862E-4,0,0,18.53795688847235,167.75995617900264,DUSP1;HGF;KDR;AQP1
Metastatic osteosarcoma,4/26,1.1744521521464305E-4,7.243814257856862E-4,0,0,18.53795688847235,167.75995617900264,VWF;EZR;MET;EGFR
Airway Obstruction,5/49,1.2103718220669326E-4,7.439528765622472E-4,0,0,11.633301931229392,104.92555197959462,CXCL10;ALDH2;SPP1;SERPING1;TIMP1
Dryness of eye,5/49,1.2103718220669326E-4,7.439528765622472E-4,0,0,11.633301931229392,104.92555197959462,MUC1;CCL2;ESR1;EGFR;TGFBR2
Female Breast Carcinoma,5/49,1.2103718220669326E-4,7.439528765622472E-4,0,0,11.633301931229392,104.92555197959462,ALDH2;CCND1;PECAM1;CXCR4;ESR1
Low density lipoprotein cholesterol measurement,11/283,1.256239003851879E-4,7.712554898072192E-4,0,0,4.223615916955017,37.937439050959945,TCF7L2;TF;MMP14;LRP1;BCL3;KDR;LEPR;PPARG;CD36;ESR1;TGFBR2
Monoclonal Gammopathy of Undetermined Significance,8/150,1.269452534297553E-4,7.784709499737237E-4,0,0,5.8295033358043,52.30087360074132,CCND1;CFH;HGF;KIT;CXCR4;FGFR3;MET;RUNX2
"Lung Diseases, Interstitial",8/151,1.3292667192941332E-4,8.106736077799001E-4,0,0,5.788443135811557,51.66598168783209,CXCL10;MUC1;HGF;KIT;SPP1;CCL2;EZR;EGFR
Malignant Squamous Cell Neoplasm,8/151,1.3292667192941332E-4,8.106736077799001E-4,0,0,5.788443135811557,51.66598168783209,MUC1;CCND1;SPP1;S100A4;KRT5;MET;EGFR;TGFBR2
Malignancy,6/79,1.3309332661204704E-4,8.106736077799001E-4,0,0,8.445633561643836,75.37271865883018,YAP1;PLK1;LAMC1;VIM;RUNX2;EGFR
Advanced bone age,5/50,1.334135398804602E-4,8.106736077799001E-4,0,0,11.374208405296487,101.48133494028836,CAV1;LEP;LEPR;PPARG;FOS
Cervical Squamous Intraepithelial Neoplasia,5/50,1.334135398804602E-4,8.106736077799001E-4,0,0,11.374208405296487,101.48133494028836,NRP1;LAMA3;MET;TLR4;EGFR
Clostridium; difficile (disorder),5/50,1.334135398804602E-4,8.106736077799001E-4,0,0,11.374208405296487,101.48133494028836,JUN;MAPKAPK2;CCL2;FOS;SORBS1
Giant Cell Tumors,5/50,1.334135398804602E-4,8.106736077799001E-4,0,0,11.374208405296487,101.48133494028836,CCND1;CCL2;FOS;VIM;MET
Moyamoya Disease,5/50,1.334135398804602E-4,8.106736077799001E-4,0,0,11.374208405296487,101.48133494028836,ACTA2;LRP1;HGF;KDR;TIMP1
Skin toxicity,4/27,1.3680740129395734E-4,8.265834937590688E-4,0,0,17.731062303899595,157.752134530299,CCND1;HGF;LIFR;EGFR
Hereditary Leiomyomatosis and Renal Cell Cancer,4/27,1.3680740129395734E-4,8.265834937590688E-4,0,0,17.731062303899595,157.752134530299,CCND1;MME;KIT;CIB1
Leg Ulcer,4/27,1.3680740129395734E-4,8.265834937590688E-4,0,0,17.731062303899595,157.752134530299,NRP1;PLAU;HGF;F13A1
Pregnancy in Diabetics,4/27,1.3680740129395734E-4,8.265834937590688E-4,0,0,17.731062303899595,157.752134530299,MMP14;LEP;LEPR;TXNIP
Premenopausal breast cancer,4/27,1.3680740129395734E-4,8.265834937590688E-4,0,0,17.731062303899595,157.752134530299,CCND1;LEP;LEPR;ESR1
Dermatomyositis,7/114,1.4112108282510704E-4,8.516809177519767E-4,0,0,6.745853109556197,59.808007091395865,STAT1;HGF;SPP1;CCL2;DMD;TIMP1;TLR4
Breast Diseases,5/51,1.4673596946807615E-4,8.825688276471533E-4,0,0,11.12637981527371,98.21117175639165,CCND2;CCND1;CXCR4;ESR1;EGFR
Malignant neoplasm of female breast,5/51,1.4673596946807615E-4,8.825688276471533E-4,0,0,11.12637981527371,98.21117175639165,ALDH2;CCND1;CXCR4;ESR1;EGFR
NONAKA MYOPATHY,5/51,1.4673596946807615E-4,8.825688276471533E-4,0,0,11.12637981527371,98.21117175639165,GSN;MME;LEP;ESR1;EGFR
"Familial Partial Lipodystrophy, Type 1",3/11,1.4871927424618865E-4,8.904775420875722E-4,0,0,38.065384615384616,335.48736763809234,CAV1;LEP;PPARG
Serum creatinine raised,3/11,1.4871927424618865E-4,8.904775420875722E-4,0,0,38.065384615384616,335.48736763809234,MUC1;CCND1;PKD2
Lipoatrophic Diabetes Mellitus,3/11,1.4871927424618865E-4,8.904775420875722E-4,0,0,38.065384615384616,335.48736763809234,CAV1;PPARG;FOS
Muscle fibrosis,3/11,1.4871927424618865E-4,8.904775420875722E-4,0,0,38.065384615384616,335.48736763809234,FHL1;TIMP1;DCN
Peptic Ulcer,6/81,1.5287424163252307E-4,9.143286573060779E-4,0,0,8.219583333333333,72.21639549125419,KRT18;CCND1;PPARG;TLR4;S100A8;EGFR
Migraine Disorders,11/290,1.5556126880969341E-4,9.293565039090317E-4,0,0,4.116171199662661,36.09252735200384,C3;YAP1;KLF6;LRP1;VWF;CXCR4;CCL2;TLR4;ESR1;TGFBR2;SYNE1
"Condition, Preneoplastic",7/116,1.5728484860263957E-4,9.386012969803654E-4,0,0,6.62140352562563,57.98662403961074,STAT5A;MUC1;CCND1;ALDH2;KRT8;SIRPA;CD36
Tumor Expansion,4/28,1.583783086794461E-4,9.409119364021943E-4,0,0,16.991408934707902,148.68373215470842,VCAN;MMP14;RASD1;CXCR4
Aortic valve disorder,4/28,1.583783086794461E-4,9.409119364021943E-4,0,0,16.991408934707902,148.68373215470842,SPP1;BGN;EGFR;RUNX2
Odontogenic Tumors,4/28,1.583783086794461E-4,9.409119364021943E-4,0,0,16.991408934707902,148.68373215470842,KRT18;MDK;KRT5;VIM
Paratuberculosis,4/28,1.583783086794461E-4,9.409119364021943E-4,0,0,16.991408934707902,148.68373215470842,C3;TF;GSN;TLR4
Invasive Lobular Breast Carcinoma,5/52,1.6105237317310346E-4,9.546697404221005E-4,0,0,10.88909712269871,95.10298897662489,CCND2;CCND1;KIT;TIMP1;ESR1
Lymphocytic infiltration,5/52,1.6105237317310346E-4,9.546697404221005E-4,0,0,10.88909712269871,95.10298897662489,CXCL10;CXCL12;CCND1;CXCR4;ESR1
"Carcinoma, Small Cell",7/117,1.65911084107029E-4,9.823779635626194E-4,0,0,6.560875773441219,57.106246878016925,KRT19;THRB;CCND1;KIT;PPARG;EGFR;TGFBR2
"Genetic Diseases, Inborn",15/507,1.6728564064320462E-4,9.89417512749875E-4,0,0,3.2170465147274423,27.974818123105006,ABCA1;SNAP25;MEF2C;VWF;TPM3;CAV1;ITSN1;LPL;PIK3R1;PKD2;ZEB2;COL1A2;CCND2;DPYSL2;FGFR3
"Carcinoma, Neuroendocrine",6/83,1.749122149454496E-4,0.0010333782632420188,0,0,8.005275974025974,69.25545435571036,PLAU;CAV1;KIT;KDR;SPP1;EGFR
Experimental Lung Inflammation,5/53,1.7641176449966048E-4,0.0010410833809730794,0,0,10.661701208981002,92.14577548391456,CCL11;SPP1;CCL2;TLR4;MYLK
Stage IV Breast Cancer AJCC v6 and v7,4/29,1.8230307473612593E-4,0.0010722881735858887,0,0,16.310927835051547,140.4344790755755,CXCR4;ESR1;MET;RUNX2
Breast cancer recurrent,4/29,1.8230307473612593E-4,0.0010722881735858887,0,0,16.310927835051547,140.4344790755755,MUC1;ANXA1;ESR1;EGFR
Lymphoid hyperplasia,4/29,1.8230307473612593E-4,0.0010722881735858887,0,0,16.310927835051547,140.4344790755755,CXCL10;CCND1;TXNIP;FGFR3
Chronic sinusitis,6/84,1.8683349726506855E-4,0.001096515095732985,0,0,7.902243589743589,67.84307441562345,SOCS3;MUC1;SPP1;TAP1;NR3C1;MET
Hemochromatosis,6/84,1.8683349726506855E-4,0.001096515095732985,0,0,7.902243589743589,67.84307441562345,TF;ALDH2;CCL2;TIMP1;CALR;TLR4
Cardiomegaly,8/159,1.896753690066441E-4,0.0011119692425042974,0,0,5.479539909376089,46.96073392431252,ACTA2;RCAN1;CCND2;THRB;CAV1;DMD;MYLK;TGFBR2
Intellectual Disability,43/2503,1.927108613302085E-4,0.0011285232747567924,0,0,1.9556936795174404,16.72962881379264,YAP1;SNAP25;THRB;LRP1;MAGED1;FHL1;PIK3R1;ETS2;SYNE1;EPS8;RPS6KA3;CCND2;LEPR;DMD;CTSD;MPDZ;ABCA1;STAT5B;JUN;MEF2C;ANXA1;STAT1;ZBTB16;CAV1;BGN;FOS;SOX10;RUNX2;FLI1;QKI;TGFBR2;ACTA2;RCAN1;ZEB2;COL1A2;MAF;MAP1B;KIT;PPARG;BMPR1B;FGFR3;MET;ARHGEF6
"Liver Failure, Acute",7/120,1.9411303951523173E-4,0.0011354867042554005,0,0,6.385720242783672,54.579197217390885,CXCL12;KRT18;VWF;HGF;KRT8;CCL2;MET
Short tibia,3/12,1.968478510580344E-4,0.0011451989064282372,0,0,33.83418803418803,288.709814868317,ZBTB16;LIFR;BMPR1B
Alacrima,3/12,1.968478510580344E-4,0.0011451989064282372,0,0,33.83418803418803,288.709814868317,DST;FGFR3;SOX10
Idiopathic urticaria,3/12,1.968478510580344E-4,0.0011451989064282372,0,0,33.83418803418803,288.709814868317,SOCS3;CCL2;TLR4
Menstrual spotting,3/12,1.968478510580344E-4,0.0011451989064282372,0,0,33.83418803418803,288.709814868317,STAT5A;NRP1;KIT
Migraine Variant,3/12,1.968478510580344E-4,0.0011451989064282372,0,0,33.83418803418803,288.709814868317,LRP1;ESR1;TGFBR2
Increased tendency to bruise,6/85,1.9938709613146776E-4,0.001158706472502281,0,0,7.8018196202531644,66.47355048696096,F8;COL1A2;VWF;PLAU;F13A1;KRT5
Hypodontia,7/121,2.0433005692428315E-4,0.0011848475226871654,0,0,6.329383668595573,53.7730128624302,COL17A1;RPS6KA3;COL1A2;LAMA3;PIK3R1;FGFR3;EGFR
Juvenile Myelomonocytic Leukemia,7/121,2.0433005692428315E-4,0.0011848475226871654,0,0,6.329383668595573,53.7730128624302,STAT5A;AKAP12;STAT5B;KIT;CXCR4;PIK3R1;CALR
Thymic Carcinoma,4/30,2.0872919291385774E-4,0.0012077284137219848,0,0,15.682791435368754,132.90339060551977,EGR1;CCND1;KIT;EGFR
Broad foot,4/30,2.0872919291385774E-4,0.0012077284137219848,0,0,15.682791435368754,132.90339060551977,CAV1;PPARG;FOS;BMPR1B
Crohn's disease of the ileum,5/55,2.1046101471452715E-4,0.0012151102355511543,0,0,10.23419689119171,86.64486134401426,TCF7L2;LEP;CCL2;PPARG;TLR4
Hypocholesterolemia,5/55,2.1046101471452715E-4,0.0012151102355511543,0,0,10.23419689119171,86.64486134401426,ABCA1;CXCL10;CAV2;CAV1;CXCR4
Diabetic Neuropathies,6/86,2.1259670771527992E-4,0.0012261123976349856,0,0,7.70390625,65.14510624421364,SREBF1;MME;HGF;LEPR;SGK1;TLR4
Dermatologic disorders,13/406,2.1416381859709244E-4,0.0012338151235717898,0,0,3.470421566604773,29.320791288308016,COL17A1;JUN;DST;LAMA3;KRT5;FOS;EGFR;CXCL10;CXCL12;PPARG;CALR;FGFR3;S100A8
Inflammatory dermatosis,8/163,2.247526303518753E-4,0.0012934198349299605,0,0,5.3370458404074705,44.83390792000434,STAT5A;STAT5B;CXCL10;CCL11;LEP;CXCR4;CCL2;EGFR
Contact Dermatitis,6/87,2.2648651197174183E-4,0.0013019920413132819,0,0,7.608410493827161,63.85605905526001,FABP4;DUSP1;SAA1;CCL2;TLR4;S100A8
Visual seizure,9/207,2.278247213443439E-4,0.0013082736422888024,0,0,4.714766714766715,39.54243721827698,EGR1;CCND1;DUSP1;LEP;MAP1B;SPP1;FOS;NR3C1;MPDZ
HER2 gene amplification,5/56,2.292542962462374E-4,0.0013150658177569418,0,0,10.033018388702631,84.08350357274209,CCND1;KDR;MET;ESR1;EGFR
Uterine Cervical Neoplasm,7/124,2.376133456225885E-4,0.00135682005901696,0,0,6.166152056204412,51.45571143366695,GHR;CXCL10;GSN;CCND1;EPAS1;FGFR3;EGFR
Recurrent upper respiratory tract infection,4/31,2.3780633047885922E-4,0.00135682005901696,0,0,15.10118365788469,126.00509119616562,STAT1;LEP;LEPR;CXCR4
"Lipomatosis, Multiple",4/31,2.3780633047885922E-4,0.00135682005901696,0,0,15.10118365788469,126.00509119616562,STAT5A;STAT5B;LEP;DCN
Atherosclerosis of aorta,4/31,2.3780633047885922E-4,0.00135682005901696,0,0,15.10118365788469,126.00509119616562,ABCA1;LPL;CCL2;TLR4
ESTROGEN RESISTANCE,4/31,2.3780633047885922E-4,0.00135682005901696,0,0,15.10118365788469,126.00509119616562,CCND1;NEDD9;ESR1;EGFR
Abnormality of the skeletal system,6/88,2.4108117105977627E-4,0.0013740337546283932,0,0,7.515243902439025,62.604813990847845,RPS6KA3;COL1A2;CALR;FGFR3;ETS2;RUNX2
Myxoid cyst,9/209,2.446737069693325E-4,0.0013930194278200566,0,0,4.667142857142857,38.81002333804822,ABCA1;CAV2;KDR;CXCR4;TXNIP;UTRN;SOX10;ESR1;AQP1
Spondylarthropathies,5/57,2.4929737257387425E-4,0.0014163173757421918,0,0,9.83957752092467,81.63763755849736,VCAN;CXCL12;CCL2;TLR4;S100A8
Carotid Artery Diseases,5/57,2.4929737257387425E-4,0.0014163173757421918,0,0,9.83957752092467,81.63763755849736,LRP1;PLAU;HGF;CCL2;PPARG
Malaria,14/469,2.5235263359267644E-4,0.0014321482262144543,0,0,3.235284280936455,26.803305034966755,ABCA1;ANXA1;GSN;CFH;TAP1;FOS;C3;CXCL10;PECAM1;CCL2;PPARG;CD36;FKBP4;TLR4
"Neoplasms, Vascular Tissue",3/13,2.5403880671621715E-4,0.0014346677892745332,0,0,30.44923076923077,252.0594484817744,KRT19;KDR;PECAM1
Tendinosis,3/13,2.5403880671621715E-4,0.0014346677892745332,0,0,30.44923076923077,252.0594484817744,VCAN;BGN;DCN
Micropapillary carcinoma,3/13,2.5403880671621715E-4,0.0014346677892745332,0,0,30.44923076923077,252.0594484817744,MUC1;CXCL12;CXCR4
Osteitis Fibrosa Disseminata,3/13,2.5403880671621715E-4,0.0014346677892745332,0,0,30.44923076923077,252.0594484817744,GHR;FOS;RUNX2
Acute GVH disease,8/166,2.5441190858780895E-4,0.0014346677892745332,0,0,5.2349100599600265,43.32702583228623,C3;HGF;CAV1;KRT15;PECAM1;S1PR1;NR3C1;TLR4
Keratoconus,8/166,2.5441190858780895E-4,0.0014346677892745332,0,0,5.2349100599600265,43.32702583228623,KLF6;GSN;HGF;S100A4;TIMP1;A2M;MPDZ;FOXO1
Retinal Degeneration,6/89,2.564058274772095E-4,0.00144438335584149,0,0,7.424322289156627,61.38985828448088,C3;CFH;CCL2;DMD;CD36;CTSD
Epilepsy,25/1177,2.6096542684832653E-4,0.0014685161137008786,0,0,2.3394849871547847,19.30337750508164,PROS1;AQP1;RPS6KA3;CCND2;ALDH2;LEPR;CCL2;DMD;FADD;CTSD;MPDZ;EGR1;MEF2C;ANK2;FOS;SOX10;ESR1;TGFBR2;ACTA2;ZEB2;MAF;VIM;SGK1;TLR4;FGFR3
Progressive Neoplastic Disease,8/167,2.649822755200377E-4,0.0014895469897112667,0,0,5.201721284342933,42.84058385459139,CXCL10;MUC1;CFH;HGF;PECAM1;CCL2;ESR1;EGFR
Bowen's Disease,4/32,2.696861508780195E-4,0.0015070686986552644,0,0,14.561119293078056,119.66694308191032,COL17A1;S100A4;FGFR3;TGFBR2
Dermatofibrosarcoma Protuberans,4/32,2.696861508780195E-4,0.0015070686986552644,0,0,14.561119293078056,119.66694308191032,VCAN;VIM;EGFR;TGFBR2
Giant Cell Fibroblastoma,4/32,2.696861508780195E-4,0.0015070686986552644,0,0,14.561119293078056,119.66694308191032,VCAN;VIM;EGFR;TGFBR2
Grade I Astrocytoma,4/32,2.696861508780195E-4,0.0015070686986552644,0,0,14.561119293078056,119.66694308191032,HGF;ESR1;MET;EGFR
Recurrent bacterial infection,5/58,2.7064453830232465E-4,0.0015070686986552644,0,0,9.653436308534559,79.3001244142105,C3;CFH;CXCR4;PIK3R1;ANTXR2
Heart valve disease,5/58,2.7064453830232465E-4,0.0015070686986552644,0,0,9.653436308534559,79.3001244142105,COL1A2;SPP1;CCL2;TIMP1;CALR
Hepatosplenomegaly,5/58,2.7064453830232465E-4,0.0015070686986552644,0,0,9.653436308534559,79.3001244142105,ABCA1;STAT1;CAV1;LPL;TIMP1
Increased susceptibility to bacterial infections,5/58,2.7064453830232465E-4,0.0015070686986552644,0,0,9.653436308534559,79.3001244142105,C3;CFH;CXCR4;PIK3R1;ANTXR2
Prone to bacterial infection,5/58,2.7064453830232465E-4,0.0015070686986552644,0,0,9.653436308534559,79.3001244142105,C3;CFH;CXCR4;PIK3R1;ANTXR2
"Gastritis, Atrophic",7/127,2.7513281232947515E-4,0.0015304621679580095,0,0,6.01108202443281,49.280393017944355,MUC1;LEP;SPP1;CCL2;TLR4;S100A8;EGFR
Papillary Renal Cell Carcinoma,8/169,2.8720239086380786E-4,0.0015942724384512834,0,0,5.136580581889507,41.89047579538584,MME;EPAS1;KDR;KRT8;TIMP1;CTSD;CRYAB;MET
Progressive cGVHD,8/169,2.8720239086380786E-4,0.0015942724384512834,0,0,5.136580581889507,41.89047579538584,CXCL10;MUC1;CFH;HGF;PECAM1;CCL2;ESR1;EGFR
Peritonitis,7/128,2.886469768019354E-4,0.0016006240784365389,0,0,5.961100774522954,48.584796303897114,SOCS3;DUSP1;CCL2;PPARG;FOS;TLR4;S100A8
Craniosynostosis,9/214,2.9137025132091015E-4,0.0016140458100718609,0,0,4.552148664343786,37.058658795335084,ZEB2;SPP1;VIM;CTSD;FGFR3;RUNX2;S100A8;EGFR;TGFBR2
SVEINSSON CHORIORETINAL ATROPHY,5/59,2.9335108505246314E-4,0.0016233311861314392,0,0,9.474189215121857,77.06438547713928,CXCL12;TEAD1;TLR4;EGFR;FOXO1
Dental caries,8/170,2.988704759135623E-4,0.0016521584711030846,0,0,5.104613385315139,41.42649130346499,COL17A1;CXCL10;MMP14;CAV1;LAMA3;PKD2;FGFR3;RUNX2
Chronic liver disease,7/129,3.0268949716537357E-4,0.0016698057250458343,0,0,5.91193888936572,47.90327640334856,ALDH2;GOLM1;HGF;CCL2;TIMP1;ANTXR2;ESR1
early pregnancy,7/129,3.0268949716537357E-4,0.0016698057250458343,0,0,5.91193888936572,47.90327640334856,BCL6;EPAS1;KDR;ESR1;TLR4;S100A8;EGFR
Renal Insufficiency,10/263,3.036220387545548E-4,0.0016729881371275472,0,0,4.110041207636027,33.29021142683856,C3;VCAN;GSN;MME;VWF;PPARG;TIMP1;PKD2;TLR4;TGFBR2
Fibrous Dysplasia,4/33,3.045221416801878E-4,0.0016729881371275472,0,0,14.05830074653395,113.82678216666292,GHR;VCAN;SPP1;RUNX2
Meniere Disease,4/33,3.045221416801878E-4,0.0016729881371275472,0,0,14.05830074653395,113.82678216666292,CFH;CAV1;ESR1;AQP1
Mixed oligoastrocytoma,4/33,3.045221416801878E-4,0.0016729881371275472,0,0,14.05830074653395,113.82678216666292,CAV1;HGF;ESR1;MET
Precursor B-cell lymphoblastic leukemia,12/367,3.099838960884301E-4,0.0017012401465038558,0,0,3.534211721944571,28.552861901432195,C3;STAT5A;STAT5B;CXCL12;MME;MDK;KIT;LMO2;CXCR4;KLF4;NR3C1;FGFR3
Cholestasis,11/315,3.16874616793281E-4,0.0017372683465960847,0,0,3.7728328173374615,30.39773058315546,EGR1;MAF;MME;BCL3;SAA1;PPARG;TIMP1;EZR;NR3C1;ESR1;AQP1
Dry Eye Syndromes,5/60,3.1747328033229923E-4,0.0017387616761467858,0,0,9.301460197833254,74.92434923058464,MUC1;CCL2;ESR1;EGFR;TGFBR2
Refractory Neoplasm,3/14,3.2096880284946175E-4,0.0017453497452905933,0,0,27.67972027972028,222.66028211721869,SOCS3;KIT;ESR1
"Familial Partial Lipodystrophy, Type 2",3/14,3.2096880284946175E-4,0.0017453497452905933,0,0,27.67972027972028,222.66028211721869,CAV1;LPL;PPARG
Acute myocarditis,3/14,3.2096880284946175E-4,0.0017453497452905933,0,0,27.67972027972028,222.66028211721869,SPP1;CCL2;DMD
Disorder of endocrine ovary,3/14,3.2096880284946175E-4,0.0017453497452905933,0,0,27.67972027972028,222.66028211721869,LEP;PPARG;ESR1
Fibromatosis,3/14,3.2096880284946175E-4,0.0017453497452905933,0,0,27.67972027972028,222.66028211721869,CAV1;KIT;ANTXR2
growth hormone treatment,3/14,3.2096880284946175E-4,0.0017453497452905933,0,0,27.67972027972028,222.66028211721869,GHR;LPL;FGFR3
Hypochondroplasia (disorder),3/14,3.2096880284946175E-4,0.0017453497452905933,0,0,27.67972027972028,222.66028211721869,KRT19;CCND1;FGFR3
"Liver Cirrhosis, Alcoholic",6/93,3.255239718258776E-4,0.0017683152353313984,0,0,7.081537356321839,56.865272212008755,ALDH2;PLAU;CAV1;PPARG;TIMP1;TLR4
"Cholestasis, Extrahepatic",5/61,3.430683459840995E-4,0.0018560519956845342,0,0,9.134900074019246,72.87440409099293,ACTA2;JUN;TIMP1;FOS;TLR4
Bile duct carcinoma,5/61,3.430683459840995E-4,0.0018560519956845342,0,0,9.134900074019246,72.87440409099293,MUC1;ANXA1;ESR1;EGFR;DEPP1
Brain Infarction,5/61,3.430683459840995E-4,0.0018560519956845342,0,0,9.134900074019246,72.87440409099293,MDK;HGF;LPL;SORBS1;UTRN
Epithelial hyperplasia of skin,5/61,3.430683459840995E-4,0.0018560519956845342,0,0,9.134900074019246,72.87440409099293,CCND1;TIMP1;VIM;S100A8;EGFR
Myopia,10/269,3.6295829971967283E-4,0.001961668133069104,0,0,4.0135956625318325,31.792584697820015,ZEB2;VCAN;MAF;LRP1;CFH;HGF;SIRPA;PIK3R1;TEAD1;ESR1
Osteomyelitis,5/62,3.7019443631508786E-4,0.001998749899820773,0,0,8.974184165075902,70.90935632141303,STAT1;CCL2;TIMP1;PIK3R1;TLR4
Right Middle Cerebral Artery Infarction,4/35,3.836847049189318E-4,0.002050808217164481,0,0,13.149983372131693,103.43368513053977,C3;PLAU;CCL2;FOS
"Embolic Infarction, Middle Cerebral Artery",4/35,3.836847049189318E-4,0.002050808217164481,0,0,13.149983372131693,103.43368513053977,C3;PLAU;CCL2;FOS
"Thrombotic Infarction, Middle Cerebral Artery",4/35,3.836847049189318E-4,0.002050808217164481,0,0,13.149983372131693,103.43368513053977,C3;PLAU;CCL2;FOS
Varicose Ulcer,4/35,3.836847049189318E-4,0.002050808217164481,0,0,13.149983372131693,103.43368513053977,NRP1;F13A1;ESR1;S100A8
Hepatitis B Virus-Related Hepatocellular Carcinoma,4/35,3.836847049189318E-4,0.002050808217164481,0,0,13.149983372131693,103.43368513053977,KRT19;CAV1;ESR1;TLR4
Left Middle Cerebral Artery Infarction,4/35,3.836847049189318E-4,0.002050808217164481,0,0,13.149983372131693,103.43368513053977,C3;PLAU;CCL2;FOS
Lipoidosis,4/35,3.836847049189318E-4,0.002050808217164481,0,0,13.149983372131693,103.43368513053977,SREBF1;LPL;PPARG;DEPP1
Middle Cerebral Artery Embolus,4/35,3.836847049189318E-4,0.002050808217164481,0,0,13.149983372131693,103.43368513053977,C3;PLAU;CCL2;FOS
Middle Cerebral Artery Syndrome,4/35,3.836847049189318E-4,0.002050808217164481,0,0,13.149983372131693,103.43368513053977,C3;PLAU;CCL2;FOS
Middle Cerebral Artery Thrombosis,4/35,3.836847049189318E-4,0.002050808217164481,0,0,13.149983372131693,103.43368513053977,C3;PLAU;CCL2;FOS
Cardiac fibrosis,6/96,3.863301670316971E-4,0.002062879218549012,0,0,6.844444444444444,53.789244562747164,NR4A1;PLAU;HGF;SPP1;CCL2;DCN
Dengue Fever,8/177,3.918572917849977E-4,0.002090297805727981,0,0,4.891435689816257,38.37141919892613,CXCL10;TCF7L2;CFH;STAT1;TAP1;CCL2;VIM;TLR4
Sclerosis of the skin,3/15,3.9829204863249285E-4,0.002104747198712745,0,0,25.371794871794872,198.6186568823224,COL1A2;CCL2;FLI1
Stromal keratitis,3/15,3.9829204863249285E-4,0.002104747198712745,0,0,25.371794871794872,198.6186568823224,CXCL10;PECAM1;CCL2
Ascending aortic dissection,3/15,3.9829204863249285E-4,0.002104747198712745,0,0,25.371794871794872,198.6186568823224,ACTA2;MYLK;TGFBR2
Chronic ulcer,3/15,3.9829204863249285E-4,0.002104747198712745,0,0,25.371794871794872,198.6186568823224,ADAM12;TIMP1;S100A8
Congenital Thrombotic Thrombocytopenic Purpura,3/15,3.9829204863249285E-4,0.002104747198712745,0,0,25.371794871794872,198.6186568823224,ZFP36;CFH;VWF
Cystic medial necrosis of aorta,3/15,3.9829204863249285E-4,0.002104747198712745,0,0,25.371794871794872,198.6186568823224,ACTA2;MYLK;TGFBR2
Descending aortic dissection,3/15,3.9829204863249285E-4,0.002104747198712745,0,0,25.371794871794872,198.6186568823224,ACTA2;MYLK;TGFBR2
Duchenne and Becker Muscular Dystrophy,3/15,3.9829204863249285E-4,0.002104747198712745,0,0,25.371794871794872,198.6186568823224,CCL2;DMD;UTRN
Mast-Cell Sarcoma,3/15,3.9829204863249285E-4,0.002104747198712745,0,0,25.371794871794872,198.6186568823224,COL17A1;CCL11;KIT
Mycoses,7/135,3.989027148846208E-4,0.002104747198712745,0,0,5.633098821989528,44.089098389659135,CXCL10;RASD1;CCND1;MDK;STAT1;CTSD;TLR4
Lymphangioleiomyomatosis,5/63,3.989106156314267E-4,0.002104747198712745,0,0,8.819010184027157,69.02439244550001,MMP14;PLAU;SPP1;CCL2;ESR1
High density lipoprotein measurement,11/324,4.020292320042529E-4,0.0021191036373399245,0,0,3.662657395226461,28.638266000773932,ABCA1;TCF7L2;LRP1;HGF;BCL3;KDR;LPL;PPARG;CD36;NR3C1;ESR1
"Hepatitis, Toxic",11/325,4.1257723566590955E-4,0.00216613210725481,0,0,3.6508055451479957,28.451045714372107,C3;CXCL10;TF;KRT18;GSN;VWF;SPP1;SERPING1;CCL2;VIM;CDC25B
Chemical and Drug Induced Liver Injury,11/325,4.1257723566590955E-4,0.00216613210725481,0,0,3.6508055451479957,28.451045714372107,C3;CXCL10;TF;KRT18;GSN;VWF;SPP1;SERPING1;CCL2;VIM;CDC25B
Chemically-Induced Liver Toxicity,11/325,4.1257723566590955E-4,0.00216613210725481,0,0,3.6508055451479957,28.451045714372107,C3;CXCL10;TF;KRT18;GSN;VWF;SPP1;SERPING1;CCL2;VIM;CDC25B
Drug-Induced Acute Liver Injury,11/325,4.1257723566590955E-4,0.00216613210725481,0,0,3.6508055451479957,28.451045714372107,C3;CXCL10;TF;KRT18;GSN;VWF;SPP1;SERPING1;CCL2;VIM;CDC25B
Myasthenia Gravis,8/179,4.2236107081030315E-4,0.0022153170731772694,0,0,4.833733456448138,37.556417109901915,CXCL10;KIT;CXCR4;KRT5;UTRN;ESR1;FGFR3;TLR4
"Astrocytoma, low grade",4/36,4.283258903386128E-4,0.002236184023958359,0,0,12.73840206185567,98.79428510947568,SPP1;CCL2;CIB1;EGFR
"Benign neoplasm of brain, unspecified",4/36,4.283258903386128E-4,0.002236184023958359,0,0,12.73840206185567,98.79428510947568,YAP1;CCND1;SPP1;TGFBR2
Endometriosis of ovary,4/36,4.283258903386128E-4,0.002236184023958359,0,0,12.73840206185567,98.79428510947568,NR4A1;MUC1;SNCG;ESR1
Oestrogen deficiency,4/36,4.283258903386128E-4,0.002236184023958359,0,0,12.73840206185567,98.79428510947568,LEP;CCL2;ESR1;FOXO1
Retinopathy of Prematurity,5/64,4.2927683552437633E-4,0.002236184023958359,0,0,8.669096337929217,67.21504560574856,NRP1;EPAS1;FZD4;HGF;KDR
Adult Medulloblastoma,5/64,4.2927683552437633E-4,0.002236184023958359,0,0,8.669096337929217,67.21504560574856,SNAP25;CXCR4;IRS2;S100A4;FLI1
Mastocytosis,5/64,4.2927683552437633E-4,0.002236184023958359,0,0,8.669096337929217,67.21504560574856,STAT5A;STAT5B;TPM3;KIT;RUNX2
Henoch-Schoenlein Purpura,6/98,4.3156094663785035E-4,0.002245886996712016,0,0,6.694972826086956,51.873331096865364,C3;CXCL10;BCL6;PLAU;CCL2;TLR4
Congenital Heart Defects,10/277,4.568484865606876E-4,0.0023719691258484057,0,0,3.8917443621005656,29.932023747293577,ACTA2;RCAN1;ZEB2;MEF2C;ALDH2;KLF4;PKD2;EGFR;TGFBR2;SYNE1
"Hepatitis, Drug-Induced",11/329,4.5712371781690984E-4,0.0023719691258484057,0,0,3.604143544210137,27.71786951178334,C3;CXCL10;TF;KRT18;GSN;VWF;SPP1;SERPING1;CCL2;VIM;CDC25B
Mental disorders,11/329,4.5712371781690984E-4,0.0023719691258484057,0,0,3.604143544210137,27.71786951178334,RGS4;SNAP25;KLF6;ALDH2;DPYSL2;DMD;CALR;FKBP4;NR3C1;ESR1;QKI
Differentiated Thyroid Gland Carcinoma,7/139,4.756185472932789E-4,0.0024631876499561817,0,0,5.461288275424401,41.78373986266866,THRB;CAV1;KDR;TXNIP;PPARG;MET;EGFR
"Meningitis, Bacterial",4/37,4.7655216121314E-4,0.0024631876499561817,0,0,12.351765073414558,94.47782809126898,C3;TIMP1;VIM;TLR4
Tubular Aggregate Myopathy,4/37,4.7655216121314E-4,0.0024631876499561817,0,0,12.351765073414558,94.47782809126898,TPM3;VIM;ESR1;EGFR
Hemorrhage,4/37,4.7655216121314E-4,0.0024631876499561817,0,0,12.351765073414558,94.47782809126898,VWF;PLAU;TIMP1;FOS
Neuralgia,6/100,4.80821336206806E-4,0.002478043424222504,0,0,6.55186170212766,50.056320366945855,MMP14;DPYSL2;HGF;CXCR4;CCL2;TLR4
Oral Cavity Carcinoma,6/100,4.80821336206806E-4,0.002478043424222504,0,0,6.55186170212766,50.056320366945855,ANXA1;CCND1;ALDH2;PLK1;EGFR;TGFBR2
Rash and Dermatitis Adverse Event Associated with Chemoradiation,6/100,4.80821336206806E-4,0.002478043424222504,0,0,6.55186170212766,50.056320366945855,EGR1;KDR;PECAM1;CCL2;ESR1;EGFR
"Dyspnea, Paroxysmal",3/16,4.8664075397796566E-4,0.0024887798252865444,0,0,23.418934911242605,178.63926966636978,ACTA2;MYLK;TGFBR2
"Glioblastoma, IDH-Mutant",3/16,4.8664075397796566E-4,0.0024887798252865444,0,0,23.418934911242605,178.63926966636978,KIT;KDR;EGFR
Sore to touch,3/16,4.8664075397796566E-4,0.0024887798252865444,0,0,23.418934911242605,178.63926966636978,GHR;LEP;CCL2
"Other specified forms of pleural effusion, except tuberculous",3/16,4.8664075397796566E-4,0.0024887798252865444,0,0,23.418934911242605,178.63926966636978,ANXA1;CCL11;ESR1
Abnormality of the iris,3/16,4.8664075397796566E-4,0.0024887798252865444,0,0,23.418934911242605,178.63926966636978,ACTA2;MYLK;TGFBR2
Growth hormone excess,3/16,4.8664075397796566E-4,0.0024887798252865444,0,0,23.418934911242605,178.63926966636978,CAV1;PPARG;FOS
Mammary Analogue Secretory Carcinoma,3/16,4.8664075397796566E-4,0.0024887798252865444,0,0,23.418934911242605,178.63926966636978,STAT5A;STAT5B;VIM
Obstructive Ureterocele,3/16,4.8664075397796566E-4,0.0024887798252865444,0,0,23.418934911242605,178.63926966636978,ACTA2;MMP14;TLR4
Thyroid Nodule,5/66,4.952035006375699E-4,0.0025277197843846834,0,0,8.384014269939692,63.80689078052438,GHR;TPM3;LEP;KIT;PPARG
Bronchiolitis,5/66,4.952035006375699E-4,0.0025277197843846834,0,0,8.384014269939692,63.80689078052438,JUN;TAP1;CCL2;NR3C1;TLR4
Thyroid Diseases,7/140,4.96524249700725E-4,0.0025320361020623574,0,0,5.419950399559108,41.23432267623175,CXCL10;JUN;CXCL12;THRB;KIT;CCL2;FOS
Proteinuria,8/184,5.071386552371903E-4,0.002583692059043009,0,0,4.695215311004785,35.62131259222316,NR4A1;CXCL10;CFH;LEP;LEPR;SPP1;SAA1;PRTN3
"Anemia, Sickle Cell",9/231,5.086541386771305E-4,0.00258893782713508,0,0,4.1999141999142,31.851066823761865,EGR1;JUN;VWF;EPAS1;CCL2;CD36;FOS;RUNX2;QKI
Respiratory Failure,8/185,5.256436494660098E-4,0.0026703098265055923,0,0,4.668450787986917,35.25094458602781,MUC1;DMD;CTSD;CRYAB;TLR4;RUNX2;EGFR;DEPP1
MIXED LINEAGE LEUKEMIA,8/185,5.256436494660098E-4,0.0026703098265055923,0,0,4.668450787986917,35.25094458602781,MEF2C;CCND1;MME;HGF;KDR;ESR1;MET;ETS2
Anti-Basement Membrane Glomerulonephritis,4/38,5.285237104607266E-4,0.002671484942930551,0,0,11.987871437234688,90.45355954451936,MMP14;CXCL12;DUSP1;CCL2
Comedone,4/38,5.285237104607266E-4,0.002671484942930551,0,0,11.987871437234688,90.45355954451936,CCND1;KRT5;ESR1;EGFR
End Stage Liver Disease,4/38,5.285237104607266E-4,0.002671484942930551,0,0,11.987871437234688,90.45355954451936,GHR;KRT18;KRT8;TLR4
Idiopathic Membranous Glomerulonephritis,4/38,5.285237104607266E-4,0.002671484942930551,0,0,11.987871437234688,90.45355954451936,C3;MME;SPP1;CCL2
Skin blisters,5/67,5.308880755420254E-4,0.002671484942930551,0,0,8.248370382751128,62.20062567315848,COL17A1;KIT;LAMA3;KRT5;TLR4
"Mastocytosis, Systemic",5/67,5.308880755420254E-4,0.002671484942930551,0,0,8.248370382751128,62.20062567315848,STAT5A;STAT5B;KIT;PLK1;SIRPA
Abnormal blistering of the skin,5/67,5.308880755420254E-4,0.002671484942930551,0,0,8.248370382751128,62.20062567315848,COL17A1;KIT;LAMA3;KRT5;TLR4
Cerebral Hemorrhage,5/67,5.308880755420254E-4,0.002671484942930551,0,0,8.248370382751128,62.20062567315848,PLAU;PROS1;KDR;SPP1;ESR1
Meningococcal Infections,5/67,5.308880755420254E-4,0.002671484942930551,0,0,8.248370382751128,62.20062567315848,CXCL10;CFH;SERPING1;CXCR4;TLR4
neurofibroma,5/67,5.308880755420254E-4,0.002671484942930551,0,0,8.248370382751128,62.20062567315848,MDK;HGF;KIT;CIB1;EGFR
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,6/102,5.343550611785118E-4,0.002686394453792726,0,0,6.414713541666667,48.33133864532886,CXCL12;MME;DUSP1;CXCR4;NR3C1;KLF4
Hashimoto Disease,8/186,5.446919558500735E-4,0.0027357808036993793,0,0,4.641986989946777,34.8858790635442,ABCA1;EGR1;CXCL10;THRB;CCND1;PPARG;ESR1;MET
Vomiting,8/187,5.642953716593406E-4,0.0028315725382039793,0,0,4.615818876800941,34.52601471512747,ZEB2;MME;SAA1;SERPING1;LPL;MET;S100A8;EGFR
"Carcinoma, Large Cell",5/68,5.684709026083959E-4,0.002841821238274054,0,0,8.117032650711407,60.655016985230795,KRT19;PPARG;MET;EGFR;TGFBR2
Skin bullae,5/68,5.684709026083959E-4,0.002841821238274054,0,0,8.117032650711407,60.655016985230795,COL17A1;KIT;LAMA3;KRT5;TLR4
Thin skin,5/68,5.684709026083959E-4,0.002841821238274054,0,0,8.117032650711407,60.655016985230795,COL1A2;PROS1;LIFR;PPARG;PIK3R1
Precocious Puberty,5/68,5.684709026083959E-4,0.002841821238274054,0,0,8.117032650711407,60.655016985230795,CAV1;PPARG;DMD;FOS;ESR1
Recurrent Brain Neoplasm,4/39,5.844016218584863E-4,0.002902625525103573,0,0,11.644771723122238,86.69441838396985,YAP1;CCND1;SPP1;TGFBR2
Short toe,4/39,5.844016218584863E-4,0.002902625525103573,0,0,11.644771723122238,86.69441838396985,GHR;BMPR1B;FGFR3;FLI1
Atypical Hemolytic Uremic Syndrome,4/39,5.844016218584863E-4,0.002902625525103573,0,0,11.644771723122238,86.69441838396985,C3;CFH;VWF;FHL1
Myofibrillar Myopathy,4/39,5.844016218584863E-4,0.002902625525103573,0,0,11.644771723122238,86.69441838396985,GSN;FHL1;DMD;CRYAB
Primary malignant neoplasm of brain,4/39,5.844016218584863E-4,0.002902625525103573,0,0,11.644771723122238,86.69441838396985,YAP1;CCND1;SPP1;TGFBR2
Scleroatonic muscular dystrophy,3/17,5.866255752554979E-4,0.002902625525103573,0,0,21.745054945054946,161.80764595422264,VWF;BGN;DMD
Alagille Syndrome,3/17,5.866255752554979E-4,0.002902625525103573,0,0,21.745054945054946,161.80764595422264,MME;HGF;MPDZ
Bone Cysts,3/17,5.866255752554979E-4,0.002902625525103573,0,0,21.745054945054946,161.80764595422264,CAV1;PPARG;FOS
Hyperkeratosis lenticularis perstans,3/17,5.866255752554979E-4,0.002902625525103573,0,0,21.745054945054946,161.80764595422264,SREBF1;LPL;EGFR
Portal vein thrombosis,3/17,5.866255752554979E-4,0.002902625525103573,0,0,21.745054945054946,161.80764595422264,VWF;ESR1;MET
Pseudopelade,3/17,5.866255752554979E-4,0.002902625525103573,0,0,21.745054945054946,161.80764595422264,ZFP36;KRT15;PPARG
Acute pancreatitis,6/104,5.924128475713669E-4,0.0029258276781351385,0,0,6.283163265306122,46.69211382660217,SNAP25;ALDH2;BCL3;KIT;CCL2;TLR4
Carcinoid tumor no ICD-O subtype,6/104,5.924128475713669E-4,0.0029258276781351385,0,0,6.283163265306122,46.69211382660217,JUN;KRT19;PLAU;CIB1;FOS;EGFR
Simple Partial Status Epilepticus,5/69,6.08016016401652E-4,0.00298353347274807,0,0,7.989799222797927,59.1669347580093,MEF2C;JUN;CCL2;DMD;FOS
"Status Epilepticus, Subclinical",5/69,6.08016016401652E-4,0.00298353347274807,0,0,7.989799222797927,59.1669347580093,MEF2C;JUN;CCL2;DMD;FOS
Chronic otitis media,5/69,6.08016016401652E-4,0.00298353347274807,0,0,7.989799222797927,59.1669347580093,TAP1;CCL2;PIK3R1;FGFR3;RUNX2
Complex Partial Status Epilepticus,5/69,6.08016016401652E-4,0.00298353347274807,0,0,7.989799222797927,59.1669347580093,MEF2C;JUN;CCL2;DMD;FOS
Grand Mal Status Epilepticus,5/69,6.08016016401652E-4,0.00298353347274807,0,0,7.989799222797927,59.1669347580093,MEF2C;JUN;CCL2;DMD;FOS
Hepatolenticular Degeneration,5/69,6.08016016401652E-4,0.00298353347274807,0,0,7.989799222797927,59.1669347580093,GOLM1;PPARG;DMD;TIMP1;A2M
Non-Convulsive Status Epilepticus,5/69,6.08016016401652E-4,0.00298353347274807,0,0,7.989799222797927,59.1669347580093,MEF2C;JUN;CCL2;DMD;FOS
Atrial Fibrillation,10/288,6.181677062764654E-4,0.003030557227918385,0,0,3.7356497780499005,27.601785166325573,TCF7L2;CXCL12;VWF;CAV2;CAV1;KIT;CCL2;ANK2;CALR;TIMP1
"Leukoencephalopathy, Progressive Multifocal",6/105,6.232184927212821E-4,0.0030497073900015723,0,0,6.219381313131313,45.902848997420215,EGR1;CXCL10;CCND1;STAT1;CCL2;PPARG
M5b Acute differentiated monocytic leukemia,6/105,6.232184927212821E-4,0.0030497073900015723,0,0,6.219381313131313,45.902848997420215,EGR1;MMP14;SPP1;LPL;CCL2;PPARG
"Neoplasm Recurrence, Local",4/40,6.443477302225934E-4,0.0031444405259672165,0,0,11.32073310423826,83.17650562591072,PLAU;KIT;ESR1;EGFR
"Purpura, Thrombotic Thrombocytopenic",4/40,6.443477302225934E-4,0.0031444405259672165,0,0,11.32073310423826,83.17650562591072,C3;ZFP36;CFH;VWF
Anthrax disease,4/40,6.443477302225934E-4,0.0031444405259672165,0,0,11.32073310423826,83.17650562591072,MMP14;VWF;CALR;ANTXR2
Respiratory Tract Infections,5/70,6.495881958179432E-4,0.003152691708118233,0,0,7.866480669589478,57.733454202659594,PLAU;STAT1;PROS1;LEPR;NR3C1
"Brain Injuries, Focal",5/70,6.495881958179432E-4,0.003152691708118233,0,0,7.866480669589478,57.733454202659594,CXCL10;JUN;CCL2;FOS;TLR4
"Injuries, Acute Brain",5/70,6.495881958179432E-4,0.003152691708118233,0,0,7.866480669589478,57.733454202659594,CXCL10;JUN;CCL2;FOS;TLR4
Brain Injuries,5/70,6.495881958179432E-4,0.003152691708118233,0,0,7.866480669589478,57.733454202659594,CXCL10;JUN;CCL2;FOS;TLR4
Brain Lacerations,5/70,6.495881958179432E-4,0.003152691708118233,0,0,7.866480669589478,57.733454202659594,CXCL10;JUN;CCL2;FOS;TLR4
Philadelphia chromosome-positive acute lymphoblastic leukemia,5/70,6.495881958179432E-4,0.003152691708118233,0,0,7.866480669589478,57.733454202659594,STAT5A;SNAP25;STAT5B;MME;BCL6
Fanconi Anemia,10/290,6.520338926663628E-4,0.0031616820873694696,0,0,3.7085866261398177,27.204018312380356,EGR1;BCL6;ALDH2;STAT1;KIT;SAA1;SPP1;PRTN3;ESR1;SPTBN1
Atrial Premature Complexes,6/106,6.552522701550386E-4,0.0031743994069601826,0,0,6.156875,45.132912165378904,TCF7L2;CAV1;PLK1;SGK1;KLF4;FOXO1
Depressive Symptoms,7/147,6.642234605505261E-4,0.003214938075634654,0,0,5.147120418848168,37.66092384578337,PER1;LEP;KDR;TIMP1;NR3C1;ESR1;EGFR
Pituitary Diseases,9/240,6.690432045839111E-4,0.0032353278014770077,0,0,4.034425891568748,29.49028930494393,EPS8;GHR;KLF6;CCND1;LEPR;PPARG;CIB1;NR3C1;ESR1
Pediatric Obesity,5/71,6.932529389206645E-4,0.003349360753860581,0,0,7.74689904223583,56.3518394392315,GHR;FABP4;LEP;PPARG;CALR
"Teratoma, Malignant",3/18,6.988360534479026E-4,0.003367176608339849,0,0,20.294358974358975,147.46072784482647,KIT;TEAD1;EGFR
Xanthomatosis,3/18,6.988360534479026E-4,0.003367176608339849,0,0,20.294358974358975,147.46072784482647,ABCA1;CXCL10;PPARG
Proliferative Inflammatory Atrophy,3/18,6.988360534479026E-4,0.003367176608339849,0,0,20.294358974358975,147.46072784482647,CIB1;VIM;MET
"Nephrotic Syndrome, Minimal Change",4/41,7.085244863093272E-4,0.0033984941382019847,0,0,11.014210086375035,79.87864150321772,MAF;SPP1;TIMP1;EZR
Alcoholic Intoxication,4/41,7.085244863093272E-4,0.0033984941382019847,0,0,11.014210086375035,79.87864150321772,SNAP25;ALDH2;NR3C1;FGFR3
Intestinal Polyps,4/41,7.085244863093272E-4,0.0033984941382019847,0,0,11.014210086375035,79.87864150321772,JUN;CCND1;SPP1;EGFR
Microcalcification,4/41,7.085244863093272E-4,0.0033984941382019847,0,0,11.014210086375035,79.87864150321772,SPP1;CCL2;DMD;TIMP1
Monoclonal B-Cell Lymphocytosis,4/41,7.085244863093272E-4,0.0033984941382019847,0,0,11.014210086375035,79.87864150321772,CCND1;MME;BCL6;VIM
"Carcinoma, Lewis Lung",6/108,7.231375900943925E-4,0.0034654678215944403,0,0,6.035539215686274,43.648482743568984,HGF;KDR;PECAM1;PRTN3;TLR4;EGFR
secondary acute myeloid leukemia,5/72,7.390764379219179E-4,0.003529156216564427,0,0,7.6308870156987085,55.01952873785934,PER1;MMP14;MAML2;LMO2;KDR
Contact hypersensitivity,5/72,7.390764379219179E-4,0.003529156216564427,0,0,7.6308870156987085,55.01952873785934,FABP4;DUSP1;SAA1;TLR4;S100A8
Familial primary gastric lymphoma,5/72,7.390764379219179E-4,0.003529156216564427,0,0,7.6308870156987085,55.01952873785934,CXCL12;CCND1;BCL6;MAP3K20;CXCR4
Isolated somatotropin deficiency,5/72,7.390764379219179E-4,0.003529156216564427,0,0,7.6308870156987085,55.01952873785934,STAT5B;LEP;LEPR;LPL;NR3C1
Mild cognitive disorder,7/150,7.485795420647091E-4,0.0035713342700652052,0,0,5.038370006956394,36.262827176409914,ABCA1;MME;CCL2;DMD;CD36;ESR1;SYNE1
Anxiety,13/464,7.566777916582052E-4,0.0036067405650684935,0,0,3.015077605321508,21.668075412714398,EGR1;CFH;MAGED1;NR3C1;ESR1;TGFBR2;RCAN1;F8;RGS2;CCND1;ALDH2;LEP;FKBP4
Flexion contracture of proximal interphalangeal joint,6/109,7.590568292184352E-4,0.003614847044597892,0,0,5.976638349514563,42.93278658511529,COL17A1;LAMA3;LIFR;ANTXR2;FGFR3;TGFBR2
Aortic aneurysm without mention of rupture NOS,4/42,7.77094825377406E-4,0.0036810118439432864,0,0,10.723819858925665,76.78199442429948,LEP;SPP1;CCL2;KLF4
Bulimia Nervosa,4/42,7.77094825377406E-4,0.0036810118439432864,0,0,10.723819858925665,76.78199442429948,DST;LEP;NR3C1;ESR1
Defective tooth enamel,4/42,7.77094825377406E-4,0.0036810118439432864,0,0,10.723819858925665,76.78199442429948,LIFR;PIK3R1;KRT5;RUNX2
Diffuse Scleroderma,4/42,7.77094825377406E-4,0.0036810118439432864,0,0,10.723819858925665,76.78199442429948,CAV1;PECAM1;TIMP1;EGFR
Dystrophic tooth enamel,4/42,7.77094825377406E-4,0.0036810118439432864,0,0,10.723819858925665,76.78199442429948,LIFR;PIK3R1;KRT5;RUNX2
PITUITARY ADENOMA PREDISPOSITION (disorder),4/42,7.77094825377406E-4,0.0036810118439432864,0,0,10.723819858925665,76.78199442429948,ABCA1;MUC1;PPARG;CD36
"ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1",5/73,7.871255546944953E-4,0.0037153162807501906,0,0,7.51828710758915,53.734121101694186,CCND1;PLAU;PIK3R1;ESR1;FOXO1
Failure to Thrive,5/73,7.871255546944953E-4,0.0037153162807501906,0,0,7.51828710758915,53.734121101694186,GHR;STAT5B;NR4A1;NR3C1;FGFR3
Guillain-Barre Syndrome,5/73,7.871255546944953E-4,0.0037153162807501906,0,0,7.51828710758915,53.734121101694186,LEP;SPP1;SERPING1;CXCR4;TLR4
mixed gliomas,5/73,7.871255546944953E-4,0.0037153162807501906,0,0,7.51828710758915,53.734121101694186,MDK;PLK1;SPP1;QKI;MYLK
Allergic asthma,8/197,7.935642770228453E-4,0.0037423929488980025,0,0,4.3693678641047065,31.192812390589953,C3;CCL11;CAV1;TAP1;CCL2;PPARG;TLR4;MYLK
Gastroesophageal reflux disease,9/246,7.973218180045158E-4,0.003756788654417387,0,0,3.931082981715893,28.04533730835593,MUC1;COL1A2;CCND1;CAV1;AGR2;EZR;TLR4;S100A8;EGFR
Osteochondrodysplasias,7/152,8.093734141288891E-4,0.0038102039963717753,0,0,4.968369741830656,35.3710671413517,STAT1;KDR;LIFR;BMPR1B;FGFR3;RUNX2;EGFR
Skeletal muscle hypertrophy,3/19,8.238410456378521E-4,0.003847720361265656,0,0,19.025,135.10666442022466,CAV1;PPARG;FOS
Squamous cell carcinoma of vulva,3/19,8.238410456378521E-4,0.003847720361265656,0,0,19.025,135.10666442022466,CCND1;FGFR3;EGFR
"Papilloma, Squamous Cell",3/19,8.238410456378521E-4,0.003847720361265656,0,0,19.025,135.10666442022466,CCND1;KRT15;EGFR
THROMBOCYTOPENIA 1 (disorder),3/19,8.238410456378521E-4,0.003847720361265656,0,0,19.025,135.10666442022466,CIB1;TIMP1;FLI1
Thromboembolism,3/19,8.238410456378521E-4,0.003847720361265656,0,0,19.025,135.10666442022466,PLAU;PROS1;A2M
Carcinoma of extrahepatic bile duct,3/19,8.238410456378521E-4,0.003847720361265656,0,0,19.025,135.10666442022466,MUC1;CCND1;CIB1
Cone-shaped epiphyses of the phalanges of the hand,3/19,8.238410456378521E-4,0.003847720361265656,0,0,19.025,135.10666442022466,BGN;FGFR3;RUNX2
Epidermolysis Bullosa Acquisita,3/19,8.238410456378521E-4,0.003847720361265656,0,0,19.025,135.10666442022466,MMP14;TIMP1;S100A8
Parathyroid hyperplasia,3/19,8.238410456378521E-4,0.003847720361265656,0,0,19.025,135.10666442022466,CCND1;LEP;EGFR
Spondylarthritis,5/74,8.374677947357063E-4,0.0039045195784309533,0,0,7.408950964932042,52.493364073000755,CXCL12;STAT1;CCL2;RUNX2;S100A8
Hamartoma,5/74,8.374677947357063E-4,0.0039045195784309533,0,0,7.408950964932042,52.493364073000755,CCND1;LAMA4;KIT;TIMP1;EGFR
Hyperlipoproteinemia Type IIa,7/153,8.411988414017368E-4,0.003918486561040084,0,0,4.934088790073872,34.93671610714925,ABCA1;GHR;LPL;CD36;TIMP1;NR3C1;ESR1
Yolk Sac Tumor,4/43,8.502220400736015E-4,0.003946718860237127,0,0,10.44832143801216,73.86976859320099,MUC1;ESR1;FGFR3;EGFR
High Grade Lymphoma (neoplasm),4/43,8.502220400736015E-4,0.003946718860237127,0,0,10.44832143801216,73.86976859320099,CCND1;BCL6;NEDD9;TIMP1
Hyperlipoproteinemias,4/43,8.502220400736015E-4,0.003946718860237127,0,0,10.44832143801216,73.86976859320099,ABCA1;SREBF1;LEP;LPL
Pyruvate Carboxylase Deficiency Disease,4/43,8.502220400736015E-4,0.003946718860237127,0,0,10.44832143801216,73.86976859320099,MMP14;PROS1;LEP;EGFR
"FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)",9/249,8.685969993012266E-4,0.004028506013295245,0,0,3.8813492063492063,27.358199473023166,EGR1;BCL6;ALDH2;STAT1;KIT;SPP1;PRTN3;ESR1;SPTBN1
Premature Menopause,7/154,8.740044961432149E-4,0.004048260662952152,0,0,4.900274245823984,34.509814041824804,CXCL12;LEP;KDR;PPARG;LAMC1;ESR1;FOXO1
Skin Erosion,6/112,8.751353506700843E-4,0.004048260662952152,0,0,5.806603773584905,40.88506362460805,CXCL10;LAMA3;PRTN3;DMD;TIMP1;VIM
Infectious disease of lung,6/112,8.751353506700843E-4,0.004048260662952152,0,0,5.806603773584905,40.88506362460805,VCAN;LEP;CXCR4;TLR4;DCN;EGFR
Angiogenic Switch,5/75,8.901712828074863E-4,0.004114243509177011,0,0,7.302738712065137,51.29514260475545,EGR1;ZFP36;CXCL12;EPAS1;CXCR4
"Arthritis, Psoriatic",8/201,9.039963733754874E-4,0.0041745205144869775,0,0,4.27793836923916,29.98272337492431,MMP14;CCND1;PPARG;VIM;TIMP1;ESR1;RUNX2;S100A8
"Adenocarcinoma, Clear Cell",6/113,9.167191802700202E-4,0.004229607369401678,0,0,5.752044392523365,40.233878809299945,VCAN;MUC1;MAML2;SPP1;MET;EGFR
"Arthritis, Adjuvant-Induced",4/44,9.280696577319636E-4,0.004259847722699082,0,0,10.18659793814433,71.1269398038258,STAT1;LEP;SAA1;EGFR
"Arthritis, Collagen-Induced",4/44,9.280696577319636E-4,0.004259847722699082,0,0,10.18659793814433,71.1269398038258,STAT1;LEP;SAA1;EGFR
"Arthritis, Experimental",4/44,9.280696577319636E-4,0.004259847722699082,0,0,10.18659793814433,71.1269398038258,STAT1;LEP;SAA1;EGFR
Tumoral calcinosis,4/44,9.280696577319636E-4,0.004259847722699082,0,0,10.18659793814433,71.1269398038258,SPP1;CCL2;DMD;TIMP1
CARCINOMA OF VULVA,4/44,9.280696577319636E-4,0.004259847722699082,0,0,10.18659793814433,71.1269398038258,CA12;CCND1;KIT;EGFR
Neurocognitive Disorders,4/44,9.280696577319636E-4,0.004259847722699082,0,0,10.18659793814433,71.1269398038258,ZFP36;STAT1;SPP1;CCL2
Acute Undifferentiated Leukemia,5/76,9.453047364839312E-4,0.004331495219882089,0,0,7.199518353645187,50.13746892512262,STAT5A;STAT5B;BCL6;KDR;NR3C1
Petit mal status,5/76,9.453047364839312E-4,0.004331495219882089,0,0,7.199518353645187,50.13746892512262,MEF2C;JUN;CCL2;DMD;FOS
Sick Sinus Syndrome,3/20,9.621891486724228E-4,0.00437127533953567,0,0,17.90497737556561,124.3733355057115,COL1A2;CCL2;FGFR3
Squamous cell carcinoma of penis,3/20,9.621891486724228E-4,0.00437127533953567,0,0,17.90497737556561,124.3733355057115,ANXA1;CCND1;EGFR
"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",3/20,9.621891486724228E-4,0.00437127533953567,0,0,17.90497737556561,124.3733355057115,MME;CCND1;BCL6
"Thymoma, type C",3/20,9.621891486724228E-4,0.00437127533953567,0,0,17.90497737556561,124.3733355057115,EGR1;KIT;EGFR
Carcinoma ex pleomorphic adenoma,3/20,9.621891486724228E-4,0.00437127533953567,0,0,17.90497737556561,124.3733355057115,MAML2;CCND1;EGFR
Cartilaginous exostosis,3/20,9.621891486724228E-4,0.00437127533953567,0,0,17.90497737556561,124.3733355057115,SPP1;S100A4;FGFR3
Dyslipoproteinemias,3/20,9.621891486724228E-4,0.00437127533953567,0,0,17.90497737556561,124.3733355057115,LEPR;LPL;PPARG
Fibrosis of pancreas,3/20,9.621891486724228E-4,0.00437127533953567,0,0,17.90497737556561,124.3733355057115,MMP14;ALDH2;CCL2
Pregnancy associated hypertension,3/20,9.621891486724228E-4,0.00437127533953567,0,0,17.90497737556561,124.3733355057115,LEP;TIMP1;ESR1
Pseudoachondroplasia,3/20,9.621891486724228E-4,0.00437127533953567,0,0,17.90497737556561,124.3733355057115,DMD;FGFR3;DCN
Left Ventricular Hypertrophy,8/203,9.636577770968024E-4,0.004374218308474327,0,0,4.2336302294197035,29.40160653741967,ABCA1;COL1A2;SPP1;LPL;DMD;TIMP1;TLR4;ESR1
Hyperkyphosis,7/157,9.785161120605382E-4,0.00443788286057073,0,0,4.801535776614311,33.27211398792722,RPS6KA3;KLC2;COL1A2;FHL1;BGN;FGFR3;RUNX2
Brachydactyly,8/204,9.946493803753783E-4,0.004507216452398292,0,0,4.2118152524167565,29.11678537155523,GHR;RPS6KA3;BGN;ANTXR2;BMPR1B;FGFR3;RUNX2;TGFBR2
Non-small cell lung cancer stage I,5/77,0.001002937441275655,0.004537057406246151,0,0,7.099165227403569,49.018473262946344,EFNA1;CXCL12;SPP1;ESR1;EGFR
Parathyroid Adenoma,5/77,0.001002937441275655,0.004537057406246151,0,0,7.099165227403569,49.018473262946344,CCND1;CAV1;LEP;CIB1;ESR1
"HYDATIDIFORM MOLE, RECURRENT, 1",4/45,0.0010108013205496669,0.004561016288915474,0,0,9.937641438270052,68.54003101928734,ZBTB16;LEP;SPP1;PPARG
"Leukemia, Plasma Cell",4/45,0.0010108013205496669,0.004561016288915474,0,0,9.937641438270052,68.54003101928734,SOCS3;CCND1;CXCR4;FGFR3
Malignant Central Nervous System Neoplasm,4/45,0.0010108013205496669,0.004561016288915474,0,0,9.937641438270052,68.54003101928734,MAML2;ZBTB16;SPP1;EGFR
Cervical Intraepithelial Neoplasia,8/205,0.0010264341902955101,0.004627637732728234,0,0,4.190221747261555,28.835699970084182,PPP2R1B;LAMA3;TAP1;EZR;TLR4;ESR1;MET;EGFR
Familial (FPAH),6/116,0.0010506471250830189,0.004732796728290286,0,0,5.594318181818182,38.36778648026601,ACTA2;RASD1;KIT;ESR1;MET;EGFR
Crohn's disease of large bowel,5/78,0.0010631392249114036,0.004772930858932493,0,0,7.0015615018809,47.936395370603826,SOCS3;LEP;CCL2;PPARG;TLR4
Giant Cell Glioblastoma,5/78,0.0010631392249114036,0.004772930858932493,0,0,7.0015615018809,47.936395370603826,PPARG;TACC1;MET;FGFR3;EGFR
Peripheral Vascular Diseases,5/78,0.0010631392249114036,0.004772930858932493,0,0,7.0015615018809,47.936395370603826,CCND1;HGF;SPP1;PPARG;TLR4
Pulmonary Embolism,5/78,0.0010631392249114036,0.004772930858932493,0,0,7.0015615018809,47.936395370603826,PLAU;PROS1;HGF;F13A1;CCL2
Turner Syndrome,7/160,0.001092627142061044,0.004874551536192242,0,0,4.706669404236389,32.095580027812915,GHR;VWF;KIT;BGN;DMD;NR3C1;ESR1
Hypotrophic malar bone,7/160,0.001092627142061044,0.004874551536192242,0,0,4.706669404236389,32.095580027812915,MAF;COL1A2;BGN;LIFR;FGFR3;RUNX2;TGFBR2
Malar flattening,7/160,0.001092627142061044,0.004874551536192242,0,0,4.706669404236389,32.095580027812915,MAF;COL1A2;BGN;LIFR;FGFR3;RUNX2;TGFBR2
Teratoma,6/117,0.0010984708831863936,0.004874551536192242,0,0,5.543637387387387,37.77343695721488,EGR1;KRT18;KIT;KLF4;ESR1;FGFR3
Hyperhomocysteinemia,6/117,0.0010984708831863936,0.004874551536192242,0,0,5.543637387387387,37.77343695721488,MEF2C;F8;KRT19;KDR;CCL2;TIMP1
Regional enteritis,4/46,0.0010985806708513571,0.004874551536192242,0,0,9.70054000981836,66.09692093056428,LEP;CCL2;PPARG;TLR4
"Sarcoidosis, Pulmonary",4/46,0.0010985806708513571,0.004874551536192242,0,0,9.70054000981836,66.09692093056428,CXCL10;CXCR4;PPARG;TLR4
Abnormality of dental enamel,4/46,0.0010985806708513571,0.004874551536192242,0,0,9.70054000981836,66.09692093056428,LIFR;PIK3R1;KRT5;RUNX2
Disseminated Intravascular Coagulation,4/46,0.0010985806708513571,0.004874551536192242,0,0,9.70054000981836,66.09692093056428,MUC1;ZFP36;PROS1;F13A1
IIeocolitis,4/46,0.0010985806708513571,0.004874551536192242,0,0,9.70054000981836,66.09692093056428,LEP;CCL2;PPARG;TLR4
Malignant neoplasm of male breast,4/46,0.0010985806708513571,0.004874551536192242,0,0,9.70054000981836,66.09692093056428,CA12;CCND1;ESR1;EGFR
Moyamoya disease 1,4/46,0.0010985806708513571,0.004874551536192242,0,0,9.70054000981836,66.09692093056428,ACTA2;LRP1;KDR;TIMP1
Obstructive nephropathy,4/46,0.0010985806708513571,0.004874551536192242,0,0,9.70054000981836,66.09692093056428,HGF;SPP1;CCL2;S100A4
Peptic Esophagitis,4/46,0.0010985806708513571,0.004874551536192242,0,0,9.70054000981836,66.09692093056428,GHR;CCL2;ESR1;EGFR
Shared Paranoid Disorder,3/21,0.0011144091167492164,0.004903952256941845,0,0,16.90940170940171,114.97430940790971,DPYSL2;CALR;ESR1
Simple renal cyst,3/21,0.0011144091167492164,0.004903952256941845,0,0,16.90940170940171,114.97430940790971,PKD2;FGFR3;EGFR
Allergic Conjunctivitis,3/21,0.0011144091167492164,0.004903952256941845,0,0,16.90940170940171,114.97430940790971,SOCS3;CCL11;CCL2
Chronic venous insufficiency,3/21,0.0011144091167492164,0.004903952256941845,0,0,16.90940170940171,114.97430940790971,EFEMP1;TIMP1;SKAP2
Diabetic peripheral neuropathy,3/21,0.0011144091167492164,0.004903952256941845,0,0,16.90940170940171,114.97430940790971,SREBF1;HGF;LEP
External exotoses,3/21,0.0011144091167492164,0.004903952256941845,0,0,16.90940170940171,114.97430940790971,TCF7L2;S100A4;DCN
Hypoalphalipoproteinemias,3/21,0.0011144091167492164,0.004903952256941845,0,0,16.90940170940171,114.97430940790971,ABCA1;PPARG;ESR1
Lung Injury,3/21,0.0011144091167492164,0.004903952256941845,0,0,16.90940170940171,114.97430940790971,MME;CCL2;TLR4
Pancreatic Intraductal Papillary-Mucinous Neoplasm,3/21,0.0011144091167492164,0.004903952256941845,0,0,16.90940170940171,114.97430940790971,MUC1;VIM;EGFR
Progressive renal failure,3/21,0.0011144091167492164,0.004903952256941845,0,0,16.90940170940171,114.97430940790971,CFH;SAA1;PKD2
"Glioblastoma, IDH-Wildtype",5/79,0.0011259804316429648,0.004946702160119835,0,0,6.906595714885871,46.88957675900747,AKAP12;KIT;KDR;S100A4;EGFR
Conduction disorder of the heart,5/79,0.0011259804316429648,0.004946702160119835,0,0,6.906595714885871,46.88957675900747,LAMA4;FHL1;DMD;CRYAB;SYNE1
Weight decreased,7/161,0.0011329010939938927,0.0049689135225460535,0,0,4.675868633983817,31.716293484675035,RPS6KA3;CCND1;BCL6;LEP;PRTN3;PIK3R1;TGFBR2
Eosinophilic disorder,7/161,0.0011329010939938927,0.0049689135225460535,0,0,4.675868633983817,31.716293484675035,CXCL10;CCL11;KIT;SPP1;NR3C1;FKBP4;TLR4
Autistic Disorder,16/677,0.0011888782216216143,0.005196303711195161,0,0,2.5457265880866484,17.144819632874597,SNAP25;MEF2C;MAGED1;ZBTB16;EPS8;GHR;PER1;TF;ALDH2;LEP;DPYSL2;PECAM1;DMD;CTSD;MPDZ;MET
Intestinal Diseases,5/80,0.0011915318967032392,0.005196303711195161,0,0,6.814162348877375,45.87645357592709,STAT5B;MUC1;ANXA1;HGF;TLR4
Abnormality of the cornea,4/47,0.0011915712394596522,0.005196303711195161,0,0,9.474466554783026,63.78668002570477,GSN;MAF;PIK3R1;DCN
Antiphospholipid Syndrome,4/47,0.0011915712394596522,0.005196303711195161,0,0,9.474466554783026,63.78668002570477,ABCA1;CCL2;PPARG;TLR4
ATRICHIA WITH PAPULAR LESIONS,4/47,0.0011915712394596522,0.005196303711195161,0,0,9.474466554783026,63.78668002570477,ABCA1;ZBTB16;KIT;PPARG
Colonic Polyps,4/47,0.0011915712394596522,0.005196303711195161,0,0,9.474466554783026,63.78668002570477,CXCR4;PPARG;EGFR;DCN
Hyperparathyroidism,4/47,0.0011915712394596522,0.005196303711195161,0,0,9.474466554783026,63.78668002570477,CCND1;LEP;LEPR;EGFR
"Infarction, Middle Cerebral Artery",6/119,0.0011991138471520093,0.005216389952222904,0,0,5.444966814159292,36.62378580755121,C3;EGR1;PLAU;CCL2;FADD;FOS
Prader-Willi Syndrome,6/119,0.0011991138471520093,0.005216389952222904,0,0,5.444966814159292,36.62378580755121,GHR;MAGED1;LEP;LEPR;DMD;CD36
Premature Birth,6/119,0.0011991138471520093,0.005216389952222904,0,0,5.444966814159292,36.62378580755121,COL1A2;FZD4;PPARG;NR3C1;TLR4;FLI1
Abnormal behavior,11/372,0.0012481248579394545,0.005425169141891805,0,0,3.1678344467981097,21.180498973989156,EGR1;SNAP25;LEP;DPYSL2;CCL2;DMD;CALR;FKBP4;NR3C1;ESR1;QKI
"Neoplasms, Experimental",5/81,0.0012598649204437389,0.0054628317014195965,0,0,6.7241614398691025,44.89555006965508,CCND1;EPAS1;HGF;KDR;SPP1
Acute myelomonocytic leukemia,5/81,0.0012598649204437389,0.0054628317014195965,0,0,6.7241614398691025,44.89555006965508,EGR1;PLAU;KIT;SIRPA;FLI1
Lobar Pneumonia,5/81,0.0012598649204437389,0.0054628317014195965,0,0,6.7241614398691025,44.89555006965508,CCL11;SPP1;CCL2;TLR4;MYLK
Weak cry,3/22,0.001281010270900907,0.005523061273164185,0,0,16.018623481781376,106.68573417874663,TPM3;LAMA3;CRYAB
Adenoid cystic carcinoma of salivary gland,3/22,0.001281010270900907,0.005523061273164185,0,0,16.018623481781376,106.68573417874663,CCND1;KIT;MET
Adrenal Gland Hyperfunction,3/22,0.001281010270900907,0.005523061273164185,0,0,16.018623481781376,106.68573417874663,VWF;LEP;NR3C1
Angiomyolipoma of kidney,3/22,0.001281010270900907,0.005523061273164185,0,0,16.018623481781376,106.68573417874663,KIT;KRT8;VIM
Disorder of skeletal system,3/22,0.001281010270900907,0.005523061273164185,0,0,16.018623481781376,106.68573417874663,FGFR3;RUNX2;EGFR
Impaired left ventricular function,3/22,0.001281010270900907,0.005523061273164185,0,0,16.018623481781376,106.68573417874663,ACTA2;MYLK;TGFBR2
Other specified manifestations of hyperkinetic syndrome,3/22,0.001281010270900907,0.005523061273164185,0,0,16.018623481781376,106.68573417874663,SNAP25;PER1;THRB
Alcoholic Steatohepatitis,4/48,0.0012899363371830428,0.005552561180006813,0,0,9.25866916588566,61.59942968745832,CXCL10;LEPR;CXCR4;CD36
Cutis marmorata,4/48,0.0012899363371830428,0.005552561180006813,0,0,9.25866916588566,61.59942968745832,ACTA2;RPS6KA3;MYLK;TGFBR2
Adult Acute Lymphocytic Leukemia,6/121,0.0013066705356422383,0.005620054305437844,0,0,5.349728260869565,35.52365587602531,CCND1;MME;KIT;SPP1;CCL2;RUNX2
Carcinoid Tumor,8/213,0.001311054680794747,0.005634363220931619,0,0,4.025057766367137,26.713999938477098,JUN;KRT19;PLAU;KIT;CXCR4;CIB1;FOS;EGFR
Congenital heart disease,6/122,0.0013631376613369012,0.005853473486917281,0,0,5.303340517241379,34.99126112234008,EGR1;MEF2C;CXCL12;ALDH2;CXCR4;S100A4
Thromboangiitis Obliterans,4/49,0.0013938389513098795,0.005965105072136335,0,0,9.0524627720504,59.52622063835553,CXCL10;FABP4;STAT1;NR3C1
cardiac event,4/49,0.0013938389513098795,0.005965105072136335,0,0,9.0524627720504,59.52622063835553,SPP1;CCL2;CD36;TLR4
Nervous System Neoplasms,4/49,0.0013938389513098795,0.005965105072136335,0,0,9.0524627720504,59.52622063835553,MDK;TPM3;CCL2;SOX10
Irritable Bowel Syndrome,7/167,0.0013996382834167809,0.005965105072136335,0,0,4.499149214659686,29.56634553016935,EGR1;CXCL12;CCL11;KRT8;NR3C1;TLR4;S100A8
Van der Woude syndrome,5/83,0.0014051630179616984,0.005965105072136335,0,0,6.551082768699349,43.0249040050253,STAT1;MAPKAPK2;CCL2;FOS;TLR4
Hay fever,5/83,0.0014051630179616984,0.005965105072136335,0,0,6.551082768699349,43.0249040050253,CXCL10;SORBS1;TLR4;EGFR;TNS1
Hydatidiform Mole,5/83,0.0014051630179616984,0.005965105072136335,0,0,6.551082768699349,43.0249040050253,ZBTB16;LEP;SPP1;PPARG;EGFR
Secondary Peritonitis,2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,LEP;LEPR
"EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder)",2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,COL17A1;LAMA3
Serrated polyp,2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,CALR;EGFR
Severe autosomal recessive muscular dystrophy of childhood - North African type (disorder),2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,DMD;UTRN
"HEMANGIOMA, CAPILLARY INFANTILE",2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,KDR;TIMP1
Vitreoretinopathy,2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,VCAN;FZD4
Adrenal incidentaloma,2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,CCND1;NR3C1
Adult junctional epidermolysis bullosa (disorder),2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,COL17A1;LAMA3
C3 Glomerulonephritis,2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,C3;CFH
Centrocytic lymphoma,2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,CCND1;MME
Chagas' disease without mention of organ involvement,2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,CCL2;VIM
Epidermolysis Bullosa Progressiva,2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,COL17A1;LAMA3
Exudative age-related macular degeneration,2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,CFH;KDR
Giant cell carcinoma of lung,2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,PLAU;EGFR
Immune dysregulation,2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,STAT1;LEPR
JEB-I,2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,COL17A1;LAMA3
LEPTIN RECEPTOR DEFICIENCY,2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,LEP;LEPR
Megakaryocytic hyperplasia,2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,CXCL12;CXCR4
Microcystic stromal tumor,2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,MME;VIM
Orthostatic hypotension due to autonomic dysfunction,2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,LEP;LEPR
Palmar hyperhidrosis,2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,COL17A1;LAMA3
Papillary urothelial carcinoma,2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,ZEB2;ESR1
Pleomorphic carcinoma,2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,KRT19;EGFR
Pleural Neoplasms,2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,SPP1;EGFR
Posterior polar cataract,2/6,0.001424953791861429,0.005965105072136335,0,0,50.505102040816325,330.9910393896135,VIM;CRYAB
Frontal bossing,8/216,0.0014327072991718228,0.005992854942925153,0,0,3.9663967611336033,25.97271726069304,RPS6KA3;COL1A2;BGN;LIFR;PIK3R1;FGFR3;RUNX2;FLI1
response to statin,3/23,0.0014624829026359668,0.0060934881846341415,0,0,15.216923076923077,99.33028638515556,ABCA1;EPB41L2;LPL
"Myopia, Degenerative",3/23,0.0014624829026359668,0.0060934881846341415,0,0,15.216923076923077,99.33028638515556,ZEB2;FLI1;SPTBN1
Acute pyelonephritis,3/23,0.0014624829026359668,0.0060934881846341415,0,0,15.216923076923077,99.33028638515556,CCL2;TIMP1;TLR4
Camurati-Engelmann Syndrome,3/23,0.0014624829026359668,0.0060934881846341415,0,0,15.216923076923077,99.33028638515556,COL1A2;TLR4;TGFBR2
Pre B-cell acute lymphoblastic leukemia,3/23,0.0014624829026359668,0.0060934881846341415,0,0,15.216923076923077,99.33028638515556,MME;CCND1;NR3C1
Polycystic Kidney Diseases,6/124,0.0014816444692735435,0.006168502638092745,0,0,5.21292372881356,33.960126895220824,JUN;HGF;SPP1;FOS;PKD2;AQP1
"Tuberculosis, Pulmonary",7/169,0.0014986757620709052,0.006234537967272329,0,0,4.443151703186607,28.894585906478202,CA12;CXCL10;CXCR4;CCL2;CD36;TLR4;EGFR
Small Lymphocytic Lymphoma,4/50,0.0015034416443697955,0.006239751186017633,0,0,8.855221873599282,57.55892773976394,CCND1;MME;KIT;ETS2
Calcinosis,4/50,0.0015034416443697955,0.006239751186017633,0,0,8.855221873599282,57.55892773976394,SPP1;CCL2;DMD;TIMP1
Li-Fraumeni Syndrome,4/50,0.0015034416443697955,0.006239751186017633,0,0,8.855221873599282,57.55892773976394,CAV1;ESR1;DCN;EGFR
Primary physiologic amenorrhea,5/85,0.001562453459054429,0.006479622165993037,0,0,6.386658031088083,41.26737785826921,LEP;LEPR;PPARG;BMPR1B;ESR1
Congenital anomaly of face,6/126,0.0016078448215055847,0.006657501984307118,0,0,5.125520833333334,32.97176110995807,GHR;ZEB2;VWF;CAV1;PPARG;FGFR3
Left-Sided Heart Failure,6/126,0.0016078448215055847,0.006657501984307118,0,0,5.125520833333334,32.97176110995807,ACTA2;VWF;PRKAR2B;PPARG;MYLK;TGFBR2
Adrenal Cushing's syndrome,4/51,0.0016189064569619275,0.006661893829459546,0,0,8.66637420486949,55.690158635934715,VWF;LEP;TXNIP;NR3C1
Angioimmunoblastic Lymphadenopathy,4/51,0.0016189064569619275,0.006661893829459546,0,0,8.66637420486949,55.690158635934715,MME;BCL6;HGF;KDR
Convex nasal ridge,4/51,0.0016189064569619275,0.006661893829459546,0,0,8.66637420486949,55.690158635934715,THRB;COL1A2;FGFR3;RUNX2
Epistaxis,4/51,0.0016189064569619275,0.006661893829459546,0,0,8.66637420486949,55.690158635934715,VWF;PLAU;F13A1;PRTN3
Frequent nosebleeds,4/51,0.0016189064569619275,0.006661893829459546,0,0,8.66637420486949,55.690158635934715,VWF;PLAU;F13A1;PRTN3
Hematuria,4/51,0.0016189064569619275,0.006661893829459546,0,0,8.66637420486949,55.690158635934715,YAP1;CFH;PLAU;PRTN3
Metaplasia,4/51,0.0016189064569619275,0.006661893829459546,0,0,8.66637420486949,55.690158635934715,BCL6;MET;ESR1;EGFR
Premature coronary artery disease,4/51,0.0016189064569619275,0.006661893829459546,0,0,8.66637420486949,55.690158635934715,ABCA1;LPL;CCL2;ESR1
Stage III Colon Cancer,3/24,0.0016592986709681567,0.0067809836024457885,0,0,14.491575091575092,92.76579279827187,CXCL12;CXCR4;EGFR
Thymus Neoplasms,3/24,0.0016592986709681567,0.0067809836024457885,0,0,14.491575091575092,92.76579279827187,KIT;DTX1;EGFR
Acute Lung Injury,3/24,0.0016592986709681567,0.0067809836024457885,0,0,14.491575091575092,92.76579279827187,PLAU;PPARG;MYLK
Chronic thromboembolic pulmonary hypertension,3/24,0.0016592986709681567,0.0067809836024457885,0,0,14.491575091575092,92.76579279827187,CDH5;CXCL10;KDR
Elastosis perforans serpiginosa,3/24,0.0016592986709681567,0.0067809836024457885,0,0,14.491575091575092,92.76579279827187,RGS2;LEP;TLR4
Endemic Cretinism,3/24,0.0016592986709681567,0.0067809836024457885,0,0,14.491575091575092,92.76579279827187,GHR;EGR1;RUNX2
Hyperlipoproteinemia Type IIb,3/24,0.0016592986709681567,0.0067809836024457885,0,0,14.491575091575092,92.76579279827187,ABCA1;C3;LPL
Orchitis,3/24,0.0016592986709681567,0.0067809836024457885,0,0,14.491575091575092,92.76579279827187,PECAM1;CCL2;TLR4
Penis carcinoma,3/24,0.0016592986709681567,0.0067809836024457885,0,0,14.491575091575092,92.76579279827187,ANXA1;TLR4;EGFR
Primary biliary cirrhosis,10/329,0.0016861064508019274,0.006885257683006492,0,0,3.2486827186020144,20.74392189002348,ABCA1;CXCL10;CDH5;HGF;BCL3;PPARG;CIB1;TLR4;FOXO1;TGFBR2
Fever,7/173,0.0017131013194633805,0.006990135475819567,0,0,4.335204693118022,27.612869159789614,CCND1;BCL6;DST;CCL2;PRTN3;PIK3R1;TLR4
Malignant Childhood Neoplasm,5/87,0.0017323207845076998,0.007057750352172425,0,0,6.230254012384683,39.61378219182946,MMP14;LEPR;EZR;ESR1;FOXO1
Multiple tumors,5/87,0.0017323207845076998,0.007057750352172425,0,0,6.230254012384683,39.61378219182946,MMP14;FHL1;CCL2;UTRN;MET
Coronary Stenosis,4/52,0.0017403948132125309,0.007075786325174291,0,0,8.485395189003436,53.913174183118734,ABCA1;MDK;PECAM1;TLR4
Malignant ascites,4/52,0.0017403948132125309,0.007075786325174291,0,0,8.485395189003436,53.913174183118734,CXCL12;HGF;KRT8;EGFR
Sarcomatoid Renal Cell Carcinoma,6/128,0.0017420588588156634,0.007075786325174291,0,0,5.040983606557377,32.023794114985016,EPAS1;KRT8;VIM;CTSD;CRYAB;MET
Biliary Tract Cancer,6/128,0.0017420588588156634,0.007075786325174291,0,0,5.040983606557377,32.023794114985016,KRT19;CCND2;AGR2;ESR1;EGFR;TGFBR2
Retroviridae Infections,5/88,0.001822154835499861,0.007389850166193881,0,0,6.15487858168425,38.82334614443829,CXCL10;KLF6;CCND1;EZR;EGFR
Alcohol Use Disorder,5/88,0.001822154835499861,0.007389850166193881,0,0,6.15487858168425,38.82334614443829,TF;ALDH2;VWF;PIK3R1;TLR4
"Ovarian Failure, Premature",7/175,0.0018288879774202127,0.00740588452254735,0,0,4.283158813263525,27.00123515019489,CXCL12;KIT;KDR;DMD;LAMC1;ESR1;FOXO1
Drug Dependence,7/175,0.0018288879774202127,0.00740588452254735,0,0,4.283158813263525,27.00123515019489,PTPRB;ABLIM1;TINAGL1;PARVA;MET;EGFR;SYNE1
Rous Sarcoma,4/53,0.0018680674312188381,0.007534300358377272,0,0,8.311803071744162,52.22181892571914,COL1A2;CAV1;DMD;SORBS1
Thrombocytopenia due to platelet alloimmunization,4/53,0.0018680674312188381,0.007534300358377272,0,0,8.311803071744162,52.22181892571914,STAT1;CXCR4;NR3C1;TLR4
Thrombocytosis,4/53,0.0018680674312188381,0.007534300358377272,0,0,8.311803071744162,52.22181892571914,CXCL12;CXCR4;CALR;AQP1
"Apraxia, Developmental Verbal",3/25,0.0018719109916478717,0.007534300358377272,0,0,13.832167832167832,86.87701677359438,LRP1;PECAM1;CCL2
Spondyloepimetaphyseal disorder,3/25,0.0018719109916478717,0.007534300358377272,0,0,13.832167832167832,86.87701677359438,BGN;FGFR3;DCN
Temporomandibular Joint Disorders,3/25,0.0018719109916478717,0.007534300358377272,0,0,13.832167832167832,86.87701677359438,CCL2;DMD;ESR1
Adolescent idiopathic scoliosis,3/25,0.0018719109916478717,0.007534300358377272,0,0,13.832167832167832,86.87701677359438,GHR;COL1A2;ESR1
Excessive wrinkled skin,3/25,0.0018719109916478717,0.007534300358377272,0,0,13.832167832167832,86.87701677359438,COL1A2;PIK3R1;FGFR3
Lyme Disease,6/130,0.0018846110451157703,0.007579692271261841,0,0,4.959173387096774,31.11402155726477,JUN;CFH;FHL1;SPP1;CCL2;DCN
"Myocardial Diseases, Secondary",5/89,0.0019153545282787074,0.00769172892328352,0,0,6.0812978040957315,38.05586491730021,LRP1;HGF;LPL;CCL2;DMD
Chagas Disease,5/89,0.0019153545282787074,0.00769172892328352,0,0,6.0812978040957315,38.05586491730021,KRT8;CCL2;PPARG;CALR;TLR4
"Adenocarcinoma, Scirrhous",2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,MMP14;MET
"Aortic Aneurysm, Thoracoabdominal",2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,ACTA2;TGFBR2
Secondary malignant neoplasm of bone marrow,2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,KRT19;CXCL12
Sertoli-Leydig Cell Tumor,2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,KRT18;VIM
Adenosarcoma,2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,S100A4;EGFR
Advanced breast cancer,2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,ESR1;EGFR
Benign neoplasm of esophagus,2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,EGFR;TGFBR2
Brachydactyly type C,2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,MUC1;BMPR1B
Broad eyebrow,2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,ZEB2;MAF
Carcinoma in situ of esophagus,2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,EGFR;TGFBR2
CD4+ T-cell lymphopenia,2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,LEP;LEPR
CHROMOSOME 8p11 MYELOPROLIFERATIVE SYNDROME,2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,STAT5A;STAT5B
Congenital Bleeding Disorder,2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,F8;VWF
Craniofacial Dysostosis,2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,BGN;FGFR3
Decreased number of CD4+ T cells,2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,LEP;LEPR
Decreased T cell activation,2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,LEP;LEPR
Desquamative interstitial pneumonia,2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,SPP1;CXCR4
Dianzani autoimmune lymphoproliferative syndrome,2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,SPP1;TIMP1
Elliptocytosis 4,2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,SPP1;TLR4
Intraocular Lymphoma,2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,CXCL12;BCL6
LEPTIN DEFICIENCY OR DYSFUNCTION,2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,LEP;PPARG
Malattia Leventinese,2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,EFEMP1;CFH
Microcolon,2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,SOX10;MYLK
Microcolon on contrast enema,2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,SOX10;MYLK
NADH cytochrome B5 reductase deficiency,2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,LPL;PPARG
Papillary cystic tumor,2/7,0.00198194526890407,0.007806198328152099,0,0,40.40204081632653,251.4492302647478,CCND1;VIM
Rotavirus Infections,4/54,0.0020020842345468454,0.007879694893574696,0,0,8.145154639175258,50.610460196958336,JUN;STAT1;SPP1;TLR4
Neutropenia,7/178,0.0020138572948599125,0.00792018119875164,0,0,4.207372707510486,26.118121624900482,SOCS3;STAT5B;GRK3;CXCR4;ESR1;MET;TLR4
Nausea and vomiting,6/132,0.0020358299129405997,0.008000691449897093,0,0,4.879960317460317,30.24039050433683,CAV1;KIT;PRTN3;TLR4;MYLK;TGFBR2
Drug abuse,8/229,0.002067398860711501,0.008112789785516633,0,0,3.730602524410574,23.06058539285242,STAT5A;ABLIM1;CCND1;LEP;CXCR4;PARVA;NR3C1;SYNE1
No development of motor milestones,8/229,0.002067398860711501,0.008112789785516633,0,0,3.730602524410574,23.06058539285242,GHR;RPS6KA3;ZEB2;MEF2C;KLC2;TPM3;DMD;FGFR3
Muscle Weakness,10/339,0.0020987931115094864,0.008219475508657101,0,0,3.1483218004268254,19.413788908259583,SNAP25;COL1A2;TPM3;CAV1;FHL1;CCL2;DMD;UTRN;MET;SYNE1
Tibial bowing,3/26,0.002100755421803523,0.008219475508657101,0,0,13.23010033444816,81.56963157644334,COL1A2;LIFR;FGFR3
Coronary Thrombosis,3/26,0.002100755421803523,0.008219475508657101,0,0,13.23010033444816,81.56963157644334,VCAN;VWF;ESR1
Epidermolysis Bullosa Simplex,3/26,0.002100755421803523,0.008219475508657101,0,0,13.23010033444816,81.56963157644334,COL17A1;KRT5;VIM
Meningitis,5/91,0.002112148410468978,0.008257988906375044,0,0,5.939269791541149,36.586196773903204,CFH;MDK;CCL2;TIMP1;TLR4
"Osteoporosis, Postmenopausal",4/55,0.0021426042679574256,0.008364789849044044,0,0,7.985041439256115,49.073934613463464,COL1A2;SPP1;DMD;ESR1
"Scoliosis, unspecified",4/55,0.0021426042679574256,0.008364789849044044,0,0,7.985041439256115,49.073934613463464,COL1A2;LEP;ESR1;RUNX2
Tumor Immunity,6/134,0.0021960478069502445,0.00856089156052513,0,0,4.80322265625,29.40098691891332,JUN;MUC1;PROS1;KDR;CALR;FOS
High forehead,6/134,0.0021960478069502445,0.00856089156052513,0,0,4.80322265625,29.40098691891332,GHR;MEF2C;CCND2;MAF;FGFR3;FLI1
"Cardiomyopathies, Primary",5/92,0.0022158918881872796,0.008631935579057027,0,0,5.870704544101007,35.88233499468095,LRP1;HGF;LPL;CCL2;DMD
Motor delay,8/232,0.002241280867236259,0.008724460001097169,0,0,3.680075187969925,22.451063259608887,GHR;RPS6KA3;ZEB2;MEF2C;KLC2;TPM3;DMD;FGFR3
Glucocorticoid Receptor Deficiency,4/56,0.002289785616223477,0.008887303385910348,0,0,7.831086439333862,47.60750094867905,JUN;FOS;NR3C1;S100A8
Laryngeal Diseases,4/56,0.002289785616223477,0.008887303385910348,0,0,7.831086439333862,47.60750094867905,MMP14;CCND1;SERPING1;EGFR
Parathyroid Neoplasms,4/56,0.002289785616223477,0.008887303385910348,0,0,7.831086439333862,47.60750094867905,SNAP25;CCND1;ESR1;EGFR
Pituitary-dependent Cushing's disease,4/56,0.002289785616223477,0.008887303385910348,0,0,7.831086439333862,47.60750094867905,CCND1;PPARG;NR3C1;EGFR
"Osteoarthritis, Knee",5/93,0.00232329953629025,0.009004264166465995,0,0,5.803697597739048,35.19807302902893,SOCS3;PLAU;EPAS1;ADAM12;ESR1
Coughing,5/93,0.00232329953629025,0.009004264166465995,0,0,5.803697597739048,35.19807302902893,MME;PRTN3;PIK3R1;EGFR;TGFBR2
Short femoral neck,3/27,0.0023462500360106487,0.009034079799061234,0,0,12.678205128205128,76.76573275023132,BMPR1B;FGFR3;RUNX2
Childhood Cerebral Astrocytoma,3/27,0.0023462500360106487,0.009034079799061234,0,0,12.678205128205128,76.76573275023132,HGF;ESR1;MET
Chronic Lung Injury,3/27,0.0023462500360106487,0.009034079799061234,0,0,12.678205128205128,76.76573275023132,MME;CCL2;TLR4
Flared metaphysis,3/27,0.0023462500360106487,0.009034079799061234,0,0,12.678205128205128,76.76573275023132,LIFR;FGFR3;RUNX2
Gastric lymphoma,3/27,0.0023462500360106487,0.009034079799061234,0,0,12.678205128205128,76.76573275023132,BCL6;MAP3K20;TLR4
Idiopathic Interstitial Pneumonias,3/27,0.0023462500360106487,0.009034079799061234,0,0,12.678205128205128,76.76573275023132,CXCL12;CXCR4;PPARG
Intracranial Astrocytoma,3/27,0.0023462500360106487,0.009034079799061234,0,0,12.678205128205128,76.76573275023132,HGF;ESR1;MET
Localized scleroderma,3/27,0.0023462500360106487,0.009034079799061234,0,0,12.678205128205128,76.76573275023132,COL1A2;DCN;FLI1
Neck muscle weakness,3/27,0.0023462500360106487,0.009034079799061234,0,0,12.678205128205128,76.76573275023132,TPM3;CRYAB;SYNE1
Delayed bone age,7/183,0.002353980199302737,0.009057299987064466,0,0,4.086803902903379,24.731897364529274,GHR;RPS6KA3;THRB;STAT1;ZBTB16;PIK3R1;ESR1
Traditional Serrated Adenoma,5/94,0.0024344463921378494,0.009353399296108579,0,0,5.7381964254526405,34.53267210485872,JUN;CALR;VIM;EGFR;AQP1
AMYOTROPHIC LATERAL SCLEROSIS 1,5/94,0.0024344463921378494,0.009353399296108579,0,0,5.7381964254526405,34.53267210485872,HGF;SNCG;FOS;VIM;CTSD
Hypersensitivity,7/185,0.0025017927725278885,0.00960522599769533,0,0,4.040472968998176,24.205454126126085,STAT5B;CCL11;SPP1;CCL2;TLR4;FOXO1;MYLK
Rheumatism,5/95,0.00254940760683789,0.009722551568586037,0,0,5.674150834772597,33.885428788320105,C3;NRP1;CFH;CALR;SPTBN1
Rotting teeth,5/95,0.00254940760683789,0.009722551568586037,0,0,5.674150834772597,33.885428788320105,COL17A1;CAV1;LAMA3;FGFR3;RUNX2
Sciatic Neuropathy,5/95,0.00254940760683789,0.009722551568586037,0,0,5.674150834772597,33.885428788320105,C3;PLAU;CAV1;CCL2;TLR4
Curvature of spine,11/408,0.0025724695541503692,0.009722551568586037,0,0,2.8752407764113204,17.14474138365796,RPS6KA3;COL1A2;KLC2;TPM3;FHL1;MAP3K20;DMD;LIFR;FGFR3;RUNX2;TGFBR2
Mental Retardation,22/1158,0.002573656754979102,0.009722551568586037,0,0,2.053917253521127,12.24633277575907,ABCA1;YAP1;SNAP25;ANXA1;ZBTB16;CAV1;FOS;SOX10;FLI1;ETS2;TGFBR2;ACTA2;RCAN1;RPS6KA3;ZEB2;MAF;LEPR;PPARG;DMD;FGFR3;MPDZ;ARHGEF6
Eosinophilia,7/186,0.002578327666777885,0.009722551568586037,0,0,4.01769575009506,23.94793466628324,CXCL10;CCL11;KIT;SPP1;NR3C1;FKBP4;TLR4
"Carcinoma, Lobular",4/58,0.0026047593316359794,0.009722551568586037,0,0,7.5402825505918285,44.86781035657885,STAT5A;MUC1;KRT5;ESR1
Silicosis,4/58,0.0026047593316359794,0.009722551568586037,0,0,7.5402825505918285,44.86781035657885,EGR1;MUC1;CCL2;CD36
Carcinoma of Male Breast,4/58,0.0026047593316359794,0.009722551568586037,0,0,7.5402825505918285,44.86781035657885,CA12;CCND1;ESR1;EGFR
Congenital defects,4/58,0.0026047593316359794,0.009722551568586037,0,0,7.5402825505918285,44.86781035657885,MMP14;ZEB2;ALDH2;VWF
Cutis Laxa,4/58,0.0026047593316359794,0.009722551568586037,0,0,7.5402825505918285,44.86781035657885,RPS6KA3;MMP14;GSN;FOS
Nausea,4/58,0.0026047593316359794,0.009722551568586037,0,0,7.5402825505918285,44.86781035657885,ALDH2;SAA1;SERPING1;LPL
Nerve Sheath Tumors,4/58,0.0026047593316359794,0.009722551568586037,0,0,7.5402825505918285,44.86781035657885,MDK;HGF;KIT;EGFR
"CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT",3/28,0.0026087957970173737,0.009722551568586037,0,0,12.170461538461538,72.40045147812198,GHR;BGN;PPARG
Sarcopenia,3/28,0.0026087957970173737,0.009722551568586037,0,0,12.170461538461538,72.40045147812198,LEP;NR3C1;FOXO1
Short ulnae,3/28,0.0026087957970173737,0.009722551568586037,0,0,12.170461538461538,72.40045147812198,ZBTB16;BMPR1B;FGFR3
ULNAR HYPOPLASIA,3/28,0.0026087957970173737,0.009722551568586037,0,0,12.170461538461538,72.40045147812198,ZBTB16;BMPR1B;FGFR3
Absence of secondary sex characteristics,3/28,0.0026087957970173737,0.009722551568586037,0,0,12.170461538461538,72.40045147812198,LEP;LEPR;ESR1
Cerebral Astrocytoma,3/28,0.0026087957970173737,0.009722551568586037,0,0,12.170461538461538,72.40045147812198,HGF;ESR1;MET
Hepatitis C Virus Infection,3/28,0.0026087957970173737,0.009722551568586037,0,0,12.170461538461538,72.40045147812198,PLAU;GOLM1;LPL
Ovarian epithelial cancer recurrent,3/28,0.0026087957970173737,0.009722551568586037,0,0,12.170461538461538,72.40045147812198,STAT5A;STAT5B;SPP1
Psoriasiform eczema,3/28,0.0026087957970173737,0.009722551568586037,0,0,12.170461538461538,72.40045147812198,CAV1;CXCR4;S100A8
Retinal Neovascularization,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,FZD4;HGF
Spinal Cord Ischemia,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,HGF;TIMP1
"Polycystic Kidney, Type 1 Autosomal Dominant Disease",2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,PPARG;PKD2
"Thanatophoric dysplasia, type 2",2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,STAT1;FGFR3
"Vasospasm, Intracranial",2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,CCL2;S100A4
Abnormality of the elbow,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,GHR;FGFR3
Uterine carcinoma,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,CAV1;LAMC1
Uterine Diseases,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,ESR1;TLR4
Vasogenic Brain Edema,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,PLAU;MYLK
Vasogenic Cerebral Edema,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,PLAU;MYLK
White eyebrow,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,KIT;SOX10
Adenomyoma,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,CCND1;MME
Apocrine Carcinoma,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,KRT5;ESR1
Avascular retina,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,NRP1;KDR
Blonde eyebrow,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,KIT;SOX10
Chondromyxoid fibroma,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,VCAN;CCND1
Cytomegalovirus encephalitis,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,CXCL10;CCL2
Cytotoxic Brain Edema,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,PLAU;MYLK
Cytotoxic Cerebral Edema,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,PLAU;MYLK
Endometrial Stromal Tumors,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,CCND1;MME
Epidermolysis Bullosa Simplex Kobner,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,DST;KRT5
Exudative vitreoretinopathy 1,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,FZD4;PRSS23
Glomerulocystic kidney disease,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,MUC1;PKD2
Grey eyebrow,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,KIT;SOX10
Hypocomplementaemia,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,C3;CFH
Osteoglophonic dwarfism,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,CCL2;FGFR3
Pfeiffer Syndrome,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,FGFR3;RUNX2
Plantar hyperkeratosis,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,COL17A1;LAMA3
Pleural Mesothelioma,2/8,0.002625399081853126,0.009722551568586037,0,0,33.666666666666664,200.0649195648365,PLAU;EGFR
Telecanthus,5/96,0.002668258420294942,0.00986755664243702,0,0,5.611512839492114,33.25567293802176,RPS6KA3;CCND2;PIK3R1;SOX10;FGFR3
MAJOR AFFECTIVE DISORDER 2,5/96,0.002668258420294942,0.00986755664243702,0,0,5.611512839492114,33.25567293802176,FZD4;ADAM12;DMD;NR3C1;TNS1
Attention deficit hyperactivity disorder,11/412,0.002771909466975671,0.010226009424465577,0,0,2.84597330203902,16.757713666456333,NRP1;SNAP25;MEF2C;THRB;ALDH2;MAP1B;ADAM12;DMD;FLI1;TGFBR2;SYNE1
Sleep Apnea Syndromes,4/59,0.0027728623791241805,0.010226009424465577,0,0,7.402811621368323,43.58683052974644,GSN;LEP;LEPR;FGFR3
Anaplastic Oligodendroglioma,4/59,0.0027728623791241805,0.010226009424465577,0,0,7.402811621368323,43.58683052974644,CCND1;KIT;DTX1;EGFR
Leukocyte adhesion deficiency type 1,4/59,0.0027728623791241805,0.010226009424465577,0,0,7.402811621368323,43.58683052974644,COL17A1;HGF;VIM;EGFR
Scrub Typhus,3/29,0.0028887769218868316,0.010580269564766272,0,0,11.701775147928995,68.4193674508354,JUN;CCL2;FOS
Staphylococcus aureus infection,3/29,0.0028887769218868316,0.010580269564766272,0,0,11.701775147928995,68.4193674508354,MDK;CD36;FOXO1
"Sterility, Postpartum",3/29,0.0028887769218868316,0.010580269564766272,0,0,11.701775147928995,68.4193674508354,LEP;LEPR;ESR1
"Subfertility, Female",3/29,0.0028887769218868316,0.010580269564766272,0,0,11.701775147928995,68.4193674508354,LEP;LEPR;ESR1
"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C",3/29,0.0028887769218868316,0.010580269564766272,0,0,11.701775147928995,68.4193674508354,CCND1;CIB1;ESR1
Angiofibroma,3/29,0.0028887769218868316,0.010580269564766272,0,0,11.701775147928995,68.4193674508354,CCL2;TIMP1;ESR1
Exostoses,3/29,0.0028887769218868316,0.010580269564766272,0,0,11.701775147928995,68.4193674508354,TCF7L2;S100A4;DCN
Female sterility,3/29,0.0028887769218868316,0.010580269564766272,0,0,11.701775147928995,68.4193674508354,LEP;LEPR;ESR1
Gall Bladder Diseases,3/29,0.0028887769218868316,0.010580269564766272,0,0,11.701775147928995,68.4193674508354,LEP;S100A8;TGFBR2
Other cataract,3/29,0.0028887769218868316,0.010580269564766272,0,0,11.701775147928995,68.4193674508354,CCL11;ANXA1;NR3C1
Central Serous Chorioretinopathy,5/98,0.002917930107031638,0.010679704354650823,0,0,5.490278009916987,32.04609820129839,CDH5;CFH;VIM;KLF4;EGFR
"AURAL ATRESIA, CONGENITAL",4/60,0.00294824796048429,0.010739038538223363,0,0,7.2702503681885124,42.36043509180512,GSN;MME;LRP1;A2M
"Fatty Liver, Alcoholic",4/60,0.00294824796048429,0.010739038538223363,0,0,7.2702503681885124,42.36043509180512,ABCA1;PLAU;LEP;PPARG
Ventricular arrhythmia,4/60,0.00294824796048429,0.010739038538223363,0,0,7.2702503681885124,42.36043509180512,ANK2;SGK1;MET;TGFBR2
Androgenetic Alopecia,4/60,0.00294824796048429,0.010739038538223363,0,0,7.2702503681885124,42.36043509180512,GHR;ZFP36;LEP;KRT5
Bullous pemphigoid,4/60,0.00294824796048429,0.010739038538223363,0,0,7.2702503681885124,42.36043509180512,COL17A1;DST;PLAU;S100A8
Cavernous Hemangioma of Brain,4/60,0.00294824796048429,0.010739038538223363,0,0,7.2702503681885124,42.36043509180512,PECAM1;VIM;KLF4;TLR4
Factor V Leiden mutation,4/60,0.00294824796048429,0.010739038538223363,0,0,7.2702503681885124,42.36043509180512,ZFP36;F8;VWF;LPL
Seizures,22/1174,0.003038434343730936,0.011059984028512403,0,0,2.023654513888889,11.729937159279784,MEF2C;HGF;FOS;SOX10;ESR1;TGFBR2;ACTA2;CXCL10;RPS6KA3;CCND2;MAF;CCND1;LEP;MAP1B;FADD;TIMP1;UTRN;TLR4;CTSD;FGFR3;MPDZ;TNS1
Acquired scoliosis,11/418,0.0030943276648206647,0.011255748891351072,0,0,2.803150744327215,16.19712254402052,RPS6KA3;COL1A2;KLC2;TPM3;FHL1;MAP3K20;DMD;LIFR;FGFR3;RUNX2;TGFBR2
Sinusitis,4/61,0.0031310682433358813,0.011358381666941397,0,0,7.142340387050099,41.18545619522775,PRTN3;PIK3R1;MET;RUNX2
"Leukemia, Large Granular Lymphocytic",4/61,0.0031310682433358813,0.011358381666941397,0,0,7.142340387050099,41.18545619522775,STAT5A;STAT5B;CXCR4;FOS
Ganglioglioma,4/61,0.0031310682433358813,0.011358381666941397,0,0,7.142340387050099,41.18545619522775,ANXA1;HGF;FGFR3;EGFR
Gastrointestinal Hemorrhage,4/61,0.0031310682433358813,0.011358381666941397,0,0,7.142340387050099,41.18545619522775,VWF;KIT;TLR4;TGFBR2
"Delirium, Dementia, Amnestic, Cognitive Disorders",3/30,0.0031865612382751957,0.011481531331148423,0,0,11.267806267806268,64.77651031278889,ZFP36;STAT1;CCL2
ST segment elevation myocardial infarction,3/30,0.0031865612382751957,0.011481531331148423,0,0,11.267806267806268,64.77651031278889,FABP4;ALDH2;TIMP1
Tendinopathy,3/30,0.0031865612382751957,0.011481531331148423,0,0,11.267806267806268,64.77651031278889,VCAN;LMO2;BGN
Arteriovenous fistula,3/30,0.0031865612382751957,0.011481531331148423,0,0,11.267806267806268,64.77651031278889,LRP1;CCL2;S100A4
Dysequilibrium syndrome,3/30,0.0031865612382751957,0.011481531331148423,0,0,11.267806267806268,64.77651031278889,MUC1;PKD2;ESR1
familial atrial fibrillation,3/30,0.0031865612382751957,0.011481531331148423,0,0,11.267806267806268,64.77651031278889,VWF;CAV2;CAV1
Lymphoid neoplasm,3/30,0.0031865612382751957,0.011481531331148423,0,0,11.267806267806268,64.77651031278889,STAT5A;STAT5B;CCND1
Narrow palate,3/30,0.0031865612382751957,0.011481531331148423,0,0,11.267806267806268,64.77651031278889,RPS6KA3;FGFR3;RUNX2
Persistent atrial fibrillation,3/30,0.0031865612382751957,0.011481531331148423,0,0,11.267806267806268,64.77651031278889,VWF;CAV2;CAV1
Protoplasmic astrocytoma,3/30,0.0031865612382751957,0.011481531331148423,0,0,11.267806267806268,64.77651031278889,HGF;ESR1;MET
Generalized osteopenia,6/145,0.003253269688164317,0.011713969032586246,0,0,4.420638489208633,25.321836035396803,COL1A2;CCND1;STAT1;LIFR;ANTXR2;ESR1
Cancer of Nasopharynx,4/62,0.0033214740107571383,0.011757338162666105,0,0,7.01884109491646,40.05895896737984,HGF;PLK1;SAA1;EGFR
"Hypertension, Portal",5/101,0.003323493123488363,0.011757338162666105,0,0,5.317897236614853,30.347851045228413,COL1A2;DUSP1;SPP1;PIK3R1;TIMP1
Hemangioma,5/101,0.003323493123488363,0.011757338162666105,0,0,5.317897236614853,30.347851045228413,CCND1;LEP;KDR;PECAM1;FOS
Neuromuscular Diseases,5/101,0.003323493123488363,0.011757338162666105,0,0,5.317897236614853,30.347851045228413,MEF2C;KLC2;BGN;DMD;TIMP1
Otitis Media,5/101,0.003323493123488363,0.011757338162666105,0,0,5.317897236614853,30.347851045228413,MUC1;DUSP1;CCL2;FGFR3;TLR4
"Cardiomyopathy, Alcoholic",2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,ALDH2;PPARG
"von Willebrand Disease, Type 2B",2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,F8;VWF
"von Willebrand Disease, Type 3",2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,F8;VWF
"WAARDENBURG SYNDROME, TYPE 4A",2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,ZEB2;SOX10
West Nile Fever,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,STAT1;CXCR4
White eyelashes,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,KIT;SOX10
Atresia,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,STAT1;FGFR3
Atypical polypoid adenomyoma,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,CCND1;MME
Burkitt-like lymphoma,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,CCND1;BCL6
Camptodactyly of toe,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,FHL1;FGFR3
Capillary Leak Syndrome,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,CXCL10;RPS6KA3
Carcinoma in situ of prostate,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,LRP1;ESR1
Craniofacial dysostosis type 1,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,BGN;FGFR3
Cystadenofibroma,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,CIB1;MET
Decreased serum leptin,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,LEP;LEPR
Dilatation of the cerebral artery,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,ACTA2;STAT1
Dyggve-Melchior-Clausen syndrome,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,LRP1;CXCR4
Dysglycemia,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,ALDH2;CD36
Factor VIII Deficiency,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,F8;VWF
Grey eyelashes,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,KIT;SOX10
Hypomenorrhea,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,SOCS3;LIFR
Hypopharyngeal Cancer,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,HGF;ETS2
Late-onset muscular dystrophy,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,COL17A1;LAMA3
LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 2,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,ABCA1;GHR
Low Grade Prostatic Intraepithelial Neoplasia,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,SPP1;EGFR
Medullary carcinoma of breast,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,KRT5;ESR1
Mild hereditary factor VIII deficiency disease,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,F8;VWF
Monogenic Obesity,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,LEP;LEPR
Myelofibrosis due to another disorder,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,STAT5A;STAT5B
Nephrogenic Fibrosing Dermopathy,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,ACTA2;TLR4
Other emphysema,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,JUN;TLR4
Other specified peritonitis,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,A2M;ESR1
Ovarian cancer stage III,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,HGF;CTSD
Peripheral Nervous System Neoplasms,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,HGF;EGFR
Persistent bleeding after trauma,2/9,0.0033535661488557854,0.011757338162666105,0,0,28.855685131195337,164.41193104324012,F8;VWF
Hypertrophy of lower jaw,5/102,0.003467263580455342,0.012116096800161652,0,0,5.26280647401314,29.81058620377177,RPS6KA3;CAV1;PPARG;FOS;RUNX2
Inflammatory Breast Carcinoma,5/102,0.003467263580455342,0.012116096800161652,0,0,5.26280647401314,29.81058620377177,MUC1;CAV1;CXCR4;ESR1;EGFR
Intervertebral Disc Degeneration,5/102,0.003467263580455342,0.012116096800161652,0,0,5.26280647401314,29.81058620377177,MMP14;BGN;SPP1;KRT5;TIMP1
mandibular excess (physical finding),5/102,0.003467263580455342,0.012116096800161652,0,0,5.26280647401314,29.81058620377177,RPS6KA3;CAV1;PPARG;FOS;RUNX2
Mandibular hyperplasia,5/102,0.003467263580455342,0.012116096800161652,0,0,5.26280647401314,29.81058620377177,RPS6KA3;CAV1;PPARG;FOS;RUNX2
"Alopecia, Male Pattern",3/31,0.0035025005386860528,0.012147685345438438,0,0,10.864835164835165,61.43279981460896,ZFP36;VCAN;LEP
Activated Protein C Resistance,3/31,0.0035025005386860528,0.012147685345438438,0,0,10.864835164835165,61.43279981460896,F8;VWF;PROS1
AIDS-Associated Nephropathy,3/31,0.0035025005386860528,0.012147685345438438,0,0,10.864835164835165,61.43279981460896,KLF6;CFH;KDR
Autoimmune Lymphoproliferative Syndrome,3/31,0.0035025005386860528,0.012147685345438438,0,0,10.864835164835165,61.43279981460896,SPP1;TIMP1;FADD
Bright Disease,3/31,0.0035025005386860528,0.012147685345438438,0,0,10.864835164835165,61.43279981460896,CCL2;PPARG;ESR1
Bulimia,3/31,0.0035025005386860528,0.012147685345438438,0,0,10.864835164835165,61.43279981460896,DST;LEP;LEPR
Endocrine Gland Neoplasms,3/31,0.0035025005386860528,0.012147685345438438,0,0,10.864835164835165,61.43279981460896,CIB1;ESR1;EGFR
Invasive Skin Melanoma,3/31,0.0035025005386860528,0.012147685345438438,0,0,10.864835164835165,61.43279981460896,ANXA1;SPP1;CCL2
Myxoma,3/31,0.0035025005386860528,0.012147685345438438,0,0,10.864835164835165,61.43279981460896,STAT1;KIT;CCL2
Plasma Cell Neoplasm,3/31,0.0035025005386860528,0.012147685345438438,0,0,10.864835164835165,61.43279981460896,CCND1;KIT;MET
"Inclusion Body Myopathy, Sporadic",4/63,0.0035196145943623474,0.012147685345438438,0,0,6.899528219465315,38.97822084193308,CXCL10;CXCR4;TIMP1;TLR4
"Lichen Planus, Oral",4/63,0.0035196145943623474,0.012147685345438438,0,0,6.899528219465315,38.97822084193308,CXCL10;SPP1;TLR4;EGFR
Brain Edema,4/63,0.0035196145943623474,0.012147685345438438,0,0,6.899528219465315,38.97822084193308,PLAU;DMD;AQP1;MYLK
Chronic ear infection,4/63,0.0035196145943623474,0.012147685345438438,0,0,6.899528219465315,38.97822084193308,TAP1;PIK3R1;FGFR3;RUNX2
Dystrophia myotonica 2,4/63,0.0035196145943623474,0.012147685345438438,0,0,6.899528219465315,38.97822084193308,CCT3;LEP;LPL;TLR4
Iron deficiency,4/63,0.0035196145943623474,0.012147685345438438,0,0,6.899528219465315,38.97822084193308,STAT5A;STAT5B;EPAS1;PPARG
Monocytic leukemia,4/63,0.0035196145943623474,0.012147685345438438,0,0,6.899528219465315,38.97822084193308,EGR1;LPL;NEDD9;PPARG
Necrotizing Enterocolitis,4/63,0.0035196145943623474,0.012147685345438438,0,0,6.899528219465315,38.97822084193308,ALDH2;HGF;TLR4;EGFR
Papule,4/63,0.0035196145943623474,0.012147685345438438,0,0,6.899528219465315,38.97822084193308,PRTN3;ANTXR2;TLR4;EGFR
Arthrogryposis,9/307,0.003611588331390211,0.01245705774626436,0,0,3.1166506871204858,17.52682056046793,TPM3;FHL1;DMD;ANTXR2;UTRN;CRYAB;FGFR3;TGFBR2;SYNE1
Severe Sepsis,5/103,0.0036154508321679336,0.012462314026276145,0,0,5.208840012689014,29.286904655654318,PER1;VWF;TIMP1;TLR4;MYLK
"Adenocarcinoma, Endometrioid",4/64,0.0037256378190833,0.012808983185738648,0,0,6.784192439862543,37.94071301121979,CXCR4;S100A4;ESR1;EGFR
Allergic Reaction,4/64,0.0037256378190833,0.012808983185738648,0,0,6.784192439862543,37.94071301121979,CCL11;SPP1;CCL2;MYLK
Mitral Valve Prolapse Syndrome,4/64,0.0037256378190833,0.012808983185738648,0,0,6.784192439862543,37.94071301121979,RPS6KA3;COL1A2;VWF;PLAU
Osteopetrosis,4/64,0.0037256378190833,0.012808983185738648,0,0,6.784192439862543,37.94071301121979,GHR;ARF1;DMD;FKBP4
Increased size of the mandible,5/104,0.0037681299884365417,0.012946721281997635,0,0,5.155963782906788,28.77634351264471,RPS6KA3;CAV1;PPARG;FOS;RUNX2
Squamous cell carcinoma of the hypopharynx,3/32,0.003836930926271927,0.013149199296529324,0,0,10.489655172413793,58.354816804882354,CXCL12;HGF;CXCR4
Verrucous carcinoma,3/32,0.003836930926271927,0.013149199296529324,0,0,10.489655172413793,58.354816804882354,CCND1;KRT5;EGFR
Gastrinoma,3/32,0.003836930926271927,0.013149199296529324,0,0,10.489655172413793,58.354816804882354,HGF;MET;EGFR
Oropharyngeal disorders,3/32,0.003836930926271927,0.013149199296529324,0,0,10.489655172413793,58.354816804882354,JUN;FOS;EGFR
Premature Obstetric Labor,5/105,0.003925376041558885,0.013443656121765617,0,0,5.104145077720207,28.278459886006978,PECAM1;CCL2;TLR4;FOXO1;EGFR
Systemic Inflammatory Response Syndrome,4/65,0.003939689946421906,0.013475357974635645,0,0,6.672638161230354,36.944083778601154,CFH;HGF;SPP1;TLR4
FRIEDREICH ATAXIA 1,4/65,0.003939689946421906,0.013475357974635645,0,0,6.672638161230354,36.944083778601154,CCT3;PPARG;ESR1;SYNE1
Cardiac Arrest,7/201,0.0039566365035740274,0.013524641390343805,0,0,3.7042154693150535,20.49305713290513,PPP1R15A;CCND1;STAT1;CCL2;CTSD;EGFR;TGFBR2
Primary Sj??gren's syndrome,6/151,0.00396947866323453,0.01355984089511334,0,0,4.236422413793103,23.42369006556037,STAT5A;STAT5B;KRT19;CXCL12;STAT1;EGFR
Chronic graft-versus-host disease,5/106,0.004087263843420228,0.013903756375749345,0,0,5.053352485507618,27.792829841059756,TF;HGF;CAV1;PECAM1;A2M
Cleft palate with cleft lip,4/66,0.004161915616409177,0.013903756375749345,0,0,6.564682407715331,35.986143586617594,SPP1;KLF4;DCN;TGFBR2
Paroxysmal atrial fibrillation,4/66,0.004161915616409177,0.013903756375749345,0,0,6.564682407715331,35.986143586617594,CXCL12;VWF;CAV2;CAV1
Proliferative vitreoretinopathy,4/66,0.004161915616409177,0.013903756375749345,0,0,6.564682407715331,35.986143586617594,CCND1;HGF;MAP1B;CCL2
"Congenital secretory diarrhea, sodium type (disorder)",2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,CAV1;HGF
"Hyalinosis, Systemic",2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,VWF;ANTXR2
"Membranoproliferative Glomerulonephritis, Type II",2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,C3;CFH
"Meningitis, Cryptococcal",2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,ACTA2;CAV1
"stage, endometrial cancer",2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,CCND1;S100A4
Ventricular Dysfunction,2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,ALDH2;DMD
Asymptomatic bacteriuria,2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,CCL2;TLR4
Childhood Soft Tissue Sarcoma,2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,EGFR;FOXO1
Constitutional delay of growth and puberty,2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,LEP;LEPR
Corneal fibrosis,2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,MMP14;CIB1
Denys-Drash Syndrome,2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,PKD2;EGFR
Generalized osteoporosis with pathologic fractures,2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,MMP14;STAT1
Histiocytoid hemangioma,2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,ZFP36;FOS
Infection by Leishmania braziliensis,2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,CCL2;FLI1
Insulin resistance in diabetes,2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,TXNIP;PIK3R1
Invasive meningococcal disease,2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,CFH;TLR4
Liver Dysplastic Nodule,2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,STAT5A;STAT5B
Liver mass,2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,KLF6;LEP
Loss of subcutaneous adipose tissue in limbs,2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,CAV1;PPARG
Medullary cystic kidney disease 1,2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,CCT3;MUC1
Merkel Cell Polyomavirus Infection,2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,KIT;EGFR
Metastatic Malignant Neoplasm to the Leptomeninges,2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,C3;EGFR
Night sweats,2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,BCL6;ESR1
Perihilar Cholangiocarcinoma,2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,JUN;FOS
Pilomatrixoma,2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,CCND1;SPP1
Precursor T cell lymphoblastic leukemia/lymphoblastic lymphoma,2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,MME;CXCR4
Proliferative glomerulonephritis,2/10,0.004164723228388281,0.013903756375749345,0,0,25.247448979591837,138.38393038592545,CXCL10;CFH
"Muscular Dystrophy, Emery-Dreifuss",3/33,0.004190173154335419,0.013903756375749345,0,0,10.13948717948718,55.51382635460182,SREBF1;FHL1;SYNE1
"Nephritis, Interstitial",3/33,0.004190173154335419,0.013903756375749345,0,0,10.13948717948718,55.51382635460182,MUC1;CCL2;DCN
"Stickler syndrome, type 1",3/33,0.004190173154335419,0.013903756375749345,0,0,10.13948717948718,55.51382635460182,RPS6KA3;CXCR4;KLF4
Thrombotic Microangiopathies,3/33,0.004190173154335419,0.013903756375749345,0,0,10.13948717948718,55.51382635460182,CFH;VWF;KLF4
Trigeminal Neuralgia,3/33,0.004190173154335419,0.013903756375749345,0,0,10.13948717948718,55.51382635460182,FOS;ESR1;EGFR
Albuminuria,3/33,0.004190173154335419,0.013903756375749345,0,0,10.13948717948718,55.51382635460182,LEPR;CCL2;DCN
Angiomyolipoma,3/33,0.004190173154335419,0.013903756375749345,0,0,10.13948717948718,55.51382635460182,KIT;VIM;EGFR
Childhood T Acute Lymphoblastic Leukemia,3/33,0.004190173154335419,0.013903756375749345,0,0,10.13948717948718,55.51382635460182,CCND2;PLK1;S100A4
CREST Syndrome,3/33,0.004190173154335419,0.013903756375749345,0,0,10.13948717948718,55.51382635460182,CAV1;TIMP1;SOX10
Disproportionate short-limb short stature,3/33,0.004190173154335419,0.013903756375749345,0,0,10.13948717948718,55.51382635460182,COL1A2;BMPR1B;FGFR3
Epithelial hyperplasia,3/33,0.004190173154335419,0.013903756375749345,0,0,10.13948717948718,55.51382635460182,NRP1;CCND1;ESR1
Fibrillary Astrocytoma,3/33,0.004190173154335419,0.013903756375749345,0,0,10.13948717948718,55.51382635460182,HGF;ESR1;MET
Gastric Mucosa-Associated Lymphoid Tissue Lymphoma,3/33,0.004190173154335419,0.013903756375749345,0,0,10.13948717948718,55.51382635460182,CXCR4;TLR4;S100A8
Harlequin Fetus,3/33,0.004190173154335419,0.013903756375749345,0,0,10.13948717948718,55.51382635460182,EPAS1;CTSD;SOX10
Periapical Periodontitis,3/33,0.004190173154335419,0.013903756375749345,0,0,10.13948717948718,55.51382635460182,MDK;CCL2;TLR4
Sezary Syndrome,6/153,0.004232332336610555,0.014034909161043961,0,0,4.178358843537415,22.8347396792643,STAT5A;SOCS3;STAT5B;CXCL10;CCND1;VIM
Cushing Syndrome,4/67,0.0043924578010948335,0.014538762498157993,0,0,6.460153820978563,35.06485150831621,VWF;LEP;TXNIP;NR3C1
Nail dysplasia,4/67,0.0043924578010948335,0.014538762498157993,0,0,6.460153820978563,35.06485150831621,COL17A1;ABCA1;LAMA3;KRT5
Oxyphilic Adenoma,4/67,0.0043924578010948335,0.014538762498157993,0,0,6.460153820978563,35.06485150831621,CAV1;KIT;NR3C1;ESR1
Red cell distribution width determination,5/108,0.004425263270550571,0.014601998742268727,0,0,4.954726092861814,26.85672368959861,PPP1R15A;TF;THRB;ITSN1;E2F2
Secondary Neoplasm,5/108,0.004425263270550571,0.014601998742268727,0,0,4.954726092861814,26.85672368959861,CXCL12;MDK;PROS1;ESR1;EGFR
Class III malocclusion,5/108,0.004425263270550571,0.014601998742268727,0,0,4.954726092861814,26.85672368959861,RPS6KA3;CAV1;PPARG;FOS;RUNX2
Congenital ocular coloboma (disorder),5/108,0.004425263270550571,0.014601998742268727,0,0,4.954726092861814,26.85672368959861,YAP1;SNAP25;MAF;BCL6;FADD
RDW - Red blood cell distribution width result,5/108,0.004425263270550571,0.014601998742268727,0,0,4.954726092861814,26.85672368959861,PPP1R15A;TF;THRB;ITSN1;E2F2
Secondary malignant neoplasm of pancreas,3/34,0.00456253296297078,0.014971513645117786,0,0,9.811910669975186,52.88499493646925,EPS8;GSN;PLAU
Short long bone,3/34,0.00456253296297078,0.014971513645117786,0,0,9.811910669975186,52.88499493646925,GHR;BGN;FGFR3
Anastomosis,3/34,0.00456253296297078,0.014971513645117786,0,0,9.811910669975186,52.88499493646925,CXCL10;PROS1;TLR4
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,3/34,0.00456253296297078,0.014971513645117786,0,0,9.811910669975186,52.88499493646925,LEP;LEPR;PRTN3
Female infertility,3/34,0.00456253296297078,0.014971513645117786,0,0,9.811910669975186,52.88499493646925,LEP;LEPR;ESR1
Infant Acute Lymphoblastic Leukemia,3/34,0.00456253296297078,0.014971513645117786,0,0,9.811910669975186,52.88499493646925,MME;TIMP1;S100A8
Metastatic Carcinoma,3/34,0.00456253296297078,0.014971513645117786,0,0,9.811910669975186,52.88499493646925,GSN;CRYAB;EGFR
Neuroectodermal Tumors,3/34,0.00456253296297078,0.014971513645117786,0,0,9.811910669975186,52.88499493646925,HGF;MET;EGFR
Prolonged bleeding time,3/34,0.00456253296297078,0.014971513645117786,0,0,9.811910669975186,52.88499493646925,VWF;CD36;CALR
Schizoaffective Disorder,5/109,0.00460152370625435,0.015090166049618112,0,0,4.906835392586688,26.405485931737598,SNAP25;TCF7L2;TF;CALR;NR3C1
Undifferentiated leukemia,4/68,0.00463145775055902,0.015151036435069992,0,0,6.358891752577319,34.178303068266494,STAT5A;STAT5B;BCL6;KDR
Dystrophia unguium,4/68,0.00463145775055902,0.015151036435069992,0,0,6.358891752577319,34.178303068266494,COL17A1;ABCA1;LAMA3;KRT5
Human papilloma virus infection,4/68,0.00463145775055902,0.015151036435069992,0,0,6.358891752577319,34.178303068266494,CCND1;CAV1;ESR1;EGFR
Leishmaniasis,4/68,0.00463145775055902,0.015151036435069992,0,0,6.358891752577319,34.178303068266494,CXCL10;TLR4;FLI1;AQP1
Bone Density,5/110,0.004782723468932765,0.01562669121149154,0,0,4.859856896126326,25.964976770871843,MEF2C;ESR1;RUNX2;SPTBN1;AQP1
Congenital myopathy (disorder),5/110,0.004782723468932765,0.01562669121149154,0,0,4.859856896126326,25.964976770871843,TPM3;FHL1;MAP3K20;DMD;CRYAB
Diphtheria,4/69,0.0048790549470431824,0.015921912928838405,0,0,6.260745440126883,33.32471922050567,MUC1;FADD;EGFR;FOXO1
Kallmann Syndrome,4/69,0.0048790549470431824,0.015921912928838405,0,0,6.260745440126883,33.32471922050567,NRP1;LEP;LEPR;SOX10
Small midface,6/158,0.004945596571397417,0.01609962378068225,0,0,4.039884868421052,21.448789763373803,MAF;COL1A2;LIFR;PIK3R1;FGFR3;RUNX2
Decreased projection of midface,6/158,0.004945596571397417,0.01609962378068225,0,0,4.039884868421052,21.448789763373803,MAF;COL1A2;LIFR;PIK3R1;FGFR3;RUNX2
Hypotrophic midface,6/158,0.004945596571397417,0.01609962378068225,0,0,4.039884868421052,21.448789763373803,MAF;COL1A2;LIFR;PIK3R1;FGFR3;RUNX2
Midface retrusion,6/158,0.004945596571397417,0.01609962378068225,0,0,4.039884868421052,21.448789763373803,MAF;COL1A2;LIFR;PIK3R1;FGFR3;RUNX2
Coagulation factor measurement,3/35,0.004954301407202251,0.016108280780342155,0,0,9.504807692307692,50.44675835420841,CFH;VWF;F13A1
Pre-renal acute kidney injury,3/35,0.004954301407202251,0.016108280780342155,0,0,9.504807692307692,50.44675835420841,CFH;HGF;PPARG
Congenital cataract,5/111,0.004968936390877433,0.016118225308683502,0,0,4.813764786391632,25.534853434977656,MAF;CAV1;DMD;VIM;CRYAB
"Arteriosclerotic cardiovascular disease, NOS",2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,CCL2;CD36
"Depressive episode, unspecified",2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,ESR1;TLR4
"Familial Partial Lipodystrophy, Type 3",2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,CAV1;PPARG
"FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, OF SORSBY",2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,KDR;TIMP1
Short Bowel Syndrome,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,LEP;LEPR
Sinonasal undifferentiated carcinoma,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,KIT;EGFR
Small face,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,GHR;FGFR3
"Nevus, Blue",2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,CCND1;KIT
Subcutaneous hemorrhage,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,COL1A2;KRT5
Abnormal diaphysis morphology,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,RPS6KA3;ANTXR2
Acute recurrent pancreatitis,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,LPL;CCL2
Adenolymphoma,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,MAML2;LEP
Angioendotheliomatosis,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,BCL6;MME
Arterial thrombosis,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,PROS1;CALR
Carney Triad,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,EPAS1;KIT
Cerebral abscess,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,CCL2;TLR4
Diabetic macular edema,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,CCL2;CTSD
Dimple chin,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,PIK3R1;RUNX2
Ear Inflammation,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,CCL2;TLR4
extranodal lymphoma,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,MUC1;CCND1
Gastrooesophageal cancer,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,HGF;MET
Malignant neoplasm of body of stomach,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,ANXA1;TXNIP
Malignant tumor of greater curve of stomach,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,ANXA1;TXNIP
Malignant tumor of lesser curve of stomach,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,ANXA1;TXNIP
Malignant tumor of parathyroid gland,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,CCND1;EGFR
Multi-centric Castleman's Disease,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,TLR4;TGFBR2
Multiple Endocrine Neoplasia Type 2b,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,CXCR4;EGFR
Non-Hereditary Clear Cell Renal Cell Carcinoma,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,VCAN;EPAS1
Oral mucosal blisters,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,COL17A1;LAMA3
Polyomavirus Infections,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,CCL11;HGF
Pseudomonas Infections,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,PRTN3;VIM
Pulmonary Blastoma,2/11,0.005057172586999214,0.016118225308683502,0,0,22.441043083900226,118.64462177173134,KIT;EGFR
"Glaucoma, Open-Angle",4/70,0.005135387062025915,0.016328447287312708,0,0,6.165573258356764,32.50243636622285,CAV2;CAV1;TAP1;ESR1
Squamous cell carcinoma of oropharynx,4/70,0.005135387062025915,0.016328447287312708,0,0,6.165573258356764,32.50243636622285,E2F2;MET;FGFR3;EGFR
Hereditary pancreatitis,4/70,0.005135387062025915,0.016328447287312708,0,0,6.165573258356764,32.50243636622285,MUC1;BGN;F13A1;S100A8
Neck Neoplasms,4/70,0.005135387062025915,0.016328447287312708,0,0,6.165573258356764,32.50243636622285,CCND1;DST;PLK1;EGFR
"EAR, PATELLA, SHORT STATURE SYNDROME",3/36,0.005365755179904156,0.016969797836029227,0,0,9.216317016317017,48.18030776390706,RGS2;LEP;TLR4
Autoimmune state,3/36,0.005365755179904156,0.016969797836029227,0,0,9.216317016317017,48.18030776390706,CAV1;SERPING1;PRTN3
Barrett's Adenocarcinoma,3/36,0.005365755179904156,0.016969797836029227,0,0,9.216317016317017,48.18030776390706,SOCS3;PECAM1;EGFR
Familial medullary thyroid carcinoma,3/36,0.005365755179904156,0.016969797836029227,0,0,9.216317016317017,48.18030776390706,KIT;FOS;EGFR
Germ Cell Cancer,3/36,0.005365755179904156,0.016969797836029227,0,0,9.216317016317017,48.18030776390706,KIT;ESR1;EGFR
Mesenchymal Cell Neoplasm,3/36,0.005365755179904156,0.016969797836029227,0,0,9.216317016317017,48.18030776390706,MMP14;BCL6;KIT
Ocular Hypertension,3/36,0.005365755179904156,0.016969797836029227,0,0,9.216317016317017,48.18030776390706,C3;JUN;NR3C1
Paranoid Schizophrenia,3/36,0.005365755179904156,0.016969797836029227,0,0,9.216317016317017,48.18030776390706,DPYSL2;CCL2;CALR
Plexiform Neurofibroma,3/36,0.005365755179904156,0.016969797836029227,0,0,9.216317016317017,48.18030776390706,KIT;SPP1;CD36
Cakut,4/71,0.005400589910765379,0.01702943410323592,0,0,6.073242037236498,31.70989730555222,ACTA2;MUC1;KIT;LIFR
Gout,4/71,0.005400589910765379,0.01702943410323592,0,0,6.073242037236498,31.70989730555222,ABCA1;MUC1;HGF;PKD2
Neurofibromatoses,4/71,0.005400589910765379,0.01702943410323592,0,0,6.073242037236498,31.70989730555222,MDK;HGF;KIT;EGFR
Proximal muscle weakness,4/71,0.005400589910765379,0.01702943410323592,0,0,6.073242037236498,31.70989730555222,TPM3;FHL1;DMD;SYNE1
Proximal neurogenic muscle weakness,4/71,0.005400589910765379,0.01702943410323592,0,0,6.073242037236498,31.70989730555222,TPM3;FHL1;DMD;SYNE1
Recurrent respiratory infections,7/213,0.005413460843905662,0.01705992480022074,0,0,3.486301021704875,18.194540232648077,STAT1;TPM3;MAP3K20;PRTN3;PIK3R1;RUNX2;FLI1
Testicular Germ Cell Tumor,5/114,0.005558388333535983,0.017495954772246455,0,0,4.680562817892285,24.30357474030599,CCND2;CCND1;KIT;ESR1;FGFR3
Urticaria,5/114,0.005558388333535983,0.017495954772246455,0,0,4.680562817892285,24.30357474030599,KIT;SERPING1;ANTXR2;ESR1;CTSD
Varying degree of multiple fractures,4/72,0.005674797410983124,0.017820268357766098,0,0,5.983626440266828,30.945643015408038,COL1A2;FZD4;LIFR;ANTXR2
Frequent fractures,4/72,0.005674797410983124,0.017820268357766098,0,0,5.983626440266828,30.945643015408038,COL1A2;FZD4;LIFR;ANTXR2
Hyperuricemia,4/72,0.005674797410983124,0.017820268357766098,0,0,5.983626440266828,30.945643015408038,MUC1;ALDH2;SAA1;PPARG
Increased fracture rate,4/72,0.005674797410983124,0.017820268357766098,0,0,5.983626440266828,30.945643015408038,COL1A2;FZD4;LIFR;ANTXR2
Blood Platelet Disorders,3/37,0.005797156931964179,0.018129723761993607,0,0,8.944796380090498,46.0691689486937,VWF;CD36;FLI1
Cervical intraepithelial neoplasia grade 1,3/37,0.005797156931964179,0.018129723761993607,0,0,8.944796380090498,46.0691689486937,CCND1;CCL2;VIM
Hereditary pyropoikilocytosis,3/37,0.005797156931964179,0.018129723761993607,0,0,8.944796380090498,46.0691689486937,COL1A2;EGFR;SYNE1
Immunoblastic Large-Cell Lymphoma,3/37,0.005797156931964179,0.018129723761993607,0,0,8.944796380090498,46.0691689486937,MME;BCL6;CIB1
Ovarian Hyperstimulation Syndrome,3/37,0.005797156931964179,0.018129723761993607,0,0,8.944796380090498,46.0691689486937,VWF;LEP;KDR
Paget Disease,3/37,0.005797156931964179,0.018129723761993607,0,0,8.944796380090498,46.0691689486937,DMD;FOS;ESR1
Pelvic Organ Prolapse,3/37,0.005797156931964179,0.018129723761993607,0,0,8.944796380090498,46.0691689486937,LAMC1;ESR1;DCN
"Fractures, Multiple",4/73,0.005958141545822115,0.018540005104739608,0,0,5.896608396832511,30.208305167716556,COL1A2;FZD4;LIFR;ANTXR2
Urinary tract infection,4/73,0.005958141545822115,0.018540005104739608,0,0,5.896608396832511,30.208305167716556,EFEMP1;PLAU;CCL2;TLR4
Dysplastic Nevus,4/73,0.005958141545822115,0.018540005104739608,0,0,5.896608396832511,30.208305167716556,CCND1;STAT1;CTSD;EGFR
hypopigmented skin patch,4/73,0.005958141545822115,0.018540005104739608,0,0,5.896608396832511,30.208305167716556,CAV1;KIT;KRT5;SOX10
Infertility,4/73,0.005958141545822115,0.018540005104739608,0,0,5.896608396832511,30.208305167716556,C3;LEP;LEPR;ESR1
"Liver Neoplasms, Experimental",5/116,0.005977762825391626,0.018540005104739608,0,0,4.595761564673482,23.5289613411956,CCND1;HGF;KDR;SPP1;MET
Experimental Hepatoma,5/116,0.005977762825391626,0.018540005104739608,0,0,4.595761564673482,23.5289613411956,CCND1;HGF;KDR;SPP1;MET
"Arterial Diseases, Common Carotid",2/12,0.0060292416675762316,0.018540005104739608,0,0,20.195918367346938,103.22404575742381,PLAU;CCL2
"CATARACT, COPPOCK-LIKE",2/12,0.0060292416675762316,0.018540005104739608,0,0,20.195918367346938,103.22404575742381,MAF;VIM
"Cataract, Pulverulent",2/12,0.0060292416675762316,0.018540005104739608,0,0,20.195918367346938,103.22404575742381,MAF;VIM
"Cirrhosis, Cryptogenic",2/12,0.0060292416675762316,0.018540005104739608,0,0,20.195918367346938,103.22404575742381,KRT18;KRT8
"Dental Fluorosis, Acquired",2/12,0.0060292416675762316,0.018540005104739608,0,0,20.195918367346938,103.22404575742381,COL1A2;TIMP1
"Melanoma, Experimental",2/12,0.0060292416675762316,0.018540005104739608,0,0,20.195918367346938,103.22404575742381,KDR;CALR
"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",2/12,0.0060292416675762316,0.018540005104739608,0,0,20.195918367346938,103.22404575742381,MUC1;MME
Abdominal obesity metabolic syndrome,2/12,0.0060292416675762316,0.018540005104739608,0,0,20.195918367346938,103.22404575742381,LEP;PPARG
Urologic Neoplasms,2/12,0.0060292416675762316,0.018540005104739608,0,0,20.195918367346938,103.22404575742381,EFEMP1;CCND1
Amaurosis Fugax,2/12,0.0060292416675762316,0.018540005104739608,0,0,20.195918367346938,103.22404575742381,SPP1;CALR
Brain Abscess,2/12,0.0060292416675762316,0.018540005104739608,0,0,20.195918367346938,103.22404575742381,CCL2;TLR4
Central Precocious Puberty,2/12,0.0060292416675762316,0.018540005104739608,0,0,20.195918367346938,103.22404575742381,LEP;LEPR
Decreased circulating high-density lipoprotein levels,2/12,0.0060292416675762316,0.018540005104739608,0,0,20.195918367346938,103.22404575742381,ABCA1;PPARG
Exaggerated startle response,2/12,0.0060292416675762316,0.018540005104739608,0,0,20.195918367346938,103.22404575742381,KLC2;CTSD
External Carotid Artery Diseases,2/12,0.0060292416675762316,0.018540005104739608,0,0,20.195918367346938,103.22404575742381,PLAU;CCL2
Heterochromia iridis,2/12,0.0060292416675762316,0.018540005104739608,0,0,20.195918367346938,103.22404575742381,KIT;SOX10
Impaired platelet aggregation,2/12,0.0060292416675762316,0.018540005104739608,0,0,20.195918367346938,103.22404575742381,VWF;CALR
Internal Carotid Artery Diseases,2/12,0.0060292416675762316,0.018540005104739608,0,0,20.195918367346938,103.22404575742381,PLAU;CCL2
Myelokathexis,2/12,0.0060292416675762316,0.018540005104739608,0,0,20.195918367346938,103.22404575742381,CXCL12;CXCR4
Non-small cell lung cancer recurrent,2/12,0.0060292416675762316,0.018540005104739608,0,0,20.195918367346938,103.22404575742381,KRT19;EGFR
Papillary Thyroid Microcarcinoma,2/12,0.0060292416675762316,0.018540005104739608,0,0,20.195918367346938,103.22404575742381,CCND1;S100A4
Paronychia Inflammation,2/12,0.0060292416675762316,0.018540005104739608,0,0,20.195918367346938,103.22404575742381,LAMA3;EGFR
"Arthritis, Reactive",3/38,0.006248755581808887,0.019078040750413836,0,0,8.688791208791208,44.098855799515434,CFH;FHL1;TLR4
Salmonella infections,3/38,0.006248755581808887,0.019078040750413836,0,0,8.688791208791208,44.098855799515434,ARF1;EZR;TLR4
"Eczema, Infantile",3/38,0.006248755581808887,0.019078040750413836,0,0,8.688791208791208,44.098855799515434,CXCL10;CCL11;S100A8
"Nephritis, Tubulointerstitial",3/38,0.006248755581808887,0.019078040750413836,0,0,8.688791208791208,44.098855799515434,MUC1;CCL2;DCN
Autosomal Recessive Polycystic Kidney Disease,3/38,0.006248755581808887,0.019078040750413836,0,0,8.688791208791208,44.098855799515434,PKD2;EGFR;AQP1
Bladder neck obstruction,3/38,0.006248755581808887,0.019078040750413836,0,0,8.688791208791208,44.098855799515434,HGF;ESR1;MET
Chronic eosinophilic leukemia,3/38,0.006248755581808887,0.019078040750413836,0,0,8.688791208791208,44.098855799515434,STAT5A;STAT5B;KIT
DOWN SYNDROME CRITICAL REGION,3/38,0.006248755581808887,0.019078040750413836,0,0,8.688791208791208,44.098855799515434,RCAN1;CXCL12;ETS2
Lipoid nephrosis,3/38,0.006248755581808887,0.019078040750413836,0,0,8.688791208791208,44.098855799515434,MUC1;MMP14;TLR4
Painful Bladder Syndrome,3/38,0.006248755581808887,0.019078040750413836,0,0,8.688791208791208,44.098855799515434,CXCL10;CXCR4;CCL2
Uveomeningoencephalitic Syndrome,4/74,0.006250752326932362,0.019078040750413836,0,0,5.812076583210604,29.496599316268345,SPP1;CCL2;TLR4;FOXO1
Marginal Zone B-Cell Lymphoma,4/74,0.006250752326932362,0.019078040750413836,0,0,5.812076583210604,29.496599316268345,CCND1;MME;BCL6;CIB1
Necrotizing enterocolitis in fetus OR newborn,4/74,0.006250752326932362,0.019078040750413836,0,0,5.812076583210604,29.496599316268345,HGF;TIMP1;TLR4;EGFR
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding),6/166,0.00626521088508094,0.019111224273953252,0,0,3.836328125,19.460706758320175,HGF;KIT;TAP1;CALR;ESR1;TLR4
Graves Disease,9/335,0.006329841880295379,0.019297326876484028,0,0,2.8448729184925505,14.402112316574158,SOCS3;CXCL10;THRB;SPP1;CXCR4;TAP1;PPARG;CALR;ESR1
Erectile dysfunction,5/118,0.006418936489991192,0.01955775446264326,0,0,4.51396212572791,22.788750569713784,CCND2;FABP4;CCND1;KDR;S100A8
Transitional cell carcinoma of bladder,6/167,0.00644653700358139,0.019630626109762985,0,0,3.812305900621118,19.230079899832283,CCND1;CAV1;KDR;VIM;FGFR3;EGFR
Apnea,4/75,0.006552757758754076,0.01990857816214394,0,0,5.7299259474372,28.809318682593226,DST;LIFR;CTSD;CRYAB
Central Nervous System Neoplasms,4/75,0.006552757758754076,0.01990857816214394,0,0,5.7299259474372,28.809318682593226,YAP1;TF;HGF;EGFR
Ovarian Cysts,4/75,0.006552757758754076,0.01990857816214394,0,0,5.7299259474372,28.809318682593226,COL1A2;PIK3R1;ESR1;EGFR
Polycythemia,4/75,0.006552757758754076,0.01990857816214394,0,0,5.7299259474372,28.809318682593226,EPAS1;ELOB;PIK3R1;EGFR
"Infant, Premature",8/278,0.006635775026525611,0.020149313456612524,0,0,3.045925925925926,15.276170796611595,COL1A2;MME;FZD4;HGF;KDR;SORBS1;TLR4;EGFR
"Hepatoma, Novikoff",5/119,0.006647876667002586,0.020163081820407956,0,0,4.4741387146623035,22.43090551872311,CCND1;HGF;KDR;SPP1;MET
Muscle Rigidity,5/119,0.006647876667002586,0.020163081820407956,0,0,4.4741387146623035,22.43090551872311,SREBF1;DMD;CD36;CTSD;CRYAB
Stage 4S neuroblastoma,3/39,0.006720786624828021,0.02033791704923823,0,0,8.447008547008547,42.25658323218377,TINAGL1;CXCL12;CCND1
Subependymal Giant Cell Astrocytoma,3/39,0.006720786624828021,0.02033791704923823,0,0,8.447008547008547,42.25658323218377,HGF;ESR1;MET
Alcohol consumption,3/39,0.006720786624828021,0.02033791704923823,0,0,8.447008547008547,42.25658323218377,TF;ALDH2;MYLK
heavy drinking,3/39,0.006720786624828021,0.02033791704923823,0,0,8.447008547008547,42.25658323218377,PER1;ALDH2;TLR4
Congenital pectus carinatum,4/76,0.006864283806213893,0.020748592401199,0,0,5.650057273768614,28.145328478746364,RPS6KA3;ZEB2;THRB;BGN
Platyspondyly,4/76,0.006864283806213893,0.020748592401199,0,0,5.650057273768614,28.145328478746364,COL1A2;BGN;FGFR3;RUNX2
Severe mental retardation (I.Q. 20-34),7/224,0.007072626002020466,0.021087477846938638,0,0,3.3077182908292517,16.37824464724237,ABCA1;ZEB2;MEF2C;ITSN1;DMD;CTSD;FGFR3
"Cerebral Amyloid Angiopathy, Hereditary",2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,GSN;CTSD
"DISORGANIZATION, MOUSE, HOMOLOG OF",2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,RCAN1;ETS2
Secondary malignant neoplasm of skin,2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,KIT;TGFBR2
Secondary Open Angle Glaucoma,2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,CAV2;CAV1
"LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS",2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,KRT19;TGFBR2
"Pneumonia, Ventilator-Associated",2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,MDK;S100A8
"Polycystic kidney disease, type 2",2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,PPARG;PKD2
White forelock,2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,KIT;SOX10
Behavioral tic,2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,SNAP25;VIM
Bethlem myopathy,2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,VWF;DMD
Canine Osteosarcoma,2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,CAV2;MET
Chronic superficial gastritis,2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,LEP;CCL2
Delayed eruption of primary teeth,2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,FGFR3;RUNX2
Epithelioid hemangioendothelioma,2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,YAP1;KIT
Heymann Nephritis,2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,C3;MME
Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma,2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,STAT1;EGFR
Hydrosalpinx (disease),2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,KDR;TAP1
IMMUNODEFICIENCY 13,2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,STAT5A;STAT5B
Lysinuric Protein Intolerance,2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,CXCL10;TLR4
Malignant Mixed Mesodermal (Mullerian) Tumor,2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,S100A4;EGFR
Mycetoma,2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,TIMP1;TEAD1
Neonatal hepatitis,2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,GOLM1;SPP1
Neonatal short-limb short stature,2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,COL1A2;FGFR3
obsolete Combined hyperlipidemia,2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,LPL;TXNIP
Peritoneal Neoplasms,2/13,0.007079282767531098,0.021087477846938638,0,0,18.35899814471243,90.88773824524405,MUC1;VIM
"Hepatoma, Morris",5/121,0.00712281743767494,0.021205303980653494,0,0,4.396551724137931,21.73853863265966,CCND1;HGF;KDR;SPP1;MET
"Niemann-Pick Disease, Type C",4/77,0.007185454361582799,0.02135588588751368,0,0,5.572376782940263,27.503560717588353,ABCA1;EGR1;ANXA1;KDR
aggressive cancer,4/77,0.007185454361582799,0.02135588588751368,0,0,5.572376782940263,27.503560717588353,YAP1;MUC1;EZR;EGFR
Distal amyotrophy,4/77,0.007185454361582799,0.02135588588751368,0,0,5.572376782940263,27.503560717588353,ABCA1;KLC2;MME;SOX10
"Degenerative Diseases, Spinal Cord",3/40,0.007213472433387994,0.02135588588751368,0,0,8.218295218295218,40.531028052911616,VIM;PKD2;CRYAB
"Dermatomyositis, Childhood Type",3/40,0.007213472433387994,0.02135588588751368,0,0,8.218295218295218,40.531028052911616,SPP1;TLR4;S100A8
AIDS Dementia Complex,3/40,0.007213472433387994,0.02135588588751368,0,0,8.218295218295218,40.531028052911616,CXCL10;CXCR4;CCL2
Chronic rejection of renal transplant,3/40,0.007213472433387994,0.02135588588751368,0,0,8.218295218295218,40.531028052911616,HGF;CIB1;EGFR
Contracture of joint of hand,3/40,0.007213472433387994,0.02135588588751368,0,0,8.218295218295218,40.531028052911616,FHL1;FGFR3;TGFBR2
Osteoarthritis of the hand,3/40,0.007213472433387994,0.02135588588751368,0,0,8.218295218295218,40.531028052911616,CCND1;TIMP1;ESR1
Prostate cancer recurrent,3/40,0.007213472433387994,0.02135588588751368,0,0,8.218295218295218,40.531028052911616,KLF6;PROS1;EGFR
Ventricular Septal Defects,7/226,0.00741080723472421,0.021927924349719775,0,0,3.2771761218293527,16.07394557254728,YAP1;NRP1;RPS6KA3;ZEB2;CCND2;FADD;FLI1
Neuropathy,8/284,0.007506662578475208,0.022199225793948046,0,0,2.9787948131197557,14.572157909577456,GSN;ALDH2;TPM3;HGF;SERPING1;CCL2;SOX10;TLR4
Abnormal skeletal development,4/78,0.007516391220102064,0.02221566767161614,0,0,5.496795764837002,26.883009455266375,LIFR;BMPR1B;FGFR3;RUNX2
"Anemia, Macrocytic",3/41,0.007727022558473128,0.022699726137873924,0,0,8.00161943319838,38.91212871973292,EGR1;ALDH2;KIT
Rheumatic Heart Disease,3/41,0.007727022558473128,0.022699726137873924,0,0,8.00161943319838,38.91212871973292,DUSP1;BGN;VIM
Alcohol withdrawal syndrome,3/41,0.007727022558473128,0.022699726137873924,0,0,8.00161943319838,38.91212871973292,LEP;PPARG;MPDZ
Arterial Occlusive Diseases,3/41,0.007727022558473128,0.022699726137873924,0,0,8.00161943319838,38.91212871973292,F8;PLAU;TLR4
Breaking out,3/41,0.007727022558473128,0.022699726137873924,0,0,8.00161943319838,38.91212871973292,NR3C1;ESR1;TLR4
Chronic viral hepatitis,3/41,0.007727022558473128,0.022699726137873924,0,0,8.00161943319838,38.91212871973292,CXCL10;LEP;LEPR
Endometrioid carcinoma ovary,3/41,0.007727022558473128,0.022699726137873924,0,0,8.00161943319838,38.91212871973292,CCND1;KRT8;EGFR
Gestational Trophoblastic Neoplasms,3/41,0.007727022558473128,0.022699726137873924,0,0,8.00161943319838,38.91212871973292,MUC1;LEP;EGFR
Laryngeal neoplasm,3/41,0.007727022558473128,0.022699726137873924,0,0,8.00161943319838,38.91212871973292,ANXA1;CCND1;S100A8
Lytic lesion,3/41,0.007727022558473128,0.022699726137873924,0,0,8.00161943319838,38.91212871973292,CAV1;SPP1;ANTXR2
Malabsorption Syndrome,3/41,0.007727022558473128,0.022699726137873924,0,0,8.00161943319838,38.91212871973292,LEP;EZR;EGFR
Gliosis,4/79,0.00785721404616262,0.023069473086501712,0,0,5.423230240549828,26.282726438406723,CXCL10;HGF;CCL2;EGFR
"Hernia, Inguinal",5/124,0.007878927476310874,0.02312048707117877,0,0,4.285061174728959,20.75496586451663,RPS6KA3;EFEMP1;COL1A2;PIK3R1;TGFBR2
Recurrent erosion of cornea,2/14,0.008205672711332105,0.02375917818384735,0,0,16.828231292517007,80.82480968270536,COL17A1;FGFR3
"Fracture, spiral",2/14,0.008205672711332105,0.02375917818384735,0,0,16.828231292517007,80.82480968270536,SPTBN1;TGFBR2
"Histiocytoma, Angiomatoid Fibrous",2/14,0.008205672711332105,0.02375917818384735,0,0,16.828231292517007,80.82480968270536,MUC1;MET
"Hydatidiform Mole, Partial",2/14,0.008205672711332105,0.02375917818384735,0,0,16.828231292517007,80.82480968270536,LEP;EGFR
Syringomyelia,2/14,0.008205672711332105,0.02375917818384735,0,0,16.828231292517007,80.82480968270536,ABCA1;RUNX2
Takotsubo Cardiomyopathy,2/14,0.008205672711332105,0.02375917818384735,0,0,16.828231292517007,80.82480968270536,VWF;ESR1
Thrombocytopenic purpura,2/14,0.008205672711332105,0.02375917818384735,0,0,16.828231292517007,80.82480968270536,STAT5B;VWF
"von Willebrand Disease, Type 1",2/14,0.008205672711332105,0.02375917818384735,0,0,16.828231292517007,80.82480968270536,F8;VWF
Adenocarcinoma of small intestine,2/14,0.008205672711332105,0.02375917818384735,0,0,16.828231292517007,80.82480968270536,MME;EGFR
Amelanotic Skin Melanoma,2/14,0.008205672711332105,0.02375917818384735,0,0,16.828231292517007,80.82480968270536,CAV1;KIT
Cancer Relapse,2/14,0.008205672711332105,0.02375917818384735,0,0,16.828231292517007,80.82480968270536,NRP1;MET
Desmoplastic melanoma,2/14,0.008205672711332105,0.02375917818384735,0,0,16.828231292517007,80.82480968270536,KIT;SOX10
Diastolic hypertension,2/14,0.008205672711332105,0.02375917818384735,0,0,16.828231292517007,80.82480968270536,KDR;ANTXR2
Disorder of face,2/14,0.008205672711332105,0.02375917818384735,0,0,16.828231292517007,80.82480968270536,CAV1;PPARG
dowling-degos disease,2/14,0.008205672711332105,0.02375917818384735,0,0,16.828231292517007,80.82480968270536,CFH;KRT5
Exudative retinopathy,2/14,0.008205672711332105,0.02375917818384735,0,0,16.828231292517007,80.82480968270536,FZD4;KDR
Facial diplegia,2/14,0.008205672711332105,0.02375917818384735,0,0,16.828231292517007,80.82480968270536,ABCA1;TPM3
Fibular hypoplasia,2/14,0.008205672711332105,0.02375917818384735,0,0,16.828231292517007,80.82480968270536,ZBTB16;BMPR1B
Gastric Gastrointestinal Stromal Tumor,2/14,0.008205672711332105,0.02375917818384735,0,0,16.828231292517007,80.82480968270536,VCAN;KIT
Germinoma,2/14,0.008205672711332105,0.02375917818384735,0,0,16.828231292517007,80.82480968270536,KIT;KLF4
Lymphoid interstitial pneumonia,2/14,0.008205672711332105,0.02375917818384735,0,0,16.828231292517007,80.82480968270536,CXCL10;BCL6
Mucocutaneous leishmaniasis,2/14,0.008205672711332105,0.02375917818384735,0,0,16.828231292517007,80.82480968270536,CXCL10;FLI1
Peritoneal Surface Malignancy,2/14,0.008205672711332105,0.02375917818384735,0,0,16.828231292517007,80.82480968270536,MUC1;VIM
Pigmented lesions,2/14,0.008205672711332105,0.02375917818384735,0,0,16.828231292517007,80.82480968270536,MMP14;KIT
Prion Diseases,4/80,0.008208040352122907,0.02375917818384735,0,0,5.351600651112317,25.701817100665263,ABCA1;GSN;LAMA3;CTSD
"Degenerative Diseases, Central Nervous System",3/42,0.008261634012407445,0.02377227195038838,0,0,7.796055226824458,37.390916875401935,VIM;PKD2;CRYAB
Short phalanx of finger,3/42,0.008261634012407445,0.02377227195038838,0,0,7.796055226824458,37.390916875401935,BGN;LIFR;BMPR1B
Arrhythmogenic Right Ventricular Dysplasia,3/42,0.008261634012407445,0.02377227195038838,0,0,7.796055226824458,37.390916875401935,MEF2C;PPARG;MET
Cervical intraepithelial neoplasia grade 2,3/42,0.008261634012407445,0.02377227195038838,0,0,7.796055226824458,37.390916875401935,CCND1;CCL2;VIM
EMG: myopathic abnormalities,3/42,0.008261634012407445,0.02377227195038838,0,0,7.796055226824458,37.390916875401935,TPM3;DMD;CRYAB
Epiretinal Membrane,3/42,0.008261634012407445,0.02377227195038838,0,0,7.796055226824458,37.390916875401935,HGF;MAP1B;MET
Ewings sarcoma-primitive neuroectodermal tumor (PNET),3/42,0.008261634012407445,0.02377227195038838,0,0,7.796055226824458,37.390916875401935,KIT;EGFR;FLI1
exudative macular degeneration,3/42,0.008261634012407445,0.02377227195038838,0,0,7.796055226824458,37.390916875401935,C3;ABCA1;CFH
High urine occult blood,3/42,0.008261634012407445,0.02377227195038838,0,0,7.796055226824458,37.390916875401935,YAP1;CFH;PRTN3
Oligoarticular Juvenile Idiopathic Arthritis,3/42,0.008261634012407445,0.02377227195038838,0,0,7.796055226824458,37.390916875401935,STAT1;SPP1;ESR1
Rat Adrenal Gland Pheochromocytoma,3/42,0.008261634012407445,0.02377227195038838,0,0,7.796055226824458,37.390916875401935,SNAP25;CXCL12;RFX2
Hypogonadotropic hypogonadism,5/126,0.008412937255280088,0.02418152245598036,0,0,4.2138055067871365,20.13349785467746,NRP1;LEP;LEPR;S1PR1;SOX10
Myocarditis,5/126,0.008412937255280088,0.02418152245598036,0,0,4.2138055067871365,20.13349785467746,CXCL10;SPP1;CCL2;TLR4;S100A8
Hemoglobin low,6/177,0.008475355274967442,0.0243477996012407,0,0,3.587536549707602,17.11467569741927,COL17A1;ABCA1;TF;MUC1;CCND1;LAMA3
Myopathy,10/415,0.00856779643509683,0.024590265792670186,0,0,2.547543997898608,12.125659054398659,GSN;TPM3;FHL1;MAP3K20;SPP1;LPL;PPARG;DMD;UTRN;CRYAB
Primary immune deficiency disorder,4/81,0.008568985471380847,0.024590265792670186,0,0,5.281831570491364,25.13943688943252,STAT1;CXCR4;PIK3R1;TLR4
"Sarcoma, Epithelioid",3/43,0.00881749156317996,0.02515439643478908,0,0,7.600769230769231,35.959374924879896,CCND1;VIM;EGFR
Thin dental enamel,3/43,0.00881749156317996,0.02515439643478908,0,0,7.600769230769231,35.959374924879896,LAMA3;FGFR3;RUNX2
Tooth Abnormalities,3/43,0.00881749156317996,0.02515439643478908,0,0,7.600769230769231,35.959374924879896,RPS6KA3;ANTXR2;RUNX2
Transient Cerebral Ischemia,3/43,0.00881749156317996,0.02515439643478908,0,0,7.600769230769231,35.959374924879896,C3;SPP1;CALR
Becker Muscular Dystrophy,3/43,0.00881749156317996,0.02515439643478908,0,0,7.600769230769231,35.959374924879896,CCL2;DMD;UTRN
Defective enamel matrix,3/43,0.00881749156317996,0.02515439643478908,0,0,7.600769230769231,35.959374924879896,LAMA3;FGFR3;RUNX2
Dysplasia of tooth enamel,3/43,0.00881749156317996,0.02515439643478908,0,0,7.600769230769231,35.959374924879896,LAMA3;FGFR3;RUNX2
Flushing,3/43,0.00881749156317996,0.02515439643478908,0,0,7.600769230769231,35.959374924879896,CXCL10;ALDH2;VWF
Gemistocytic astrocytoma,3/43,0.00881749156317996,0.02515439643478908,0,0,7.600769230769231,35.959374924879896,HGF;ESR1;MET
Proliferative retinopathy,3/43,0.00881749156317996,0.02515439643478908,0,0,7.600769230769231,35.959374924879896,CXCL12;ALDH2;LPL
Radial deviation of finger,3/43,0.00881749156317996,0.02515439643478908,0,0,7.600769230769231,35.959374924879896,PIK3R1;BMPR1B;FGFR3
"Osteoporosis, Age-Related",4/82,0.008940162538559457,0.025477072817103392,0,0,5.2138514406555645,24.594787883119434,GSN;COL1A2;DMD;ANTXR2
Cholecystolithiasis,4/82,0.008940162538559457,0.025477072817103392,0,0,5.2138514406555645,24.594787883119434,MUC1;PPARG;TLR4;ESR1
Testicular Neoplasms,4/83,0.00932168246677275,0.026176973367216562,0,0,5.147592326764975,24.067115678930318,CCND2;KIT;KDR;FGFR3
Strawberry nevus of skin,3/44,0.009394768013373897,0.026176973367216562,0,0,7.415009380863039,34.610315129706294,KDR;PECAM1;CCL2
Toxic Shock Syndrome,3/44,0.009394768013373897,0.026176973367216562,0,0,7.415009380863039,34.610315129706294,AGR2;A2M;AQP1
Abnormal form of the vertebral bodies,3/44,0.009394768013373897,0.026176973367216562,0,0,7.415009380863039,34.610315129706294,RPS6KA3;FGFR3;FLI1
Endometriosis of uterus,3/44,0.009394768013373897,0.026176973367216562,0,0,7.415009380863039,34.610315129706294,HGF;ESR1;TLR4
Linear atrophy,3/44,0.009394768013373897,0.026176973367216562,0,0,7.415009380863039,34.610315129706294,ANK2;SOX10;TGFBR2
Medullomyoblastoma,3/44,0.009394768013373897,0.026176973367216562,0,0,7.415009380863039,34.610315129706294,IRS2;S100A4;FLI1
Melanotic medulloblastoma,3/44,0.009394768013373897,0.026176973367216562,0,0,7.415009380863039,34.610315129706294,IRS2;S100A4;FLI1
Monoclonal Gammapathies,3/44,0.009394768013373897,0.026176973367216562,0,0,7.415009380863039,34.610315129706294,CFH;KIT;CXCR4
Muscular stiffness,3/44,0.009394768013373897,0.026176973367216562,0,0,7.415009380863039,34.610315129706294,TPM3;ESR1;CRYAB
Paranasal Sinus Diseases,3/44,0.009394768013373897,0.026176973367216562,0,0,7.415009380863039,34.610315129706294,PRTN3;PIK3R1;RUNX2
Pneumococcal Infections,3/44,0.009394768013373897,0.026176973367216562,0,0,7.415009380863039,34.610315129706294,VWF;CCL2;TLR4
"Epilepsy, Temporal Lobe",6/181,0.009402741894549756,0.026176973367216562,0,0,3.5048214285714288,16.35613921544409,C3;DPYSL2;KDR;CXCR4;ESR1;CTSD
"Breast Fibrocystic Change, Proliferative Type",2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,KRT5;ESR1
Salivary gland carcinoma,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,KIT;EGFR
Scarring alopecia of scalp,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,COL17A1;LAMA3
Short middle phalanx of the 5th finger,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,BMPR1B;RUNX2
Stage 0 Breast Carcinoma,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,CXCL10;EGFR
Sudden sensorineural hearing loss,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,CAV1;ESR1
Systemic amyloidosis,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,GSN;CALR
Systolic hypertension,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,PPARG;ANTXR2
Thanatophoric Dysplasia,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,STAT1;FGFR3
Triglyceride storage disease with ichthyosis,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,CCND1;ESR1
Abnormality of the face,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,CAV1;PPARG
Urinary Stress Incontinence,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,BGN;DCN
Afibrinogenemia,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,EGR1;CFH
Autonomic neuropathy,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,TCF7L2;DST
Brachydactyly type A3,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,BMPR1B;RUNX2
Carpal synostosis,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,BMPR1B;FGFR3
Congenital hypoplasia of femur,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,ZBTB16;FGFR3
Fracture,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,SPTBN1;TGFBR2
Gastroschisis,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,LRP1;KIT
Helicobacter Infections,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,MUC1;TIMP1
Hereditary Paraganglioma,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,KIT;ESR1
Low grade B-cell lymphoma,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,MME;BCL6
Malignant melanoma of ciliary body,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,CCND1;KIT
maternal hyperglycemia,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,LEP;PPARG
Meleda Disease,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,CXCL12;PLAU
Meningococcal meningitis,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,CFH;TLR4
Metaphyseal chondrodysplasia,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,CCND1;FGFR3
Mucosal Melanoma,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,KIT;FGFR3
Multiple renal cysts,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,MUC1;EPAS1
Nevi and Melanomas,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,CCND1;KIT
Progesterone Resistance,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,CIB1;FKBP4
Pulmonary Pathology,2/15,0.009406812534850763,0.026176973367216562,0,0,15.532967032967033,72.48181203601595,EPAS1;CCL2
Tauopathies,5/130,0.009555233429848252,0.026562252972175973,0,0,4.078134715025906,18.96604356965297,RCAN1;PROS1;LEP;LEPR;FKBP4
Primary sclerosing cholangitis,5/130,0.009555233429848252,0.026562252972175973,0,0,4.078134715025906,18.96604356965297,MME;BCL3;TLR4;FOXO1;EGFR
Retrusion of upper jaw bones,4/84,0.009713653925796772,0.026904398009652285,0,0,5.082989690721649,23.555706523889203,RPS6KA3;BGN;FGFR3;RUNX2
Decreased projection of maxilla,4/84,0.009713653925796772,0.026904398009652285,0,0,5.082989690721649,23.555706523889203,RPS6KA3;BGN;FGFR3;RUNX2
Deficiency of upper jaw bones,4/84,0.009713653925796772,0.026904398009652285,0,0,5.082989690721649,23.555706523889203,RPS6KA3;BGN;FGFR3;RUNX2
Hypoplasia of the maxilla,4/84,0.009713653925796772,0.026904398009652285,0,0,5.082989690721649,23.555706523889203,RPS6KA3;BGN;FGFR3;RUNX2
Hypotrophic maxilla,4/84,0.009713653925796772,0.026904398009652285,0,0,5.082989690721649,23.555706523889203,RPS6KA3;BGN;FGFR3;RUNX2
Late tooth eruption,4/84,0.009713653925796772,0.026904398009652285,0,0,5.082989690721649,23.555706523889203,GHR;ZEB2;PIK3R1;RUNX2
Maxillary retrognathia,4/84,0.009713653925796772,0.026904398009652285,0,0,5.082989690721649,23.555706523889203,RPS6KA3;BGN;FGFR3;RUNX2
Disorder of eye,5/131,0.00985666731439903,0.027286327334250616,0,0,4.045562957480056,18.688911637256204,NRP1;CFH;LAMA3;KDR;DMD
Feeding difficulties,7/239,0.009908221090093544,0.02741480279808333,0,0,3.0914876331467775,14.265331020896966,CA12;THRB;DST;TPM3;LAMA3;LIFR;ANTXR2
"Obesity, Visceral",3/45,0.00999362447732192,0.027565230248265276,0,0,7.238095238095238,33.337276529522526,SREBF1;LEP;LPL
Abetalipoproteinemia,3/45,0.00999362447732192,0.027565230248265276,0,0,7.238095238095238,33.337276529522526,PECAM1;CCL2;CIB1
Congenital neutropenia,3/45,0.00999362447732192,0.027565230248265276,0,0,7.238095238095238,33.337276529522526,STAT5A;STAT5B;CXCR4
Distal Muscular Dystrophies,3/45,0.00999362447732192,0.027565230248265276,0,0,7.238095238095238,33.337276529522526,FHL1;DMD;CRYAB
Infectious Otitis Media,3/45,0.00999362447732192,0.027565230248265276,0,0,7.238095238095238,33.337276529522526,DUSP1;CCL2;TLR4
Inherited neuropathies,3/45,0.00999362447732192,0.027565230248265276,0,0,7.238095238095238,33.337276529522526,DST;CCL2;SOX10
Hypogammaglobulinemia,4/85,0.010116183331669332,0.027874426563839642,0,0,5.019982181494209,23.05988466211336,CXCL12;CCND1;CXCR4;PIK3R1
Lesion of brain,4/85,0.010116183331669332,0.027874426563839642,0,0,5.019982181494209,23.05988466211336,PECAM1;S1PR1;CCL2;EGFR
Lewy Body Disease,5/133,0.010479020265653491,0.028859275966753202,0,0,3.981946243523316,18.151224478161264,PECAM1;SPP1;SNCG;A2M;AQP1
"Leishmaniasis, Visceral",4/86,0.010529374819127283,0.02895306419562915,0,0,4.958511440784511,22.579009894079444,CXCL10;LPL;TLR4;AQP1
"Malaria, Cerebral",4/86,0.010529374819127283,0.02895306419562915,0,0,4.958511440784511,22.579009894079444,ABCA1;CXCL10;VWF;CD36
Chronic gastritis,4/86,0.010529374819127283,0.02895306419562915,0,0,4.958511440784511,22.579009894079444,MUC1;CAV1;TLR4;S100A8
Single tumor,3/46,0.010614210649157109,0.029055501115089297,0,0,7.069409660107334,32.134436721037815,EFEMP1;ESR1;EGFR
Toxoplasmosis,3/46,0.010614210649157109,0.029055501115089297,0,0,7.069409660107334,32.134436721037815,SOCS3;CCL2;TLR4
Foot-drop,3/46,0.010614210649157109,0.029055501115089297,0,0,7.069409660107334,32.134436721037815,MME;FHL1;CRYAB
Ketosis,3/46,0.010614210649157109,0.029055501115089297,0,0,7.069409660107334,32.134436721037815,SREBF1;ALDH2;LPL
Malonic aciduria,3/46,0.010614210649157109,0.029055501115089297,0,0,7.069409660107334,32.134436721037815,MUC1;KDR;TLR4
"Depression, Postpartum",2/16,0.010681127169161182,0.029055501115089297,0,0,14.422740524781341,65.46881305511042,NR3C1;ESR1
Skin Manifestations,2/16,0.010681127169161182,0.029055501115089297,0,0,14.422740524781341,65.46881305511042,FGFR3;EGFR
"RETINOSCHISIS 1, X-LINKED, JUVENILE",2/16,0.010681127169161182,0.029055501115089297,0,0,14.422740524781341,65.46881305511042,CXCL10;ESR1
Vitamin K Deficiency,2/16,0.010681127169161182,0.029055501115089297,0,0,14.422740524781341,65.46881305511042,F8;PROS1
AIDS (Disease),2/16,0.010681127169161182,0.029055501115089297,0,0,14.422740524781341,65.46881305511042,CXCL12;CXCR4
Auricular swelling,2/16,0.010681127169161182,0.029055501115089297,0,0,14.422740524781341,65.46881305511042,CXCL10;CCL2
Codependency,2/16,0.010681127169161182,0.029055501115089297,0,0,14.422740524781341,65.46881305511042,RPS6KA3;ESR1
Condyloma,2/16,0.010681127169161182,0.029055501115089297,0,0,14.422740524781341,65.46881305511042,JUN;ESR1
cystic disease,2/16,0.010681127169161182,0.029055501115089297,0,0,14.422740524781341,65.46881305511042,HGF;PKD2
Diffuse mesangial sclerosis (disorder),2/16,0.010681127169161182,0.029055501115089297,0,0,14.422740524781341,65.46881305511042,BGN;DCN
Disorder of skeletal muscle,2/16,0.010681127169161182,0.029055501115089297,0,0,14.422740524781341,65.46881305511042,DMD;CRYAB
Hereditary Sensory and Autonomic Neuropathies,2/16,0.010681127169161182,0.029055501115089297,0,0,14.422740524781341,65.46881305511042,DST;LIFR
Inverted Papilloma,2/16,0.010681127169161182,0.029055501115089297,0,0,14.422740524781341,65.46881305511042,FGFR3;EGFR
Morphine Dependence,2/16,0.010681127169161182,0.029055501115089297,0,0,14.422740524781341,65.46881305511042,FADD;FGFR3
Nephropathic cystinosis,2/16,0.010681127169161182,0.029055501115089297,0,0,14.422740524781341,65.46881305511042,COL1A2;CTSD
Primary Systemic Amyloidosis,2/16,0.010681127169161182,0.029055501115089297,0,0,14.422740524781341,65.46881305511042,GSN;CALR
Vitiligo,7/243,0.010787429327722697,0.029329699432364412,0,0,3.038468364539888,13.762358923189925,HGF;KIT;TAP1;CALR;TLR4;ESR1;FLI1
Absent tendon reflex,5/134,0.01080006639991744,0.029349084061784825,0,0,3.950877615777001,17.89037585947631,SNAP25;DST;MME;FHL1;SOX10
Hirschsprung Disease,5/135,0.01112777594933441,0.030224219181449064,0,0,3.9202869669190914,17.634669823835186,ZEB2;KIT;CXCR4;SVEP1;SOX10
Rhinovirus infection,3/47,0.011256665078498882,0.03048108140412629,0,0,6.908391608391608,30.99653605846247,ABCA1;CXCL10;EGFR
Severe congenital neutropenia,3/47,0.011256665078498882,0.03048108140412629,0,0,6.908391608391608,30.99653605846247,STAT5A;STAT5B;CXCR4
"Hypertension, Renovascular",3/47,0.011256665078498882,0.03048108140412629,0,0,6.908391608391608,30.99653605846247,CXCL10;STAT1;SPP1
Foot dorsiflexor weakness,3/47,0.011256665078498882,0.03048108140412629,0,0,6.908391608391608,30.99653605846247,MME;FHL1;CRYAB
Lumbar hyperlordosis,3/47,0.011256665078498882,0.03048108140412629,0,0,6.908391608391608,30.99653605846247,TPM3;BGN;FGFR3
Peripheral demyelinating neuropathy,3/47,0.011256665078498882,0.03048108140412629,0,0,6.908391608391608,30.99653605846247,CXCL10;DMD;SOX10
Orbital separation excessive,9/368,0.011304764597696667,0.030595779858367464,0,0,2.578989255869479,11.560399278604987,RPS6KA3;MEF2C;CCND2;MAF;BGN;FGFR3;RUNX2;FLI1;TGFBR2
Spina Bifida,4/88,0.011388149133249268,0.030805810523393574,0,0,4.839960726558664,21.659705191977334,JUN;LEPR;CCL2;FOS
"Amyotrophic Lateral Sclerosis, Sporadic",5/136,0.011462210823719447,0.030974706632657674,0,0,3.890163350868172,17.38397168128502,HGF;SNCG;FOS;VIM;CTSD
Cholelithiasis,5/136,0.011462210823719447,0.030974706632657674,0,0,3.890163350868172,17.38397168128502,MUC1;PPARG;ESR1;TLR4;S100A8
"Reflex, Deep Tendon, Absent",5/137,0.01180343226374502,0.031864483552936786,0,0,3.8604961532422672,17.138151196483378,SNAP25;DST;MME;FHL1;SOX10
Absent reflex,5/137,0.01180343226374502,0.031864483552936786,0,0,3.8604961532422672,17.138151196483378,SNAP25;DST;MME;FHL1;SOX10
Hemophilia A,4/89,0.011833928730337043,0.031914476823869484,0,0,4.782777440873256,21.220153090166587,F8;CCND1;VWF;CXCR4
Hypotension,4/89,0.011833928730337043,0.031914476823869484,0,0,4.782777440873256,21.220153090166587,RGS2;MUC1;PLAU;SAA1
Right Ventricular Hypertrophy,3/48,0.011921115421544603,0.032068462433826946,0,0,6.754529914529915,29.918812314050808,PPARG;KLF4;TLR4
"Mental Retardation, X-Linked 1",3/48,0.011921115421544603,0.032068462433826946,0,0,6.754529914529915,29.918812314050808,RPS6KA3;DMD;ARHGEF6
Manic Disorder,3/48,0.011921115421544603,0.032068462433826946,0,0,6.754529914529915,29.918812314050808,SNAP25;GRK3;NR3C1
Neuroblastic tumors,3/48,0.011921115421544603,0.032068462433826946,0,0,6.754529914529915,29.918812314050808,KIT;SPP1;CXCR4
Paresthesia,3/48,0.011921115421544603,0.032068462433826946,0,0,6.754529914529915,29.918812314050808,SERPING1;LIFR;CALR
Central nervous system lesion,2/17,0.01202706512555413,0.03215867037334569,0,0,13.460544217687074,59.50362444997404,CCL2;EGFR
Childhood Astrocytoma,2/17,0.01202706512555413,0.03215867037334569,0,0,13.460544217687074,59.50362444997404,SIRPA;FLI1
Complement deficiency disease,2/17,0.01202706512555413,0.03215867037334569,0,0,13.460544217687074,59.50362444997404,CALR;TLR4
Hypertrophy of kidney,2/17,0.01202706512555413,0.03215867037334569,0,0,13.460544217687074,59.50362444997404,HGF;DCN
Ileal Diseases,2/17,0.01202706512555413,0.03215867037334569,0,0,13.460544217687074,59.50362444997404,TCF7L2;TLR4
Ileus,2/17,0.01202706512555413,0.03215867037334569,0,0,13.460544217687074,59.50362444997404,MUC1;SOX10
Mature B-Cell Non-Hodgkin Lymphoma,2/17,0.01202706512555413,0.03215867037334569,0,0,13.460544217687074,59.50362444997404,CCND1;BCL6
Metastatic hepatocellular carcinoma,2/17,0.01202706512555413,0.03215867037334569,0,0,13.460544217687074,59.50362444997404,SPP1;EZR
Neonatal Deformity,2/17,0.01202706512555413,0.03215867037334569,0,0,13.460544217687074,59.50362444997404,ZEB2;ESR1
Parainfluenza,2/17,0.01202706512555413,0.03215867037334569,0,0,13.460544217687074,59.50362444997404,STAT1;PLK1
Pathologic Neovascularization,2/17,0.01202706512555413,0.03215867037334569,0,0,13.460544217687074,59.50362444997404,NRP1;KDR
Psychological symptom,2/17,0.01202706512555413,0.03215867037334569,0,0,13.460544217687074,59.50362444997404,NR3C1;MPDZ
Peripheral Neuropathy,8/309,0.012088538496190375,0.03230683131705041,0,0,2.727889491169785,12.044989247649998,ABCA1;JUN;PTPRB;GSN;DST;CCL2;SOX10;EGFR
"Periodontitis, Juvenile",4/90,0.01229076393208153,0.03278152201905029,0,0,4.726923999040998,20.79330000614869,STAT1;PRTN3;TLR4;S100A8
Bacteremia,4/90,0.01229076393208153,0.03278152201905029,0,0,4.726923999040998,20.79330000614869,CFH;SPP1;VIM;TLR4
Dehydration,4/90,0.01229076393208153,0.03278152201905029,0,0,4.726923999040998,20.79330000614869,CA12;LAMA3;PPARG;SGK1
Micromelia,4/90,0.01229076393208153,0.03278152201905029,0,0,4.726923999040998,20.79330000614869,LIFR;ANTXR2;BMPR1B;FGFR3
Prominent globes,5/139,0.012506476368048854,0.0333401763708516,0,0,3.8024901399737066,16.66064347558677,THRB;BGN;DMD;FGFR3;TGFBR2
Antisocial behavior,3/49,0.012607678708895275,0.03352610770444257,0,0,6.607357859531772,28.896944138515423,C3;SNAP25;ALDH2
Dental Enamel Hypoplasia,3/49,0.012607678708895275,0.03352610770444257,0,0,6.607357859531772,28.896944138515423,LAMA3;FGFR3;RUNX2
Malignant hyperpyrexia due to anesthesia,3/49,0.012607678708895275,0.03352610770444257,0,0,6.607357859531772,28.896944138515423,DMD;TLR4;RUNX2
Multiple Endocrine Neoplasia,3/49,0.012607678708895275,0.03352610770444257,0,0,6.607357859531772,28.896944138515423,CCND1;CXCR4;CIB1
Polyarthritis,3/49,0.012607678708895275,0.03352610770444257,0,0,6.607357859531772,28.896944138515423,ZFP36;VCAN;MMP14
"Cholangitis, Sclerosing",5/140,0.012868418041659495,0.034202393887283515,0,0,3.774131644597966,16.4287164836485,ACTA2;PLAU;ANTXR2;TLR4;SKAP2
Body Height,8/314,0.01320902969089577,0.034962552595775256,0,0,2.6826281389748883,11.607341945505176,GHR;CCND2;EFEMP1;MAML2;TEAD1;ESR1;FLI1;SYNE1
Decreased tendon reflex,6/195,0.013220052088077418,0.034962552595775256,0,0,3.2428902116402116,14.028809549299742,ABCA1;KLC2;MME;FHL1;DMD;SOX10
Adrenal Cortical Adenoma,4/92,0.013237969058823202,0.034962552595775256,0,0,4.619025304592315,19.975742309575832,ABLIM1;NR3C1;ESR1;EGFR
"Leishmaniasis, Cutaneous",3/50,0.013316461594383946,0.034962552595775256,0,0,6.466448445171849,27.927001997452024,CXCL10;CCL2;TLR4
"stage, prostate cancer",3/50,0.013316461594383946,0.034962552595775256,0,0,6.466448445171849,27.927001997452024,EGR1;PROS1;MET
Candidiasis,3/50,0.013316461594383946,0.034962552595775256,0,0,6.466448445171849,27.927001997452024,STAT1;RFX2;EGFR
Dyspnea on exertion,3/50,0.013316461594383946,0.034962552595775256,0,0,6.466448445171849,27.927001997452024,ACTA2;MYLK;TGFBR2
Idiopathic generalized epilepsy,3/50,0.013316461594383946,0.034962552595775256,0,0,6.466448445171849,27.927001997452024,DST;PROS1;F13A1
Lymphedema,3/50,0.013316461594383946,0.034962552595775256,0,0,6.466448445171849,27.927001997452024,HGF;ANTXR2;MET
Microscopic Polyarteritis,3/50,0.013316461594383946,0.034962552595775256,0,0,6.466448445171849,27.927001997452024,PRTN3;ESR1;EGFR
Nephrosis,3/50,0.013316461594383946,0.034962552595775256,0,0,6.466448445171849,27.927001997452024,CFH;CD36;VIM
Reduced subcutaneous adipose tissue,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,CAV1;PPARG
Residual Cancer,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,VIM;ESR1
"B-CELL MALIGNANCY, LOW-GRADE",2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,CCND1;EGFR
"Central Nervous System Embryonal Tumor, Not Otherwise Specified",2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,MUC1;EGFR
Sexually Transmitted Diseases,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,CXCL10;KIT
Short middle phalanx of finger,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,BMPR1B;FGFR3
"Infarction, Lacunar",2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,ALDH2;SORBS1
Smoldering myeloma,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,CCND1;KIT
Stenosis,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,PECAM1;TLR4
Tarsal Coalition,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,BMPR1B;FGFR3
Thymus Hyperplasia,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,CCND1;ESR1
3-Methylglutaconic aciduria type 2,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,DMD;MEST
Venous malformation,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,STAT1;PECAM1
Alexander Disease,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,KRT8;CRYAB
Aneurysmal disease,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,JUN;FOS
Benign neoplasm of stomach,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,KLF6;MET
Carcinoma in situ of stomach,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,KLF6;MET
Choroid Plexus Carcinoma,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,CAV1;TGFBR2
Congenital scar,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,COL17A1;LAMA3
Diastrophic dysplasia,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,A2M;FGFR3
Heat Stroke,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,JUN;FOS
Hyperlipoproteinemia Type I,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,CCND1;LPL
Idiopathic scoliosis,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,GHR;ESR1
Narrowing,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,CD36;ESR1
Neoplasm of uncertain or unknown behavior of stomach,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,KLF6;MET
Niemann-Pick Diseases,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,ABCA1;TLR4
Oppositional Defiant Disorder,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,SNAP25;NR3C1
Papillomatosis,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,CCND1;EGFR
Periventricular Nodular Heterotopia,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,ARF1;MAP1B
Primary antiphospholipid syndrome,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,ABCA1;SKAP2
Primary Cutaneous Anaplastic Large Cell Lymphoma,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,MUC1;CCND1
Pseudohypoaldosteronism,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,NR4A1;SGK1
Pulpitis,2/18,0.013443098192670951,0.034962552595775256,0,0,12.618622448979592,54.37729659500092,CXCL10;TLR4
Exophthalmos,5/142,0.0136134327977718,0.03538828457528094,0,0,3.718656631746152,15.977945508843312,THRB;BGN;PPARG;FGFR3;TGFBR2
Small for gestational age (disorder),4/93,0.013728517068990803,0.035583301294091436,0,0,4.566894474690143,19.58412256520565,THRB;COL1A2;FZD4;PIK3R1
"Muscular Dystrophies, Limb-Girdle",4/93,0.013728517068990803,0.035583301294091436,0,0,4.566894474690143,19.58412256520565,ANXA1;FHL1;DMD;SYNE1
Subarachnoid Hemorrhage,4/93,0.013728517068990803,0.035583301294091436,0,0,4.566894474690143,19.58412256520565,ABCA1;TIMP1;KLF4;AQP1
Low Birth Weights,4/93,0.013728517068990803,0.035583301294091436,0,0,4.566894474690143,19.58412256520565,THRB;COL1A2;FZD4;PIK3R1
Manic,4/93,0.013728517068990803,0.035583301294091436,0,0,4.566894474690143,19.58412256520565,SNAP25;GRK3;CCL2;NR3C1
Mucinous Adenocarcinoma,4/93,0.013728517068990803,0.035583301294091436,0,0,4.566894474690143,19.58412256520565,MUC1;AGR2;ESR1;EGFR
Substance Use Disorders,5/143,0.013996620550510094,0.036260569233674426,0,0,3.691522114590373,15.758884081913882,ABLIM1;LEP;PARVA;TLR4;SYNE1
"Lymphohistiocytosis, Hemophagocytic",3/51,0.014047560603519462,0.03632190706266628,0,0,6.331410256410257,27.00540545253821,KRT18;SIRPA;CCL2
Tumors of Adrenal Cortex,3/51,0.014047560603519462,0.03632190706266628,0,0,6.331410256410257,27.00540545253821,GHR;CCND2;PPARG
Bicuspid aortic valve,3/51,0.014047560603519462,0.03632190706266628,0,0,6.331410256410257,27.00540545253821,ACTA2;EGFR;TGFBR2
Pauci-immune Glomerulonephritis associated with Granulomatosis with Polyangiitis,3/51,0.014047560603519462,0.03632190706266628,0,0,6.331410256410257,27.00540545253821,PRTN3;TIMP1;TLR4
Disease Exacerbation,5/144,0.014387003754237255,0.03718154365001471,0,0,3.664778022141872,15.543899435388422,ZEB2;STAT1;TXNIP;ESR1;EGFR
Behcet Syndrome,7/258,0.014593279031423713,0.03769635674185989,0,0,2.8546963976554514,12.067356045139611,CXCL10;VWF;LEP;TAP1;CCL2;TLR4;FOXO1
Decreased antibody level in blood,3/52,0.014801062374415972,0.03811683080328046,0,0,6.201883830455259,26.128885859948436,CCND1;CXCR4;PIK3R1
Desmoplastic Medulloblastoma,3/52,0.014801062374415972,0.03811683080328046,0,0,6.201883830455259,26.128885859948436,IRS2;S100A4;FLI1
Generalized hirsutism,3/52,0.014801062374415972,0.03811683080328046,0,0,6.201883830455259,26.128885859948436,CAV1;PPARG;FOS
Speech impairment,6/200,0.01481370070245473,0.03811683080328046,0,0,3.158505154639175,13.30426426657909,RPS6KA3;MEF2C;THRB;DMD;PIK3R1;BMPR1B
"Anaplastic Large Cell Lymphoma, ALK-Positive",2/19,0.014927721127124474,0.03811683080328046,0,0,11.875750300120048,49.9320115437787,STAT1;TPM3
Research-Related Injuries,2/19,0.014927721127124474,0.03811683080328046,0,0,11.875750300120048,49.9320115437787,LAMA3;SPP1
Staphylococcal Infections,2/19,0.014927721127124474,0.03811683080328046,0,0,11.875750300120048,49.9320115437787,CD36;EGFR
"stage, cervical cancer",2/19,0.014927721127124474,0.03811683080328046,0,0,11.875750300120048,49.9320115437787,MDK;EZR
"THANATOPHORIC DYSPLASIA, TYPE I (disorder)",2/19,0.014927721127124474,0.03811683080328046,0,0,11.875750300120048,49.9320115437787,STAT1;FGFR3
Traumatic injury,2/19,0.014927721127124474,0.03811683080328046,0,0,11.875750300120048,49.9320115437787,LAMA3;SPP1
Wounds and Injuries,2/19,0.014927721127124474,0.03811683080328046,0,0,11.875750300120048,49.9320115437787,LAMA3;SPP1
Amyloid angiopathy,2/19,0.014927721127124474,0.03811683080328046,0,0,11.875750300120048,49.9320115437787,MME;CTSD
Apert syndrome,2/19,0.014927721127124474,0.03811683080328046,0,0,11.875750300120048,49.9320115437787,CCND1;FGFR3
Asymmetric Septal Hypertrophy,2/19,0.014927721127124474,0.03811683080328046,0,0,11.875750300120048,49.9320115437787,CD36;TLR4
Congenital Hydrocephalus,2/19,0.014927721127124474,0.03811683080328046,0,0,11.875750300120048,49.9320115437787,KLF6;MPDZ
Endogenous Hyperinsulinism,2/19,0.014927721127124474,0.03811683080328046,0,0,11.875750300120048,49.9320115437787,LEP;LEPR
Exogenous Hyperinsulinism,2/19,0.014927721127124474,0.03811683080328046,0,0,11.875750300120048,49.9320115437787,LEP;LEPR
Fallopian Tube Carcinoma,2/19,0.014927721127124474,0.03811683080328046,0,0,11.875750300120048,49.9320115437787,CIB1;EGFR
Female Urogenital Diseases,2/19,0.014927721127124474,0.03811683080328046,0,0,11.875750300120048,49.9320115437787,TIMP1;ESR1
Fragile nails,2/19,0.014927721127124474,0.03811683080328046,0,0,11.875750300120048,49.9320115437787,COL17A1;LAMA3
Injury wounds,2/19,0.014927721127124474,0.03811683080328046,0,0,11.875750300120048,49.9320115437787,LAMA3;SPP1
Lipidemias,2/19,0.014927721127124474,0.03811683080328046,0,0,11.875750300120048,49.9320115437787,LEPR;LPL
Lobular Neoplasia,2/19,0.014927721127124474,0.03811683080328046,0,0,11.875750300120048,49.9320115437787,CFH;ESR1
Pulmonary Infiltrate,2/19,0.014927721127124474,0.03811683080328046,0,0,11.875750300120048,49.9320115437787,CAV1;PRTN3
Erythrocyte Mean Corpuscular Hemoglobin Test,9/387,0.015256975856806652,0.038876396459517154,0,0,2.4469639707734947,10.234961340398938,TF;MEF2C;THRB;ALDH2;ITSN1;ADAM12;LEPR;E2F2;CALR
Finding of Mean Corpuscular Hemoglobin,9/387,0.015256975856806652,0.038876396459517154,0,0,2.4469639707734947,10.234961340398938,TF;MEF2C;THRB;ALDH2;ITSN1;ADAM12;LEPR;E2F2;CALR
Retinal Detachment,4/96,0.015268961867098781,0.038876396459517154,0,0,4.417301658449126,18.472860226607835,CXCL12;FZD4;CCL2;FBLN2
"PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE",4/96,0.015268961867098781,0.038876396459517154,0,0,4.417301658449126,18.472860226607835,UBE2L6;DMD;ESR1;EGFR
Werner Syndrome,4/96,0.015268961867098781,0.038876396459517154,0,0,4.417301658449126,18.472860226607835,RPS6KA3;EFEMP1;TIMP1;DCN
IMMUNE SUPPRESSION,4/96,0.015268961867098781,0.038876396459517154,0,0,4.417301658449126,18.472860226607835,DUSP1;STAT1;DMD;EGFR
Interstitial Cystitis,3/53,0.01557704391187205,0.0396229436784564,0,0,6.077538461538461,25.294453697927946,CXCL10;CCND1;VIM
Myeloid neoplasm,3/53,0.01557704391187205,0.0396229436784564,0,0,6.077538461538461,25.294453697927946,EGR1;NR4A1;KIT
Ductal Breast Carcinoma,4/97,0.01580564630690436,0.0401660892558385,0,0,4.36958208624321,18.122352491235524,RPS6KA3;CCND1;ESR1;EGFR
Ovarian Serous Adenocarcinoma,4/97,0.01580564630690436,0.0401660892558385,0,0,4.36958208624321,18.122352491235524,GSN;LAMA3;KRT8;CALR
Dilated ventricles (finding),6/204,0.016181304890124037,0.04110113143921401,0,0,3.0940656565656566,12.759613407714369,ACTA2;RPS6KA3;MEF2C;CCND2;FGFR3;FLI1
Hypercalcemia,4/98,0.016354060865679677,0.04126832530816936,0,0,4.322877824084229,17.781202752720034,VIM;ESR1;FGFR3;EGFR
"Hemophilia, NOS",3/54,0.016375572804880743,0.04126832530816936,0,0,5.9580693815987935,24.49936989066364,F8;VWF;CXCR4
Diabetic Cardiomyopathies,3/54,0.016375572804880743,0.04126832530816936,0,0,5.9580693815987935,24.49936989066364,LEP;SPP1;TXNIP
Hepatocellular Adenoma,3/54,0.016375572804880743,0.04126832530816936,0,0,5.9580693815987935,24.49936989066364,SREBF1;SAA1;A2M
Malignant neoplasm of nasopharynx,3/54,0.016375572804880743,0.04126832530816936,0,0,5.9580693815987935,24.49936989066364,HGF;PLK1;SAA1
Pancreatic Diseases,3/54,0.016375572804880743,0.04126832530816936,0,0,5.9580693815987935,24.49936989066364,KRT19;LEPR;SPP1
Adrenoleukodystrophy,5/149,0.016448765348731027,0.04126832530816936,0,0,3.536629245826137,14.526721813041766,SOCS3;TCF7L2;SPP1;CCL2;TLR4
Rokitansky Kuster Hauser syndrome,2/20,0.016479451352183223,0.04126832530816936,0,0,11.215419501133788,46.046486660840145,LAMC1;ESR1
"Jaundice, Obstructive",2/20,0.016479451352183223,0.04126832530816936,0,0,11.215419501133788,46.046486660840145,CFH;CCL2
Tonsillar Carcinoma,2/20,0.016479451352183223,0.04126832530816936,0,0,11.215419501133788,46.046486660840145,VIM;EGFR
Alveolar Soft Part Sarcoma,2/20,0.016479451352183223,0.04126832530816936,0,0,11.215419501133788,46.046486660840145,KDR;MET
Arteriosclerosis Obliterans,2/20,0.016479451352183223,0.04126832530816936,0,0,11.215419501133788,46.046486660840145,CXCL12;HGF
Cerebral Vasospasm,2/20,0.016479451352183223,0.04126832530816936,0,0,11.215419501133788,46.046486660840145,S100A4;TIMP1
Chronic multifocal osteomyelitis,2/20,0.016479451352183223,0.04126832530816936,0,0,11.215419501133788,46.046486660840145,STAT1;TLR4
Chronic myocardial ischemia,2/20,0.016479451352183223,0.04126832530816936,0,0,11.215419501133788,46.046486660840145,HGF;CCL2
Compensatory Hyperinsulinemia,2/20,0.016479451352183223,0.04126832530816936,0,0,11.215419501133788,46.046486660840145,LEP;LEPR
Congenital abnormality of vein,2/20,0.016479451352183223,0.04126832530816936,0,0,11.215419501133788,46.046486660840145,STAT1;PECAM1
Constitutional Symptom,2/20,0.016479451352183223,0.04126832530816936,0,0,11.215419501133788,46.046486660840145,CXCL10;HGF
Cutaneous Fibrous Histiocytoma,2/20,0.016479451352183223,0.04126832530816936,0,0,11.215419501133788,46.046486660840145,ESR1;TGFBR2
Destructive Arthritis,2/20,0.016479451352183223,0.04126832530816936,0,0,11.215419501133788,46.046486660840145,JUN;TIMP1
Eczema Herpeticum,2/20,0.016479451352183223,0.04126832530816936,0,0,11.215419501133788,46.046486660840145,CAV2;CAV1
Endometrial Endometrioid Adenocarcinoma,2/20,0.016479451352183223,0.04126832530816936,0,0,11.215419501133788,46.046486660840145,ESR1;FOXO1
Endophthalmitis,2/20,0.016479451352183223,0.04126832530816936,0,0,11.215419501133788,46.046486660840145,SOX10;TLR4
Filarial Elephantiases,2/20,0.016479451352183223,0.04126832530816936,0,0,11.215419501133788,46.046486660840145,SOCS3;TLR4
Hypophosphatasia,2/20,0.016479451352183223,0.04126832530816936,0,0,11.215419501133788,46.046486660840145,FGFR3;TNS1
Hypoplasia of iris,2/20,0.016479451352183223,0.04126832530816936,0,0,11.215419501133788,46.046486660840145,PIK3R1;SOX10
Infantile neuronal ceroid lipofuscinosis,2/20,0.016479451352183223,0.04126832530816936,0,0,11.215419501133788,46.046486660840145,DPYSL2;VIM
malignant neoplasm of breast staging,2/20,0.016479451352183223,0.04126832530816936,0,0,11.215419501133788,46.046486660840145,CCND1;ESR1
Ovarian Clear Cell Adenocarcinoma,2/20,0.016479451352183223,0.04126832530816936,0,0,11.215419501133788,46.046486660840145,ESR1;MET
Peyronie Disease,2/20,0.016479451352183223,0.04126832530816936,0,0,11.215419501133788,46.046486660840145,CCND1;CCL2
Language Delay,6/206,0.016896823363761023,0.04229364570478276,0,0,3.0628125,12.498203473435314,RPS6KA3;MEF2C;THRB;DMD;PIK3R1;BMPR1B
"Bone Diseases, Developmental",3/55,0.017196707468804112,0.04296355091479471,0,0,5.84319526627219,23.74112055013548,RPS6KA3;BMPR1B;FGFR3
Russell-Silver syndrome,3/55,0.017196707468804112,0.04296355091479471,0,0,5.84319526627219,23.74112055013548,GHR;MEST;EGFR
Bone pain,3/55,0.017196707468804112,0.04296355091479471,0,0,5.84319526627219,23.74112055013548,MEF2C;CCND1;PLAU
Primary central nervous system lymphoma,3/55,0.017196707468804112,0.04296355091479471,0,0,5.84319526627219,23.74112055013548,MME;BCL6;CIB1
Liver Dysfunction,6/207,0.017262638951044663,0.043108061373063264,0,0,3.0474191542288556,12.370116471688103,ACTA2;SOCS3;NRP1;CCL2;DMD;FADD
Constipation,6/208,0.01763387301053804,0.044014477411314853,0,0,3.032178217821782,12.243734378919994,THRB;KIT;FOS;SOX10;FLI1;TGFBR2
Respiratory insufficiency due to muscle weakness,3/56,0.01804049737404705,0.0446059204341889,0,0,5.732656023222061,23.017394687188755,TPM3;FHL1;CRYAB
Caries (morphologic abnormality),3/56,0.01804049737404705,0.0446059204341889,0,0,5.732656023222061,23.017394687188755,CXCL10;MMP14;RUNX2
Gastrointestinal Diseases,3/56,0.01804049737404705,0.0446059204341889,0,0,5.732656023222061,23.017394687188755,S100A8;MYLK;TGFBR2
Gonorrhea,3/56,0.01804049737404705,0.0446059204341889,0,0,5.732656023222061,23.017394687188755,CFH;CAV1;TLR4
Forced expiratory volume function,4/101,0.01807041000752177,0.0446059204341889,0,0,4.188542884472314,16.81063093752566,LRP1;SVEP1;TNS1;SYNE1
Respiratory Hypersensitivity,2/21,0.018096828669303136,0.0446059204341889,0,0,10.624597207303974,42.626081270062826,CCL11;TLR4
SMITH-MCCORT DYSPLASIA 1,2/21,0.018096828669303136,0.0446059204341889,0,0,10.624597207303974,42.626081270062826,KLF4;RUNX2
"Neoplasms, Neuroepithelial",2/21,0.018096828669303136,0.0446059204341889,0,0,10.624597207303974,42.626081270062826,ANXA1;SOX10
"Oncocytoma, renal",2/21,0.018096828669303136,0.0446059204341889,0,0,10.624597207303974,42.626081270062826,CCND1;PROS1
Sudden Cardiac Arrest,2/21,0.018096828669303136,0.0446059204341889,0,0,10.624597207303974,42.626081270062826,MAML2;ESR1
Xanthoma,2/21,0.018096828669303136,0.0446059204341889,0,0,10.624597207303974,42.626081270062826,ABCA1;CCL2
allergic symptom,2/21,0.018096828669303136,0.0446059204341889,0,0,10.624597207303974,42.626081270062826,SPP1;SERPING1
Amyloid nephropathy,2/21,0.018096828669303136,0.0446059204341889,0,0,10.624597207303974,42.626081270062826,GSN;SAA1
AORTIC VALVE DISEASE 2,2/21,0.018096828669303136,0.0446059204341889,0,0,10.624597207303974,42.626081270062826,ACTA2;TGFBR2
Asthma chronic,2/21,0.018096828669303136,0.0446059204341889,0,0,10.624597207303974,42.626081270062826,TIMP1;EGFR
Choroid Plexus Papilloma,2/21,0.018096828669303136,0.0446059204341889,0,0,10.624597207303974,42.626081270062826,LEP;LEPR
Classical galactosemia,2/21,0.018096828669303136,0.0446059204341889,0,0,10.624597207303974,42.626081270062826,DMD;S100A8
Esophageal Stenosis,2/21,0.018096828669303136,0.0446059204341889,0,0,10.624597207303974,42.626081270062826,LAMA3;KIT
Fibrolamellar Hepatocellular Carcinoma,2/21,0.018096828669303136,0.0446059204341889,0,0,10.624597207303974,42.626081270062826,CCND1;EGFR
Gitelman Syndrome,2/21,0.018096828669303136,0.0446059204341889,0,0,10.624597207303974,42.626081270062826,RGS2;DMD
Indolent Non-Hodgkin Lymphoma,2/21,0.018096828669303136,0.0446059204341889,0,0,10.624597207303974,42.626081270062826,BCL3;CDC25B
Latent Tuberculosis,2/21,0.018096828669303136,0.0446059204341889,0,0,10.624597207303974,42.626081270062826,CXCL10;CCL2
Limited elbow extension,2/21,0.018096828669303136,0.0446059204341889,0,0,10.624597207303974,42.626081270062826,BGN;FGFR3
Lumbar disc disease,2/21,0.018096828669303136,0.0446059204341889,0,0,10.624597207303974,42.626081270062826,ESR1;FGFR3
Myomatous neoplasm,2/21,0.018096828669303136,0.0446059204341889,0,0,10.624597207303974,42.626081270062826,NEDD9;FOXO1
Pathological accumulation of air in tissues,2/21,0.018096828669303136,0.0446059204341889,0,0,10.624597207303974,42.626081270062826,HGF;MET
Polymyalgia Rheumatica,2/21,0.018096828669303136,0.0446059204341889,0,0,10.624597207303974,42.626081270062826,KRT15;CXCR4
Childhood Acute Myeloid Leukemia,4/102,0.018666457931082864,0.04598869824999565,0,0,4.145592257521566,16.503714953773493,MEF2C;KIT;CXCR4;TLR4
Abnormality of the voice,3/57,0.01890698326246999,0.04643102018695971,0,0,5.626210826210826,22.326064494152536,FHL1;SOX10;TGFBR2
Ameloblastoma,3/57,0.01890698326246999,0.04643102018695971,0,0,5.626210826210826,22.326064494152536,FOS;VIM;EGFR
Cardiac defects,3/57,0.01890698326246999,0.04643102018695971,0,0,5.626210826210826,22.326064494152536,RCAN1;MMP14;ALDH2
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,3/57,0.01890698326246999,0.04643102018695971,0,0,5.626210826210826,22.326064494152536,CCND2;CCND1;DUSP1
Geographic Atrophy,3/57,0.01890698326246999,0.04643102018695971,0,0,5.626210826210826,22.326064494152536,C3;ABCA1;CFH
Malignant neoplasm of colon stage IV,3/57,0.01890698326246999,0.04643102018695971,0,0,5.626210826210826,22.326064494152536,CCND1;CAV1;EGFR
Necrosis,3/57,0.01890698326246999,0.04643102018695971,0,0,5.626210826210826,22.326064494152536,KRT18;LPL;DMD
Mood Disorders,8/336,0.01905745927189401,0.046778996066293495,0,0,2.4998716302952504,9.900233345935687,DST;PPARG;DMD;PIK3R1;CALR;FKBP4;NR3C1;ESR1
Substance abuse problem,5/155,0.019171417088592317,0.046999361930549585,0,0,3.3941278065630396,13.42151770947499,ABLIM1;CXCR4;PARVA;ESR1;SYNE1
Abnormality of metabolism/homeostasis,5/155,0.019171417088592317,0.046999361930549585,0,0,3.3941278065630396,13.42151770947499,GHR;ZEB2;KIT;FGFR3;CTSD
Growth failure,6/212,0.019173693532935784,0.046999361930549585,0,0,2.9726941747572817,11.754675070854114,GHR;STAT5B;DST;KRT5;NR3C1;FGFR3
HIV Coinfection,4/103,0.01927458056615627,0.04722493785611345,0,0,4.103509320004165,16.204627485969155,CCT3;CXCL12;CCL11;CCL2
Speech Delay,6/213,0.01957254147037351,0.04793293818732557,0,0,2.9581823671497585,11.636387924693931,RPS6KA3;MEF2C;THRB;DMD;PIK3R1;BMPR1B
"Breast cancer, lobular",2/22,0.01977841494840752,0.048082924240465445,0,0,10.092857142857143,39.595934708889004,MUC1;EGFR
Saethre-Chotzen Syndrome,2/22,0.01977841494840752,0.048082924240465445,0,0,10.092857142857143,39.595934708889004,FGFR3;RUNX2
"Leukemia, T-Cell, Chronic",2/22,0.01977841494840752,0.048082924240465445,0,0,10.092857142857143,39.595934708889004,STAT5A;STAT5B
Spade-like hand,2/22,0.01977841494840752,0.048082924240465445,0,0,10.092857142857143,39.595934708889004,RPS6KA3;FHL1
"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A",2/22,0.01977841494840752,0.048082924240465445,0,0,10.092857142857143,39.595934708889004,DMD;TIMP1
"Psychoses, Drug",2/22,0.01977841494840752,0.048082924240465445,0,0,10.092857142857143,39.595934708889004,CALR;ESR1
"Psychosis, Brief Reactive",2/22,0.01977841494840752,0.048082924240465445,0,0,10.092857142857143,39.595934708889004,SNAP25;NR3C1
AIDS with Kaposi's sarcoma,2/22,0.01977841494840752,0.048082924240465445,0,0,10.092857142857143,39.595934708889004,HGF;KDR
Benign neoplasm of aortic body and other paraganglia,2/22,0.01977841494840752,0.048082924240465445,0,0,10.092857142857143,39.595934708889004,EPAS1;MET
Conduct Disorder,2/22,0.01977841494840752,0.048082924240465445,0,0,10.092857142857143,39.595934708889004,ALDH2;NR3C1
Disorder of Achilles tendon,2/22,0.01977841494840752,0.048082924240465445,0,0,10.092857142857143,39.595934708889004,BGN;TLR4
Hypotrichosis simplex,2/22,0.01977841494840752,0.048082924240465445,0,0,10.092857142857143,39.595934708889004,CCL2;TLR4
Malignant Adrenal Medulla Neoplasm,2/22,0.01977841494840752,0.048082924240465445,0,0,10.092857142857143,39.595934708889004,EPAS1;MET
Malignant neoplasm of aortic body and other paraganglia,2/22,0.01977841494840752,0.048082924240465445,0,0,10.092857142857143,39.595934708889004,EPAS1;MET
Mastitis,2/22,0.01977841494840752,0.048082924240465445,0,0,10.092857142857143,39.595934708889004,RPS6KA3;TLR4
Severe Dengue,3/58,0.019796197369784423,0.048082924240465445,0,0,5.5236363636363635,21.665167856214616,TAP1;CCL2;TLR4
Inclusion Body Myositis (disorder),3/58,0.019796197369784423,0.048082924240465445,0,0,5.5236363636363635,21.665167856214616,CD36;TIMP1;NR3C1
Oncocytic Neoplasm,3/58,0.019796197369784423,0.048082924240465445,0,0,5.5236363636363635,21.665167856214616,KIT;NR3C1;ESR1
Acquired flat foot,4/104,0.01989483973241151,0.048300501564474234,0,0,4.062268041237114,15.913101843028302,RPS6KA3;COL1A2;FLI1;TGFBR2
Cocaine Dependence,5/157,0.0201409263025789,0.0488756813599467,0,0,3.3491273520589036,13.078346997137118,EGR1;PER1;GRK3;FOS;NR3C1
Acne,3/59,0.02070816364581049,0.05016082003114732,0,0,5.424725274725275,21.032892807745707,NR3C1;TLR4;ESR1
AICARDI-GOUTIERES SYNDROME 1,3/59,0.02070816364581049,0.05016082003114732,0,0,5.424725274725275,21.032892807745707,RASD1;CCND1;MME
Hemorrhagic Disorders,3/59,0.02070816364581049,0.05016082003114732,0,0,5.424725274725275,21.032892807745707,C3;F8;VWF
Progeria,3/59,0.02070816364581049,0.05016082003114732,0,0,5.424725274725275,21.032892807745707,SREBF1;TIMP1;FOS
Retinal Vein Occlusion,2/23,0.0215227938545348,0.051617897592626444,0,0,9.61175898931001,36.89610872992742,NRP1;AQP1
Severe hereditary factor VIII deficiency disease,2/23,0.0215227938545348,0.051617897592626444,0,0,9.61175898931001,36.89610872992742,F8;VWF
Stage III Colon Cancer AJCC v7,2/23,0.0215227938545348,0.051617897592626444,0,0,9.61175898931001,36.89610872992742,CXCL12;CXCR4
Stage IV Bladder Cancer AJCC v6,2/23,0.0215227938545348,0.051617897592626444,0,0,9.61175898931001,36.89610872992742,CAV1;FOXO1
Superficial spreading malignant melanoma of skin,2/23,0.0215227938545348,0.051617897592626444,0,0,9.61175898931001,36.89610872992742,YAP1;CCND1
Benign neoplasm of adrenal gland,2/23,0.0215227938545348,0.051617897592626444,0,0,9.61175898931001,36.89610872992742,EPAS1;MET
Cholesteatoma,2/23,0.0215227938545348,0.051617897592626444,0,0,9.61175898931001,36.89610872992742,HGF;CTSD
Chronic arthritis,2/23,0.0215227938545348,0.051617897592626444,0,0,9.61175898931001,36.89610872992742,DUSP1;TLR4
Chronic glomerulonephritis,2/23,0.0215227938545348,0.051617897592626444,0,0,9.61175898931001,36.89610872992742,CFH;CCL2
Congenital hypoplasia of clavicle,2/23,0.0215227938545348,0.051617897592626444,0,0,9.61175898931001,36.89610872992742,BGN;RUNX2
Enthesitis-Related Arthritis,2/23,0.0215227938545348,0.051617897592626444,0,0,9.61175898931001,36.89610872992742,ESR1;TLR4
Ferritin measurement,2/23,0.0215227938545348,0.051617897592626444,0,0,9.61175898931001,36.89610872992742,EPS8;TF
fibroma,2/23,0.0215227938545348,0.051617897592626444,0,0,9.61175898931001,36.89610872992742,CCL2;ANTXR2
Functional Gastrointestinal Disorders,2/23,0.0215227938545348,0.051617897592626444,0,0,9.61175898931001,36.89610872992742,TLR4;MYLK
Increased gastric cancer,2/23,0.0215227938545348,0.051617897592626444,0,0,9.61175898931001,36.89610872992742,KIT;FGFR3
Job Syndrome,2/23,0.0215227938545348,0.051617897592626444,0,0,9.61175898931001,36.89610872992742,STAT1;CCL2
Lipids measurement,2/23,0.0215227938545348,0.051617897592626444,0,0,9.61175898931001,36.89610872992742,ABCA1;LPL
Liver cyst,2/23,0.0215227938545348,0.051617897592626444,0,0,9.61175898931001,36.89610872992742,KRT19;PKD2
Menorrhagia,2/23,0.0215227938545348,0.051617897592626444,0,0,9.61175898931001,36.89610872992742,VWF;PLAU
Neuroepithelioma,2/23,0.0215227938545348,0.051617897592626444,0,0,9.61175898931001,36.89610872992742,EGFR;FLI1
Osteophyte,2/23,0.0215227938545348,0.051617897592626444,0,0,9.61175898931001,36.89610872992742,LEP;SPP1
Pseudoaphakia,2/23,0.0215227938545348,0.051617897592626444,0,0,9.61175898931001,36.89610872992742,VIM;CRYAB
Absence Epilepsy,3/60,0.021642897959238256,0.0518359565055194,0,0,5.329284750337382,20.427563690905835,EGR1;MEF2C;ESR1
Gastrointestinal Stromal Sarcoma,3/60,0.021642897959238256,0.0518359565055194,0,0,5.329284750337382,20.427563690905835,KIT;DMD;TGFBR2
Post-Traumatic Osteoporosis,3/60,0.021642897959238256,0.0518359565055194,0,0,5.329284750337382,20.427563690905835,GSN;COL1A2;ANTXR2
Flatfoot,4/108,0.022498395646189637,0.05386071446475498,0,0,3.9052339413164154,14.817673182578273,RPS6KA3;COL1A2;FLI1;TGFBR2
Delayed speech and language development,6/220,0.022523787081771024,0.05389728844129223,0,0,2.8603971962616823,10.850010946545776,RPS6KA3;MEF2C;THRB;DMD;PIK3R1;BMPR1B
"Depression, Bipolar",3/61,0.022600408305363247,0.05403211119752388,0,0,5.237135278514589,19.84762879967108,SNAP25;GRK3;NR3C1
Leukoplakia,3/61,0.022600408305363247,0.05403211119752388,0,0,5.237135278514589,19.84762879967108,KRT19;FGFR3;EGFR
"Acute myeloid leukemia, minimal differentiation",2/24,0.023328570549778514,0.05527699086694962,0,0,9.174397031539888,34.478085571504906,MME;SIRPA
"Angioedemas, Hereditary",2/24,0.023328570549778514,0.05527699086694962,0,0,9.174397031539888,34.478085571504906,SERPING1;A2M
Secondary hypothyroidism,2/24,0.023328570549778514,0.05527699086694962,0,0,9.174397031539888,34.478085571504906,LEP;LEPR
"Leukemia, Mast-Cell",2/24,0.023328570549778514,0.05527699086694962,0,0,9.174397031539888,34.478085571504906,KIT;KDR
Thickened calvaria,2/24,0.023328570549778514,0.05527699086694962,0,0,9.174397031539888,34.478085571504906,RPS6KA3;RUNX2
Uterine Neoplasms,2/24,0.023328570549778514,0.05527699086694962,0,0,9.174397031539888,34.478085571504906,ESR1;EGFR
X-linked centronuclear myopathy,2/24,0.023328570549778514,0.05527699086694962,0,0,9.174397031539888,34.478085571504906,TPM3;VIM
Asymptomatic human immunodeficiency virus infection,2/24,0.023328570549778514,0.05527699086694962,0,0,9.174397031539888,34.478085571504906,CXCL10;EGFR
Basophilic leukemia,2/24,0.023328570549778514,0.05527699086694962,0,0,9.174397031539888,34.478085571504906,FOS;CD36
bilateral breast cancer,2/24,0.023328570549778514,0.05527699086694962,0,0,9.174397031539888,34.478085571504906,RPS6KA3;ESR1
Carotid artery occlusion,2/24,0.023328570549778514,0.05527699086694962,0,0,9.174397031539888,34.478085571504906,EGR1;HGF
Childhood Solid Neoplasm,2/24,0.023328570549778514,0.05527699086694962,0,0,9.174397031539888,34.478085571504906,MDK;FOXO1
Congenital hypoplasia of adrenal gland,2/24,0.023328570549778514,0.05527699086694962,0,0,9.174397031539888,34.478085571504906,CXCL10;SOCS3
Eosinophilic granulomatosis with polyangiitis,2/24,0.023328570549778514,0.05527699086694962,0,0,9.174397031539888,34.478085571504906,LEPR;PRTN3
Increased thickness of cranium,2/24,0.023328570549778514,0.05527699086694962,0,0,9.174397031539888,34.478085571504906,RPS6KA3;RUNX2
Norrie disease,2/24,0.023328570549778514,0.05527699086694962,0,0,9.174397031539888,34.478085571504906,FZD4;PLAU
Ovarian Diseases,2/24,0.023328570549778514,0.05527699086694962,0,0,9.174397031539888,34.478085571504906,CCND1;SPP1
Peripheral demyelination,2/24,0.023328570549778514,0.05527699086694962,0,0,9.174397031539888,34.478085571504906,ABCA1;SOX10
Precocious pubarche,2/24,0.023328570549778514,0.05527699086694962,0,0,9.174397031539888,34.478085571504906,SORBS1;NR3C1
Pure gonadal dysgenesis,2/24,0.023328570549778514,0.05527699086694962,0,0,9.174397031539888,34.478085571504906,KIT;FGFR3
Microphthalmos,6/222,0.023419160113915302,0.05546697966535762,0,0,2.833622685185185,10.637988504503264,YAP1;MME;KIT;E2F2;CIB1;MET
Xerostomia,3/62,0.023580695019013095,0.05572573115579636,0,0,5.148109517601043,19.291649327691985,CA12;CAV1;FGFR3
Heroin Dependence,3/62,0.023580695019013095,0.05572573115579636,0,0,5.148109517601043,19.291649327691985,ALDH2;LEP;MPDZ
Macular degeneration,3/62,0.023580695019013095,0.05572573115579636,0,0,5.148109517601043,19.291649327691985,EFEMP1;CFH;CD36
Marijuana Abuse,3/62,0.023580695019013095,0.05572573115579636,0,0,5.148109517601043,19.291649327691985,ABCA1;ESR1;EGFR
Precursor cell lymphoblastic lymphoma,3/62,0.023580695019013095,0.05572573115579636,0,0,5.148109517601043,19.291649327691985,CCND1;BCL6;LMO2
Atrial Septal Defects,5/165,0.02433831062265224,0.057490628239412145,0,0,3.1803756476683938,11.817333247471566,ACTA2;SNAP25;NRP1;ZEB2;DMD
Plasmacytoma,4/111,0.0245811758160908,0.0578651982753253,0,0,3.7951633105308797,14.064018811117286,CCND1;STAT1;KIT;PECAM1
"Bulbo-Spinal Atrophy, X-Linked",3/63,0.024583750965535087,0.0578651982753253,0,0,5.062051282051282,18.75828946928507,STAT1;PPARG;MET
"Large, late-closing fontanelle",3/63,0.024583750965535087,0.0578651982753253,0,0,5.062051282051282,18.75828946928507,THRB;COL1A2;RUNX2
Abdomen distended,3/63,0.024583750965535087,0.0578651982753253,0,0,5.062051282051282,18.75828946928507,ZEB2;THRB;MYLK
Viral hepatitis,3/63,0.024583750965535087,0.0578651982753253,0,0,5.062051282051282,18.75828946928507,CXCL10;ALDH2;LEP
Wide bregma sutures,3/63,0.024583750965535087,0.0578651982753253,0,0,5.062051282051282,18.75828946928507,THRB;COL1A2;RUNX2
Large bregma sutures,3/63,0.024583750965535087,0.0578651982753253,0,0,5.062051282051282,18.75828946928507,THRB;COL1A2;RUNX2
Large fontanelle,3/63,0.024583750965535087,0.0578651982753253,0,0,5.062051282051282,18.75828946928507,THRB;COL1A2;RUNX2
Tooth Attrition,2/25,0.02519437140945269,0.05898980898109551,0,0,8.775066548358474,32.30220166920191,RCAN1;SAA1
Ulnar deviation of the fingers,2/25,0.02519437140945269,0.05898980898109551,0,0,8.775066548358474,32.30220166920191,LIFR;BMPR1B
Abnormality of the liver,2/25,0.02519437140945269,0.05898980898109551,0,0,8.775066548358474,32.30220166920191,ABCA1;TF
Uterine Carcinosarcoma,2/25,0.02519437140945269,0.05898980898109551,0,0,8.775066548358474,32.30220166920191,PIK3R1;EGFR
Aortic Diseases,2/25,0.02519437140945269,0.05898980898109551,0,0,8.775066548358474,32.30220166920191,ACTA2;LAMC1
Congenital infectious disease,2/25,0.02519437140945269,0.05898980898109551,0,0,8.775066548358474,32.30220166920191,ADAM12;TLR4
Dyspepsia,2/25,0.02519437140945269,0.05898980898109551,0,0,8.775066548358474,32.30220166920191,LEP;S100A8
Hepatic Form of Wilson Disease,2/25,0.02519437140945269,0.05898980898109551,0,0,8.775066548358474,32.30220166920191,TIMP1;A2M
Hyperostosis,2/25,0.02519437140945269,0.05898980898109551,0,0,8.775066548358474,32.30220166920191,FGFR3;RUNX2
Lupus anticoagulant disorder,2/25,0.02519437140945269,0.05898980898109551,0,0,8.775066548358474,32.30220166920191,F8;VWF
Lymphomatoid Papulosis,2/25,0.02519437140945269,0.05898980898109551,0,0,8.775066548358474,32.30220166920191,KIT;CXCR4
Malignant neoplasm of penis,2/25,0.02519437140945269,0.05898980898109551,0,0,8.775066548358474,32.30220166920191,ANXA1;EGFR
Synovitis,4/112,0.02530047105927401,0.0591862204894079,0,0,3.759831996945399,13.824647578586625,PLAU;STAT1;SPP1;PRTN3
Uric acid measurement (procedure),4/112,0.02530047105927401,0.0591862204894079,0,0,3.759831996945399,13.824647578586625,MUC1;ALDH2;SPP1;PKD2
"Osteoporosis, Senile",3/64,0.02560956173282167,0.059804274528574355,0,0,4.978814627994955,18.246307531510734,GSN;COL1A2;ANTXR2
Uterine Cancer,3/64,0.02560956173282167,0.059804274528574355,0,0,4.978814627994955,18.246307531510734,CCND1;ESR1;EGFR
Hirsutism,3/64,0.02560956173282167,0.059804274528574355,0,0,4.978814627994955,18.246307531510734,CAV1;PPARG;NR3C1
Muscle biopsy shows dystrophic changes,3/64,0.02560956173282167,0.059804274528574355,0,0,4.978814627994955,18.246307531510734,DMD;CRYAB;SYNE1
Erythema,4/113,0.026032353906683087,0.06076496450666411,0,0,3.725148964343138,13.590889856180802,ALDH2;KIT;SERPING1;KRT5
"HEMOCHROMATOSIS, TYPE 1",3/65,0.02665810584757164,0.06206249281857111,0,0,4.898263027295285,17.754547935661442,TF;ALDH2;CALR
"Multiple, subcutaneous nodules",3/65,0.02665810584757164,0.06206249281857111,0,0,4.898263027295285,17.754547935661442,KIT;ANTXR2;TLR4
Subcutaneous nodule,3/65,0.02665810584757164,0.06206249281857111,0,0,4.898263027295285,17.754547935661442,KIT;ANTXR2;TLR4
"Stress, Psychological",3/65,0.02665810584757164,0.06206249281857111,0,0,4.898263027295285,17.754547935661442,KLF6;LEP;NR3C1
Mammary Ductal Carcinoma,3/65,0.02665810584757164,0.06206249281857111,0,0,4.898263027295285,17.754547935661442,CAV2;CAV1;ESR1
Melanocytic nevus of skin,3/65,0.02665810584757164,0.06206249281857111,0,0,4.898263027295285,17.754547935661442,VCAN;CCND1;HGF
Head and Neck Carcinoma,4/114,0.02677686292729476,0.062284549340704404,0,0,3.6910965323336455,13.362570739635308,MMP14;CCND1;EGFR;TGFBR2
Joint hyperflexibility,4/114,0.02677686292729476,0.062284549340704404,0,0,3.6910965323336455,13.362570739635308,RPS6KA3;COL1A2;PIK3R1;FGFR3
"Arthritis, Gouty",2/26,0.027118843760692908,0.06264253073287061,0,0,8.409013605442176,30.335739008548607,MUC1;TLR4
Schizophreniform Disorders,2/26,0.027118843760692908,0.06264253073287061,0,0,8.409013605442176,30.335739008548607,SNAP25;NR3C1
"Osteoarthrosis, localized, not specified whether primary or secondary",2/26,0.027118843760692908,0.06264253073287061,0,0,8.409013605442176,30.335739008548607,CAV1;PECAM1
"Tuberculosis, Meningeal",2/26,0.027118843760692908,0.06264253073287061,0,0,8.409013605442176,30.335739008548607,CCL2;TIMP1
AA amyloidosis,2/26,0.027118843760692908,0.06264253073287061,0,0,8.409013605442176,30.335739008548607,SAA1;TLR4
Acute hepatitis,2/26,0.027118843760692908,0.06264253073287061,0,0,8.409013605442176,30.335739008548607,GOLM1;HGF
Adult T Acute Lymphoblastic Leukemia,2/26,0.027118843760692908,0.06264253073287061,0,0,8.409013605442176,30.335739008548607,PLK1;KIT
ANONYCHIA,2/26,0.027118843760692908,0.06264253073287061,0,0,8.409013605442176,30.335739008548607,COL17A1;LAMA3
Aortic root dilatation,2/26,0.027118843760692908,0.06264253073287061,0,0,8.409013605442176,30.335739008548607,ACTA2;TGFBR2
Dermatitis Herpetiformis,2/26,0.027118843760692908,0.06264253073287061,0,0,8.409013605442176,30.335739008548607,COL17A1;PLAU
Hereditary nonpolyposis colorectal carcinoma,2/26,0.027118843760692908,0.06264253073287061,0,0,8.409013605442176,30.335739008548607,FGFR3;TGFBR2
Hyperprolactinemia,2/26,0.027118843760692908,0.06264253073287061,0,0,8.409013605442176,30.335739008548607,STAT5B;LPL
Indian childhood cirrhosis,2/26,0.027118843760692908,0.06264253073287061,0,0,8.409013605442176,30.335739008548607,KRT18;KRT8
Pathological fracture,2/26,0.027118843760692908,0.06264253073287061,0,0,8.409013605442176,30.335739008548607,CCND1;LIFR
Pituitary carcinoma,2/26,0.027118843760692908,0.06264253073287061,0,0,8.409013605442176,30.335739008548607,CIB1;EGFR
Plasmablastic lymphoma,2/26,0.027118843760692908,0.06264253073287061,0,0,8.409013605442176,30.335739008548607,MME;BCL6
hearing impairment,7/294,0.02746570100821001,0.06341625679062009,0,0,2.492018899246584,8.958352623080152,COL1A2;THRB;STAT1;SOX10;TLR4;FGFR3;RUNX2
Arachnodactyly,3/66,0.027729354930768665,0.0639695811368252,0,0,4.82026862026862,17.281934022354477,FZD4;FGFR3;TGFBR2
Glycogen storage disease type II,3/66,0.027729354930768665,0.0639695811368252,0,0,4.82026862026862,17.281934022354477,EFEMP1;CFH;CXCR4
Bipolar I disorder,3/67,0.028823273914584644,0.06637823106777077,0,0,4.744711538461538,16.827461546640098,EGR1;ALDH2;CCL2
Cervical Adenocarcinoma,3/67,0.028823273914584644,0.06637823106777077,0,0,4.744711538461538,16.827461546640098,SOCS3;MUC1;EGFR
Congenital Hypothyroidism,3/67,0.028823273914584644,0.06637823106777077,0,0,4.744711538461538,16.827461546640098,GHR;EGR1;RUNX2
Congenital muscular dystrophy (disorder),3/67,0.028823273914584644,0.06637823106777077,0,0,4.744711538461538,16.827461546640098,BGN;DMD;SYNE1
Recurrent skin infections,2/27,0.029100655575342308,0.06638587053124964,0,0,8.072244897959184,28.55148642584497,PIK3R1;KRT5
"Gonadal Dysgenesis, Mixed",2/27,0.029100655575342308,0.06638587053124964,0,0,8.072244897959184,28.55148642584497,KIT;FGFR3
Vascular anomaly,2/27,0.029100655575342308,0.06638587053124964,0,0,8.072244897959184,28.55148642584497,PECAM1;SYNE1
Achondroplasia,2/27,0.029100655575342308,0.06638587053124964,0,0,8.072244897959184,28.55148642584497,FGFR3;DCN
Visual field defects,2/27,0.029100655575342308,0.06638587053124964,0,0,8.072244897959184,28.55148642584497,VCAN;FGFR3
Appendicitis,2/27,0.029100655575342308,0.06638587053124964,0,0,8.072244897959184,28.55148642584497,LEPR;TLR4
Bulbar palsy,2/27,0.029100655575342308,0.06638587053124964,0,0,8.072244897959184,28.55148642584497,GSN;TPM3
Cervical dysplasia,2/27,0.029100655575342308,0.06638587053124964,0,0,8.072244897959184,28.55148642584497,ESR1;EGFR
Congenital vascular anomaly,2/27,0.029100655575342308,0.06638587053124964,0,0,8.072244897959184,28.55148642584497,PECAM1;SYNE1
Coronary Microvascular Disease,2/27,0.029100655575342308,0.06638587053124964,0,0,8.072244897959184,28.55148642584497,BGN;PPARG
Cryoglobulinemia,2/27,0.029100655575342308,0.06638587053124964,0,0,8.072244897959184,28.55148642584497,CXCL10;CCL2
Cutaneous lymphoma,2/27,0.029100655575342308,0.06638587053124964,0,0,8.072244897959184,28.55148642584497,CCND1;BCL6
Episodic abdominal pain,2/27,0.029100655575342308,0.06638587053124964,0,0,8.072244897959184,28.55148642584497,LPL;ESR1
Fluid overload,2/27,0.029100655575342308,0.06638587053124964,0,0,8.072244897959184,28.55148642584497,DUSP1;DMD
Increased susceptibility to fractures,2/27,0.029100655575342308,0.06638587053124964,0,0,8.072244897959184,28.55148642584497,COL1A2;RUNX2
Intermittent abdominal pain,2/27,0.029100655575342308,0.06638587053124964,0,0,8.072244897959184,28.55148642584497,LPL;ESR1
Mixed Oligodendroglioma-Astrocytoma,2/27,0.029100655575342308,0.06638587053124964,0,0,8.072244897959184,28.55148642584497,DTX1;TIMP1
Mucinous neoplasm,2/27,0.029100655575342308,0.06638587053124964,0,0,8.072244897959184,28.55148642584497,MUC1;EGFR
Nevus elasticus,2/27,0.029100655575342308,0.06638587053124964,0,0,8.072244897959184,28.55148642584497,VWF;SPP1
Primary amyloidosis,2/27,0.029100655575342308,0.06638587053124964,0,0,8.072244897959184,28.55148642584497,CCND1;CALR
Protein S Deficiency,2/27,0.029100655575342308,0.06638587053124964,0,0,8.072244897959184,28.55148642584497,F8;PROS1
Reactive systemic amyloidosis,2/27,0.029100655575342308,0.06638587053124964,0,0,8.072244897959184,28.55148642584497,SAA1;TLR4
Anorexia,4/118,0.02988185308782108,0.06803808409812939,0,0,3.5608609151745343,12.50041614067433,TINAGL1;CCND1;LEP;LEPR
Recurrent infections,3/68,0.02993982120662665,0.06803808409812939,0,0,4.671479289940828,16.390192807184754,TF;FADD;ANTXR2
Wiskott-Aldrich Syndrome,3/68,0.02993982120662665,0.06803808409812939,0,0,4.671479289940828,16.390192807184754,CXCL12;CIB1;TIMP1
Adenomatous polyp of colon,3/68,0.02993982120662665,0.06803808409812939,0,0,4.671479289940828,16.390192807184754,MUC1;CCND1;TGFBR2
Angle class 2 malocclusion,3/68,0.02993982120662665,0.06803808409812939,0,0,4.671479289940828,16.390192807184754,RPS6KA3;PIK3R1;FGFR3
Angle class 3 malocclusion,3/68,0.02993982120662665,0.06803808409812939,0,0,4.671479289940828,16.390192807184754,RPS6KA3;PIK3R1;FGFR3
Migraine with Aura,3/68,0.02993982120662665,0.06803808409812939,0,0,4.671479289940828,16.390192807184754,LRP1;ESR1;TGFBR2
Osteoarthritis of hip,3/68,0.02993982120662665,0.06803808409812939,0,0,4.671479289940828,16.390192807184754,SOCS3;LEP;ESR1
Primary hypogonadism,3/68,0.02993982120662665,0.06803808409812939,0,0,4.671479289940828,16.390192807184754,LEP;LEPR;BMPR1B
Giant Cell Arteritis,4/119,0.030689992591719423,0.06971311616422542,0,0,3.5297176154190946,12.296896063976588,KRT15;CCL2;TLR4;S100A8
Adenomatous Polyps,3/69,0.031078948875931073,0.0701933337661641,0,0,4.6004662004662,15.96925132693923,MUC1;TIMP1;CALR
Diabetic Angiopathies,3/69,0.031078948875931073,0.0701933337661641,0,0,4.6004662004662,15.96925132693923,TCF7L2;CCL2;SGK1
"GASTRIC CANCER, INTESTINAL",2/28,0.031138495219217858,0.0701933337661641,0,0,7.76138147566719,26.926641757721413,COL1A2;TLR4
"Hyperglycemia, Postprandial",2/28,0.031138495219217858,0.0701933337661641,0,0,7.76138147566719,26.926641757721413,LEPR;IRS2
"Liposarcoma, well differentiated",2/28,0.031138495219217858,0.0701933337661641,0,0,7.76138147566719,26.926641757721413,JUN;EGFR
"Lung Diseases, Obstructive",2/28,0.031138495219217858,0.0701933337661641,0,0,7.76138147566719,26.926641757721413,NR3C1;A2M
"Lymphoma, AIDS-Related",2/28,0.031138495219217858,0.0701933337661641,0,0,7.76138147566719,26.926641757721413,CXCL12;BCL6
"Lymphoma, Small Noncleaved-Cell",2/28,0.031138495219217858,0.0701933337661641,0,0,7.76138147566719,26.926641757721413,MME;BCL6
von Willebrand Disease,2/28,0.031138495219217858,0.0701933337661641,0,0,7.76138147566719,26.926641757721413,F8;VWF
Childhood Burkitt Lymphoma,2/28,0.031138495219217858,0.0701933337661641,0,0,7.76138147566719,26.926641757721413,BCL6;KIT
Condylomata Acuminata,2/28,0.031138495219217858,0.0701933337661641,0,0,7.76138147566719,26.926641757721413,JUN;STAT1
Hyperemia,2/28,0.031138495219217858,0.0701933337661641,0,0,7.76138147566719,26.926641757721413,HGF;ESR1
Low serum estradiol levels,2/28,0.031138495219217858,0.0701933337661641,0,0,7.76138147566719,26.926641757721413,LEP;LEPR
Malignant Mesothelioma of Peritoneum,2/28,0.031138495219217858,0.0701933337661641,0,0,7.76138147566719,26.926641757721413,CXCL12;EGFR
Oligomenorrhea,2/28,0.031138495219217858,0.0701933337661641,0,0,7.76138147566719,26.926641757721413,PPARG;NR3C1
Placental Insufficiency,2/28,0.031138495219217858,0.0701933337661641,0,0,7.76138147566719,26.926641757721413,LEP;KDR
Plasma cell dyscrasia,2/28,0.031138495219217858,0.0701933337661641,0,0,7.76138147566719,26.926641757721413,CCND2;CCND1
Pseudomonas aeruginosa infection,2/28,0.031138495219217858,0.0701933337661641,0,0,7.76138147566719,26.926641757721413,PPARG;S100A8
Neurologic Symptoms,4/120,0.03151094249203708,0.07100288056662393,0,0,3.499111269107714,12.097898728379377,ANXA1;CFH;CCL2;SOX10
Carcinoma of larynx,5/177,0.03162638838064532,0.0712027983440891,0,0,2.956681527894927,10.211678539735013,ANXA1;CCND1;PLK1;CRYAB;EGFR
Platelet mean volume determination (procedure),5/177,0.03162638838064532,0.0712027983440891,0,0,2.956681527894927,10.211678539735013,MEF2C;VWF;ZBTB16;RFX2;CD36
"Leukoplakia, Oral",3/70,0.032240602824136856,0.07252434463901448,0,0,4.531572904707233,15.563817031954146,CCND1;KRT5;EGFR
Neurofibromatosis 2,3/70,0.032240602824136856,0.07252434463901448,0,0,4.531572904707233,15.563817031954146,YAP1;SGK1;EZR
Dyschezia,5/178,0.03228897973992287,0.07260252026753121,0,0,2.9394411333073767,10.09118751126278,THRB;KIT;SOX10;FLI1;TGFBR2
Recurrent major depressive episodes,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,NR3C1;SYNE1
"alpha-1-Antitrypsin Deficiency, Autosomal Recessive",2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,PRTN3;A2M
Salivary duct carcinoma,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,ESR1;EGFR
"Hyalinosis, Segmental Glomerular",2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,ACTA2;SPP1
T-Cell Prolymphocytic Leukemia,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,STAT5A;STAT5B
Acquired CJD,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,CTSD;AQP1
Acute monocytic/monoblastic leukemia,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,MME;TLR4
Alveolar Bone Loss,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,HGF;TLR4
Autoinflammatory disorder,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,STAT1;SAA1
Brain Aneurysm,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,ACTA2;STAT1
Bulbar weakness,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,GSN;TPM3
Cardiac Lymphoma,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,CCND1;FGFR3
Collagen Diseases,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,COL1A2;SPTBN1
Community acquired pneumonia,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,TIMP1;MYLK
Congenital Fiber Type Disproportion,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,TPM3;MAP3K20
Contiguous gene syndrome,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,DMD;FLI1
Coronary Aneurysm,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,CCL2;S100A8
Diffusely thickened skin,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,KIT;ANTXR2
Disease of capillaries,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,CFH;VWF
Dysgerminoma,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,KIT;TLR4
Ileitis,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,CXCL10;TLR4
Infection of bone,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,CCL2;PIK3R1
Macrothrombocytopenia,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,VWF;FLI1
Metaphyseal irregularity,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,BGN;FGFR3
Muckle-Wells Syndrome,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,ZEB2;MME
Open Bite,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,FGFR3;RUNX2
Paget Disease Extramammary,2/29,0.03323107118118974,0.07387917326848566,0,0,7.473544973544974,25.441964661375263,STAT5A;KRT19
Splenic Marginal Zone B-Cell Lymphoma,3/71,0.03342472296780239,0.07421681195642456,0,0,4.464705882352941,15.173121871466257,CCND1;MME;BCL6
Abnormality of the skull,3/71,0.03342472296780239,0.07421681195642456,0,0,4.464705882352941,15.173121871466257,ANTXR2;FGFR3;TGFBR2
Malocclusion,3/71,0.03342472296780239,0.07421681195642456,0,0,4.464705882352941,15.173121871466257,RPS6KA3;PIK3R1;FGFR3
Absence Seizures,4/123,0.034050873274918236,0.07557563668556404,0,0,3.41037858442346,11.526737212915167,LEP;FOS;MPDZ;FGFR3
Cataract,10/519,0.03433586012944834,0.07617643573265204,0,0,2.0161560005016095,6.7976009778576785,VCAN;MAF;FZD4;LAMA3;SPP1;VIM;PIK3R1;CRYAB;ESR1;EGFR
West Nile viral infection,3/72,0.034631243394974115,0.0767678436155645,0,0,4.399777034559643,14.796445838164997,SOCS3;STAT1;TAP1
Eating Disorders,3/72,0.034631243394974115,0.0767678436155645,0,0,4.399777034559643,14.796445838164997,LEP;NR3C1;ESR1
"ALBINOIDISM, OCULOCUTANEOUS, AUTOSOMAL DOMINANT",2/30,0.03537711180032136,0.077902739166906,0,0,7.206268221574344,24.081116091085146,ZEB2;SOX10
"Carcinoma, Signet Ring Cell",2/30,0.03537711180032136,0.077902739166906,0,0,7.206268221574344,24.081116091085146,MUC1;ESR1
Serum cholesterol raised,2/30,0.03537711180032136,0.077902739166906,0,0,7.206268221574344,24.081116091085146,CAV1;LPL
Welts,2/30,0.03537711180032136,0.077902739166906,0,0,7.206268221574344,24.081116091085146,SERPING1;CTSD
X-Linked Emery-Dreifuss Muscular Dystrophy,2/30,0.03537711180032136,0.077902739166906,0,0,7.206268221574344,24.081116091085146,FHL1;SYNE1
African Burkitt's lymphoma,2/30,0.03537711180032136,0.077902739166906,0,0,7.206268221574344,24.081116091085146,BCL6;PIK3R1
Bone necrosis,2/30,0.03537711180032136,0.077902739166906,0,0,7.206268221574344,24.081116091085146,SREBF1;PPARG
Brain hemorrhage,2/30,0.03537711180032136,0.077902739166906,0,0,7.206268221574344,24.081116091085146,PLAU;PROS1
Childhood Rhabdomyosarcoma,2/30,0.03537711180032136,0.077902739166906,0,0,7.206268221574344,24.081116091085146,EGFR;FOXO1
Christ-Siemens-Touraine syndrome,2/30,0.03537711180032136,0.077902739166906,0,0,7.206268221574344,24.081116091085146,KRT19;EGFR
Femoral bowing,2/30,0.03537711180032136,0.077902739166906,0,0,7.206268221574344,24.081116091085146,LIFR;FGFR3
Generalized osteoarthritis,2/30,0.03537711180032136,0.077902739166906,0,0,7.206268221574344,24.081116091085146,GHR;ESR1
Hypergammaglobulinemia,2/30,0.03537711180032136,0.077902739166906,0,0,7.206268221574344,24.081116091085146,STAT5A;STAT5B
Lymphadenitis,2/30,0.03537711180032136,0.077902739166906,0,0,7.206268221574344,24.081116091085146,SOCS3;CXCL10
Poorly differentiated carcinoma,2/30,0.03537711180032136,0.077902739166906,0,0,7.206268221574344,24.081116091085146,PPARG;MET
Prostatic Hypertrophy,2/30,0.03537711180032136,0.077902739166906,0,0,7.206268221574344,24.081116091085146,EGR1;ESR1
Congenital hypoplasia of lung,4/125,0.0358085756649081,0.07877099470065954,0,0,3.353667887875948,11.166264847963616,LEP;LIFR;NR3C1;EGFR
Myotonic Dystrophy,4/125,0.0358085756649081,0.07877099470065954,0,0,3.353667887875948,11.166264847963616,CCT3;MEF2C;BCL3;DMD
"Cardiomyopathy, Hypertrophic, Familial",3/73,0.03586009253965097,0.07877099470065954,0,0,4.336703296703297,14.43311334128344,ACTA2;CAV1;CD36
Attention Deficit Disorder,3/73,0.03586009253965097,0.07877099470065954,0,0,4.336703296703297,14.43311334128344,SNAP25;PER1;THRB
Hypopigmentation disorder,3/73,0.03586009253965097,0.07877099470065954,0,0,4.336703296703297,14.43311334128344,ZEB2;KIT;SOX10
Inborn Errors of Metabolism,3/73,0.03586009253965097,0.07877099470065954,0,0,4.336703296703297,14.43311334128344,MUC1;LEPR;TNS1
Short stature,13/750,0.036208768427307025,0.07950413141702478,0,0,1.8177784297187283,6.032214042558759,STAT1;ZBTB16;CAV1;LIFR;RUNX2;FLI1;GHR;RPS6KA3;COL1A2;MAF;DMD;BMPR1B;FGFR3
Generalized seizures,4/126,0.036706794514484824,0.08053129187636461,0,0,3.3260098022646614,10.991775257569902,LEP;FOS;MPDZ;FGFR3
Memory Loss,4/126,0.036706794514484824,0.08053129187636461,0,0,3.3260098022646614,10.991775257569902,ABCA1;ALDH2;MDK;EGFR
Chronic heart failure,3/74,0.03711119333308614,0.08138499970041813,0,0,4.275406283856988,14.082489901925209,CXCL12;CXCR4;CCL2
"Aggressive periodontitis, generalized",2/31,0.037575365000100946,0.08186390845688386,0,0,6.9574243490499645,22.830138383092528,TIMP1;TLR4
Thick skin,2/31,0.037575365000100946,0.08186390845688386,0,0,6.9574243490499645,22.830138383092528,KIT;ANTXR2
Acute colitis,2/31,0.037575365000100946,0.08186390845688386,0,0,6.9574243490499645,22.830138383092528,TLR4;EGFR
Adenocarcinoma in Situ,2/31,0.037575365000100946,0.08186390845688386,0,0,6.9574243490499645,22.830138383092528,CAV1;EGFR
Antisocial Personality Disorder,2/31,0.037575365000100946,0.08186390845688386,0,0,6.9574243490499645,22.830138383092528,SNAP25;ALDH2
Generalized elastolysis,2/31,0.037575365000100946,0.08186390845688386,0,0,6.9574243490499645,22.830138383092528,RPS6KA3;GSN
Hallux Valgus,2/31,0.037575365000100946,0.08186390845688386,0,0,6.9574243490499645,22.830138383092528,FHL1;BMPR1B
Hanging skin,2/31,0.037575365000100946,0.08186390845688386,0,0,6.9574243490499645,22.830138383092528,RPS6KA3;GSN
Histiocytic sarcoma,2/31,0.037575365000100946,0.08186390845688386,0,0,6.9574243490499645,22.830138383092528,BCL6;MET
HIV Encephalopathy,2/31,0.037575365000100946,0.08186390845688386,0,0,6.9574243490499645,22.830138383092528,SPP1;CCL2
Impaired pain sensation,2/31,0.037575365000100946,0.08186390845688386,0,0,6.9574243490499645,22.830138383092528,ABCA1;LIFR
Intervertebral disc disorder,2/31,0.037575365000100946,0.08186390845688386,0,0,6.9574243490499645,22.830138383092528,MMP14;TIMP1
Invasive aspergillosis,2/31,0.037575365000100946,0.08186390845688386,0,0,6.9574243490499645,22.830138383092528,CXCL10;TLR4
Myelomonocytic leukemia,2/31,0.037575365000100946,0.08186390845688386,0,0,6.9574243490499645,22.830138383092528,MEF2C;CCL2
Oral Ulcer,2/31,0.037575365000100946,0.08186390845688386,0,0,6.9574243490499645,22.830138383092528,LEP;TLR4
Pericardial effusion,2/31,0.037575365000100946,0.08186390845688386,0,0,6.9574243490499645,22.830138383092528,MET;EGFR
Childhood asthma,4/127,0.03761793938299909,0.08192317080997227,0,0,3.298801441622664,10.82097336252873,CCL11;PPARG;TIMP1;TLR4
Clouding of corneal stroma,3/75,0.03838446339668751,0.08352421618658544,0,0,4.215811965811966,13.743979130560717,ABCA1;MMP14;CAV2
Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,3/75,0.03838446339668751,0.08352421618658544,0,0,4.215811965811966,13.743979130560717,CCND1;CAV1;FLI1
Cocaine Abuse,4/128,0.03854201835222025,0.08383282277509459,0,0,3.27203192550715,10.653756389981716,EGR1;GRK3;FOS;NR3C1
Dyspnea,5/188,0.039393454812721766,0.0856498248457749,0,0,2.7774002661457007,8.982544618593142,STAT5B;CAV1;LAMA3;LIFR;EGFR
Malignant neoplasm of larynx,4/129,0.039479037455482625,0.08580089339325732,0,0,3.2456907216494844,10.49002517223292,ANXA1;CCND1;CRYAB;EGFR
Autoimmune thrombocytopenia,3/76,0.03967981514445567,0.08585165167662802,0,0,4.157850368809273,13.417019973680777,STAT1;NR3C1;TLR4
Familial dilated cardiomyopathy,3/76,0.03967981514445567,0.08585165167662802,0,0,4.157850368809273,13.417019973680777,LAMA4;DMD;CRYAB
Granulomatosis with polyangiitis,3/76,0.03967981514445567,0.08585165167662802,0,0,4.157850368809273,13.417019973680777,PRTN3;TIMP1;TLR4
Primary infection NOS,3/76,0.03967981514445567,0.08585165167662802,0,0,4.157850368809273,13.417019973680777,CXCR4;TIMP1;TLR4
"MICROPHTHALMIA, SYNDROMIC 7",2/32,0.03982459803802298,0.08585165167662802,0,0,6.725170068027211,21.677042398344934,MET;EGFR
"Myopathies, Nemaline",2/32,0.03982459803802298,0.08585165167662802,0,0,6.725170068027211,21.677042398344934,ACTA2;TPM3
Bunion,2/32,0.03982459803802298,0.08585165167662802,0,0,6.725170068027211,21.677042398344934,FHL1;BMPR1B
Cardiovascular morbidity,2/32,0.03982459803802298,0.08585165167662802,0,0,6.725170068027211,21.677042398344934,FABP4;LEP
Complete hydatidiform mole,2/32,0.03982459803802298,0.08585165167662802,0,0,6.725170068027211,21.677042398344934,SPP1;EGFR
Congenital malrotation of intestine,2/32,0.03982459803802298,0.08585165167662802,0,0,6.725170068027211,21.677042398344934,ACTA2;MYLK
Decrease in appetite,2/32,0.03982459803802298,0.08585165167662802,0,0,6.725170068027211,21.677042398344934,LEP;PIK3R1
Fibrillation,2/32,0.03982459803802298,0.08585165167662802,0,0,6.725170068027211,21.677042398344934,CALR;S100A8
Gastro-esophageal reflux disease with esophagitis,2/32,0.03982459803802298,0.08585165167662802,0,0,6.725170068027211,21.677042398344934,GHR;ESR1
Hallopeau-Siemens Disease,2/32,0.03982459803802298,0.08585165167662802,0,0,6.725170068027211,21.677042398344934,TIMP1;DCN
HIV encephalitis,2/32,0.03982459803802298,0.08585165167662802,0,0,6.725170068027211,21.677042398344934,SPP1;CCL2
Intestinal Obstruction,2/32,0.03982459803802298,0.08585165167662802,0,0,6.725170068027211,21.677042398344934,KIT;SOX10
Lipid Metabolism Disorders,2/32,0.03982459803802298,0.08585165167662802,0,0,6.725170068027211,21.677042398344934,ABCA1;LPL
Nodular Lymphocyte Predominant Hodgkin Lymphoma,2/32,0.03982459803802298,0.08585165167662802,0,0,6.725170068027211,21.677042398344934,BCL6;SGK1
Papillary serous cystadenocarcinoma,2/32,0.03982459803802298,0.08585165167662802,0,0,6.725170068027211,21.677042398344934,CCND1;SNCG
Pulmonary Alveolar Proteinosis,2/32,0.03982459803802298,0.08585165167662802,0,0,6.725170068027211,21.677042398344934,MUC1;PPARG
Muscle hypotonia,9/460,0.04007943938009287,0.08636608671917302,0,0,2.043184457818604,6.572703348320418,RPS6KA3;MEF2C;THRB;TPM3;MAP3K20;ANTXR2;SOX10;FGFR3;TGFBR2
Congenital pes cavus,4/130,0.04042900068134837,0.08704894732561837,0,0,3.2197676321387663,10.329683995097023,KLC2;MME;TPM3;SOX10
Delayed Puberty,4/130,0.04042900068134837,0.08704894732561837,0,0,3.2197676321387663,10.329683995097023,GHR;STAT1;LEPR;SOX10
Hydrocephalus,6/253,0.040449008109673765,0.08705685146060238,0,0,2.474063765182186,7.93608689125438,RPS6KA3;KLF6;CCND2;FGFR3;MPDZ;AQP1
Deglutition Disorders,5/191,0.04169630247712716,0.08966892489935861,0,0,2.732185637082846,8.681090427061559,TPM3;CAV1;KIT;SERPING1;LIFR
Platelet Count measurement,5/191,0.04169630247712716,0.08966892489935861,0,0,2.732185637082846,8.681090427061559,MEF2C;TPM3;ZBTB16;CD36;FLI1
"Chromosome 5, trisomy 5q",2/33,0.042123597241946545,0.09007891240061522,0,0,6.507899934167216,20.611476994235183,EGR1;FLI1
"Hyperkinesia, Generalized",2/33,0.042123597241946545,0.09007891240061522,0,0,6.507899934167216,20.611476994235183,SNCG;FOS
Superinfection,2/33,0.042123597241946545,0.09007891240061522,0,0,6.507899934167216,20.611476994235183,CXCR4;CCL2
Ventricular hypertrophy,2/33,0.042123597241946545,0.09007891240061522,0,0,6.507899934167216,20.611476994235183,FHL1;SPP1
X-Linked Combined Immunodeficiency Diseases,2/33,0.042123597241946545,0.09007891240061522,0,0,6.507899934167216,20.611476994235183,GHR;LMO2
Anemia of chronic disease,2/33,0.042123597241946545,0.09007891240061522,0,0,6.507899934167216,20.611476994235183,CXCL10;LEP
Atrioventricular Block,2/33,0.042123597241946545,0.09007891240061522,0,0,6.507899934167216,20.611476994235183,CAV1;PKD2
Corneal Ulcer,2/33,0.042123597241946545,0.09007891240061522,0,0,6.507899934167216,20.611476994235183,GSN;FGFR3
Craniopharyngioma,2/33,0.042123597241946545,0.09007891240061522,0,0,6.507899934167216,20.611476994235183,GHR;ESR1
High altitude pulmonary edema,2/33,0.042123597241946545,0.09007891240061522,0,0,6.507899934167216,20.611476994235183,VWF;NR3C1
Megacolon,2/33,0.042123597241946545,0.09007891240061522,0,0,6.507899934167216,20.611476994235183,KIT;SOX10
Metabolic Bone Disorder,2/33,0.042123597241946545,0.09007891240061522,0,0,6.507899934167216,20.611476994235183,LEP;ESR1
Pleural Tuberculosis,2/33,0.042123597241946545,0.09007891240061522,0,0,6.507899934167216,20.611476994235183,SOCS3;CCL2
Primary angle-closure glaucoma,2/33,0.042123597241946545,0.09007891240061522,0,0,6.507899934167216,20.611476994235183,ABCA1;HGF
Acute monocytic leukemia,3/78,0.042336388479290825,0.09031649888156157,0,0,4.046564102564102,12.795673995872372,MMP14;SPP1;CCL2
Androgen-Insensitivity Syndrome,3/78,0.042336388479290825,0.09031649888156157,0,0,4.046564102564102,12.795673995872372,FKBP4;ESR1;EGFR
Bronchial Hyperreactivity,3/78,0.042336388479290825,0.09031649888156157,0,0,4.046564102564102,12.795673995872372,CCL2;TLR4;ESR1
Cardiac Hypertrophy,3/78,0.042336388479290825,0.09031649888156157,0,0,4.046564102564102,12.795673995872372,CCND2;CAV1;DMD
Klinefelter Syndrome,3/78,0.042336388479290825,0.09031649888156157,0,0,4.046564102564102,12.795673995872372,NRP1;LEP;LEPR
Marinesco-Sjogren syndrome,3/78,0.042336388479290825,0.09031649888156157,0,0,4.046564102564102,12.795673995872372,PECAM1;EGFR;TGFBR2
"Polyendocrinopathies, Autoimmune",3/79,0.04369741040585582,0.09307094326650905,0,0,3.9931174089068824,12.500320027917539,CCL2;VIM;TLR4
Chronic granulomatous disease,3/79,0.04369741040585582,0.09307094326650905,0,0,3.9931174089068824,12.500320027917539,PPARG;DMD;ESR1
Distal sensory impairment,3/79,0.04369741040585582,0.09307094326650905,0,0,3.9931174089068824,12.500320027917539,MME;CAV1;SOX10
Osteitis Deformans,3/79,0.04369741040585582,0.09307094326650905,0,0,3.9931174089068824,12.500320027917539,DMD;FOS;ESR1
Muscle degeneration,6/259,0.04446112446107601,0.09411709806975962,0,0,2.414649209486166,7.517141231365583,CCT3;MME;HGF;FHL1;DMD;UTRN
Renal interstitial fibrosis,2/34,0.044471167749982124,0.09411709806975962,0,0,6.3042091836734695,19.624462385524268,EGR1;HGF
"Biliary Cirrhosis, Secondary",2/34,0.044471167749982124,0.09411709806975962,0,0,6.3042091836734695,19.624462385524268,CDH5;CXCL10
Richter's syndrome,2/34,0.044471167749982124,0.09411709806975962,0,0,6.3042091836734695,19.624462385524268,CCND1;BCL6
Cancer of Urinary Tract,2/34,0.044471167749982124,0.09411709806975962,0,0,6.3042091836734695,19.624462385524268,CCND1;FGFR3
Coxa valga,2/34,0.044471167749982124,0.09411709806975962,0,0,6.3042091836734695,19.624462385524268,RPS6KA3;BGN
Coxa valga deformity,2/34,0.044471167749982124,0.09411709806975962,0,0,6.3042091836734695,19.624462385524268,RPS6KA3;BGN
Dysautonomia,2/34,0.044471167749982124,0.09411709806975962,0,0,6.3042091836734695,19.624462385524268,LEP;LIFR
Generalized Anxiety Disorder,2/34,0.044471167749982124,0.09411709806975962,0,0,6.3042091836734695,19.624462385524268,RGS2;NR3C1
Gestational trophoblastic disease,2/34,0.044471167749982124,0.09411709806975962,0,0,6.3042091836734695,19.624462385524268,PPARG;EGFR
Idiopathic osteoarthritis,2/34,0.044471167749982124,0.09411709806975962,0,0,6.3042091836734695,19.624462385524268,GHR;ESR1
Increased appetite (finding),2/34,0.044471167749982124,0.09411709806975962,0,0,6.3042091836734695,19.624462385524268,LEP;LEPR
Malignant neoplasm of vulva,2/34,0.044471167749982124,0.09411709806975962,0,0,6.3042091836734695,19.624462385524268,KIT;EGFR
Myelodysplastic Syndrome with Isolated del(5q),2/34,0.044471167749982124,0.09411709806975962,0,0,6.3042091836734695,19.624462385524268,EGR1;FLI1
Nonnuclear polymorphic congenital cataract,2/34,0.044471167749982124,0.09411709806975962,0,0,6.3042091836734695,19.624462385524268,CXCL10;DUSP1
prostatitis,2/34,0.044471167749982124,0.09411709806975962,0,0,6.3042091836734695,19.624462385524268,CCL11;RUNX2
Extrahepatic Cholangiocarcinoma,3/80,0.04508011501370713,0.09533013210636718,0,0,3.941058941058941,12.21457930253793,CIB1;EGFR;DEPP1
Lordosis,3/80,0.04508011501370713,0.09533013210636718,0,0,3.941058941058941,12.21457930253793,FHL1;DMD;FGFR3
Sensorineural Hearing Loss (disorder),9/471,0.045368117060364956,0.09587335510589655,0,0,1.9934034219748507,6.165488518507204,YAP1;RPS6KA3;MAF;THRB;MAP3K20;PIK3R1;FADD;SOX10;FGFR3
Motor Neuron Disease,4/135,0.04537297834060257,0.09587335510589655,0,0,3.0960887699693083,9.57570267680199,COL17A1;ZEB2;SNCG;VIM
Micrognathism,8/400,0.046161300708844485,0.0975004246838812,0,0,2.084854994629431,6.412208123058098,CCT3;GHR;RPS6KA3;COL1A2;LIFR;PIK3R1;RUNX2;TGFBR2
Reduced fetal movement,3/81,0.04648439109138168,0.09806623916309302,0,0,3.8903353057199213,11.93803346808487,SNAP25;TPM3;FGFR3
Congenital ear anomaly NOS (disorder),3/81,0.04648439109138168,0.09806623916309302,0,0,3.8903353057199213,11.93803346808487,KIT;FGFR3;FLI1
Connective Tissue Diseases,3/81,0.04648439109138168,0.09806623916309302,0,0,3.8903353057199213,11.93803346808487,ACTA2;COL1A2;TGFBR2
Abnormality of the metacarpal bones,2/35,0.04686613328502421,0.09832662373066695,0,0,6.112863327149041,18.70817350974744,FGFR3;RUNX2
Ventricular Fibrillation,2/35,0.04686613328502421,0.09832662373066695,0,0,6.112863327149041,18.70817350974744,PLAU;MET
Acinar Cell Carcinoma,2/35,0.04686613328502421,0.09832662373066695,0,0,6.112863327149041,18.70817350974744,CD36;EGFR
Asthenozoospermia,2/35,0.04686613328502421,0.09832662373066695,0,0,6.112863327149041,18.70817350974744,PLAU;CDC25B
Complete trisomy 18 syndrome,2/35,0.04686613328502421,0.09832662373066695,0,0,6.112863327149041,18.70817350974744,GHR;BCL6
Hereditary Melanoma,2/35,0.04686613328502421,0.09832662373066695,0,0,6.112863327149041,18.70817350974744,COL17A1;S100A4
HTLV-I Infections,2/35,0.04686613328502421,0.09832662373066695,0,0,6.112863327149041,18.70817350974744,LRP1;CCL2
Hyperphagia,2/35,0.04686613328502421,0.09832662373066695,0,0,6.112863327149041,18.70817350974744,LEP;LEPR
Inflammatory abnormality of the eye,2/35,0.04686613328502421,0.09832662373066695,0,0,6.112863327149041,18.70817350974744,PRTN3;FGFR3
Intracranial Hypertension,2/35,0.04686613328502421,0.09832662373066695,0,0,6.112863327149041,18.70817350974744,FGFR3;TGFBR2
Intrahepatic Cholestasis,2/35,0.04686613328502421,0.09832662373066695,0,0,6.112863327149041,18.70817350974744,EGR1;MAF
Neoplasm of uncertain or unknown behavior of ovary,2/35,0.04686613328502421,0.09832662373066695,0,0,6.112863327149041,18.70817350974744,PIK3R1;ESR1
Nephrogenic Diabetes Insipidus,2/35,0.04686613328502421,0.09832662373066695,0,0,6.112863327149041,18.70817350974744,VWF;AQP1
PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA,2/35,0.04686613328502421,0.09832662373066695,0,0,6.112863327149041,18.70817350974744,KIT;EGFR
Male infertility,6/263,0.04726956576149467,0.09913400863557856,0,0,2.376580739299611,7.253059714119358,KRT18;THRB;ALDH2;KIT;MEST;ESR1
Prominent eyes,4/137,0.04744109539773032,0.0994154924791604,0,0,3.0492209906208823,9.294837996740535,THRB;BGN;FGFR3;TGFBR2
Protruding eyes,4/137,0.04744109539773032,0.0994154924791604,0,0,3.0492209906208823,9.294837996740535,THRB;BGN;FGFR3;TGFBR2
Prediabetes syndrome,3/82,0.04791012314996256,0.10035890183417866,0,0,3.840895813047712,11.670287141219873,TCF7L2;PPARG;TLR4
Ureteral obstruction,4/138,0.048494517310671836,0.101463401157664,0,0,3.0263117402677335,9.158540936540746,RGS2;KDR;CCL2;TLR4
Drug habituation,4/138,0.048494517310671836,0.101463401157664,0,0,3.0263117402677335,9.158540936540746,ABLIM1;PARVA;NR3C1;SYNE1
Measles,4/138,0.048494517310671836,0.101463401157664,0,0,3.0263117402677335,9.158540936540746,CXCL10;STAT1;TLR4;EGFR
Redundant skin,2/36,0.04930733587510383,0.10266372897762141,0,0,5.932773109243698,17.855762859273696,RPS6KA3;FGFR3
"DEAFNESS, AUTOSOMAL RECESSIVE (disorder)",2/36,0.04930733587510383,0.10266372897762141,0,0,5.932773109243698,17.855762859273696,EPS8;HGF
5q-syndrome,2/36,0.04930733587510383,0.10266372897762141,0,0,5.932773109243698,17.855762859273696,EGR1;FLI1
Decreased testosterone in males,2/36,0.04930733587510383,0.10266372897762141,0,0,5.932773109243698,17.855762859273696,LEP;LEPR
Hepatitis E,2/36,0.04930733587510383,0.10266372897762141,0,0,5.932773109243698,17.855762859273696,SIRPA;EGFR
Inflammatory Myofibroblastic Tumor,2/36,0.04930733587510383,0.10266372897762141,0,0,5.932773109243698,17.855762859273696,CCND1;TPM3
Invasive Streptococcus pneumoniae disease,2/36,0.04930733587510383,0.10266372897762141,0,0,5.932773109243698,17.855762859273696,CCL2;SORBS1
Lichen Sclerosus et Atrophicus,2/36,0.04930733587510383,0.10266372897762141,0,0,5.932773109243698,17.855762859273696,CXCL10;CCND1
Parvovirus B19 (disease),2/36,0.04930733587510383,0.10266372897762141,0,0,5.932773109243698,17.855762859273696,F8;CALR
Rapidly progressive,2/36,0.04930733587510383,0.10266372897762141,0,0,5.932773109243698,17.855762859273696,FHL1;CRYAB
Rapidly progressive disorder,2/36,0.04930733587510383,0.10266372897762141,0,0,5.932773109243698,17.855762859273696,FHL1;CRYAB
Adverse reaction to drug,3/83,0.04935719152573955,0.10266372897762141,0,0,3.792692307692308,11.410966387605566,C3;TF;SPP1
Drug toxicity,3/83,0.04935719152573955,0.10266372897762141,0,0,3.792692307692308,11.410966387605566,C3;TF;SPP1
Gait Ataxia,3/83,0.04935719152573955,0.10266372897762141,0,0,3.792692307692308,11.410966387605566,MME;CAV1;SYNE1
HIV-1 infection,3/83,0.04935719152573955,0.10266372897762141,0,0,3.792692307692308,11.410966387605566,PTPRB;CXCL12;CXCR4
Eosinophil count procedure,5/201,0.049951410392958084,0.10381866848052793,0,0,2.591466638468859,7.765859836070073,ZBTB16;LEPR;E2F2;PPARG;FOXO1
Eosinophil count result,5/201,0.049951410392958084,0.10381866848052793,0,0,2.591466638468859,7.765859836070073,ZBTB16;LEPR;E2F2;PPARG;FOXO1
Substance Dependence,4/140,0.05064002059220429,0.10520883810364783,0,0,2.981503941782899,8.8938652996632,ABLIM1;ALDH2;PARVA;SYNE1
Situs Inversus,3/84,0.05082547253308336,0.1055118594190889,0,0,3.745679012345679,11.159717315949,ZFP36;SPP1;PKD2
Distal muscle weakness,3/84,0.05082547253308336,0.1055118594190889,0,0,3.745679012345679,11.159717315949,ABCA1;SOX10;CRYAB
Blepharoptosis,7/337,0.050971092978565696,0.10577295735310616,0,0,2.162525781373949,6.436750660095395,SNAP25;MAF;TPM3;DMD;KRT5;FGFR3;FLI1
Salivary Gland Pleomorphic Adenoma,2/37,0.051793635642599485,0.10689708920968731,0,0,5.762973760932945,17.061214671092433,PROS1;FOXO1
"Truncus Arteriosus, Persistent",2/37,0.051793635642599485,0.10689708920968731,0,0,5.762973760932945,17.061214671092433,NRP1;FGFR3
Thyroid Hormone Resistance Syndrome,2/37,0.051793635642599485,0.10689708920968731,0,0,5.762973760932945,17.061214671092433,THRB;DMD
Aggressive Non-Hodgkin Lymphoma,2/37,0.051793635642599485,0.10689708920968731,0,0,5.762973760932945,17.061214671092433,NR4A1;BCL6
Atypical Lipoma,2/37,0.051793635642599485,0.10689708920968731,0,0,5.762973760932945,17.061214671092433,JUN;EGFR
Bone Marrow Diseases,2/37,0.051793635642599485,0.10689708920968731,0,0,5.762973760932945,17.061214671092433,CCND1;SPP1
Cone-shaped epiphysis,2/37,0.051793635642599485,0.10689708920968731,0,0,5.762973760932945,17.061214671092433,BMPR1B;FGFR3
Congenital hypoplasia of breast,2/37,0.051793635642599485,0.10689708920968731,0,0,5.762973760932945,17.061214671092433,ESR1;SOX10
Fuchs Endothelial Dystrophy,2/37,0.051793635642599485,0.10689708920968731,0,0,5.762973760932945,17.061214671092433,CFH;LAMC1
Infantile uterus,2/37,0.051793635642599485,0.10689708920968731,0,0,5.762973760932945,17.061214671092433,BMPR1B;ESR1
Influenza due to Influenza A virus subtype H1N1,2/37,0.051793635642599485,0.10689708920968731,0,0,5.762973760932945,17.061214671092433,ADAM12;DMD
Malignant neoplasm of oropharynx,2/37,0.051793635642599485,0.10689708920968731,0,0,5.762973760932945,17.061214671092433,ALDH2;EGFR
Multiple Epiphyseal Dysplasia,2/37,0.051793635642599485,0.10689708920968731,0,0,5.762973760932945,17.061214671092433,VWF;KDR
Pseudoxanthoma Elasticum,2/37,0.051793635642599485,0.10689708920968731,0,0,5.762973760932945,17.061214671092433,VWF;SPP1
Severe Acute Respiratory Syndrome,3/85,0.05231483860519873,0.10793100074607201,0,0,3.699812382739212,10.916204780603257,CXCL10;CCL2;CALR
Clear-cell metastatic renal cell carcinoma,4/142,0.05283695872337293,0.10892385030439238,0,0,2.9379949200657403,8.63930438402614,KRT19;CCND1;KIT;CXCR4
Mycosis Fungoides,4/142,0.05283695872337293,0.10892385030439238,0,0,2.9379949200657403,8.63930438402614,SOCS3;MEF2C;CCND1;TLR4
Recurrent urinary tract infection,3/86,0.05382515838616386,0.11083240689330265,0,0,3.655050973123262,10.680111185558149,CCL2;PKD2;TLR4
"Cystadenocarcinoma, Serous",3/86,0.05382515838616386,0.11083240689330265,0,0,3.655050973123262,10.680111185558149,SPP1;ESR1;EGFR
Distal limb muscle weakness due to peripheral neuropathy,3/86,0.05382515838616386,0.11083240689330265,0,0,3.655050973123262,10.680111185558149,ABCA1;SOX10;CRYAB
Leprosy,4/143,0.05395466746061663,0.1109763310324393,0,0,2.916709931024253,8.515658621434108,CFH;CCL2;TLR4;TGFBR2
Weight less than 3rd percentile,2/38,0.05432391052176327,0.1109763310324393,0,0,5.602607709750567,16.31922423702565,RPS6KA3;DMD
Bacterial Vaginosis,2/38,0.05432391052176327,0.1109763310324393,0,0,5.602607709750567,16.31922423702565,CXCL10;TLR4
Common acute lymphoblastic leukemia,2/38,0.05432391052176327,0.1109763310324393,0,0,5.602607709750567,16.31922423702565,SNAP25;MME
Keratosis,2/38,0.05432391052176327,0.1109763310324393,0,0,5.602607709750567,16.31922423702565,CCND1;FGFR3
Milroy Disease,2/38,0.05432391052176327,0.1109763310324393,0,0,5.602607709750567,16.31922423702565,CCND1;FGFR3
Monoparesis - leg,2/38,0.05432391052176327,0.1109763310324393,0,0,5.602607709750567,16.31922423702565,CAV1;FHL1
Pelvic Inflammatory Disease,2/38,0.05432391052176327,0.1109763310324393,0,0,5.602607709750567,16.31922423702565,CXCL12;TLR4
Prostatic Diseases,2/38,0.05432391052176327,0.1109763310324393,0,0,5.602607709750567,16.31922423702565,PROS1;FOS
Cytopenia,5/206,0.05441480831636467,0.1109763310324393,0,0,2.5263578480653726,7.354528207159695,KIT;CXCR4;TXNIP;CALR;CD36
Triangular face,3/87,0.05535629690745097,0.1109763310324393,0,0,3.6113553113553114,10.451135371765963,RPS6KA3;COL1A2;PIK3R1
Gynecomastia,3/87,0.05535629690745097,0.1109763310324393,0,0,3.6113553113553114,10.451135371765963,LEP;KIT;LEPR
Uranostaphyloschisis,6/274,0.05555049872607592,0.1109763310324393,0,0,2.277751865671642,6.583757001119039,SPP1;F13A1;CIB1;RUNX2;TNS1;TGFBR2
Ataxia,5/208,0.05626300298892921,0.1109763310324393,0,0,2.5012123841854055,7.197784150825724,SNAP25;CCND1;BCL6;SPTBN1;SYNE1
Congenital anemia,5/208,0.05626300298892921,0.1109763310324393,0,0,2.5012123841854055,7.197784150825724,KIT;CXCR4;TXNIP;CALR;CD36
Neurodevelopmental Disorders,5/208,0.05626300298892921,0.1109763310324393,0,0,2.5012123841854055,7.197784150825724,TCF7L2;MEF2C;KLF6;PLK1;ANK2
Concave bridge of nose,6/275,0.0563441293481782,0.1109763310324393,0,0,2.2691682156133828,6.526756860202444,RPS6KA3;MEF2C;CCND2;MAF;FGFR3;RUNX2
Depressed nasal root/bridge,6/275,0.0563441293481782,0.1109763310324393,0,0,2.2691682156133828,6.526756860202444,RPS6KA3;MEF2C;CCND2;MAF;FGFR3;RUNX2
Recurrent pulmonary infections,2/39,0.05689705606135651,0.1109763310324393,0,0,5.450910093767237,15.625097439536829,LEP;EGFR
Sialorrhea,2/39,0.05689705606135651,0.1109763310324393,0,0,5.450910093767237,15.625097439536829,CA12;ZEB2
Benign Ovarian Neoplasm,2/39,0.05689705606135651,0.1109763310324393,0,0,5.450910093767237,15.625097439536829,CCND1;EGFR
Broad hallux,2/39,0.05689705606135651,0.1109763310324393,0,0,5.450910093767237,15.625097439536829,BMPR1B;FGFR3
Disorder of macula of retina,2/39,0.05689705606135651,0.1109763310324393,0,0,5.450910093767237,15.625097439536829,EFEMP1;CFH
Malignant neoplasm of adrenal cortex,2/39,0.05689705606135651,0.1109763310324393,0,0,5.450910093767237,15.625097439536829,KRT5;ESR1
Multiple pulmonary infections,2/39,0.05689705606135651,0.1109763310324393,0,0,5.450910093767237,15.625097439536829,LEP;EGFR
Neuronal Ceroid-Lipofuscinoses,2/39,0.05689705606135651,0.1109763310324393,0,0,5.450910093767237,15.625097439536829,DPYSL2;CTSD
Iron Overload,3/88,0.05690811568566139,0.1109763310324393,0,0,3.56868778280543,10.228991592039097,TF;EPAS1;CCL2
Depressed nasal bridge,6/277,0.05795188103509848,0.1109763310324393,0,0,2.252190959409594,6.4145602267902335,RPS6KA3;MEF2C;CCND2;MAF;FGFR3;RUNX2
"Achondrogenesis, type IB (disorder)",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,DCN
Reduced factor XIII activity,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,F13A1
Renal cancer metastatic,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,CXCR4
response to fenofibrate,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,CD36
Reticulate acropigmentation of Kitamura,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,KRT5
"Carcinoma, Giant Cell",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,TGFBR2
Retinal pigment epithelium atrophy,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,CFH
"Cataract, congenital, cerulean type 1",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,MAF
"Choledochal Cyst, Type I",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,AQP1
"Choledochal Cyst, Type II",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,AQP1
"Choledochal Cyst, Type III",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,AQP1
"Choledochal Cyst, Type IV",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,AQP1
"Choledochal Cyst, Type V",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,AQP1
RIPPLING MUSCLE DISEASE 1,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,EGFR
"Corneal dystrophy, Fuchs' endothelial, 1",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,JUN
Scleritis,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,STAT1
"Dissection, Blood Vessel",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,TGFBR2
"Dysfibrinogenemia, Congenital",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,F13A1
"EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,COL1A2
"EHLERS-DANLOS SYNDROME, PROGEROID FORM",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,DCN
Secondary malignant neoplasm of prostate,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,CXCR4
"Familial Amyloid Polyneuropathy, Type V",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,GSN
"Gastritis, Hypertrophic",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,HGF
Severe platyspondyly,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,FGFR3
Short 5th metacarpal,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,RUNX2
Sinus bradycardia,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,ANK2
Sitosterolemia,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,SREBF1
"Leiomyosarcoma, Myxoid",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,DMD
"Leukemia, Natural Killer Cell Large Granular Lymphocytic",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,STAT5B
Small thenar eminence,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,FGFR3
Somatostatinoma,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,EPAS1
Speech and language disorder,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,CALR
Splenic Neoplasms,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,EGFR
Squamous cell carcinoma of pharynx,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,EGFR
Squamous Lung Dysplasia,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,EGFR
"Ovarian Small Cell Carcinoma, Hypercalcemic Type",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,HGF
"PITUITARY ADENOMA, FAMILIAL ISOLATED (disorder)",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,CIB1
Subcoronal hypospadias,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,FGFR3
Superficial thrombophlebitis,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,PROS1
Symptoms of stress,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,NR3C1
Tension Headache,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,ESR1
"stage, chronic lymphocytic leukemia",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,BCL6
"Sterility, Reproductive",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,LEPR
"THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,THRB
"Thyroid Hormone Resistance, Generalized, Autosomal Recessive",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,THRB
"TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,ETS2
Thymic hypoplasia or aplasia,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,ANTXR2
"Von Willebrand disease, platelet type",1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,VWF
Transferrin measurement,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,TF
Abnormal joint morphology,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,GHR
Trichinellosis,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,TLR4
Troyer syndrome,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,EGFR
Abnormality of bone marrow cell morphology,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,CCND1
Ulnar deviation of the 2nd finger,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,BMPR1B
Valvular disease,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,TIMP1
Vascular fragility,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,FLI1
Acanthamoeba Keratitis,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,TLR4
Visual Pathway Glioma,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,CXCR4
Acute and subacute liver necrosis (disorder),1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,TF
Wide pubic symphysis,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,RUNX2
Adiponectin Deficiency,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,LEP
Adult Rhabdomyosarcoma,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,FOXO1
Agenesis of punctum lacrimale,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,FGFR3
Alcohol-Induced Disorders,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,ALDH2
Alcoholic Neuropathy,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,ALDH2
Alpha fetoprotein abnormal,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,MET
Aortic aneurysm and dissection,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,ACTA2
Aplasia/Hypoplasia involving the metacarpal bones,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,BMPR1B
Aplasia/Hypoplasia of the fibula,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,BMPR1B
Aplasia/Hypoplasia of the middle phalanges of the toes,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,BMPR1B
Aplasia/Hypoplasia of the middle phalanx of the 2nd finger,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,BMPR1B
Aplasia/Hypoplasia of the middle phalanx of the 5th finger,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,BMPR1B
Aplasia/Hypoplasia of the thymus,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,ANTXR2
Aromatase deficiency,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,ESR1
ATRIAL SEPTAL DEFECT 1,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,SNAP25
Autosomal Recessive Emery-Dreifuss Muscular Dystrophy,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,SYNE1
Bacteriuria,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,TLR4
Benign neoplasm of prostate,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,FKBP4
Bile Reflux,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,MUC1
Blood group deletion syndrome,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,DMD
Breast Diffuse Large B-Cell Lymphoma,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,MME
Broad columella,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,FLI1
Broad phalanx,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,BGN
Bullous impetigo,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,AGR2
Bursitis,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,CXCL12
Calf muscle pseudohypertrophy,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,DMD
Campylobacter jejuni infection,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,TLR4
Cecal Neoplasms,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,CCND1
Cerebrovascular Occlusion,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,PLAU
Childhood Hepatocellular Carcinoma,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,MET
Chorioretinal degeneration,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,TEAD1
Chronic kidney disease stage 3,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,PKD2
Chronic myocarditis,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,SPP1
Cocaine withdrawal,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,NR3C1
Congenital Generalized Lipodystrophy Type 2,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,PPARG
Congenital lamellar cataract,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,CRYAB
Congenital pyloric atresia,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,COL17A1
Crisponi syndrome,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,LIFR
Critical illness myopathy,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,SAA1
Crumpled long bones,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,COL1A2
Cutaneous Follicular Lymphoma,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,BCL6
Cyanotic congenital heart disease,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,ALDH2
Decreased serum insulin-like growth factor 1,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,GHR
Delusional disorder,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,DPYSL2
Dental Diseases,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,FADD
Disorder of soft tissue,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,PROS1
Disseminated Bacillus Calmette-Guerin infection,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,STAT1
Distal motor neuropathy,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,KLC2
Eisenmenger Complex,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,TGFBR2
Elevated alpha-fetoprotein,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,MET
Embryopathies,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,EGR1
Endometrial neoplasm malignant metastatic,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,EZR
Epithelial tumor of ovary,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,VIM
Eruptive xanthoma,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,LPL
Exercise-induced angina,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,CD36
Exudative vitreoretinopathy,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,FZD4
Familial hyperchylomicronemia syndrome,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,LPL
Familial Thrombotic Thrombocytopenic Purpura,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,CFH
Genomic Instability,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,CCND1
hazardous drinking,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,ALDH2
Headache associated with sexual activity,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,KIT
Hematocrit increased,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,EPAS1
Hemodynamic instability,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,NR3C1
Hemophilic arthropathy,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,F8
Hepatoblastoma Caused By Somatic Mutation,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,MET
Herlitz Disease,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,LAMA3
Heterotopic Ossification,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,RUNX2
Histiocytic Necrotizing Lymphadenitis,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,CXCL10
Hoarse cry,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,LAMA3
Hyperplasia of columella,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,FLI1
Hypoplasia of lower limb,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,FGFR3
Idiopathic retroperitoneal fibrosis,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,CCL11
Increased circulating very-low-density lipoprotein levels,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,LPL
Insulin resistance - type A,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,CALR
Intermediate Grade Ductal Breast Carcinoma In Situ,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,CCND1
Intestinal-Type Sinonasal Adenocarcinoma,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,EGFR
Intestinal obstruction co-occurrent and due to decreased peristalsis,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,MUC1
Intraductal papillary-mucinous adenoma,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,MUC1
Lacrimation abnormality,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,LIFR
Length dependent motor neuropathy,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,KLC2
Lentigo maligna melanoma,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,CCND1
Lesion of stomach,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,TLR4
Loeys-Dietz Aortic Aneurysm Syndrome,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,TGFBR2
Loss of gluteal subcutaneous adipose tissue,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,PPARG
Male Germ Cell Tumor,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,KIT
Malignant neoplasm of cecum,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,CCND1
Mediastinal Neoplasms,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,KIT
Megacystis microcolon intestinal hypoperistalsis syndrome,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,MYLK
Mixed phenotype acute leukemia B/myeloid,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,KIT
Motor axonal neuropathy,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,KLC2
Mydriasis,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,ACTA2
Necrotizing vasculitis,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,PRTN3
Nephrogenic Systemic Fibrosis,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,TLR4
Non-Metastatic Childhood Soft Tissue Sarcoma,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,EGFR
Numerous nevi,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,FGFR3
Osteoblastic Osteosarcoma,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,ESR1
Parietal bossing,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,RUNX2
Physical addiction,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,FGFR3
Pineal germinoma,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,KIT
Posterior Fossa Hemorrhage,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,PLAU
Posterior rib cupping,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,BGN
Primary Hypothyroidism,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,STAT1
Prominent superficial veins,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,PPARG
Proteus Syndrome,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,FGFR3
Pygmy (disorder),1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,GHR
Radial deviation of the 2nd finger,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,BMPR1B
Reactive thrombocytosis,1/6,0.05795592592668016,0.1109763310324393,0,0,20.098477157360406,57.241919181742155,CALR
"Malaria, Falciparum",3/89,0.058480472824523295,0.11186017217583799,0,0,3.5270125223613595,10.013408560165383,PECAM1;CD36;TLR4
Congenital clinodactyly,3/89,0.058480472824523295,0.11186017217583799,0,0,3.5270125223613595,10.013408560165383,RPS6KA3;PIK3R1;FGFR3
Nasopharyngeal Neoplasms,3/89,0.058480472824523295,0.11186017217583799,0,0,3.5270125223613595,10.013408560165383,ALDH2;HGF;EGFR
Autism Spectrum Disorders,10/572,0.0589608895994233,0.11273863676904441,0,0,1.8210040130233967,5.155045557647769,SNAP25;MEF2C;MDK;HGF;CCL2;IRS2;NR3C1;MPDZ;MET;SYNE1
"Anxiety States, Neurotic",2/40,0.05951198515243541,0.11358859916809753,0,0,5.307196562835661,14.974666704757507,MDK;FOS
"Depression, Neurotic",2/40,0.05951198515243541,0.11358859916809753,0,0,5.307196562835661,14.974666704757507,SNAP25;NR3C1
Fibrodysplasia Ossificans Progressiva,2/40,0.05951198515243541,0.11358859916809753,0,0,5.307196562835661,14.974666704757507,C3;KDR
Hereditary Nonpolyposis Colorectal Neoplasms,2/40,0.05951198515243541,0.11358859916809753,0,0,5.307196562835661,14.974666704757507,MUC1;TGFBR2
Islet Cell Tumor,2/40,0.05951198515243541,0.11358859916809753,0,0,5.307196562835661,14.974666704757507,KRT19;KIT
Chronic Periodontitis,4/148,0.0597346584876649,0.11397278735437388,0,0,2.8147193585337917,7.931436911670672,CXCL12;PPARG;TIMP1;TLR4
Short palm,3/90,0.0600732231799833,0.11441394078846713,0,0,3.486295313881521,9.804128564744659,BGN;ANTXR2;FGFR3
Skin carcinoma,3/90,0.0600732231799833,0.11441394078846713,0,0,3.486295313881521,9.804128564744659,KRT19;CCND1;EGFR
Adenovirus Infections,3/90,0.0600732231799833,0.11441394078846713,0,0,3.486295313881521,9.804128564744659,PLAU;VIM;EGFR
Degenerative disorder,3/90,0.0600732231799833,0.11441394078846713,0,0,3.486295313881521,9.804128564744659,FZD4;F13A1;DMD
Motor neuron atrophy,3/90,0.0600732231799833,0.11441394078846713,0,0,3.486295313881521,9.804128564744659,SPP1;SORBS1;TEAD1
Big calvaria,5/213,0.06104049322800526,0.11617313871858573,0,0,2.440464328417696,6.824069823774588,CCND2;ANTXR2;FGFR3;MPDZ;FLI1
Increased size of skull,5/213,0.06104049322800526,0.11617313871858573,0,0,2.440464328417696,6.824069823774588,CCND2;ANTXR2;FGFR3;MPDZ;FLI1
Acute Cerebrovascular Accidents,3/91,0.06168621842316671,0.11736017778545355,0,0,3.4465034965034964,9.600906652339221,VWF;PLAU;ANK2
Recurrent pneumonia,2/41,0.06216762783487358,0.11781340282078284,0,0,5.170852956567242,14.364220331003802,LEP;EGFR
Schwartz-Jampel Syndrome,2/41,0.06216762783487358,0.11781340282078284,0,0,5.170852956567242,14.364220331003802,KDR;EGFR
"Pancreatitis, Alcoholic",2/41,0.06216762783487358,0.11781340282078284,0,0,5.170852956567242,14.364220331003802,ALDH2;LPL
TNF receptor-associated periodic fever syndrome (TRAPS),2/41,0.06216762783487358,0.11781340282078284,0,0,5.170852956567242,14.364220331003802,HGF;CCL2
alpha 1-Antitrypsin Deficiency,2/41,0.06216762783487358,0.11781340282078284,0,0,5.170852956567242,14.364220331003802,PRTN3;A2M
Bowing of the long bones,2/41,0.06216762783487358,0.11781340282078284,0,0,5.170852956567242,14.364220331003802,BMPR1B;FGFR3
Cloudy cornea,2/41,0.06216762783487358,0.11781340282078284,0,0,5.170852956567242,14.364220331003802,ABCA1;LIFR
Corneal stromal opacities,2/41,0.06216762783487358,0.11781340282078284,0,0,5.170852956567242,14.364220331003802,ABCA1;LIFR
Genitourinary Cancer,2/41,0.06216762783487358,0.11781340282078284,0,0,5.170852956567242,14.364220331003802,FZD4;EGFR
Growth Hormone-Secreting Pituitary Adenoma,2/41,0.06216762783487358,0.11781340282078284,0,0,5.170852956567242,14.364220331003802,GHR;CXCR4
Hemophilia B,2/41,0.06216762783487358,0.11781340282078284,0,0,5.170852956567242,14.364220331003802,F8;TLR4
Increased head circumference,5/215,0.06301420167062514,0.11937528642117362,0,0,2.4169750801875156,6.681474200583479,CCND2;ANTXR2;FGFR3;MPDZ;FLI1
Thickened facial skin with coarse facial features,4/151,0.06335478896465481,0.11997785017506947,0,0,2.7568553194473666,7.60617700339119,RPS6KA3;MMP14;THRB;ANTXR2
Coarse facial features,4/152,0.06458666014977964,0.12060593734665764,0,0,2.7380886040679857,7.501671103152908,RPS6KA3;MMP14;THRB;ANTXR2
Decreased platelet count,4/152,0.06458666014977964,0.12060593734665764,0,0,2.7380886040679857,7.501671103152908,VWF;PLAU;CD36;FLI1
Reduced bone mineral density,2/42,0.06486293104564635,0.12060593734665764,0,0,5.041326530612245,13.79044280007415,COL1A2;SOX10
Anaphylaxis (non medication),2/42,0.06486293104564635,0.12060593734665764,0,0,5.041326530612245,13.79044280007415,SORBS1;ESR1
Cerebral Edema,2/42,0.06486293104564635,0.12060593734665764,0,0,5.041326530612245,13.79044280007415,PLAU;MYLK
Chronic diarrhea,2/42,0.06486293104564635,0.12060593734665764,0,0,5.041326530612245,13.79044280007415,SAA1;ANTXR2
Eye Abnormalities,2/42,0.06486293104564635,0.12060593734665764,0,0,5.041326530612245,13.79044280007415,BMPR1B;TGFBR2
Gonadal Dysgenesis,2/42,0.06486293104564635,0.12060593734665764,0,0,5.041326530612245,13.79044280007415,KIT;FGFR3
Hyperextensible skin,2/42,0.06486293104564635,0.12060593734665764,0,0,5.041326530612245,13.79044280007415,COL1A2;FGFR3
Melancholia,2/42,0.06486293104564635,0.12060593734665764,0,0,5.041326530612245,13.79044280007415,SNAP25;NR3C1
Nail Diseases,2/42,0.06486293104564635,0.12060593734665764,0,0,5.041326530612245,13.79044280007415,LAMA3;KRT5
Ptosis,2/42,0.06486293104564635,0.12060593734665764,0,0,5.041326530612245,13.79044280007415,LAMC1;DCN
Joint laxity,3/93,0.06497233529082283,0.12060593734665764,0,0,3.3695726495726497,9.211716516794466,COL1A2;PIK3R1;TGFBR2
Myelodysplasia,3/94,0.06664514552633603,0.12060593734665764,0,0,3.3323753169907016,9.025315568749445,KIT;IRS2;CD36
"ACTH Syndrome, Ectopic",1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,NR3C1
"Chondrodysplasia punctata, X-linked dominant type",1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,FGFR3
Rippling muscle disease,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,EGFR
Scarlet Fever,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,CALR
Senile sclerosis of aortic cusp,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,SPP1
"Fibromatosis, Abdominal",1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,KIT
Serum Sickness,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,CFH
"Hypomagnesemia 1, Intestinal",1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,PKD2
"Lacrimal Puncta, Absence of",1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,FGFR3
"Leiomyosarcoma, Epithelioid",1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,DMD
Skin Vesicle,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,KRT5
"Membranoproliferative Glomerulonephritis, Type III",1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,CFH
"Mental Retardation, X-Linked 46",1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,ARHGEF6
Spinocerebellar ataxia type 31,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,SYNE1
"Nemaline Myopathy, Autosomal Recessive",1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,TPM3
"Peroxisome Biogenesis Disorder, Complementation Group H",1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,CCND1
Subacute Bacterial Endocarditis,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,EGFR
"Pneumonia, Viral",1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,BCL6
"PROSTATE CANCER, SOMATIC",1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,KLF6
Synovial sarcoma non-metastatic,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,CIB1
Temporomandibular Joint Dysfunction Syndrome,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,CCL2
"Squamous cell carcinoma, metastatic",1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,EGFR
Thickened cortex of long bones,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,LIFR
Toxic multinodular goiter,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,THRB
Abdominal sepsis,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,S100A8
Abnormal macular morphology,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,SOX10
Type 1 fibers relatively smaller than type 2 fibers,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,TPM3
Ulcerative colitis in remission,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,SOCS3
Abnormality of oral mucosa,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,SAA1
Abnormality of the sacrum,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,RUNX2
Venous Insufficiency,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,F13A1
Acquired haemophilia,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,F8
ACTIVATED PI3K-DELTA SYNDROME,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,PIK3R1
Vitreous Hemorrhage,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,FZD4
Acute glaucoma,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,TLR4
Acute glomerulonephritis,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,DCN
Acute Motor Axonal Neuropathy,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,TLR4
Acute peritonitis,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,ANXA1
Adenitis,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,CXCL10
Adenoid cystic breast carcinoma,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,ESR1
Adnexal mass,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,ESR1
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,FLI1
Alcohol-Related Disorders,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,ALDH2
Angiodysplasia,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,VWF
Angiodysplasia of colon,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,VWF
Angiosarcoma of Soft Tissue,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,KIT
Anterior Horn Cell Disease,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,VIM
Anus Neoplasms,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,CCND1
Aplasia of muscle,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,DMD
Ascending aorta dilatation,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,ACTA2
asthma with copd,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,CXCR4
Ataxic cerebral palsy,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,EGFR
Autoimmune Lymphoproliferative Syndrome Type 2B,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,TLR4
Autonomic dysregulation,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,SOX10
Bacterial keratitis,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,S100A8
Broad long bones,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,COL1A2
Broad metacarpals,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,BGN
Bronchopulmonary Aspergillosis,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,TLR4
Carcinoma of Endocrine Gland,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,ESR1
Carcinoma of unknown primary,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,MET
Childhood Acute Promyelocytic Leukemia with PML-RARA,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,KIT
Chronic intestinal pseudo-obstruction,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,SOX10
Chronic neutropenia,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,CXCR4
Chronic osteomyelitis,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,TLR4
Circadian Rhythm Disorders,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,PPARG
Cleft Soft Palate,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,TGFBR2
Clinodactyly of the 5th toe,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,TGFBR2
Cloverleaf cranium shape,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,FGFR3
colon (non-specific) lesion,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,KIT
Complement C3 Measurement,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,C3
Complicated malaria,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,TLR4
Composite Lymphoma,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,BCL6
Congenital localized absence of skin,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,LAMA3
Congenital melanocytic nevus,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,MET
Conjunctivochalasis,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,TIMP1
Curvature of the little toe,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,TGFBR2
Drinking behavior processes,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,ALDH2
Ehlers-Danlos syndrome type 1,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,COL1A2
Elephantiasis,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,HGF
Endotoxic shock,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,AQP1
Enlarged joints,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,LIFR
Excessive sputum secretion,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,PRTN3
Familial juvenile gout,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,MUC1
Familial Motor Neuron Disease,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,VIM
Fenestration (morphologic abnormality),1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,MEF2C
Fetid chronic bronchitis,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,CXCL10
Generalized amyloid deposition,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,GSN
GIANT AXONAL NEUROPATHY 1,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,VIM
Heart Neoplasm,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,CCND1
Hemangioma of liver,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,GOLM1
Hemangioma of retina,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,ELOB
Hemoglobin increased,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,EPAS1
Hemorrhagic colitis,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,CFH
Hepatorenal Syndrome,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,TLR4
Hyperplasia of foramen magnum,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,RUNX2
Hypothalamic Dysfunction Syndromes,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,LEP
Hypotriglyceridemia,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,LPL
Idiopathic osteoporosis,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,ESR1
Immunodeficiency congenital,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,CXCR4
impaired motor coordination,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,CCND1
In situ cancer,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,EGFR
Increased circumference of foramen magnum,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,RUNX2
Increased diameter of foramen magnum,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,RUNX2
Increased megakaryocyte count,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,CALR
Increased vertebral height,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,FGFR3
Infantile myofibromatosis,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,VIM
Infected ascites,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,CCL2
Infectious colitis,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,PPARG
Intratubular malignant germ cells,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,KLF4
Invasive Prostate Carcinoma,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,PLK1
Junctional split,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,LAMA3
Keratosis pilaris,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,LRP1
Large foramen magnum,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,RUNX2
Laryngismus,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,LAMA3
Lipidemia retinalis,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,LPL
Lymphangiectasis,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,KDR
Lymphoepithelioid lymphoma (clinical),1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,BCL3
Malignant Cystosarcoma Phyllodes,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,KIT
Malignant neoplasm of appendix,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,KDR
Megacystis,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,MYLK
Metastatic Endometrial Carcinoma,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,EGFR
Multiple fibrofolliculomas,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,MET
Myeloid hyperplasia,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,ZFP36
Myelolipoma,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,KIT
Myxoinflammatory fibroblastic sarcoma,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,VIM
Narrow foramen obturatorium,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,CAV1
Neuroborreliosis,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,CFH
Nose symptoms,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,LEP
Null Cell Pituitary Gland Adenoma,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,ESR1
Olfactory lobe agenesis,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,SOX10
Overriding aorta,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,MEF2C
Oxalosis,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,CCL2
Pancreatic Pseudocyst,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,ALDH2
Papillary adenocarcinoma,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,EGFR
Paraneoplastic Encephalomyelitis,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,MUC1
Parotid Neoplasms,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,LEP
Partial duplication of thumb phalanx,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,FGFR3
Pediatric follicular lymphoma,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,BCL6
Periampullary Adenocarcinoma,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,EGFR
Postoperative confusion,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,CFH
Postpartum Thyroiditis,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,THRB
Primary malignant neoplasm of appendix,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,KDR
Prominent joints,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,LIFR
Pulmonary Valve Insufficiency,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,COL1A2
Pupillary abnormality,1/7,0.06728494121441418,0.12060593734665764,0,0,16.74788494077834,45.199507131472544,PIK3R1
"CATARACT, ANTERIOR POLAR",2/43,0.06759685837358557,0.12088042223920722,0,0,4.918118466898955,13.250364137460942,TIMP1;EGFR
"Macular dystrophy, corneal type 1",2/43,0.06759685837358557,0.12088042223920722,0,0,4.918118466898955,13.250364137460942,KDR;TLR4
Autoimmune hemolytic anemia,2/43,0.06759685837358557,0.12088042223920722,0,0,4.918118466898955,13.250364137460942,STAT1;SIRPA
Cleft uvula,2/43,0.06759685837358557,0.12088042223920722,0,0,4.918118466898955,13.250364137460942,BGN;TGFBR2
Depressive Syndrome,2/43,0.06759685837358557,0.12088042223920722,0,0,4.918118466898955,13.250364137460942,SNAP25;NR3C1
Macrocephaly,2/43,0.06759685837358557,0.12088042223920722,0,0,4.918118466898955,13.250364137460942,CCND2;FGFR3
Pulmonary Cystic Fibrosis,2/43,0.06759685837358557,0.12088042223920722,0,0,4.918118466898955,13.250364137460942,ZFP36;PPARG
Renal cyst,3/95,0.06833757811136497,0.12204120434164341,0,0,3.2959866220735785,8.844105977919796,PKD2;FGFR3;EGFR
Anorexia Nervosa,3/95,0.06833757811136497,0.12204120434164341,0,0,3.2959866220735785,8.844105977919796,LEP;LEPR;ESR1
Fragile X Syndrome,3/95,0.06833757811136497,0.12204120434164341,0,0,3.2959866220735785,8.844105977919796,RGS4;RCAN1;DMD
Polyneuropathy,3/95,0.06833757811136497,0.12204120434164341,0,0,3.2959866220735785,8.844105977919796,GSN;ALDH2;SPP1
nervous system disorder,8/436,0.06907174407242016,0.12331099636915478,0,0,1.9059517953762912,5.093864961404309,CXCL10;SNAP25;MEF2C;CXCR4;CCL2;PPARG;FOS;SOX10
Elevated creatine kinase,4/156,0.06963894681923337,0.12428196503673632,0,0,2.665491047205643,7.102017742492807,FHL1;DMD;CRYAB;SYNE1
Renal failure in adulthood,3/96,0.07004947064381682,0.1249727583062939,0,0,3.2603804797353186,8.66789614133527,C3;GSN;PKD2
Downward slant of palpebral fissure,5/222,0.07020326685909198,0.12503939634250805,0,0,2.3381724409636826,6.21102875672225,RPS6KA3;FHL1;BGN;FGFR3;FLI1
"AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED",2/44,0.07036838987261805,0.12503939634250805,0,0,4.800777453838679,12.741316767024726,GSN;BGN
Short ribs,2/44,0.07036838987261805,0.12503939634250805,0,0,4.800777453838679,12.741316767024726,FGFR3;RUNX2
Sickle Cell Trait,2/44,0.07036838987261805,0.12503939634250805,0,0,4.800777453838679,12.741316767024726,TPM3;CD36
Split hand foot deformity 1,2/44,0.07036838987261805,0.12503939634250805,0,0,4.800777453838679,12.741316767024726,MAP3K20;EGFR
Acquired aplastic anemia,2/44,0.07036838987261805,0.12503939634250805,0,0,4.800777453838679,12.741316767024726,CXCL10;CXCR4
Amelogenesis Imperfecta,2/44,0.07036838987261805,0.12503939634250805,0,0,4.800777453838679,12.741316767024726,COL17A1;LAMA3
Behavior Disorders,2/44,0.07036838987261805,0.12503939634250805,0,0,4.800777453838679,12.741316767024726,LEP;ESR1
Blue sclera,2/44,0.07036838987261805,0.12503939634250805,0,0,4.800777453838679,12.741316767024726,COL1A2;TGFBR2
Mixed anxiety and depressive disorder,2/44,0.07036838987261805,0.12503939634250805,0,0,4.800777453838679,12.741316767024726,GSN;ALDH2
Neuromyelitis Optica,2/44,0.07036838987261805,0.12503939634250805,0,0,4.800777453838679,12.741316767024726,SPP1;AQP1
Osteosclerosis,2/44,0.07036838987261805,0.12503939634250805,0,0,4.800777453838679,12.741316767024726,DMD;RUNX2
Hemoglobin measurement,3/97,0.07178065819391924,0.12749708520013975,0,0,3.225531914893617,8.496503359863171,THRB;ALDH2;PPARG
Low set ears,6/293,0.07179935310294978,0.12749708520013975,0,0,2.1248911149825784,5.596707811888839,RPS6KA3;MEF2C;MAF;FHL1;LIFR;CTSD
Tall stature,2/45,0.07317652182093962,0.12847697710668568,0,0,4.688894162316089,12.260898613128823,FGFR3;TGFBR2
"Skin Diseases, Genetic",2/45,0.07317652182093962,0.12847697710668568,0,0,4.688894162316089,12.260898613128823,COL17A1;KRT5
Widely spaced teeth,2/45,0.07317652182093962,0.12847697710668568,0,0,4.688894162316089,12.260898613128823,RPS6KA3;ZEB2
Atypical Teratoid Rhabdoid Tumor,2/45,0.07317652182093962,0.12847697710668568,0,0,4.688894162316089,12.260898613128823,CCND1;SPP1
Congenital hypoplasia of ovary,2/45,0.07317652182093962,0.12847697710668568,0,0,4.688894162316089,12.260898613128823,LEP;LEPR
Delirium,2/45,0.07317652182093962,0.12847697710668568,0,0,4.688894162316089,12.260898613128823,CCL2;NR3C1
gallbladder neoplasm,2/45,0.07317652182093962,0.12847697710668568,0,0,4.688894162316089,12.260898613128823,YAP1;EGFR
Hypoplastic ovary,2/45,0.07317652182093962,0.12847697710668568,0,0,4.688894162316089,12.260898613128823,LEP;LEPR
Melanoderma (disorder),2/45,0.07317652182093962,0.12847697710668568,0,0,4.688894162316089,12.260898613128823,KIT;ANTXR2
Peripheral axonal neuropathy,2/45,0.07317652182093962,0.12847697710668568,0,0,4.688894162316089,12.260898613128823,ABCA1;SERPING1
Purpura,2/45,0.07317652182093962,0.12847697710668568,0,0,4.688894162316089,12.260898613128823,PROS1;MET
Frontotemporal Lobar Degeneration,3/98,0.07353097344146252,0.12847697710668568,0,0,3.191417004048583,8.329753337150311,SNAP25;CCL2;DCN
Mycobacterium Infections,3/98,0.07353097344146252,0.12847697710668568,0,0,3.191417004048583,8.329753337150311,ANXA1;STAT1;SPP1
Creatine phosphokinase serum increased,4/159,0.0735580343802111,0.12847697710668568,0,0,2.613501829065514,6.820405023771018,FHL1;DMD;CRYAB;SYNE1
Refractive Errors,2/46,0.07602026649927245,0.12847697710668568,0,0,4.582096474953618,11.806941421762529,HGF;TIMP1
"Dysautonomia, Familial",2/46,0.07602026649927245,0.12847697710668568,0,0,4.582096474953618,11.806941421762529,DST;FKBP4
Telangiectasia of the skin,2/46,0.07602026649927245,0.12847697710668568,0,0,4.582096474953618,11.806941421762529,CAV1;ANTXR2
Telangiectasis,2/46,0.07602026649927245,0.12847697710668568,0,0,4.582096474953618,11.806941421762529,ACTA2;F8
Thrombasthenia,2/46,0.07602026649927245,0.12847697710668568,0,0,4.582096474953618,11.806941421762529,VWF;PECAM1
Acute periodontitis,2/46,0.07602026649927245,0.12847697710668568,0,0,4.582096474953618,11.806941421762529,STAT1;TLR4
Basal Cell Nevus Syndrome,2/46,0.07602026649927245,0.12847697710668568,0,0,4.582096474953618,11.806941421762529,NRP1;CCND1
Bilateral single transverse palmar creases,2/46,0.07602026649927245,0.12847697710668568,0,0,4.582096474953618,11.806941421762529,BMPR1B;FGFR3
Cutaneous Mastocytosis,2/46,0.07602026649927245,0.12847697710668568,0,0,4.582096474953618,11.806941421762529,CXCL12;KIT
Early gastric cancer,2/46,0.07602026649927245,0.12847697710668568,0,0,4.582096474953618,11.806941421762529,PER1;EGFR
Facial asymmetry,2/46,0.07602026649927245,0.12847697710668568,0,0,4.582096474953618,11.806941421762529,FGFR3;FLI1
Hereditary Diseases,2/46,0.07602026649927245,0.12847697710668568,0,0,4.582096474953618,11.806941421762529,LPL;DMD
Hypoalbuminemia,2/46,0.07602026649927245,0.12847697710668568,0,0,4.582096474953618,11.806941421762529,LPL;A2M
Charcot-Marie-Tooth Disease,6/298,0.07648564124667102,0.12847697710668568,0,0,2.087970890410959,5.36744707131302,MME;LAMA4;CCL2;DMD;SOX10;CRYAB
Recurrent mycobacterial infections,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,STAT1
"Amyloidosis, Primary Cutaneous",1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,GSN
Renal corticomedullary cysts,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,MUC1
"BRACHYDACTYLY, TYPE A1 (disorder)",1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,BMPR1B
Reticular pigmentation pattern,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,KRT5
"Bronchiolitis, Viral",1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,STAT5A
Reticulated skin pigmentation,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,KRT5
Rheumatic disease of heart valve,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,CALR
"Charcot-Marie-Tooth disease, X-linked, 1",1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,SOX10
"Dementia, familial British",1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,GSN
"Ehlers-Danlos Syndrome, Type IV",1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,COL1A2
"Endometrial stromal sarcoma, high grade",1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,CCND1
Secretory breast carcinoma,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,STAT5A
Segmental vitiligo,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,SPP1
Sensory denervation disorder,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,STAT1
Short 2nd finger,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,BMPR1B
Short distal phalanx of the thumb,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,BMPR1B
Shprintzen-Goldberg syndrome,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,TGFBR2
Skin appendage adenoma,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,MAML2
"Membranoproliferative Glomerulonephritis, Type I",1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,CFH
"Motor Neuron Disease, Upper",1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,VIM
Spindle Cell Oncocytoma of the Adenohypophysis,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,SPP1
"Nemaline Myopathy, Childhood Onset",1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,TPM3
Spondylolysis,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,RUNX2
Sprains and Strains,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,MUC1
Squamous cell carcinoma of lip,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,CCL2
Stinging Sensation,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,SORBS1
"PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS",1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,CCL2
Supratentorial Neoplasms,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,VIM
"Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia",1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,CAV1
"PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED",1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,CAV1
"Pulmonary Hypertension, Primary, Fenfluramine-Associated",1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,CAV1
"Rett Syndrome, Atypical",1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,MEF2C
T-cell/histiocyte rich large B-cell lymphoma,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,MUC1
"Skin Diseases, Bullous",1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,DST
"stage, bladder cancer",1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,EGR1
Thickening of glomerular basement membrane,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,CFH
"Thrombotic thrombocytopenic purpura, acquired",1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,VWF
Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,ESR1
"Viral hepatitis, type G",1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,LEP
"VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1",1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,F8
Abnormality of femur morphology,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,FGFR3
Abnormality of the cervical spine,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,FGFR3
Upper airway obstruction,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,FGFR3
Abnormality of the larynx,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,SERPING1
Very Low Birth Weight,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,GHR
Visually threatening diabetic retinopathy,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,CXCL12
acute aortic dissection,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,ACTA2
Weakness,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,DMD
Wernicke-Korsakoff Syndrome,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,ALDH2
White matter dysmyelination/demyelination,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,SOX10
Adenofibroma,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,ESR1
Alcohol Withdrawal Seizures,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,MPDZ
Altitude Sickness,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,EPAS1
Amyloid Neuropathies,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,GSN
anaphylaxis,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,PECAM1
Aplasia/Hypoplasia involving the nose,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,GHR
Arterial tortuosity,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,TGFBR2
Beading of ribs,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,COL1A2
Boutonneuse Fever,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,TLR4
Brachyturricephaly,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,FHL1
Brenner Tumor,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,EGFR
Cap Myopathy,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,TPM3
Cardiac Carcinoma,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,CCND1
Cerebral dysmyelination,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,SOX10
Choroidal and/or chorioretinal disorder,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,FZD4
Chronic mountain sickness,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,EPAS1
Chronic noninfectious lymphadenopathy,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,ABCA1
Chronic rhinosinusitis with nasal polyps,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,NR3C1
Claudication (finding),1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,F8
Cleft palate and bilateral cleft lip,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,YAP1
Cloverleaf skull,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,FGFR3
COMPLEMENT COMPONENT 2 DEFICIENCY,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,CFH
Congenital hypoplasia of nose,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,GHR
Craniofacial asymmetry,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,ESR1
Decreased pneumatization of frontal sinus,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,RUNX2
Delayed maturation of wrist bone,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,BGN
Delayed ossification of carpal bones,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,BGN
Dermal translucency,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,TGFBR2
Developmental Psychomotor Disorders,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,RPS6KA3
Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,CXCR4
Ectopic Pregnancy,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,MUC1
Extraosseous Ewings sarcoma-primitive neuroepithelial tumor,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,FLI1
Familial HDL deficiency,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,ABCA1
fertility disorders,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,TLR4
Fibular bowing,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,FGFR3
Gastrointestinal lymphoma,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,MAP3K20
Giant platelet (morphologic abnormality),1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,CD36
Hemorrhagic diarrhea,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,CFH
Hereditary Renal Cell Carcinoma,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,MET
Histoplasmosis,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,STAT1
Hot flushes,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,ESR1
Hyperhidrosis Palmaris Et Plantaris,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,COL17A1
Hypoplastic frontal sinuses,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,RUNX2
Hypotrophic frontal sinus,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,RUNX2
Hypotrophic nose,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,GHR
Increased circulating cortisol level,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,NR3C1
Increased neuronal autofluorescent lipopigment,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,CTSD
Infantile Colic,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,PPARG
Infantile fibrosarcoma,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,BCL6
Intestinal Graft Versus Host Disease,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,CXCL10
Invasive Candidiasis,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,CXCR4
Legionnaires' Disease,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,TLR4
Leukocytoclastic vasculitis,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,VWF
Lichen planus follicularis,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,PPARG
Long hallux,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,FLI1
Lymphomatoid Granulomatosis,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,PECAM1
Macrocytosis,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,ALDH2
Malignant neoplasm of border of tongue,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,FOS
Malignant neoplasm of dorsal surface of tongue,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,FOS
Malignant neoplasm of ventral surface of tongue,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,FOS
Malignant tumor of base of tongue,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,FOS
Malignant tumor of junctional zone of tongue,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,FOS
malignant tumor of lingual tonsil,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,FOS
Medullary cystic disease,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,MUC1
Melanoma recurrent,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,EGFR
Meningeal Carcinomatosis,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,EGFR
metabolic disturbance,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,PPARG
Metastases to adrenals,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,EGFR
Mixed Oligodendroglioma-Ependymoma,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,DTX1
Multiple prenatal fractures,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,COL1A2
Myofibromatosis,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,VIM
Narrow iliac wings,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,RPS6KA3
Neonatal disorder,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,PKD2
Neonatal encephalopathy,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,TLR4
Neuronal lipopigments,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,CTSD
Oligodendroblastoma,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,DTX1
Osteoporosis of vertebrae,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,RUNX2
Ovarian Small Cell Carcinoma,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,KIT
Pancreatic adenocarcinoma metastatic,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,EGFR
Panuveitis,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,CFH
Periosteal Disorder,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,FGFR3
Peripheral hypomyelination,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,SOX10
Peritoneal Mesothelioma,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,EGFR
Polyostotic fibrous dysplasia,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,BGN
Polysyndactyly,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,FZD4
Poxviridae Infections,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,DUSP1
Premenstrual Dysphoric Disorder,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,ESR1
Prodrome,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,CFH
Progressive spasticity,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,RPS6KA3
Proximal weakness,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,DMD
Pseudoepiphyses of the metacarpals,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,RPS6KA3
Psychomotor Disorders,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,RPS6KA3
Pulmonary Aspergillosis,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,TLR4
Pyloric Atresia,1/8,0.07652203515417907,0.12847697710668568,0,0,14.354604786076868,36.89386843909958,LAMA3
Rhinitis,3/100,0.07708830635407195,0.12938695576719667,0,0,3.125297383029342,8.009523629556108,C3;CCL11;EGFR
Hepatomegaly,7/373,0.07825545994045494,0.13130457998195352,0,0,1.946213486682116,4.958517328662279,ABCA1;CAV1;SAA1;LEPR;PPARG;FOS;MET
Single Seizure,3/101,0.07889497825568491,0.1315553555595966,0,0,3.0932496075353217,7.855733319132799,LEP;FOS;MPDZ
Sleep disturbances,3/101,0.07889497825568491,0.1315553555595966,0,0,3.0932496075353217,7.855733319132799,THRB;LEP;FKBP4
"Seizures, Auditory",3/101,0.07889497825568491,0.1315553555595966,0,0,3.0932496075353217,7.855733319132799,LEP;FOS;MPDZ
"Seizures, Clonic",3/101,0.07889497825568491,0.1315553555595966,0,0,3.0932496075353217,7.855733319132799,LEP;FOS;MPDZ
"Seizures, Sensory",3/101,0.07889497825568491,0.1315553555595966,0,0,3.0932496075353217,7.855733319132799,LEP;FOS;MPDZ
"Seizures, Somatosensory",3/101,0.07889497825568491,0.1315553555595966,0,0,3.0932496075353217,7.855733319132799,LEP;FOS;MPDZ
Vertiginous seizure,3/101,0.07889497825568491,0.1315553555595966,0,0,3.0932496075353217,7.855733319132799,LEP;FOS;MPDZ
Xeroderma Pigmentosum,3/101,0.07889497825568491,0.1315553555595966,0,0,3.0932496075353217,7.855733319132799,HGF;KIT;MET
Atonic Absence Seizures,3/101,0.07889497825568491,0.1315553555595966,0,0,3.0932496075353217,7.855733319132799,LEP;FOS;MPDZ
Generalized Absence Seizures,3/101,0.07889497825568491,0.1315553555595966,0,0,3.0932496075353217,7.855733319132799,LEP;FOS;MPDZ
Gustatory seizure,3/101,0.07889497825568491,0.1315553555595966,0,0,3.0932496075353217,7.855733319132799,LEP;FOS;MPDZ
Jacksonian Seizure,3/101,0.07889497825568491,0.1315553555595966,0,0,3.0932496075353217,7.855733319132799,LEP;FOS;MPDZ
Mean corpuscular hemoglobin concentration determination,3/101,0.07889497825568491,0.1315553555595966,0,0,3.0932496075353217,7.855733319132799,TF;THRB;ALDH2
Non-epileptic convulsion,3/101,0.07889497825568491,0.1315553555595966,0,0,3.0932496075353217,7.855733319132799,LEP;FOS;MPDZ
Nonepileptic Seizures,3/101,0.07889497825568491,0.1315553555595966,0,0,3.0932496075353217,7.855733319132799,LEP;FOS;MPDZ
Olfactory seizure,3/101,0.07889497825568491,0.1315553555595966,0,0,3.0932496075353217,7.855733319132799,LEP;FOS;MPDZ
Disseminated neuroblastoma,2/47,0.07889865197381699,0.1315553555595966,0,0,4.4800453514739225,11.377483465836477,TINAGL1;CCND1
Kidney damage,2/47,0.07889865197381699,0.1315553555595966,0,0,4.4800453514739225,11.377483465836477,CCND1;SAA1
Lower limb muscle weakness,2/47,0.07889865197381699,0.1315553555595966,0,0,4.4800453514739225,11.377483465836477,CAV1;FHL1
Male sterility,2/47,0.07889865197381699,0.1315553555595966,0,0,4.4800453514739225,11.377483465836477,ALDH2;ESR1
Heart Decompensation,3/102,0.08072008651158788,0.1345503099844391,0,0,3.061849261849262,7.705963726169715,VWF;PRKAR2B;PPARG
Sleep Disorders,2/48,0.08181072190551267,0.13611281206196596,0,0,4.382431233362911,10.970745946307456,LEP;FKBP4
Synovial Cyst,2/48,0.08181072190551267,0.13611281206196596,0,0,4.382431233362911,10.970745946307456,KDR;UTRN
Underdeveloped brows,2/48,0.08181072190551267,0.13611281206196596,0,0,4.382431233362911,10.970745946307456,GHR;FGFR3
Underdeveloped supraorbital ridges,2/48,0.08181072190551267,0.13611281206196596,0,0,4.382431233362911,10.970745946307456,GHR;FGFR3
Corneal Neovascularization,2/48,0.08181072190551267,0.13611281206196596,0,0,4.382431233362911,10.970745946307456,VIM;DCN
keratoacanthoma,2/48,0.08181072190551267,0.13611281206196596,0,0,4.382431233362911,10.970745946307456,CCND1;FGFR3
Fetal Growth Retardation,6/304,0.0823335429894802,0.1367251723538663,0,0,2.045302013422819,5.107071440471125,ACTA2;LEP;CCL2;LIFR;PIK3R1;FGFR3
Death in infancy,3/103,0.08256345325766513,0.1367251723538663,0,0,3.031076923076923,7.560076145928414,LAMA3;ANTXR2;TGFBR2
Epileptic Seizures,3/103,0.08256345325766513,0.1367251723538663,0,0,3.031076923076923,7.560076145928414,LEP;FOS;MPDZ
Hypoplastic feet,3/103,0.08256345325766513,0.1367251723538663,0,0,3.031076923076923,7.560076145928414,BGN;BMPR1B;FGFR3
Sclerocystic Ovaries,4/166,0.08312778486806312,0.1367251723538663,0,0,2.499681812396589,6.217649243690986,LEP;LIFR;DMD;ANTXR2
Respiratory distress,3/104,0.08442489877948275,0.1367251723538663,0,0,3.000913937547601,7.417937890699555,STAT5B;LIFR;EGFR
Tonic Seizures,3/104,0.08442489877948275,0.1367251723538663,0,0,3.000913937547601,7.417937890699555,LEP;FOS;MPDZ
Death in early childhood,3/104,0.08442489877948275,0.1367251723538663,0,0,3.000913937547601,7.417937890699555,LAMA3;ANTXR2;TGFBR2
Hereditary hemochromatosis,4/167,0.0845427222603014,0.1367251723538663,0,0,2.4842198469420023,6.137260867723485,TF;SPP1;CALR;EGFR
Microcephaly,5/235,0.08470192996295642,0.1367251723538663,0,0,2.2045505744537057,5.442190786739661,ZEB2;FZD4;PLK1;PIK3R1;CTSD
Sparse body hair,2/49,0.08475553532049038,0.1367251723538663,0,0,4.288970907511941,10.585112525518486,COL17A1;LAMA3
Abnormality of vision,2/49,0.08475553532049038,0.1367251723538663,0,0,4.288970907511941,10.585112525518486,LIFR;SOX10
Cardiovascular Abnormalities,2/49,0.08475553532049038,0.1367251723538663,0,0,4.288970907511941,10.585112525518486,PKD2;FLI1
Endogenous depression,2/49,0.08475553532049038,0.1367251723538663,0,0,4.288970907511941,10.585112525518486,SNAP25;NR3C1
Gingival Overgrowth,2/49,0.08475553532049038,0.1367251723538663,0,0,4.288970907511941,10.585112525518486,MMP14;ANTXR2
Intracranial Hemorrhages,2/49,0.08475553532049038,0.1367251723538663,0,0,4.288970907511941,10.585112525518486,PLAU;F13A1
Low anterior hairline,2/49,0.08475553532049038,0.1367251723538663,0,0,4.288970907511941,10.585112525518486,RPS6KA3;FGFR3
Oral soft tissue hyperplasia,2/49,0.08475553532049038,0.1367251723538663,0,0,4.288970907511941,10.585112525518486,MMP14;ANTXR2
Renal medullary carcinoma,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,CCND1
"Arthritis, Bacterial",1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,CXCL10
"Bare Lymphocyte Syndrome, Type I",1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,TAP1
Rhegmatogenous retinal detachment,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,FZD4
"Clinically Isolated Syndrome, CNS Demyelinating",1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,QKI
"Dementia, familial Danish",1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,GSN
"Epithelioid hemangioendothelioma, malignant",1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,YAP1
Seronegative rheumatoid arthritis,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,CCL2
Skin Wrinkling,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,PIK3R1
Small vessel vasculitis,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,PRTN3
Snoring,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,GSN
Spinal Cord Contusion,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,AQP1
Spinal Cord Injuries,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,AQP1
Spinal Cord Laceration,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,AQP1
"MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B",1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,AQP1
Spinal Cord transection injury,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,AQP1
Spindle Cell Neoplasm,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,KIT
Spondylolisthesis,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,RUNX2
Spontaneous hematomas,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,F13A1
"Osteogenesis imperfecta, dominant perinatal lethal",1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,COL1A2
"Prostatic Cancer, Castration-Resistant",1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,EGFR
"RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL",1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,FZD4
"Retinoschisis, Juvenile, X-Linked",1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,DMD
"SHORT STATURE, IDIOPATHIC, X-LINKED",1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,GHR
"Thyroid cancer, follicular",1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,PPARG
"TIBIAL MUSCULAR DYSTROPHY, TARDIVE",1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,CCL2
THROMBOCYTOPENIA 2 (disorder),1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,FLI1
Urine color abnormal,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,DMD
Absent frontal sinuses,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,RUNX2
Vasculitic neuropathy,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,SERPING1
Venous retinal branch occlusion,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,CCL2
Acrocyanosis,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,CALR
Acute alcoholic liver disease,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,TLR4
von Willebrand's factor (lab test),1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,VWF
Vulvar Vestibulitis,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,ESR1
Waardenburg Syndrome Type 2,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,SOX10
Wasting Syndrome,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,DMD
Adult-onset citrullinemia type 2,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,CD36
Adult Oligodendroglioma,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,DTX1
Adult Soft Tissue Sarcoma,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,EGFR
After-cataract,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,CFH
Aggressive Systemic Mastocytosis,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,KIT
Anuria,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,PLAU
Aplasia of frontal sinus,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,RUNX2
Argyrophilic grain disease,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,A2M
Asthma attack,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,CCL2
Attention deficit-hyperactivity,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,NR3C1
Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder),1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,SYNE1
Avascular Necrosis of Femur Head,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,STAT1
Birth length less than 3rd percentile,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,PIK3R1
Bone Sarcoma,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,KIT
Broad nail,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,FHL1
Broad philtrum,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,MAF
Bronchial carcinoid,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,EGFR
Brooke-Spiegler syndrome,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,VWF
Calcaneovalgus deformity,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,COL1A2
Capitate-hamate fusion,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,FGFR3
Carcinoid tumor of lung,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,EGFR
Central nervous system leukaemia,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,MME
Cerebral Thrombosis,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,VWF
Childhood Oligodendroglioma,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,DTX1
Chronic acquired lymphedema,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,HGF
Chronic periaortitis,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,TLR4
Coagulation factor deficiency syndrome,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,F8
Congenital coloboma of iris,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,MAF
Congenital Fibrosis of the Extraocular Muscles,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,MAP1B
Congenital hypomyelinating neuropathy,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,SOX10
Corneal infection,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,S100A8
Cutaneous Candidiasis,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,CXCL10
Decreased calvarial ossification,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,COL1A2
Decreased glomerular filtration rate,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,MUC1
Delayed eruption of permanent teeth,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,RUNX2
Demyelination,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,QKI
Diseases of mitral valve,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,VWF
Eichsfeld type congenital muscular dystrophy,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,FHL1
Endometrial Diseases,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,ESR1
Erythema Infectiosum,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,STAT5A
Esophageal Diseases,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,GOLM1
Exercise-induced muscle cramps,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,DMD
Factor XII Deficiency,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,VWF
Familial pulmonary arterial hypertension,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,CAV1
Feeling powerless,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,SGK1
Female Pseudohermaphroditism,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,NR3C1
Fetal Diseases,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,S100A8
Fibular aplasia,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,BMPR1B
Flexion contracture of toe,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,LIFR
Glycogen storage disease type Ia,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,VWF
Glycogen Storage Disease Type IV,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,COL1A2
Glycogen Storage Disease Type VI,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,VWF
Gram-Negative Bacterial Infections,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,TLR4
Hemorrhagic cystitis,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,TLR4
Hepatopulmonary Syndrome,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,CCL2
High weight,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,DMD
Hypoalgesia,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,NRP1
Increased nuchal translucency,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,FGFR3
Infection of ear,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,TLR4
Langer-Giedion Syndrome,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,VIM
Lung cancer stage I,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,EGFR
Magnesium measurement,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,MUC1
Maladaptive behavior associated with physical illness,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,KLF4
Malignant neoplasm of duodenum,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,MDK
Mature Teratoma,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,EGFR
Megalencephaly cutis marmorata telangiectatica congenita,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,CIB1
Microvillus inclusion disease,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,EZR
Narrow internal auditory canal,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,FGFR3
Narrow pelvis bone,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,BGN
Nose Diseases,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,SPP1
Obsessions,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,ESR1
Organ dysfunction syndrome,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,TLR4
Oropharyngeal candidiasis,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,TLR4
Oropharyngeal Neoplasms,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,MET
Pneumonia due to Klebsiella pneumoniae,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,S100A8
Post-Traumatic Myelopathy,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,AQP1
Premature osteoarthritis,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,COL1A2
Protrusio acetabuli,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,COL1A2
Psychomotor Impairment,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,RPS6KA3
psychosocial stressor,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,CCND1
Psychoticism,1/9,0.08566810855499336,0.1367251723538663,0,0,12.559644670050762,30.86249647975658,ESR1
Bulging forehead,3/105,0.08630424160765618,0.13765797770942825,0,0,2.971342383107089,7.279421974495557,RPS6KA3;CCND2;PIK3R1
Prominent forehead,3/105,0.08630424160765618,0.13765797770942825,0,0,2.971342383107089,7.279421974495557,RPS6KA3;CCND2;PIK3R1
Single transverse palmar crease,2/50,0.08773216638795828,0.1397264538796861,0,0,4.199404761904762,10.219111519148857,RPS6KA3;LIFR
Active tuberculosis,2/50,0.08773216638795828,0.1397264538796861,0,0,4.199404761904762,10.219111519148857,CXCR4;TLR4
Childhood onset,2/50,0.08773216638795828,0.1397264538796861,0,0,4.199404761904762,10.219111519148857,DMD;SYNE1
Chronic inflammatory disorder,2/50,0.08773216638795828,0.1397264538796861,0,0,4.199404761904762,10.219111519148857,TLR4;ETS2
Muscular fasciculation,2/50,0.08773216638795828,0.1397264538796861,0,0,4.199404761904762,10.219111519148857,SOX10;EGFR
Dull intelligence,14/947,0.08812003876837042,0.14026036039326342,0,0,1.5387832611025676,3.7377896622431446,YAP1;ZBTB16;CAV1;FOS;SOX10;FLI1;ACTA2;RPS6KA3;MAF;PPARG;DMD;FGFR3;MPDZ;ARHGEF6
Low intelligence,14/947,0.08812003876837042,0.14026036039326342,0,0,1.5387832611025676,3.7377896622431446,YAP1;ZBTB16;CAV1;FOS;SOX10;FLI1;ACTA2;RPS6KA3;MAF;PPARG;DMD;FGFR3;MPDZ;ARHGEF6
"Heart Failure, Right-Sided",3/106,0.0882012986116829,0.1403058866572114,0,0,2.9423450336071695,7.144406817089898,VWF;PRKAR2B;PPARG
Malignant Testicular Germ Cell Tumor,3/106,0.0882012986116829,0.1403058866572114,0,0,2.9423450336071695,7.144406817089898,KIT;ESR1;TEAD1
Mental deficiency,15/1032,0.088515046504186,0.14076296115213582,0,0,1.5140158292631816,3.670856624134552,YAP1;MEF2C;ZBTB16;CAV1;FOS;SOX10;FLI1;ACTA2;RPS6KA3;MAF;PPARG;DMD;FGFR3;MPDZ;ARHGEF6
Developmental Disabilities,4/170,0.08885803322610751,0.1412662467368517,0,0,2.438951683020743,5.904007691923494,ZEB2;BCL6;SOX10;EGFR
White Blood Cell Count procedure,3/107,0.09011588508667766,0.1431378693373786,0,0,2.9139053254437868,7.01277596622521,ZBTB16;LEPR;E2F2
Hairy Cell Leukemia,3/107,0.09011588508667766,0.1431378693373786,0,0,2.9139053254437868,7.01277596622521,ANXA1;CCND1;CIB1
Microstomia,3/107,0.09011588508667766,0.1431378693373786,0,0,2.9139053254437868,7.01277596622521,CCND2;MAF;ZBTB16
Celiac Disease,6/312,0.09050850863763221,0.14340210082231244,0,0,1.9910130718954249,4.783033429232781,STAT1;CCL2;DMD;TIMP1;TLR4;EGFR
"Cockayne Syndrome, Type I",2/51,0.09073970425461392,0.14340210082231244,0,0,4.113494377342774,9.871400352988514,STAT1;TXNIP
"Pain, Crushing",2/51,0.09073970425461392,0.14340210082231244,0,0,4.113494377342774,9.871400352988514,HGF;AQP1
"Pain, Migratory",2/51,0.09073970425461392,0.14340210082231244,0,0,4.113494377342774,9.871400352988514,HGF;AQP1
"Pain, Splitting",2/51,0.09073970425461392,0.14340210082231244,0,0,4.113494377342774,9.871400352988514,HGF;AQP1
"Suffering, Physical",2/51,0.09073970425461392,0.14340210082231244,0,0,4.113494377342774,9.871400352988514,HGF;AQP1
Abnormality of the ribs,2/51,0.09073970425461392,0.14340210082231244,0,0,4.113494377342774,9.871400352988514,FGFR3;RUNX2
Ache,2/51,0.09073970425461392,0.14340210082231244,0,0,4.113494377342774,9.871400352988514,HGF;AQP1
Adult Lymphoma,2/51,0.09073970425461392,0.14340210082231244,0,0,4.113494377342774,9.871400352988514,BCL6;EGFR
Albinism,2/51,0.09073970425461392,0.14340210082231244,0,0,4.113494377342774,9.871400352988514,FZD4;CALR
Autoimmune Primary Adrenal Insufficiency,2/51,0.09073970425461392,0.14340210082231244,0,0,4.113494377342774,9.871400352988514,CXCL10;NR3C1
Cystadenoma,2/51,0.09073970425461392,0.14340210082231244,0,0,4.113494377342774,9.871400352988514,DUSP1;PLK1
Gingival Hyperplasia,2/51,0.09073970425461392,0.14340210082231244,0,0,4.113494377342774,9.871400352988514,MMP14;ANTXR2
Hyperpigmentation,2/51,0.09073970425461392,0.14340210082231244,0,0,4.113494377342774,9.871400352988514,KIT;ANTXR2
Lafora Disease,2/51,0.09073970425461392,0.14340210082231244,0,0,4.113494377342774,9.871400352988514,SNCG;CTSD
Rabies (disorder),2/51,0.09073970425461392,0.14340210082231244,0,0,4.113494377342774,9.871400352988514,CXCL10;STAT1
Radiating pain,2/51,0.09073970425461392,0.14340210082231244,0,0,4.113494377342774,9.871400352988514,HGF;AQP1
Malabsorption,3/108,0.09204781483929661,0.14538316694683212,0,0,2.886007326007326,6.884417836504132,CAV1;SAA1;TGFBR2
Myocardial Failure,3/108,0.09204781483929661,0.14538316694683212,0,0,2.886007326007326,6.884417836504132,VWF;PRKAR2B;PPARG
X-linked agammaglobulinemia,2/52,0.09377725278603731,0.14547103213350315,0,0,4.031020408163266,9.540751964438103,PIK3R1;TLR4
Congenital neurologic anomalies,2/52,0.09377725278603731,0.14547103213350315,0,0,4.031020408163266,9.540751964438103,COL1A2;MME
Drug usage,2/52,0.09377725278603731,0.14547103213350315,0,0,4.031020408163266,9.540751964438103,ZFP36;PPARG
Flexion contracture - elbow,2/52,0.09377725278603731,0.14547103213350315,0,0,4.031020408163266,9.540751964438103,BGN;LIFR
Gingival Hypertrophy,2/52,0.09377725278603731,0.14547103213350315,0,0,4.031020408163266,9.540751964438103,MMP14;ANTXR2
Hoarseness,2/52,0.09377725278603731,0.14547103213350315,0,0,4.031020408163266,9.540751964438103,LAMA3;LIFR
Progressive visual loss,2/52,0.09377725278603731,0.14547103213350315,0,0,4.031020408163266,9.540751964438103,CFH;DCN
"Hyperalgesia, Thermal",3/109,0.09399690023379141,0.14547103213350315,0,0,2.858635703918723,6.759225465007381,EGR1;CCL2;FOS
Convulsive Seizures,3/109,0.09399690023379141,0.14547103213350315,0,0,2.858635703918723,6.759225465007381,LEP;FOS;MPDZ
Oligospermia,3/109,0.09399690023379141,0.14547103213350315,0,0,2.858635703918723,6.759225465007381,SIRPA;ESR1;MEST
"46, XX Testicular Disorders of Sex Development",1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,SOX10
"Agammaglobulinemia, non-Bruton type",1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,PIK3R1
Refractory anemia with ring sideroblasts associated with marked thrombocytosis,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,CXCR4
Rickettsia Infections,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,TLR4
"FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF",1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,F8
Seropositive rheumatoid arthritis,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,VIM
"Hemoglobinuria, Paroxysmal",1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,PLAU
Shoulder girdle muscle atrophy,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,TPM3
Simple syndactyly of fingers - first web,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,FGFR3
Splenic Hypoplasia,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,CCL2
Spondylitis,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,VCAN
"Neuroepithelial, Perineurial, and Schwann Cell Neoplasm",1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,RASD1
Stage 0 Skin Melanoma,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,CCND1
Subacute progressive viral hepatitis,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,MET
"Post-transplant lymphoproliferative disorder, polymorphic",1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,BCL6
Symptomatic dermographism,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,SERPING1
"Thrombocytosis, Autosomal Dominant",1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,CALR
"Tuberculosis, Central Nervous System",1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,TIMP1
"Tuberculosis, Spinal",1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,CCL2
"Vasculitis, Leukocytoclastic, Cutaneous",1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,VWF
Trypanosomiasis,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,A2M
Abnormality of female external genitalia,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,CXCR4
Abnormality of the cerebral vasculature,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,ACTA2
Urban cutaneous leishmaniasis,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,CCL2
Abnormality of tibia morphology,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,BMPR1B
Vascular Endothelial Growth Factor Measurement,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,MEF2C
Adenosquamous cell lung cancer,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,EGFR
Amputation Stumps,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,CIB1
Anal intraepithelial neoplasia,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,CCL2
Atopic rhinitis,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,CCL11
Bile Duct Neoplasms,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,EGFR
Bladder Adenocarcinoma,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,EGFR
Cancer Cell Growth,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,EGFR
cervical cancer metastasis,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,EGFR
Chronic idiopathic neutropenia,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,TLR4
Chronic idiopathic pulmonary fibrosis,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,KRT8
Chronic skin ulcer,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,DCN
Congenital musculoskeletal anomalies,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,TGFBR2
Decrease in jaw opening,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,LIFR
Dementia due to Alzheimer's disease (disorder),1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,ESR1
Dextrocardia,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,PKD2
Distemper,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,STAT1
Donohue Syndrome,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,EGFR
Duodenal Cancer,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,MDK
Emotional Stress,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,RCAN1
Enlarged polycystic ovaries,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,ESR1
Epithelioid and spindle cell nevus,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,CCND1
Exercise-induced muscle fatigue,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,DMD
Fatty Liver Disease,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,CD36
Femoral artery occlusion,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,CCL2
Friend leukemia,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,FLI1
Gangrene,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,TLR4
Hand clenching,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,DST
Hemoptysis,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,PRTN3
Heroin Smoking,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,LEP
Hyperconvex fingernails,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,RPS6KA3
Hyperlipoproteinemia Type IV,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,LPL
Hypoadiponectinemia,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,PPARG
Hypochromic anemia,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,TF
Infections specific to perinatal period,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,CCL2
Intestinal carcinoma,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,CAV1
Laryngostenosis,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,LAMA3
Left ventricular dilatation,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,HGF
Leukostasis,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,PPARG
Limited jaw mobility,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,LIFR
Limited jaw opening,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,LIFR
Lobstein Disease,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,COL1A2
Lymphangioma,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,KDR
Malignant melanoma of iris,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,KIT
Mild dementia,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,ESR1
Nodular thyroid disease,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,PPARG
Oculocutaneous albinism type 1,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,CALR
Oliguria,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,CAV1
Ossifying Fibroma,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,RUNX2
Pancreatic disorders (not diabetes),1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,KRT8
Paraneoplastic pemphigus,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,COL17A1
Persistent Hyperplastic Primary Vitreous,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,FZD4
Phototoxicity,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,SNAP25
Platelet thrombus,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,VWF
Poor wound healing,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,COL1A2
Premature adrenarche,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,TCF7L2
Premature arteriosclerosis,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,LPL
Primary acquired melanosis,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,KIT
Primary bacterial peritonitis,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,CCL2
Pulmonary lymphangioleiomyomatosis,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,ESR1
Quebec platelet disorder,1/10,0.09472405357539049,0.14547103213350315,0,0,11.163564579808234,26.310147374168167,PLAU
"Abortion, Tubal",3/110,0.09596295232330061,0.14728875948469727,0,0,2.8317757009345796,6.637096278644644,CXCL10;COL1A2;LAMA4
Small testicle,3/110,0.09596295232330061,0.14728875948469727,0,0,2.8317757009345796,6.637096278644644,LEP;LEPR;SOX10
"Hyperparathyroidism, Primary",2/53,0.09684393045207626,0.14817149163913707,0,0,3.951780712284914,9.226042862678687,CCND1;ESR1
"Other specified types of schizophrenia, unspecified",2/53,0.09684393045207626,0.14817149163913707,0,0,3.951780712284914,9.226042862678687,SNAP25;MDK
"Pain, Burning",2/53,0.09684393045207626,0.14817149163913707,0,0,3.951780712284914,9.226042862678687,HGF;AQP1
Stevens-Johnson Syndrome,2/53,0.09684393045207626,0.14817149163913707,0,0,3.951780712284914,9.226042862678687,CAV1;EGFR
"Prostate cancer, familial",2/53,0.09684393045207626,0.14817149163913707,0,0,3.951780712284914,9.226042862678687,KLF6;PROS1
Tachycardia,2/53,0.09684393045207626,0.14817149163913707,0,0,3.951780712284914,9.226042862678687,DST;LEP
Abnormality of pelvic girdle bone morphology,2/53,0.09684393045207626,0.14817149163913707,0,0,3.951780712284914,9.226042862678687,COL1A2;FGFR3
Anxiety neurosis (finding),2/53,0.09684393045207626,0.14817149163913707,0,0,3.951780712284914,9.226042862678687,MDK;FOS
Bradycardia,2/53,0.09684393045207626,0.14817149163913707,0,0,3.951780712284914,9.226042862678687,DST;ANK2
Childhood Lymphoma,2/53,0.09684393045207626,0.14817149163913707,0,0,3.951780712284914,9.226042862678687,BCL6;EGFR
Polycystic Kidney - body part,2/53,0.09684393045207626,0.14817149163913707,0,0,3.951780712284914,9.226042862678687,PKD2;AQP1
Small nose,4/176,0.09780034659422997,0.14959186194048552,0,0,2.3531527211699834,5.4706733531902065,MEF2C;MAF;LIFR;FLI1
Physical Activity Measurement,3/111,0.09794578087283178,0.14977132461156972,0,0,2.8054131054131055,6.5179318783586355,ABCA1;TCF7L2;EFEMP1
Splenomegaly,5/247,0.09937800956775789,0.15191778915277734,0,0,2.0939493855179205,4.834561478684715,ABCA1;CCND1;BCL6;LPL;CALR
Reduced tendon reflexes,2/54,0.09993887001581798,0.15243501469502638,0,0,3.8755886970172684,8.926242631510387,TPM3;MAP3K20
Congenital ichthyosis,2/54,0.09993887001581798,0.15243501469502638,0,0,3.8755886970172684,8.926242631510387,F13A1;DMD
Drug Withdrawal Symptoms,2/54,0.09993887001581798,0.15243501469502638,0,0,3.8755886970172684,8.926242631510387,PER1;FOS
"Muscular Dystrophy, Facioscapulohumeral",3/112,0.09994519447258814,0.15243501469502638,0,0,2.7795342272406494,6.401637833093279,FHL1;DMD;DCN
Bilateral cataracts (disorder),3/112,0.09994519447258814,0.15243501469502638,0,0,2.7795342272406494,6.401637833093279,VIM;CRYAB;EGFR
Bronchiectasis,3/112,0.09994519447258814,0.15243501469502638,0,0,2.7795342272406494,6.401637833093279,STAT1;TAP1;CXCR4
Merkel cell carcinoma,3/112,0.09994519447258814,0.15243501469502638,0,0,2.7795342272406494,6.401637833093279,CCND1;KIT;EGFR
Neonatal Hypotonia,3/112,0.09994519447258814,0.15243501469502638,0,0,2.7795342272406494,6.401637833093279,DST;TPM3;SOX10
Aplasia/Hypoplasia of the mandible,7/397,0.1004067110458985,0.15309509675639288,0,0,1.8241911665995436,4.1929512465536245,GHR;COL1A2;LIFR;PIK3R1;FGFR3;RUNX2;TGFBR2
Cocaine-Related Disorders,3/113,0.10196100060169108,0.15361913443561453,0,0,2.754125874125874,6.288123487024435,EGR1;FOS;NR3C1
Short nose,4/179,0.10242382439042166,0.15361913443561453,0,0,2.312459499263623,5.269253309496851,MEF2C;MAF;LIFR;FLI1
"Decreased visual acuity, progressive",2/55,0.10306121844716908,0.15361913443561453,0,0,3.802271852137081,8.64040466088152,CFH;DCN
Early Rheumatoid Arthritis,2/55,0.10306121844716908,0.15361913443561453,0,0,3.802271852137081,8.64040466088152,VIM;TLR4
Gingivitis,2/55,0.10306121844716908,0.15361913443561453,0,0,3.802271852137081,8.64040466088152,TLR4;ESR1
Hantavirus Infections,2/55,0.10306121844716908,0.15361913443561453,0,0,3.802271852137081,8.64040466088152,CXCL10;KDR
Brain Diseases,5/250,0.10323549507715912,0.15361913443561453,0,0,2.067991963624828,4.695877325264504,RCAN1;MUC1;CXCL12;CCL2;TLR4
Recurrent Endometrial Cancer,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,EGFR
"Brain Stem Ischemia, Transient",1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,C3
"CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)",1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,CRYAB
Retinoschisis,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,DMD
Rudiger syndrome 1,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,LRP1
Sarcoglycanopathies,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,DMD
"Dendritic Cell Sarcoma, Follicular",1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,EGFR
SHORT syndrome,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,PIK3R1
"Mixed Tumor, Mullerian",1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,S100A4
Spermatocytic seminoma,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,FGFR3
Splanchnic vein thrombosis,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,CALR
"Nephrogenic Diabetes Insipidus, Type I",1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,VWF
"Parkinson Disease, Secondary Vascular",1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,RGS2
Sturge-Weber Syndrome,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,KDR
Supraventricular tachycardia,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,CALR
Systemic Anaplastic Large Cell Lymphoma,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,CIB1
"Spastic paraplegia 10, autosomal dominant",1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,S100A4
Thick nasal alae,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,RPS6KA3
"Transient Ischemic Attack, Anterior Circulation",1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,C3
"Transient Ischemic Attack, Vertebrobasilar Circulation",1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,C3
Abnormal platelet morphology,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,CALR
Trisomy 4,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,KIT
Abnormality of the endocrine system,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,CD36
Abnormality of the ulna,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,BMPR1B
Absence of rib,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,FLI1
Vascular System Injuries,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,SPP1
Vitreoretinal degeneration,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,VCAN
Wolman Disease,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,ABCA1
Akathisia,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,RGS2
Angioma,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,KDR
Anovulatory (finding),1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,NR3C1
Apparent mineralocorticoid excess,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,NR3C1
Atherosclerotic Parkinsonism,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,RGS2
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,FGFR3
Bilateral pheochromocytoma and islet cell adenoma of the pancreas,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,EPAS1
Carotid Circulation Transient Ischemic Attack,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,C3
Cataract microcornea syndrome,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,MAF
Choledochal Cyst,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,AQP1
Chondroma,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,RUNX2
Communicable Diseases,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,HGF
Congenital Pain Insensitivity,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,LIFR
Conical incisor,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,FGFR3
Crescendo Transient Ischemic Attacks,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,C3
Dedifferentiated chondrosarcoma,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,RUNX2
Digestive System Disorders,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,PPARG
Early onset schizophrenia,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,SOX10
Ectromelia,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,TLR4
Electrocardiogram,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,CAV1
Exaggerated acoustic startle response,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,KLC2
Fungal keratitis,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,TLR4
Granular cell tumor,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,SPP1
Granulomatosis,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,PRTN3
Hereditary Factor XI Deficiency,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,VWF
HFE-Associated Hereditary Hemochromatosis,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,TF
HIV-Associated Lipodystrophy Syndrome,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,PPARG
HODGKIN'S AND NON-HODGKIN'S LYMPHOMA,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,KRT18
Hyperoxia,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,JUN
HYPERPARATHYROIDISM 3,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,CCND1
Hyperplastic lymph node,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,NEDD9
Immunoproliferative Small Intestinal Disease,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,BCL6
Increased circulating ACTH level,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,NR3C1
Increased startle response,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,KLC2
Indolent Systemic Mastocytosis,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,KIT
Jaw Keratocyst,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,CCND1
Kallmann Syndrome 1,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,EZR
Lean body mass,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,VCAN
Limbal stem cell deficiency,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,KRT19
Limited elbow movement,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,FHL1
Lipoblastoma,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,COL1A2
Malignant neoplasm of body of pancreas,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,MET
Malignant neoplasm of fallopian tube,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,EGFR
malignant neoplasm of head of pancreas,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,MET
Malignant neoplasm of other specified sites of pancreas,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,MET
Malignant neoplasm of tail of pancreas,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,MET
MASA SYNDROME (disorder),1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,F8
Metabolic alkalosis,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,NR3C1
Muscle fiber splitting,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,CRYAB
Nasopharyngeal Angiofibroma,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,KIT
Nemaline bodies,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,TPM3
Odontome,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,RUNX2
Ornithine carbamoyltransferase deficiency,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,DMD
Overweight or obesity,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,RGS2
pediatric AIDS,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,CXCL12
Peg shaped front tooth,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,FGFR3
Peripheral Nerve Sheath Neoplasm,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,SOX10
Perry Syndrome,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,SORBS1
Pigmentation Disorders,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,KRT5
Pigmented villonodular synovitis,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,SPP1
Placental Steroid Sulfatase Deficiency,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,DMD
Pointed front tooth,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,FGFR3
Pointed incisor,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,FGFR3
Polymorphous corneal dystrophy,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,KRT19
Posterior Circulation Transient Ischemic Attack,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,C3
Prehypertension,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,PECAM1
Primary Hyperthyroidism,1/11,0.10369075371831592,0.15361913443561453,0,0,10.046700507614213,22.769262652105503,AQP1
Ciliopathies,4/181,0.10556129517824803,0.15634689883404218,0,0,2.286097035354418,5.140205736489915,NRP1;MUC1;LEP;PKD2
Epileptic drop attack,3/115,0.10604101519431147,0.1570137732621522,0,0,2.70467032967033,6.069089064270181,LEP;FOS;MPDZ
Adenoviral infections,2/56,0.10621013664473684,0.1570895970524015,0,0,3.7316704459561603,8.36765795898803,HGF;IRS2
Autoimmune arthritis,2/56,0.10621013664473684,0.1570895970524015,0,0,3.7316704459561603,8.36765795898803,PECAM1;TLR4
Cystitis,2/56,0.10621013664473684,0.1570895970524015,0,0,3.7316704459561603,8.36765795898803,MUC1;KDR
Familial Mediterranean Fever,2/56,0.10621013664473684,0.1570895970524015,0,0,3.7316704459561603,8.36765795898803,SAA1;TLR4
"Organic Mental Disorders, Substance-Induced",3/116,0.10810483367134834,0.15975891809057552,0,0,2.6805990469707286,5.9634049647459095,ABLIM1;PARVA;SYNE1
Complex partial seizures,3/116,0.10810483367134834,0.15975891809057552,0,0,2.6805990469707286,5.9634049647459095,LEP;FOS;MPDZ
Prescription Drug Abuse,3/116,0.10810483367134834,0.15975891809057552,0,0,2.6805990469707286,5.9634049647459095,ABLIM1;PARVA;SYNE1
"Ataxia, Appendicular",2/57,0.10938479931304602,0.16156086350865362,0,0,3.6636363636363636,8.107199889755803,MME;SYNE1
Bleeding tendency,2/57,0.10938479931304602,0.16156086350865362,0,0,3.6636363636363636,8.107199889755803,F8;VWF
"Hypogonadism, Isolated Hypogonadotropic",3/117,0.11018426485040132,0.16202058856136434,0,0,2.6569500674763833,5.860172203123165,LEP;LEPR;SOX10
Poor school performance,14/985,0.11145802332157646,0.16202058856136434,0,0,1.4755854564993507,3.2375927206800683,YAP1;ZBTB16;CAV1;FOS;SOX10;FLI1;ACTA2;RPS6KA3;MAF;PPARG;DMD;FGFR3;MPDZ;ARHGEF6
Red Blood Cell Count measurement,3/118,0.11227911165079854,0.16202058856136434,0,0,2.6337123745819397,5.759316465557757,MEF2C;THRB;CD36
"Anemia, Hemolytic",3/118,0.11227911165079854,0.16202058856136434,0,0,2.6337123745819397,5.759316465557757,CFH;SIRPA;A2M
Convulsions,3/118,0.11227911165079854,0.16202058856136434,0,0,2.6337123745819397,5.759316465557757,LEP;FOS;MPDZ
recurrent muscle twitches (symptom),1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,VIM
Recurrent respiratory papillomatosis,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,TAP1
"Alport Syndrome, X-Linked",1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,CFH
"Arthritis, Infectious",1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,CXCL10
Retinal Pigment Epithelial Detachment,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,CFH
"Cerebral Infarction, Left Hemisphere",1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,PLAU
"Cerebral Infarction, Right Hemisphere",1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,PLAU
Secondary hypertension,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,SGK1
Secondary Parkinson Disease,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,RGS2
Secondary pulmonary hypertension,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,S100A4
Senile dementia,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,ESR1
"Leishmaniasis, New World",1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,CCL2
"Lymphoma, Lymphocytic, Intermediate",1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,CCND1
Social Anxiety,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,RGS2
"MYCOBACTERIUM TUBERCULOSIS, PROTECTION AGAINST",1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,CCL2
"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO (finding)",1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,CCL2
"NEVUS, EPIDERMAL (disorder)",1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,FGFR3
Stage IV Colorectal Cancer,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,EGFR
Trismus,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,LIFR
Accessory rib,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,ZBTB16
Violence,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,NR3C1
Vulvar Lichen Sclerosus,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,DCN
Waardenburg Syndrome,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,SOX10
Acute mountain sickness,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,EPAS1
Adenocarcinoma of the gastroesophageal junction,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,HGF
Amebiasis,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,LEPR
Anterior Choroidal Artery Infarction,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,PLAU
Aplasia/Hypoplasia of the earlobes,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,FLI1
Aspiration Pneumonia,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,KDR
Astler-Coller B1 Rectal Carcinoma,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,BCL6
Biliary System Disorder,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,TGFBR2
Breast cancer stage II,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,ESR1
Broad hallux phalanx,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,FLI1
Carditis,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,DCN
Childhood Ependymoma,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,EGFR
Choroid Diseases,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,TEAD1
Chronic calcifying pancreatitis,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,SPP1
Congenital blindness,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,FZD4
Congenital exomphalos,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,LRP1
Congenital leukocyte adherence deficiency,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,COL17A1
Corneal Scar,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,DST
Coronavirus Infections,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,CCL2
Cystic renal dysplasia,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,FGFR3
Distal lower limb muscle weakness,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,TPM3
Foot Ulcer,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,TGFBR2
Gigantism,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,DMD
Glucose tolerance test,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,TCF7L2
Hereditary Connective Tissue Disorder,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,COL1A2
Hyaline Membrane Disease,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,EPAS1
hyperparathyroid,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,CCND1
HYPERPARATHYROIDISM 1,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,CCND1
Idiopathic gingival hyperplasia,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,ANTXR2
Inflammatory cardiomyopathy,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,TLR4
Insulin measurement,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,TCF7L2
Intestinal metaplasia of gastric mucosa,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,TIMP1
Inverted Squamous Cell Papilloma,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,FGFR3
Irido-corneal dysgenesis,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,MAF
Lacrimal Duct Obstruction,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,FGFR3
Leri-Weill dyschondrosteosis,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,FGFR3
Lower limb atrophy,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,TPM3
Lower limb muscle hypotrophy,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,TPM3
Lymphoblastic leukemia in children,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,NR3C1
Lymphoepithelial carcinoma,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,EGFR
Malignant neoplasm of anus,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,EGFR
Mucopolysaccharidosis II,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,PER1
Myeloperoxidase Measurement,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,CFH
Myotonia,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,LIFR
Neuropil Threads,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,GSN
Nevus sebaceous,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,FGFR3
Obstruction of nasolacrimal duct,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,FGFR3
Onchocerciasis,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,CALR
Pelizaeus Merzbacher like disease,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,SOX10
Persistent Fetal Circulation Syndrome,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,SIRPA
Placental dysfunction,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,PPARG
Posterior Choroidal Artery Infarction,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,PLAU
Priapism,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,F8
Proximal muscle weakness in lower limbs,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,DMD
Raised TSH level,1/12,0.11256908393690102,0.16202058856136434,0,0,9.13290263036456,19.947977849834988,THRB
SCHIZOPHRENIA 1 (disorder),2/58,0.1125843947162192,0.16202058856136434,0,0,3.5980320699708455,7.85828972612605,SNAP25;MDK
Severe global developmental delay,2/58,0.1125843947162192,0.16202058856136434,0,0,3.5980320699708455,7.85828972612605,RPS6KA3;FGFR3
Substance Withdrawal Syndrome,2/58,0.1125843947162192,0.16202058856136434,0,0,3.5980320699708455,7.85828972612605,PER1;FOS
Tooth Crowding,2/58,0.1125843947162192,0.16202058856136434,0,0,3.5980320699708455,7.85828972612605,RPS6KA3;FGFR3
Tooth mass arch size discrepancy,2/58,0.1125843947162192,0.16202058856136434,0,0,3.5980320699708455,7.85828972612605,RPS6KA3;FGFR3
Tooth size discrepancy,2/58,0.1125843947162192,0.16202058856136434,0,0,3.5980320699708455,7.85828972612605,RPS6KA3;FGFR3
Wide anterior fontanel,2/58,0.1125843947162192,0.16202058856136434,0,0,3.5980320699708455,7.85828972612605,COL1A2;FGFR3
Amnesia,2/58,0.1125843947162192,0.16202058856136434,0,0,3.5980320699708455,7.85828972612605,ALDH2;EGFR
Inadequate arch length for tooth size,2/58,0.1125843947162192,0.16202058856136434,0,0,3.5980320699708455,7.85828972612605,RPS6KA3;FGFR3
Intestinal Cancer,2/58,0.1125843947162192,0.16202058856136434,0,0,3.5980320699708455,7.85828972612605,TCF7L2;CXCR4
Large cell carcinoma of lung,2/58,0.1125843947162192,0.16202058856136434,0,0,3.5980320699708455,7.85828972612605,VIM;EGFR
Mycoplasma Infections,2/58,0.1125843947162192,0.16202058856136434,0,0,3.5980320699708455,7.85828972612605,KRT5;TLR4
Narcolepsy,5/258,0.11387994194985249,0.16384076961413713,0,0,2.001781728071433,4.349092053804692,TF;LEP;SERPING1;TAP1;ANTXR2
Drug Use Disorders,3/119,0.1143891763476958,0.16452899345664532,0,0,2.6108753315649866,5.660766261095806,ABLIM1;PARVA;SYNE1
Urinary Incontinence,2/59,0.11580812452808689,0.1663454166065162,0,0,3.5347296813462226,7.6202429080226235,A2M;DCN
Waddling gait,2/59,0.11580812452808689,0.1663454166065162,0,0,3.5347296813462226,7.6202429080226235,FHL1;DMD
Well Differentiated Pancreatic Endocrine Tumor,2/59,0.11580812452808689,0.1663454166065162,0,0,3.5347296813462226,7.6202429080226235,FZD4;KIT
Angina Pectoris,2/59,0.11580812452808689,0.1663454166065162,0,0,3.5347296813462226,7.6202429080226235,PLAU;SVEP1
Cytokine Measurement,2/59,0.11580812452808689,0.1663454166065162,0,0,3.5347296813462226,7.6202429080226235,COL1A2;SGK1
"Hearing Loss, Partial",5/260,0.1166208336012424,0.16746764275424972,0,0,1.98587828913949,4.26730957194384,COL1A2;THRB;SOX10;FGFR3;RUNX2
Cryptorchidism,7/414,0.11797376729659777,0.16936481840613402,0,0,1.7464656469892073,3.7327087850696485,ACTA2;ZBTB16;KIT;SOX10;ESR1;FGFR3;FLI1
"Subfertility, Male",2/60,0.11905520366638651,0.17064035984200115,0,0,3.473610133708656,7.392425920895251,ALDH2;ESR1
Autoimmune thyroiditis,2/60,0.11905520366638651,0.17064035984200115,0,0,3.473610133708656,7.392425920895251,CXCL10;CCL2
Oropharyngeal Carcinoma,2/60,0.11905520366638651,0.17064035984200115,0,0,3.473610133708656,7.392425920895251,ALDH2;EGFR
Acute Megakaryocytic Leukemias,3/122,0.1208086907885828,0.17064035984200115,0,0,2.544667097608274,5.378273643629554,CXCR4;CD36;ETS2
"Adenocarcinoma, intestinal type",1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,EGFR
"Amyloid Neuropathies, Familial",1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,GSN
Relapsing Fever,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,CFH
Renal Cell Dysplasia,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,ESR1
"Breast Neoplasms, Male",1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,ESR1
Retinitis,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,CXCL12
Rieger syndrome,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,PIK3R1
"Cystadenoma, Mucinous",1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,PLAU
Secondary Trigeminal Neuralgia,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,FOS
"Eosinophilia, Tropical",1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,TLR4
Senile cardiac amyloidosis,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,GSN
"Fibromatosis, Gingival",1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,ANTXR2
"Hypoalphalipoproteinemia, Familial",1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,ABCA1
Sotos' syndrome,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,FGFR3
"MYOPATHY, MYOFIBRILLAR, DESMIN-RELATED",1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,CRYAB
"Niemann-Pick Disease, Type C1",1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,SNAP25
Stage IV Colorectal Cancer AJCC v7,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,EGFR
Status Dysraphicus,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,CCL2
"Pemphigoid, Benign Mucous Membrane",1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,COL17A1
"Pseudohypoaldosteronism, Type I, Autosomal Dominant",1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,SGK1
"Scleroderma, Limited",1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,CAV1
"stage, pancreatic cancer",1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,EGFR
"Tooth, Supernumerary",1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,RUNX2
"Trigeminal Neuralgia, Idiopathic",1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,FOS
Abnormality of the abdominal wall,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,ZEB2
Urolithiasis,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,SPP1
Adrenal Gland Diseases,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,ANTXR2
Age-related cognitive decline,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,ESR1
Akinetic-Rigid Variant of Huntington Disease,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,RCAN1
American cutaneous leishmaniasis,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,FLI1
Ataxia with vitamin E deficiency,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,ZFP36
Bacteroides fragilis infection in conditions classified elsewhere and of unspecified site,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,TLR4
Brain and/or spinal cord issue,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,COL1A2
Breech Presentation,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,COL1A2
cancer angiogenesis,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,CCL2
Cells in urine,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,KLF4
Cerebral metastasis,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,EGFR
Cholera Infantum,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,MYLK
Coffin-Lowry syndrome,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,RPS6KA3
Diabetes in children,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,NRP1
Diaphyseal thickening,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,FGFR3
Diarrheal disorder,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,SAA1
Epithelial corneal erosions,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,FGFR3
Extramedullary Plasmacytoma,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,PECAM1
Folliculitis,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,PPARG
Generalized joint laxity,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,FGFR3
Infection in children,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,LEPR
Influenza A virus infection,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,MUC1
Infrequent generalized seizures,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,FGFR3
Juvenile Huntington Disease,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,RCAN1
Keratoconjunctivitis,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,MUC1
Lecithin Acyltransferase Deficiency,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,ABCA1
Liver and Intrahepatic Bile Duct Epithelial Neoplasm,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,MET
Liver and Intrahepatic Bile Duct Neoplasm,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,MET
Low density lipoprotein increased,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,LPL
Lymphatic Abnormalities,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,PECAM1
Macular retinal edema,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,KDR
Malignant Hypertension,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,CFH
Mediastinal lymphadenopathy,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,BCL6
Metabolic myopathy,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,DMD
MILES-CARPENTER X-LINKED MENTAL RETARDATION SYNDROME,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,CCL11
Mineralocorticoid insufficiency,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,NR3C1
Morphea,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,DCN
Myoglobinuria,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,DMD
Nesidioblastosis,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,PPARG
Occupational Diseases,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,EGFR
Osteogenesis imperfecta type III (disorder),1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,COL1A2
Osteogenesis imperfecta type IV (disorder),1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,COL1A2
Perivascular Epithelioid Cell Neoplasms,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,VIM
Pimples,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,EGFR
Prelingual sensorineural hearing impairment,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,HGF
Primary Cutaneous Follicle Center Lymphoma,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,BCL6
pustule,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,EGFR
Rectal Prolapse,1/13,0.12135991064011717,0.17064035984200115,0,0,8.37140439932318,17.655247344501635,RPS6KA3
Viremia,2/61,0.1223248600244283,0.17181580892730058,0,0,3.414562435143549,7.174251720956937,CCL2;SORBS1
Aura,2/61,0.1223248600244283,0.17181580892730058,0,0,3.414562435143549,7.174251720956937,MEF2C;FOS
Awakening Epilepsy,2/61,0.1223248600244283,0.17181580892730058,0,0,3.414562435143549,7.174251720956937,MEF2C;FOS
Profound intellectual disabilities,2/61,0.1223248600244283,0.17181580892730058,0,0,3.414562435143549,7.174251720956937,EZR;FGFR3
Substance-Related Disorders,3/123,0.12297763742147952,0.17268717518288917,0,0,2.5233333333333334,5.288282771794861,ABLIM1;PARVA;SYNE1
Developmental delay (disorder),4/193,0.12527735897914455,0.175870138566876,0,0,2.1396389025255003,4.44451169297413,MEF2C;MUC1;DMD;FGFR3
Bardet-Biedl Syndrome,2/62,0.12561633441268988,0.17620675074630807,0,0,3.3574829931972787,6.965175632228617,LEP;PECAM1
Coloboma of iris,2/62,0.12561633441268988,0.17620675074630807,0,0,3.3574829931972787,6.965175632228617,YAP1;MAF
Hereditary Malignant Neoplasm,2/62,0.12561633441268988,0.17620675074630807,0,0,3.3574829931972787,6.965175632228617,MUC1;MET
Memory impairment,5/267,0.126458411268341,0.1773412825392077,0,0,1.9321283075584386,3.9953356571354064,ABCA1;RPS6KA3;MME;MDK;PPARG
Tetralogy of Fallot,3/125,0.1273579917662965,0.17855583744346068,0,0,2.48171500630517,5.1142024513851005,NRP1;ALDH2;DMD
"Epilepsy, Cryptogenic",2/63,0.12892888030731356,0.17905232380005967,0,0,3.3022750083640013,6.764691670684913,MEF2C;FOS
Difficulty walking,2/63,0.12892888030731356,0.17905232380005967,0,0,3.3022750083640013,6.764691670684913,SNAP25;DMD
Fibroadenoma,2/63,0.12892888030731356,0.17905232380005967,0,0,3.3022750083640013,6.764691670684913,KIT;ESR1
Idiopathic hypogonadotropic hypogonadism,2/63,0.12892888030731356,0.17905232380005967,0,0,3.3022750083640013,6.764691670684913,SOX10;FGFR3
ROSE Cluster 5,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,CXCR4
"Depressive Disorder, Treatment-Resistant",1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,RGS4
"Dermatitis, Phototoxic",1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,SNAP25
SEBASTIAN SYNDROME,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,CXCL12
Sensory axonal neuropathy,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,KLC2
Sensory hearing loss,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,FADD
Serum iron measurement,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,TF
Short extremities,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,FGFR3
"Huntington Disease, Late Onset",1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,RCAN1
"Lymphoma, Extranodal NK-T-Cell",1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,TINAGL1
Stage II Colorectal Cancer AJCC v7,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,EZR
Stickler syndrome (disorder),1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,RPS6KA3
Subcortical Infarction,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,PLAU
Testicular Feminization,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,FKBP4
"Supratentorial Embryonal Tumor, Not Otherwise Specified",1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,EGFR
Thoracolumbar scoliosis,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,RPS6KA3
"Toxoplasmosis, Congenital",1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,TLR4
Trisomy 11,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,CCND1
Tubulointerstitial scarring,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,MUC1
Abnormality of the antihelix,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,FGFR3
Urticaria Pigmentosa,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,KIT
Abnormality of the thyroid gland,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,THRB
Uterine Polyp,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,KIT
Vasculitis of the skin,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,C3
Achromatopsia 1,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,LIFR
Viral meningitis,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,TIMP1
AIDS-Related Non-Hodgkin Lymphoma,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,BCL6
ALZHEIMER DISEASE 2,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,LRP1
Anal squamous cell carcinoma,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,EGFR
Angioedema,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,SERPING1
Antibiotic-associated diarrhea,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,CCL2
B lymphocytopenia,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,STAT1
Biconcave vertebral bodies,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,COL1A2
Central retinal vein occlusion,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,VWF
Contralateral breast cancer,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,ESR1
Coronary Occlusion,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,CCL2
Delayed epiphyseal ossification,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,ESR1
Delayed maturation of end part of long bone,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,ESR1
Distal lower limb amyotrophy,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,TPM3
Dysferlinopathy,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,DMD
Dyspareunia,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,CAV1
Enterovirus 71 infection,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,CXCL10
Eye Neoplasms,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,FLI1
Falls,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,DMD
Familial Exudative Vitreoretinopathy,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,FZD4
Female pattern alopecia (disorder),1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,ZFP36
First myocardial infarction,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,VWF
Gastrointestinal symptom,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,LEP
Genital ulcers,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,CXCR4
Granulomatous disorder,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,PPARG
Hashimoto's encephalitis,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,S1PR1
Hyperexplexia,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,KLC2
Hyperextensibility of the finger joints,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,RPS6KA3
Hypoparathyroidism - autosomal dominant,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,ESR1
Inflammatory neuropathy,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,CXCL10
Leiomyomatosis,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,MET
Loeys-Dietz Syndrome,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,TGFBR2
Low Grade Cervical Squamous Intraepithelial Neoplasia,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,CCND1
Micronodular cirrhosis,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,MET
Mirror movements disorder,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,MEF2C
Myxoma of heart,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,EGFR
Nephrogenic rest,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,HGF
Neuroma,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,NRP1
Partial thromboplastin time increased (finding),1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,F8
Peripheral sensory axonal neuropathy,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,KLC2
POEMS Syndrome,1/14,0.13006409184275305,0.17905232380005967,0,0,7.727059742288168,15.761099618273683,HGF
Hyperkeratosis,3/127,0.1317936211868671,0.18138641717583026,0,0,2.441439205955335,4.947620632900682,CAV1;KRT5;FGFR3
Short metacarpal,2/64,0.13226176364444261,0.18151504982262032,0,0,3.248847926267281,6.572329238772686,RPS6KA3;BGN
Smooth philtrum,2/64,0.13226176364444261,0.18151504982262032,0,0,3.248847926267281,6.572329238772686,MAF;FLI1
Synophrys,2/64,0.13226176364444261,0.18151504982262032,0,0,3.248847926267281,6.572329238772686,FHL1;SOX10
Unspecified visual loss,2/64,0.13226176364444261,0.18151504982262032,0,0,3.248847926267281,6.572329238772686,ANXA1;CFH
Congenital Camptodactyly,2/64,0.13226176364444261,0.18151504982262032,0,0,3.248847926267281,6.572329238772686,FGFR3;TGFBR2
Diaphragmatic Hernia,2/64,0.13226176364444261,0.18151504982262032,0,0,3.248847926267281,6.572329238772686,THRB;LRP1
Esophagitis,2/64,0.13226176364444261,0.18151504982262032,0,0,3.248847926267281,6.572329238772686,CCL11;S100A8
Febrile Convulsions,2/64,0.13226176364444261,0.18151504982262032,0,0,3.248847926267281,6.572329238772686,C3;TIMP1
High-Grade Squamous Intraepithelial Lesions,2/64,0.13226176364444261,0.18151504982262032,0,0,3.248847926267281,6.572329238772686,CCL2;SORBS1
Multiple Endocrine Neoplasia Type 2a,2/64,0.13226176364444261,0.18151504982262032,0,0,3.248847926267281,6.572329238772686,NRP1;NR3C1
Polyp of large intestine,2/64,0.13226176364444261,0.18151504982262032,0,0,3.248847926267281,6.572329238772686,ALDH2;PPARG
Congenital clubfoot,4/198,0.13392214082655884,0.18374641824529664,0,0,2.0839621638856416,4.189799025298756,DST;LIFR;BMPR1B;TGFBR2
Arthralgia,3/128,0.13403166075063724,0.18380203812149917,0,0,2.4217846153846154,4.86701024756506,CAV1;PRTN3;TLR4
Hereditary Nonpolyposis Colorectal Cancer,3/128,0.13403166075063724,0.18380203812149917,0,0,2.4217846153846154,4.86701024756506,CCND1;EGFR;TGFBR2
Deafness,5/273,0.1351852196521541,0.18533625817502683,0,0,1.8882917021112056,3.778678357080783,COL1A2;THRB;SOX10;FGFR3;RUNX2
Adult Liver Carcinoma,2/65,0.13561426276275013,0.18578108130146412,0,0,3.197116942014901,6.387650145486205,YAP1;CAV1
Lymphocytosis,2/65,0.13561426276275013,0.18578108130146412,0,0,3.197116942014901,6.387650145486205,CCND1;MME
Open mouth (finding),2/65,0.13561426276275013,0.18578108130146412,0,0,3.197116942014901,6.387650145486205,RPS6KA3;DST
Rett Syndrome,3/129,0.13628291474652712,0.18660114406069964,0,0,2.4024420024420023,4.7881204817013945,LEP;MET;RUNX2
"Seizures, Focal",3/129,0.13628291474652712,0.18660114406069964,0,0,2.4024420024420023,4.7881204817013945,LEP;FOS;MPDZ
"Adenocarcinoma, metastatic",1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,ZEB2
Reiter Syndrome,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,TAP1
Reproductive tract infection,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,TLR4
"Carcinoma of urinary bladder, invasive",1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,EFEMP1
Retinal depigmentation,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,SOX10
"Chromosome 10, monosomy 10q",1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,EGFR
"Down Syndrome, Partial Trisomy 21",1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,RCAN1
Selective immunoglobulin A deficiency,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,C3
"Leukemia, Prolymphocytic, B-Cell",1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,CCND1
Small wings of the pelvic girdle,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,FGFR3
Smoker's lung,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,EGFR
"MELORHEOSTOSIS, ISOLATED",1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,SOX10
Stage II Colorectal Cancer,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,EZR
"Pyogenic Arthritis, Pyoderma Gangrenosum and Acne",1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,S100A8
Synostosis of carpal bones,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,BMPR1B
"Septicaemia due to gram-negative organism, unspecified",1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,TLR4
"Trisomy 21, Meiotic Nondisjunction",1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,RCAN1
"Trisomy 21, Mitotic Nondisjunction",1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,RCAN1
Tic disorder,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,VIM
Total iron binding capacity function,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,TF
Trichomonas Infections,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,TLR4
Abnormality of the hypothalamus-pituitary axis,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,PRTN3
Uterine Corpus Carcinosarcoma,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,EGFR
X-Linked Lissencephaly,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,ANXA1
Adult Synovial Sarcoma,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,MET
Aplasia/Hypoplasia of the thumb,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,BMPR1B
Aspergillosis,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,TLR4
Bacterial sepsis,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,TLR4
Cervix Intraepithelial Neoplasia Grade 3 AJCC v7,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,KLF4
Chorioamnionitis,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,TLR4
Complex Regional Pain Syndromes,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,CCL2
Congenital abnormal Synostosis,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,FGFR3
Core binding factor acute myeloid leukemia,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,KIT
Epithelial cyst,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,PKD2
Erythrophagocytosis,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,TF
Esophageal Varices,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,KDR
Excessive tearing,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,COL17A1
Familial cold urticaria,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,MME
Foot-and-Mouth Disease,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,VIM
Fowlpox,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,MUC1
Group B streptococcal pneumonia,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,CCND1
Hemangioendothelioma,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,CCL2
Humoral hypercalcemia of malignancy (disorder),1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,EGFR
Hypoplastic ilia,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,FGFR3
Immunologic hypersensitivity,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,TLR4
Iron binding capacity total measurement,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,TF
Jacobsen Distal 11q Deletion Syndrome,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,FLI1
Juvenile hemochromatosis,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,ESR1
Lethal skeletal dysplasia,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,FGFR3
Malignant tumor of peritoneum,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,VCAN
Maternal hypertension,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,LPL
Mesomelia,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,FGFR3
Microangiopathic hemolytic anemia,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,CFH
Monoblastic leukemia,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,KIT
Neonatal thrombocytopenia (disorder),1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,CD36
Nodular melanoma,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,SPP1
Oestrogen receptor positive breast cancer,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,MUC1
Patent ductus arteriosus - persisting type,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,ACTA2
Pemphigus Foliaceus,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,C3
Periorbital fullness,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,FGFR3
Phobic anxiety disorder,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,ESR1
Platybasia,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,COL1A2
Poikiloderma of Kindler,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,KRT5
Primary Adrenal Insufficiency,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,NR3C1
Progressive pseudorheumatoid dysplasia,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,ESR1
Pulmonary Fibrosis - from Asbestos Exposure,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,SPP1
Rapidly progressive glomerulonephritis,1/15,0.13868247719449792,0.18667312982305617,0,0,7.174764321972444,14.174236923314213,EGFR
"Bronchitis, Chronic",2/66,0.13898566811264107,0.1867981400686669,0,0,3.147002551020408,6.210245924321761,CCL11;NR3C1
Severe psychomotor retardation,2/66,0.13898566811264107,0.1867981400686669,0,0,3.147002551020408,6.210245924321761,RPS6KA3;FGFR3
"stage, non-small cell lung cancer",2/66,0.13898566811264107,0.1867981400686669,0,0,3.147002551020408,6.210245924321761,CCND1;EGFR
Addison Disease,2/66,0.13898566811264107,0.1867981400686669,0,0,3.147002551020408,6.210245924321761,CXCL10;NR3C1
Beckwith-Wiedemann Syndrome,2/66,0.13898566811264107,0.1867981400686669,0,0,3.147002551020408,6.210245924321761,S100A8;SPTBN1
Congenital arteriovenous malformation,2/66,0.13898566811264107,0.1867981400686669,0,0,3.147002551020408,6.210245924321761,PECAM1;TLR4
Reticulocyte count (procedure),4/202,0.14100955966121878,0.1894704849809972,0,0,2.041445381651567,3.999043685446485,THRB;LAMA3;IRS2;TNS1
Schistosomiasis,2/67,0.1423752821610712,0.19096850708188987,0,0,3.098430141287284,6.039735405617296,THRB;EGFR
"High, narrow palate",2/67,0.1423752821610712,0.19096850708188987,0,0,3.098430141287284,6.039735405617296,FGFR3;RUNX2
Flat face,2/67,0.1423752821610712,0.19096850708188987,0,0,3.098430141287284,6.039735405617296,MAF;FGFR3
Joint swelling,2/67,0.1423752821610712,0.19096850708188987,0,0,3.098430141287284,6.039735405617296,SOCS3;CCL2
Metastatic Renal Cell Cancer,2/67,0.1423752821610712,0.19096850708188987,0,0,3.098430141287284,6.039735405617296,KDR;EZR
Multiple Chronic Conditions,2/67,0.1423752821610712,0.19096850708188987,0,0,3.098430141287284,6.039735405617296,LRP1;EGFR
Parasitemia,2/67,0.1423752821610712,0.19096850708188987,0,0,3.098430141287284,6.039735405617296,CXCL10;TLR4
Autoimmune thyroid disease,3/132,0.14311394606993147,0.19186269650482132,0,0,2.3462134764460347,4.561306795851138,CXCL10;CXCL12;THRB
Cardiac Arrhythmia,3/132,0.14311394606993147,0.19186269650482132,0,0,2.3462134764460347,4.561306795851138,FHL1;ANK2;DMD
Short neck,4/204,0.1446085702661893,0.19251866846435065,0,0,2.0208247422680414,3.907718723000556,FHL1;LIFR;ANTXR2;FLI1
beta Thalassemia,3/133,0.14541604046523057,0.19251866846435065,0,0,2.3280473372781065,4.48883937380504,GSN;ANK2;SPTBN1
Byzanthine arch palate,5/280,0.14569686865866305,0.19251866846435065,0,0,1.8395666509656148,3.5434230575626495,RPS6KA3;TPM3;FGFR3;RUNX2;TGFBR2
Persistent infection,2/68,0.1457824192048369,0.19251866846435065,0,0,3.0513296227581943,5.875762522036254,SOCS3;CCND1
"Amyloidosis, Familial",1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,GSN
Reoviridae Infections,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,STAT1
Replication Error Phenotype,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,TGFBR2
Retinal pigment epithelial atrophy,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,VCAN
Round cell liposarcoma,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CIB1
Sacroiliitis,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,VCAN
"Cystadenocarcinoma, Mucinous",1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,ESR1
Secondary polycythemia,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,EPAS1
Secretory meningioma,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,KLF4
Selenium deficiency,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,FKBP4
Serous cystadenocarcinoma ovary,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,ESR1
Severe [Duchenne] muscular dystrophy,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,DMD
"Gonadal Dysgenesis, 46,XY",1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,F8
"Guillain-Barre Syndrome, Familial",1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,LEP
Severe periodontitis,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,COL17A1
"HYPERTRICHOSIS, CONGENITAL GENERALIZED",1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CCND1
"Malignant melanoma, metastatic",1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,KIT
social stress,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,NR3C1
"Nephronophthisis, familial juvenile",1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,MUC1
"Nephrosis, congenital",1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,SIRPA
"Neuralgia, Atypical",1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CXCR4
"Neuralgia, Iliohypogastric Nerve",1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CXCR4
"Neuralgia, Ilioinguinal",1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CXCR4
"Neuralgia, Perineal",1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CXCR4
"Neuralgia, Stump",1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CXCR4
"Neuralgia, Supraorbital",1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CXCR4
"Neuralgia, Vidian",1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CXCR4
Steroid-sensitive nephrotic syndrome,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,SPP1
"Phobia, Social",1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,RGS2
Subcapsular cataract,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,FZD4
"SPHEROCYTOSIS, TYPE 1 (disorder)",1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,EGFR
Thinking and speaking disturbances,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,LEP
Tonsillitis,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,EGFR
Transferrin saturation measurement,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,TF
Tubular atrophy,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,MUC1
Tumor thrombus,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,VIM
Unsaturated iron binding capacity measurement,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,TF
Achalasia,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CALR
Achromatopsia,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,LIFR
Vital Capacity Adverse Event,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,EFEMP1
Adenocarcinoma of salivary gland,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,EGFR
Adenosine deaminase deficiency,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,TLR4
Adult Neuronal Ceroid Lipofuscinosis,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CTSD
Anxiety and fear,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,RGS2
Arachnoid Cysts,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,COL1A2
Arnold Chiari Malformation,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,FGFR3
Autosomal Dominant Myotubular Myopathy,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,TPM3
Benign neoplasm of bladder,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,FGFR3
Benign neurologic neoplasms,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CCND1
Blastoma,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,EZR
BREAST CANCER 3,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,ESR1
Cancer Pain,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CCL2
Carotid Artery Thrombosis,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CD36
Central nervous system lymphoma,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CXCL12
Cerebral hypomyelination,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,SOX10
Cervical Disc Degenerative Disorder,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,TIMP1
Childhood Synovial Sarcoma,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,MET
Common Cold,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CXCL10
Congenital heart block,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CALR
Cortical cataract,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,MAF
Dermatofibrosarcoma,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,VCAN
Disease caused by Shigella dysenteriae,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CFH
Diverticulitis,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,LEP
Empyema,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,SORBS1
Fibrous Meningioma,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,DMD
Focal Nodular Hyperplasia,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,KRT19
Group B Streptococcal Infection,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,LEP
Hereditary persistence of fetal hemoglobin thalassemia,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,SORBS1
Hyperoxaluria,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CCL2
Idiopathic bronchiectasis,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,TAP1
Increased number of platelets,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CALR
infertility tubal factor,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,TLR4
Intestinal infectious disease (disorder),1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,LEPR
Latent Autoimmune Diabetes in Adults,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,TCF7L2
Lateral Sclerosis,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,VIM
Lepidic Predominant Adenocarcinoma,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CCND1
Lhermitte-Duclos disease,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,FGFR3
Limb-girdle muscle weakness,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CRYAB
Macroencephaly,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CCND2
Meconium ileus,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,MUC1
Microsatellite Instability,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,TGFBR2
Monocytoid B-cell lymphoma,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,BCL6
Mucolipidosis Type IV,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,PKD2
Myxoma of the Endocardium,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,EGFR
Neoplasm of uncertain or unknown behavior of bladder,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,FGFR3
Non-small cell carcinoma,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,EGFR
Optic Nerve Glioma,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CXCL12
Osteoblastoma,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,RUNX2
Ovarian Granulosa Cell Tumor,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,EGFR
Paroxysmal Nerve Pain,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CXCR4
Pdgfra-Associated Chronic Eosinophilic Leukemia,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,KIT
Pleomorphic Xanthoastrocytoma,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,EGFR
premalignant lesion,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CCND1
Pyle metaphyseal dysplasia,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,RUNX2
Q Fever,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CCL2
Rachischisis,1/16,0.1472159080488326,0.19251866846435065,0,0,6.696108291032149,12.82877260042208,CCL2
Thin lips,2/69,0.14920640519815692,0.19497815922044584,0,0,3.0056350898568382,5.717994319469603,ZBTB16;RUNX2
Underdeveloped nasal alae,2/69,0.14920640519815692,0.19497815922044584,0,0,3.0056350898568382,5.717994319469603,PIK3R1;SOX10
hiv-infection/aids,2/69,0.14920640519815692,0.19497815922044584,0,0,3.0056350898568382,5.717994319469603,CXCL12;CXCR4
"Anemia, Diamond-Blackfan",2/70,0.15264657758572944,0.19932703061856216,0,0,2.961284513805522,5.566119151638943,LEP;FLI1
"Chromosome 8, trisomy",2/70,0.15264657758572944,0.19932703061856216,0,0,2.961284513805522,5.566119151638943,CCND1;KIT
Abnormality of brain morphology,2/70,0.15264657758572944,0.19932703061856216,0,0,2.961284513805522,5.566119151638943,ZEB2;SYNE1
"Affective Disorders, Psychotic",1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,SKAP2
Relative short stature,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,COL1A2
Rhinosinusitis,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,MET
Ridged nails,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,KRT5
"Colitis, Collagenous",1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,TIMP1
Schistosomiasis mansoni,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,SPP1
"Gonadal Dysgenesis, 45,X",1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,DMD
"Hearing Loss, Mixed Conductive-Sensorineural",1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,FGFR3
"Keratoconjunctivitis, Vernal",1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,PLAU
"Liposarcoma, Pleomorphic",1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,LEPR
"Motor Neuron Disease, Lower",1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,VIM
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,CCND1
"Polyposis, Adenomatous Intestinal",1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,EGFR
Thick craniofacial bones,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,RPS6KA3
Abnormality of female internal genitalia,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,CXCR4
Abnormality of the eyebrow,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,SOX10
Viral respiratory infection,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,CCL2
Acute hepatitis C,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,CXCL10
Acute malaria,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,CD36
Zollinger-Ellison syndrome,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,MET
AICARDI-GOUTIERES SYNDROME,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,RASD1
Alcohol problem,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,ALDH2
Anal carcinoma,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,EGFR
Aplasia/Hypoplasia of the lungs,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,FGFR3
Aplastic clavicles,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,RUNX2
Autosome Abnormalities,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,EPAS1
Blastic plasmacytoid dendritic cell neoplasm,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,CIB1
Brain Stem Glioma,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,EGFR
Carcinoma in situ of bladder,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,FGFR3
child abuse behavior,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,NR3C1
Childhood Myelodysplastic Syndrome,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,PPARG
Chromosome Aberrations,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,EPAS1
Chronic sinus disease,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,TAP1
Congenital atresia of pulmonary artery,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,FADD
Corneal diameter increased,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,PIK3R1
Coronary Restenosis,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,FABP4
Craniofacial hyperostosis,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,RPS6KA3
Dermoid Cyst,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,EGFR
Endomyocardial Fibrosis,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,CCL2
Enlargement of craniofacial bones,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,RPS6KA3
Ethylmalonic encephalopathy,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,MUC1
Familial Intestinal Polyposis,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,EGFR
Fish-Eye Disease,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,PPARG
Flat acetabular roof,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,BGN
Genu recurvatum,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,COL1A2
Hepatic necrosis,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,MET
Hypertrophy of craniofacial bones,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,RPS6KA3
Laryngeal cleft,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,PLAU
Lofgrens syndrome,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,CXCR4
Long foot,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,RPS6KA3
Macroangiopathy,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,LPL
Malignant Female Reproductive System Neoplasm,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,ESR1
McCune-Albright Syndrome,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,GHR
Melnick-Needles Syndrome,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,KDR
Mesangial proliferative glomerulonephritis,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,VWF
Mild short stature,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,COL1A2
Mitochondrial cardiomyopathy,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,C3
Mucosal telangiectasiae,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,CAV1
Mucosal ulcer,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,MMP14
Nerve Pain,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,CXCR4
Onychogryposis,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,KRT5
Otosclerosis,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,COL1A2
Pancreatic Cyst,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,PKD2
Pediatric Crohn's disease,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,STAT5B
Polycystic liver disease,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,PKD2
Pulmonary Thromboembolisms,1/17,0.15566521760209712,0.20003374598542933,0,0,6.277284263959391,11.676047647649668,PLAU
Tracheal Diseases,2/71,0.1561022852070619,0.20054702938004648,0,0,2.9182194616977224,5.419845037847333,HGF;EGFR
Spontaneous abortion,3/138,0.15710557349570023,0.2017386990743582,0,0,2.2412535612535613,4.148195593494446,CXCL10;COL1A2;LAMA4
Psoriasis vulgaris,3/138,0.15710557349570023,0.2017386990743582,0,0,2.2412535612535613,4.148195593494446,DST;PROS1;VIM
Spinocerebellar Ataxia Type 7,2/72,0.1595728880321379,0.20480826597381088,0,0,2.8763848396501457,5.2788981714619965,MME;CTSD
Neutrophil count decreased,2/72,0.1595728880321379,0.20480826597381088,0,0,2.8763848396501457,5.2788981714619965,CXCR4;PIK3R1
Congenital deafness,5/289,0.15970981426932812,0.20493464970894523,0,0,1.7804495365978252,3.266050881289194,COL1A2;THRB;SOX10;FGFR3;RUNX2
Acid reflux,3/140,0.16186119657228895,0.2076300307542005,0,0,2.2083099382369453,4.021368000574755,RPS6KA3;COL1A2;CAV1
Syndactyly of fingers,2/73,0.16305775708765646,0.2076300307542005,0,0,2.835728657660247,5.143021556990856,FGFR3;FLI1
Withdrawal Symptoms,2/73,0.16305775708765646,0.2076300307542005,0,0,2.835728657660247,5.143021556990856,PER1;FOS
Cystic Kidney Diseases,2/73,0.16305775708765646,0.2076300307542005,0,0,2.835728657660247,5.143021556990856,MUC1;PKD2
Parkinsonian Disorders,4/214,0.16312822706010444,0.2076300307542005,0,0,1.9236131566028474,3.487931382429924,RGS2;SPP1;SGK1;TNS1
"Carney Complex, Type 1",1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,CAV1
Rimmed vacuoles on biopsy,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,FHL1
"ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE",1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,KRT19
"ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE",1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,KRT19
"Leprosy, Paucibacillary",1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,LRP1
Small intestine biopsy shows villous atrophy,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,STAT1
Smith-Lemli-Opitz Syndrome,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,ABCA1
"Myopathy, Centronuclear, Autosomal Dominant",1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,TPM3
"Papillary renal cell carcinoma, sporadic",1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,FGFR3
"Pseudohypoaldosteronism, Type I",1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,SGK1
"Psychoses, Substance-Induced",1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,ESR1
Tooth Loss,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,ESR1
Abnormality of the rib cage,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,ZEB2
Variable degree of villous atrophy,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,STAT1
Villous atrophy,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,STAT1
Villous atrophy of intestine,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,STAT1
Vitamin B 12 Deficiency,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,CALR
Wolfram Syndrome,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,TXNIP
Adult Burkitt Lymphoma,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,BCL6
Autosomal Recessive Centronuclear Myopathy,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,TPM3
Biopsy shows villous atrophy,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,STAT1
Cellulitis of periorbital region,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,PRTN3
Centrally nucleated skeletal muscle fibers,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,TPM3
Chorioretinal atrophy,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,VCAN
Chronic Neutrophilic Leukemia,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,CALR
Chronic Q Fever,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,CCL2
Cleidocranial Dysplasia,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,RUNX2
Compression of spinal cord,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,CCL2
Congenital cystic kidney disease,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,PKD2
Coxsackievirus Infections,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,CCND1
Degeneration of lumbar intervertebral disc,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,FGFR3
Dental Plaque,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,BGN
Diffuse cutaneous leishmaniasis,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,CCL2
Disease due to Papilloma virus,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,ESR1
Duodenal villous atrophy,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,STAT1
Exercise-induced myalgia,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,DMD
Hyperlipoproteinemia Type III,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,LPL
Hypoplastic fingernail,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,RPS6KA3
Hypoplastic scapulae,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,RUNX2
Immunosuppression,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,TLR4
Laryngitis,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,MUC1
Late-Infantile Neuronal Ceroid Lipfuscinosis,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,CTSD
Malignant neoplasm tonsil,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,EGFR
Myeloid and Lymphoid Neoplasms with FGFR1 Rearrangement,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,KIT
Nail-Patella Syndrome,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,GSN
Osteofibrous Dysplasia,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,MET
Overgrowth Syndrome,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,FGFR3
Periorbital edema,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,PRTN3
Periorbital swelling,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,PRTN3
Pleural Diseases,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,CCL2
Post-kala-azar dermal leishmaniasis,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,AQP1
Primary cutaneous B-cell lymphoma,1/18,0.16403123090170466,0.2076300307542005,0,0,5.907733651836369,10.679400888402991,BCL6
Decreased corneal diameter,2/74,0.16655627424084804,0.21067609433408005,0,0,2.796201814058957,5.011973768857596,MAF;FLI1
DiGeorge Syndrome,2/74,0.16655627424084804,0.21067609433408005,0,0,2.796201814058957,5.011973768857596,LAMC1;TGFBR2
Keratitis,2/74,0.16655627424084804,0.21067609433408005,0,0,2.796201814058957,5.011973768857596,TLR4;S100A8
Shy-Drager Syndrome,2/75,0.17006783218574845,0.2147989198557144,0,0,2.7577578976796198,4.885527813801126,SPP1;CRYAB
Congenital Bilateral Cataracts,2/75,0.17006783218574845,0.2147989198557144,0,0,2.7577578976796198,4.885527813801126,MAF;CAV1
Mitral Valve Stenosis,2/75,0.17006783218574845,0.2147989198557144,0,0,2.7577578976796198,4.885527813801126,C3;CCL2
Refractory anemia with ringed sideroblasts,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,CXCR4
"Aneurysm, Dissecting",1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,TGFBR2
"Arteriovenous Malformations, Cerebral",1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,EGFR
Renal salt wasting,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,MUC1
Short hallux,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,BMPR1B
Smooth Muscle Tumor,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,KIT
"Melanoma, Amelanotic",1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,CAV1
Somnolence,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,CXCL10
"Myasthenic Syndromes, Congenital, Slow Channel",1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,SNAP25
T-Lymphocytopenia,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,STAT5B
Tachyarrhythmia,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,LEP
"Spondyloepiphyseal Dysplasia Tarda, X-Linked",1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,KDR
Thrombosis of cerebral veins,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,PROS1
Thumb aplasia,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,ZBTB16
"Tuberculosis, Drug-Resistant",1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,DST
ABLEPHARON-MACROSTOMIA SYNDROME,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,EPAS1
Abnormality of the musculature,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,PPARG
absence of radius and ulna,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,FGFR3
Adult Non-Hodgkin Lymphoma,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,ADAM12
Alcohol Withdrawal Delirium,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,ALDH2
Alloimmunisation,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,MME
Angiolymphoid hyperplasia,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,TLR4
Aortic Rupture,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,STAT1
Atrophic retina,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,CTSD
Back Pain,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,FHL1
Bell-shaped thorax,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,FGFR3
Bipolar II disorder,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,ALDH2
Blepharospasm,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,FGFR3
blue iris (physical finding),1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,SOX10
Borderline ovarian tumour,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,SPP1
Carcinoma in situ of endometrium,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,EGFR
Cerebral Small Vessel Diseases,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,MYLK
Chronic berylliosis,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,CXCR4
Communicating Hydrocephalus,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,MPDZ
Congenital dyserythropoietic anemia,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,AQP1
Congenital keratoglobus,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,PIK3R1
Congenital Structural Myopathy,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,TPM3
Decreased calcification of skull,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,RUNX2
Defect of skull ossification,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,RUNX2
Delayed closure of the soft spot on the skull,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,RPS6KA3
Dent's disease,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,CTSD
Dyschondroplasias,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,KDR
Endocarditis,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,VWF
Flared iliac wings,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,BGN
Galactosemias,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,DMD
Gastric Cardia Carcinoma,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,TLR4
Generalized hyperkeratosis,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,KRT5
HER2-positive carcinoma of breast,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,EGFR
Holt-Oram syndrome,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,MET
Hypopigmentation of hair,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,SOX10
Intermittent fever,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,LIFR
Late closure of anterior fontanel,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,RPS6KA3
Mandibulofacial Dysostosis,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,NR3C1
Mannose-Binding Protein Deficiency,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,SORBS1
Mixed Connective Tissue Disease,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,COL17A1
Nasal Type Extranodal NK/T-Cell Lymphoma,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,MME
Peri-Implantitis,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,RUNX2
Proximal amyotrophy,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,SYNE1
Pyoderma Gangrenosum,1/19,0.17231476494336256,0.2147989198557144,0,0,5.579244218838127,9.810724057952932,COL17A1
Axonal neuropathy,2/76,0.17359183405203202,0.21628966183382714,0,0,2.720353006067292,4.763470096264379,ABCA1;SERPING1
Microcornea,2/76,0.17359183405203202,0.21628966183382714,0,0,2.720353006067292,4.763470096264379,MAF;FLI1
Nerve Degeneration,3/145,0.17393578170190696,0.21666755041829414,0,0,2.1300108342361863,3.7255361723812888,LEP;PPARG;ETS2
"Neoplastic Syndromes, Hereditary",2/77,0.1771276934917909,0.22048901626203074,0,0,2.6839455782312927,4.64559946298882,PLAU;MET
Ulnar polydactyly of fingers,2/77,0.1771276934917909,0.22048901626203074,0,0,2.6839455782312927,4.64559946298882,CCND2;BMPR1B
Decreased width of tooth,2/77,0.1771276934917909,0.22048901626203074,0,0,2.6839455782312927,4.64559946298882,GHR;PIK3R1
Polydactyly,3/147,0.1788356589297924,0.22230805644562798,0,0,2.1002136752136753,3.615072599514781,CCND2;ZBTB16;FGFR3
Renal glomerular fibrosis,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,MUC1
"ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA",1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,EGFR
Retinoic acid syndrome,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,PECAM1
Soft skin,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,COL1A2
Sprengel deformity,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,THRB
"stage, gastric cancer",1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,KRT19
Abnormal nasal morphology,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,CCND2
Abnormality of abdomen morphology,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,GSN
Absent radius,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,FGFR3
Velvety skin,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,COL1A2
Accessory nipple,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,ZEB2
Acral pseudolymphomatous angiokeratoma of children (APACHE),1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,TIMP1
Vitamin A Deficiency,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,S100A8
Vulval intraepithelial neoplasia,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,CCND1
Warts,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,CXCR4
Wolf-Hirschhorn Syndrome,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,FGFR3
Adenomatous goiter,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,MET
Amebic colitis,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,LEPR
Asthmatic pulmonary eosinophilia,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,CCL2
Atrophy of testis,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,ALDH2
Calf muscle hypertrophy,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,DMD
Central hypothyroidism,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,DEPP1
Cholesteryl Ester Transfer Protein Deficiency,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,LPL
Chronic small plaque psoriasis,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,PPARG
Clear cell sarcoma of kidney,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,EGFR
Corneal pannus,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,MMP14
Coronal craniosynostosis,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,FGFR3
Disproportionate short-trunk short stature,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,BGN
Gastric dysplasia,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,VIM
Gray Platelet Syndrome,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,CD36
High Grade Intraepithelial Neoplasia,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,ALDH2
Hypernatremia,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,SGK1
Hypoventilation,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,DMD
Leukaemia recurrent,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,MME
Mastocytoma,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,KIT
Multiple System Atrophy,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,CRYAB
Observation of Neuromuscular Block,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,RGS2
Ophthalmoparesis,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,KRT5
Other Creutzfeldt-Jakob disease,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,CTSD
Perineurioma,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,BCL6
Piebaldism,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,KIT
Placental Choriocarcinoma,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,KDR
Pouchitis,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,TLR4
Prune Belly Syndrome,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,CXCR4
Radial aplasia,1/20,0.18051662874040858,0.22230805644562798,0,0,5.285332620892333,9.048132049958218,FGFR3
Stereotyped Behavior,2/78,0.18067483439031992,0.22230805644562798,0,0,2.648496240601504,4.531726332759098,MEF2C;EGFR
Abnormal vision,2/78,0.18067483439031992,0.22230805644562798,0,0,2.648496240601504,4.531726332759098,VCAN;CTSD
Electromyogram abnormal,2/78,0.18067483439031992,0.22230805644562798,0,0,2.648496240601504,4.531726332759098,ABCA1;DMD
Narrow thorax,2/78,0.18067483439031992,0.22230805644562798,0,0,2.648496240601504,4.531726332759098,FGFR3;RUNX2
"Dementia, Vascular",2/80,0.18780070677341396,0.22956151985746936,0,0,2.5803244374672945,4.315267368616446,CTSD;ESR1
Corneal Opacity,2/80,0.18780070677341396,0.22956151985746936,0,0,2.5803244374672945,4.315267368616446,ABCA1;MMP14
Eosinophilic esophagitis,2/80,0.18780070677341396,0.22956151985746936,0,0,2.5803244374672945,4.315267368616446,CCL11;FKBP4
Microdontia (disorder),2/80,0.18780070677341396,0.22956151985746936,0,0,2.5803244374672945,4.315267368616446,GHR;PIK3R1
Regurgitation,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,TGFBR2
response to risperidone,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,PRKAR2B
"Congenital Myasthenic Syndromes, Presynaptic",1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,SNAP25
Severe diarrhea,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,CFH
Sinus Node Dysfunction (disorder),1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,ANK2
Small chin,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,MEF2C
"Polyarticular Juvenile Idiopathic Arthritis, Rheumatoid Factor Negative",1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,STAT1
"Xanthomatosis, Cerebrotendinous",1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,UTRN
Torsades de Pointes,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,ANK2
Tubulointerstitial fibrosis,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,MUC1
Abnormality of the hip bone,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,BMPR1B
Van Buchem disease,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,KDR
Bile duct proliferation,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,SPP1
Chagas Cardiomyopathy,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,CXCL10
Chediak-Higashi Syndrome,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,TLR4
Congenital anomaly of neck,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,PPARG
Cryopyrin-Associated Periodic Syndromes,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,MME
Deformity of neck,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,PPARG
Difficulty walking up stairs,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,DMD
Early tooth exfoliation,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,RUNX2
Erythema Chronicum Migrans,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,CXCL10
Glucose measurement,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,TCF7L2
Heparin-induced thrombocytopenia,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,CIB1
Hereditary Multiple Exostoses,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,TCF7L2
Herpes encephalitis,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,STAT1
Hyperkalemia,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,CA12
Hypoplasia of the odontoid process,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,BGN
inflammatory joint disease,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,SOCS3
Intestinal Polyposis,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,TCF7L2
Malformation of the neck,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,PPARG
Microcytic hypochromic anemia (disorder),1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,TF
Neonatal Death,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,FGFR3
Neonatal respiratory distress,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,RUNX2
Neonatal Systemic lupus erythematosus,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,CALR
Nodular Goiter,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,CCND1
Oculo-dento-digital syndrome,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,NRP1
Olivopontocerebellar Atrophies,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,SNAP25
Oropharynx (excludes nasopharynx),1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,SERPING1
Otitis Media with Effusion,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,BCL6
Periapical Granuloma,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,MDK
Premature tooth loss,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,RUNX2
Prolonged QT interval,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,ANK2
Pseudomyxoma Peritonei,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,VIM
Rare Diseases,1/21,0.1886376234670404,0.22956151985746936,0,0,5.020812182741117,8.374350413278753,KIT
Sensory neuropathy,2/81,0.1913783361497037,0.2327904938009064,0,0,2.5475329372255233,4.212353335525955,MUC1;DST
Granulocyte count,2/81,0.1913783361497037,0.2327904938009064,0,0,2.5475329372255233,4.212353335525955,ZBTB16;LEPR
Cerebellar Dysmetria,2/82,0.19496504257308805,0.23704510880036192,0,0,2.515561224489796,4.112779104006726,CAV1;SYNE1
Decreased size of teeth,2/82,0.19496504257308805,0.23704510880036192,0,0,2.515561224489796,4.112779104006726,GHR;PIK3R1
Renal Artery Stenosis,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,STAT1
Restrictive cardiomyopathy,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,CRYAB
"CATARACT, MARNER TYPE",1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,PECAM1
Severe depression,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,ESR1
Short finger,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,BMPR1B
Short lower third of face,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,MEF2C
Shwachman syndrome,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,MDK
"Lymphoma, Mixed-Cell",1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,BCL6
Spastic syndrome,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,PLAU
"Pancreatic carcinoma, familial",1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,CCND1
"SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1",1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,GHR
"THYROID CARCINOMA, SPORADIC MEDULLARY",1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,EGFR
22q11 Deletion Syndrome,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,CXCR4
Abnormality of the immune system,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,PIK3R1
Wasting,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,DMD
Adrenal Cancer,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,TLR4
Anaplastic large B-cell lymphoma,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,EGFR
ANOPHTHALMIA AND PULMONARY HYPOPLASIA,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,EGFR
Bare Lymphocyte Syndrome,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,TAP1
Benign Mastocytoma,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,KIT
Biliary Tract Diseases,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,KRT19
CAMPOMELIC DYSPLASIA,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,SOX10
Cluster Headache,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,MME
Dystonia Musculorum Deformans,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,GSN
Gastrointestinal inflammation,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,CCL2
Herpes zoster disease,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,ESR1
Hidradenitis Suppurativa,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,TLR4
Hypoaldosteronism,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,NR3C1
Hypoplastic finger,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,BMPR1B
Hypoplastic iliac wing,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,RUNX2
Hypothalamic gonadotropin-releasing hormone deficiency,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,SOX10
Infantile muscular hypotonia,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,FGFR3
Intracranial Meningioma,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,VIM
Liver calculus,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,EGFR
Pancolitis,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,TLR4
Peritoneal adhesion,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,EGR1
Platelet Storage Pool Deficiency,1/22,0.19667854246153751,0.2371266861487632,0,0,4.781484167270969,7.77557614353097,FLI1
Retrusion of lower jaw,6/395,0.19852104685972566,0.2389629255728505,0,0,1.5595276349614395,2.5215380935212868,GHR;COL1A2;LIFR;PIK3R1;RUNX2;TGFBR2
Decreased projection of lower jaw,6/395,0.19852104685972566,0.2389629255728505,0,0,1.5595276349614395,2.5215380935212868,GHR;COL1A2;LIFR;PIK3R1;RUNX2;TGFBR2
Decreased projection of mandible,6/395,0.19852104685972566,0.2389629255728505,0,0,1.5595276349614395,2.5215380935212868,GHR;COL1A2;LIFR;PIK3R1;RUNX2;TGFBR2
Hypoplastic mandible condyle,6/395,0.19852104685972566,0.2389629255728505,0,0,1.5595276349614395,2.5215380935212868,GHR;COL1A2;LIFR;PIK3R1;RUNX2;TGFBR2
Maturity onset diabetes mellitus in young,2/83,0.1985602991999591,0.2389629255728505,0,0,2.484378936759889,4.016402140314714,LEPR;CD36
MRSA - Methicillin resistant Staphylococcus aureus infection,2/83,0.1985602991999591,0.2389629255728505,0,0,2.484378936759889,4.016402140314714,VWF;AGR2
Paraganglioma,2/83,0.1985602991999591,0.2389629255728505,0,0,2.484378936759889,4.016402140314714,EPAS1;KIT
Protein Deficiency,2/83,0.1985602991999591,0.2389629255728505,0,0,2.484378936759889,4.016402140314714,CFH;STAT1
Platelet hematocrit measurement,3/155,0.1987962079477091,0.23919281827801803,0,0,1.9888663967611335,3.21296406094616,MEF2C;ZBTB16;FLI1
Feeding difficulties in infancy,4/233,0.20046283161844022,0.24114366358796116,0,0,1.762301355062351,2.8322410816127332,RPS6KA3;LIFR;FLI1;TGFBR2
Myoclonic Seizures,3/156,0.2013287037610781,0.2421305940742011,0,0,1.9757667169431876,3.1667912264378995,LEP;FOS;MPDZ
"Hyperalgesia, Secondary",2/84,0.2021635886549317,0.24286063208794656,0,0,2.4539571926331507,3.923087535089334,CCL2;FOS
Short philtrum,2/84,0.2021635886549317,0.24286063208794656,0,0,2.4539571926331507,3.923087535089334,MEF2C;RUNX2
Sloping forehead,2/84,0.2021635886549317,0.24286063208794656,0,0,2.4539571926331507,3.923087535089334,CTSD;RUNX2
Allodynia,2/84,0.2021635886549317,0.24286063208794656,0,0,2.4539571926331507,3.923087535089334,CCL2;FOS
Mitochondrial Myopathies,2/84,0.2021635886549317,0.24286063208794656,0,0,2.4539571926331507,3.923087535089334,CFH;MET
Encephalopathies,4/234,0.20249637093909081,0.243205580512602,0,0,1.7545495293590319,2.8020740492468703,MUC1;CXCR4;CCL2;FADD
"Bone Cysts, Aneurysmal",1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,RUNX2
"Congenital Myasthenic Syndromes, Postsynaptic",1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,SNAP25
Rubinstein-Taybi Syndrome,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,ZEB2
"Dermatitis, Irritant",1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,CXCL10
Spider Veins,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,ACTA2
Sporadic Burkitt's lymphoma,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,BCL6
Squamous Cell Neoplasms,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,CCND1
"Schizophrenia, Childhood",1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,MEST
"Skin Diseases, Infectious",1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,CD36
Tumor Necrosis Factor Receptor 1-Associated Periodic Syndrome,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,FOS
Typhoid Fever,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,TLR4
Abnormality of the thorax,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,COL1A2
Absence of pubertal development,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,ESR1
Varicocele,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,STAT1
Activated B-cell type diffuse large B-cell lymphoma,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,BCL6
Alveolitis,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,CCL2
Andersen Syndrome,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,ANK2
Antithrombin III Deficiency,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,F8
Bloch Sulzberger syndrome,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,BGN
C-cell hyperplasia of thyroid,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,SPP1
Capillary malformation (disorder),1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,STAT1
Childhood Non-Hodgkin Lymphoma,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,ADAM12
Chronic urticaria,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,SERPING1
Diffuse Mixed-Cell Lymphoma,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,BCL6
Electrocardiogram: P-R interval,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,CAV1
Enlarged kidney,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,SAA1
Esophageal Achalasia,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,CALR
Exfoliation Syndrome,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,TLR4
Granulomatous Slack Skin,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,STAT5B
Hemimegalencephaly,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,CCND1
Hepatocellular necrosis,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,KRT18
Hypoplastic myelodysplasia,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,KIT
Hypoxic-Ischemic Encephalopathy,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,CCL2
Isodicentric Chromosome 15 Syndrome,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,DMD
Macule,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,KIT
Meningomyelocele,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,MEOX2
Myasthenias,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,CXCL10
Neonatal Alloimmune Thrombocytopenia,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,CD36
Neurocysticercosis,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,TLR4
Pena-Shokeir syndrome type I,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,COL1A2
Posterior subcapsular cataract,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,CRYAB
PR interval feature,1/23,0.20464017128814416,0.2434756581367538,0,0,4.56391324411629,7.240657964857908,CAV1
"Hyperalgesia, Primary",2/85,0.20577440286180937,0.24455213935115566,0,0,2.4242685025817554,3.832707512898453,CCL2;FOS
Syndactyly,2/85,0.20577440286180937,0.24455213935115566,0,0,2.4242685025817554,3.832707512898453,FZD4;BMPR1B
Convex nasal bridge,2/85,0.20577440286180937,0.24455213935115566,0,0,2.4242685025817554,3.832707512898453,SOX10;FGFR3
Downturned corners of mouth,2/85,0.20577440286180937,0.24455213935115566,0,0,2.4242685025817554,3.832707512898453,MEF2C;PIK3R1
Prominent nasal bridge,2/85,0.20577440286180937,0.24455213935115566,0,0,2.4242685025817554,3.832707512898453,SOX10;FGFR3
Clinodactyly of the 5th finger,3/159,0.2089715199025211,0.24829637225429987,0,0,1.937475345167653,3.0332286793260397,DMD;BMPR1B;FGFR3
Curvature of digit,2/86,0.20939224289493977,0.24874080748710076,0,0,2.3952866861030127,3.745140978393362,PIK3R1;FGFR3
"Candidiasis, Chronic Mucocutaneous",1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,STAT1
"CONSTRICTING BANDS, CONGENITAL",1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,CXCR4
"Epilepsy, Benign Psychomotor, Childhood",1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,KDR
Senile lentigo,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,FGFR3
"Focal Segmental Glomerulosclerosis, Not Otherwise Specified",1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,CXCR4
"Glossitis, Benign Migratory",1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,CXCL10
Severe combined immunodeficiency due to adenosine deaminase deficiency,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,TLR4
"Hydrops Fetalis, Non-Immune",1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,COL1A2
"Lymphoma, Undifferentiated",1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,BCL6
Spinal rigidity,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,FHL1
Staphylococcal toxic shock syndrome,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,AGR2
Steatorrhea,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,ANTXR2
"Pseudohypoparathyroidism, Type Ia",1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,LEP
"Signs and Symptoms, Respiratory",1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,TLR4
"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)",1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,ANK2
Uncinate Epilepsy,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,KDR
Adenoma of lung,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,MET
Alcohol or Other Drugs use,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,ALDH2
Aplasia/Hypoplasia of the skin,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,ANTXR2
Asphyxia Neonatorum,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,KDR
Bronchitis,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,EGFR
Candidemia,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,TLR4
Cognitive changes,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,ESR1
Colonic Diseases,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,TLR4
Complications of Diabetes Mellitus,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,ALDH2
Corneal erosion,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,COL17A1
Dentinogenesis Imperfecta,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,COL1A2
Erectile abnormalities,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,SOX10
Familial primary pulmonary hypertension,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,CAV1
Fetal overgrowth,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,ESR1
Gardner Syndrome,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,CCND1
Generalized overgrowth,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,ESR1
Heart Block,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,CALR
Inattention,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,SNAP25
Intestinal Pseudo-Obstruction,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,HGF
Lens dislocation,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,TAP1
Ostium secundum atrial septal defect,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,VWF
Overgrowth,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,ESR1
Paroxysmal nonkinesigenic dyskinesia,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,MUC1
Pelger-Huet Anomaly,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,CA12
Pinched bridge of nose,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,BMPR1B
Pinched nasal bridge,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,BMPR1B
POLYCYSTIC KIDNEY DISEASE 1,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,PKD2
Poor eye contact,1/24,0.21252328787467278,0.25000807970952127,0,0,4.365261531670713,6.760496714480504,MEF2C
Everted lower lip vermilion,2/87,0.21301661893318138,0.250422581578408,0,0,2.3669867947178873,3.6602730950485687,RPS6KA3;FHL1
Generalized muscle weakness,2/87,0.21301661893318138,0.250422581578408,0,0,2.3669867947178873,3.6602730950485687,CCND1;TPM3
Protruding lower lip,2/87,0.21301661893318138,0.250422581578408,0,0,2.3669867947178873,3.6602730950485687,RPS6KA3;FHL1
Neural Tube Defects,3/163,0.21926072164119031,0.25636057702553866,0,0,1.8886538461538462,2.8660204026988163,TCF7L2;LEP;CCL2
Tactile Allodynia,2/89,0.22028306409152282,0.25636057702553866,0,0,2.312338728594886,3.4982029264778536,CCL2;FOS
Wheezing,2/89,0.22028306409152282,0.25636057702553866,0,0,2.312338728594886,3.4982029264778536,CXCL10;TLR4
Cerebral Palsy,2/89,0.22028306409152282,0.25636057702553866,0,0,2.312338728594886,3.4982029264778536,RFX2;ESR1
Creutzfeldt-Jakob disease,2/89,0.22028306409152282,0.25636057702553866,0,0,2.312338728594886,3.4982029264778536,CTSD;AQP1
"Aganglionosis, Colonic",1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,PPARG
Rhomboid shaped head,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,FGFR3
Sclerosis,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,TIMP1
"Hydrocephalus, Normal Pressure",1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,MUC1
Small cheekbone,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,RUNX2
"Lymphoma, Follicular, Grade 1",1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,MME
"Lymphoma, Intermediate-Grade",1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,BCL6
"Plagiocephaly, Nonsynostotic",1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,FGFR3
T-Cell Large Granular Lymphocyte Leukemia,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,STAT5B
Type II Mucolipidosis,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,CTSD
Abnormality of the clavicle,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,FGFR3
Uroureter,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,MYLK
Acrocephaly,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,FGFR3
X-linked retinitis pigmentosa,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,TIMP1
Asymmetry of the posterior cranium,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,FGFR3
Bernard-Soulier Syndrome,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,VWF
CNS metastases,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,EGFR
Cyanosis,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,ALDH2
Depressed cheekbone,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,RUNX2
Diabetes Insipidus,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,LEPR
Down-sloping shoulders,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,RUNX2
Enterocolitis,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,STAT1
ESR raised,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,PRTN3
Flat head,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,FGFR3
Flattening of cranial vault,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,FGFR3
Flattening of head,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,FGFR3
Flattening of the zygomatic bone,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,RUNX2
Frequent falls,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,FHL1
Goiter,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,THRB
Hereditary macular dystrophy,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,EFEMP1
Hypoplasia of the zygomatic bone,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,RUNX2
Hypotrophic cheekbone,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,RUNX2
Invasive Pulmonary Aspergillosis,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,CCL2
Leukokeratosis,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,KRT5
Non-infiltrating lobular carcinoma,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,ESR1
Parathyroid Diseases,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,LEP
Pendred's syndrome,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,THRB
Plagiocephaly,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,FGFR3
Port-Wine Stain,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,KDR
Prematurely aged appearance,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,KRT5
Pulmonary Sclerosing Hemangioma,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,EGFR
Pyemia,1/25,0.2203286625590105,0.25636057702553866,0,0,4.1831641285956005,6.327600165017342,TLR4
Retinitis Pigmentosa,6/410,0.22183216027014593,0.25805360883641293,0,0,1.500464108910891,2.259450197880046,NRP1;GSN;CAV1;SPP1;TLR4;CTSD
Cystic kidney,2/90,0.22392419754529538,0.2603167645547293,0,0,2.285946196660482,3.4207989013747016,YAP1;PKD2
Gaucher Disease,2/90,0.22392419754529538,0.2603167645547293,0,0,2.285946196660482,3.4207989013747016,SPP1;CXCR4
Hip circumference,2/90,0.22392419754529538,0.2603167645547293,0,0,2.285946196660482,3.4207989013747016,TCF7L2;EFEMP1
Waist Circumference,2/91,0.22756999547526713,0.26294159733947314,0,0,2.260146755331346,3.345689400553753,TCF7L2;EFEMP1
Ichthyoses,2/91,0.22756999547526713,0.26294159733947314,0,0,2.260146755331346,3.345689400553753,F13A1;DMD
Lymphadenopathy,2/91,0.22756999547526713,0.26294159733947314,0,0,2.260146755331346,3.345689400553753,ABCA1;CCND1
Retinal Dysplasia,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,MPDZ
"Epilepsy, Lateral Temporal",1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,KDR
Severe Aplastic Anemia,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,KIT
"Hypotension, Orthostatic",1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,CAV1
Spondyloepiphyseal Dysplasia,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,KDR
Tachypnea,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,ACTA2
Tangier Disease,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,ABCA1
Thin rib,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,LIFR
Tick-Borne Encephalitis,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,CXCR4
Trichothiodystrophy Syndromes,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,SREBF1
Abnormal pattern of respiration,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,KRT5
Acne Vulgaris,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,TLR4
Yellow Fever,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,FADD
Zinc deficiency,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,NEDD9
Bare lymphocyte syndrome 2,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,TAP1
Beta thalassemia trait,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,LPL
Blurred vision,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,ABCA1
Capuchin ears,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,FGFR3
Carpal Tunnel Syndrome,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,ESR1
Cortical gyral simplification,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,MPDZ
Cupped ears (finding),1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,FGFR3
Cyclic neutropenia,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,CCND1
Ectrodactyly,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,MAP3K20
Human anaplasmosis due to Anaplasma phagocytophilum,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,TF
Increased drug resistance,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,KRT8
Malignant Uterine Corpus Neoplasm,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,PIK3R1
Mast Cell Neoplasm,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,KIT
Melioidosis,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,TLR4
Multiple lipomata,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,EGFR
MUTYH-Associate Polyposis,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,CCL2
Neonatal onset,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,KRT5
Overactive bladder syndrome,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,SNAP25
Pfaundler-Hurler Syndrome,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,VCAN
Pharyngeal Carcinoma,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,ALDH2
Radial polydactyly,1/26,0.22805705815407112,0.26294159733947314,0,0,4.015634517766498,5.935748014910027,FGFR3
Degenerative brain disorder,3/167,0.22965200278576428,0.2646659867745108,0,0,1.8422138836772983,2.710246914725091,FADD;FGFR3;CTSD
Infratentorial atrophy,3/167,0.22965200278576428,0.2646659867745108,0,0,1.8422138836772983,2.710246914725091,MME;CTSD;SYNE1
Premature aging syndrome,2/92,0.23122001139185985,0.26641544663939914,0,0,2.234920634920635,3.2727855758488826,C3;CAV1
Speech Disorders,2/93,0.23487380705231975,0.2700697670963358,0,0,2.210248934738731,3.2020028832166227,RPS6KA3;PIK3R1
"PARKINSON DISEASE, LATE-ONSET",2/93,0.23487380705231975,0.2700697670963358,0,0,2.210248934738731,3.2020028832166227,MUC1;CCL2
Panic Disorder,2/93,0.23487380705231975,0.2700697670963358,0,0,2.210248934738731,3.2020028832166227,CALCOCO1;RGS2
"Chronic Infantile Neurological, Cutaneous, and Articular Syndrome",1/27,0.23570923001783783,0.2700697670963358,0,0,3.8609918000780943,5.579736661899487,MME
Rothmund-Thomson syndrome,1/27,0.23570923001783783,0.2700697670963358,0,0,3.8609918000780943,5.579736661899487,RUNX2
"Encephalopathy, Toxic",1/27,0.23570923001783783,0.2700697670963358,0,0,3.8609918000780943,5.579736661899487,FOS
"stage, neuroblastoma",1/27,0.23570923001783783,0.2700697670963358,0,0,3.8609918000780943,5.579736661899487,STAT1
Thymic Lymphoma,1/27,0.23570923001783783,0.2700697670963358,0,0,3.8609918000780943,5.579736661899487,EGR1
Toxic Encephalitis,1/27,0.23570923001783783,0.2700697670963358,0,0,3.8609918000780943,5.579736661899487,FOS
Aphasia,1/27,0.23570923001783783,0.2700697670963358,0,0,3.8609918000780943,5.579736661899487,S100A4
Congenital central hypoventilation,1/27,0.23570923001783783,0.2700697670963358,0,0,3.8609918000780943,5.579736661899487,ZEB2
Corneal Diseases,1/27,0.23570923001783783,0.2700697670963358,0,0,3.8609918000780943,5.579736661899487,S100A8
Ectopia Lentis,1/27,0.23570923001783783,0.2700697670963358,0,0,3.8609918000780943,5.579736661899487,TAP1
Elevated C-reactive protein,1/27,0.23570923001783783,0.2700697670963358,0,0,3.8609918000780943,5.579736661899487,PRTN3
Elevated C-reactive protein level,1/27,0.23570923001783783,0.2700697670963358,0,0,3.8609918000780943,5.579736661899487,PRTN3
Extramedullary Hematopoiesis (disorder),1/27,0.23570923001783783,0.2700697670963358,0,0,3.8609918000780943,5.579736661899487,ABCA1
Extraskeletal Myxoid Chondrosarcoma,1/27,0.23570923001783783,0.2700697670963358,0,0,3.8609918000780943,5.579736661899487,PPARG
Failure to thrive in infant,1/27,0.23570923001783783,0.2700697670963358,0,0,3.8609918000780943,5.579736661899487,NR4A1
Fukuyama Type Congenital Muscular Dystrophy,1/27,0.23570923001783783,0.2700697670963358,0,0,3.8609918000780943,5.579736661899487,DMD
Gastroenteritis,1/27,0.23570923001783783,0.2700697670963358,0,0,3.8609918000780943,5.579736661899487,MME
Homocystinuria,1/27,0.23570923001783783,0.2700697670963358,0,0,3.8609918000780943,5.579736661899487,CCL2
Lobular carcinoma in situ of breast,1/27,0.23570923001783783,0.2700697670963358,0,0,3.8609918000780943,5.579736661899487,ESR1
Loss of appetite (finding),1/27,0.23570923001783783,0.2700697670963358,0,0,3.8609918000780943,5.579736661899487,PIK3R1
Mumps,1/27,0.23570923001783783,0.2700697670963358,0,0,3.8609918000780943,5.579736661899487,STAT1
Personality Disorders,1/27,0.23570923001783783,0.2700697670963358,0,0,3.8609918000780943,5.579736661899487,SNAP25
Primary Malignant Liver Neoplasm,1/27,0.23570923001783783,0.2700697670963358,0,0,3.8609918000780943,5.579736661899487,HGF
Congenital diaphragmatic hernia,2/95,0.24219102545322174,0.2770236539308855,0,0,2.162497256967303,3.0664827476720657,TCF7L2;LEP
Intermittent migraine headaches,2/95,0.24219102545322174,0.2770236539308855,0,0,2.162497256967303,3.0664827476720657,TLR4;TGFBR2
"AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE",1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,SNCG
"Creutzfeldt-Jakob Disease, Sporadic",1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,CTSD
Seborrheic keratosis,1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,FGFR3
Serum gamma-glutamyl transferase measurement,1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,ALDH2
Spina Bifida Occulta,1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,RUNX2
Viral myocarditis,1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,CCL2
ADENOMAS AND ADENOCARCINOMAS,1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,PLK1
Agammaglobulinemia,1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,PIK3R1
Agranulocytosis,1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,ALDH2
Aphthous Stomatitis,1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,TLR4
Benign Meningioma,1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,HGF
Centronuclear myopathy,1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,TPM3
Chronic colitis,1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,CCL2
Double Outlet Right Ventricle,1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,MEF2C
Elevated heart rate,1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,DST
Extrinsic allergic alveolitis,1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,TAP1
Granulocytic Sarcoma,1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,KIT
Hereditary non-polyposis colorectal cancer syndrome,1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,TGFBR2
Hereditary spherocytosis,1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,AQP1
Immunoglobulin G subclass deficiency (finding),1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,CXCR4
Incontinentia Pigmenti Achromians,1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,CCL2
Increased circulating gonadotropin level,1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,ESR1
Premature canities,1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,SOX10
Pulmonary artery stenosis,1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,ZEB2
Radial ray hypoplasia,1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,FGFR3
Rat Insulinoma,1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,IRS2
Reactive airway disease,1/28,0.24328592613934025,0.2770236539308855,0,0,3.7178040985147582,5.255182554848429,LIFR
Cerebral atrophy,5/338,0.24421400921435024,0.27802103292101527,0,0,1.514649364390297,2.1352168873602335,MUC1;ALDH2;FADD;CTSD;FGFR3
Tonic - clonic seizures,3/173,0.24540512362355,0.27931736518366035,0,0,1.7766515837104073,2.4959198600646046,LEP;FOS;MPDZ
Broad forehead,2/96,0.24585361218265625,0.27976807587473307,0,0,2.139383412939644,3.001595560816009,MEF2C;FGFR3
Lens Opacities,5/339,0.24605553626248605,0.27993807701596674,0,0,1.5100369209766995,2.1173707676805167,VCAN;MAF;VIM;PIK3R1;CRYAB
Very poor growth,3/174,0.24804777517708862,0.28214441705842164,0,0,1.7661718398560504,2.4622800519952093,DST;KRT5;FGFR3
Gilles de la Tourette syndrome,2/97,0.24951830635914535,0.2829660493462701,0,0,2.1167561761546723,2.938529597067055,CCL2;MET
Renal hypertension,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,PKD2
Romano-Ward Syndrome,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,ANK2
Smith-Magenis syndrome,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,SREBF1
Social disinhibition,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,NR3C1
Spinal Cord Myelodysplasia,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,CCL2
Stippled epiphyses,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,THRB
Trachoma,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,CCL2
Upper Aerodigestive Tract Neoplasms,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,EGFR
Upper Respiratory Infections,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,LEPR
Adult Fanconi syndrome,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,CTSD
Alport Syndrome,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,CFH
Anterior hypopituitarism,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,SOX10
Anthracosis,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,CCL2
Asbestosis,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,SPP1
Aspartate aminotransferase measurement,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,LPL
Central Core Myopathy (disorder),1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,RUNX2
Childhood Brain Neoplasm,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,KIT
Cholesterol gallstones,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,ESR1
Chronic Kidney Insufficiency,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,TLR4
Congenital hypoplasia of radius,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,FGFR3
Costello syndrome (disorder),1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,VCAN
Deep philtrum,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,RPS6KA3
Diastematomyelia,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,CCL2
Head Neoplasms,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,EGFR
Hereditary hemorrhagic telangiectasia,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,EGFR
High Grade Cervical Intraepithelial Neoplasia,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,MMP14
Iniencephaly,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,CCL2
Intermittent Claudication,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,EPAS1
Juvenile Neuronal Ceroid Lipofuscinosis,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,CTSD
Keratoconjunctivitis Sicca,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,KLF4
Keratosis Follicularis,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,A2M
Malignant melanoma of eye,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,KIT
Microvascular Angina,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,SREBF1
Neurenteric Cyst,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,CCL2
Pierre Robin Syndrome,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,BMPR1B
Pigmented Basal Cell Carcinoma,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,KRT5
Primary peritoneal carcinoma,1/29,0.25078788723258283,0.2829660493462701,0,0,3.584844089920232,4.958369101280273,EGFR
Recurrent aphthous ulcer,1/30,0.2582158467438044,0.28987407779602564,0,0,3.4610537370908454,4.686126340024527,TLR4
Recurrent bronchitis,1/30,0.2582158467438044,0.28987407779602564,0,0,3.4610537370908454,4.686126340024527,TAP1
Respiratory Depression,1/30,0.2582158467438044,0.28987407779602564,0,0,3.4610537370908454,4.686126340024527,DMD
"Ventricular Dysfunction, Left",1/30,0.2582158467438044,0.28987407779602564,0,0,3.4610537370908454,4.686126340024527,TLR4
Tobacco Dependence,1/30,0.2582158467438044,0.28987407779602564,0,0,3.4610537370908454,4.686126340024527,TLR4
Tongue Neoplasms,1/30,0.2582158467438044,0.28987407779602564,0,0,3.4610537370908454,4.686126340024527,CRYAB
TUBEROUS SCLEROSIS 2 (disorder),1/30,0.2582158467438044,0.28987407779602564,0,0,3.4610537370908454,4.686126340024527,CCND1
Abnormality of the sternum,1/30,0.2582158467438044,0.28987407779602564,0,0,3.4610537370908454,4.686126340024527,TGFBR2
Acute Chest Syndrome,1/30,0.2582158467438044,0.28987407779602564,0,0,3.4610537370908454,4.686126340024527,TLR4
Cancer of Head,1/30,0.2582158467438044,0.28987407779602564,0,0,3.4610537370908454,4.686126340024527,EGFR
Cancer of Neck,1/30,0.2582158467438044,0.28987407779602564,0,0,3.4610537370908454,4.686126340024527,EGFR
Congenital Nonbullous Ichthyosiform Erythroderma,1/30,0.2582158467438044,0.28987407779602564,0,0,3.4610537370908454,4.686126340024527,COL17A1
Dilatation of ureter,1/30,0.2582158467438044,0.28987407779602564,0,0,3.4610537370908454,4.686126340024527,MYLK
Ectropion,1/30,0.2582158467438044,0.28987407779602564,0,0,3.4610537370908454,4.686126340024527,ABCA1
gastritis h pylori,1/30,0.2582158467438044,0.28987407779602564,0,0,3.4610537370908454,4.686126340024527,MUC1
genetic hypertension,1/30,0.2582158467438044,0.28987407779602564,0,0,3.4610537370908454,4.686126340024527,LPL
High grade serous carcinoma,1/30,0.2582158467438044,0.28987407779602564,0,0,3.4610537370908454,4.686126340024527,ESR1
High pitched voice,1/30,0.2582158467438044,0.28987407779602564,0,0,3.4610537370908454,4.686126340024527,GHR
Horseshoe Kidney,1/30,0.2582158467438044,0.28987407779602564,0,0,3.4610537370908454,4.686126340024527,EGFR
Increased variability in muscle fiber diameter,1/30,0.2582158467438044,0.28987407779602564,0,0,3.4610537370908454,4.686126340024527,FHL1
Malignant transformation,1/30,0.2582158467438044,0.28987407779602564,0,0,3.4610537370908454,4.686126340024527,EGFR
Noncancerous mole,1/30,0.2582158467438044,0.28987407779602564,0,0,3.4610537370908454,4.686126340024527,FGFR3
Nuclear non-senile cataract,1/30,0.2582158467438044,0.28987407779602564,0,0,3.4610537370908454,4.686126340024527,CRYAB
Polydipsia,1/30,0.2582158467438044,0.28987407779602564,0,0,3.4610537370908454,4.686126340024527,LEP
Abnormal heart beat,2/100,0.26052108658368917,0.2922157167763586,0,0,2.0516451478550604,2.75960936414797,FHL1;DMD
Childhood Neuroblastoma,2/100,0.26052108658368917,0.2922157167763586,0,0,2.0516451478550604,2.75960936414797,ITSN1;UTRN
ECG abnormality,2/100,0.26052108658368917,0.2922157167763586,0,0,2.0516451478550604,2.75960936414797,FHL1;DMD
Myalgia,2/100,0.26052108658368917,0.2922157167763586,0,0,2.0516451478550604,2.75960936414797,DMD;TLR4
Penile hypospadias,3/180,0.26399089405311654,0.29604534394130005,0,0,1.7057800956106042,2.2718273031142586,KLF6;FKBP4;ESR1
Hematocrit procedure,2/101,0.264190301111838,0.2962066304702261,0,0,2.030818387961245,2.7031931083070115,TCF7L2;PPARG
Reduced number of teeth,1/31,0.2655705309713454,0.29663076075168726,0,0,3.3455160744500847,4.435735523700054,GHR
Seasonal Affective Disorder,1/31,0.2655705309713454,0.29663076075168726,0,0,3.3455160744500847,4.435735523700054,RGS2
21-hydroxylase deficiency,1/31,0.2655705309713454,0.29663076075168726,0,0,3.3455160744500847,4.435735523700054,NR3C1
Acute interstitial pneumonia,1/31,0.2655705309713454,0.29663076075168726,0,0,3.3455160744500847,4.435735523700054,EGFR
Childhood Ataxia with Central Nervous System Hypomyelinization,1/31,0.2655705309713454,0.29663076075168726,0,0,3.3455160744500847,4.435735523700054,SPP1
Chronic interstitial cystitis,1/31,0.2655705309713454,0.29663076075168726,0,0,3.3455160744500847,4.435735523700054,CXCL10
Deformity of limb,1/31,0.2655705309713454,0.29663076075168726,0,0,3.3455160744500847,4.435735523700054,DMD
Drug-Induced Stevens Johnson Syndrome,1/31,0.2655705309713454,0.29663076075168726,0,0,3.3455160744500847,4.435735523700054,CAV1
Exotropia,1/31,0.2655705309713454,0.29663076075168726,0,0,3.3455160744500847,4.435735523700054,TGFBR2
Glycogen Storage Disease,1/31,0.2655705309713454,0.29663076075168726,0,0,3.3455160744500847,4.435735523700054,VWF
Latent autoimmune diabetes mellitus in adult,1/31,0.2655705309713454,0.29663076075168726,0,0,3.3455160744500847,4.435735523700054,TCF7L2
Lymphatic obstruction,1/31,0.2655705309713454,0.29663076075168726,0,0,3.3455160744500847,4.435735523700054,ANTXR2
Mycoplasma-Induced Stevens-Johnson Syndrome,1/31,0.2655705309713454,0.29663076075168726,0,0,3.3455160744500847,4.435735523700054,CAV1
Neoplastic disease,1/31,0.2655705309713454,0.29663076075168726,0,0,3.3455160744500847,4.435735523700054,KIT
Onset of lymphedema around puberty,1/31,0.2655705309713454,0.29663076075168726,0,0,3.3455160744500847,4.435735523700054,ANTXR2
Opportunistic Infections,1/31,0.2655705309713454,0.29663076075168726,0,0,3.3455160744500847,4.435735523700054,TLR4
Progressive muscle weakness,1/31,0.2655705309713454,0.29663076075168726,0,0,3.3455160744500847,4.435735523700054,DMD
Pulmonary Eosinophilia,1/31,0.2655705309713454,0.29663076075168726,0,0,3.3455160744500847,4.435735523700054,CCL2
Adult Acute Myeloblastic Leukemia,2/102,0.26785970560933436,0.29906230278486123,0,0,2.010408163265306,2.6482944335340326,ESR1;EGFR
Cardiac conduction abnormality,2/102,0.26785970560933436,0.29906230278486123,0,0,2.010408163265306,2.6482944335340326,FHL1;DMD
Mental impairment,3/182,0.2693344865123644,0.3006458899506473,0,0,1.686549204984959,2.212417317394081,MEF2C;DMD;FGFR3
Specific learning disability,2/103,0.2715289384947017,0.3029685329225849,0,0,1.9904021014346334,2.594860464318352,RPS6KA3;DMD
Electrocardiogram abnormal,2/103,0.2715289384947017,0.3029685329225849,0,0,1.9904021014346334,2.594860464318352,FHL1;DMD
"Acidosis, Lactic",3/183,0.27201102436831076,0.30298641805954407,0,0,1.6770940170940172,2.183429971004827,RPS6KA3;TXNIP;MET
Slender long bone,1/32,0.27285265908571066,0.30298641805954407,0,0,3.2374324545603406,4.2048528330153285,COL1A2
Subacute Sclerosing Panencephalitis,1/32,0.27285265908571066,0.30298641805954407,0,0,3.2374324545603406,4.2048528330153285,TIMP1
"POLYDACTYLY, POSTAXIAL",1/32,0.27285265908571066,0.30298641805954407,0,0,3.2374324545603406,4.2048528330153285,ZBTB16
Tires quickly,1/32,0.27285265908571066,0.30298641805954407,0,0,3.2374324545603406,4.2048528330153285,SNAP25
Unverricht-Lundborg Syndrome,1/32,0.27285265908571066,0.30298641805954407,0,0,3.2374324545603406,4.2048528330153285,SNAP25
Acrania,1/32,0.27285265908571066,0.30298641805954407,0,0,3.2374324545603406,4.2048528330153285,CCL2
Adrenal hyperplasia,1/32,0.27285265908571066,0.30298641805954407,0,0,3.2374324545603406,4.2048528330153285,NR3C1
African Trypanosomiasis,1/32,0.27285265908571066,0.30298641805954407,0,0,3.2374324545603406,4.2048528330153285,CXCL10
Aortic valve calcification,1/32,0.27285265908571066,0.30298641805954407,0,0,3.2374324545603406,4.2048528330153285,MMP14
Bone marrow hypocellularity,1/32,0.27285265908571066,0.30298641805954407,0,0,3.2374324545603406,4.2048528330153285,FLI1
Cataplexy,1/32,0.27285265908571066,0.30298641805954407,0,0,3.2374324545603406,4.2048528330153285,LEP
CHARGE Syndrome,1/32,0.27285265908571066,0.30298641805954407,0,0,3.2374324545603406,4.2048528330153285,LEP
Easy fatigability,1/32,0.27285265908571066,0.30298641805954407,0,0,3.2374324545603406,4.2048528330153285,SNAP25
Folic Acid Deficiency,1/32,0.27285265908571066,0.30298641805954407,0,0,3.2374324545603406,4.2048528330153285,ESR1
Hypereosinophilia,1/32,0.27285265908571066,0.30298641805954407,0,0,3.2374324545603406,4.2048528330153285,KIT
Idiopathic Hypereosinophilic Syndrome,1/32,0.27285265908571066,0.30298641805954407,0,0,3.2374324545603406,4.2048528330153285,KIT
Increased hepatocellular carcinoma risk,1/32,0.27285265908571066,0.30298641805954407,0,0,3.2374324545603406,4.2048528330153285,MET
Increased incidence of hepatocellular carcinoma,1/32,0.27285265908571066,0.30298641805954407,0,0,3.2374324545603406,4.2048528330153285,MET
Juvenile polyposis syndrome,1/32,0.27285265908571066,0.30298641805954407,0,0,3.2374324545603406,4.2048528330153285,TLR4
Neurotoxicity Syndromes,1/32,0.27285265908571066,0.30298641805954407,0,0,3.2374324545603406,4.2048528330153285,FOS
Periodic Fever Syndrome,1/32,0.27285265908571066,0.30298641805954407,0,0,3.2374324545603406,4.2048528330153285,GSN
Peritoneal Fibrosis,1/32,0.27285265908571066,0.30298641805954407,0,0,3.2374324545603406,4.2048528330153285,LEP
Electrocardiographic changes,2/104,0.27519764529088014,0.3055267191156459,0,0,1.9707883153261305,2.5428406230004748,FHL1;DMD
Malignant neoplasm of testis,3/185,0.2773727812156264,0.3078774320137624,0,0,1.6584953508030431,2.126842657550794,KIT;ESR1;TEAD1
"Albinism, Oculocutaneous",1/33,0.2800629433371513,0.3093813070156881,0,0,3.1361040609137056,3.9914479157798444,KIT
Refractory anaemia with excess blasts,1/33,0.2800629433371513,0.3093813070156881,0,0,3.1361040609137056,3.9914479157798444,AKAP12
Scapular weakness,1/33,0.2800629433371513,0.3093813070156881,0,0,3.1361040609137056,3.9914479157798444,FHL1
"Foramen Ovale, Patent",1/33,0.2800629433371513,0.3093813070156881,0,0,3.1361040609137056,3.9914479157798444,VWF
Short metatarsal,1/33,0.2800629433371513,0.3093813070156881,0,0,3.1361040609137056,3.9914479157798444,BMPR1B
Soluble Interleukin 6 Receptor Measurement,1/33,0.2800629433371513,0.3093813070156881,0,0,3.1361040609137056,3.9914479157798444,SORBS2
Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum,1/33,0.2800629433371513,0.3093813070156881,0,0,3.1361040609137056,3.9914479157798444,CAV1
"Pneumonia, Interstitial",1/33,0.2800629433371513,0.3093813070156881,0,0,3.1361040609137056,3.9914479157798444,MUC1
Taste bitter,1/33,0.2800629433371513,0.3093813070156881,0,0,3.1361040609137056,3.9914479157798444,FZD4
Usher Syndrome,1/33,0.2800629433371513,0.3093813070156881,0,0,3.1361040609137056,3.9914479157798444,CIB1
Chronic Airflow Obstruction,1/33,0.2800629433371513,0.3093813070156881,0,0,3.1361040609137056,3.9914479157798444,MMP14
Congenital adrenal hyperplasia due to 21 hydroxylase deficiency,1/33,0.2800629433371513,0.3093813070156881,0,0,3.1361040609137056,3.9914479157798444,NR3C1
Death in early adulthood,1/33,0.2800629433371513,0.3093813070156881,0,0,3.1361040609137056,3.9914479157798444,TGFBR2
Echinococcosis,1/33,0.2800629433371513,0.3093813070156881,0,0,3.1361040609137056,3.9914479157798444,TF
Ectopic Tissue,1/33,0.2800629433371513,0.3093813070156881,0,0,3.1361040609137056,3.9914479157798444,FGFR3
Fulminant hepatitis,1/33,0.2800629433371513,0.3093813070156881,0,0,3.1361040609137056,3.9914479157798444,CXCL10
Hereditary Motor and Sensory Neuropathies,1/33,0.2800629433371513,0.3093813070156881,0,0,3.1361040609137056,3.9914479157798444,EGFR
Metaphyseal widening,1/33,0.2800629433371513,0.3093813070156881,0,0,3.1361040609137056,3.9914479157798444,LIFR
Neuronal loss in central nervous system,1/33,0.2800629433371513,0.3093813070156881,0,0,3.1361040609137056,3.9914479157798444,CTSD
Nuclear cataract,1/33,0.2800629433371513,0.3093813070156881,0,0,3.1361040609137056,3.9914479157798444,CRYAB
Oral cleft,1/33,0.2800629433371513,0.3093813070156881,0,0,3.1361040609137056,3.9914479157798444,TGFBR2
Osteomalacia,1/33,0.2800629433371513,0.3093813070156881,0,0,3.1361040609137056,3.9914479157798444,ANTXR2
Pemphigus,1/33,0.2800629433371513,0.3093813070156881,0,0,3.1361040609137056,3.9914479157798444,C3
Teratocarcinoma,2/106,0.2825320973506965,0.31204425840038585,0,0,1.9326923076923077,2.4428517913246384,PPP4C;LMO2
Hypoplasia of corpus callosum,3/187,0.28274505796529537,0.3122147562986032,0,0,1.6403010033444816,2.0720440441898114,MEF2C;ZEB2;FGFR3
Photophobia,3/188,0.2854347503881683,0.31511949136493655,0,0,1.6313513513513513,2.0452934140265038,COL17A1;ALDH2;TLR4
"Carcinoma, Ehrlich Tumor",1/34,0.28720208890875654,0.31621899417247185,0,0,3.040916782033533,3.7937540211642773,VIM
"Parkinson Disease, Familial, Type 1",1/34,0.28720208890875654,0.31621899417247185,0,0,3.040916782033533,3.7937540211642773,UTRN
"Sarcoma, Spindle Cell",1/34,0.28720208890875654,0.31621899417247185,0,0,3.040916782033533,3.7937540211642773,MET
Underweight,1/34,0.28720208890875654,0.31621899417247185,0,0,3.040916782033533,3.7937540211642773,RPS6KA3
Adducted thumb,1/34,0.28720208890875654,0.31621899417247185,0,0,3.040916782033533,3.7937540211642773,LIFR
Winged scapula,1/34,0.28720208890875654,0.31621899417247185,0,0,3.040916782033533,3.7937540211642773,FHL1
Anoxemia,1/34,0.28720208890875654,0.31621899417247185,0,0,3.040916782033533,3.7937540211642773,EGR1
Cleft Lip with or without Cleft Palate,1/34,0.28720208890875654,0.31621899417247185,0,0,3.040916782033533,3.7937540211642773,BCL3
Hypoxia,1/34,0.28720208890875654,0.31621899417247185,0,0,3.040916782033533,3.7937540211642773,EGR1
Infective endocarditis,1/34,0.28720208890875654,0.31621899417247185,0,0,3.040916782033533,3.7937540211642773,TLR4
Monocytosis,1/34,0.28720208890875654,0.31621899417247185,0,0,3.040916782033533,3.7937540211642773,EGR1
Narrow nose,1/34,0.28720208890875654,0.31621899417247185,0,0,3.040916782033533,3.7937540211642773,BMPR1B
Parathyroid Gland Adenocarcinoma,1/34,0.28720208890875654,0.31621899417247185,0,0,3.040916782033533,3.7937540211642773,CCND1
Mechanical Allodynia,2/108,0.28986036342467353,0.3190799166887183,0,0,1.896033885252214,2.3479648951450587,CCL2;FOS
Cerebellar atrophy,3/190,0.2908204726345779,0.3200706936533799,0,0,1.613739201974496,1.9930472050608043,MME;CTSD;SYNE1
Pediatric failure to thrive,7/543,0.2926897383429241,0.32206145274198694,0,0,1.3173204657341564,1.6185154420337111,CA12;NR4A1;TPM3;LAMA3;PIK3R1;ANTXR2;EGFR
"COLORBLINDNESS, PARTIAL, DEUTAN SERIES",1/35,0.2942707941583518,0.3229343208545833,0,0,2.9513287548521947,3.610227263492937,CXCR4
"Gait, Drop Foot",1/35,0.2942707941583518,0.3229343208545833,0,0,2.9513287548521947,3.610227263492937,FHL1
Split-Hand/Foot Malformation,1/35,0.2942707941583518,0.3229343208545833,0,0,2.9513287548521947,3.610227263492937,RUNX2
"Neoplasms, Germ Cell and Embryonal",1/35,0.2942707941583518,0.3229343208545833,0,0,2.9513287548521947,3.610227263492937,KIT
Tooth agenesis,1/35,0.2942707941583518,0.3229343208545833,0,0,2.9513287548521947,3.610227263492937,GHR
Acanthosis,1/35,0.2942707941583518,0.3229343208545833,0,0,2.9513287548521947,3.610227263492937,EGFR
Deficiency of glucose-6-phosphate dehydrogenase,1/35,0.2942707941583518,0.3229343208545833,0,0,2.9513287548521947,3.610227263492937,CCND1
Follicular neoplasm,1/35,0.2942707941583518,0.3229343208545833,0,0,2.9513287548521947,3.610227263492937,PPARG
Leiomyosarcoma of uterus,1/35,0.2942707941583518,0.3229343208545833,0,0,2.9513287548521947,3.610227263492937,FGFR3
Limb defects,1/35,0.2942707941583518,0.3229343208545833,0,0,2.9513287548521947,3.610227263492937,MAP3K20
Low Grade Squamous Intraepithelial Neoplasia,1/35,0.2942707941583518,0.3229343208545833,0,0,2.9513287548521947,3.610227263492937,EGFR
Multinodular goiter,1/35,0.2942707941583518,0.3229343208545833,0,0,2.9513287548521947,3.610227263492937,CXCL10
Polyuria,1/35,0.2942707941583518,0.3229343208545833,0,0,2.9513287548521947,3.610227263492937,LEP
Aggressive reaction,2/110,0.29717985167427285,0.3258583188420165,0,0,1.8607331821617537,2.25784669407056,LEPR;TIMP1
Borderline Personality Disorder,2/110,0.29717985167427285,0.3258583188420165,0,0,1.8607331821617537,2.25784669407056,NR3C1;EGFR
Lethargy,2/110,0.29717985167427285,0.3258583188420165,0,0,1.8607331821617537,2.25784669407056,LEP;SYNE1
Neutrophil count (procedure),2/110,0.29717985167427285,0.3258583188420165,0,0,1.8607331821617537,2.25784669407056,ZBTB16;LEPR
Cerebellar degeneration,3/193,0.298912625626704,0.3276908829386352,0,0,1.5880161943319837,1.9176946611456402,MME;CTSD;SYNE1
Multiple Endocrine Neoplasia Type 1,2/111,0.3008355225828406,0.3291239239369435,0,0,1.843568620108594,2.214479140840955,CCND1;CIB1
"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",1/36,0.30126975060319205,0.3291239239369435,0,0,2.8668600435097895,3.439513141639341,CALR
Squamous intraepithelial lesion,1/36,0.30126975060319205,0.3291239239369435,0,0,2.8668600435097895,3.439513141639341,CCL2
Stage IV Skin Melanoma,1/36,0.30126975060319205,0.3291239239369435,0,0,2.8668600435097895,3.439513141639341,ADAM12
Tethered Cord Syndrome,1/36,0.30126975060319205,0.3291239239369435,0,0,2.8668600435097895,3.439513141639341,CCL2
Adrenal gland hypofunction,1/36,0.30126975060319205,0.3291239239369435,0,0,2.8668600435097895,3.439513141639341,NR3C1
Avellino corneal dystrophy,1/36,0.30126975060319205,0.3291239239369435,0,0,2.8668600435097895,3.439513141639341,CXCL10
Craniorachischisis,1/36,0.30126975060319205,0.3291239239369435,0,0,2.8668600435097895,3.439513141639341,CCL2
Exencephaly,1/36,0.30126975060319205,0.3291239239369435,0,0,2.8668600435097895,3.439513141639341,CCL2
Exocrine pancreatic insufficiency,1/36,0.30126975060319205,0.3291239239369435,0,0,2.8668600435097895,3.439513141639341,KRT8
Hepatic Encephalopathy,1/36,0.30126975060319205,0.3291239239369435,0,0,2.8668600435097895,3.439513141639341,TLR4
Hereditary Motor and Sensory-Neuropathy Type II,1/36,0.30126975060319205,0.3291239239369435,0,0,2.8668600435097895,3.439513141639341,MME
Hip joint varus deformity - observation,1/36,0.30126975060319205,0.3291239239369435,0,0,2.8668600435097895,3.439513141639341,RUNX2
Low Tension Glaucoma,1/36,0.30126975060319205,0.3291239239369435,0,0,2.8668600435097895,3.439513141639341,TLR4
Nail abnormality,1/36,0.30126975060319205,0.3291239239369435,0,0,2.8668600435097895,3.439513141639341,KRT5
Ovarian Mucinous Adenocarcinoma,1/36,0.30126975060319205,0.3291239239369435,0,0,2.8668600435097895,3.439513141639341,MYLK
Peripheral arterial occlusive disease,1/36,0.30126975060319205,0.3291239239369435,0,0,2.8668600435097895,3.439513141639341,VWF
Hypospadias,3/195,0.3043147020814718,0.3323822601746594,0,0,1.5713141025641026,1.8693812453414032,KLF6;FKBP4;ESR1
Body mass index,5/370,0.3046872092029024,0.3326527633358465,0,0,1.3795869117751438,1.639597066852074,TCF7L2;EFEMP1;ALDH2;PPARG;DMD
Finding of body mass index,5/370,0.3046872092029024,0.3326527633358465,0,0,1.3795869117751438,1.639597066852074,TCF7L2;EFEMP1;ALDH2;PPARG;DMD
Dysarthria,4/282,0.3056538834518388,0.3336398084626893,0,0,1.448045687161611,1.7163713289491556,SNAP25;KLC2;MME;SYNE1
Anteverted nostril,4/283,0.3078810778242096,0.33497774785849355,0,0,1.4427816576137162,1.6996569300143891,RPS6KA3;MEF2C;FGFR3;FLI1
Sessile Serrated Adenoma/Polyp,1/37,0.30819964303812986,0.33497774785849355,0,0,2.7870840383530737,3.2804188561600878,CALR
Spinocerebellar Ataxia Type 4,1/37,0.30819964303812986,0.33497774785849355,0,0,2.7870840383530737,3.2804188561600878,MME
"Simple syndactyly of toes, first web space",1/37,0.30819964303812986,0.33497774785849355,0,0,2.7870840383530737,3.2804188561600878,BMPR1B
Abnormality of the hair,1/37,0.30819964303812986,0.33497774785849355,0,0,2.7870840383530737,3.2804188561600878,ANTXR2
Abnormality of the hair shaft,1/37,0.30819964303812986,0.33497774785849355,0,0,2.7870840383530737,3.2804188561600878,ANTXR2
Vitelliform Macular Dystrophy,1/37,0.30819964303812986,0.33497774785849355,0,0,2.7870840383530737,3.2804188561600878,DMD
X-linked Adrenal Hypoplasia,1/37,0.30819964303812986,0.33497774785849355,0,0,2.7870840383530737,3.2804188561600878,DMD
Aplasia/Hypoplasia of the radius,1/37,0.30819964303812986,0.33497774785849355,0,0,2.7870840383530737,3.2804188561600878,ZBTB16
Bacterial Endocarditis,1/37,0.30819964303812986,0.33497774785849355,0,0,2.7870840383530737,3.2804188561600878,TLR4
Brucellosis,1/37,0.30819964303812986,0.33497774785849355,0,0,2.7870840383530737,3.2804188561600878,TLR4
Chronic leukemia (category),1/37,0.30819964303812986,0.33497774785849355,0,0,2.7870840383530737,3.2804188561600878,CCND1
Combined immunodeficiency,1/37,0.30819964303812986,0.33497774785849355,0,0,2.7870840383530737,3.2804188561600878,STAT1
Escherichia coli Infections,1/37,0.30819964303812986,0.33497774785849355,0,0,2.7870840383530737,3.2804188561600878,TLR4
Fundus coloboma,1/37,0.30819964303812986,0.33497774785849355,0,0,2.7870840383530737,3.2804188561600878,YAP1
Gowers sign,1/37,0.30819964303812986,0.33497774785849355,0,0,2.7870840383530737,3.2804188561600878,DMD
Hematopoetic Myelodysplasia,1/37,0.30819964303812986,0.33497774785849355,0,0,2.7870840383530737,3.2804188561600878,EGR1
Hypoxemia,1/37,0.30819964303812986,0.33497774785849355,0,0,2.7870840383530737,3.2804188561600878,EGR1
Macular dystrophy,1/37,0.30819964303812986,0.33497774785849355,0,0,2.7870840383530737,3.2804188561600878,EFEMP1
Malignant neoplasm of pharynx,1/37,0.30819964303812986,0.33497774785849355,0,0,2.7870840383530737,3.2804188561600878,ALDH2
Oculocerebrorenal Syndrome,1/37,0.30819964303812986,0.33497774785849355,0,0,2.7870840383530737,3.2804188561600878,CTSD
Lymphocyte Count measurement,2/114,0.3117826420840456,0.3388029567018514,0,0,1.7939139941690962,2.0907152597192966,S1PR1;ANTXR2
Congenital hypoplasia of penis,4/285,0.3123405250693598,0.33933999145659904,0,0,1.432365997725355,1.6667888214667619,GHR;LEP;ZBTB16;SOX10
Calcification of coronary artery,5/375,0.3143602249480538,0.341390985314982,0,0,1.3605937543761377,1.5745005047854785,ABCA1;THRB;LPL;ARHGEF6;SYNE1
Sensorimotor neuropathy,1/38,0.3150611495175608,0.341390985314982,0,0,2.7116202496913155,3.131890295718747,HGF
Subfertility,1/38,0.3150611495175608,0.341390985314982,0,0,2.7116202496913155,3.131890295718747,LEPR
Abnormality of the eye,1/38,0.3150611495175608,0.341390985314982,0,0,2.7116202496913155,3.131890295718747,LAMA3
Vitamin D Deficiency,1/38,0.3150611495175608,0.341390985314982,0,0,2.7116202496913155,3.131890295718747,TIMP1
Disorder of the optic nerve,1/38,0.3150611495175608,0.341390985314982,0,0,2.7116202496913155,3.131890295718747,EGFR
Genu varum,1/38,0.3150611495175608,0.341390985314982,0,0,2.7116202496913155,3.131890295718747,FGFR3
Gross motor development delay,1/38,0.3150611495175608,0.341390985314982,0,0,2.7116202496913155,3.131890295718747,COL1A2
Infectious Mononucleosis,1/38,0.3150611495175608,0.341390985314982,0,0,2.7116202496913155,3.131890295718747,BCL6
Lichen Planus,1/38,0.3150611495175608,0.341390985314982,0,0,2.7116202496913155,3.131890295718747,S100A8
Mediastinal (Thymic) Large B-Cell Lymphoma,1/38,0.3150611495175608,0.341390985314982,0,0,2.7116202496913155,3.131890295718747,BCL6
Pituitary dwarfism,1/38,0.3150611495175608,0.341390985314982,0,0,2.7116202496913155,3.131890295718747,GHR
Radioulnar Synostosis,1/38,0.3150611495175608,0.341390985314982,0,0,2.7116202496913155,3.131890295718747,MAF
Spastic Paraplegia,2/115,0.31542408657502663,0.3417147707579421,0,0,1.777948347480585,2.051463012390042,KLC2;S100A4
"Ataxia, Spinocerebellar",2/116,0.3190612661601876,0.3455848551560244,0,0,1.7622627998567848,2.013159921878105,MME;F13A1
Sense of smell impaired,1/39,0.32185494148715865,0.347410367264547,0,0,2.6401282393801764,2.992992802977873,SOX10
"Liver dysfunction, mild",1/39,0.32185494148715865,0.347410367264547,0,0,2.6401282393801764,2.992992802977873,FADD
"Obesity, Abdominal",1/39,0.32185494148715865,0.347410367264547,0,0,2.6401282393801764,2.992992802977873,GHR
Sweet Syndrome,1/39,0.32185494148715865,0.347410367264547,0,0,2.6401282393801764,2.992992802977873,TGFBR2
Talipes foot deformities,1/39,0.32185494148715865,0.347410367264547,0,0,2.6401282393801764,2.992992802977873,LIFR
Adenocarcinoma of rectum,1/39,0.32185494148715865,0.347410367264547,0,0,2.6401282393801764,2.992992802977873,EGFR
Anosmia,1/39,0.32185494148715865,0.347410367264547,0,0,2.6401282393801764,2.992992802977873,SOX10
Clonus,1/39,0.32185494148715865,0.347410367264547,0,0,2.6401282393801764,2.992992802977873,CAV1
Decreased liver function,1/39,0.32185494148715865,0.347410367264547,0,0,2.6401282393801764,2.992992802977873,FADD
Drooling,1/39,0.32185494148715865,0.347410367264547,0,0,2.6401282393801764,2.992992802977873,ZEB2
Fasting blood glucose measurement,1/39,0.32185494148715865,0.347410367264547,0,0,2.6401282393801764,2.992992802977873,TCF7L2
Flexion contracture of the knee,1/39,0.32185494148715865,0.347410367264547,0,0,2.6401282393801764,2.992992802977873,LIFR
Gowers sign present,1/39,0.32185494148715865,0.347410367264547,0,0,2.6401282393801764,2.992992802977873,DMD
Klinefelter's syndrome - male with more than two X chromosomes,1/39,0.32185494148715865,0.347410367264547,0,0,2.6401282393801764,2.992992802977873,LEP
Low Grade Lymphoma (neoplasm),1/39,0.32185494148715865,0.347410367264547,0,0,2.6401282393801764,2.992992802977873,BCL6
Lymphatic Diseases,1/39,0.32185494148715865,0.347410367264547,0,0,2.6401282393801764,2.992992802977873,AQP1
Pyelonephritis,1/39,0.32185494148715865,0.347410367264547,0,0,2.6401282393801764,2.992992802977873,TIMP1
Joint stiffness,2/117,0.32269390934390657,0.34817490238786764,0,0,1.7468500443655723,1.9757765841265966,ANTXR2;BMPR1B
Muscle Hypertonia,2/117,0.32269390934390657,0.34817490238786764,0,0,1.7468500443655723,1.9757765841265966,SOX10;TGFBR2
"Mental Retardation, X-Linked",2/118,0.32632175032416594,0.3520179367363321,0,0,1.7317030260380013,1.9392847270641864,RPS6KA3;CALR
Rhizomelia,1/40,0.32858168380858743,0.3533114998014452,0,0,2.57230248600807,2.8628950220174127,FGFR3
Short thorax,1/40,0.32858168380858743,0.3533114998014452,0,0,2.57230248600807,2.8628950220174127,FGFR3
Spinal Cord Diseases,1/40,0.32858168380858743,0.3533114998014452,0,0,2.57230248600807,2.8628950220174127,SPP1
"Pneumonia, Bacterial",1/40,0.32858168380858743,0.3533114998014452,0,0,2.57230248600807,2.8628950220174127,PECAM1
Syncope,1/40,0.32858168380858743,0.3533114998014452,0,0,2.57230248600807,2.8628950220174127,ANK2
Talipes,1/40,0.32858168380858743,0.3533114998014452,0,0,2.57230248600807,2.8628950220174127,LIFR
"stage, ovarian epithelial cancer",1/40,0.32858168380858743,0.3533114998014452,0,0,2.57230248600807,2.8628950220174127,S100A4
Abnormal coordination,1/40,0.32858168380858743,0.3533114998014452,0,0,2.57230248600807,2.8628950220174127,ANK2
Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,1/40,0.32858168380858743,0.3533114998014452,0,0,2.57230248600807,2.8628950220174127,EGR1
Adrenal cortical hypofunction,1/40,0.32858168380858743,0.3533114998014452,0,0,2.57230248600807,2.8628950220174127,NR3C1
Chemical Carcinogenesis,1/40,0.32858168380858743,0.3533114998014452,0,0,2.57230248600807,2.8628950220174127,GSN
Congenital omphalocele,1/40,0.32858168380858743,0.3533114998014452,0,0,2.57230248600807,2.8628950220174127,LRP1
Hereditary retinal dystrophy,1/40,0.32858168380858743,0.3533114998014452,0,0,2.57230248600807,2.8628950220174127,EFEMP1
Hypokalemia,1/40,0.32858168380858743,0.3533114998014452,0,0,2.57230248600807,2.8628950220174127,NR3C1
Hypoplasia of thumb,1/40,0.32858168380858743,0.3533114998014452,0,0,2.57230248600807,2.8628950220174127,BMPR1B
Polyglandular Type I Autoimmune Syndrome,1/40,0.32858168380858743,0.3533114998014452,0,0,2.57230248600807,2.8628950220174127,CXCL10
Retrognathia,2/119,0.3299445289819985,0.3546338029336567,0,0,1.7168149311006453,1.90365715786809,FHL1;TGFBR2
Hyperalgesia,2/119,0.3299445289819985,0.3546338029336567,0,0,1.7168149311006453,1.90365715786809,CCL2;FOS
Hypogonadism,3/205,0.3313697244288335,0.35609382163364667,0,0,1.4927646610814929,1.6487892217055935,LEP;LEPR;SOX10
Platelet distribution width measurement,2/120,0.33356199072658105,0.35830514988549694,0,0,1.702179176755448,1.8688677138421257,MEF2C;SVEP1
Platelet distribution width result,2/120,0.33356199072658105,0.35830514988549694,0,0,1.702179176755448,1.8688677138421257,MEF2C;SVEP1
"Conjunctivitis, recurrent",1/41,0.3352420349621892,0.3595300471550626,0,0,2.5078680203045685,2.7408552681952725,PIK3R1
"Human immunodeficiency virus, type 2 [HIV-2] infection in conditions classified elsewhere and of unspecified site",1/41,0.3352420349621892,0.3595300471550626,0,0,2.5078680203045685,2.7408552681952725,CXCR4
Unable to walk,1/41,0.3352420349621892,0.3595300471550626,0,0,2.5078680203045685,2.7408552681952725,MEF2C
Unilateral agenesis of kidney,1/41,0.3352420349621892,0.3595300471550626,0,0,2.5078680203045685,2.7408552681952725,FGFR3
AIDS related complex,1/41,0.3352420349621892,0.3595300471550626,0,0,2.5078680203045685,2.7408552681952725,NEDD9
Gastrointestinal mucositis,1/41,0.3352420349621892,0.3595300471550626,0,0,2.5078680203045685,2.7408552681952725,KDR
Malignant Meningioma,1/41,0.3352420349621892,0.3595300471550626,0,0,2.5078680203045685,2.7408552681952725,KLF4
Prolymphocytic Leukemia,1/41,0.3352420349621892,0.3595300471550626,0,0,2.5078680203045685,2.7408552681952725,CCND1
Wide skull shape,2/121,0.3371738865541782,0.36138367687997097,0,0,1.6877894014748758,1.834891214838342,MAF;FGFR3
Broad cranium shape,2/121,0.3371738865541782,0.36138367687997097,0,0,1.6877894014748758,1.834891214838342,MAF;FGFR3
Polyhydramnios,2/121,0.3371738865541782,0.36138367687997097,0,0,1.6877894014748758,1.834891214838342,FGFR3;MYLK
"Memory Disorder, Semantic",1/42,0.3418366468986575,0.36549909536977243,0,0,2.4465766992695306,2.626209979517433,MDK
"Memory Disorder, Spatial",1/42,0.3418366468986575,0.36549909536977243,0,0,2.4465766992695306,2.626209979517433,MDK
Age-Related Memory Disorders,1/42,0.3418366468986575,0.36549909536977243,0,0,2.4465766992695306,2.626209979517433,MDK
Choanal Atresia,1/42,0.3418366468986575,0.36549909536977243,0,0,2.4465766992695306,2.626209979517433,FGFR3
Disease due to Parvoviridae,1/42,0.3418366468986575,0.36549909536977243,0,0,2.4465766992695306,2.626209979517433,CCL2
Drug Allergy,1/42,0.3418366468986575,0.36549909536977243,0,0,2.4465766992695306,2.626209979517433,CCL11
Ganglioneuroblastoma,1/42,0.3418366468986575,0.36549909536977243,0,0,2.4465766992695306,2.626209979517433,EGFR
Hernia,1/42,0.3418366468986575,0.36549909536977243,0,0,2.4465766992695306,2.626209979517433,COL1A2
Infection by Cryptococcus neoformans,1/42,0.3418366468986575,0.36549909536977243,0,0,2.4465766992695306,2.626209979517433,TAP1
Late fontanel closure,1/42,0.3418366468986575,0.36549909536977243,0,0,2.4465766992695306,2.626209979517433,FGFR3
Mixed cryoglobulinemia,1/42,0.3418366468986575,0.36549909536977243,0,0,2.4465766992695306,2.626209979517433,CXCL10
Other ureteric obstruction,1/42,0.3418366468986575,0.36549909536977243,0,0,2.4465766992695306,2.626209979517433,COL1A2
Nicotine Dependence,2/124,0.34797376771407956,0.3718836726902454,0,0,1.6460354633656742,1.737601423997908,ALDH2;NR3C1
Secondary physiologic amenorrhea,1/43,0.3483661651472519,0.3718836726902454,0,0,2.3882040125694948,2.518363886481836,PPARG
Triploidy syndrome,1/43,0.3483661651472519,0.3718836726902454,0,0,2.3882040125694948,2.518363886481836,KRT5
Acute intermittent porphyria,1/43,0.3483661651472519,0.3718836726902454,0,0,2.3882040125694948,2.518363886481836,FOXO1
Acute respiratory failure,1/43,0.3483661651472519,0.3718836726902454,0,0,2.3882040125694948,2.518363886481836,MUC1
Chloracne,1/43,0.3483661651472519,0.3718836726902454,0,0,2.3882040125694948,2.518363886481836,EGFR
Hyponatremia,1/43,0.3483661651472519,0.3718836726902454,0,0,2.3882040125694948,2.518363886481836,CA12
Peroxisomal Disorders,1/43,0.3483661651472519,0.3718836726902454,0,0,2.3882040125694948,2.518363886481836,EPAS1
"Intellectual disability, progressive",1/44,0.3548312291114732,0.37802791282187936,0,0,2.3325463345531814,2.4167816118314542,CTSD
"Leprosy, Lepromatous",1/44,0.3548312291114732,0.37802791282187936,0,0,2.3325463345531814,2.4167816118314542,LRP1
"Liposarcoma, Myxoid",1/44,0.3548312291114732,0.37802791282187936,0,0,2.3325463345531814,2.4167816118314542,LRP1
Autonomic nervous system disorders,1/44,0.3548312291114732,0.37802791282187936,0,0,2.3325463345531814,2.4167816118314542,LIFR
Birth Weight,1/44,0.3548312291114732,0.37802791282187936,0,0,2.3325463345531814,2.4167816118314542,ESR1
Birthmark,1/44,0.3548312291114732,0.37802791282187936,0,0,2.3325463345531814,2.4167816118314542,SOX10
Confusion,1/44,0.3548312291114732,0.37802791282187936,0,0,2.3325463345531814,2.4167816118314542,TLR4
Conjunctivitis,1/44,0.3548312291114732,0.37802791282187936,0,0,2.3325463345531814,2.4167816118314542,PIK3R1
Memory Disorders,1/44,0.3548312291114732,0.37802791282187936,0,0,2.3325463345531814,2.4167816118314542,MDK
Neoplasm of uncertain or unknown behavior of breast,1/44,0.3548312291114732,0.37802791282187936,0,0,2.3325463345531814,2.4167816118314542,ESR1
Intelligence,3/214,0.35570166009288495,0.3788795016260212,0,0,1.428436018957346,1.4765213648488686,MEF2C;TINAGL1;TEAD1
Alopecia,3/216,0.36109662870439546,0.38400316015674,0,0,1.4148790176959192,1.4412094732521261,ZFP36;PIK3R1;EGFR
Rough hair texture,1/45,0.36123247173310896,0.38400316015674,0,0,2.279418550992155,2.320980470207381,RPS6KA3
"Limb Deformities, Congenital",1/45,0.36123247173310896,0.38400316015674,0,0,2.279418550992155,2.320980470207381,BMPR1B
Age-related cataract,1/45,0.36123247173310896,0.38400316015674,0,0,2.279418550992155,2.320980470207381,CRYAB
Bronchogenic Carcinoma,1/45,0.36123247173310896,0.38400316015674,0,0,2.279418550992155,2.320980470207381,EGFR
Cafe-au-Lait Spots,1/45,0.36123247173310896,0.38400316015674,0,0,2.279418550992155,2.320980470207381,SOX10
Coarse hair,1/45,0.36123247173310896,0.38400316015674,0,0,2.279418550992155,2.320980470207381,RPS6KA3
Diminished sweating,1/45,0.36123247173310896,0.38400316015674,0,0,2.279418550992155,2.320980470207381,LIFR
Hypoparathyroidism,1/45,0.36123247173310896,0.38400316015674,0,0,2.279418550992155,2.320980470207381,FHL1
Myxoid/Round Cell Liposarcoma,1/45,0.36123247173310896,0.38400316015674,0,0,2.279418550992155,2.320980470207381,PPARG
Pervasive Development Disorder,2/129,0.36584053266331923,0.3888241321425665,0,0,1.5808291820665274,1.5896150253874397,MPDZ;MET
Sparse or absent eyebrows,1/46,0.3675705199058439,0.3895750398922518,0,0,2.228652002256063,2.2305242656976114,FLI1
Sparse/absent eyebrows,1/46,0.3675705199058439,0.3895750398922518,0,0,2.228652002256063,2.2305242656976114,FLI1
Spinocerebellar Ataxia Type 5,1/46,0.3675705199058439,0.3895750398922518,0,0,2.228652002256063,2.2305242656976114,MME
"Sleep Apnea, Central",1/46,0.3675705199058439,0.3895750398922518,0,0,2.228652002256063,2.2305242656976114,FGFR3
Absence of eyebrow,1/46,0.3675705199058439,0.3895750398922518,0,0,2.228652002256063,2.2305242656976114,FLI1
Adult Diffuse Large B-Cell Lymphoma,1/46,0.3675705199058439,0.3895750398922518,0,0,2.228652002256063,2.2305242656976114,CCND1
Aplasia/Hypoplasia of the eyebrow,1/46,0.3675705199058439,0.3895750398922518,0,0,2.228652002256063,2.2305242656976114,FLI1
Childhood Diffuse Large B-Cell Lymphoma,1/46,0.3675705199058439,0.3895750398922518,0,0,2.228652002256063,2.2305242656976114,CCND1
Decreased fertility,1/46,0.3675705199058439,0.3895750398922518,0,0,2.228652002256063,2.2305242656976114,SOX10
Exfoliative dermatitis,1/46,0.3675705199058439,0.3895750398922518,0,0,2.228652002256063,2.2305242656976114,KIT
Hypohidrosis,1/46,0.3675705199058439,0.3895750398922518,0,0,2.228652002256063,2.2305242656976114,LIFR
Infiltrating Cervical Carcinoma,1/46,0.3675705199058439,0.3895750398922518,0,0,2.228652002256063,2.2305242656976114,EGFR
Nodular Sclerosis Classical Hodgkin Lymphoma,1/46,0.3675705199058439,0.3895750398922518,0,0,2.228652002256063,2.2305242656976114,CXCL10
Pyloric Stenosis,1/46,0.3675705199058439,0.3895750398922518,0,0,2.228652002256063,2.2305242656976114,LAMA3
Brachycephaly,2/130,0.36939199055264915,0.3914277028544576,0,0,1.5683992346938775,1.5619639260190763,MAF;FGFR3
Abnormality of the outer ear,1/47,0.3738459943589709,0.3959899232635572,0,0,2.1800926947693666,2.145017938066358,FGFR3
Cholestasis of pregnancy,1/47,0.3738459943589709,0.3959899232635572,0,0,2.1800926947693666,2.145017938066358,PPARG
Vesicular Stomatitis,2/133,0.3799989556459923,0.4020121333023203,0,0,1.5322480137093004,1.4825829134193798,STAT1;CXCR4
Renal tubular disorder,1/48,0.3800595097723944,0.4020121333023203,0,0,2.133599740792742,2.064102922116796,CCL2
"Epilepsies, Partial",1/48,0.3800595097723944,0.4020121333023203,0,0,2.133599740792742,2.064102922116796,NR3C1
Spinocerebellar Ataxia Type 6 (disorder),1/48,0.3800595097723944,0.4020121333023203,0,0,2.133599740792742,2.064102922116796,MME
contracture of elbow,1/48,0.3800595097723944,0.4020121333023203,0,0,2.133599740792742,2.064102922116796,LIFR
Embryonal Neoplasm,1/48,0.3800595097723944,0.4020121333023203,0,0,2.133599740792742,2.064102922116796,TPM3
Infantile Spasm,1/48,0.3800595097723944,0.4020121333023203,0,0,2.133599740792742,2.064102922116796,NR3C1
Blood basophil count (lab test),3/224,0.3826023408385043,0.4046215269554256,0,0,1.3631047685346327,1.3096153157415191,ZBTB16;LEPR;E2F2
Amenorrhea,1/49,0.3862116748146341,0.40803370640110725,0,0,2.0890439932318103,1.9874531142481775,NR3C1
Astigmatism,1/49,0.3862116748146341,0.40803370640110725,0,0,2.0890439932318103,1.9874531142481775,TEAD1
Chronic schizophrenia,1/49,0.3862116748146341,0.40803370640110725,0,0,2.0890439932318103,1.9874531142481775,LEP
Hypermelanotic macule,1/49,0.3862116748146341,0.40803370640110725,0,0,2.0890439932318103,1.9874531142481775,KIT
Medullary carcinoma,1/49,0.3862116748146341,0.40803370640110725,0,0,2.0890439932318103,1.9874531142481775,ESR1
Dystonia Disorders,2/135,0.38702887521653206,0.40881603092743296,0,0,1.5090532453582937,1.4324778109162237,GSN;DST
Renal dysplasia,1/50,0.39230309216925463,0.4139768669643481,0,0,2.0463068476121413,1.914771355908193,ESR1
Sudden Cardiac Death,1/50,0.39230309216925463,0.4139768669643481,0,0,2.0463068476121413,1.914771355908193,ANK2
Congenital cerebral hernia,1/50,0.39230309216925463,0.4139768669643481,0,0,2.0463068476121413,1.914771355908193,LAMC1
Endocardial Cushion Defects,1/50,0.39230309216925463,0.4139768669643481,0,0,2.0463068476121413,1.914771355908193,EGFR
Fibromyalgia,1/50,0.39230309216925463,0.4139768669643481,0,0,2.0463068476121413,1.914771355908193,NR3C1
Pruritus,2/137,0.3940240073765334,0.4157105395584135,0,0,1.4865457294028723,1.384484612020455,KIT;EGFR
"Amaurosis congenita of Leber, type 1",1/51,0.39833435868049344,0.4195935555264577,0,0,2.005279187817259,1.845786358238875,MEF2C
Tapering fingers (finding),1/51,0.39833435868049344,0.4195935555264577,0,0,2.005279187817259,1.845786358238875,RPS6KA3
Tardive Dyskinesia,1/51,0.39833435868049344,0.4195935555264577,0,0,2.005279187817259,1.845786358238875,RGS2
"Tachycardia, Ventricular",1/51,0.39833435868049344,0.4195935555264577,0,0,2.005279187817259,1.845786358238875,MET
C-reactive protein measurement,1/51,0.39833435868049344,0.4195935555264577,0,0,2.005279187817259,1.845786358238875,LEPR
Congenital adrenal hyperplasia,1/51,0.39833435868049344,0.4195935555264577,0,0,2.005279187817259,1.845786358238875,LEP
Drug-induced tardive dyskinesia,1/51,0.39833435868049344,0.4195935555264577,0,0,2.005279187817259,1.845786358238875,RGS2
Hermanski-Pudlak Syndrome,1/51,0.39833435868049344,0.4195935555264577,0,0,2.005279187817259,1.845786358238875,VWF
"Gait, Unsteady",1/52,0.4043060652476696,0.42512766805541263,0,0,1.96586045585747,1.7802500069596723,MME
Allergic sensitization,1/52,0.4043060652476696,0.42512766805541263,0,0,1.96586045585747,1.7802500069596723,TLR4
Congenital absence of kidney,1/52,0.4043060652476696,0.42512766805541263,0,0,1.96586045585747,1.7802500069596723,FGFR3
Decreased nerve conduction velocity,1/52,0.4043060652476696,0.42512766805541263,0,0,1.96586045585747,1.7802500069596723,SOX10
Friedreich Ataxia,1/52,0.4043060652476696,0.42512766805541263,0,0,1.96586045585747,1.7802500069596723,PPARG
Hypocalcemia,1/52,0.4043060652476696,0.42512766805541263,0,0,1.96586045585747,1.7802500069596723,CAV1
Non-arthropod borne lymphocytic choriomeningitis,1/52,0.4043060652476696,0.42512766805541263,0,0,1.96586045585747,1.7802500069596723,STAT1
Parasitic Diseases,1/52,0.4043060652476696,0.42512766805541263,0,0,1.96586045585747,1.7802500069596723,TLR4
Range of joint movement increased,1/52,0.4043060652476696,0.42512766805541263,0,0,1.96586045585747,1.7802500069596723,BGN
RESTING HEART RATE,1/53,0.4102187971882732,0.4307499448702084,0,0,1.9279578289730575,1.717934990867154,SREBF1
Situs ambiguus,1/53,0.4102187971882732,0.4307499448702084,0,0,1.9279578289730575,1.717934990867154,PKD2
"Leukemia, Lymphocytic, Acute, L2",1/53,0.4102187971882732,0.4307499448702084,0,0,1.9279578289730575,1.717934990867154,MME
Hemiplegia/hemiparesis,1/53,0.4102187971882732,0.4307499448702084,0,0,1.9279578289730575,1.717934990867154,ABCA1
Hypophosphatemia,1/53,0.4102187971882732,0.4307499448702084,0,0,1.9279578289730575,1.717934990867154,FGFR3
Mental deterioration,1/53,0.4102187971882732,0.4307499448702084,0,0,1.9279578289730575,1.717934990867154,CTSD
NEUROTICISM,1/53,0.4102187971882732,0.4307499448702084,0,0,1.9279578289730575,1.717934990867154,SNAP25
Broad flat nasal bridge,4/330,0.41312688731156183,0.43371812105660223,0,0,1.2318006451204857,1.0889123861962573,MAF;PIK3R1;SOX10;CTSD
Supratentorial atrophy,2/143,0.41478742661276047,0.4353756542090606,0,0,1.4228542480822115,1.252096250562335,FADD;CTSD
"Xeroderma Pigmentosum, Complementation Group D",1/54,0.4160731339213949,0.4363813679722719,0,0,1.891485489895604,1.6586327150113274,EGFR
Autistic behavior,1/54,0.4160731339213949,0.4363813679722719,0,0,1.891485489895604,1.6586327150113274,MEF2C
Cognition,1/54,0.4160731339213949,0.4363813679722719,0,0,1.891485489895604,1.6586327150113274,MEF2C
Dizziness,1/54,0.4160731339213949,0.4363813679722719,0,0,1.891485489895604,1.6586327150113274,CCL2
Nasal bridge wide,4/333,0.41978915629921154,0.4401921318218218,0,0,1.2203804092376147,1.059293493375306,MAF;PIK3R1;SOX10;CTSD
Frontotemporal dementia,2/145,0.421630480203881,0.4413316374896436,0,0,1.4028114742400457,1.211504445235203,SNAP25;CTSD
"Lymphoma, Diffuse",1/55,0.42186964934739063,0.4413316374896436,0,0,1.8563639781913894,1.6021514538791723,BCL6
Spastic Quadriplegia,1/55,0.42186964934739063,0.4413316374896436,0,0,1.8563639781913894,1.6021514538791723,SOX10
Spinocerebellar Ataxia Type 2,1/55,0.42186964934739063,0.4413316374896436,0,0,1.8563639781913894,1.6021514538791723,MME
Systemic onset juvenile chronic arthritis,1/55,0.42186964934739063,0.4413316374896436,0,0,1.8563639781913894,1.6021514538791723,STAT1
Brugada Syndrome (disorder),1/55,0.42186964934739063,0.4413316374896436,0,0,1.8563639781913894,1.6021514538791723,ANK2
Common Migraine,1/55,0.42186964934739063,0.4413316374896436,0,0,1.8563639781913894,1.6021514538791723,LRP1
Dysmorphic features,1/55,0.42186964934739063,0.4413316374896436,0,0,1.8563639781913894,1.6021514538791723,MEF2C
Fetal Alcohol Syndrome,1/55,0.42186964934739063,0.4413316374896436,0,0,1.8563639781913894,1.6021514538791723,BCL6
Ganglioneuroma,1/55,0.42186964934739063,0.4413316374896436,0,0,1.8563639781913894,1.6021514538791723,CCND1
Immunoglobulin A deficiency (disorder),1/55,0.42186964934739063,0.4413316374896436,0,0,1.8563639781913894,1.6021514538791723,MUC1
Lymphocytic Choriomeningitis,1/55,0.42186964934739063,0.4413316374896436,0,0,1.8563639781913894,1.6021514538791723,STAT1
Undergrowth,6/529,0.42629809772468197,0.44587685236012364,0,0,1.151947896749522,0.9821696888887747,CA12;TPM3;LAMA3;PIK3R1;ANTXR2;EGFR
Vertigo,1/56,0.42760891156016617,0.44689701700414314,0,0,1.8225196123673282,1.548314718948253,CCL2
Channelopathies,1/56,0.42760891156016617,0.44689701700414314,0,0,1.8225196123673282,1.548314718948253,ANK2
Claw hand,1/56,0.42760891156016617,0.44689701700414314,0,0,1.8225196123673282,1.548314718948253,FGFR3
Congenital hypoplasia of kidney,1/56,0.42760891156016617,0.44689701700414314,0,0,1.8225196123673282,1.548314718948253,MUC1
Mild Mental Retardation,2/147,0.42843259873041845,0.4476700624773333,0,0,1.3833216045038705,1.1725336163947473,RPS6KA3;DMD
"Respiratory Distress Syndrome, Newborn",1/57,0.4332914832901502,0.4519495624296752,0,0,1.7898839738941261,1.4969598067303158,NR3C1
Abnormality of epiphysis morphology,1/57,0.4332914832901502,0.4519495624296752,0,0,1.7898839738941261,1.4969598067303158,BMPR1B
Broad nasal tip,1/57,0.4332914832901502,0.4519495624296752,0,0,1.7898839738941261,1.4969598067303158,RPS6KA3
Heart Septal Defects,1/57,0.4332914832901502,0.4519495624296752,0,0,1.7898839738941261,1.4969598067303158,ACTA2
Hyperaldosteronism,1/57,0.4332914832901502,0.4519495624296752,0,0,1.7898839738941261,1.4969598067303158,NR3C1
Long eyelashes,1/57,0.4332914832901502,0.4519495624296752,0,0,1.7898839738941261,1.4969598067303158,EGFR
Obsessive compulsive behavior,1/57,0.4332914832901502,0.4519495624296752,0,0,1.7898839738941261,1.4969598067303158,ESR1
Peutz-Jeghers Syndrome,1/57,0.4332914832901502,0.4519495624296752,0,0,1.7898839738941261,1.4969598067303158,EGFR
Pneumocystis jiroveci pneumonia,1/57,0.4332914832901502,0.4519495624296752,0,0,1.7898839738941261,1.4969598067303158,C3
Respiratory Tract Diseases,1/58,0.4389179216885566,0.4575496096788572,0,0,1.758393445542791,1.4479365100929313,MUC1
Chlamydia Infections,1/58,0.4389179216885566,0.4575496096788572,0,0,1.758393445542791,1.4479365100929313,TLR4
Maternal oligohydramnios,1/58,0.4389179216885566,0.4575496096788572,0,0,1.758393445542791,1.4479365100929313,LIFR
Failure to gain weight,6/539,0.4438605612126159,0.4626115647764581,0,0,1.129749061913696,0.9176328202729037,CA12;TPM3;LAMA3;PIK3R1;ANTXR2;EGFR
"Paraparesis, Spastic",1/59,0.4444887784531854,0.4627233249417904,0,0,1.7279887974794328,1.4011059682473626,SOX10
Alopecia Areata,1/59,0.4444887784531854,0.4627233249417904,0,0,1.7279887974794328,1.4011059682473626,CXCL10
Chronic lung disease,1/59,0.4444887784531854,0.4627233249417904,0,0,1.7279887974794328,1.4011059682473626,A2M
Drug Resistant Epilepsy,1/59,0.4444887784531854,0.4627233249417904,0,0,1.7279887974794328,1.4011059682473626,SGK1
Moderate mental retardation (I.Q. 35-49),1/59,0.4444887784531854,0.4627233249417904,0,0,1.7279887974794328,1.4011059682473626,ZEB2
Radial club hand,1/59,0.4444887784531854,0.4627233249417904,0,0,1.7279887974794328,1.4011059682473626,FGFR3
Common Variable Immunodeficiency,2/152,0.44525207712350073,0.4634274060529561,0,0,1.3368707482993196,1.0816817634208848,BCL6;NEDD9
Angelman Syndrome,1/60,0.45000459991217345,0.46800829682513123,0,0,1.6986148154521208,1.356339639850197,MEF2C
Hypotrichosis,1/60,0.45000459991217345,0.46800829682513123,0,0,1.6986148154521208,1.356339639850197,PIK3R1
MAJOR AFFECTIVE DISORDER 8,1/60,0.45000459991217345,0.46800829682513123,0,0,1.6986148154521208,1.356339639850197,NR3C1
MAJOR AFFECTIVE DISORDER 9,1/60,0.45000459991217345,0.46800829682513123,0,0,1.6986148154521208,1.356339639850197,NR3C1
Icterus,2/154,0.4519030507768526,0.4698909966028971,0,0,1.3191460794844254,1.047781388809089,THRB;LPL
Visual Impairment,3/251,0.4537021356338579,0.4716696607087063,0,0,1.2130272952853598,0.9586729210721365,ABCA1;COL17A1;EFEMP1
Aplastic Anemia,2/155,0.45521163575878426,0.4725813716370322,0,0,1.3104575163398693,1.0313206754549795,KIT;CXCR4
Monocyte count procedure,2/155,0.45521163575878426,0.4725813716370322,0,0,1.3104575163398693,1.0313206754549795,THRB;FOXO1
Monocyte count result,2/155,0.45521163575878426,0.4725813716370322,0,0,1.3104575163398693,1.0313206754549795,THRB;FOXO1
"Hemorrhagic Fever, Ebola",1/61,0.4554659269521106,0.4725813716370322,0,0,1.6702199661590524,1.313518384672778,TLR4
Bradykinesia,1/61,0.4554659269521106,0.4725813716370322,0,0,1.6702199661590524,1.313518384672778,RGS2
Disorders of Sex Development,1/61,0.4554659269521106,0.4725813716370322,0,0,1.6702199661590524,1.313518384672778,SOX10
Hemiparesis,1/61,0.4554659269521106,0.4725813716370322,0,0,1.6702199661590524,1.313518384672778,TLR4
Hypernasal voice,1/61,0.4554659269521106,0.4725813716370322,0,0,1.6702199661590524,1.313518384672778,LIFR
MAJOR AFFECTIVE DISORDER 7,1/61,0.4554659269521106,0.4725813716370322,0,0,1.6702199661590524,1.313518384672778,NR3C1
Nasal voice,1/61,0.4554659269521106,0.4725813716370322,0,0,1.6702199661590524,1.313518384672778,LIFR
Reticulosarcoma,1/62,0.4608732953304373,0.47781980366068105,0,0,1.6427560955313305,1.2725316388995522,BCL6
Leber Congenital Amaurosis,1/62,0.4608732953304373,0.47781980366068105,0,0,1.6427560955313305,1.2725316388995522,MEF2C
Multiple polyps,1/62,0.4608732953304373,0.47781980366068105,0,0,1.6427560955313305,1.2725316388995522,CALR
Nijmegen Breakage Syndrome,1/62,0.4608732953304373,0.47781980366068105,0,0,1.6427560955313305,1.2725316388995522,PECAM1
Curvature of little finger,2/157,0.4617944907343906,0.4786817430701357,0,0,1.2934167215273207,0.9993394323316794,BMPR1B;FGFR3
"Blindness, Legal",2/158,0.4650685656148285,0.4819817942748777,0,0,1.2850601779173207,0.9838040746928887,FZD4;PROS1
Rheumatic Fever,1/63,0.4662272355021483,0.48271321896074376,0,0,1.6161781562141804,1.2332766761682552,MUC1
Thin face,1/63,0.4662272355021483,0.48271321896074376,0,0,1.6161781562141804,1.2332766761682552,TPM3
Kidney Calculi,1/63,0.4662272355021483,0.48271321896074376,0,0,1.6161781562141804,1.2332766761682552,SPP1
Narrow face,1/63,0.4662272355021483,0.48271321896074376,0,0,1.6161781562141804,1.2332766761682552,TPM3
Pallor of optic disc,1/63,0.4662272355021483,0.48271321896074376,0,0,1.6161781562141804,1.2332766761682552,KLC2
Autosomal dominant retinitis pigmentosa,1/64,0.47152827265030506,0.4876332553761839,0,0,1.5904439610023366,1.1956579419721822,TPM3
Chronic Fatigue Syndrome,1/64,0.47152827265030506,0.4876332553761839,0,0,1.5904439610023366,1.1956579419721822,NR3C1
Cortical Dysplasia,1/64,0.47152827265030506,0.4876332553761839,0,0,1.5904439610023366,1.1956579419721822,MAP1B
Extrapyramidal sign,1/64,0.47152827265030506,0.4876332553761839,0,0,1.5904439610023366,1.1956579419721822,RGS2
Nephronophthisis,1/64,0.47152827265030506,0.4876332553761839,0,0,1.5904439610023366,1.1956579419721822,MUC1
Oligohydramnios,1/64,0.47152827265030506,0.4876332553761839,0,0,1.5904439610023366,1.1956579419721822,LIFR
Rhabdomyolysis,1/65,0.47677692695547874,0.49267873642539195,0,0,1.565513959390863,1.159586453002292,DMD
Syndactyly of the toes,1/65,0.47677692695547874,0.49267873642539195,0,0,1.565513959390863,1.159586453002292,FLI1
Familial Nonmedullary Thyroid Cancer,1/65,0.47677692695547874,0.49267873642539195,0,0,1.565513959390863,1.159586453002292,ZEB2
Limitation of joint mobility,1/65,0.47677692695547874,0.49267873642539195,0,0,1.565513959390863,1.159586453002292,BMPR1B
Heartburn,2/162,0.4780470441699423,0.49389544365677057,0,0,1.2526785714285715,0.9245345749935645,COL1A2;CAV1
Low Vision,3/261,0.4792066053884076,0.4949974801540656,0,0,1.1654144305307097,0.8573061818249758,ABCA1;COL17A1;EFEMP1
Shigella Infections,1/66,0.48197371337921646,0.49747005977103326,0,0,1.54135103475205,1.1249792565126313,EZR
Dentatorubral-Pallidoluysian Atrophy,1/66,0.48197371337921646,0.49747005977103326,0,0,1.54135103475205,1.1249792565126313,VWF
GRN-related frontotemporal dementia,1/66,0.48197371337921646,0.49747005977103326,0,0,1.54135103475205,1.1249792565126313,CCL2
Pulmonary Stenosis,1/66,0.48197371337921646,0.49747005977103326,0,0,1.54135103475205,1.1249792565126313,ZEB2
Blindness,2/164,0.48446439995477636,0.4999439944537186,0,0,1.2370874275636181,0.8965312727990068,FZD4;PROS1
Short distal phalanx of finger,1/67,0.4871191419956142,0.5020030763284912,0,0,1.5179203199507767,1.0917589397373917,RPS6KA3
Toxic Epidermal Necrolysis,1/67,0.4871191419956142,0.5020030763284912,0,0,1.5179203199507767,1.0917589397373917,CAV1
West Syndrome,1/67,0.4871191419956142,0.5020030763284912,0,0,1.5179203199507767,1.0917589397373917,NR3C1
Wide nose,1/67,0.4871191419956142,0.5020030763284912,0,0,1.5179203199507767,1.0917589397373917,RPS6KA3
Aplasia/Hypoplasia of the cerebellum,1/67,0.4871191419956142,0.5020030763284912,0,0,1.5179203199507767,1.0917589397373917,FGFR3
Pustulosis of Palms and Soles,1/67,0.4871191419956142,0.5020030763284912,0,0,1.5179203199507767,1.0917589397373917,PPARG
Pyramidal sign,1/67,0.4871191419956142,0.5020030763284912,0,0,1.5179203199507767,1.0917589397373917,SOX10
Cerebellar Ataxia,6/565,0.4889619286071603,0.5038047404384295,0,0,1.0757491055456172,0.7696669097885465,SNAP25;CCND1;SOX10;CTSD;SPTBN1;SYNE1
Restless Legs Syndrome,1/68,0.4922137176728752,0.5068612370007249,0,0,1.4951890294719297,1.059853187664649,TF
Short palpebral fissure,1/68,0.4922137176728752,0.5068612370007249,0,0,1.4951890294719297,1.059853187664649,LIFR
Low posterior hairline,1/68,0.4922137176728752,0.5068612370007249,0,0,1.4951890294719297,1.059853187664649,RPS6KA3
"Ataxias, Hereditary",2/167,0.4939988217634718,0.5086011826077167,0,0,1.2144094001236858,0.8564284043601353,SNAP25;SYNE1
Epileptic encephalopathy,5/468,0.49494954705790006,0.5094815793454799,0,0,1.0820958157544287,0.761037388543786,ZEB2;MEF2C;CCND2;CTSD;FGFR3
Growth retardation,2/168,0.4971522469118917,0.5113638682486332,0,0,1.2070322104745512,0.843545284931886,DST;KRT5
Poor growth,2/168,0.4971522469118917,0.5113638682486332,0,0,1.2070322104745512,0.843545284931886,DST;KRT5
Bowed and upward slanting eyebrows,1/69,0.4972579405637863,0.5113638682486332,0,0,1.4731263063601074,1.029194379515607,RPS6KA3
Highly arched eyebrow,1/69,0.4972579405637863,0.5113638682486332,0,0,1.4731263063601074,1.029194379515607,RPS6KA3
Progressive supranuclear palsy,1/69,0.4972579405637863,0.5113638682486332,0,0,1.4731263063601074,1.029194379515607,SPP1
Cleft upper lip,2/169,0.5002932028626188,0.5142867434519475,0,0,1.199743370402053,0.8308954044067238,F13A1;FGFR3
Growth delay,2/169,0.5002932028626188,0.5142867434519475,0,0,1.199743370402053,0.8308954044067238,DST;KRT5
Deformity of face,1/70,0.5022523058176744,0.5159025708755565,0,0,1.4517030824689179,0.9997192245802698,GHR
Distortion of face,1/70,0.5022523058176744,0.5159025708755565,0,0,1.4517030824689179,0.9997192245802698,GHR
Funny looking face,1/70,0.5022523058176744,0.5159025708755565,0,0,1.4517030824689179,0.9997192245802698,GHR
Knee joint valgus deformity,1/70,0.5022523058176744,0.5159025708755565,0,0,1.4517030824689179,0.9997192245802698,LIFR
"Leukemia, Myeloid, Chronic-Phase",1/71,0.5071973037574192,0.5208815632536687,0,0,1.430891950688905,0.9713684296427824,CXCL12
alpha^+^ Thalassemia,1/72,0.5120934198937148,0.5256059003493078,0,0,1.4106670479731178,0.9440863965597768,ABCA1
MAJOR AFFECTIVE DISORDER 4,1/72,0.5120934198937148,0.5256059003493078,0,0,1.4106670479731178,0.9440863965597768,NR3C1
MAJOR AFFECTIVE DISORDER 6,1/72,0.5120934198937148,0.5256059003493078,0,0,1.4106670479731178,0.9440863965597768,NR3C1
"Infant, Small for Gestational Age",3/275,0.513953190941838,0.5274131628209233,0,0,1.1046380090497738,0.7352725603645731,LIFR;PIK3R1;FGFR3
Chorea,1/73,0.5169411349805915,0.5299690858621724,0,0,1.3910039481105472,0.9178209463511099,CXCL10
Congenital small ears,1/73,0.5169411349805915,0.5299690858621724,0,0,1.3910039481105472,0.9178209463511099,FGFR3
Difficulty speaking,1/73,0.5169411349805915,0.5299690858621724,0,0,1.3910039481105472,0.9178209463511099,SNAP25
Long QT Syndrome,1/73,0.5169411349805915,0.5299690858621724,0,0,1.3910039481105472,0.9178209463511099,ANK2
Problems speaking,1/73,0.5169411349805915,0.5299690858621724,0,0,1.3910039481105472,0.9178209463511099,SNAP25
Intrauterine retardation,3/278,0.5212399206097941,0.5342734250682041,0,0,1.0924195804195804,0.7117603440317687,LIFR;PIK3R1;FGFR3
Thick eyebrow,1/74,0.5217409250967877,0.5344785447598581,0,0,1.3718795633127043,0.8925230671939328,RPS6KA3
MAJOR AFFECTIVE DISORDER 1,1/74,0.5217409250967877,0.5344785447598581,0,0,1.3718795633127043,0.8925230671939328,NR3C1
Photoreceptor degeneration,1/74,0.5217409250967877,0.5344785447598581,0,0,1.3718795633127043,0.8925230671939328,CCL2
Endometrial Hyperplasia,1/75,0.5264932617585523,0.5391396218123222,0,0,1.353272053779668,0.8681466839460674,ESR1
Impaired exercise tolerance,1/75,0.5264932617585523,0.5391396218123222,0,0,1.353272053779668,0.8681466839460674,DMD
Retinal Dystrophies,2/178,0.5279910685516253,0.5405695301271107,0,0,1.1378710575139146,0.7267308343047355,EFEMP1;FZD4
Respiration Disorders,1/76,0.5311986116109761,0.5429147298187366,0,0,1.335160744500846,0.8446484482402136,MUC1
Systemic arterial pressure,1/76,0.5311986116109761,0.5429147298187366,0,0,1.335160744500846,0.8446484482402136,TGFBR2
Amphetamine-Related Disorders,1/76,0.5311986116109761,0.5429147298187366,0,0,1.335160744500846,0.8446484482402136,FOS
Amphetamine Abuse,1/76,0.5311986116109761,0.5429147298187366,0,0,1.335160744500846,0.8446484482402136,FOS
Blood Pressure,1/76,0.5311986116109761,0.5429147298187366,0,0,1.335160744500846,0.8446484482402136,TGFBR2
Blood pressure finding,1/76,0.5311986116109761,0.5429147298187366,0,0,1.335160744500846,0.8446484482402136,TGFBR2
Inflammatory pain,1/76,0.5311986116109761,0.5429147298187366,0,0,1.335160744500846,0.8446484482402136,TLR4
Nonverbal,1/76,0.5311986116109761,0.5429147298187366,0,0,1.335160744500846,0.8446484482402136,ZEB2
Poor speech,1/76,0.5311986116109761,0.5429147298187366,0,0,1.335160744500846,0.8446484482402136,SNAP25
Recurrent otitis media,1/77,0.5358574369263035,0.5473613727008378,0,0,1.3175260486240983,0.821987544086677,FGFR3
Amphetamine Addiction,1/77,0.5358574369263035,0.5473613727008378,0,0,1.3175260486240983,0.821987544086677,FOS
PANIC DISORDER 1,1/77,0.5358574369263035,0.5473613727008378,0,0,1.3175260486240983,0.821987544086677,RGS2
Photodysphoria,2/181,0.5369914756032313,0.5484146365445802,0,0,1.118629574734922,0.6955337322449517,COL17A1;TLR4
Sicca Syndrome,1/78,0.5404701953926593,0.5513333980182774,0,0,1.3003493967960973,0.8001255112715814,TGFBR2
Sudden infant death syndrome,1/78,0.5404701953926593,0.5513333980182774,0,0,1.3003493967960973,0.8001255112715814,FOS
Thick lower lip vermilion,1/78,0.5404701953926593,0.5513333980182774,0,0,1.3003493967960973,0.8001255112715814,RPS6KA3
Dyskinetic syndrome,1/78,0.5404701953926593,0.5513333980182774,0,0,1.3003493967960973,0.8001255112715814,MEF2C
Full lower lip,1/78,0.5404701953926593,0.5513333980182774,0,0,1.3003493967960973,0.8001255112715814,RPS6KA3
Protruding ear,1/78,0.5404701953926593,0.5513333980182774,0,0,1.3003493967960973,0.8001255112715814,RPS6KA3
Spinocerebellar Ataxia Type 1,1/79,0.5450373402761145,0.5557795611043655,0,0,1.283613171938045,0.7790260822318089,MME
Lysosomal Storage Diseases,1/79,0.5450373402761145,0.5557795611043655,0,0,1.283613171938045,0.7790260822318089,CAV2
Abnormality of the fingernails,1/80,0.5495593203888742,0.5599620685186063,0,0,1.2673006489751333,0.7586550325138808,BMPR1B
Abnormality of the metaphysis,1/80,0.5495593203888742,0.5599620685186063,0,0,1.2673006489751333,0.7586550325138808,FGFR3
Dandy-Walker Syndrome,1/80,0.5495593203888742,0.5599620685186063,0,0,1.2673006489751333,0.7586550325138808,LAMC1
Prominent ear,1/80,0.5495593203888742,0.5599620685186063,0,0,1.2673006489751333,0.7586550325138808,RPS6KA3
Multicystic Dysplastic Kidney,1/81,0.554036579997623,0.564416160353151,0,0,1.2513959390862943,0.7389800432450613,MYLK
Thalassemia,1/82,0.5584695592402922,0.5686060911714782,0,0,1.2358839380835998,0.7199705732655993,PPP1R15A
Absent speech,1/82,0.5584695592402922,0.5686060911714782,0,0,1.2358839380835998,0.7199705732655993,ZEB2
Non-medullary thyroid carcinoma,1/82,0.5584695592402922,0.5686060911714782,0,0,1.2358839380835998,0.7199705732655993,ZEB2
Long philtrum,2/190,0.5632814825751873,0.573395801460014,0,0,1.0645896656534954,0.6110487121854885,MAF;FLI1
Kyphoscoliosis deformity of spine,1/84,0.5672044153065768,0.5772789016747035,0,0,1.2059812855482845,0.6838342246417898,RPS6KA3
"Hip Dislocation, Congenital",1/85,0.5715071508482795,0.5813249869957017,0,0,1.1915639352187575,0.6666541450436337,FHL1
"Malformations of Cortical Development, Group II",1/85,0.5715071508482795,0.5813249869957017,0,0,1.1915639352187575,0.6666541450436337,DMD
Hyperopia,1/85,0.5715071508482795,0.5813249869957017,0,0,1.1915639352187575,0.6666541450436337,HGF
Acquired Hypogammaglobulinemia,1/86,0.575767323420109,0.5848768712363249,0,0,1.1774858166616902,0.6500329906392318,BCL6
Headache,1/86,0.575767323420109,0.5848768712363249,0,0,1.1774858166616902,0.6500329906392318,VWF
Irritation - emotion,1/86,0.575767323420109,0.5848768712363249,0,0,1.1774858166616902,0.6500329906392318,TGFBR2
Leukoencephalopathies,1/86,0.575767323420109,0.5848768712363249,0,0,1.1774858166616902,0.6500329906392318,SPP1
Muscle Cramp,1/86,0.575767323420109,0.5848768712363249,0,0,1.1774858166616902,0.6500329906392318,DMD
Muscular hypotonia of the trunk,1/86,0.575767323420109,0.5848768712363249,0,0,1.1774858166616902,0.6500329906392318,SOX10
Myocardial Reperfusion Injury,1/86,0.575767323420109,0.5848768712363249,0,0,1.1774858166616902,0.6500329906392318,CCL2
Gait abnormality,2/195,0.5774209184876817,0.58644483983626,0,0,1.0367452680554088,0.5693636889884579,RPS6KA3;TLR4
Adrenal Gland Neoplasms,1/87,0.5799853520992417,0.5888249078561362,0,0,1.1637350962106008,0.6339475224236494,LEP
Dysmorphic facies,1/87,0.5799853520992417,0.5888249078561362,0,0,1.1637350962106008,0.6339475224236494,GHR
Profound Mental Retardation,2/196,0.5802085808177078,0.5889393385100122,0,0,1.031348621922996,0.5614327926342166,MEF2C;FGFR3
"Myoclonic Epilepsies, Progressive",1/88,0.5841616516113389,0.5926132574598943,0,0,1.1503004842756286,0.6183756974104047,SNAP25
Atypical scarring of skin,1/88,0.5841616516113389,0.5926132574598943,0,0,1.1503004842756286,0.6183756974104047,TGFBR2
Facial muscle weakness of muscles innervated by CN VII,1/88,0.5841616516113389,0.5926132574598943,0,0,1.1503004842756286,0.6183756974104047,TPM3
Non-obstructive azoospermia,1/89,0.5882966327203135,0.5966944719768845,0,0,1.1371712044300877,0.6032965943094887,SIRPA
Age at menarche,1/90,0.592390702164663,0.6007326454491893,0,0,1.1243369645810757,0.58869034541816,DST
Nonsyndromic Deafness,1/91,0.5964442626887184,0.6047282107816172,0,0,1.1117879300620417,0.574538073155522,CIB1
Generalized hypotonia,6/633,0.6002276365265697,0.6083344397271914,0,0,0.9556917862838915,0.48782933768906495,RPS6KA3;ZEB2;MEF2C;COL1A2;DMD;LIFR
Stereotypic Movement Disorder,1/92,0.6004577130728141,0.6083344397271914,0,0,1.0995146984994701,0.5608218310496504,MEF2C
Bell Palsy,1/92,0.6004577130728141,0.6083344397271914,0,0,1.0995146984994701,0.5608218310496504,TPM3
Facial Paresis,1/92,0.6004577130728141,0.6083344397271914,0,0,1.0995146984994701,0.5608218310496504,TPM3
Edema,1/93,0.6044314482795703,0.6122439056988843,0,0,1.0875082763186934,0.5475245486104855,TIMP1
Macroglossia,1/94,0.6083658592709782,0.6161120608238393,0,0,1.0757600567654604,0.5346299805772539,THRB
Agenesis,1/95,0.6122613332929504,0.6199393207520678,0,0,1.0642617993303813,0.5221226587890779,COL1A2
Smoking Behaviors,2/209,0.6152239082104353,0.6228207079888696,0,0,0.9659370994774722,0.4692222979537208,TCF7L2;EFEMP1
Leigh Disease,1/99,0.6274614713313367,0.6347270654374891,0,0,1.0206153527400808,0.4756812696365203,GHR
Malformations of Cortical Development,1/99,0.6274614713313367,0.6347270654374891,0,0,1.0206153527400808,0.4756812696365203,CCND2
Nephrolithiasis,1/99,0.6274614713313367,0.6347270654374891,0,0,1.0206153527400808,0.4756812696365203,SPP1
Palmoplantar Keratosis,1/99,0.6274614713313367,0.6347270654374891,0,0,1.0206153527400808,0.4756812696365203,KRT5
Skeletal muscle atrophy,2/215,0.630618500021988,0.6376785553353272,0,0,0.9384401647983137,0.43267177485631314,FHL1;DMD
"Neurogenic muscle atrophy, especially in the lower limbs",2/215,0.630618500021988,0.6376785553353272,0,0,0.9384401647983137,0.43267177485631314,FHL1;DMD
Mood swings,1/100,0.6311679368829785,0.6381130593150052,0,0,1.010254832589858,0.4649024106032371,LEPR
Sunken eyes,1/103,0.6420686222871914,0.6488874811622308,0,0,0.9803921568627451,0.43437263990835,PIK3R1
Hydrops Fetalis,1/103,0.6420686222871914,0.6488874811622308,0,0,0.9803921568627451,0.43437263990835,CD36
Xerosis,1/104,0.6456304733483079,0.6521161471707985,0,0,0.9708245034744468,0.42476286602560065,ABCA1
Enophthalmos,1/104,0.6456304733483079,0.6521161471707985,0,0,0.9708245034744468,0.42476286602560065,PIK3R1
Macrostomia,1/104,0.6456304733483079,0.6521161471707985,0,0,0.9708245034744468,0.42476286602560065,RPS6KA3
Tremor,2/226,0.6575947873046939,0.6640747814187442,0,0,0.8918549562682215,0.3738355975573547,SREBF1;MME
Reduced visual acuity,1/108,0.6595286584316571,0.6655232381712366,0,0,0.934342236348973,0.38890113167083573,FZD4
"Leukemia, Myelomonocytic, Chronic",1/108,0.6595286584316571,0.6655232381712366,0,0,0.934342236348973,0.38890113167083573,KIT
Long face,1/108,0.6595286584316571,0.6655232381712366,0,0,0.934342236348973,0.38890113167083573,TPM3
Physical aggression,1/108,0.6595286584316571,0.6655232381712366,0,0,0.934342236348973,0.38890113167083573,LEPR
Neurogenic Muscular Atrophy,2/228,0.6623277252290805,0.6682212131286955,0,0,0.883872132923966,0.36415071584799563,FHL1;DMD
Dry skin,1/110,0.6662730008463877,0.6719471653123391,0,0,0.9171052018814325,0.3723958692398915,ABCA1
Polymicrogyria,1/110,0.6662730008463877,0.6719471653123391,0,0,0.9171052018814325,0.3723958692398915,CCND2
"Diabetes, Autoimmune",1/111,0.6695951566037892,0.6747867983248095,0,0,0.9087217351176742,0.36447192469516754,TCF7L2
Umbilical hernia,1/111,0.6695951566037892,0.6747867983248095,0,0,0.9087217351176742,0.36447192469516754,THRB
Hydronephrosis,1/111,0.6695951566037892,0.6747867983248095,0,0,0.9087217351176742,0.36447192469516754,EGR1
Kartagener Syndrome,1/111,0.6695951566037892,0.6747867983248095,0,0,0.9087217351176742,0.36447192469516754,PPARG
Aggressive behavior,1/112,0.6728844064272897,0.6779733412461764,0,0,0.9004893218091188,0.3567574108246512,LEPR
Obsessive-Compulsive Disorder,1/114,0.6793654823166962,0.6842446900899025,0,0,0.8844616144827276,0.3419293494427533,ESR1
Posteriorly rotated ear,1/114,0.6793654823166962,0.6842446900899025,0,0,0.8844616144827276,0.3419293494427533,FHL1
Pancytopenia,1/116,0.6857187849837366,0.6903826573168963,0,0,0.8689913926285588,0.32785973753884723,ALDH2
Primary microcephaly,1/116,0.6857187849837366,0.6903826573168963,0,0,0.8689913926285588,0.32785973753884723,ZEB2
Diastolic blood pressure,1/117,0.688848306579426,0.6934024604763432,0,0,0.8614563276737266,0.3210942323948353,TCF7L2
Subclinical abnormal liver function tests,1/118,0.691946820869215,0.6956016993797485,0,0,0.8540500672480368,0.3145006703281603,DMD
Systolic Pressure,1/118,0.691946820869215,0.6956016993797485,0,0,0.8540500672480368,0.3145006703281603,TCF7L2
Transaminases increased,1/118,0.691946820869215,0.6956016993797485,0,0,0.8540500672480368,0.3145006703281603,DMD
Elevated liver enzymes,1/118,0.691946820869215,0.6956016993797485,0,0,0.8540500672480368,0.3145006703281603,DMD
Increased liver function tests,1/118,0.691946820869215,0.6956016993797485,0,0,0.8540500672480368,0.3145006703281603,DMD
Liver enzymes abnormal,1/118,0.691946820869215,0.6956016993797485,0,0,0.8540500672480368,0.3145006703281603,DMD
Liver function tests abnormal finding,1/118,0.691946820869215,0.6956016993797485,0,0,0.8540500672480368,0.3145006703281603,DMD
Elevated hepatic transaminases,1/119,0.6950146336739874,0.6985539386738361,0,0,0.8467693366600706,0.30807363367521096,DMD
Upward slant of palpebral fissure,1/124,0.7099036646533924,0.7133842407953853,0,0,0.8121414716685238,0.27826078528453674,MEF2C
Thin upper lip vermilion,1/125,0.7127935214761938,0.7161532194469526,0,0,0.8055510070411004,0.2727301616902763,MAF
Dystonia,2/251,0.7130510021927096,0.7162768691206314,0,0,0.8012867797721498,0.2709970553554665,GSN;DST
"Spastic Paraplegia, Hereditary",1/126,0.7156547340556769,0.7187568936642862,0,0,0.7990659898477157,0.2673334746158674,ZEB2
Congenital Epicanthus,2/255,0.7211942424317751,0.7241839302654852,0,0,0.7884568847301766,0.25770458684823444,RPS6KA3;FLI1
Large auricle,1/134,0.7375465690103099,0.7401856245303092,0,0,0.7506965383000649,0.22853158065790288,PIK3R1
Large pinnae,1/134,0.7375465690103099,0.7401856245303092,0,0,0.7506965383000649,0.22853158065790288,PIK3R1
Macrotia,1/134,0.7375465690103099,0.7401856245303092,0,0,0.7506965383000649,0.22853158065790288,PIK3R1
"Mental Retardation, Psychosocial",1/138,0.7478551468476323,0.7503897717098537,0,0,0.7286301826670125,0.2117005658960412,MEF2C
Abnormally small eyeball,1/145,0.7649350449493618,0.7670942518884362,0,0,0.6929639029892837,0.185689626912882,YAP1
Babinski Reflex,1/145,0.7649350449493618,0.7670942518884362,0,0,0.6929639029892837,0.185689626912882,CAV1
Decreased size of eyeball,1/145,0.7649350449493618,0.7670942518884362,0,0,0.6929639029892837,0.185689626912882,YAP1
Strabismus,3/404,0.7662706307055578,0.7682890293565225,0,0,0.7443314789948207,0.1981558279712305,ZBTB16;FGFR3;FLI1
"Low-set, posteriorly rotated ears",1/149,0.7741728961594803,0.7760660954916986,0,0,0.6740979558238441,0.1725421466710422,FLI1
Anxiety disease,1/157,0.791578815660227,0.7933653392238762,0,0,0.6392685149030327,0.1494135623408729,TGFBR2
Movement Disorders,1/169,0.8152160993631751,0.8169023304825799,0,0,0.5932438965433889,0.1212009432024149,RGS2
Small head,4/570,0.8194035913797526,0.8209441132661593,0,0,0.700739499471786,0.139572264076798,RPS6KA3;ZBTB16;CTSD;FGFR3
Azoospermia,1/174,0.8242592887014091,0.8256537123101145,0,0,0.5759514098764708,0.111314202603199,ESR1
Conductive hearing loss,1/181,0.8361846212127936,0.8374418053830064,0,0,0.553355893965031,0.09899860739647633,FGFR3
Global developmental delay,8/1102,0.8594837449451737,0.8606142196190963,0,0,0.720023092466083,0.10902832066222243,SNAP25;MUC1;MEF2C;CCND2;DMD;SOX10;FGFR3;FLI1
Muscle Spasticity,2/353,0.8671967499328784,0.8681742401638755,0,0,0.5654689226117797,0.08057332528207994,SOX10;CTSD
Leukodystrophy,1/204,0.8699812220813703,0.8707982592921906,0,0,0.4900852691855668,0.06826086578018564,SOX10
Nystagmus,3/500,0.8755468890046573,0.8762045768086043,0,0,0.5975855130784709,0.07942304193667099,CAV1;SOX10;SYNE1
Optic Atrophy,2/363,0.8772829798270433,0.8777771309610052,0,0,0.5495223019955905,0.07194657593485475,VCAN;KLC2
Mitochondrial Diseases,2/384,0.89621231826511,0.8965487974534958,0,0,0.5187520034191687,0.05684377161489394,C3;ALDH2
Cognitive delay,6/966,0.9207095563878033,0.9208823622354736,0,0,0.6133463541666667,0.05066894053993573,SNAP25;CCND2;DMD;SOX10;FGFR3;FLI1
Mental and motor retardation,6/1021,0.9424379387159356,0.9424379387159356,0,0,0.5784174876847291,0.0342916018457717,SNAP25;CCND2;DMD;SOX10;FGFR3;FLI1